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Oliver Russell Grace
(1909-1992)
FABtAN PACHRACH
On January 16, 1992, we suffered a grievous loss with the passing of Oliver Rus-
sell Grace. In his 82 years, Oliver lived at least three lives: he was a dedicated,
loving husband and father; a successful businessman; and a generous and
thoughtful philanthropist. It was in this last capacity that the Laboratory and I ini-
tially became acquainted with him. My first visit with him was in 1977, soon after
he and his wife Lorraine moved to Oyster Bay. They had long been friends with
Franz and Betty Schneider who brought us all together for a Sunday lunch at the
Piping Rock Club. The Schneiders knew of Oliver's dedication to cancer research
and wanted to interest him in our Laboratory, of which Betty was then a trustee.
Later, his fiscal, intellectual, and moral support would help make possible the
substantive changes that have so enlarged this Laboratory's potential to promote
science.
Oliver's generosity and intelligence go back well before his association with
the Laboratory. In fact, they go back at least six generations. The Grace family
genealogy, which traces to William the Conqueror, credits John Grace of Shef-
field (1706-1780) with being "the ancestor of that branch of the family whose su-
perior business capacities, rare political integrity, and far-reaching generosity ac-
quired fame and fortune in North and South America." His great-grandson, James
Grace, lived in Ireland, having married a well-to-do woman named Ellen Russell.
They emigrated from Ireland to Peru during the potato famine of the 19th century.
The oldest of their sons, William Russell, and the youngest, Michael Paul, came to
the United States and went into business together in the firm of Bryce, Grace,
and Company, which would ultimately become W.R. Grace and Company, a
major New York trading and shipping firm. W.R. Grace had a reputation for being
tough, fair, and concerned for the underpriviledged. On these strengths, he was
twice elected mayor of New York City, serving from 1880 to 1882 and 1884 to
1886.
Another brother, Morgan S. Grace, Count of the Holy Roman Empire, was
trained as a physician and went off to Auckland to the New Zealand war. He be-
came surgeon general of New Zealand and was awarded the prestigious Cross
of St. Michael and St. George. Morgan fathered ten children, one of whom was
Oliver's father, Morgan H. Grace. The younger Morgan Grace was born in Wel-
lington, New Zealand, and emigrated to the United States, where his eldest son,
Oliver Russell Grace, was born in 1909, in Great Neck, New York. Unlike his
younger siblings, Oliver had dual citizenship because his father had not yet relin-
quished his allegiance to the Queen.
Oliver's childhood was a happy one and he adored his parents. His mother,
in particular, was enthusiastic about her son's sports endeavors and was the one
who taught him to play bridge, a game he continued to enjoy throughout his life.
He went to school at St. Paul's for one year, but found the other boys cruel and
was not happy there. He transferred to Phillips Academy at Andover, Massachu-
setts, where he flourished. He was a bright and sociable student. At the age of
13, he got into a game involving slingshots and rocks and took an irreparable
blow to his eye, which had to be removed. He lived out his childhood and early
adulthood with a glass eye, which did not stop him from enjoying tennis and sail-
ing, but which later prevented his serving in the military during World War II. In-
stead, Oliver served without pay in Washington, D.C. on the War Production
Board, which was responsible for allocating scarce resources during the war.
At one point in his schooling, Oliver's grades began to slip. The headmaster
called the boy in saying, "When we see somebody of your caliber falling behind
in his work, we smell a rat." It came out that he had fallen in with a card-playing
group at school and was spending his study time playing bridge instead of
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studying algebra. While on academic probation
for this episode, Oliver pro-
ceeded to win a school prize for having the
most greatly improved grades in his
class. He finished Andover two years early.
Oliver matriculated at Yale at age 16. He was
young for his class and was a
late-bloomer, and so must have seemed still a boy among his collegiate peers.
Nevertheless, he did well at Yale, graduating with honors in 1930. He took a job
at Grace National Bank, a subsidiary of W.R. Grace
and Co. run by his father's
cousin, Joseph Grace. It was here that Oliver began to learn the complexities of
finance, managing trusts and investments for the Grace bank. In addition to
managing the investments of the bank's clients, he began investing his own
money and accumulating his own fortune. He left in 1936 because, as he put it,
he realized that "working for a bank put unacceptble limits on economic free-
dom." He joined his childhood friend Duncan Sterling, Jr., in an investment firm
with Sterling's father. Sterling, Grace & Co. became a major force in New York in-
vesting and secured Oliver's ability to take on major philanthropic projects.
At the age of 24, Oliver married Anne Chilton McDonnell. They had three
daughters, Helen, Anne, and Ruth, and were married ten years, divorcing in
1944. In 1949, Oliver married Lorraine Graves, with whom he would have four
children and to whom he would be married 42 years, until his death. He was a
loving and caring father, taking particular pleasure in initiating his two sons
Oliver, Jr., and John very early into the world of business and finance. Later, they
went into business for themselves and, in the family tradition, work on some
projects together. When only eight, Oliver, Jr., would listen with rapt attention to
his father explain details of business and finance that no one else in the family
was interested in.
Despite the lack of depth perception resulting from the loss of his eye, he was
an excellent tennis player and sailor and won championships at the
numerous clubs to which he belonged. Here he frequently played tennis at the
Piping Rock Club in Locust Valley and the even nearer to his home Cove Neck
Tennis Club. In his later years, he sailed at the Sewanaka Yacht Club on Center
Island, having earlier spent many summers in the Hamptons and Martha's
Vineyard sailing with his children.
In both his business and his personal life, Oliver was a man of principle, and
one who respected the principles of others. He had a reputation as a tough, fair
businessman, with a flair for identifying undervalued stocks and burgeoning ex-
perimental industries. He was one of the first to invest in geothermal energy,
owning at one point one million acres of geothermal federal land. Oliver initiated
exploratory operations on this land and later owned a geothermal vegetable
dehydration plant and a geothermal mushroom-growing facility. In 1964, Oliver
was one of the first Americans to invest in Japan, setting a very lucrative trend.
His business ventures ranged widely, from Long Island real estate (he once
owned Roosevelt Field), to an oil concession in the Ecuadorian Andes, to a Flor-
ida bus company, to trading in stocks and bonds, to a Panamanian shrimp fleet.
Tough as he was, Oliver's kindness was famous among his family and
friends. He was always concerned about others troubles-even when he dis-
approved of those troubles. Lorraine was reminded of a father of the Old West
when Oliver rode horses with his children if one wanted to ride off through the
bushes, Oliver rode along with them and scooped them up when they fell. He
was always riding at their side, a little behind but keeping up.
Lorraine and Oliver were totally devoted to one another, and she often in-
fluenced him in subtle ways that affected his business life. It was she who con-
vinced him to replace the glass eye with an eyepatch. Lorraine and Oliver made
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the patches at home, and they became an instant trademark. Oliver would
remark to her that the patch increased his recognition on Wall Street so dramati-
cally that people he did not recall addressed him by name. The Graces moved
into an apartment on New York's Upper East Side, where Lorraine still lives. Their
weekdays were spent in New York, but they also had a house in Greenwich, Con-
necticut, where they spent weekends. In 1976 they sold this house and bought a
house in Oyster Bay that had been built by James Alfred Roosevelt, uncle of
Theodore. Named Yellowbanks, the house was built a few years before 1882
Sagamore Hill, the Theodore Roosevelt home. Yellowbanks was passed along to
sons for three generations, but when, in 1974, James Alfred's grandson, John
Kean Roosevelt, died, the Graces purchased the lovely home that looked
westward over Oyster Bay.
In 1953, the Graces' New York apartment became the site of a series of
portentous meetings that gathered together groups of unconventional doctors
bringing photographic slides and cancer patients. The woman who first brought
them together was Helen Coley Nauts, a childhood friend of Oliver Grace. Her
passionate interest was a then-unorthodox form of treatment for cancer, first con-
ceived by her father Dr. William B. Coley. Coley discovered that small amounts of
certain toxins found in bacteria could stimulate the immune system into fighting
off certain cancerous tumors. He died without his ideas gaining wide accep-
tance, but his daughter felt his findings were prescient. Without formal medical
training, she digested thousands of medical articles as well as her father's writ-
ings, synthesizing his concepts and publishing her own articles in medical jour-
nals. She was already a professional-caliber scholar on immunological cancer re-
search when, in 1953, she first enlisted Oliver's help in forming the Cancer Re-
search Institute (CRI).
Those early meetings in the Grace livingroom were the beginnings of a far-
seeing medical institute. With the exception, however, of the prevailing treatment
for superficial bladder cancer, major clinical applications of the Coley approach
have yet to be realized. But through the research done to understand its basis,
the relationship between the immune system and cancer has become a well-
respected and fertile area of basic research, giving rise to such mainstream
fields, of study as the function of cytokines, intercellular immune system mes-
senger molecules.
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Oliver's support of Helen, adding his name and prestige
to her cause and
bringing many other respected names to
the board, helped to quickly establish
CRI as a very serious, dedicated effort. Oliver
later worked closely with Dr. Lloyd
Old, who became chairman of CRT's
Scientific Advisory Council, and whose
scientific daring led in the mid 1970s to
the discovery of the important cytokine
tumor necrosis factor.
Oliver personally supported several programs
that are now integral to the CRI
operation. He backed their core Fellowship
Program, which supports postdoc-
toral students in immunological and cancer
research. He was also interested in
public education. He pushed for the establishment
of an "800" number, which the
public could use to obtain information about cancer or its treatment or to donate
support for cancer research. Skeptics initially criticized this idea, but it has turned
out to be a valuable link between the Institute and the public. Today, CRI is a
major funder of cancer and immunology research. Known in philanthropy circles
for their administrative efficiency, a full 85% of their more than $5 million annual
budget goes toward program support. In 1991, CRI funded 96 postdoctoral fel-
lows, 20 established investigators, and 21 institutional grants. They also
sponsored two workshops and three scientific conferences.
This long-standing interest in cancer research prepared Oliver for a call in the
early 1980s from his friend Ed Pulling. Pulling was the vice-chairman of our board
as well as chairman of the Long Island Biological Association, our community
support group then mounting a drive to raise funds for a new auditorium in which
to hold our ever-swelling meetings. Oliver liked the plans and soon made the
major gifts making possible the Oliver and Lorraine Grace Auditorium, with its im-
posing outside terrace carved out of the hillside to the north. Later, he supported
the Laboratory in other ways, most notably in establishing the Oliver R. Grace
Professorship for Cancer of which I am the first recipient. He joined the
Laboratory's board of trustees in 1983 and immediately became one of its most
active members, later serving as the board's secretary as well as a member of
the board's committees.
Everyone who knew him well remembers Oliver Grace as a man of integrity,
intelligence, discipline, and compassion. From his family life, to his Wall Street
transactions, to his philanthropy with the Cancer Research Institute and Cold
Spring Harbor Laboratory, Oliver Grace lived up to the Latin motto of his ancient
Irish lineage: Concordant Nomine Acta-"Our deeds bear out our name."
In 1990, we celebrated his 80th birthday at our annual trustee dinner at
Robertson House. At that event, I took great pleasure in presenting him with a
rare reprint of my original 1953 paper with Francis Crick on the double helix.
Then Oliver seemed in peak form, a condition that suddenly changed for the
worse when he suffered a seizure several weeks later. This cruel blow did not
stop him, and he pursued every possible medical lead that might hasten his
recovery. Happily, his strength returned, and on the day before he died in his
sleep, he had not only played tennis, but was also on the dance floor in Palm
Beach.
His death leaves a gaping hole in the lives of his wife Lorraine and his chil-
dren-Anne, Helen, Ruth, Lori, Wendy, Oliver, Jr., and John. I personally feel the
deep lament that comes from the loss of an invaluable friend and supporter.
James D. Watson
Elinor Montgomery
(1937-1992)
Elinor Montgomery, who died much too prematurely at the age of 54 on March
18, 1992, was a compassionately intelligent woman, embodying so well the
heritage of public service and decency that long has been the hallmark of Oyster
Bay's North Shore families. Her father Alexander M. White was the noted invest-
ment banker and supporter of Harvard University, and her mother Posy was a
LIBA member for more than 25 years, serving on both the LIBA and Laboratory
boards. I first appreciated Elinor's warmth and wit at the Symposium dinner
parties given each year by her mother at her family's Georgian home to whose
grounds had been moved a schoolhouse at which Walt Whitman had taught.
Becoming a member of LIBA herself in 1970, Elinor's goals became even
more deeply intertwined with the Laboratory's when in 1972 her daughter
Alexandra died of leukemia, instilling in her a strong emotional desire to support
cancer research. That year she not only joined the board at Memorial Sloan-
Kettering Cancer Center, but also learned firsthand about cancer research
through working in Joseph Burchenal's laboratory at Sloan-Kettering. Also linking
her both to Cold Spring Harbor Laboratory and to Memorial Sloan-Kettering was
the deep friendship initiated then with our trustee Bayard Clarkson, who headed
the Hematology Section of Memorial Hospital while also doing research on
leukemia.
In 1988, Elinor joined our board, hopefully for a long period of service that
would equal her mother's. The year before, she had dedicated a large gift to our
Second Century Fund in honor of her mother, establishing the Posy White Fund.
In Elinor's words, the Fund was intended to encourage a young postdoctoral
scientist to "take the plunge and make a contribution in the field of science."
Elinor knew that the opportunities to find better cancer cures and treatments were
to be found through basic research.
She devoted great amounts of time and
energy to spreading the word about
the Laboratory, encouraging her friends
to join LIBA and to contribute to the Posy
White Fund. She was particularly valuable in expanding the
Laboratory's support
base to include more people from New York
City, where she lived and had many
friends and contacts.
As a member of the Laboratory board,
Elinor served on the DNA Learning
Center committee, combining her commitment to
molecular biology and cancer
research with her long-standing interest in education. She taught at the Brearly
School in Manhattan for ten years during the 1970s and 1980s and was a trustee
of the Thatcher School and of Miss Porter's
school, her alma mater. She was also
chairman of the board of the School Volunteer Program in New York City, a not-
for-profit organization with more than 1000 members. The volunteers go into New
York City elementary schools to give special courses in reading, math, and other
subjects. For relaxation, Elinor loved to sing and be with her family, spending the
summers at her family's residence on an island off the Maine coast.
Cruelly, she was diagnosed with breast cancer all too soon after coming on
our board. Unfortunately, the best medicine we have today did not stop the can-
cer's spread. Despite all of the major advances made so far in cancer research,
we still have a long road ahead. Characteristically, Elinor did not falter as her
condition worsened but remained vibrant and optimistic. In particular, Liz and I
will always cherish the lovely Lewis Carroll-inspired poem she read two years ago
at her home to mark our wedding anniversary.
She leaves bereaved her husband George and her three surviving children,
George, Jonathan, and Diana. With her passing, the Laboratory has lost a com-
passionate advocate, caring supporter, and devoted friend.
James D. Watson
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REPORT
It is now impossible for any one individual to effectively appreciate all of the
scientific accomplishments of this century. Almost all that is now learned in uni-
versities has been discovered since 1900, and the brains of even the best of my
scientific friends are inadequate to store all of the facts that we deem important.
Nowhere does this rush of achievement so overwhelm than in the study of the
gene, the fundamental unit of heredity that is transmitted from one generation to
the next through the chromosomes. An active pursuit of the gene and its ex-
traordinary implications for all of biology, as well as for human existence, has
been going on since the start of the century.
In evaluating the immensity of what has already been accomplished, we can
divide the achievements in genetics during this century into six separate in-
tellectual movements. The first was the Mendel-Morgan era in which genetic
crosses were used to establish the existence of genes and their linear arrange-
ment along chromosomes. Following this was a much shorter second era that be-
gan in 1944 with the announcement by Avery, MacCleod, and McCarty that DNA
carried genetic information in 1953 with the finding by Francis
Crick and me of the double helical structure of DNA. This finding immediately in-
itiated the search for the way in which the genetic information of DNA is used to
determine the order of amino acids in proteins. This third movement, led by Fran-
cis Crick and George Gamow, needed only the 13 years between 1953 and 1966
to find "the genetic code," the rules by which the information conveyed by the se-
quence of the four different nucleotides along DNA molecules is translated into
the information conveyed by the order of the 20 different amino acids within the
individual polypeptide chains of proteins.
Overlapping the search for the genetic code was the Lwoff-Monod-Jacob-
initiated movement that used genetics to learn how gene functioning is control-
led. This era, which effectively began in the early 1960s, was initially dominated
by the elegant genetic analysis of bacteria and their viruses, the phages. From
these experiments, largely done in Paris at the Institut Pasteur, came the concept
that specific genes interact with sets of specific molecules that can positively or
negatively affect the rate at which their respective genetic messages are read.
The identification of these controlling molecules as proteins was first demon-
strated in the mid 1960s at Harvard through Gilbert and Muller-Hill's isolation of
the lactose repressor and by Ptashne's isolation of the bacteriophage repres-
sor. Today, a very large number of gene regulatory proteins are known not only in
microorganisms, but also in higher organisms where their differential functioning
in time is known to control the order and development of multicellular organisms
from fertilized eggs. Molecular genetic analysis is now providing the keys to un-
lock the once totally mysterious phenomena of embryological development.
A decade later in the laboratories of Paul Berg and Stanley Cohen at Stanford
University, the recombinant DNA era began in which the rules underlying gene
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marry among themselves, thereby effectively making conventional Mendelian
analysis impossible. So except for those disease genes that preferentially ex-
pressed themselves in males and so were assigned to the X chromosome, the
location of most disease genes remained unknown. This barren picture suddenly
changed after the now celebrated 1980 Botstein, White, Scolnick, and Davis
proposal that high-quality human genetic maps could easily be made using as
genetic markers the frequently found natural variations (polymorphisms) of DNA
sequences within homologous DNA segments from different humans. Within five
years, the first comprehensive genetic maps of these polymorphic markers had
been constructed by research groups led by Helen Donis-Keller in Boston, Ray
White in Salt Lake City, and Jean Dausset in Paris, making possible the mapping
of a number of important human disease genes to specific chromosomal regions.
Cystic fibrosis, for example, was assigned to chromosome 7, and Huntington's
disease was mapped to chromosome 4.
Important as these findings were in opening up first-generation genetic diag-
nostic tests for these diseases, genetic mapping is only the first step in the isola-
tion (cloning) of the disease gene itself-the ultimate objective of most human
genetics research. With the disease gene in hand, the means become available
to search out the function of its respective protein. For example, the isolation of
the gene responsible for cystic fibrosis immediately revealed that its correspond-
ing protein product was a membrane protein regulating the transport of ions. On
the way to ultimate cloning must be the isolation of the DNA encompassing the
chromosomal region pinpointed by the genetic linkage analysis. Toward this end,
not only must all of the human DNA be cloned as discrete pieces, but these DNA
fragments must also be assembled into overlapping fragments (contigs) that go
from one end of a given chromosome to another. With such physical maps in
hand, the task facing a scientist wishing to clone a disease gene of interest be-
comes much, much simpler than if he or she had to find de novo the DNA seg-
ments located between the flanking genetic markers. Even with the DNA in hand,
however, the finding of the desired disease gene is not necessarily routine. In
many cases, large sections of DNA must be sequenced to spot the changes that
cause the disease.
Although considerable progress had already been made by 1986 to ac-
celerate the construction of contig maps, as well as to improve the resolution of
the genetic map, it was very clear that the sums of money available were vastly
inadequate to ensure the cloning of many important disease genes whose
chromosomal locations could by then only be roughly pinpointed by genetic
analysis. The human genetics community thus soon became a strong partisan for
an HGP, particularly one led by the NIH, their traditional funding source. By mid
1987, so encouraged by key NIH supporters, the United States Congress voted
$18 million for fiscal 1988 to support the HGP. At the same time, $10 million was
appropriated for the DOE to start its own HGP, principally within the DOE-
operated national laboratories such as Los Alamos, Berkeley, and Livermore.
In so acting, Congress believed it was initiating an HGP that would en-
compass a 15-20-year period and eventually cost some $3 billion (in 1988 dol-
lars). These were the time intervals and sums of money considered in three sepa-
rate evaluations of the potential usefulness of the HGP carried out in 1986-1987
by the committees organized by the National Academy of Science, the Office of
Technology Assessment of the United States Congress, and the DOE. In all three
reports, the HGP was divided into two overlapping phases. In the first phase,
most efforts should be directed toward the making of high-resolution genetic and
physical maps and the development of more efficient ways to sequence DNA.
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Particularly important would be the lowering
of sequencing costs, since these
would eventually consume most of the needed money.
When they had been
lowered to some 50 cents per base pair, then the second phase of massive se-
quencing could begin. Most likely, full-blown sequencing of human DNA would
not start until the mid 1990s. On the other hand, there were strong medical rea-
sons for a sense of urgency about completing as soon as possible the needed
genetic and physical mapping. Only with these tasks finished could the serious
hunts for many important disease genes commence.
I was then arguing that a project this big needed an active director, as op-
posed to being run by a committee, and so was not surprised when in May 1988,
the director of the NIH, James Wyngaarden, asked me to lead the NIH com-
ponent of the HGP. After being reassured that I could simultaneously remain the
director of Cold Spring Harbor Laboratory, I accepted his offer as of October 1,
1988, and began to live a life in which I had to carry the burdens of two full-time
jobs. In taking on the HGP position, I focused on four immediate objectives. (1)
The building up of a high-level NIH genome bureaucracy capable of functioning
smoothly when I was at Cold Spring Harbor. Here I was well served by Jim
Wyngaarden, who urged me to appoint as my deputy director Elke Jordan, then
holding a high-level position at the Institute for General Medical Science. (2) The
appointment of a program advisory committee that commanded great respect in
the outside worlds of human and molecular genetics. Here it was important to
have the presence of several major scientists not perceived as partially motivated
by wanting more genome monies for their own labs. (3) The active recruitment
into human genome research of the many more bright young scientists who
would be needed both to develop new genome technologies and to supervise
production-level acquisition of genetic maps, physical maps, and DNA se-
quences. (4) The establishment of a proactive Human Genome Ethics program
aimed at anticipating potential misuses of genetic knowledge and so reassure
the American people that the HGP would improve, not impoverish, the quality of
the lives of our citizens bearing genetic diseases.
From the start, I tried as much as possible to avoid micromanagement, letting
my staff and advisers know that they were there to make real decisions not just to
follow orders laid down from the top. The multiplicity and breadth of decisions
that needed to be made obviously far exceeded my competence, and I knew I
had been chosen to lead the effort in part because I did not have many precon-
ceived ideas as to how we should proceed at the tactical level. My primary task
was to focus on long-term strategic planning, working to be sure that the means
would be available for final victory. Not only did we need top brains, but also the
monies to pay for their staffs and the instruments they would operate. I thus had
to be a credible witness when I appeared before Congress to argue for the con-
tinually needed real increase in our annual budget that would let us together with
the DOE soon reach a combined appropriation of some $200 million a year.
Here I was helped by the fact that I did not have real doubts as to whether we
had a realistic chance of winning on time. Giving me that confidence were two
major scientific breakthroughs that preceded my appointment. The first was the
development in Maynard Olson's laboratory in St. Louis of the YAC (Yeast Artifi-
cial Chromosome) vector for use in the cloning of DNA segments approaching
one half million base pairs in length. Given human DNA pieces that big, assem-
bling them into contigs that duplicated their order within human chromosomes
should be an achievable goal within a decade at most. Equally important was the
emergence of the PCR (polymerase chain reaction) technique of Kary Mullis,
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which took off like a flash following its 1986 announcement and which ever-
increasingly is being used as a way to clone desired DNA fragments. Now it is
virtually impossible to conceive of the HGP proceeding without the help of PCR.
Completing the task of finding all the human genes will be some 10 to 100 times
more efficient because of PCR.
Even with these powerful techniques, however, the tasks ahead would be
daunting, and there was never any doubt in my mind that we would need to
create "genome centers" where a variety of intellectual disciplines would be util-
ized to develop even more cost-effective ways to make maps and explore poten-
tially powerful new ways to sequence DNA. Although the concept of multimillion-
dollar-funded centers, containing 20-30 people, raised the hackles of the many
scientists who feared their eventual demise in a future ever dominated by "Big
Science," there was no other way to proceed. The only real question was "how
big" was big. Here our concern was that most centers should be large enough to
complete the physical map of an average-sized chromosome within several
years of hard work.
It was never thought, however, that we should have as many American map-
ping centers as 24, that being the number of human chromosomes. To start with,
we believed that genome centers in other nations would come into being. We
also anticipated further technological breakthroughs that would permit single
centers to complete high-resolution maps of several chromosomes. These ex-
pectations are now in the process of being realized. Suddenly, several end-to-
end maps are nearing completion in the UK and France as well as in the United
States. In fact, one chromosome has already been completed. The physical map
of the human Y chromosome has just been effectively completed in David Page's
laboratory at the Whitehead Institute. Most importantly, the French made the de-
cision to create a super, 200-person laboratory capable of simultaneously
making low-resolution maps of all of the human chromosomes. Their gamble is
now paying off, particularly aided by their ability to make YACs with human DNA
inserts averaging 1 million (mega) base pairs, approximately twice the size of
YACs made here or in England. Happily, they intend to share their resources with
other nations, which should greatly reduce the time for the American laboratories
to complete their intended high-resolution maps. Now there is every reason to
believe that the mapping phase of the HGP should effectively be completed by
1996.
How to proceed toward production-level DNA sequencing was always much
less clear than was the path toward production-level mapping. Should we aim for
complete automation in which machines replace human beings as the key in-
gredient for day-to-day success? Instruments for sequencing had already been
developed by the late 1980s at Caltech and Heidelberg, but there was no con-
sensus as to whether the first-generation efforts could ever be improved to se-
quence at an acceptable cost. Moreover, the largest DNA sequences then
known (several herpesviruses) contained less than a quarter of a million base
pairs, more than 100 times fewer than the smallest human chromosome. Clearly,
we had to induce some key scientists to take on megabase-pair goals. At NIH,
we made the proviso that the pilot project should focus not only on finding genes,
but also on technological improvements aimed at bringing sequencing costs
toward the 50 cents per base pair goal. In addition, we stated our desire to fund
the sequencing of smaller model organisms, such as E. coli (4.5 megabases),
Saccharomyces cerevisiae (15 megabases), the roundworm C. elegans (100
megabases), and Drosophila (125 megabases). Here we believed that the se-
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laboratories on the even smaller 1-megabase-sized mycoplasmas, the smallest
of all bacteria. It is thus possible that we shall know the complete genetic instruc-
tions for several forms of single-cell existence within at most four years. We must
be cautious, however, not to underestimate the difficulty of assigning functions to
a genome-sized set of instructions. Less than one third of both the E. coli and S.
cerevisiae genes are essential, and many decades, if not centuries, will pass be-
fore we can assign specific functions to virtually all of the E. coli and yeast genes.
Even with this caveat, there certainly remains every reason to push on as fast
and sensibly as possible toward sequencing the complete human genome. Only
in this way are we likely to find all of the human genes. Merely sequencing the ex-
pressed regions of DNA by making cDNA copies of their respective messenger
RNA products is likely to severely underestimate the gene number as well as
leave us ignorant of many rarely used genes that nonetheless have important
biological roles. Even so, having in hand large libraries of human expressed se-
quences, each member mapped to its corresponding DNA region, will vastly
simplify the process of delineating the borders of individual genes. The time re-
quired for this cDNA component of the HGP, however, will necessarily be
dwarfed by the total sequencing tasks. Toward this end, production-level DNA
sequencing factories, each aimed at sequencing 10-25 megabases per year,
must be set up. Consolidation of these efforts into only a few worldwide sites
might eventually make sense, but now it seems premature to predict what the
HGP will look like more than five years ahead. In any event, the question remains
of how to finance the setting up of the supersequencing laboratories. In Europe,
governmental (foundation) monies are likely to eventually get them going as well
as provide funds for sequencing itself. Here in the United States, the route we
shall take remains open, with the likelihood being that sequencing companies,
perhaps in some cases partly owned by nonprofit research institutions or univer-
sities, will come into existence. The rate at which they are formed obviously will
depend on the amount of federal monies specifically targeted for sequencing.
We must now work hard to increase public, and with that Congressional, sup-
port for the HGP. Almost paradoxically, because its mission relates to all of hu-
man disease, it does not yet enjoy the strong backing of organizations like the
American Heart Association founded to encourage research aimed at specific
diseases. So conceivably, the most effective way to keep the HGP on its needed
upward course is for Congress to hear more directly and often from its sup-
porters among our nation's leading biomedical scientists. This was how the HGP
gained its initial support from Congress, and we should not underestimate the
respect that Congress continues to have for those who have made major ad-
vances in the past. Congress needs our advice as much as we need their help.
They want to know what is best for our country, not for the individual self interests
of its scientists. So those of us who feel so strongly about what the HGP can do
for our futures must take the time to see that our views are heard. Otherwise,
those who oppose and even hate the HGP may be perceived as the voice of true
science. Fortunately by now, the HGP is a truly international effort, and the major
programs now being developed outside our borders can be seen as a testament
to the deep importance of the HGP to all of human kind.
In so moving toward the identification of all human genes, we must never
forget the ethical, legal, and social consequences of this new knowledge. That so
many human characteristics are largely determined by our genes is inherently
unsettling to the vast majority of our citizens who would like to believe that we are
all born with equal chances for meaningful lives. But such equality does not exist,
and the throws of the genetic dice invariably lead to all too many cases of genet-
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is injustice. DNA replication will never be a perfect copying process. Only
through the continuous creation of new mutant genes through mistakes in DNA
replication can the evolution occur that allows species to adapt to the ever-
changing biological and physical environments of our earth. But in generating in-
dividuals with increased survival potential, evolution also necessarily leads to in-
dividuals severely impaired by newly created deleterious mutant genes.
As a compassionate society, however, we must never forget, and thus aban-
don, the victims of genetic injustice. To do so would abrogate the moral values
that are the hallmarks of a civilized human society. We must thus not consider
ourselves off the moral hook when we have passed laws to ensure genetic
privacy and so prevent future discrimination on the basis of genetic heritage.
Such laws will only truly work if we are part of societies in which the more
fortunate share their resources with those who are less so. As long as we accept
the fact that significant numbers of human beings belong to perpetual un-
derclasses based on poverty, race, or nationality, we might well also learn to live
with an ever-growing genetic underclass that we feel impotent to help.
The forthcoming explosion of genome knowledge will thus bring us not only
the power to vastly improve the human condition, but also the obligation to reaf-
firm that successful human beings are more than well-fed, adequately clothed,
and decently housed savages.
HIGHLIGHTS OF THE YEAR
Neuroscience Center Dedicated, Inhabited
The Laboratory inaugurated its search for the seat of memory this year at the
ribbon-cutting and dedication ceremonies for the new Neuroscience Center. On
April 26, Arnold Beckman cut the ribbon at the entrance to the Arnold and Mabel
Beckman Laboratory, following the first Laboratory trustees meeting to be held in
its beautiful new Plimpton seminar room. During a reception with members of the
board, a portrait of Mr. Beckman was unveiled in the lobby on the main floor, and
recently we received a portrait of Mrs. Beckman that now graces a facing
column. One week later, on May 3, the Neuroscience Center was dedicated.
Christened in high style, with balloons, a brass band, and a keynote speech from
U.S. Representative Bob Mrazek, the center symbolizes the beginning of the
Laboratory's "second century." It includes three structures: the Arnold and Mabel
Beckman Laboratory for research and teaching; Dolan Hall, a 60-room residence
for visiting scientists and Laboratory guests; and Hazen Tower, an instant
Laboratory landmark with its one-ton brass bell, helical staircase, and the DNA
initials, a, c, t, and g, adorning each of the sides. Designed by Centerbrook Ar-
chitects of Essex, Connecticut, the center projects a modern, state-of-the-art ap-
pearance while maintaining architectural harmony with other Laboratory build-
ings. The end of the ceremony was marked by a cloud of colored balloons rising
to the main plaza through the air shaft from the garage below and the tolling of
the Hazen Tower bell. Our Public Affairs Department produced a splendid book-
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let for the occasion, the most extensive of the nine
brochures they have pro-
duced since 1979. It features many photographs
as well as essays on the ar-
chitecture of the Neuroscience Center, on the future
facing Neurobiology, and on
the past history of neurobiology teaching and research
at Cold Spring Harbor.
By summer's end, Beckman Laboratory had begun
to fill with scientists. The
third floor contains laboratories dedicated to identifying
and characterizing genes
related to learning and memory in the fruitfly
Drosophila. Research on the main
floor will focus on chemical signals in the vertebrate
brain, and the ground floor
houses the W.M. Keck Structural Biology Laboratory
where scientists will explore
protein structure and function, focusing in large part on
proteins involved in cell
signaling processes or in gene expression. The center is filling rapidly and will
ultimately house a total of 75 scientists.
McClintock Campaign
As the Second Century campaign winds down, one of its most important remain-
ing objectives is the $4 million drive to raise funds for the renovation of
McClintock Laboratory. A committee of investment bankers from the community
will lead the way to complete this key fund-raising priority. We are already more
than one quarter of the way toward our goal, with contributions totaling more than
$1.4 million raised. We wish to express our thanks to Lita Hazen, the Starr Foun-
dation, Michel David-Weill, and Margo Walker for getting the campaign off to an
encouraging start.
Funds raised from the McClintock campaign will go toward transforming the
1914 building into a state-of-the-art laboratory for cell cycle and gene sequenc-
ing research. Three quarters of the monies will go toward renovations of the
Laboratory. These include structural renovations and the addition of a third floor
to the building. The remaining funds will be used to purchase laboratory equip-
ment.
The first floor of McClintock Laboratory once boasted a dirt-floor pen for hous-
ing sheep when the building was known as the "Animal House." Once renovated,
the first floor will be home to a gene-sequencing laboratory, focusing on
deciphering genes related to cancer. The second floor will become a laboratory
for research on the cell cycle, the set of events responsible for the duplication of
the cell. The third floor will house offices, a library, and a seminar room with one
of the Laboratory's most spectacular views of the harbor.
The erstwhile inhabitants of McClintock Laboratory have moved to other
buildings. David Helfman and Daphna Bar-Sagi continue their cancer-related re-
search in Demerec Laboratory, and David Beach and Robert Franza have been
given temporary laboratory space in the Neuroscience Center. Beach is pursuing
his research on the cell cycle and will return to McClintock when renovations are
completed. Franza, who works on questions relating to AIDS and cancer, will set
up shop in Jones Laboratory following renovations there.
LIBA: 1924-1991
The Laboratory's oldest supporting institution, the Long Island Biological Associ-
ation, was formed in 1924 by a group of concerned neighbors to reinvigorate the
summer program at Cold Spring Harbor and provide it with financial backing.
LIBA took over the administration of the Biological Laboratory (Bio Lab) from the
Brooklyn Institute of Arts and Sciences, sharing the current Laboratory grounds
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with the Carnegie Institution of Washington's Department of Genetics. For 38
years, LIBA ran the Bio Lab, continuing the summer courses and establishing re-
search programs in genetics, neurophysiology, and endocrinology.
When Milislav Demerec became director in 1941, the focus of the Bio Lab
shifted to a heavy emphasis on genetics. In 1962, the facilities of the Carnegie In-
stitution were merged with those of the Bio Lab to form a new, single institution:
Cold Spring Harbor Laboratory of Quantitative Biology (shortened in 1968 to Cold
Spring Harbor Laboratory). When the two laboratories were joined, LIBA's opera-
tional role ended. LIBA then moved on to its current role as "Friends of Cold
Spring Harbor Laboratory," taking on the job of explaining the Laboratory to the
public and organizing community support for the Laboratory. So organized, LIBA
mounted four major capital fund drives, culminating in the successful 1983 drive
to build Grace Auditorium.
For more than 20 years, LIBA has continued in this role, although it retained
its original name. The group's obsolete acronym, however, frequently misled
newcomers as to its and the Laboratory's activities. Other biological centers have
since developed on Long Island, and the Association no longer played an opera-
tional role for the Laboratory. In November, at a retreat at Arden House north of
New York City, LIBA directors voted to remove this confusion by changing the
group's name to the Cold Spring Harbor Laboratory Association. Confirmed at
the January 1992 annual meeting, the new name removes all doubt as to the al-
legiance of this unique and valuable group. Hereafter known as the Association,
this loyal band of Laboratory neighbors will continue to support and raise money
for the Laboratory under the able presidency of George Cutting. The Laboratory
welcomes and appreciates this support which is now channeled exclusively
toward operating as opposed to capital funds. Last year, the Association mem-
bers raised more than $350,000 which was used to provide stipends for postdoc-
toral fellows and new staff scientists.
Symposium: The Cell Cycle
This year's Symposium, organized by Laboratory scientists David Beach and
Bruce Stillman, focused on the life cycle of the cell. This fundamental set of pro-
cesses, which includes DNA synthesis and replication, cell division, and a "rest-
ing" phase, goes awry in cancer cells. The topic of this year's Dorcas Cummings
Lecture for Laboratory neighbors, always held on the Sunday afternoon of the
Symposium, was "Understanding Cancer." The speaker, Dr. J. Michael Bishop, a
professor at the University of California at San Francisco Medical School, ex-
plained that a tumor is a cluster of cells descended from a single cell whose cell
cycle ran amok due to some genetic aberration. When that cell divided, it passed
along its genetic miscue to its two progeny, which then passed it along to their
progeny, and so on in an exponentially increasing manner. Although cancer
remains a frightening thing, research into cancer and the cell cycle is making it
less of a terrible "black box" and is leading us closer to eventual understanding
and cures.
Banbury Meetings on the Cutting Edge
Banbury Center director Jan Witkowski continues to assemble leading experts to
discuss important issues bridging biology, industry, and society. Typically three
days in length, each meeting aims to be timely, rich in discussion, and on the
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Jan Witkowski
cutting edge of a field.
This happens by bringing
together the right people on the
right topic and placing
them in the idyllic setting
of the Banbury estate generous-
ly donated to the Laboratory
in 1976 by Charles Robertson.
This year's meetings
included conferences on the
biology of Lyme disease;
patents and molecular
biology; the molecular
genetics of breast cancer;
nin, from cells to health
care. The conferences range
from basic researcha, sudc as
g
the meeting on the
genome of Escherichia coli,
to the impact of biology on the public sector such as
the meeting for science journalists
on controversial issues in biology and societ
y.
Important new support for
the Banbury Center came from a $150,000 grant
from the William Stamps Farish
Fund that our trustee Martha Farish Gerry helped
us obtain. It will go toward the holding
of three Banbury conferences on complex
genetic diseases like arthritis in
which several genes are involved.
Baring Brothers Executive Conference
Baring Brothers & Co., Ltd., the celebrated English
merchant bank, sponsors an
annual meeting on new developments in biology
which is held at the Banbury
Center each October. The topic of this
year's meeting was the molecular biology
of signal transduction, the fundamental
process by which cells communicate.
The program featured presentations by leading
researchers in genetics, cell biol-
ogy, and neurobiology, including a special segment
highlighting the research
program at Cold Spring Harbor, during which
attendees met in small groups with
Laboratory scientists David Beach, Ron Davis, Mike
Wigler, and others.
Participants included Laboratory trustees, scientists, and executives from the
biotechnology, pharmaceutical, and financial communities of the United States,
Europe, and Japan. In addition to listening to a broad range of talks, the business
leaders had a chance to "get their hands dirty" at the Neuroscience Center's new
Hughes teaching laboratory, where, led by Nobel laureate Sidney Altman, they
performed a simple experiment preparing DNA from bacterial cells.
Sadly, Trustee Terms End
Cold Spring Harbor Laboratory continues to benefit from the expertise and
generosity of an outstanding board of trustees. Our board consists of 30 trustees,
ten of whom are chosen because of their direct involvement with the world of
science. The remaining 20 public members live primarily on Long Island or in
New York City and join us because of their interest in promoting biomedical re-
search and their willingness to contribute their own expertise in business, the law,
or public service. This year, we have five new members, four of whom have never
before served on our board and whose interests and knowledge span a broad
range.
We lost the service of five valuable trustees this year. During the summer,
Elinor Montgomery to our sorrow tendered her resignation because of illness.
Then at our November board meeting, David Botstein, Jim Darnell, Fred
Richards, and Sidney Strickland reached the ends of their second terms on our
board. Each of these scientifically trained trustees brought us unique talents.
David Botstein, long a leading yeast molecular biologist, recently has be-
come chairman of the genetics department at Stanford University. He is also well-
known in human genetics circles for first proposing the use of distinctive seg-
ments of DNA as "flags" along the chromosomes for mapping disease-causing
genes. Botstein taught our summer course in Advanced Bacterial Genetics be-
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tween 1976 and 1980, after spending a sabbatical year at the Laboratory in
1973-1974 studying yeast genetics. This was the second time Jim Darnell of The
Rockefeller University completed two full terms. Earlier, he was on our board
while serving as a professor at Columbia University. As a board member, Darnell
served on the executive, nominating, and tenure committees. Jim first came to
Cold Spring Harbor in 1958 to take the newly instituted course in Animal Viruses.
Fred Richards first came here in 1971 as an organizer of that year's Symposium
on the Structure and Function of Proteins at the Three-dimensional Level. Retiring
trustee Sidney Strickland, who studies developmental biology in the pharmacol-
ogy department at SUNY Stony Brook, served as a member of the Banbury com-
mittee.
Our single returning trustee is Wendy Hatch. Mrs. Hatch is a loyal neighbor
whose enthusiasm for the Laboratory is unsurpassed. In her previous two terms
on the board, she served on 7 of the board's 12 committees, including the Ban-
bury, building, development, and executive committees, as well as serving as
secretary of the Laboratory. This year she will chair the DNA Learning Center ad-
visory committee and serve on three other committees.
New to the board are Mrs. Martha Farish Gerry and Mr. David H. Koch. A resi-
dent of Mill Neck, Mrs. Gerry is also a member of the board of Columbia Pres-
byterian Hospital as well as several other health and family services organiza-
tions. In addition, she is vice president and a trustee of the William Stamps Farish
Fund, a fund with an emphasis on education and medical research. Her back-
ground will be a valuable asset to the Banbury, building, and DNA Learning Cen-
ter committees.
David H. Koch of New York City is executive vice president for chemical tech-
nology for Koch Industries, Inc., of Wichita, Kansas. A graduate of MIT and cap-
tain of its basketball team, he continued his postgraduate training at MIT in
chemical engineering. Early in his career, he worked at the Scientific Design
Company, Inc., the petroleum-related engineering firm founded by our former
trustee Ralph Landau. He is also a trustee or director of a variety of organiza-
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tions, including the MIT Corporation,
NYU Medical Center, Mem
h.
orial Sloan-
Kettering Hospital, the American
Ballet Theater, and Earthwatc
Three new scientific trustees
were elected. GOnther
Blobel, a professor at
as an
The Rockefeller University and
Howard Hughes Medical Investigator, studies the
fundamental problem of how proteins
are transported across cell membranes.
Gerald Fink, director of the Whitehead
Institute for Biomedical Research and a
professor at MIT, although a newcomer
to the board, is no stranger to the
Laboratory. He helped initiate a
Yeast Genetics course in 1970, continuing
instructor with only one year's
interruption until 1987, including one year in which
he co-taught with David Botstein.
He will serve on the Banbury and tenure and
appointments committees.
Joining us from SUNY Stony Brook is Dr. Eckard Wim_
mer, chairman of the department
of microbiology. In prior years, he helped
organize several important Banbury
meetings and most appropriately will chair
the Banbury committee.
Robertson Research Fund
In this year of recession, the Robertson
Research Fund was more valuable than
ever in maintaining the Laboratory's
commitment to young scientists. The Fund
supported the research of graduate students,
postdoctoral fellows, visiting
scientists, investigators in the plant genetics program,
and key newly arrived
scientists. The fund also supports the Outstanding Junior Fellow Award, which
this year went to David Barford, who came here
following his Ph.D. at Oxford and
a postdoctoral year in Dundee. David works on
the three-dimensional atomic
structure of an important class of enzymes called protein phosphatases. In addi-
tion, the Fund contributes to meetings, courses, and travel and relocation ex-
penses for Laboratory scientists and provides backup support for underfunded
research projects and meetings.
Major Gifts
The Laboratory received a number of substantial gifts in 1991, making possible
essential programs such as new construction, purchase of laboratory equipment,
and funding for scientists. Among these were new pledges from the Upjohn,
Ciba-Geigy, and Baxter International Corporations toward our infrastructure
campaign, whose primary purpose is the refurbishment and expansion of Black-
ford Hall and the construction of the 11 guest cabins. In addition, Bristol-Myers
Squibb, the Pall Corporation, and Westvaco increased their pledges toward the
infrastructure campaign. A total of 13 corporations, primarily from the
pharmaceutical industry, have now pledged contributions totaling over $2.8 mil-
lion.
Unrestricted giving is one of the most important sources of money for the
Laboratory. These funds are used at the discretion of the trustees wherever and
whenever needed, whether it be to purchase equipment, fund a scientist, or
renovate a building. Generous gifts and pledges to the Laboratory's unrestricted
endowment were received from Dr. Bayard Clarkson, Mr. & Mrs. George Lindsay,
David Luke, Dr. David Pall, Taggart Whipple, Martha Makanna, Mrs. Alexandra
White Smith, Mrs. Bayard Walker, and Morris Williams.
Support for specific research programs at the Laboratory helps shape the
direction of Cold Spring Harbor science. The Mathers Foundation donated
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$1,028,000 to support Ron Davis' learning and memory research, and the Sara
Chait Memorial Foundation pledged $125,000 to support research on Alzheimer's
disease. The Donaldson Charitable Trust and Ira J. Hechler provided support for
two Russian scientists here, Grisha Enikolopov and his wife Natasha. Toward
equipment for the Neuroscience Center came a much appreciated gift of
$300,000 from The Gould Foundation. We are also grateful to the Samuel
Freeman Charitable Trust and the Mellan Family Foundation for their support of
Robert Franza's laboratory and the Oxnard Foundation for its support of Michael
Gilman. The Garfield Foundation supported Jacek Skowronsky's AIDS-related re-
search with transgenic mice. Leonie T. Brigham, in addition to an unrestricted
gift, provided endowment funds for the neuroscience program by means of a
generous bequest.
Other gifts made possible a variety of programs. Mrs. Maxine Harrison had
pledged a bequest of $1.5 million in honor of her mother, Alle Davis Harrison, to
endow a neuroscience chair. Sadly, that bequest has materialized sooner than
expected, and we offer sincere condolences to the Harrison family on the occa-
sion of Maxine's passing last fall. Trustee Lita Hazen deserves special thanks.
Adding to her past $1 million contributions to the Neuroscience Center and the
Blackford Hall renovation, in June Mrs. Hazen donated $1 million toward the
renovation of McClintock Laboratory. Former trustee Norris Darrell established
the "William Shakespeare Fellowship" to support a student in the Undergraduate
Research Program. Support for young scientists here at the Laboratory included
a planned gift from Katya Davey and a donation from former trustee Elinor Mont-
gomery, whose gift toward the Posy White Fund, named in honor of Mrs. Mont-
gomery's mother, brought that endowment's total to $180,000 as of the end of the
year.
Seligson Family Postdoctoral Fellowships for Cancer Research
Our neighbors Alan and Edith Seligson lived through the heroically long but final-
ly losing battle of their son Andrew against neuroblastoma. When more conven-
tional therapies had failed, Andrew underwent a then very experimental bone
marrow transplant in Holland. Through this treatment, his life was prolonged for
several more years, but finally the awful cancer reappeared and Andrew died at
the age of 25. To encourage the new knowledge that we will need to fight such
cancers successfully, the Seligson family has established a postdoctoral re-
search program where they help choose several young scientists to do cancer
research here. The Seligson Family Fellows of 1991 were Mart Ustav, who works
on the cancer-causing papillomaviruses, and Jeffrey Gerst, who studies the RAS
oncogene.
Honoring David Luke's Leadership of the Second
Century Campaign
Initially, we considered a $25 million goal for the Second Century campaign. But
by the time we started this fund drive, we had upped our sights to $44 million to
be raised by the end of 1991. Happily, the expanded target was itself exceeded
with more than $46 million either received or firmly pledged. This extraordinary
success was achieved only through the help of a very effective group of
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Blackford Hall
David Luke receives Steuben glass bowl
volunteers led by David Luke. To honor David, as well as more than 60 key
volunteers who provided so much of their valuable time during the campaign's
duration, a special dinner was held on April 11, 1992, in the new downstairs
Blackford Hall dining room. Before the dinner, Barney Clarkson, David Helfman,
and I made brief remarks in Grace Auditorium about the importance of the
campaign for the Laboratory's future, with Barney presenting David with a suitab-
ly inscribed Steuben glass bowl to honor his extraordinary efforts. In response,
David graciously told of his pleasure in so working for the good of the Laboratory.
A Much Expanded and Modernized Blackford Hall Is Now
Nearing Completion
Through doubling the size of Blackford Hall, we now have two functioning dining
rooms, which can seat a total of 400 people, enabling us to accommodate the
ever-increasing numbers of scientists attending our meetings. Completely new is
a 120-person dining room on the ground floor equipped with its own serving sec-
tion. A brand new elevator connects it to the kitchen on the main floor. Renova-
tion of the basement bar was complete.d by January 1992, allowing it to be the
site of a Super Bowl party. Other renovations include enlarging the existing
dining room through a major addition on the east (harbor) side, nearly quadrup-
ling the kitchen area, adding an outside eating area more than twice the size of
the old terrace, and adding much enlarged rest room facilities.
In other building news, a future athletic facility is in the planning stages. A
committee has been formed to consider the facility's size, usage, and equipment.
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Mike Wig ler David Helfman
Wig ler Honored Once Again
Laboratory scientist Michael Wig ler received the thirty-first Clowes Award from
the American Association for Cancer Research for his work on the genetics of
cancer. Wig ler and his group share credit with Bob Weinberg at MIT for isolating
the first human cancer gene, or oncogene. Wigler's laboratory continues to work
on the RAS oncogene, gaining insight into this gene's function in healthy cells
and its role in transforming healthy cells into cancerous ones.
Helfman Receives Award
David Helfman received an Established Investigator Award from the American
Heart Association in recognition of his work on RNA splicing. Helfman's research
focuses on the ability of multi-parted genes to be put together in different ways to
make a variety of related proteins. The "splicing" of these neighboring stretches
of RNA into different combinations could explain structural differences between
heart muscle and skeletal muscle, as well as many other biological phenomena.
DNA Learning Center
The DNA Learning Center, under the able directorship of David Mick los, con-
tinues to push the envelope of science education to include ever-younger stu-
dents. The new "Fun With DNA" workshop brings primary school students into the
laboratory to learn about DNA fingerprinting, genetic engineering, and other
aspects of DNA science. Perhaps nothing illustrates the rapid progress of
biotechnology so well as the fact that here in Cold Spring Harbor, fourth graders
are carrying out experiments that less than 15 years ago won Nobel prizes.
With support from the E.S. Webster Foundation, architectural plans were in-
ititated for a 3500-square-foot addition at the rear of the DNA Learning Center's
current facility. The Stone Foundation pledged $250,000 over three years toward
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a new multimedia laboratory
to be housed in the
new addition, which will allow
state-of-the-art computer
technology to bring the sights
and sounds of DNA to
many young minds. The
Weezie Foundation also pledged
$100,000 toward the
development of the DNA Learning
Center's proposed new exhibit "Exploring the
Human Genome."
CSHL Press
Cold Spring Harbor Laboratory Press
published 15 new titles in 1991, up from 12
in 1990. The Press is also
distributing a new line of children's books, published
by Harper Collins Publishers in
London. The first two books, entitled Cells Are Us
and Cell Wars, have become two
of our biggest sellers. This year saw the publi-
cation of our first audiotape, a
recording of a concert given at the Laboratory this
fall by geneticist/humorist/folksinger
Ron Laskey, entitled Songs for Cynical
Scientists.
The press launched a new journal this year, PCR
Methods and Applications.
Polymerase chain reaction is an
increasingly important technique for scientists in-
terested in cloning DNA, and this journal documents
the latest uses and methods
for researchers in genetics. Genes &
Development continues to lead the field of
professional journals in developmental and molecular biology. It was recognized
for the second year in a row as the
most-cited journal in its field. The Press's third
journal, Cancer Cells, ended with the December 1991 issue. Although its quality
was high, it suffered from an overcrowded
field of competing publications and
the effects of cuts in government research grants that has greatly reduced the
monies available to purchase books and journals.
Three new series were begun in 1991. The first three volumes of a series on
Genome Analysis were published, as were the first four volumes of Current Com-
munications in Cell and Molecular Biology and the first two volumes of Cancer
Surveys, published in collaboration with the Imperial Cancer Research Fund of
the U.K. Finally, this year marked the release of the comprehensive review
Origins of Human Cancer, the result of the centennial meeting of the same name
held in September 1990, edited by Joan Brugge, Tom Curran Frank
and former Laboratory scientist Ed Harlow.
Next year promises continued expansion for the Press, with 26 new titles, in-
cluding a textbook on the The Power of Bacterial Genetics, laboratory manuals
on nervous system probes and bacterial genetics, and a monograph on
Drosophila development.
Finally, we bid goodbye this year to Charlie Apsel, business manager of
CSHL Press. Charlie came to the Press in August 1980 from Human Sciences
Press as fulfillment officer. She left at the end of January 1992 to pursue a career
in hospice work near her home in Mt. Sinai.
Houses for Science Makes Its Appearance
Mid November marked the publication of Houses for Science by my wife Liz.
Published by Cold Spring Harbor Laboratory Press, this book traces the unique
architectural and scientific evolution of Cold Spring Harbor Laboratory from whal-
ing village to world-famous village for DNA. Superbly illustrated with photos and
drawings chronicling the nearly 200-year architectural heritage of our buildings,
the 350-page Houses for Science is, as noted in a review in Nature, the first
coffee-table book about science.
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To mark its publication, LIBA sponsored a Sunday afternoon lecture by
Michael Crosbie of Architecture magazine in which he compared new scientific
laboratories elsewhere with our new Beckman Laboratory. Several days later, a
small party at the Century Association introduced the book to friends in New
York, and on our way to the Nobel Jubilee in Stockholm, we hosted a small
gathering at the Travelers' Club in London.
I have heard only great praise for my wife's book, and I am very proud of her
achievement in bringing forth what should be the first of a new genre in books
where intellectual history is seen through the form of the buildings that make it
possible.
Lloyd Harbor Seminar Series, Miniatures, McClintock's First 50,
Orth Redux
The year was marked by a number of special events. The Lloyd Harbor seminar
series at the Banbury Center was reinstated this year after a two-year hiatus.
Organized by Laboratory Associate George Toumanoff, these public lectures
present a broad range of topics for the enjoyment of Banbury's neighbors in the
village of Lloyd Harbor. This fall, for example, Ann Gill of the Cold Spring Harbor
Whaling Museum presented a talk and slide show on the village of Cold Spring
Harbor during the whaling era. The talk was followed by a presentation by Liz
Watson, who discussed the history of Cold Spring Harbor Laboratory as it devel-
oped out of the old whaling village here on the harbor's western shore. The eve-
ning also included a sneak preview of her book Houses for Science.
In September, the Laboratory hosted an exhibit of 32 miniature rooms
designed by Mrs. Madeline Ridder. The miniatures, painstakingly detailed with
period furniture, art, and functioning light fixtures, delighted 120 people and
raised $7500 for the Laboratory. Very sadly, Mrs. Ridder suddenly passed away
shortly after this exhibition. Happily, she was able to greet her many friends at the
exhibit, and we will long remember her by the happy event of her miniatures
show here.
Jim Watson enjoying one of the miniature rooms designed by Mrs. Ridder
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Liz Watson showing
Jack Richards (left)
and Jim Childress
Houses for Science
3arbara McClintock
Near the close of the year, Barbara
McClintock celebrated her 50th year at
Cold Spring Harbor. Barbara has worked
in her laboratory here nearly every day
since December 1941. On December 19,
Laboratory scientists and staff crowded
the Grace Auditorium lobby to toast this milestone.
Piano virtuoso Peter Orth gave a second
benefit concert in Grace Auditorium
on January 25, 1992. Mr. Orth's Grace Auditorium
debut was in 1989, during our
centennial celebration. The concert,
organized by Laboratory loyalist Mary
Lenore Blair, was by all standards a great success.
Mr. Orth's program of
Chopin, Schumann, and Brahms lulled,
aroused, and enthused his rapt audience
and raised $8000 for the Laboratory.
Undergraduate Research Program
Each summer since 1959, up to 20 undergraduates from around the country and
overseas have come to the Laboratory to carry out research projects with our
scientists. This year, 19 students participated in the program, coming from as
near as upstate New York and as far away as Paris. Each student worked for 10
weeks, learning techniques and developing and carrying out a project. This
year's studies included gene cloning, protein analysis and characterization, isola-
tion of cDNA, and X-ray crystallography and utilized molecules derived from
yeast, plants, and humans. Each student in the program has a sponsor, with sup-
port coming from the National Science Foundation; Baring Brothers and Co., Ltd.;
Philips Petroleum; Burroughs-Wellcome; the Olney Memorial Cancer Fund; and
anonymous donors.
Partners for the Future
The second year of the Laboratory's Partners for the Future program began in
October. Initiated in 1990 to involve high school students in research at the
Laboratory, the program is highly competitive. From the 150 Long Island schools
eligible, five students are selected to conduct research and hopefully to begin
Benefit concert given by piano virtuoso Peter Orth
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building rewarding scientific careers. Sponsored by area businesses, students
receive a stipend as well as hands-on experience unattainable in a classroom.
The following is a list of 1991 Partners, their high schools, and their Laboratory
mentors: Nicole Chasen, Oyster Bay High School (Dr. Jeff Kuret); Rose Cohen,
Great Neck High School South (Dr. Jeff Kuret); Richard Lavi, Cold Spring Harbor
High School (Dr. Hong Ma); Steve Xydas, Herricks High School (Dr. Richard
Roberts); and Elizabeth Yong, Syosset High School (Dr. Venkatesen
Sundaresan). The students work from October through March and commit at
least 10 hours each week after their regular school day.
Changes in Scientific Staff
Senior Staff Investigator David Frendewey left this year to take a position at NYU
Medical Center as an associate professor. Frendewey's work centers on the
synthesis and splicing of RNA in yeast. The simplicity of this organism allows
David to unravel details of the way genetic information is translated into the build-
ing blocks of cells. Edward Chang, an associate investigator in John Anderson's
laboratory, left for a senior scientist position at the Development Center for
Biotechnology in Taiwan.
Staff associates Jeffrey Field, Dalian Young, and Karl Riabowol also departed
in 1991. Jeff took an associate professorship in Columbia's biology department,
and Dalian and Karl have both migrated north to take assistant professorships at
the University of Calgary in Alberta.
New Staff Members
The dedication and opening of Beckman Laboratory marked a record year for ar-
riving staff. Ron Davis, senior staff scientist, and Tim Tully, senior staff investi-
gator, came here from, respectively, Baylor College of Medicine, Houston, Texas,
and Brandeis University, Waltham, Massachusetts. They study the process of
learning and memory using the fruitfly Drosophila as a model organism.
We are also pleased to have Hiroyuki Nawa on board in Beckman as a senior
staff investigator. Dr. Nawa came to Cold Spring Harbor Laboratory from Kyoto
University in Japan. He studies the development of neurotransmitter phenotypes
in the nervous system and its relationship to the learning and memory processes.
Two staff investigators are welcomed this year. Ryuji Kobayashi comes to us
from Nagasaki University in Japan and is researching protein chemistry and en-
zymology in Beckman. Scott Patterson works with the QUEST group in Demerec
Laboratory and utilizes his skills in computer science to identify proteins from
two-dimensional gels. He worked previously at The University of Queensland in
Brisbane, Australia.
James Cherry, a staff associate in Beckman, arrived in 1991 to research
mammalian learning and memory.
New visiting scientists came to us from various corners of the globe. Nikolai
Lisitsyn, associated with Michael Wigler's laboratory, comes to us from the In-
stitute of Molecular Genetics in Moscow. Nikolai has a special interest in human
genome mapping. Jean-Pierre Renaudin specializes in plant genetics and comes
to us from the French National Institute for Agronomic Research to join
Venkatesen Sundaresan's laboratory. Janos Posfai came from Hungary for the
fourth time as a visiting scientist in Rich Roberts' laboratory and is continuing his
work in mathematical analysis of biological sequences. Dr. Posfai has since
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returned to The Academy of
Sciences of Hungary, Department of Biophysics.
Stefan Stamm, a German
scientist currently researching alternative RNA
in David Helfman's laboratory,
arrived in 1991 for a one-year sabbatical.
Frederick Southwick, an
M.D. from Boston City Hospital, spent the summer in
David Helfman's laboratory
researching the molecular biology of cytoskeletal
proteins. Huanran Tan, from the
People's Republic of China, researches c_rei.in
Robert Franza's laboratory.
Magsood Ahmed, visiting scientist, has returned to
Pakistan after researching
restriction enzymes in Hershey Laboratory.
Staff Promotions
Many changes at the Laboratory
occurred in 1991, including a number of staff
promotions. David Helfman, former
senior staff investigator, was promoted to
senior staff scientist. David
first came to Cold Spring Harbor Laboratory in 1981
to work with Steven Hughes
and John Fiddes and developed an antibody
screening-DNA cloning technique. He quickly
became interested in cytoskeletal
structure in normal and tumor cells.
Helfman's laboratory continues to work on
the molecular biology of the cytoskeleton.
Roymarie Ballester and James Lees-Miller were
made staff associates.
Roymarie continues to work in Demerec Laboratory, furthering her work in RAS-
mediated signal transduction in yeast. James is studying the role of tropomyosins
and actins in cell motility.
Eric Richards was promoted to staff investigator. Eric is conducting work on
molecular chromosome structure in plants and works in DelbrOck-Page
Laboratory. Michael Laspia of Demerec Laboratory was also promoted to staff in-
vestigator. He researches the transcriptional regulation of HIV-1 gene expression
by the viral trans-activator protein Tat. Susan Lobo of James Laboratory was
promoted to research associate. She studies the transcription of small nuclear
RNA genes.
Postdoctoral Fellows
The following scientists have departed after having completed their postdoctoral
studies here: Ulrich Deuschule to the Basil Institute for Immunology as staff
scientist; Ashok Dubey to the Indian Institute of Technology as associate profes-
sor; Jeffrey Gerst to Mount Sinai Medical School as assistant professor; Makoto
Kawamukai to Shimane University (Japan) as associate professor; Daemyung
Kim to Chonjin University; Tsfrira Pe'ery to Israel; and Ratneswaran Rat-
nasabapathy to Long Island University as assistant professor of pharmacology.
Also departed to continue their postdoctoral research are Gary Heisermann
to the Marine Biological Laboratory; Ellen Katz to Albert Einstein Medical College;
Li-Kuo Su to Johns Hopkins Oncology Center; Anne Vojtek to Fred Hutchinson
Cancer Research Center; and Jong-Chang Wu returned to Taiwan.
We must also mention our feelings of deep regret regarding the tragic pass-
ing of the talented Australian M.D. William Clouston, then working with Winship
Herr in James Laboratory, and express our condolences to his wife and family.
Several graduate students completed their doctorate work at the Laboratory
and moved on: Tom Baxter left to pursue other activities in the Bronx, New York;
Rui-Hong Chen moved to SUNY Stony Brook; Christian Dahmann to Universitat
TObingen (Germany); Barbara Faha to MGH Cancer Center East; Qianjin Hu
returned to Japan to pursue other activities; and Kenneth Mellits to ICRF
(London).
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Top row: Peter Stahl, Jim Watson, John Maroney; Bottom row: Guy Cozza,
Roberta Salant, Bill Keen
Long-Term Service
During 1991, seven employees reached important milestones here at the
Laboratory. William Keen, comptroller, and John Maroney, assistant administra-
tive director, each completed 20 years of service. John began here as a research
assistant in James Laboratory working with Joe Sambrook. From early 1973 to
December 1982, he was head of Purchasing, and in early 1983, he became as-
sistant administrative director. Bill Keen has been comptroller of the Laboratory
since 1971 when he came here from KPMG Peat Marwick.
Five employees reached 15-year milestones: Guy Cozza, chief accountant;
Joseph Ellis, groundskeeper; Roberta Salant, administrative assistant; Peter
Stahl, maintenance manager; and Margaret Wallace, mediamaker.
My Resignation from the Directorship of the National
Center for Human Genome Research
Bearing the responsibilities of two major administrative positions, one here at
Cold Spring Harbor and the other at NIH in Bethesda, has been an ever-
increasing burden during the past year to both me and this Laboratory, whose
growing size demands a full-time director. At the January meeting of the Program
Advisory Committee of the National Center for Human Genome Research, I told
its members that the increasing scope of the Human Genome Project would soon
necessitate the appointment of a full-time director who could take a more direct
role in the management of an effort whose growing yearly budget already ex-
ceeded $100 million. While initially I could function effectively in getting the Hu-
man Genome Project off to an irreversible start, I was becoming frustrated over
my inability to be the active manager the Project now needs. Also worrying me
was a disagreement festering since last October between the new director of the
NIH, Dr. Bernadine Healy, and me over the desirability of patenting expressed
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ity to feed all of the visitors to our meetings in heated quarters. Gone forever are
the leaky tents that so characterized our big meetings. Happily, both major build-
ing projects have been accomplished without a ruthless impersonalization of our
character. Bungtown Road still retains a village feeling. We will not rest, however,
on new architectural triumphs but continue to work hard to see that all of our
visitors feel they are wanted. In a real sense, Cold Spring Harbor Laboratory
belongs collectively to its staff and visitors, both of whom are indispensable to its
present as well as to its future.
However, with 220 people already doing science here and some 600 total
employees, we are just at the limits of what still can be called a village. Clearly,
we must strive even harder to know each other and to make everyone feel that
the Laboratory is as much a home as a place to work. Toward this end, we plan
for Blackford Hall to return quickly to its former role as the social center that
breaks down the walls between individuals who come here as competitors but
leave as friends. We must also soon take steps to improve our athletic facilities,
since such activities provide easy ways to start speaking to strangers. A decade
ago, I thought we had the money to build near the tennis courts a building hous-
ing a squash court and an exercise room. But then suddenly the money was
needed to build Grace Auditorium. Now our need for a complex is even greater,
and a major goal of mine remains to ensure its construction over the next several
years. We must also come to grips with how to provide the child care needed by
many of our younger staff. A facility on the Laboratory grounds would im-
measurably simplify the lives of those individuals who have very small children
and yet want to work full time at the Laboratory.
I have much work cut out for me in the near future.
May 14, 1992 James D. Watson
25


35
30 -
25 -
20 -
DOLLARS
(in Millions)
to
600
500
400
Employees 300
200
100
STAFF
Scientists
Support
72 73 74 75 76 77 78
79 80 81 82 83 84 85 86 87 88 89 90
Years
Consists of Full-time and Part-time
Technical Support, Core Services, Publications, Meetings, Library, Public Affairs.
Buildings and Grounds, Administrative
Personnel, Banbury Center, and DNA Learning Center
Actual Expense Adjusted Expense
0
72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91
Years
6000
5000
4000
Participants 3000
2000
1000
28
MEETINGS & COURSE PARTICIPANTS
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ADMINISTRATION
The past year was difficult for most academic institutions engaged in basic re-
search, and the Laboratory was no exception. Most of our federal research
grants were funded at reduced levels due to federal budget pressures and be-
cause, nationwide, too many deserving projects are competing for the same
funds. In addition, Congress began an investigation of reimbursement of re-
search overhead costs. A few highly publicized abuses were found at some in-
stitutions, and thus a range of new regulations and rule interpretations have been
proposed. As a result, the issue of how legitimate research overhead costs are to
be recovered in the future has become clouded and makes forward planning dif-
ficult at best.
The Laboratory nevertheless completed 1991 with satisfactory operating
results and a strong financial condition. The outstanding quality of our research
and education programs enables them to compete successfully for a good share
of available federal funding. In addition, foundations, corporations, and individu-
als support the Laboratory generously.
For the third successive year, there was a modest surplus from operations
after full funding of depreciation, which amounted to $1.9 million. A reserve was
established to provide for the present uncertainties of federal grants, and funds
previously designated for start-up expenses of the Neuroscience Center were
used only sparingly. The good financial results were helped importantly by a 6-
month wage freeze instituted at mid-year and strongly supported by the great
majority of staff. The normal schedule of salary reviews resumed, as planned, at
the end of the year. Cost containment was emphasized by all departments, and
new hiring of support personnel was curtailed despite rapid growth of the
scientific staff associated with the opening of the Neuroscience Center. The
cooperation and support of all employees were major factors in the successful
financial results and are greatly appreciated.
The Laboratory's endowment, consisting of the Robertson and Cold Spring
Harbor Funds, reached a new high level of over $57 million by the end of the
year, a gain of more than $13 million over the previous year. This was the result of
some new gifts to the Cold Spring Harbor Fund and another year of outstanding
investment results achieved by our investment manager, Miller, Anderson & Sher-
rerd. Total return for all of the Funds ranged from 32% to 33% compared to a
benchmark index return of 24.5%. The Laboratory continued its policy of reinvest-
ing a substantial portion of endowment income to provide for inflation and the fu-
ture growth of our research programs.
There were 53 meetings and courses held this year on the main Laboratory
campus and at Banbury Center. As in the past, they dealt with a broad range of
cutting-edge science and were attended by more than 5000 scientists from aca-
demia and industry. For the first time, our visitors enjoyed the new overnight ac-
commodations available in our five new cabins and Dolan Hall. Blackford Hall,
halfway through a major expansion of kitchen and dining space, was available for
uninterrupted meal service despite the inconvenience of ongoing construction.
Visitors and staff watched with growing anticipation the progress of what will
surely be a spectacular facility when completed in April, 1992.
The DNA Learning Center extended its program for high school and first-year
college students to include middle school children for the first time and moved
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of the year, plans were proceeding
for acquiring the present DNA Learning Cen-
ter from the Cold
Spring Harbor School District under terms of the pur-
chase option included in the current
lease. It is then intended to add a new addi-
tion to the rear of the building to
include a second teaching laboratory, lun-
chroom, and multimedia computer
facilities. A new exhibit dealing with the Hu-
man Genome Project and an auditorium are planned for the main building.
Following on the heels of two good years, the Cold Spring Harbor Laboratory
Press had a very difficult year in 1991. Book sales declined substantially with the
outbreak of war in the Persian Gulf and were adversely affected throughout the
year by the limited funding available to scientists for such purchases. A number
of important new titles scheduled for publication were delayed until 1992, further
subtracting from expected sales. The journal Genes and Development for the
second year in a row received "most cited" status in its field of genetics and de-
velopmental biology from the Institute for Scientific Information, and again earned
a surplus. The newly launched journal PCR promises to be a resounding success
in terms of both editorial and advertising content. Cancer Cells, however, after 2
years of competing bravely in an overcrowded market for cancer review journals,
was unable to make sufficient progress toward break-even operation and was
terminated with publication of a final issue in February, 1992.
As 1991 drew to a close, the Laboratory's first ever capital drive, the Second
Century Campaign, surpassed its goal of $44 million. With more than $46 million
in hand, including interest, the Campaign will now wind down as a last few pend-
ing, but important, solicitations are completed. Its successful conclusion
represents a monumental achievement on the part of David Luke III, the
Campaign Chairman, the Committee Chairs, Oliver Grace, Wendy Vander Poel
Hatch, George Cutting, Taggart Whipple, William Miller, and Townsend Knight,
and all the other volunteers. At a dinner this April, the Laboratory will express
some small measure of gratitude to those who have devoted so much time and
energy to this very large undertaking. Much credit is due to the Development Of-
fice and its Director, Konrad Matthaei. Konrad has left the Laboratory as planned
following the successful completion of the 3-year long Campaign, and he will be
greatly missed by his many good friends here and in the community. The Devel-
opment Department is now headed by Gordon (Skip) Hargraves, who joined us
in March of 1991 and was appointed Director of Development in January, 1992.
The task of raising capital for the Laboratory will continue on a more focused
basis, as of course it must. The need for additional endowment and facilities will
always be inherent at an institution as dynamic and forward looking as Cold
Spring Harbor Laboratory. In the future, there will also be increased emphasis on
raising unrestricted annual funds through annual giving. Such funds support our
scientists by providing fellowships and start-up laboratory equipment and sup-
plies, by bridging gaps between federal grants, and by maintaining many other
research support functions around the Laboratory.
Each year while tending to the Laboratory's administrative affairs I find my
task made immeasurably easier by the very capable and dedicated efforts of the
administrative staff. The Laboratory functions so well because of Bill Keen, Jack
Richards, Susan Cooper, Art Brings, Susan Schultz, Sande Chmelev, Cheryl Sin-
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clair, and Barbara Ward. Thanks also should go to Roberta Salant, who cares so
well for the needs of the Board of Trustees.
Special mention should be made of John Maroney who, in addition to admin-
istrative tasks, serves as in-house legal counsel and manages so very well our
technology transfer activities. John acts as interface between the scientific staff,
the Commercial Relations Committee, outside patent counsel, and the corporate
world. John's efforts have been instrumental in a substantial and growing stream
of royalty income which benefits both the Laboratory and its scientists.
Looking to the future, we must be concerned by the scarcity of funding for
basic research. On the one hand, political and business leaders point to biotech-
nology as the answer to depressed economies at the federal, state, and local
levels. Nations such as Japan and Germany target the industry as key to winning
the competition for a higher standard of living in the next century. Last year, the
American public invested some $3 billion in stock offerings of fledgling biotech
companies. On the other hand, there remains the serious need for a dependable
and growing source of support for the basic science that makes the industry pos-
sible.
G. Morgan Browne
BUILDINGS AND GROUNDS
The Buildings and Grounds Department had another busy year in 1991. With
completion of some buildings, new construction in progress, and the relocation
of many of the laboratory staff from one building to another, the workload on the
department was tremendous.
Three major ongoing projects occupied Buildings and Grounds during the
year: five new Log Cabins, the Neuroscience Building, and Blackford Hall. Two of
these projects, the Log Cabins and the Neuroscience Building, were finally com-
pleted in 1991.
Log Cabins
The first project to be completed was the five new Log Cabins situated above the
first complex of six cabins on the southwest edge of the Laboratory campus.
Water, electricity, gas, and telephone systems were installed by the different
Buildings and Grounds trades. Interconnecting boardwalks, including built-in
benches and a small community area with a telephone, were built between the
cabins. Finally, the area was landscaped and the roadway was finished, all in
time for the spring meetings.
31
Neuroscience Building
Most of the construction of the
laboratories and installation of the equipment Was
completed in March, and we
immediately began to move the scientists into their
new offices. At this point,
however, much work still needed to be done to
customize each laboratory area
before their staffs could move in. This customiza-
tion process included reworking
many of the support rooms, wiring the rooms for
emergency power, installing the pipes
for the benchtop utilities, and setting up
all
of the sophisticated scientific equipment.
Dan Marshak, John Anderson, and
James Pflugraph from Demerec
Laboratory were the first scientists to move into
their new laboratories in the Neuroscience
Building. While the relocation of equip
ment was in progress, the department was
also engaged in installing the com-
pressed air and vacuum systems, all of
which were in place before the courses
began. The building itself was also
undergoing final touches by both the con-
tractor and the department in order to
be ready for the May Dedication
Ceremonies.
The summer months continued to be just as hectic as the spring. In addition
to the ongoing relocation of our own scientists, new incoming scientists had to be
moved into Beckman Laboratory. The second floor of the Neuroscience Building
had to be specialized for the use of fruit flies as a research tool, which meant
adding environmental rooms; rewiring for emergency power; piping the carbon
dioxide, compressed air, gas, and vacuum to the benchtops; and installing the
new equipment.
Blackford Hall
The pace of the Blackford Hall project continued with little letup. The concrete
structure was completed just in time for the spring meetings. The "Open Air"
decks of the addition were used as temporary dining areas and were a pleasant
change from the tents used in previous years. After the meetings were over,
renovation of the lower level went into full swing. The bar was completed along
with the new lavatory facilities, and the mechanical equipment was relocated to
the new mechanical room. At the close of 1991, the lower dining room was com-
plete, and so were the recreation room and many of the support facilities. The
spring of 1992 should see the completion of the Blackford Hall project.
James, McClintock, and Demerec Play "Musical" Laboratories
James Laboratory: While work continued in the Neuroscience Building, we
revamped the old P-3 laboratory in James Annex, renovated the darkroom, and
added larger windows. Four of the postdoc offices were also renovated to ac-
commodate more staff. In addition, the painting throughout James Annex and the
second floor of Sambrook Laboratory was finished, the fume hood in Sambrook
was relocated, and the existing cold room was enlarged. After completing these
first steps, Bruce Stillman's laboratory was moved from Demereck Laboratory to
Sambrook, Nicholas Tonk's laboratory was moved from Sambrook to the newly
painted Demerec, and Mike Gilman's laboratory moved from Sambrook to the
third floor of James.
McClintock Laboratory: A decision was made during the year to renovate and
add to McClintock Laboratory. This meant that all of the scientific staff in the
building had to be relocated to other areas. Bob Franza's laboratory, the first to
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move out, was relocated to the second floor of Beckman Laboratory, and David
Beach's laboratory, as well as his laboratory in Demerec, was relocated to the
first floor of Beckman. As with the other areas in the new building, the Buildings
and Grounds trades had to reinstall all of the existing equipment from the old
locations, provide support utilities, complete the darkrooms, and make some
alterations to the support rooms.
Demerec Laboratory: When the laboratories in Demerec were emptied, the
Buildings and Grounds trades moved in to paint, add shelves, and complete
minor alterations, which included reworking two rooms into a microscope room
and a cell-culture room. Upon completion, Adrian Greider's laboratory was
moved in from Page Laboratory, Scott Patterson moved into the lower level of
Demerec, and Dave Helfman's and Dafna Bar-Sagi's laboratories were moved in
from McClintock Laboratory, leaving that building quite empty and lonely, but
ready for renovation in 1992.
Thanks for a Job Well Done
While all of the frantic activities described above were taking place, we were also
working on many small projects, namely, converting from oil to gas heating in
Nichols and Grace, altering the second floor of Wawepex from bedrooms to of-
fices, and moving 200 phone extensions. Every department in Buildings and
Grounds had a large part in completing all of these projects and bringing the
year of 1991 to a successful end.
The Equipment Repair Service received and is maintaining more scientific
equipment than ever before. It looks like more help will be needed for Cliff Sut-
kevich and Bob Borruso to keep up with the work load in 1992. The amount of
mechanical equipment has also increased, and our staff of mechanics, plumb-
ers, and electricians are doing an excellent job. Buck Trede and his grounds
crew have done a great job with maintaining the Laboratory's grounds, cleaning
up and putting in new plants in the spring, mowing and trimming in the summer,
raking and pruning in the fall, and shoveling and sanding the roads and walk-
ways through the winter months. In addition, they did a fine job of landscaping
the Cabin and Neuroscience Building areas.
The year 1991 saw big changes in the Carpentry department, beginning with
the hiring of Frank Russo in May. Three or four months later, we hired new men to
work with Frank, and we now have a most competent crew of carpenters. Never
before has the Receiving department delivered as much mail and material as it
did this year. Jim Sabin, Randy Wilfong, and Christopher Oravitz did a great job
in keeping up with the work load.
All of the Buildings and Grounds trades pitched in to help move the scientists,
equipment, and material without disrupting the course and meeting schedules or
the Dedication Ceremonies for the new Neuroscience Building. The entire staff
did a great job. They are real professionals and I wish to thank them for a job well
done.
Jack Richards
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DEVELOPMENT
Second Century Campaign
The Cold Spring Harbor Laboratory
Development Department came into being
initially to coordinate the Laboratory's
first capital drive, the Second Century
Campaign. In addition, it was
charged with expsatnedr i1n9g9a1nenduoan/dcmonytraindutitonnesinand
broadening its constituency.
Despite the lacklu
tense competition for the
philanthropic dollar, I am pleased to report that during
the year, more than $5,000,000
was added to the Campaign, surpassing our
original goal of $44,000,000. Initiated
in 1986, the Laboratory's first broad, public
funding campaign, has now raised
$45,965,194. Foundations, national and local,
those new to the Laboratory as
well as those familiar with it, have accounted for
slightly more than 50% of this amount. Laboratory
Trustees and other individuals
have accounted for approximately 40%,
and an ever widening group of corpora-
tions have contributed nearly 10%.
Campaign Chairman David L. Luke Ill and his
Steering Committee members, Oliver
R. Grace, George W. Cutting, Jr., Mrs. Sin-
clair Hatch, Townsend J. Knight, and
Taggart Whipple, provided enthusiastic and
dynamic leadership for the Campaign.
Fifty-five diligent and persistent volunteers
ably manned the six different Campaign
Committees (listed later in this report).
Through their efforts, three foundation challenge
grants were matched and count-
less new individuals and organizations were
made aware of the Laboratory's ex-
istence and its mission.
The Second Century Campaign was designed to raise money for new and
renovated facilities and for staff endowment. The Neuroscience Center, dedi-
cated in May, is an unusually powerful and prompt testimony of the Campaign's
success.
Several areas in the Neuroscience Center have been named as a result of
significant campaign gifts: Arnold and Mabel Beckman Laboratory (Arnold and
Mabel Beckman), Dolan Hall (The Dolan Family Foundation), The Gardner
Neuroscience Library (Mr. and Mrs. Robert B. Gardner, Jr.), The Hatch Recrea-
tion Room (Mrs. Sinclair Hatch), Hazen Tower (Lita Annenberg Hazen), Hughes
Teaching Laboratories (Howard Hughes Medical Institute), Keck Structural Biol-
ogy Laboratory (The W.M. Keck Foundation), The Plimpton Seminar Room (Mrs.
Pauline A. Plimpton and Mr. Amyas Ames), The Lucy and Edward Pulling Semi-
nar Room (Mr. and Mrs. George W. Cutting, Jr.), and The Whipple Lounge (Tag-
gart and Katharine Whipple). All donors of $5000 or more are being honored on a
permanent plaque in Grace Lobby. A complete list of all Second Century
Campaign participants may be found later in this report.
Annual Giving
Our Annual Giving program is an important source of unrestricted income. Under
the very able direction of Chairman George W. Cutting, Jr., and its 28 directors,
$354,750 was raised in Annual Giving (Jan. 1, 1991-Dec. 31, 1991), an increase
of 28% from the previous high. This was a truly remarkable achievement as this
program was run in direct competition with the capital campaign. Eighty percent
of this goal was achieved by the newly formed Associates Committee, deftly
chaired by John Reese. The Associates Committee is composed of David Bank-
er, Charles Gay, Missy Geddes, Dawn Kisner, Gordon Lamb, Carol Large, Harry
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Lee, Jordan Saunders, and Jim Spingarn. The Laboratory has the highest num-
ber of Associates it has ever had and is growing steadily.
In November, Chairman Cutting called his directors to a first-ever 2-day LIBA
Retreat in Harriman, New York. It proved to be an exceedingly stimulating,
thought-provoking meeting in which LIBA's strengths and weaknesses, threats,
and opportunities were thoroughly discussed. As a result, several changes of
structure and operation are being recommended to the Cold Spring Harbor
Laboratory Board of Trustees. (A complete report of the Long Island Biological
Association 1991 activities may be found in Financial Support of the Laboratory,
later in this Annual Report.)
Planned Giving
In addition to making outright gifts to the Laboratory, to take effect immediately
(cash, securities, insurance policies, real estate), gifts may also be made to take
effect in the future. These can be made in trust or by will. These gifts are most
often added to the Laboratory's endowment. Endowment means those funds of
the Laboratory's that are held and invested in perpetuity, with only the annual in-
vestment income being applied to the current operating budget. The mechanism
for two of these "planned gifts" is in place: the pooled income fund and the be-
quest. The Cold Spring Harbor Pooled Income Fund was established with the
U.S. Trust Company as its administrator. This allows individuals to give cash or
stock to the Laboratory that will be pooled with other such gifts. These funds are
then invested, and the donors (or the persons they designate) will receive the net
income from their share of the Fund for life. Afterward, the principal amount of the
gift is paid to the Laboratory. There are several significant benefits of making
such a gift: long-term stability for Cold Spring Laboratory, it in-
creases income for the donors or their relatives, it avoids capital gains tax, and it
provides an immediate charitable deduction for income tax purposes. With a low-
cost-based stock, for instance, it is now possible to make a gift to the Laboratory
and increase your income! Of course, the most frequently used mechanism is
that of the bequest, the basic building block of our budding Planned Giving ef-
fort. The excellence of an institution is almost directly proportional to the size of
its endowment. Please consider and urge your friends to consider making gifts to
Cold Spring Harbor Laboratory in their wills.
Staff
The considerable success of Development Department is due largely to its tiny,
but excellent, staff. The Department has effectively handled a variety of demands
from within and without the Laboratory and surpassed the Second Century
Campaign goal! Although limited in numbers, George Cutting, Claire Fairman,
Joan Pesek, and Debra Mullen were not in any way limited in their intelligence,
their energy, their dedication, their creativity, their responsiveness, and their
senses of humor.
We thank all who have supported the Laboratory in 1991. We urge those who
have not yet participated in our various donor programs to consider doing so in
1992. (Methods of giving either outright or by bequest are outlined under Finan-
cial Support of the Laboratory.) Your generous support honors our distinguished
reputation and ensures our vigorous future.
Konrad Matthaei
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LIBRARY SERVICES
Neuroscience Center Library Opens
In conjunction with the opening and dedication
of the Beckman Neuroscience
Center at the Laboratory, a
branch library was opened at the Center. Books and
reference materials are housed
in the Gardner Library and bound journals are
housed in the Pulling Seminar Room,
both of which have large windows overlook-
ing the harbor. Just off the stairway
from the main floor is a pleasant reading
room where current journals and newspapers can
be found.
The collection, comprised mainly of
books and journals, was transferred to
the Main Library in 1985 from the former
neuroscience library housed in the
McClintock building. Some new subscriptions,
books, and reference tools were
ordered in 1991, and, as the neurobiologists use the collection, it will be ex-
panded to meet their needs.
The move to the Center was efficiently accomplished by the library staff with
little or no disruption of library services at either
building. A job well done!
Archives Continue to be Active
It will be another 100 years before the archives will be used as much as they
were during preparations for the Centennial in 1990. There does, however, con-
tinue to be a great deal of activity that produces income for the Laboratory. The
number of photographs invoiced has more than doubled since 1988. Archives
showed a net profit of over $1500 in 1991. As the Laboratory gains more ex-
posure, calls for information and literature are also increasing.
Archives provided a work haven and resource center for Elizabeth Watson
during the writing of her book, Houses for Science. We prepared a photo essay
of Edward Pulling that has been hung in the Pulling Room in the Neuroscience
Center, and we provided the research for the Center's dedication booklet as well
The DNA Learning Center used the archives to research material for an exhibit on
Nobel and Lasker prize winners which will open there in 1992.
The opening celebration of New York Archives Week, sponsored by the Long
Island Archives Conference and coordinated by Laura Hyman, was held in Grace
Auditorium in October. The theme for the exhibits focused on the early years of
World War II. Lynn Kasso, who manages the archives, compiled an extensive
booklet entitled "Wartime Research at Cold Spring Harbor...1942-45." She also
borrowed a wonderful photograph called "Tea and Talk" from the Carnegie In-
stitution for the Conference. It features 15 Carnegie Institution investigators at an
informal talk, including Al Hershey and Milislav Demerec. A copy of this photo-
graph is being considered for permanent display in Bush Auditorium, where it
was taken in the 1940s.
Interlibrary Loans from Around the World
Wanda Stolen, who handles interlibrary loans, is now able to procure copies of
patents, theses, and foreign publications, as well as journal articles and books.
Searches go as far afield as the British Lending Library, and we are presently ne-
gotiating an agreement with the St. Petersburg Lending Library in Russia.
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Reference Services
INTERNET access played an important role in literature searching this year.
Scientists were able to do online searching from their personal computers by
connecting directly to the National Library of Medicine. The GENINFO databases
available include a subset of Med line designed for molecular biologists by the
National Biotechnology Center at NLM. GEN BANK, PIR, EMBL, Swiss Prot, HIV
Databases, Mendelian Inheritance in Man, Cloning Vector Database, and the
Brookhaven Protein Crystallographic Database are also available. The library has
been a beta test site for a subset of the Med line database on CD-ROM called
ENTREZ, which enables scientists to find related citations and associated se-
quences in protein and/or nucleotide databases.
Genemary Falvey, Head of Library Services, taught several GENINFO system
workshops to the scientific and administrative staff. She also serves as the beta
test coordinator between the Laboratory and National Library of Medicine and is
a member of the Laboratory's computer committee.
The Library's journal holdings were computerized in 1991 and will go online
next year. This will contribute to a more efficient system for both the user and the
library staff. Leigh Johnson efficiently but manually processes over 600 claims for
missing issues each year. This new system should greatly reduce the workload.
Several current awareness services were provided, and more than 3600
reference questions were answered by the library staff.
Space Needs
The Library and its staff continue to endure a critical lack of space. By 1995,
there will be no more room for the physical collection. Use of library services has
increased in proportion to the growth of the Laboratory. Additional staffing and
equipment will be required to handle this increase, and there is no room to put
people or machinery.
The time has come to address the need for a dedicated library to comple-
ment its dedicated staff.
Susan Cooper
PUBLIC AFFAIRS
Neuroscience Center Opens
The final observance of the Laboratory's three-year Centennial celebration con-
cluded with the dedication of the Neuroscience Center in a two-part ceremony
that began on April 27, 1991. Dr. Arnold Beckman, who accepted our invitation to
join the Laboratory's Trustees at the ribbon-cutting ceremony, attended with his
daughter Pat and cut the ribbon to officially open the Arnold and Mabel Beckman
Neuroscience Center. A specially engraved pair of ceremonial scissors was pre-
sented to Dr. Beckman. Afterward, his portrait was unveiled in the Center's main
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floor lobby, as Dr. Watson
offered a champagne toast. This ceremony was fol
lowed by a luncheon in the new
Plimpton seminar room with the Trustees and
guests.
Just six days later, on May 3,
1991, 500 friends and contributors were present
for the second part of the dedication
of the Neuroscience Center. Among the
speakers were Dr. Susan Hockfield,
who described the history of neurobiology at
the Laboratory, Dr. Max Cohen, who
discussed the future of neuroscience, and
Dr. Stephen Heinemann, who related his
experience as one of the students in the
Laboratory's first neurobiology course.
Keynote speaker U.S. Congressman
Robert Mrazek spoke in support of
government funding for science. On a lighter
note, he shared with the audience his
experience of mowing lawns at the
Laboratory as a teenager.
The Public Affairs staff produced the dedication
booklet for the event, includ-
ing three other pieces that detailed the
individual components of the Neuro-
science complex. In record time, Margot
Bennett designed each of the four
pieces: Beckman Neuroscience Center,
Dolan Hall, Hazen Tower, and The
Neuroscience Center Dedication.
Staff Moves On and Moves In
Following the dedication of the Neuroscience Center, Emily Eryou, true to her
conviction that she would join her husband to run their specialized engineering
consulting firm, completed her successful career at the Laboratory on May 24,
She began working in the Laboratory's library in 1987 and joined Public Affairs in
1988 where she projected the patience of Job, the wit of Lucille Ball, and her own
brand of grace that mobilized the staff to produce the Centennial. Emily's last
task was to train Lisa Gentry, who began working as the assistant in Public Affairs
on April 29. Before coming to the Laboratory, Lisa worked for ABC Sports in New
York, where she was an assistant director. As a freelance public relations person,
Lisa designed advertising campaigns for New York retailers; prior to coming to
New York, she was chairman of broadcasting at Fugazzi College in Lexington,
Kentucky, where she taught courses in radio and television. Her background at
ABC matched our need for the difficult multi-tasking done by our department.
Lisa handles the requests from both television and radio, and her teaching back-
ground lends a helping hand to the Partners for the Future program for which she
has complete responsibility.
David Siegel, science writer from September to May, left to pursue a degree
in law. Nathaniel Comfort came to us from Cornell University, where he earned
his Master's degree in neurobiology, to take on the responsibility of communicat-
ing the Laboratory's science to our lay audience. Nathan was associate editor of
The Living Bird Quarterly at Cornell, where he wrote extensively; this coupled with
his neuroscience background and a substantive body of freelance writing makes
him eminently qualified to expand the Laboratory's reading public.
Because of these staff changes, we relied heavily on Clare Bunce, who
shares her time between the Library and Public Affairs. Clare capably handled
the details of public information and kept work moving while the new people
learned their jobs. Help was also received from four wonderful volunteers. Jim
Kurfess, who has been working for the department during winters since the be-
ginning of our Centennial planning, now proofreads, stuffs envelopes, answers
phones, and generally supports the work of Public Affairs. Katya Davey, who has
her own full-time job at Robertson House, still finds time to affix labels for the Har-
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bor Transcript; Mia Hao-Peng, a high school student, volunteered during the
summer and did anything we asked. She was solely responsible for the inventory
of our postcards and note cards. James Elkus, a prep school student and
talented photographer, had the opportunity to take pictures during meetings and
work in the Laboratory's bookstore.
New Pieces Produced
The third edition of F.A.C.E.S. will be distributed in January 1992; more than 130
new photographs were taken to complete this printing. Since the staff moved
from a variety of places to the new Neuroscience Center and to Wawepex, it was
difficult to place the faces with the right buildings.
Several brochures and flyers were updated in 1991. An especially nice
brochure detailing the planned renovation of McClintock Laboratory was a com-
bined effort between Bill Grover of Centerbrook Architects, who provided the
beautiful poster that became the cover art, and Margot Bennett and Nathaniel
Comfort, who designed and wrote the piece. Margot also created the 1992 meet-
ings and courses posters, due out in December and January. This year, we have
a new poster that combines the information from neurobiology and the molecular
biology posters of the past. This "all courses poster" includes the new spring and
fall listings as well. Three Harbor Transcript issues were generated in 1991; the
third and fourth issues were combined because of staff changes and delayed
hirings. Mailing of the Transcript has been simplified through Lisa Gentry's per-
sistence and sound investigation. We have found an exceptional mailing house
that handles all of our bulk mailings at an affordable cost, saving countless hours
of staff time.
Media Mentions
Without the Centennial, it would seem that there might be less all-around
coverage, but this does not appear to be the case. The Laboratory was featured
in more than a dozen articles and mentioned in more than 100 others. Our senior
scientific and administrative staffs cooperate regularly with the Public Affairs
staff, fielding a wide variety of queries by the press. Dr. Watson had another ac-
tive press year, producing an additional 40 mentions in 40 newspapers and mag-
azines. Key articles appeared in Forbes, Nature, Science, Newsday, The New
York Times, and The Wall Street Journal, as well as many in local Long Island
newspapers and magazines.
Our newest celebrities are Houses for Science and its author Elizabeth Wat-
son. A half dozen reviewers and reporters interviewed Mrs. Watson, and as of
this writing, 11 articles and reviews have appeared. We anticipate an extensive
article in Newsday on the growth of the Laboratory as seen through this new
book. The literary press, book buyers, and the interested public were exposed to
our "best book" of the season at several parties organized by the Publications
and Public Affairs Departments. In Grace Auditorium, members of the Long Is-
land Biological Association heard Michael Crosbie (Senior Editor of Architecture
magazine) address "Science and Architecture." At a Lloyd Harbor seminar featur-
ing Mrs. Ann Gill, Executive Director of the Whaling Museum, Mrs. Watson un-
veiled freshly printed copies of her book and talked about some of the interesting
historical findings she discovered. At the Century Club in Manhattan and the
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Travellers' Club in London, Dr.
and Mrs. Watson hosted friends and publishing
colleagues at inaugural parties
for Houses for Science.
Other Events
Art Brings, the Laboratory's director
of Environmental Health and Safety, worked
with the Occupational Safety and
Health Administration (OSHA) to co-sponsor a
meeting entitled "Safety and Health
and the Working Woman." Public Affairs also
assisted the Development department in
planning the exhibit of miniature rooms
designed by Mrs. Eric Ridder.
At each event, every meeting, and all
of the courses, indoors or out, Herb
Parsons and Ed Campodonico, our
audiovisual team, are there to manage the
special sound, lights, and equipment
needs. This year, during some very difficult
times for Herb Parsons and his family, Ed
Campodonico often worked 7 days a
week to keep up with the demands in
the AV department. His loyalty and good
common sense kept everything on schedule.
Special Tours
In addition to our regularly scheduled tours held four times each year, Public Af-
fairs provides tours for various individuals and special groups. This year, among
the more than 20 tours scheduled, we hosted the USA-Soviet Running Cultural
Exchange, providing a tour led by visiting scientist Nikolai Lisitsyn. The Friends of
the UN were treated to a very special tour by Elizabeth Watson, and a class of
young women from Georgian Court College, studying maize genetics and Bar-
bara McClintock, were given a talk by Rob Martienssen from the Laboratory's
plant group.
Plans for New Materials
In 1992, we will be creating a new press kit for use by both the Development and
Public Affairs Departments. The kit will contain two new four-color brochures:
One will detail the many facets of Cold Spring Harbor Laboratory and illustrate its
accomplishments and its beauty and the other will be a brief introductory flyer.
Supplementing these pieces will be detailed flyers on each of our scientifc pro-
grams. Rounding off the package will be a revision of the walking tour brochure.
We look forward to a busy year of events planning, writing, and design.
Susan Cooper
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RESEARCH
Top row: Vincent Jung, Carol Greider, Nouria Hernandez
Middle row: John Horton, David Helfman, Stephen Bell
Bottom row: Jeff Kuret, Nancy Walworth, Hong Sun
TUMOR VIRUSES
Research in the Tumor Virus Section covers a broad sweep of topics in
eukaryotic molecular biology. Originally, this work was tightly focused on the in-
vestigation of cellular transformation and gene expression in mammalian cells,
studied principally through the medium of two DNA tumor viruses, adenovirus
and SV40, and funded by a single large program project grant. Transformation
remains a central theme, but the work has now expanded in its scope and diver-
sified to embrace additional viruses (human immunodeficiency virus type 1 and
bovine papillomavirus) and simpler model systems such as yeast. Eight labora-
tories participate in this section, and their reports follow in the order listed.
Bruce Stillman's laboratory (DNA Synthesis) is dissecting the mechanism of
DNA replication and chromosome assembly in mammalian and yeast cells
with a view to understanding how the genetic blueprint is duplicated from
generation to generation.
Arne Stenlund's group (Molecular Biology of Bovine Papillomaviruses) is
characterizing the viral elements that control gene expression and DNA
replication in an animal virus that is closely related to the human papil-
lomaviruses associated with warts and carcinomata.
Work in Elizabeth Moran's group (Adenovirus Transforming Functions) is
defining the pathway whereby the protein encoded by an adenovirus on-
cogene interacts with cellular proteins and modulates the activity of cellular
transcription factors, thereby contributing to cell transformation.
Together with their co-workers, Michael Mathews, Michael Laspia, and Gilbert
Morris (Protein Synthesis) are investigating the transcriptional and transla-
tional alterations of cellular metabolism produced by adenovirus and HIV-1
gene products.
In Adrian Krainer's group (RNA Splicing), attention is devoted to messenger
RNA splicing, whereby the information present in the primary transcript of a
gene is edited, with a view to understanding the mechanism and control of
this process.
Winship Herr and Masafumi Tanaka (Transcriptional Regulation) and their fel-
low workers are exploring the regulation of gene expression at the transcrip-
tional level, focusing on the structure and function of viral and cellular tran-
scription factors.
Daniel Marshak and Ryuji Kobayashi with their colleagues (Protein Chemistry)
are applying sophisticated protein chemistry techniques to illuminate issues
of signal transduction and cell growth control.
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DNA SYNTHESIS
B. Stillman G. Bauer A. Dutta
S.P. Bell T. Melendy
S. Brill J.M. Ruppert
S.-U. Din S. Waga
F. Bunz
K. Fien
Y. Marahrens
We continue to seek a better understanding of the
mechanism and regulation of DNA replication. As in
past years, our studies have focused heavily on the
replication of DNA tumor virus chromosomes, with
the ultimate goal of transferring this knowledge to
understand the replication of cellular chromosomes.
Toward this end, we have increasingly studied DNA
replication in the yeast Saccharomyces cerevisiae be-
cause it offers a wonderful mix of biochemical and
genetic approaches. Information obtained with this
experimental system can then be used to better under-
stand DNA replication in human cells. This year has
produced new results that should be of great import
in the future.
SV40 DNA Replication
F. Bunz, L. Borzillo, T. Melendy, M. Ruppert,
S. Waga, B. Stillman
The small double-stranded DNA chromosome con-
taining the genetic information for simian virus 40
(SV40) replication contains a single origin of DNA
replication (ori) where initiation of DNA synthesis
begins. The virus encodes a single protein that is re-
quired for DNA replication, the SV40 large tumor
antigen (TAg). This initiator protein recognizes the
ori and initiates a series of complex events that
ultimately lead to the unwinding of ori and the
bidirectional replication of DNA.
During the past 6 years, we have concentrated on
identifying cellular DNA replication proteins from
human cells that combine with TAg to replicate DNA
containing the SV40 ori. Seven proteins or activities
have been described in detail in previous Annual
Reports. When combined, these replication factors
will support initiation and elongation of DNA
replication. The products, however, are not the same
as the products obtained when the crude cellular ex-
tract is combined with TAg, and we continue to
search for cellular DNA replication proteins that will
yield completely replicated DNA.
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H. Rao
L. Borzillo
N. Kessler
A new replication activity called MF1 has been
purified to apparent homogeneity. This DNA replica-
tion factor is required, together with the previously
identified replication factors and other partially
purified proteins, for complete replication of template
DNAs containing the SV40 ori. The DNA products
of this highly fractionated system contain covalently
closed, circular DNA that is identical to the products
obtained with the crude cell extract in vitro or follow-
ing DNA replication in vivo. MF1 has a 5 ' to
3' exonuclease activity and is similar to a DNA
replication exonuclease identified in J. Hurwitz's
laboratory.
Detailed studies on the functions of the cellular
proteins required for SV40 DNA replication in vitro
continue. DNA-binding studies with the purified
proteins replication factor C (RFC), proliferating cell
nuclear antigen (PCNA), and RPA (formerly called
RFA) and DNA polymerases a and 8 have revealed
an ordered assembly of these proteins onto the
replication template DNA. Other studies have shown
that polymerase a binds to SV40 T antigen, probably
reflecting the mechanism of assembly of this DNA
polymerase onto the template DNA when TAg and
RPA are bound to ori. Following the assembly of this
initiation complex, other replication factors are as-
sembled onto the DNA. We have demonstrated that
RFC binds to the primers made by DNA polymerase
a-primase complex and that PCNA can subsequently
bind RFC. The assembled PCNA/RFC primer recog-
nition complex is then recognized by DNA poly-
merase 8. Together with RPA coating the single-
strand template DNA, the RFC/PCNA/polymerase 8
multiprotein complex functions as a processive
leading-strand DNA polymerase complex (Fig. 1).
These results, coupled with our studies over the past
3 years, have clearly demonstrated that DNA poly-
merase 8 functions as the leading strand polymerase.
Recently, Akio Sugino and his colleagues have found
that a third DNA polymerase, polymerase E, is essen-
tial for growth of the yeast S. cerevisiae. However,
addition of polymerase e purified from human cells
(obtained from S. Linn) has failed to produce any ef-
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FIGURE 1 Model for the function of RFC and PCNA in loading DNA polymerase 6 onto a DNA
replication fork. (From Tsurimoto and Stillman, J. Biol. Chem. 266: 1967 [1991].)
fect on SV40 DNA replication in vitro. Thus, the role
of polymerase E in cellular DNA metabolism remains
to be determined.
Cellular DNA Replication
S. Bell, S. Brill, K. Hen, Y. Marahrens, B. Stillman
Substantial progress has been made in the past year in
our attempts to understand the mechanism and
regulation of cellular DNA replication. We have
taken a number of paths to approach this complex
problem, and all have yielded interesting new results.
The first of these approaches was to identify and
characterize functional homologs of the cellular DNA
replication factors that are required for SV40 ori-
dependent DNA replication. Because the yeast S.
cerevisiae offers an excellent combination of
biochemical and genetic approaches, we have sought
to purify these replication factors from S. cerevisiae,
clone the genes encoding these proteins, and study
the role of these proteins in the S phase of growing
cells. RPA from S. cerevisiae was purified previous-
ly, and the genes encoding the three subunits have
been cloned. A genetic analysis is currently under
way. Most recently, we have purified the S.
cerevisiae homolog of RFC and have shown that the
multi-protein complex has all of the functions found
with the human RFC, including a DNA-dependent
ATPase activity, a primer-template DNA-binding
function, and the ability to stimulate DNA poly-
merase 8 activity in cooperation with S. cerevisiae
PCNA and RPA. Except for the 5 ' to 3' exonuclease
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activity (MF1), all of the known
cellular DNA
replication proteins required for SV40
ori-dependent
replication have been purified from S.
cerevisiae by
our laboratory or others, and we are
currently con-
centrating on cloning the genes encoding these
proteins so that their function in the cell can be
studied genetically.
A second approach to understanding cellular
DNA replication, and particularly initiation,
has been
to characterize fully a cellular origin of DNA replica-
tion. In last year's Annual Report, we described the
identification of multiple cis-acting elements that
contribute to the function of the cellular DNA
replication origin ARS]. Four functional elements
were identified, one of which was essential for ori
function and was designated element A (Fig. 2). This
element contained the previously recognized ARS
consensus sequence that is found in all origins of
DNA replication in S. cerevisiae. The other three ele-
ments, designated B1, B2, and B3, were individually
not essential, but when each one was mutated, ori
function was reduced. Interestingly, mutation of any
combination of two of the B elements rendered the
cellular ori nonfunctional. We have now determined
probable functions for each of the four ori elements.
Element B3 was shown to bind the cellular tran-
scription factor, ori-binding protein called ABF1.
ABF1 was initially identified in our search for cel-
lular origin-binding proteins and by numerous other
laboratories as a transcription factor that activates
cellular genes. We have now been able to replace the
ABF1 DNA-binding site within element B3 with the
binding sites for other S. cerevisiae transcription fac-
tors, including RAP1, GAL4, and a hybrid LexA-
GAL4 fusion protein. The observation that all of
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FIGURE 2 Summary of the structure of the ARS1
chromosomal origin of DNA replication. The four func-
tional elements A, B1, B2, and B3 are indicated by boxes.
Elements A and B2 contain 11/11 and 9/11 matches to a
sequence found in all S. cerevisiae origins of DNA replica-
tion. The binding sites for two origin-binding proteins,
ABF1 and ORC, are shown. Under some circumstances,
ORC binds to the B2 element in addition to binding the Aand B1 elements. Arrows represent protein induced
DNase I hypersensitive sites.
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FIGURE 3 Glycerol gradient sedimentation of purified
ORC protein. (a) SDS-polyacrylamide gel of the proteins
in each fraction; (b) DNase I footprint.
these proteins stimulated oni function led to the sug-
gestion that transcription activation domains present
on these transcription factors activate DNA replica-
tion from cellular origins. A similar activation of
DNA replication by transcription factors has been ob-
served with several eukaryotic virus genomes.
Perhaps the most interesting observation was the
recent discovery of a multiprotein complex that
recognizes the essential A domain and interacts with
both the B1 and B2 elements (Fig. 3). This multi-
protein, origin recognition complex (ORC) binds in a
sequence-specific manner to the A element. Muta-
tions in this element that reduce or eliminate origin
function also reduce or eliminate ORC binding to ori,
respectively. Thus, there is a precise correlation be-
tween origin function and ORC binding. Further-
more, we have found that ORC binds to all origins of
DNA replication (ARS sequences) that have been
tested, including ARS1 , ARS307, H4ARS, ARS121,
HMR E ARS, and the 2 LM plasmid ARS.
In the studies of the DNA-binding properties of
ORC to the origins of DNA replication, an unusual
DNA-binding property was revealed. ORC requires
ATP for its sequence-specific DNA binding to the
origins of DNA replication. This mode of DNA bind-
ing is unusual and perhaps unique, placing ORC in a
new class of nucleotide-dependent, sequence-specific
DNA-binding proteins.
These data strongly implicate ORC as the initiator
protein for eukaryotic chromosomes, analogous to
other well-characterized initiator proteins such as
SV40 TAg, Escherichia coli DnaA protein, and bac-
teriophage X 0 protein. The identification of homo-
logs of S. cerevisiae ORC in metazoan species should
facilitate the identification of replicator sequences
that have heretofore remained elusive.
Regulation of DNA Replication
S.-U. Din, A. Dutta, B. Stillman
One of the cellular DNA replication proteins, RPA, is
involved in the early stages of unwinding the SV40
ori with TAg. We had demonstrated previously that
one of the three subunits of RPA, the RPA 34K
protein, is phosphorylated in a cell-cycle-dependent
manner. The protein was not phosphorylated during
the G1 phase, but it was phosphorylated in the S and
G2 phases of the cell cycle in proliferating cells. Both
the yeast and human RPA 34K subunits were
phosphorylated in this manner.
Experiments during the past year have continued
to explore the functional significance of this
phosphorylation. Detailed timing studies with syn-
chronized human cells revealed that RPA first be-
comes phosphorylated at the G1 /S -phase transition,
and the increase in RPA phosphorylation parallels the
onset of S phase. Phosphopeptide analysis demon-
strated that RPA was phosphorylated on multiple
serine residues, and this pattern of phosphorylation
was constant throughout the S and G2 phases of the
cell cycle.
To identify the protein kinases that phosphorylate
RPA, large amounts of the human RPA protein were
purified and used as a substrate to search for RPA
kinases that are in human cell extracts. Three separate
activities have been extensively purified, one of
which has been identified as the human cdc2/ cyclin
protein kinase. This kinase, which associates with
different cyclin subunits in a cell-cycle-dependent
manner, phosphorylates a subset of the phospho-
serines present in the human RPA 34K subunit.
These cdc2 kinase sites have been mapped, and muta-
tion of these residues, using the human cDNA clone
encoding the RPA 34K subunit (obtained from L. Er-
dile and T. Kelly), blocked all phosphorylation of
RPA when the cDNA was transfected into mouse
cells. This suggests that phosphorylation of the 34K
subunit by cdc2 kinase might be critical for all sub-
sequent phosphorylation and for the function of the
protein. A full characterization of these mutants is
under investigation.
As previously demonstrated by J. Roberts and his
colleagues, we have shown that addition of the hu-
man cdc2/cyclin kinase to extracts prepared from hu-
man cells that were in the G1 phase of the cell cycle
stimulated SV40 DNA replication. The G1 extracts
otherwise have a low specific activity for DNA
replication compared to similar extracts made from
S-phase cells. Recently, we have carried this further
and demonstrated that the cdc2 kinase stimulated the
ori unwinding reaction that is dependent on TAg and
RPA. Indeed, the cdc2 kinase was required for ori
unwinding if an extract from G1 -phase human cells
was included in ori unwinding reactions containing
RPA and TAg. We are currently attempting to identi-
fy the component(s) in this extract that causes initia-
tion to be absolutely dependent on cdc2 kinase.
Chromatin Assembly
G. Bauer, N. Kessler, B. Stillman
In the presence of a purified protein called chromatin
assembly factor 1 (CAF1), plasmids containing the
SV40 ori replicate and assemble into a chromatin
structure that is identical to the structure of cellular
chromatin. Chromatin assembly is dependent on con-
comitant DNA replication, and we have demonstrated
that CAF1 functions to assemble histones H3 and H4
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onto the DNA. Histones H2A and H2B are then as-
sembled to complete the nucleosome in a reaction
that is independent of ongoing DNA replication.
Purified CAF1 contains multiple protein subunits
of 150K, a triplet at 62K, 60K, and 58K, and another
subunit of 50K molecular weight. To study the func-
tion of the CAF1 protein further, we have prepared a
series of monoclonal antibodies that independently
recognize either the 150K or the 62K-58K proteins.
Immunoprecipitation studies demonstrate that all of
the CAF1 subunits form a complex. Interestingly,
however, the 150K subunit appears to be in excess
amounts that are not associated with the 62K-58K
proteins, suggesting that in addition to being a CAF1
subunit, it may be bound to other proteins. In support
of this, we have found that the monoclonal antibodies
that recognize the 62K-58K proteins will im-
munoprecipitate all of the CAF1 activity present in
nuclear extracts, but they will not deplete all of the
150K protein present in these extracts. These
monoclonal antibodies have also been useful reagents
to begin cloning cDNAs encoding the multiple CAF1
proteins. To date, we have obtained a partial cDNA
encoding the 150K subunit.
In addition to CAF1, other proteins are required
for the replication-dependent assembly of chromatin
in addition to the DNA replication factors them-
selves. We have extensively purified a second such
activity called CAF2 and have demonstrated that
CAF2 interacts with CAF1. We are in the process of
trying to identify the proteins that constitute CAF2
and determine the biochemical function of these
proteins.
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MOLECULAR BIOLOGY OF BOVINE PAPILLOMAVIRUS
A. Stenlund M. Ustav
P. Szymanski
E. Ustav
L. Gandhi
The papillomaviruses are a large family of closely re-
lated, small DNA viruses that infect a variety of
mammalian hosts. These viruses all carry transform-
ing genes that are expressed in the natural course of
infection and result in the production of (usually)
benign tumors. In recent years, the human papil-
lomaviruses have been recognized as a major cause
of disease and have therefore attracted considerable
attention. Bovine papillomavirus (BPV) has come to
serve as the prototype virus for the papillomavirus
group because a part of the viral life cycle for this
virus can be reproduced in tissue-culture cells. Our
interest in this virus is specifically related to the
ability of the viral DNA to persist as a stably replicat-
ing plasmid in BPV-transformed cells. This capacity
for regulated replication appears to be intrinsic to
BPV and has been suggested to take place in two
stages. In a hypothetical stage I, the viral DNA enters
the cell and is replicated at a rate more rapid than that
of the cellular DNA (more than once per cell cycle),
resulting in an amplification of the viral DNA and an
increase in the viral copy number to approximately
100 copies per cell. In stage II, which corresponds to
the state of the viral DNA in BPV-transformed
mouse cells, the viral DNA persists over many gener-
ations without apparent loss or change in copy num-
ber. We refer to stages I and II in our terminology as
amplification and maintenance, respectively.
In last year's Annual Report, we described the de-
velopment of a short-term replication assay that we
designed and used to define the replication apparatus
of BPV. This assay has allowed us to initiate a
detailed study of the viral trans-acting factors and
cis-acting elements that are required for replication of
BPV. The assay was developed expressly to study the
early events (stage I, amplification) and measures
primarily the requirements for initiation of replication
and DNA synthesis. With the use of this assay, we
have identified the two viral polypeptides, El and E2,
that are required for replication and also defined the
necessary cis-acting elements. During the past year,
we have concentrated our work on the functional role
of these two polypeptides and their interaction with
the on sequence.
Maintenance replication (stage II) has always
been assumed to involve a number of functions in ad-
dition to DNA synthesis. These include copy number
control, segregation control, and mitotic stability,
which are not readily measured in the short-term
replication assay. However, our description of
amplification replication has allowed us to create an
assay where we provide the stage I functions and then
ask specifically what additional functions are re-
quired for maintenance replication. This year, we
have therefore initiated studies to determine what
viral components, if any, are required specifically for
maintenance replication.
In addition, we have expanded our scope, and in
collaboration with the laboratory of L. Chow and T.
Broker (University of Rochester Medical Center), we
have addressed the issue of how representative BPV
is for the large group of human papillomaviruses in
terms of viral replication. These studies indicate re-
markable similarities between these viruses and
clearly validate BPV as a model for papillomavirus
DNA replication.
Role of El and E2 Polypeptides
in DNA Replication
M. Ustav, P. Szymanski, E. Ustav, A. Stenlund
Our initial in vivo studies demonstrated that the two
viral polypeptides, El and E2, were necessary and
sufficient for replication of BPV in tissue-culture
cells. A commonly encountered role of viral replica-
tion factors is to recognize the cis-acting sequence in
the DNA where replication will be initiated. Due to
the large number of binding sites for the E2 polypep-
tide in the viral genome, it seemed unlikely that the
E2 polypeptide could serve as an on recognition fac-
tor in spite of the presence of an E2-binding site in
the minimal on sequence. The other required
polypeptide, El, had previously been shown to bind
nonspecifically to DNA. We therefore decided to ask
directly if the El polypeptide could bind to the origin
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region. To generate a convenient source
of El
polypeptide, we used an Escherichia colt
expression
system. The El polypeptide, tagged
with an epitope
from the influenza hemagglutinin (HA),
was used for
DNA precipitation assays, with a
monoclonal anti-
body directed against the epitope tag.
Using this pro-
cedure, we showed that the El protein in
addition to
its nonspecific DNA-binding activity
specifically
recognized a single sequence in the viral
genome, lo-
cated in the origin region. By using
DNase footprint
analysis and methylation and ethylation
interference
analyses, we found that the recognition
sequence was
located in the center of the minimal on fragment,
overlapping an interrupted palindrome
(Fig. 1).
Mutations in this palindrome that affected
binding of
El also affected DNA replication. On the
basis of
these results, we concluded that El functions
as the
viral on recognition factor.
The role of the E2 polypeptide was investigated
initially by generation of deletion mutants in the E2-
Top strand
I +El II -El I
011,41.1111POP
alb ---
ilmor gr.Jig
AGACTATGTATTITTICCCAGTGAATAATTGT
coding sequence.
These mutants were subsequently
tested for their ability
to support replication and to
trans-activate
transcription when expressed from a
heterologous
expression vector. The deletion mutants
were designed to
affect the amino-terminal part of the
protein that has been
shown to be required for trans-
activation, as well as the carboxy-terminal part of the
protein that contains sequences
required for DNA
binding and dimerization. All
deletions were, as ex-
pected, defective for trans-activation.
Interestingly,
all mutants were also defective
in their ability to sup-
port replication,
indicating that sequences both from
the amino-terminal
trans-activation domain and from
the carboxy-terminal
DNA-binding/dimerization do-
main were important for replication. To determine if
the trans-activation
function per se was of impor-
tance, we tested a chimeric protein consisting of the
trans-activation domain of the herpesvirus protein
VP16 fused to the DNA-binding domain of E2. This
construct was capable of activating transcription but
Bottom strand
I +El II -E1 I
4.0 4WD 1101104P
aiggp UMW
0141.1* 0110.0
NNW 01011.
4/IN 41,110.
MSS"
ATAATCAC ACCATCACCGTT
E2 BS 12
FIGURE 1 El binds specifically to the minimal origin region. DNase footprint assays were used to determine
the specific binding site for the El polypeptide. The protected regions on each strand are indicated by a
hatched bar, and the actual sequence protected is shown below.
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ACCATCACCGTT
was not able to support replication, indicating that the
trans-activation function was not sufficient for
replication but that, more likely, a specific domain of
the amino-terminal portion of E2 was required. To
determine if the lack of function of the carboxy-
terminal deletion resulted from the loss of DNA-
binding ability or was caused by the inability of the
protein to form dimers, we wanted to generate muta-
tions in this region that would affect DNA binding
but not the ability to dimerize. Therefore, point
mutants were generated in conserved motifs in the
carboxy-terminal part of E2, and the resulting
mutants were tested for their ability to bind to DNA
and subsequently tested also for their ability to
dimerize in an in vivo dimerization assay, since
dimerization is a prerequisite for DNA binding.
Mutants that were capable of dimerization but were
defective in their ability to bind DNA were chosen
and tested for their ability to support replication. A
perfect correlation was observed between the DNA-
binding ability and the ability to support replication.
These results indicate strongly that the DNA-binding
capacity of E2 is required for DNA replication and
that both the El and E2 polypeptides are required to
bind to the ori region.
Definition of the cis-acting Elements
Required for Replication
E. Ustav, M. Ustav, A. Stenlund
Our previous studies had demonstrated that the cis-
acting elements required for replication were con-
fined to an approximately 100-nucleotide sequence
located between the E2-dependent enhancer of BPV
and the early coding sequences. We have continued
the mutational analysis of this region by generating
deletions and point mutations. Deletion analysis from
either end of the fragment resulted in a minimal on
fragment of approximately 60 nucleotides (Fig. 2).
This sequence contained three recognizable elements:
an A/T-rich region, a palindromic element, and a
low-affinity E2-binding site. The palindromic se-
quence was identified as a binding site for the El
polypeptide (see above), and point mutations within
this element that affected binding of El in vitro also
affected DNA replication. Our initial mutational anal-
ysis indicated that mutations in the E2-binding site
that rendered E2 binding to this site undetectable still
allowed replication of the origin fragment, which led
us to the conclusion that binding of E2 to the on was
not required for replication. However, on the basis of
the results obtained with mutations that rendered the
E2 polypeptide defective for DNA binding (see
above), we suspected that this conclusion was in-
correct. Further mutational analysis of the E2-binding
site, with mutations that either increased or decreased
the affinity of E2 for the site, showed good correla-
tion between how well E2 supported replication and
the strength of the E2-binding site. These results indi-
cated strongly that binding of E2 to the on sequence
was necessary for a functional ori. This conclusion
was further supported by experiments showing that a
deletion of the entire E2 BS12, which was inactive
for
by insertion of an unrelated E2-binding site at a.dif-
ferent position in the plasmid. This apparent para-
dox-that the E2-binding site, even when mutated so
that binding of E2 in vitro could no longer be
detected, still appeared to be functional-indicated a
stabilizing interaction with another DNA-binding
component in vivo. To address this question, we gen-
erated a series of ori constructs in which we inserted
a spacer sequence between E2 BS12 and the
palindrome that serves as a recognition sequence for
El binding. Insertion of a 10-bp spacer resulted in
loss of ori function with the low-affinity E2 BS12,
whereas high-affinity E2-binding sites functioned at
AGACTATGTATTTTTTCCCAGTGAATAATTGTT GTTAACAATAATCAC
A/T-rich region
1 4111 E2 BS 12
El BS
FIGURE 2 DNA sequence of the minimal ori. The 60-bp minimal ori region contains three recog-
nizable elements: an ALT -rich region of unknown function, an inverted repeat that serves as a
recognition sequence for binding of the El polypeptide (El BS), and a low-affinity binding site for
the E2 polypeptide (E2 BS 12).
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considerably greater distances. These results were
consistent with an interaction between
the E2
polypeptide and another component of the replication
machinery, resulting in a stabilization of the E2 inter-
action with a low-affinity binding site. A potential
partner in this interaction is the El polypeptide,
which has been reported to interact with E2 in vitro
by M. Botchan and colleagues (University of Califor-
nia, Berkeley).
Maintenance Replication
M. Ustav, A. Stenlund
A unique and interesting aspect of BPV replication is
the ability of the viral genome to persist in BPV-
transformed cells by replicating as a nuclear plasmid
with a constant copy number under cell cycle control.
To study this particular aspect of BPV replication
that we call maintenance, we have started to design
experiments addressing the requirements for main-
tenance replication. The following are the initial
questions that we asked: (1) Are viral gene products
other than El and E2 required? (2) Are cis-acting se-
quences other than the minimal ori required? (3) Can
maintenance be achieved without the transcriptional
control that is normally provided when El and E2 are
expressed from the viral genome? Our strategy to ad-
dress these questions has been to establish stable cell
lines that constitutively express the El and E2 poly-
peptides transcribed from heterologous promoters.
We chose Chinese hamster ovary (CHO) cells for this
purpose since these cells support short-term replica-
tion of BPV efficiently and also can be transfected
with virtually 100% efficiency. The cell lines were
verified to express both El and E2 polypeptides both
by detection of the polypeptides by immunoprecipita-
tion and by functional assays where short-term
replication of a minimal ori fragment was assayed.
To assay for maintenance replication, we generated a
vector containing a neo resistance marker into which
we could insert various fragments from BPV. A 2.5-
kb fragment from BPV containing the origin of
replication was initially inserted and transfected into
the El+E2 cell line. After selection for G418-
resistant colonies and further passage for 6-8 weeks,
DNA was prepared and analyzed for the presence of
episomal BPV sequences. In all cases, the origin con-
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struct was maintained at high copy number exclusive-
ly in episomal form.
These results indicated clearly that the El and E2
gene products were sufficient for maintenance and
also that transcriptional control of the levels of these
two proteins was not required. The next question that
we addressed was whether the cis-acting sequences
that were sufficient for short-term replication (i.e.,
the minimal ori) were also sufficient for maintenance
replication. These experiments were carried out by
inserting small fragments containing the minimal ori
into the neo plasmid. The ori constructs were tested
initially in a short-term replication assay in which all
constructs replicated to similar levels. After G418 se-
lection and passaging, however, the minimal ori con-
structs could not be recovered as episomal DNA.
These results indicated that the minimal ori was not
sufficient and that additional sequences were required
for stable maintenance of BPV. The inability to func-
tion in maintenance was not purely a consequence of
a lower replication efficiency, since the minimal ori
functioned in short-term replication with an ef-
ficiency similar to that of the larger fragment. Further
mapping of the sequences important for maintenance
indicates that these are located in the E2-dependent
transcriptional enhancer.
Viral Gene Regulation
P. Szymanski, A. Stenlund
Last year, we reported that the E2 trans-activator
through its action on the E2-dependent enhancer ap-
peared to function as a master regulator of viral tran-
scription. During this year, we have continued our
work on E2 by studying its role in negative regula-
tion. The E2 open reading frame encodes, in addition
to the full-length polypeptide that functions as a
trans-activator, two shorter polypeptides that contain
the same carboxy-terminal DNA-binding/dimeriza-
tion domain as E2. These two polypeptides have been
shown to act as competitive repressors of tran-
scription from E2 responsive promoters; however, the
mechanism of action has not been determined. Two
obvious possibilities are either competition for DNA
binding, since these three proteins have the same
DNA-binding specificity, or formation of inactive
heterodimers, since the dimerization domain is also
shared. To distinguish between these possibilities, we
utilized the point mutants in the carboxyl terminus of
E2 that are deficient for DNA binding but still are
capable of dimerization (see above). In functional as-
says where an E2 responsive reporter construct is
cotransfected with an expression vector for the E2 ac-
tivator, the reporter is activated. If either of the short
forms of E2 is included, repression of this activation
is observed. If instead the DNA-binding-deficient
mutant version of the short E2 is used, no repression
is observed. However, the DNA-binding-deficient
form of full-length E2 in the same assay can effi-
ciently repress E2-dependent trans-activation. The
conclusion from these experiments is that the three
forms of E2 despite their common dimerization
domain cannot heterodimerize efficiently. In addi-
tion, hybrid dimers, formed between the wild-type
activator and the DNA-binding deficient mutant, are
incapable of activating transcription due to a lack of
DNA-binding activity of the hybrid. Taken together,
these results indicate that the naturally occurring
repressor forms of E2 act largely through competition
for DNA binding but that mutant forms of the full-
length E2 can function as repressors through forma-
tion of inactive hybrid dimers.
Replication of Human
Papillomaviruses
M. Ustav, A. Stenlund [in collaboration with C.-M. Chiang,
T. Broker, and L. Chow, University of Rochester Medical
Center]
To determine whether the information that we have
gathered about replication of BPV also applies to the
very large group of clinically important human papil-
lomaviruses, we have initiated a collaboration with
the laboratory of L. Chow and T. Broker. Consistent
with the similar genomic organization of all papil-
lomaviruses, expression vectors containing the El
and E2 open reading frames from HPV-11 supported
efficient replication of the HPV-11 genome in a vari-
ety of cell lines in a short-term replication assay. A
surprising finding in these experiments was that the
El and E2 polypeptides from BPV were also quite ef-
ficient in supporting replication of the HPV-11
genome. Furthermore, both HPV-11 and BPV El and
E2 polypeptides could also replicate a variety of
other animal and human papillomaviruses. In addi-
tion, the combination of BPV El and HPV-11 E2 (or
the converse) also functioned well for replication.
These results taken together clearly demonstrate the
universality of BPV as a prototype for the papil-
lomavirus group. Another important point is the ap-
parent lack of cell type or species specificity, indicat-
ing that the high degree of tissue and species tropism
that is observed in vivo for these viruses is not a
result of restrictions in DNA replication but is more
likely due to restrictions in expression of viral
proteins.
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ADENOVIRUS TRANSFORMING FUNCTIONS
E. Moran S. Abraham
Y. Rikitake
H.-G.H. Wang
P. Yaciuk
M. Carter
A. Pepe
Our goal continues to be to understand the genetic
and biological mechanisms that are the basis of
adenovirus E1A transforming functions. In previous
years, we have identified two independent active sites
that are the basis of E1A cell-growth-regulating func-
tions. These sites can be inactivated selectively by
mutations confined to either the extreme amino
terminus or the region designated conserved region 2
(Fig. 1). Although the immortalization function of
E1A requires that both of these sites be functional,
we have shown through a variety of biological and
genetic analyses that either site alone is sufficient to
induce a transcriptional program sufficient to bring
cells out of a resting state, through G1, and into S
phase. Our most recent work has focused on
determining how these transcriptional signals are
communicated from the El A products to the various
cellular promoters. This process must involve inter-
mediate products because E1A is not itself a DNA-
binding protein.
Within the last several years, it has become appar-
ent that the two E1A active sites involved in cell
growth control function as the binding sites for
specific cellular proteins. Since the identification by
Ed Harlow, then at Cold Spring Harbor Laboratory,
of one of the region-2-associated proteins as the
retinoblastoma gene product (pRB), El A became an
important tool for probing the function of this tumor
susceptibility gene. Last year, we reported genetic
evidence, from a study done in collaboration with
Joseph Nevins at Duke University, that indicated a
link between E1A region 2 and activation of the cel-
lular E2F transcription factor. This suggested that
pRB, as a region-2-associated protein, might con-
stitute a physical link between El A and the E2F tran-
scription factor. Subsequent work in the Nevins
laboratory has shown that pRB is indeed a com-
ponent of E2F complexes and, moreover, that other
region-2-associated proteins participate in these com-
plexes as well. It is thus very likely that activation of
E2F is one pathway by which E1A can regulate cell-
cycle-specific gene expression.
But it is not the only pathway. In this laboratory
during the past year, we have focused on an alternate
pathway: that signaled by the E1A amino-terminal
active site. To date, the only cellular protein known
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FIGURE 1 Schematic diagram of E1A active sites and associated proteins. The
E1A regions required for cell-growth-regulating functions (shown as unshaded
regions in this diagram) are the binding sites for several cellular proteins. These
regions constitute two independent active sites that can be inactivated selectively
by mutations confined to either the extreme amino terminus or region 2. The ac-
tivity of either site is sufficient to induce G1 and S phase in resting cells, although
both sites are required for the E1A immortalization function. Although both sites
can induce cell cycle functions, the ability of E1A to block cellular differentiation
and repress enhancers controlling tissue-specific gene expression is linked withthe amino-terminal active site and the binding of a cellular protein designatedp300.
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to bind to E1A via the amino terminus is a 300-kD
protein, designated p300, that has become a special
focus of our studies. The biochemical basis of the
amino-terminal active site has a special interest be-
cause this site is linked not only with cell cycle ac-
tivation, but with the abilities of ElA to repress en-
hancer activity required for tissue-specific gene ex-
pression and to block cellular differentiation.
p300 Binding Is Dependent on
Specific, Conserved, Positively
Charged Residues at Positions
2 and 3 of E1A
H.-G.H. Wang, P. Yaciuk, S. Abraham, Y. Rikitake,
M. Carter, E. Moran
p300 binding is dependent on residues included
within the amino-terminal 25 amino acids of ElA.
Because the extreme amino-terminal sequence is not
strongly conserved among the El A products of the
various adenovirus serotypes, there are few clues to
the nature of the essential residues. However, these
sequences are implicated in the E1A functions target-
ing the control of cell growth and differentiation.
Therefore, it is of significant interest to determine
which E1A residues are essential for amino-terminal
function, especially as these sequences could con-
ceivably contain motifs homologous to important cel-
lular control proteins.
To determine whether there are specific residues
required for p300 binding in the ElA amino termi-
nus, we first constructed a chimera in which ElA
residues 1 to 24 were replaced with the first 24
residues from SV40 large T antigen, a transforming
protein encoded by a different class of DNA tumor
virus. The chimeric protein showed no evidence of
binding p300, even when highly overexpressed. (The
chimera did, however, continue to bind the region -2-
associated proteins.) These results suggest that there
are indeed specific residues in the ElA amino
terminus required for p300 binding. To explore this
possibility further, we considered the significance of
the small degree of homology that occurs in the ElA
amino-terminal sequences. Two conserved features
have been noted (Fig. 2). All serotypes sequenced
show a leucine residue at approximately position 20,
which is invariably followed by a negatively charged
residue, either glutamic or aspartic acid, in the next
position. However, changing either of these residues
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FIGURE 2 Comparison of amino-terminal E1A protein se-
quences from various primate adenoviruses. The first 25
amino acid residues of Ad5 E1A are compared with the
amino-terminal sequences of E1A from other serotypes.
Conserved features are boxed. The first 24 residues of SV40
large T antigen are also shown for comparison.
(Leu to Ser or Asp to Ala) had only a minimally dis-
ruptive affect on p300 binding. The other conserved
feature is the occurrence of positively charged
residues in positions 2 and 3. The ElA gene of al-
most every primate serotype sequenced encodes an
arginine at position 2 and a histidine at position 3.
The conservation of these positively charged residues
is intriguing, especially as the occurrence of positive-
ly charged residues in the highly acidic ElA products
is rare. We have found that mutation of either of
these residues (Arg to Gly or His to Asn) severely
disrupts the p300 interaction, indicating that the in-
tegrity of this small region of positive charge is es-
sential for stable p300 binding. These results com-
bine with results reported last year, from which we
concluded that p300 and the region-2-associated
proteins bind to distinct subregions in conserved
region 1, to give a clearer picture of the requirements
for p300 association in each of its binding regions.
Amino-terminal Point Mutations
Support the Link between p300
Binding and the E1A-mediated
Enhancer Repression Function
Y. Rikitake, S. Abraham, P. Yaciuk, H.-G.H. Wang, E. Moran
It has been known for some years that ElA can
repress the activity of viral and cellular enhancers.
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Examination of this function with the newly con-
structed point mutants strongly supports
previous evi-
dence indicating that the enhancer repression func-
tion is primarily a property of the amino-terminal ac-
tive site.
Enhancer repression assayed on the long terminal
repeat (LTR) of the human immunodeficiency virus
(HIV) is shown in Figure 3. Enhancer activity of the
HIV.LTR is dependent on the presence of two NFK13-
related enhancer elements and can be detected
by ex-
pression of a heterologous reporter gene product,
an
enzyme designated CAT, whose presence is detected
by the conversion of chloramphenicol (Cm) to its
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FIGURE 3 The enhancer repression function is linked with
the p300-binding activity of E1A. In this experiment, the ac-
tivity of the HIV.LTR enhancer was visualized by the ability
of a reporter gene product to convert chloramphenicol (Cm)
to acetylated forms (Ac-Cm) with distinguishable
chromatographic properties. The activity of the HIV.LTR is
dependent on the presence of two NFKB-related elements in
the enhancer; in their absence (HIV.LTR.NFA), activity is
very low. Coexpression of the E1A 12S wild-type products
(12S.WT) with the HIV.LTR construct strongly represses the
enhancer. Mutation of either of the two amino-terminal posi-
tively charged residues essential for p300 binding (12S.RG2
and 12S.HN3) impairs the repression activity severely.
Nearby mutations with little disruptive effect on p300 bind-
ing (12S.LS20 and 12S.DA21) have, likewise, little effect on
the enhancer repression function. In contrast to the extreme
amino-terminal mutations, a combination of two point muta-
tions (12S.928/YH47), which together abrogate the region
-2-
specific associations without impairing p300 binding, has no
effect on enhancer repression function. The approximate
locations of the single point mutations are indicated by dots
in the upper bar diagram.
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acetylated forms (Ac-Cm). Coexpression of the EiA
12S wild -type products with the HIV.LTR.CAT con_
struct strongly represses CAT activity. Mutation of
either of the two amino-terminal positively charged
residues essential for p300 binding (12S.RG2 and
12S.HN3) severely impairs this enhancer repression
activity. Nearby mutations with little disruptive effect
on p300 binding (12S.LS20 and 12S.DA21) have
likewise, little effect on the enhancer repression fune:
tion. In contrast to the extreme amino-terminal muta-
tions, a combination of the two point mutations
(12S.928/YH47), which together abrogate the region
-
2- specific associations without impairing p300 bind-
ing, has no effect on enhancer repression. These
results indicate that enhancer repression via the
NFKB-related elements is not linked with any region-
2-associated products, but is tightly linked with p300
binding, and is indeed dependent on the same indi-
vidual ElA residues.
p300 Is a Sequence-specific
DNA-binding Protein with Affinity
for Known Enhancer Motifs
Y. Rikitake, S. Abraham, P. Yaciuk, H.-G.H. Wang, E. Moran
Last year, we reported preliminary biochemical evi-
dence indicating that p300 is a DNA-binding protein.
During the past year, we have confirmed this obser-
vation and determined that the interaction of p300
with DNA shows a preference for specific sequences.
Moreover, the consensus sequence derived for p300
binding shows a provocative degree of similarity to
known enhancer motifs, raising the exciting pos-
sibility that p300 is a direct intermediate between
El A and upstream DNA elements that control cel-
lular gene expression.
To determine whether p300 has preferred DNA-
binding sequences, we asked whether immobilized
p300 can select sequence-specific oligonucleotides
out of a random pool. (This technique was described
in detail in last year's Annual Report.) The propor-
tion of retained oligonucleotides increased through
each of several rounds of selection, indicating that
p300 is indeed capable of distinguishing preferred se-
quences. Cloning and sequencing of the selected
oligonucleotides indicated that the selected fragments
were in fact related and not random. From the se-
quencing of 16 cloned fragments, we derived a 7-bp
consensus sequence: 5' -GGGAGTG-3 , (5 '"
CACTCCC-3 ' ). This sequence bears an intriguing
degree of similarity to several enhancer elements, in-
cluding the NFKB element, that are the best-
characterized targets of E1A repression. This obser-
vation prompted us to test the ability of p300 to bind
to specific enhancer motifs. NFKB-related motifs in-
clude an element found in major histocompatibility
complex (MHC) class I genes and bound by a cellular
factor designated H2TF1. The ability of p300 to bind
to an oligonucleotide containing the H2TF1 motif
(5 ' -TGGGGATTCCCCA-3 ' ) is shown in the UV
cross-linking experiment illustrated in Figure 4. A
positive autoradiography signal in this assay depends
on the ability of the protein to form a direct physical
bond with the DNA molecule and indicates that the
DNA-binding activity of the protein is direct and in-
trinsic. The ability of p300 to bind to preferred se-
quences was tested in competition assays. The
amount of radioisotope signal transferred from the
oligonucleotide to the protein can be competed by the
presence of unlabeled oligonucleotide; the efficiency
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of the competition is a measure of the affinity of the
protein for the probe sequence. In Figure 4, the af-
finity of p300 binding to the H2TF1-binding se-
quence was tested against competition from each of
three different unlabeled oligonucleotides: a random
sequence oligonucleotide (ran), the H2TF1 motif it-
self (H2TF1), and a double point mutation variant of
the H2TF1 motif (H2TF1.DM: 5 ' TGCGGATTCCC-
GA-3 ' ), which reduces the extent of homology with
the p300 consensus sequence, and is known to impair
binding of the H2TF1 protein. The H2TF1 motif it-
self competed very strongly (lanes 9-12). The double
point mutant variant competed less efficiently (lanes
13-16), showing both that p300 is capable of dis-
tinguishing a very subtle level of difference among
preferred binding sequences and that p300 can make
the same qualitative distinctions as known enhancer-
binding proteins such as H2TF1. The random se-
quence oligonucleotide competed very poorly; a 125 -
fold excess of this oligomer was required to compete
the H2TF1 signal (lanes 5-8), showing that p300 has
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FIGURE 4 UV cross-linking of p300 to a specific DNA enhancer motif is resistant to competition from mutant or random DNA
sequences. Protein products on the same gel were visualized either by silver staining (panel A) , which reveals all detectable
proteins, or autoradiography (panel B), which reveals only those proteins that successfully cross-linked to a radioisotope-
tagged DNA probe containing the H2TF1 enhancer-binding motif. The silver-stained gel shows the presence of equal levels of
p300 in each reaction; the samples in lanes 2 and 3 contained a control protein, BSA. Only p300 shows a radioactive signal on
the autoradiogram; BSA neither binds to the H2TF1 probe (lane 2) nor interferes with p300 binding (lane 3). The ability of vari-
ous (nontagged) DNA probes to compete with the tested enhancer motif for p300 binding is indicated by the decrease in p300
signal in each of the three competition experiments shown. The H2TF1 enhancer motif competes strongly with the identical
labeled sequence (lanes 9- 12). A double point mutant variant of the H2TF1 motif does not compete as well (lanes 13- 16) , and
random sequences compete very poorly (lanes 5-8).
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a relatively high affinity for the
enhancer-specific
motif over random DNA sequence.
Basis of p300 Function
P. Yaciuk, S. Abraham, A. Pepe, Y. Rikitake,
H.-G.H. Wang, E. Moran
The progress in the past year raises the exciting pos-
sibility that p300 is an enhancer-binding protein and
that its targeting by E1A results in the repression
of a
variety of tissue-specific genes. The implication
that
p300 plays a basic role in tissue-specific gene expres-
sion suggests that further characterization of p300
will give us novel and important insights into this
fundamental process. To understand why p300, of all
the enhancer-binding proteins in the cell, is targeted
by El A, it will be important to understand both the
structure of p300 and the nature of p300 interactions
in the cell in the absence of El A. Work on both of
these fronts is in progress. We are currently screening
expression libraries for the purpose of obtaining a
cDNA clone corresponding to the p300 product. We
are also exploring the protein-protein interactions of
p300 and have begun to characterize a number of
protein species that interact specifically with p300.
We are particularly interested in associated proteins
that may modulate p300 function. We expect that
p300 is regulated because its function is implicated in
highly regulated processes. Regulation may be ef-
fected at various levels, including expression, post-
translational modifications, and protein-protein inter-
actions. As reported last year, p300 does not appear
to be strongly growth- or cell-cycle-regulated at the
levels of expression or posttranslational modifica-
tions. (Posttranslational modifications of p300 do,
however, vary specifically during the cell cycle, and
we are exploring the significance of this observation.)
It is likely, however, that p300 is regulated via its as-
sociations with other cellular products. Important
preliminary results obtained this year suggest that the
p300-associated products include those whose ex-
pression or association is strongly growth-regulated.
Characterization of the p30() associations will
greatly facilitated by the availability of Monoclonal
antibody lines specific for p300, and the development
of these reagents is a high priority for the coming
year. Indeed, recent preliminary evidence suggests
that we may have already succeeded in developing
these important reagents.
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Work in this laboratory continues to investigate the
regulation of gene expression, focusing on three sys-
tems. The first of these is concerned with the regula-
tion of protein synthesis by a cellular protein kinase.
The kinase forms an important part of the interferon-
induced antiviral response, and it is the target of viral
countermeasures designed to neutralize this cellular
defense mechanism. Our studies seek to understand
the enzyme's role in translational control and its in-
teractions with viral components, specifically RNAs,
that modulate its activity. The second project deals
with the mechanism whereby an oncogene activates
cellular genes that are required for cell division, an
issue that is central to cellular transformation and car-
cinogenesis. In particular, we are investigating the
transcriptional activation of the gene encoding a
DNA replication factor, PCNA (proliferating cell
nuclear antigen), by the adenovirus El A oncogene
product. Finally, in the third project, we are examin-
ing an unusual form of transcriptional regulation
adopted by the AIDS virus, human immunode-
ficiency virus type 1 (HIV-1). The virus encodes a
protein, Tat, which binds to the nascent transcript
generated from the viral promoter and then increases
the ability of subsequent RNA polymerase molecules
to transcribe the template. During the year, Paul
Clarke and Debbie Taylor joined our laboratory, and
Tsafi Pe'ery and Ken Mellits, with his newly
awarded and well-earned Ph.D. degree, left Cold
Spring Harbor Laboratory.
Adenovirus VA RNA and
Translational Control
S. Green, P. Clarke, F. Ma, T. Pe'ery, K.H. Mellits,
D. Taylor, L. Manche, M.B. Mathews
Interferon induces a cellular response that serves to
limit viral infection and protect the host. One com-
ponent of the response involves the induction of a
protein kinase known as DAI, the double-stranded
(ds) RNA-activated inhibitor of protein synthesis.
This enzyme phosphorylates a translation factor,
eukaryotic initiation factor 2 (eIF-2), interfering with
its function in protein synthesis. DAI is present in
most cells in an inactive state, but during viral infec-
tion, the presence of low levels of dsRNA (probably
generated by symmetrical transcription of the viral
genome) leads to the autophosphorylation and activa-
tion of the kinase. Once activated, DAI blocks trans-
lational initiation thereby preventing the virus from
usurping this process for its own proliferation. For
their part, a number of viruses have evolved
strategies to circumvent this cellular defense mecha-
nism: The best understood of these involve small
highly structured yet single-stranded (ss) RNAs that
inhibit the activation of DAI. This laboratory has for
many years studied the inhibitor VA RNA produced
by adenovirus, but a similar effect is also seen with
RNAs derived from Epstein-Barr virus and HIV-1.
The recent cloning of a cDNA encoding DAI af-
forded a new approach to studying this system, using
mutagenic methods to determine which regions of
DAI are involved in interacting with dsRNA ac-
tivators and ssRNA inhibitors. Our procedure is to
generate functional DAI protein in vitro through the
use of T7 RNA polymerase transcription and wheat
germ translation systems. Wild-type and mutant
forms of DAI are then tested to determine whether
they are still capable of binding RNA. From the anal-
ysis of mutants carrying large internal deletions or
extensive carboxy-terminal truncations, we conclude
that the RNA-binding domain lies within the first 170
amino acids of the protein. This region is devoid of
obvious RNA-binding domains, so we examined the
role of basic amino acids with the idea that the posi-
tively charged side chains of these amino acids might
interact with the negatively charged RNA backbone.
A number of basic amino acids were replaced by un-
charged amino acids using site-directed mutagenesis,
and the RNA-binding properties of the resultant
proteins were studied. Most of the basic residues ap-
pear to function in a synergistic manner, which is
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also dependent on their location within the protein
molecule, but two regions were identified in which
mutations completely abrogate the ability of DAI to
bind to RNA. The binding of VA RNA is considera-
bly more susceptible to mutation of the enzyme, with
most substitutions of basic residues resulting in loss
of function. Studies are now in progress to determine
which individual amino acids are involved and how
they interact spatially.
Even in the most favorable situations, DAI is a
scarce protein and difficult to obtain in sufficient
quantities for biochemical work. To remedy this
deficiency, we attempted to use the cDNA encoding
DAI to overexpress the kinase in Escherichia coli.
Surprisingly, despite the use of a strongly regulated
promoter, once the protein is produced, it is highly
toxic, killing the bacteria before significant levels of
DAI accumulate. To overcome this problem, we
made a mutant protein containing a single-amino-
acid substitution that renders the protein nonfunc-
tional. This mutant produces a significant amount of
protein during overexpression. After the development
of a suitable purification scheme, the bacterially ex-
pressed protein was used as antigen for the successful
production of polyclonal antibodies that should facili-
tate large-scale protein purification. We now hope to
follow a similar method for the production of
monoclonal antibodies.
As mentioned above, several viruses have
evolved measures to evade the DAI-mediated anti-
viral defense mechanism. One of these exploits a
characteristic of DAI that high concentrations of
dsRNA or of specific ssRNA effectors block its ac-
tivation. At late times in adenovirus infection, large
quantities of two small RNAs, VA RNA/ and VA
RNA//, are synthesized by RNA polymerase III. Pre-
vious studies have shown that the VA RNA' encoded
by adenovirus-2 (Ad2), and that encoded by the
closely related virus AdS, is a highly structured
molecule. It contains two short duplexes, the apical
and terminal stems, and a central domain that is
largely single-stranded. Structural and mutagenic
studies suggested two possible conformations for the
central domain but so far have not allowed us to de-
cide between the two alternatives. Taking a fresh ap-
proach to this problem, we have begun a phylo-
genetic comparison of the RNA from several sources.
Six other VA RNA species from human, simian, and
avian adenoviruses have been analyzed at the DNA
and RNA levels. Alignment of their primary se-
quences revealed regions of homology corresponding
to transcription signals, notably the A and B boxes of
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the promoter and the initiation and termination sites
at the two ends of the RNAs. The region to the
3' side of the B box is heterogeneous in sequence,
but in all cases, it can pair with the B box region to
form a stem-loop structure equivalent to the apical
stem of Ad2 VA RNA/. Similarly, the sequences at
the 5' and 3' ends of the molecules can pair, forming
a terminal stem. The regions corresponding to the
central domain of Ad2 VA RNA, are heterogeneous
in sequence (except in two cases that display -65%
homology), but they all form a structure correspond-
ing to the central domain of Ad2 VA RNA/. Al-
though this region is largely open, there are some
bases that are inaccessible to nucleases, suggesting
that they are base-paired or protected because of
tertiary folding. Strikingly, there is also a short con-
served sequence that occupies a similar position in all
six VA RNA species. The significance of this se-
quence remains to be ascertained.
Earlier studies using deletion and linker scanner
mutants indicated that the apical stem of VA RNA is
important for DAI binding. Mutants that disrupt the
central domain retain the ability to bind DAI effi-
ciently but are unable to block DAI activation by
dsRNA, suggesting that binding and functional
domains of Ad2 VA RNA/ can be distinguished.
These studies have now been extended using further
mutational analysis to investigate the roles of the api-
cal stem, the central domain, and the potential base
pairing within the central domain. Extensive disrup-
tions of base pairing within the apical stem were ob-
served to reduce binding, whereas small mutations
that maintain significant base pairing still allow effi-
cient binding to DAI. A mutation that brings the api-
cal stem closer to the central domain abolishes DAI
binding, implying that spatial separation of the bind-
ing domain and central domain is crucial for efficient
binding. As predicted, mutations in the apical stem
have no effect on the function of the molecule pro-
vided the ability to bind DAI is retained. On the other
hand, mutations in the central domain disrupt the
function of VA RNA but in many cases do not affect
its ability to bind to DAI. Other mutations within the
central domain were observed to decrease binding ef-
ficiency, however, suggesting that DAI binding is in-
fluenced by sequences within the central domain as
well as by the apical stem. One possibility is that both
parts of the molecule are involved in forming a
tertiary structure that binds to DAI. We are now de-
veloping chemical methods to examine the interac-
tion of DAI with RNA directly: These studies will
complement studies of the enzyme itself.
Regulation of PCNA
G.F. Morris, C. Kannabiran, C. Labrie,
R. Packer, M.B. Mathews
The transforming region of adenovirus (El) stimu-
lates the expression of the gene encoding a DNA
replication factor, the human proliferating cell
nuclear antigen (PCNA). In a cotransfection assay,
either the 12S or 13S product of the El A gene can in-
duce CAT expression from a PCNA promoter-CAT
reporter gene fusion. The induction of this cellular
gene by the El A 12S product, more familiar as a
transcriptional repressor, is clearly distinct from
trans-activation by the EIA 13S product and appears
to be related to the transforming properties of the
E1A protein. Our objective is to understand how the
12S product activates transcription of this growth-
regulated gene.
Last year, we reported that a site for the activating
transcription factor (ATF), located approximately 50
nucleotides upstream of the transcription initiation
site in the PCNA promoter, mediates a positive
response to the E1A 12S and 13S products. Homol-
ogy with an ATF site cannot be sufficient for an in-
ducible response to 12S, however, because such se-
quences are quite common. The adenovirus E3
promoter, for example, also possesses a sequence that
has homology with an ATF site about 55 nucleotides
upstream of the transcription initiation site, and this
promoter is repressed by the E1A 12S product. The
conservation between humans and mice of the ATF
site and of sequences further downstream in the
PCNA promoter suggests that more extensive
stretches of sequence may play a part in the response
to E1A 12S. To address this possibility systematical-
ly, we constructed a series of substitution mutations
throughout the minimal E1A-responsive PCNA
promoter by linker scanning mutagenesis. Eight-
base-pair linkers were substituted for wild-type se-
quences in the PCNA-CAT reporter gene fusion fol-
lowing bidirectional digestion with BAL-31. On
average, each mutant contains six altered bases out of
a maximum of eight. The resulting contiguous and
overlapping mutant constructs were assayed for their
response to E1A 12S. Transfection experiments in
HeLa cells showed that the mutation of flanking se-
quences upstream of the ATF site decreases basal ex-
pression of the PCNA promoter and abolishes its
response to E1A 12S. These results suggest that
PCNA promoter sequences in the proximity of the
ATF site contribute to the specificity of transcription
factor binding to this site. Alteration of downstream
sequences has little effect on basal or 12S-stimulated
transcription in HeLa cells. We are presently
determining if the same holds true in other cell types.
It has been reported that an ATF site may require
a TATA element downstream for activity and that
bound ATF may alter TFIID binding to the TATA
motif. No correctly positioned A/T-rich segment is
evident in the PCNA promoter, but sequence homol-
ogy suggests that the transcription initiation site may
be specified by an initiator motif located between
nucleotides -10 and +10 (relative to the transcription
start site at +1). Consistent with this idea, deletion of
sequences from -1 to +60 results in ill-defined tran-
scription initiation sites in vitro. This deletion causes
no appreciable change in the response of the PCNA
promoter to 12S or 13S, however, and several other
mutations in the vicinity of the transcription initiation
site also have no effect on the response to 12S or
13S. These observations argue that sequences near
the initiation site may select the precise location of
the transcriptional start but are not absolutely re-
quired for the E1A response in vivo, although the
possibility that cryptic elements subserve the same
function in the initiation site mutants has not yet been
excluded.
To examine the ATF site requirement in the
response of PCNA-CAT to E1A 12S, we replaced it
with five copies of the Gal4 recognition motif. The
resulting construct, G5PCNA-CAT, contains PCNA
promoter sequences from -47 to +60 but lacks all up-
stream PCNA promoter sequences. Like promoters
that contain a correctly positioned TATA motif,
G5PCNA-CAT can be activated by a variety of tran-
scriptional activation domains (Spl, E1A 13S, and
VP16) supplied as Ga14-fusion proteins. However,
G5PCNA-CAT differs from TATA-containing
promoters (such as G5E1B-CAT) in its response to
these chimeric activators when E1A 12S is coex-
pressed. In the absence of fusion proteins that recog-
nize the Ga14-binding sites, G5PCNA-CAT is un-
responsive to El A 12S. Coexpression of Ga14-Spl, a
fusion protein that can bind the Gal4 sites and weakly
activates transcription via the glutamine-rich tran-
scriptional activation domain of Spl, produces a pos-
itive response to E1A 12S by G5PCNA-CAT. Thus,
it seems that bound Ga14-Spl can serve the same
function in the response of G5PCNA-CAT to E1A
12S as the ATF motif binding protein serves in the
wild-type PCNA-CAT promoter. Coexpression of
EIA 12S with either of the two strong transcriptional
activators Ga14-VP16 or Ga14-E1A, however, re-
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duces expression from G5PCNA-CAT. In contrast,
We went on to study the regulation of PCNA
with the TATA-containing construct G5E1B-CAT,
promoter activity in human and rodent cells that dis-
E1A 12S produces similar effects upon transcrip- play a greater
degree of growth regulation than He La
tional activation by these three chimeric transcrip- cells do.
Surprisingly, in these cells, the full-length
tional activators, but the magnitude of the effect is PCNA promoter
is repressed by cotransfection of
CMV 12S. The repression activity maps to the
greatly reduced.
These experiments indicate that the PCNA basal
amino-terminal 60 amino acids of the El A protein,
promoter is configured in a manner that permits the again correlating
with the binding of p300 and
response of some transcriptional activators to be colocalizing with
enhancer repression mediated by
modulated by E1A 12S, whereas the TATA-contain- 12S. The significance
of the repression is uncertain
ing EIB promoter remains less responsive to the ef- and is the subject
of active investigation. As a first
fects of E1A 12S. Supporting this conclusion are ex- step, we have
determined that the promoter element
periments with a Ga14-Rb fusion protein that can
responsible for repression is located between nucleo-
bind either the E1A 12S or 13S proteins to DNA con- tides -234 and
-213 relative to the transcriptional
taining the Gal4 recognition site. Ga14-Rb can start site of PCNA
mRNA transcription.
cooperate effectively with either E1A 12S or 13S to
activate G5PCNA-CAT, whereas only ElA 13S can
cooperate with Ga14-Rb to activate G5E1B-CAT.
Thus, E1A 12S can activate transcription when posi- Regulation of HIV Gene
tioned at the PCNA promoter but does so only weak- Expression
ly at the El B promoter. Our current hypothesis is that
the E1A 12S response of the PCNA promoter relates M. Kessler, S. Gunnery, B. Hofmann, M.B. Mathews
to the recruitment of TFIID to this TATA-minus
promoter.
The HIV-1 Tat protein is a potent trans-activator of
Many of the activities of the ElA 12S gene prod- HIV gene expression, capable of greatly stimulating
uct are due to its interactions with cellular proteins, transcription and also implicated in regulating trans-
some of which are known to be concerned with cell lation. Tat acts through the trans-activator response
cycle regulation. The regions of the 12S product that element (TAR) situated in the R region of the long
bind to these cellular proteins have been defined, and terminal repeat (LTR) between residues +1 and +59
in several cases, the cellular proteins can be dis- relative to the transcription start site. (Residues +14
tinguished by their E1A-binding specificity. To shed to +44 are required for minimal activity.) TAR func-
further light on the mechanism of PCNA regulation, tions at the RNA level in a position- and orientation-
we are mapping the regions of the 12S protein that dependent manner. RNA encompassing the TAR
region folds into a stem-and-loop structure of whichare required for induction of PCNA-CAT expression
in HeLa cells. A variety of ElA deletion and point three parts are required for trans-activation: an intact
mutants were assayed for their ability to stimulate ex- stem, a three-nucleotide pyrimidine-rich bulge at +23
pression of PCNA-CAT in HeLa cells. Trans-activa- to +25 important for Tat binding, and loop sequences
tion was most severely affected by deletion of amino (+30 to +35) that can bind cellular proteins (e.g., p68,
acids 2-60, including the amino-terminal non- TRP185). TAR is dispensable if Tat is brought to the
conserved region of ElA as well as conserved region promoter by alternative means, suggesting that TAR
1 (CR1). A point mutant in CR2 (pm928) that is functions, at least in part, to provide a suitable Tat
defective for binding the retinoblastoma suscep- binding site.
tibility gene product (Rb) stimulated expression of As described in previous Annual Reports, by
the PCNA promoter as efficiently as wild-type 12S comparing transcription complex distributions on
E1A. These results suggest that PCNA induction in HIV-promoted templates, we found that Tat increases
HeLa cells may correlate with p300 binding and both the initiation rate and the efficiency of elonga-
probably is independent of Rb, despite the fact that tion. The degree to which Tat stimulates initiation is
the PCNA promoter contains a potential Rb control determined by the basal rate of LTR-directed tran-
element and is repressed by Rb expression. Addi- scription: Tat stimulates initiation severalfold when
tional mutants are being tested to confirm and refine the basal rate of transcription is low but has little or
these conclusions.
no effect on initiation when the basal transcription
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rate is high. Interestingly, when plasmids containing
an SV40 replication origin are transfected into COS
cells (monkey cells that express SV40 T antigen and
permit plasmid amplification as a result of DNA
replication), the basal transcription rate from the HIV
promoter varies depending on the position of the
origin region relative to the promoter. As a con-
sequence, the degree of stimulation by Tat of the in-
itiation rate also varies. When the origin region is
situated immediately upstream of the HIV promoter,
the basal transcription rate is relatively low and Tat
acts predominantly to stimulate initiation. Alterna-
tively, when the origin is situated approximately 2 kb
downstream from the promoter, basal transcription is
severalfold higher and Tat primarily stimulates
elongation.
The influence of the origin on HIV-directed tran-
scription does not appear to be due to differences in
plasmid copy number related to the position of the
origin. Furthermore, in CV-1 cells (monkey cells
lacking T antigen), the promoter's basal transcription
rate is unaffected by the SV40 origin. However, the
position effect returns when T antigen is transiently
expressed, indicating the involvement of T antigen in
its induction. Moreover, the effect is not observed in
COS cells treated with hydroxyurea, an inhibitor of
DNA replication, or when the origin is rendered non-
functional by mutating T-antigen-binding site II.
Taken together, these results suggest that the position
effect is due to T antigen functioning as a DNA
replication factor and not as a viral trans-activator.
On the basis of the comparison of reporter gene ex-
pression in the presence and absence of DNA replica-
tion, it appears that the origin region is acting to en-
hance basal expression when situated distal to the
HIV promoter, rather than to suppress basal expres-
sion when situated adjacent to the promoter. Since
virus replication is dependent on the proliferation of
the host T cell, this mechanism of activation may
play an important role in the transition from viral
latency to active infection when resting T cells are in-
duced to proliferate.
Tat enhances transcriptional elongation by in-
creasing the processivity of complexes initiated at the
HIV promoter. In COS cells, the majority of the com-
plexes on HIV-promoted templates accumulate
within the 83-nucleotide promoter-proximal region
when transcription is carried out in the absence of
Tat. Last year, we reported that when the distribution
of these complexes is mapped directly by sizing the
RNA that is pulse-labeled in nuclear run-on reac-
tions, several transcripts of 60-80 nucleotides are
detected. The accumulation of these transcripts indi-
cates that the complexes are stopping in the
promoter-proximal regions as the result of an in-
herent inability to elongate efficiently and not be-
cause of a specific elongation block. In the presence
of Tat, the same short transcripts are detected, as well
as long RNA, suggesting that Tat acts at least in part
to overcome this inability to elongate efficiently.
When pulse-labeling run-on transcription is fol-
lowed by 30 minutes of "chase" transcription in the
presence of a high concentration of the limiting
nucleotide, the short transcripts elongate, implying
that their accumulation in vitro is due to pausing rath-
er than termination events. During chase transcrip-
tion, a new short transcript accumulates. This RNA is
observed when a-amanitin is added at the beginning
of the chase reaction but not at the beginning of the
pulse-labeling, suggesting that it is produced from
longer RNAs that have undergone processing. Direct
analysis of RNA labeled in vivo with 32P-phosphate
revealed that short RNAs of 57-66 nucleotides ac-
cumulate. In contrast, RNase protection analysis indi-
cates that the short RNAs that accumulate in vivo are
predominantly smaller and less heterogeneous
(55-60 nucleotides). On the basis of these and other
results, we propose that short transcript formation is a
multistep process. Transcription complexes tend to
pause at several sites and (perhaps because they are
stalled) to terminate before reaching the end of the
transcription unit. Such attenuated transcripts, gener-
ated by the premature termination of transcription at
heterogeneous sites, undergo processing to generate
RNAs terminating just beyond the 3' base of the
TAR stem-and-loop structure. These RNAs are then
processed further to generate the 50-55-nucleotide
species that are detected in RNase protection assays.
We reported previously that TAR RNA (nucleo-
tides 1-83) can inhibit the activation of DAI in vitro.
As described above, DAI is a protein kinase that
forms part of the host's antiviral defenses, and
several viruses have devised countermeasures to
defeat this cellular defense mechanism. The TAR se-
quence is found at the 5' end of all full-length HIV
mRNAs as well as in the form of short RNAs, raising
the possibility that it plays a role in translational con-
trol and viral pathogenesis. The inhibition of DAI by
TAR RNA was initially observed in kinase assays
conducted in vitro using TAR RNA made by tran-
scribing the HIV-LTR with T7 RNA polymerase.
The transcript was purified through two gels to rid it
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of any dsRNA contaminants. This form of TAR RNA
contains a short stem of 4 by and a loop of eight
nucleotides, in addition to the main 29-bp-long stem
and loop.
We have now confirmed the ability of TAR RNA
to inhibit ribosome-associated DAI in a translation
system from rabbit reticulocytes. Activation of the
enzyme by incubation with dsRNA leads to an inhibi-
tion of in vitro translation which is reversed by both
TAR RNA and VA RNA, presumably by blocking
the activation of DAI. To extend this work, we have
tested several TAR RNA mutants for their ability to
reverse protein synthesis inhibition. The mutations
were made at different points in the main stem-and-
loop structure, and nuclease sensitivity analysis was
performed to determine the structure of each mutant
RNA. In general, mutants in which the stem structure
is disrupted lost their translation rescue ability, con-
sistent with observations that the stem of the TAR
RNA structure is crucial for DAI binding. Mutants in
which the loop is shortened or deleted exhibit
reduced activity, possibly because these mutations
created structures with shorter stems. Unexpectedly,
TAR RNA truncated at +68 is inactive even though
nuclease sensitivity analysis indicated that the RNA
has the same first stem-and-loop structure as the
wild-type TAR RNA. This finding suggests that al-
though the stem is essential, it may not be sufficient
for the DAI inhibition activity. To study the action of
TAR RNA in vivo, we have placed it under the con-
trol of heterologous promoters and are currently ex-
amining its expression in transfected cells.
Mechanism of Trans-activation
by the HIV-1 Tat Protein
M.P. Laspia, P. Wendel
Human immunodeficiency virus (HIV), the causative
agent of acquired immunodeficiency syndrome
(AIDS), exhibits a novel genomic organization. In
addition to the structural genes gag, pol, and env that
are common to all retroviruses, HIV also has at least
two essential regulatory genes. One of these genes,
tat, encodes a trans-activator protein that greatly in-
creases the expression of genes linked to the long ter-
minal repeat (LTR) of the virus. Trans-activation is
mediated by the binding of Tat to an RNA secondary
structure, called TAR, that is present in the 5 ' end of
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all HIV mRNAs. The molecular mechanism of trans-
activation of HIV gene expression by Tat has been
controversial as regulation has been proposed to oc-
cur at several different levels. The principal mode of
regulation, however, appears to be transcriptional.
During the past several years, our research has
focused on elucidation of the mechanism of stimula-
tion of HIV-1 transcription by Tat. To do this, we
have analyzed trans-activation in vivo, in a recombi-
nant adenovirus model system and, more recently in
vitro, in a cell-free transcription system with purified
Tat protein.
On the basis of findings in vivo, which are sum-
marized in previous Annual Reports, we have pro-
posed a model for trans-activation by Tat. In the ab-
sence of Tat, the level of HIV-directed transcriptional
initiation is low, and transcriptional elongation is un-
stable such that the number of transcriptional com-
plexes declines with increasing distance from the
promoter (polarity). Tat interacts with TAR to stimu-
late HIV transcription bimodally by increasing tran-
scriptional initiation and stabilizing transcriptional
elongation. The combination of these two effects of
Tat leads to large stimulation in HIV LTR-directed
transcription rates. We have also studied the basis of
the synergistic stimulation of HIV gene expression
produced by Tat and general trans-activators. Such a
synergistic interaction could be important in the
transition from low levels of gene expression, early in
infection or during viral latency, to high levels of
gene expression in the productive stages of infection.
Interestingly, synergy does not result from increased
rates of transcription; rather, synergy is due principal-
ly to increased rates of transcriptional elongation.
At the time of last year's Annual Report, we had
begun to study trans-activation by Tat in a cell-free
system. A cell-free approach should permit analysis
of the mechanism of trans-activation in detail and
should enable us to dissect the interaction between
Tat and TAR and the cellular transcriptional appara-
tus. As discussed previously, Tat protein was over-
expressed in bacteria and purified to greater than
90% homogeneity by C18 reversed-phase high-
pressure liquid chromatography. Purified Tat was
biologically active in vivo since it stimulated LTR-
directed transcription levels when introduced into
HeLa cells by the technique of scrape-loading. In a
cell-free transcription system consisting of an HIV
promoter DNA template and a nuclear extract
prepared from HeLa cells, Tat stimulated HIV-
directed transcription of a 745-nucleotide runoff
RNA 12-fold. In addition, there was a class of short
Tat-responsive HIV RNAs approximately 83 nucleo-
tides in length. Synthesis of the short RNA was
decreased about threefold in the presence of Tat and
is presumed to represent prematurely terminated, pos-
sibly processed RNA generated in the in vitro tran-
scription system. Trans-activation by Tat in vitro was
specific since Tat was unable to stimulate transcrip-
tion from either an HIV TAR mutant promoter or the
adenovirus major late promoter. In addition, trans-
activation required TAR RNA since it was inhibited
by synthetic competitor TAR RNA.
To characterize trans-activation in the cell-free
system, we have investigated the basis of the stimula-
tion in runoff transcription produced by Tat. To do
this, HIV transcription was analyzed by RNase pro-
tection assay with antisense riboprobes that distin-
guish between promoter proximal and promoter distal
effects of Tat. Tat differentially increased promoter
distal RNA levels, suggesting that it acts to stimulate
the efficiency of transcriptional elongation. To fur-
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ther examine trans-activation by Tat in vitro, HIV
transcription rates were analyzed directly. In these
experiments, short single-stranded DNA probes were
used to measure the distribution of elongating tran-
scriptional complexes along the HIV-directed DNA
template. In the absence of Tat, polarity caused less
than 2% of the initiating RNA polymerases to tran-
scribe beyond +630 nucleotides. Thus, HIV transcrip-
tion in vitro is also subject to polarity. Tat did not in-
crease the number of promoter proximal RNA poly-
merases significantly, but it did suppress polarity,
resulting in a 15-fold increase in the number of
promoter distal transcription complexes. These data
suggest that Tat does not increase transcriptional in-
itiation in vitro; rather, trans-activation is due princi-
pally to increased transcriptional elongation. Among
the possible explanations for the lack of an initiation
effect is that high basal levels of HIV promoter ac-
tivity in vitro might reduce the stimulation of initia-
tion by Tat. Alternatively, low levels of reinitiation in
the in vitro transcription system might bias against
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FIGURE 1 Tat stimulates HIV-directed transcription in a cell-free system. Transcription reactions contained a wild-
type HIV DNA template (lanes 1-12) , a TAR mutant template (lanes 13-18), or an adenovirus major late promoter
template (lanes 19 -24), and a HeLa cell nuclear extract with the indicated amounts of Tat. On the left are the posi-
tions of the correctly initiated runoff RNA transcripts as well as the short, prematurely terminated HIV RNA.
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detecting an effect on initiation. We are examining
both of these possibilities and are attempting
op-
timize conditions that favor stimulation of initiation
in vitro.
To explore the basis of the inefficient elongation
by HIV-directed complexes, the effects of the
deter-
gent sarkosyl on HIV transcription in vitro have been
analyzed. Interestingly, the addition of sarkosyl to
transcription reactions produced a 15-fold increase in
LTR-directed transcription in the absence of Tat.
This indicates that sarkosyl is able to suppress the re-
quirement for Tat in order to achieve high levels of
transcription. Furthermore, it may imply that low
levels of HIV transcription are due to a repressor of
transcription present in the He La cell nuclear ex-
tracts. Interestingly, low basal levels of HIV tran-
scription are primarily due to repression of elonga-
tion, since sarkosyl increased the efficiency of
elongation without similarly increasing initiation. In
addition, repression caused pausing and termination
of transcription by RNA polymerase complexes. We
believe that these data suggest that Tat stabilizes tran-
scriptional elongation by acting as an antirepressor,
which when bound to TAR RNA enables transcrip-
tional complexes to overcome repression of elonga-
tion.
results suggest that repression is also
exhibited by other eukaryotic genes. We have also
recently observed that, in vitro, Tat is capable of
stimulating expression from a heterologous RNA
polymerase II transcription unit containing the TAR
element cloned downstream from the promoter.
These data suggest that repression of elongation may
be a general phenomenon and intimate that Tat oper-
ates to stimulate transcription by a general mecha-
nism. Elucidation of the basis of repression and the
mechanism by which Tat increases efficient elonga-
tion is likely to provide important insights into
regulation at the level of transcriptional elongation.
Our efforts in the future will be directed toward iden-
tification of the activity(s) in He La cell nuclear ex-
tracts responsible for repression of elongation. In ad-
dition, we will attempt to characterize HIV-1 tran-
scription in vitro using fractionated nuclear extracts
and to reconstitute transcriptional
trans-activation
with purified components.
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RNA SPLICING
A.R. Krainer E. Birney
J. Caceres
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G. Joshi-Tope
D. Kozak
A. Mayeda
M. Wallace
K. Otto
BIOCHEMISTRY OF MAMMALIAN PRE -MRNA SPLICING
AND SPLICE SITE SELECTION
RNA splicing is a required step in the expression of
most eukaryotic protein-coding genes. In addition,
alternative pre-mRNA splicing is a widespread mech-
anism for generating structurally and functionally
distinct protein isoforms from single genes, often in a
tissue-specific, developmentally regulated, or phys-
iologically controlled manner. Our laboratory is
studying the mechanisms of splice site selection and
RNA cleavage/ligation during mammalian pre-
mRNA splicing. To this end, we are purifying and
characterizing several of the nucleoprotein and
protein factors that are necessary for the catalysis of
splicing in vitro. In addition, we are purifying and
characterizing protein factors that modulate the selec-
tion of alternative splice sites in vitro. These experi-
ments should help elucidate the contribution of RNA
and protein catalysis to pre-mRNA cleavage/ligation
and provide insights into the molecular basis of the
specificity of splice site selection.
STRUCTURE AND FUNCTION OF HUMAN
SPLICING FACTOR SF2
We previously purified from He La cells a protein
factor required for pre-mRNA splicing in vitro and
showed that the same factor, called SF2, could modu-
late alternative 5 ' splice site selection in vitro in a
concentration-dependent manner. This effect is not
substrate-specific but occurs with a conserved po-
larity, i.e., proximal sites are activated at high SF2
concentrations. We isolated full-length HeLa SF2
cDNAs and were able to show that a single 28-kD
polypeptide expressed in Escherichia coli was active
and sufficient for both general splicing and splice site
selection activities. We have also shown that SF2 is
required for the initial steps of spliceosome assembly
and that it can accelerate the annealing of com-
plementary RNAs. SF2 binds RNA in a sequence-
independent manner, but sequence preferences can be
observed, which are currently under detailed investi-
gation by E. Birney and A. Mayeda. SF2 is identical
to ASF, a factor isolated independently in J. Man-
ley's laboratory (Columbia University), which can
modulate alternative splicing of the SV40 tumor
antigens.
The carboxyl terminus of SF2 (Fig. 1) contains
clusters of alternating arginine and serine residues
(RS domain) similar to regions in the Drosophila
proteins tra, tra2, and Suppressor of white apricot, all
of which are involved in the regulation of specific
alternative splicing pathways. A similar region is
present in the Ul small nuclear ribonucleoprotein
(snRNP)-specific 70K protein from several species.
P. Bingham's laboratory (SUNY, Stony Brook) has
shown that one the functions of RS domains is to
serve as a signal for localization of proteins within
the speckled region of the nucleoplasm, which is
thought to be a site of RNA processing and/or storage
of splicing factors (see D. Spector in Molecular
Genetics of Eukaryotic Cells). The amino terminus of
SF2 comprises a region that has strong homology
with an 80-amino-acid RNA recognition motif
(RRM), including the two internal RNP1 and RNP2
consensus elements, which is common to a large fam-
ily of RNA-binding proteins. These include several
heterogeneous nuclear ribonucleoprotein (hnRNP)
and snRNP proteins, the Drosophila alternative splic-
ing regulators sxl and tra2, and many other prokary-
otic and eukaryotic proteins. These two domains of
SF2 are separated by a putative hinge region consist-
ing of multiple consecutive glycines. An additional
octapeptide motif of unknown function, EFEDPRDA,
is shared by SF2 and Ul 70K polypeptides.
J. Caceres is improving the expression of SF2 in
E. coli and has generated a number of mutants in or-
der to examine the roles of conserved SF2 structural
domains in splicing, splice site selection, RNA bind-
ing, and RNA annealing by biochemical analysis of
the respective recombinant proteins. In addition,
wild-type and mutant SF2 are being tested in co-
transfection experiments with several alternatively
spliced genes to determine whether transient over-
expression of SF2 can modulate alternative splicing
in mammalian cells and to allow an in vivo analysis
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FIGURE 1 Domain structure of human SF2 and hnRNP Al. The
248-amino-acid SF2 polypeptide and the
320-amino-acid hnRNP Al polypeptide are drawn to scale. The
RNA recognition motifs (RRM), glycine
hinge, glycine-rich domain, and arginine plus serine-rich domain are
indicated. Within the RRMs, the
smaller boxes denote the RNP1 and RNP2 consensus elements,
and an eight-amino-acid identity to a
region in the U1 snRNP specific 70K polypeptide.
hnRNP Al
of SF2 structure and function. To facilitate the analy-
sis of SF2 function and in vivo expression, D. Kozak
is in the process of generating monoclonal antibodies
to this protein, in collaboration with C. Bautista and
M. Falkowski, of the Monoclonal Antibody Facility.
A phylogenetic analysis of SF2 structure and
function was undertaken by A. Mayeda in collabora-
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tion with A. Zahler and M. Roth (Fred Hutchinson
Cancer Research Center, Seattle). This was made
possible by the previous structural and immunologi-
cal characterization in the Roth laboratory of a con-
served family of nuclear phosphoproteins associated
with active sites of RNA polymerase II transcription
and with amphibian B-snurposomes. This family
FIGURE 2 Drosophila SRp55 can replace human SF2 in a
human cell-free system. Wild-type (lanes 1-5) or p-
thalassemic (lanes 6-10) pre-mRNAs containing the first
two exons and first intron of human p-globin were spliced
in vitro with the indicated extracts and fractions in 25-111
reactions containing 15 vl of extract and splicing extract
buffer. HeLa SF2 was obtained by our previously published
chromatographic procedures. HeLa or Kc extracts were
fractionated by ammonium sulfate and magnesium chlo-
ride precipitation, and 33-kD (human SRp33) and 55-kD
(Drosophila SRp55) polypeptides were isolated from the
respective extracts by preparative SDS-PAGE. The purified
proteins were denatured in guanidinium hydrochloride and
renatured. (Lane 1) 8µl HeLa nuclear extract; (lane 2) 7 RI
S100; (lane 3) 7µl S100 plus 8µl chromatographically
purified HeLa SF2; (lane 4) 7 RI S100 plus 8 vl gel-purified
human SRp33; (lane 5) 7 vl S100 plus 8 vl gel-purified
Drosophila SRp55; (lane M) Hpall-digested pBR322
molecular weight markers; (lane 6) HeLa nuclear extract;
(lanes 7-10) 7 RI S100 plus 0, 2, 4, or 8 vl of gel-purified
Drosophila SRp55, respectively.
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FIGURE 3 Primary sequence homology between human SF2 and Drosophila SRp55. The complete amino acid sequences of
human SF2 (H. SF2) and Drosophila SRp55 (D. SRp55) are shown in the single-letter code. Amino acid identities are indi-
cated in reverse type, amino acid similarities are shown in stippled boxes, and dashes denote gaps introduced to maximize
homology. Amino acid positions in each protein are shown at the right. The conserved RNP-1 and RNP-2 elements of the
RNA recognition motif (RRM) are indicated by solid bars. The alignment shown preserves the RRM homology and minimizes
the number of gaps (nine in H. SF2, two in D. SRp55).
comprises proteins with approximate molecular
masses of 20, 30, 40, 55, and 75 kD in the somatic
tissues of a variety of animal cells. Remarkably, as
shown in the Roth laboratory, the entire family of
proteins can be purified from an ammonium sulfate
cut by precipitation with millimolar concentrations of
magnesium. Our recent work in collaboration with
the Roth laboratory demonstrated that SF2 is a mem-
ber of the same phosphoprotein family and that a dif-
ferent member of this family from Drosophila,
SRp55, can replace human SF2 in the human in vitro
system (Fig. 2). Drosophila SRp55, cloned in the
Roth laboratory, is a 39-kD protein that is 50%
homologous to human SF2 (Fig. 3).
It appears that many other, perhaps all, members
of the family have several conserved structural fea-
tures and similar functional properties (M. Roth, pers.
comm.). Another example is the human splicing fac-
tor SC-35, which shares 25% homology with SF2 and
has similar functional properties in vitro (in col-
laboration with X.-D. Fu and T. Maniatis, Harvard
University; M. Roth, pers. comm.). The family mem-
bers so far cloned, which include human SF2 (ASF),
human SC-35, Drosophila SRp55 (as well as a close-
ly related variant, B52), mouse X16 (an 18-kD tissue-
specifically expressed protein of unknown function),
and Drosophila rbpl (a 15-kD protein of unknown
function; B. Baker, pers. comm.), share all of the
conserved motifs described above. Further work will
be necessary to understand the significance of this
apparent functional redundancy, as well as to estab-
lish whether each member of the family has unique
functional properties in vivo.
HNRNP Al AS A REGULATOR OF
ALTERNATIVE SPLICING
A. Mayeda recently identified an activity in HeLa
cell nuclear extracts, termed SF5, that specifically
counteracts the effects of SF2 on splice site selection.
SF5 is not a general inhibitor of SF2, because the lat-
ter activity is essential for splicing, and a large excess
of SF5 still results in efficient splicing. However, the
ratios of these two activities precisely determine
which splice site is used in vitro. Thus, high levels of
SF5 result in utilization of distal 5 ' splice sites,
whereas high levels of SF2 favor use of proximal 5 '
splice sites. Like SF2, this activity does not operate in
a substrate-specific manner, but rather, it has a gener-
al effect on the polarity of 5 ' splice site selection.
A functional assay was designed for the purifica-
tion of this activity, based on the switch toward distal
5 ' splice sites. Purification of SF5 (Fig. 4) led to the
demonstration that this factor is identical to hnRNP
Al, one of the abundant core hnRNP proteins that are
thought to package hnRNA into ribonucleosomes.
This was confirmed by overproducing cloned hnRNP
Al in E. coli and by demonstrating that the soluble
recombinant product was fully functional in stimulat-
ing distal 5' splice sites with a variety of alternative-
ly spliced pre-mRNAs. For example, increasing the
concentration of hnRNP Al causes a partial switch in
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FIGURE 4 Purification of HeLa cell SF5. SF5 active fractions
were analyzed by SDS-PAGE and Coomassie blue staining.
(M) Molecular weight markers (Mr shown in kilodaltons); (I)
crude HeLa cell nuclear extract (67 lig); (II) ammonium sul-
fate fraction (22 pg); (Ill) CsCI density gradient fraction (12
tg); (IV) phenyl-Superose fraction (1.7 [ig). Recombinant
rat hnRNP Al (4 p.g; a gift from S. Wilson) is also shown.
The arrowhead indicates the Mr of the active p34 polypep-
tide.
the splicing of adenovirus El A pre-mRNA in vitro,
such that there is a decrease in use of the proximal
12S and 13S sites and an increase in use of the 9S
site (Fig. 5). A comparable switch occurs in the early
to late transition of an adenovirus infection.
We have proposed that the intracellular ratios of
SF2 and hnRNP Al may control the specificity of
splice site selection. Furthermore, in vivo regulation
of one or both of these activities may play an impor-
tant role in the tissue-specific or developmental
regulation of alternative splicing. Interestingly, the
levels of hnRNP Al were previously reported to be
increased in proliferating cells, and on the basis of
our recent findings, such changes may explain the
alterations in the alternative splicing patterns of many
pre-mRNAs that have been observed in transformed
cells. Current experiments are aimed at determining
whether the in vivo ratio of the levels or activities of
SF2 and hnRNP Al varies among different cell lines,
e.g., in response to transformation. These studies of
SF2 and hnRNP Al must take into account the exis-
tence of complex gene families, as well as isoforms
generated by alternative splicing and posttranslational
modification. Interestingly, a previously documented
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FIGURE 5 Effect of HeLa cell and recombinant human
hnRNP Al on alternative splicing of adenovirus E1A pre-
mRNA. The structure of the adenovirus pre-mRNA is shown
schematically (sizes in nucleotides). Constant amounts of
S100 extract (6 A and partially purified SF2 (3 RI) and vari-
able amounts ([-] none; [+] 3 [++] 6 A of purified HeLa
cell hnRNP Al (SF5 fraction IV, concentrated to 4741.1g/m1
by ultrafiltration) or recombinant human hnRNP Al (431
µg /ml) were used. (M) 32P-labeled pBR322/Hpall DNA
markers (sizes shown in nucleotides). Spliced products
derived from use of 13S, 12S, and 9S 5' splice sites are in-
dicated. A longer exposure of the bottom of the gel is
shown to facilitate simultaneous visualization of the short
9S mRNA and the longer 13S and 12S mRNAs.
but unknown posttranslational modification of
hnRNP Al appears to eliminate activity in our assay.
We have shown that SF2 is multiply phosphorylated
but do not know at present the consequence of this
modification on activity. In collaboration with R.
Kobayashi and D. Marshak (see this Section), we are
attempting to map the phosphorylation sites on SF2.
Previous work on hnRNP Al has shown that it
binds single-stranded nucleic acids in a sequence-
independent fashion and in a cooperative manner due
to protein-protein interactions between carboxy-
terminal domains. However, in crude extracts, dis-
tinct binding preferences for 3 ' splice sites, as well as
changes in the ability to cross-link this protein to pre-
mRNA depending on the integrity of snRNAs, have
been shown in other laboratories. To understand the
mechanisms by which hnRNP Al antagonizes SF2,
such that the ratio of the two proteins can determine
the outcome of alternative 5 ' splice site selection in
vitro, E. Birney and A. Mayeda are studying the
RNA-binding properties of hnRNP Al and SF2 as
purified proteins and in the presence of other factors.
ALTERNATIVE 3' SPLICE SITE SELECTION
AND EXON SKIPPING
Interestingly, even high levels of SF2 result in proper
discrimination between authentic and cryptic 5'
splice sites. These properties are consistent with a
role for SF2 in ensuring the specificity of splice site
selection during constitutive splicing in vivo by help-
ing to avoid aberrant exon skipping. Furthermore,
SF2 may play a role in the tissue-specific or develop-
mental regulation of certain alternatively spliced
genes. In collaboration with D. Helfman (Molecular
Genetics of Eukaryotic Cells Section), SF2 was
shown to be able to modulate the pattern of splicing
of a natural alternatively spliced pre-mRNA in vitro.
High levels of SF2 led to the preferential utilization
of the proximal skeletal-muscle-specific tropomyosin
5 ' splice site, at the expense of the fibroblast-specific
5' splice site. Thus, high levels of SF2 can overcome
tissue-specific differences between 5 ' splice sites, at
least in some cases. In addition, these studies showed
that SF2 can prevent aberrant exon skipping in vitro.
Using model substrates containing alternative 3'
splice sites, A. Mayeda has identified and partially
purified activities that stimulate proximal (SF6) or
distal (SF7) 3' splice sites. Further purification and
characterization of these activities is in progress.
These factors will be used together with SF2 and
hnRNP Al to investigate the molecular mechanisms
of splice site selection in vitro. So far, A. Mayeda has
shown that the ratio of SF2 to hnRNP Al is sufficient
to determine whether exon skipping or exon inclusion
takes place in vitro. In collaboration with D. Helf-
man, we are investigating this phenomenon further as
it relates to natural alternative splicing and to the
specificity of splice site selection in constitutively
spliced pre-mRNAs.
OTHER ESSENTIAL PROTEIN SPLICING
FACTORS
We are continuing to purify and characterize addi-
tional protein factors that are essential for one or both
RNA cleavage-ligation reactions. G. Joshi-Tope is
pursuing the general strategy of selective depletion or
inactivation to isolate a novel activity required for
cleavage at the 5 ' splice site and lariat formation. B.
Dong is using immunological and genetic approaches
to identify and attempt to isolate cDNA homologs of
the Saccharomyces cerevisiae PRP18 splicing factor,
which is required for 3 ' splice site cleavage and exon
ligation (in collaboration with D. Horowitz and J.
Abelson, California Institute of Technology).
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The regulation of transcription in multicellular or-
ganisms is more complex than anticipated from para-
digms first established in bacteria. First, cis -
regulatory sequences are rarely confined to the se-
quences neighboring the transcriptional start site; in-
stead, distal enhancers and silencers can profoundly
affect the levels of transcription. Second, enhancers
represent complex arrangements of subelements or
enhansons, which cooperate with one another to
regulate transcription. Third, there exist large num-
bers of sequence-specific and basal transcription fac-
tors. With the advent of cloned cDNAs encoding
many of these regulatory ractors, the field is now in a
position to uncover how these proteins, assembled
into promoter complexes, interact with one another to
regulate transcription.
We use three primate viruses to probe the cellular
transcriptional machinery: the simian DNA tumor
virus SV40 and the human pathogens herpes simplex
virus (HSV) and human immunodeficiency virus
(HIV). Our earlier studies focused on the structure of
the SV40 enhancer. SV40 relies entirely on the cel-
lular transcriptional apparatus to activate transcrip-
tion from its early promoter, and perhaps not sur-
prisingly, its enhancer is an accurate reflection of the
structure of cellular enhancers. We now study the
structure and function of the cellular transcription
factors Oct-1 and Oct-2, which bind to the SV40 en-
hancer. In contrast to SV40, HSV encodes its own
immediate early promoter trans-activator, called
VP16 or Vmw65, which it brings into the cell upon
infection. Therefore, as our studies have progressed
toward an understanding of the structure and function
of the proteins that regulate transcription, we have in-
creasingly used HSV as a model. Our current studies
on cis-acting regulatory sequences involve an analy-
sis of HIV promoter sequences in infected individu-
als. HIV provides an excellent model to study varia-
tion in promoter sequences in vivo, because, like
other retroviruses, it mutates rapidly and because, un-
fortunately, there exist a large number of infected in-
dividuals.
"` deceased
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DIFFERENTIAL TRANSCRIPTIONAL
REGULATION BY PROTEINS THAT BIND
TO THE SAME DNA SEQUENCE
The promoter specificity of transcriptional activators
is generally thought to be conferred by the sequence
specificity of the DNA binding domain, which brings
the activator to the appropriate promoter sequence.
Many of our studies over the past several years have
focused on the question of how the two activators
Oct-1 and Oct-2, which recognize the same 8-bp "oc-
tamer" sequence, ATGCAAAT, can selectively ac-
tivate different promoters. These studies have
elucidated two mechanisms: First, promoter-selective
activation domains can selectively activate transcrip-
tion from different promoters even when tethered to
the same DNA binding domain. Second, selective in-
teractions with a second trans-activator, in this case
the HSV activator VP16, can result in recruitment of
one activator (Oct-1) but not the other (Oct-2) to a
new cis-regulatory element.
These studies arose from a convergence several
years ago of two separate lines of investigation in our
laboratory. On the one hand, we were characterizing
the structure and activity of subelements of the SV40
enhancer. These studies, done in collaboration with
N. Hernandez and colleagues (Cold Spring Harbor
Laboratory), showed that multimerized copies of the
octamer motif can activate an unusual type of RNA
polymerase II transcription unit exemplified by the
U2 small nuclear RNA (snRNA) gene in both B cells
and non-B cells, whereas a more typical mRNA tran-
scription unit was active in B cells but not in He La
cells, a non-B cell line. These different patterns of ac-
tivity corresponded to the known ubiquitous and B-
cell expression patterns of the two octamer motif-
binding proteins Oct-1 and Oct-2, respectively, sug-
gesting that Oct-1 preferentially activated RNA
polymerase II snRNA promoters and Oct-2 activated
mRNA promoters. These studies ultimately led to the
discovery of promoter-selective activation domains.
On the other hand, we serendipitously purified
and subsequently cloned cDNAs encoding Oct-1. The
deduced amino acid sequence of Oct-1 led to the dis-
covery of a new class of homeodomain-containing
DNA binding domains called the POU domain. The
160-amino-acid POU domain is bipartite, containing
an unusual amino-terminal POU-specific region and
a carboxy-terminal homeodomain that are tethered by
a short nonconserved linker sequence. We were sur-
prised to find in our early studies of Oct-1 that it
could bind to two very different sites within the SV40
enhancer even though only one octamer consensus
sequence had been recognized within the SV40 en-
hancer sequence. The second atypical Oct-1 binding
site instead displayed similarity to the target of VP16
activation in the HSV immediate early (IE) pro-
moters, called TAATGARAT. We subsequently
showed that the TAATGARAT element, which is
sometimes associated with an overlapping octamer
motif, is by itself a bona fide, albeit low affinity,
binding site for Oct-1.
After HSV infects a cell, the virion-associated
VP16 enters the nucleus and forms a multiprotein-
DNA complex on the TAATGARAT target site with
two cellular factors, Oct-1 and a less well character-
ized factor we refer to as HCF. VP16 itself does not
bind DNA effectively, but, by virtue of a very potent
carboxy-terminal acidic transcriptional activation
domain, once tethered to the HSV IE promoters by
Oct-1 and HCF, VP16 is able to activate HSV IE
transcription. R.G. Roeder and colleagues (Rockefel-
ler University) showed that VP16 does not associate
effectively with Oct-2, and our mapping studies
revealed that VP16 selectively associates with Oct-1
by distinguishing among the seven amino acids that
differ between the Oct-1 and Oct-2 homeodomains.
This selective association between Oct-1 and VP16
can lead to differential transcriptional regulation by
Oct-1 and Oct-2, because only Oct-1 is recruited by
VP16 to the TAATGARAT element. As described
below, many of our current studies continue to focus
on how Oct-1 and Oct-2 activate transcription from
different promoters.
The POU Domain Is an Integral
DNA Binding Unit
R. Aurora
Since discovery of the POU domain, a central ques-
tion has been how this unusual type of DNA binding
domain recognizes DNA. Early studies showed that
both the POU-specific region and the POU homeo-
domain are involved in DNA binding, but given the
novelty of the POU-specific segment, it was not ini-
tially evident whether it might be involved in making
sequence-specific contacts with DNA. Last year, we
described studies with protein chimeras carrying dif-
ferent subsegments of the POU domain from either
Oct-1 or the pituitary-specific POU protein Pit-1
(GHF-1), which differs in binding specificity. These
studies showed that the POU-specific region as well
as the nonconserved linker region can influence DNA
binding specificity. Their influence on DNA se-
quence recognition, however, was dependent on the
origin, either Oct-1 or Pit-1, of the other POU-
domain segments.
This year we showed, using a DNA cross-linking
assay and an engineered POU domain containing a
protease cleavage site between the POU-specific and
homeodomain segments, that the POU-specific re-
gion contacts DNA in the DNA-bound POU domain.
To elucidate the three-dimensional structure of the
POU domain, we have developed a protocol for high-
level expression and purification of the Oct-1 POU
domain from Escherichia coli and are using this
material for NMR spectroscopy in collaboration with
N. Assa-Munt and P. Wright (Scripps Research
Clinic) and for X-ray crystallography in collaboration
with J. Klemm and C. Pabo (Massachusetts Institute
of Technology). Although these approaches have yet
to bear fruit, we have already obtained structural in-
formation about the POU domain free in solution and
bound to DNA by tryptophan fluorescence in col-
laboration with P. Hensley (SmithKline Beecham
Pharmaceuticals) and J. Knutson (National Institutes
of Health).
Fortuitously, the POU domain contains two tryp-
tophan residues, one within the POU-specific region
and the other within the POU homeodomain.
Polarized fluorescence can be used to measure the
rotational motion of macromolecules in solution,
which is a reflection of their size, shape, and
flexibility. If a fluorophore is excited by a polarized
beam of light, only properly aligned molecules will
be excited and their initial fluorescent emission will
also be polarized. But if the fluorophore rotates be-
tween the time of excitation and fluorescent emis-
sion, then the amount of decay over time (in
nanoseconds) of the fluorescence polarization (or flu-
orescence anisotropy) is a measure of the rotation of
the particular fluorophore.
The two tryptophans within the POU domain
represent two fluorophores whose respective fluores-
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cent anisotropy can be measured. If the POU-specific
region and POU homeodomain are not fixed with
respect to one another in solution, then the anisotropy
decay of the two tryptophans will probably differ.
But if the POU domain segments are fixed with
respect to one another in solution as an integral struc-
ture, then the anisotropy decay pattern of the two
tryptophans should be identical. Analysis of the fluo-
rescence anisotropy decay of the Oct-1 POU domain
reveals a single exponential decay pattern, suggesting
that the POU-specific and POU-homeodomain
regions are indeed fixed with respect to one another
in solution as a single structural unit. These results
suggest that the POU domain is an integral DNA
binding unit, which may explain why the POU-
specific region and the POU-type of homeodomain
have always been found associated with one another
in nature.
Regulation of RNA Polymerase II and
III Transcription from snRNA
Promoters by Oct-1 and Oct-2
G. Das, M. Tanaka, K. Visvanathan
When we first obtained cDNAs encoding Oct-1 and a
cDNA encoding Oct-2 from P. Sharp (Massachusetts
Institute of Technology), we set out to determine how
these two proteins might differentially activate
mRNA and snRNA promoters. Determining how
Oct-2 can preferentially activate an mRNA promoter
was relatively easy because this protein is cell-
specific, and therefore we only had to assay activa-
tion in cells lacking Oct-2. These results showed that
Oct-2 is a more potent activator of mRNA promoters
than Oct-1 because it contains two interdependent
mRNA promoter activation domains, whereas Oct-1
only contains one corresponding domain. Assaying
Oct-1 activation of snRNA promoters, however, was
complicated by the fact that Oct-1 is expressed ubiq-
uitously in mammalian cells and transient over-
expression of Oct-1 had little effect on activation of
the U2 snRNA promoter.
To circumvent the endogenous Oct-1 protein, we
altered the DNA binding specificity of Oct-1 without
grossly altering its structure. We took advantage of
the different DNA binding specificities of the Pit-1
POU domain and created Oct-1 and Oct-2 derivatives
in which the majority of the Oct POU domain had
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been replaced by the corresponding Pit_ I
domain sequences. We then used a Pit -1 cis-
regulatory target from the prolactin promoter in place
of the octamer motif in the model (3-globin mRNA
and U2 snRNA promoters. Figure 1 shows the ac-
tivity of these Oct/Pit-1 POU domain chimeras,
called Oct-1.P.1 and Oct-2.P.2, in a transient expres-
sion assay in HeLa cells. As expected from our pre-
vious results, Oct-2.P.2, but not Oct-1.P.1, activated
the (3-globin promoter (compare the bands labeled (3
in lanes 9 and 12). On the U2 promoter, however,
these two activators display the opposite activities:
Oct-1.P.1, but not Oct-2.P.2, activates transcription
from this promoter (compare the bands labeled U2 in
lanes 3 and 6). Thus, the Oct-1.P.1 and Oct-2.1).2
proteins can activate different promoters containing
the same DNA binding sites while possessing the
same DNA binding domain. Therefore, here the
specificity of promoter activation is conferred by
qualitatively distinct promoter-selective activation
domains that lie outside the DNA binding domain.
These studies have progressed in two different
directions. First, we are mapping the regions of Oct-1
responsible for activation of the U2 promoter to iden-
tify minimal snRNA promoter-selective activation
domains. Our hypothesis is that mRNA and snRNA
promoter-selective activation domains will interact
with different targets within the transcriptional ma-
chinery to stimulate transcription; we plan to identify
these different targets by using well-defined activa-
tion domains as probes. Second, we are analyzing the
ability of Oct-1 and Oct-2 to activate RNA polymer-
ase III transcription from the U6 snRNA promoter.
The U6 promoter differs from the U2 snRNA pro-
moter by containing a TATA box, which serves as a
binding site for the general RNA polymerase II tran-
scription factor TFIID. Paradoxically, the TATA box
and the TATA box-binding TFIID core protein TBP,
which are commonly associated with RNA poly-
merase II transcription, are responsible for ensuring
that the U6 gene is transcribed by RNA polymerase
III and not RNA polymerase II. Thus, although tran-
scribed by RNA polymerase III, the U6 gene
represents a composite of elements found within the
very different mRNA and snRNA promoters tran-
scribed by RNA polymerase II. Consistent with such
a composite structure, the U6 promoter can be effec-
tively activated by the snRNA promoter activator
Oct-1.P.1 or the mRNA promoter activator Oct-2.P.2,
suggesting that the U6 promoter can respond to both
mRNA and snRNA promoter-selective activation
domains.
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FIGURE 1 Oct-1 and Oct-2 possess distinct promoter-selective activation domains. An assay of
transcriptional activation by Oct/Pit-1 POU-domain chimeras is shown. The structure of the
chimeras is illustrated at the bottom of the figure with sequences derived from Oct-1 (open rec-
tangle), Oct-2 (hatched rectangle), and Pit-1 (closed rectangle) indicated alongside the quantita-
tive results of activation of the U2 and 13-globin promoters by each protein. The relative expression
levels (Binding) of the various activators were measured in a DNA-binding assay. The position of
the a-globin (a) internal reference signal and the fragments corresponding to correctly initiated U2
(U2) and 13-globin (13) transcripts are indicated as well as incorrectly initiated transcripts (it) that
arise in each assay. Activation of the U2 and 13-globin promoters containing six Pit-1 cis-regulatory
sites (6XPrl) are shown to the left and right, respectively.
Activation of mRNA Transcription
in Nonlymphoid Cells by the Octamer
Motif: The Histone H2B Promoter
W. Thomann
As multimerized copies, the octamer motif can ac-
tivate mRNA-type transcription from the (3-globin
promoter when positioned either close or far from the
start site of transcription in cells expressing Oct-2,
but not in cells only expressing Oct-1. Our studies in-
dicate that Oct-1 fails to activate mRNA transcription
under these conditions because it possesses only one
of two interdependent mRNA promoter activation
domains found in Oct-2. As shown by Schaffner and
colleagues (Zurich), when assayed in an mRNA pro-
moter context in which Oct-2 does not require both
activation domains, Oct-1 is able to activate mRNA
transcription, albeit less effectively than Oct-2. To
understand the promoter context required for effec-
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five activation of mRNA transcription
y an octamer
motif in Oct-1 expressing cells, we
use the histone
H2B promoter as a model.
The histone H2B promoter is unique among
octamer-containing promoters because the
octamer
motif is positioned adjacent to the TATA box. Point
mutational analysis of the human histone
H2B
promoter showed that it contains
three critical up-
stream elements: the TATA box, which positions
the
start site as well as activates transcription,
and two
upstream elements, the octamer motif
and a CCAAT
box, which can activate transcription independently
of one another. When the CCAAT box is deleted by
truncation, the histone H2B promoter displays com-
plete dependence on the octamer motif for activity in
cells only expressing Oct-1. The position of the oc-
tamer motif is apparently important for this activation
because insertion of 5 by between the octamer motif
and the TATA box reduces transcription significant-
ly. But the exact structure of the TATA box and the
transcriptional initiation site associated with a cor-
rectly positioned octamer motif is not absolutely criti-
cal, because the histone H2B octamer motif can still
activate a promoter in which the histone H2B TATA
box and initiation site sequences have been replaced
with the corresponding 13-globin promoter sequences.
uncover the mechanism of position-dependent
mRNA promoter activation by Oct-1, we plan to
study interactions between Oct-1 and other transcrip-
tion factors involved in histone H2B gene transcrip-
tion.
Transcriptional Activation by
Reiterated 18-amino-acid
Glutamine-rich Sequences
In Vivo and In Vitro
M. Tanaka
Oct-2 effectively activates a 13-globin mRNA promot-
er through two interdependent activation domains,
one amino-terminal and the other carboxy-terminal
with respect to the central POU domain. We have
studied the structure and function of both activation
domains of Oct-2 in more detail.
By truncation analysis, we have shown that the
amino-terminal activation domain is a 66-amino-acid
(66aa) glutamine-rich domain and the carboxy-
terminal domain is a 43-amino-acid (43aa) proline-
rich domain. These two mini-domains, by cooperat-
ing with one another, are sufficient to activate tran-
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scription as well as the parental Oct-2. The positions
or combinations of mini-domains, however, arc
critical for activity because it was possible to genera-
te a functional activator that contains multiple copies
of only one or the other mini-domain as well as one
that contains a transposition of the two mini-domains
relative to the central POU domain.
To characterize further the structure and function
of an activation domain, one of the crucial surfaces in
protein-protein interactions involved in transcrip-
tional activation, we have dissected the 66aa gluta-
mine-rich mini-domain by use of a novel "multi-
merization approach." This multimerization approach
involves tandem reiteration of a small portion of a
polypeptide to amplify its otherwise weak activity.
Our rationale for such an approach was as follows: In
general, transcription factors appear to have
redundant and modular structures. Specifically, we
found that a fusion of the Oct-1 glutamine-rich amino
terminus to the Oct-2 glutamine-rich domain in-
creased transcriptional activity of the protein tenfold,
and reiteration of such multiple glutamine-rich
domains further increased transcriptional activity of
the protein by three orders of magnitude compared to
the parental Oct-2 protein. This multimerization ap-
proach has led to identification of an 18-amino-acid
(18aa) segment within the 66aa glutamine-rich mini-
domain, which is sufficient for activation upon multi-
merization.
The 18aa segment was chosen because it is one of
several repeated sequence motifs found within the
66aa glutamine-rich mini-domain. When replacing
the amino terminus of Oct-2, a single copy of the
18aa segment shows a weak but significant activity,
and the activity increases with increasing copy num-
ber of the 18aa segment. Multiple copies of the 18aa
segment fused to either the Oct-2 POU domain alone
or to the heterologous GAL4 DNA binding domain
generate functional activators. These reiterated seg-
ments thus contain an intrinsic transcriptional activa-
tion function. Taken together, these results suggest
that the general architecture of transcriptional ac-
tivators can be defined by multiple and modular
small functional units (activation domains) cooperat-
ing with each other independently of their precise
position or combination.
The future focus of our interest is to understand
the mechanism of transcriptional activation by well-
defined activation domains such as the 18aa gluta-
mine-rich segment and the carboxy-terminal 43aa
proline-rich mini-domain. We have initiated in vitro
transcription studies that will allow us to dissect the
protein-protein interactions involved in the activation
process. In a reconstituted system composed of multi-
ple fractions derived from a He La cell nuclear ex-
tract, E. coli- produced Oct-2 protein stimulates tran-
scription severalfold better than the Oct-2 POU
domain, which itself only slightly stimulates tran-
scription. This result indicates that transcriptional
stimulation by Oct-2 in this system relies mostly on
the presence of the activation domains that lie outside
of the DNA binding domain. In the same recon-
stituted system, the Oct-2 derivative that contains
multiple copies of the 18aa glutamine-rich activation
domain efficiently activates transcription. Thus,
protein-protein interactions involving the 18aa activa-
tion domain are reproduced in vitro. Therefore, we
will further refine and characterize our reconstituted
system to investigate such interactions.
Ethidium Bromide Provides
a Simple Tool for Establishing
Genuine DNA-independent
Protein Associations
J.-S. Lai
DNA-dependent and -independent associations of
DNA binding proteins are important in transcrip-
tional regulation and are the focus of intensive inves-
tigation. During the course of characterizing a series
of monoclonal antibodies raised against Oct-1 and
Oct-2, we noticed four cellular proteins of 68 kD, 70
kD, 85 kD, and 110 kD that coimmunoprecipitate
with the Oct-2 POU domain from labeled cell ex-
tracts in the absence of any added Oct-2 DNA bind-
ing sites, suggesting a DNA-independent association.
We discovered, however, that the three larger Oct -2-
associated proteins can bind DNA on their own and,
subsequently, that the 70-kD and 85-kD proteins are
the two heterologous subunits of the human autoan-
tigen Ku, which possesses strong nonspecific DNA
binding properties. These observations led us to test
whether the association of these three proteins with
Oct-2 might indeed be DNA-dependent and result
from association with contaminating DNA in the ex-
tracts, which could serve to tether the different
proteins to one another during the immunoprecipita-
tion.
For the test, we sought a reagent that could easily
disrupt protein-DNA association without generally
disrupting protein-protein associations. As illustrated
by the experiment shown in Figure 2, the DNA inter-
calator ethidium bromide serves this purpose and
shows that the association between Oct-2 and the 70-
kD, 85-kD, and 110-kD proteins is indeed DNA-
dependent. Figure 2 shows three series of precipita-
tion experiments with an extract from human 293
cells containing ectopically expressed Oct-2.
Ethidium bromide does not generally affect protein-
protein associations, because increasing ethidium
bromide concentration does not affect recovery of
several adenovirus E1A-associated proteins (ar-
rowheads) in an E1A immunoprecipitation (compare
lanes 2 and 3 with lane 1). In contrast, ethidium
bromide does affect protein-DNA association, be-
cause it impedes recovery of either Oct-2 or the three
nonspecific DNA binding proteins (indicated by dots
in the figure) in a DNA affinity precipitation assay
(lanes 7-9). In an Oct-2 immunoprecipitation, how-
ever, ethidium bromide only affects recovery of the
three Oct-2-associated proteins (lanes 4-6), indicat-
ing that the association of Oct-2 with the three larger
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FIGURE 2 Association of 70-kD, 85-kD, and 110-kD
proteins with Oct-2 is sensitive to the presence of
ethidium bromide. A 293 cell extract containing Oct-2 was
immunoprecipitated with the E1A-specific monoclonal
antibody M73 (lanes 1-3) or the Oct-2-specific mono-
clonal antibody PT1 (lanes 4-6) or used for DNA-affinity
precipitation with multimerized octamer and heptamer
motifs (lanes 7-9). The reactions were done in the ab-
sence (lanes 1, 4, and 7) or presence of either 12.5 µg /ml
(lanes 2, 5, and 8) or 50 µg /ml (lanes 3, 6, and 9) ethidium
bromide. The precipitates were separated by 10% SDS-
PAGE and visualized by fluorography. Arrowheads indi-
cate the positions of the E1A-associated proteins, p300,
p107/p105Rb, and p600yclin A respectively. Dots indicate
the positions of the three Oct-2-associated proteins.
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proteins is DNA-dependent and presumably
due to
contaminating DNA in the extracts. Consistent
with
this result, treatment of the immunoprecipitates
with
DNase also disrupts these associations.
We extended these studies to show
that un-
suspected DNA contamination can also
stabilize as-
sociation between DNA binding proteins
in protein
affinity assays when using a glutathione S-transferase
fusion protein as a probe to assay association
with in
vitro translated proteins, a commonly used strategy
to
study protein-protein associations. Thus,
these studies
suggest that ethidium bromide is an excellent reagent
to discriminate between protein associations
that are
entirely independent or remain dependent on DNA.
VP16 Complex Formation
with Oct-1 and HCF: Oct-1
Acquires New cis-regulatory
Activation Properties through
Association with VP16
M. Cleary, S. Stern, M. Tanaka, A. Wilson
Differential transcriptional regulation by homeo-
domain proteins elicits complex patterns of cell dif-
ferentiation during development, and yet, when ana-
lyzed biochemically, these proteins frequently dis-
play very similar, if not identical, DNA binding
properties. Therefore, a central question in regulation
of development by these proteins is how they can
control transcription from different promoters while
possessing the same DNA binding specificity. The
differential association of VP16 with the octamer
motif-binding proteins Oct-1 and Oct-2 serves as a
model to elucidate such mechanisms. We, as well as
T. Kristie and P. Sharp (Massachusetts Institute of
Technology), have shown previously that VP16
engineers formation of the VP16-induced complex by
interacting with each of the three other components
of the complex: HCF, DNA, and Oct-1. To dissect
the complex in greater detail, we are purifying the
least well characterized component HCF. This com-
ponent forms a heteromeric complex with VP16, in-
dependently of Oct-1 or the TAATGARAT motif,
and we are using this property as one of the strategies
to purify the factor.
Association of VP16 with Oct-1 has two impor-
tant effects on the transcriptional activation proper-
ties of Oct-1. The first of these effects results in im-
parting Oct-1 with activation properties more normal-
ly associated with Oct-2. Oct-1 does not readily ac-
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tivate mRNA promoters, but VP16 contains a potent
acidic activation domain and the VP16-induced com
plex can readily activate mRNA -type transcription.
Thus, this first effect makes the two normally (its_
similar activators Oct-1 and Oct-2 more similar. The
second effect, however, displays another mechanism
by which two proteins that possess the same DNA
binding properties can activate different promoters.
This difference is achieved by selective recruitment
of Oct-1 to a new regulatory site, the TAATGARAT
motif. In the absence of VP16, TAATGARAT motifs
that lack any overlapping octamer motif are poor
binding sites for Oct-1 and Oct-2. But in the presence
of VP16, the affinity of Oct-1 for these sites in-
creases, whereas the affinity of Oct-2 for these sites
is unaffected. This differential influence on affinity is
reflected in the activity of such a TAATGARAT site
in vivo, because it fails to activate either the U2
snRNA promoter in the presence of Oct-1 or an
mRNA promoter in the presence of Oct-2, but it can
activate mRNA transcription in the presence of both
Oct-1 and VP16. Thus, as a result of recruitment to a
new site, Oct-1 is able to participate in activation of a
new promoter that is resistant to Oct-2 activation be-
cause Oct-2 does not associate with either this site or
VP16 effectively.
HIV-1 Promoter Sequences
Isolated Directly from Infected
Individuals Contain a Hot Spot
for Tandem Sequence Duplication
W. Phares, D. Taylor
To study the influence of variation in promoter struc-
ture on HIV-1 pathogenesis, we have been analyzing
the sequence of the HIV-1 promoter isolated directly
from individuals infected with HIV-1. Retroviruses
like HIV-1 display very high rates of mutation, and in
other retroviruses, viral pathogenicity can be in-
fluenced by the potency or cell-specific activity of
the viral promoter. One type of mutation that can
arise in promoter sequences are tandem duplications.
Our earlier studies on the SV40 enhancer revealed
that selection for improved activity resulted in
tandem sequence duplications that duplicate individu-
al subelements called proto-enhancers. Different
SV40 proto-enhancer duplications resulted in enhan-
cers with new cell-specific activities. We hypothesize
that similar changes in HIV promoter sequences
could also influence virus growth and hence the
course of acquired immunodeficiency syndrome or
AIDS.
To analyze HIV-1 promoter structure in infected
individuals, P. Baron and J. Gold (Memorial Sloan-
Kettering Cancer Center and Bronx-Lebanon Hospi-
tal Center) provide us with DNA from infected blood
samples, and we amplify the HIV-1 promoter se-
quences directly by polymerase chain reaction (PCR).
Characterization of the amplified promoter sequences
has revealed a hot spot for tandem sequence duplica-
tions (TSDs) immediately upstream of the HIV core
enhancer elements. Although numerous different
TSDs varying in sequence and size (15-29 bp) have
been isolated, they all duplicate a common 12-bp
"core" sequence. This pattern of sequence duplication
has not been observed in HIV isolates that have been
passaged in cell culture and is therefore apparently
unique to in vivo viral isolates. The 12-bp core region
does not encompass any previously recognized HIV
promoter or enhancer element. This type of overlap-
ping duplication pattern is reminiscent, however, of
the duplication patterns we observed in the SV40 en-
hancer, suggesting that an HIV-1 regulatory element
(either positive or negative) is being amplified by the
TSDs. By examining the patterns of nuclear factor
binding to the duplicated and nonduplicated forms of
the HIV promoter, we have identified a factor en-
riched in T-cell lines, a natural host for HIV infec-
tion, that binds to the duplicated sequences but binds
poorly, if at all, to the nonduplicated form. This result
was unexpected and suggests that rather than dupli-
cate a regulatory element the TSDs may create a new
element that is recognized by the T-cell factor.
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The Protein Chemistry laboratory conducts research
on signal transduction and cell growth using ad-
vanced methods of analytical and preparative
biochemistry. These methods include automated
protein sequence analysis, high-performance liquid
chromatography (HPLC), amino acid analysis, pre-
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parative electrophoresis, mass spectrometry, and pep-
tide synthesis. Such procedures allow us to deduce
chemical structures of proteins and to synthesize
structural and functional domains. In addition, physi-
cal analysis of proteins by mass spectrometry, in con-
junction with chemical studies, permits the determi-
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nation of posttranslational modifications of proteins,
such as phosphorylation and acylation. Our goal is to
attack biological problems of the control of cell
growth by using an arsenal of state-of-the-art
biochemical methods. Often, this requires the devel-
opment of new methods when existing procedures are
not adequate to solve the cell biological question.
This chemical approach to cell biology is highly
complementary to genetic approaches in many of the
other laboratories at Cold Spring Harbor, and analyti-
cal biochemistry is an essential part of a multi-
disciplinary approach to problems of normal and ab-
normal cell growth, as in cancer.
Synthetic Peptide Substrates
for Protein Kinases
D.R. Marshak, M. Vandenberg, I.J. Yu, F. Sun,
M. Meneilly, G. Binns
Protein kinases are enzymes that catalyze the transfer
of phosphates from the y-phosphate position of ATP
to a hydroxyl moiety (serine, threonine, or tyrosine)
on proteins. The recognition sequences for protein
kinases are surprisingly short; usually only four to six
amino acid residues in linear sequence are required
for specifying the substrate. Therefore, synthetic pep-
tide substrates have been quite useful as model sub-
strates for protein kinases. Such peptides, usually
10-20 residues in length, can be synthesized by
solid-phase methods using automated instrumenta-
tion. They are constructed as protected molecules on
polystyrene supports and then deprotected and
cleaved from the support by treatment with acid. In
our laboratory, rigorous purification
and characteriza-
tion are carried out to assure purity and identity of the
material. We have documented evidence that prod-
ucts of the side reactions of peptide synthesis can
alter the measured kinetic properties of the substrate
(Marshak and Carroll 1991). Therefore, we use mass
spectrometric measurements to assess the molecular
weight of the product to eliminate unwanted,
modified side products that arise from incomplete
removal of protecting groups or other modifications.
Combined with HPLC and amino acid analysis, mass
spectrometry has allowed us to prepare peptides with
excellent characteristics as kinase substrates, includ-
ing low KM values.
We have focused on two particular protein
kinases, casein kinase II (CKII) and p34cdc2, in our
approach to synthetic peptide substrates. Figure 1
shows a comparison of the amino acid sequences of
several peptide substrates for CKII and p34cdc2 CKII
substrates have been prepared based on novel sites of
action of the enzymes on nuclear oncoproteins, such
as c-myc, SV40 large T antigen, and adenovirus E1A
(Marshak and Carroll 1991). These peptides have KM
values below 0.1 mm, which suggests that they are
high-affinity substrates for the enzyme. Peptide sub-
strates of p34cdc2 were developed based on sites of
phosphorylation that we determined on SV40 T
antigen and the recessive oncogenes, p.53 and retino-
blastoma (RB). The T-antigen peptide, CSH103, was
shown to be specific for p34cdc2 among eight classes
of protein kinases (Marshak et al. 1991). This peptide
can be used as a specific substrate of p34cdc2 in
whole-cell extracts and gives results similar to those
of very involved procedures that require specific pre-
cipitation of the enzyme from the extracts: histone
H1 phosphorylation, electrophoresis, and autoradi-
Liver Casein Kinase II
His-Glu-Ala-Gly-Phe-Pro-Pro-Ser-Asp-Asp-Glu-Asp-Glu-Glu-Gly
Ser-Glu-Glu-Met-Pro-Ser-Ser-Asp-Asp-Glu-Ala-Thr-Ala-Asp
Glu-Glu-Glu-Thr-Pro-pro-Thr-Thr-Ser-Ser-Asp-Ser-Glu-Glu-Glu-Gln-Glu-Asp-Glu-Glu-Glu
Mitotic p34cdc2 Kinase
Ala-Asp-Ala-Gln-His-Ala-Thr-Pro-Pro-Lys-Lys-Lys-Arg-Lys-Val-Glu-Asp-Pro-Lys-Asp-Phe
Lys-Arg-Ala-Leu-pro-Asn-Asn-Thr-Ser-Ser-Ser-Pro-Gln-Pro-Lys-Lys-Lys-Pro-Leu-Asp-Gly-Glu-Tyr
FIGURE 1 Synthetic peptide substrates for CKII and for mitotic p34cdc2 kinase.
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ography. Because CSH103 binds well to phosphocel-
lulose paper, the peptide assay is rapid: 30 minutes
compared to 2 days. Recent work has centered on
analyzing the substrate specificity of p34cdc2 and re-
lated protein kinases. By using CSH103 as a starting
point, we have altered each amino acid individually
to evaluate the details of substrate requirements for
the enzyme. In addition, these studies will allow us to
identify new forms of the enzyme with alternate sub-
strate specificities.
Molecular Cloning and Expression
of Casein Kinase II Subunits
N. Chester, I.J. Yu, D.R. Marshak
CKII is a protein serine/threonine kinase found in all
eukaryotic cells. Its ubiquitous distribution among
species and tissues implies a function central to all
nucleated cells. The enzyme consists of two subunits,
a and p, with molecular mass ranges of 37-44 kD
and 24-28 kD, respectively, and an apparent subunit
composition of a2132. The a subunit is found in two
different forms, known as a and a ' , that arise from
separate genes. To answer questions about the mech-
anism of enzyme regulation, we have cloned and ex-
pressed DNA molecules coding for the full-length
forms of the a and 13 subunits, using a novel method
called the polymerase chain reaction (PCR). Typical-
ly, the PCR for a particular DNA is optimized by
varying the temperatures used in denaturing and
renaturing the DNA templates. This is time-
consuming because most automated temperature
cyclers are limited to one or two temperatures at one
time, although many samples can be run simulta-
neously. Nick Chester utilized a solvent modifier,
dimethylsulfoxide, to alter the apparent melting
temperature of the DNA template and related the
modifier concentration directly to the apparent
change in melting temperature. Therefore, one can set
up PCR in samples with a wide variety of concentra-
tions of the modifier, perform one overnight reaction,
and identify the optimal conditions for product
formation. The predicted, optimal melting tempera-
ture in the absence of modifier can be calculated
directly from the modifier concentration determined
empirically. This greatly reduces the time required
for generation of specific DNAs by PCR. The new
method permitted the generation of PCR products for
the CKII a and p subunits using either one-step or
two-step PCR cycles. These DNA products were
cloned into both bacterial and mammalian expression
vectors for studies of cell physiology.
Cell Cycle Regulation of
Casein Kinase II
I.J. Yu, M. Vandenberg, D.R. Marshak
We studied the relationship between the changes of
protein kinase activity during the cell cycle. The cel-
lular activities in HeLa extracts of three endogenous
kinases, CKII, cAMP-dependent protein kinase
(CAK), and histone H1 kinase (p34cdc2 kinase), were
analyzed. CKII activity was determined by measuring
the total [32P]phosphate incorporation into the
synthetic peptide RRREEETEEE, which is a specific
substrate for CKII (Marshak and Carroll 1991). CAK
activity was measured by [32P]phosphate incorpora-
tion into Kemptide, a synthetic substrate for CAK.
Histone H1 kinase activity was determined by
measuring the incorporation of [32P]phosphate into
histone H1 or peptide CSH103, which is a specific
substrate for p34cdc2 kinase (Marshak et al. 1991). As
shown in Figure 2, CKII activity is high in G1 cells
and gradually decreases as cells are in S to G2/M
phase. In addition, the CKII activity can be inhibited
by addition of heparin, which is a known inhibitor of
CKII. The CKII peptide kinase activity is found at
high levels in G1 cellular extracts and lower in S and
G2/M-phase extracts. CAK activity does not change
significantly during the cell cycle. In contrast, histone
H1 kinase activity is high in G2/M cells and low in S
and G1 cells. In addition, p34cdc2 kinase activity
measured by CSH103 also indicated that the kinase
activity is high in G2/M cells and low in G1 cells.
To develop further our studies of cell-cycle-
associated changes in the phosphorylation of c-myc
and the role of cellular kinase(s), we tested extracts
of HeLa cells specifically in G1 phase (more than
85% by cell sorter analysis), S phase (arrested by
hydroxyurea), and M phase (arrested in the presence
of nocodazole) for differential levels of c-myc
phosphorylation and kinase activity. As seen in the
case of the elutriated HeLa cells, CKII activity is
maximal in G1, lower during S phase, and slightly
elevated in M phase. Histone H1 kinase activity, on
the other hand, is maximal during M phase and lower
during S phase and G1. CAK, in contrast with both
CKII and histone H1 kinase or p34cdc2, shows no sig-
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Cell Division Cycle Regulation of Protein
Kinase Activities in Elutriated HeLa Cells
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FIGURE 2 Cell division cycle control of CKII and p34cdc2
kinase in human cells. HeLa cells, grown in suspension,
were subjected to centrifugal elutriation. Peak fractions
corresponding to G1 (2N DNA content), G2/M (4N DNA
content), and S (intermediate DNA content) phases were
collected, and extracts were tested for kinase activities
with the appropriate synthetic peptide substrate. Results
are expressed as a percentage of the maximal activity for
comparison.
nificant changes in its cellular activity during G1, S,
or M phase. CKII activity associated with each of the
extracts can be competitively inhibited when a
synthetic peptide whose primary sequence is derived
from a CKII phosphorylation region in c-myc is
added to the reaction mixture. When the c-myc
synthetic peptide is added to the reaction mixture,
phosphorylation of histone H1 is slightly depressed in
M-phase cells. These experiments establish that the
phosphorylation of a known substrate of CKII is
regulated during the cell division cycle.
Interactions between Casein
Kinase II and cdc2
G.L. Russo, I.J. Yu, M. Vandenberg, G. Binns, D.R. Marshak
The biological importance of CKII stems from
studies of hormonal and growth regulation for the en-
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zymatic activity. In recent years, CKII has been
found to be stimulated by serum, growth factors, and
cell differentiation. The molecular basis for this
regulation is unknown. In all of these cases, there ap_
pears to be no increase in the amount of CKII protein,
and inhibitors of protein synthesis do not block the
rapid increase (30 min) in CKII activity. CKII is not
phosphorylated on tyrosine, but the serine/threonine
phosphorylation of the 13 subunit increases on growth
factor stimulation of the enzyme. The bulk of the
phosphorylation of CKII appears to be at the amino
terminus of the p subunit, which is catalyzed by
autophosphorylation. The remaining phosphorylation
of the p subunit may be accounted for by p34cdc2
kinase. II Je Yu has conducted a series of studies of
the p subunit phosphorylation during the cell division
cycle in HeLa cells. This project involves h..
munoprecipitating (3 from cell extracts with a specific
antibody, followed by electrophoresis and transfer of
the protein to a solid supporting membrane. The
protein can then be digested with cyanogen bromide,
and the peptides are then separated by HPLC. The
amino-terminal peptide containing the autophos-
phorylation site and the carboxy-terminal peptide
containing the p34cdc2 site are thus separated and can
be quantitated by solid-phase, radioactively labeled,
sequence analysis. These ongoing studies will estab-
lish the regulation of these two sites during the cell
division cycle, and we will extend these experiments
to other models of cell growth in which CKII is regu-
lated.
A parallel set of studies has been conducted by
Gian Luigi Russo to investigate the cell cycle regula-
tion of the phosphorylation of p34cdc2. This enzyme
has major phosphorylation sites at threonine and
tyrosine residues that regulated its activity positively
and negatively, respectively. Previous reports of
serine phosphorylation have led us to attempt to iden-
tify these minor sites of phosphate attachment. We
have used a similar strategy of synthetic peptide sub-
strates as models of various domains of the proteins
and then examined in vivo and in vitro phosphoryla-
tion of p34cdc2 by purified kinases. One candidate en-
zyme for this is CKII. It would be of interest if
reciprocal phosphorylations by p34cdc2 and CKII
were important to cell cycle control. Our next ap-
proach will be to determine the functional sig-
nificance of serine phosphorylations of p34cdc2 and
whether these are involved in modifying protein-
protein interactions among associated subunits of the
enzyme.
Subcellular Localization
of Casein Kinase II
I.J. Yu, D.R. Marshak [in collaboration with D. Spector,
Cold Spring Harbor Laboratory]
The CKII enzyme activity is found both in cytosol
and in nuclei, and there are substrates identified in
both locations. Cytosolic substrates include proteins
involved in translational control (eIF-2, -3, -4B, -5),
metabolic regulation (glycogen synthase), and the
cytoskeleton (nonmuscle myosin heavy chain, (3-
tubulin). Substrates found in the nucleus include
DNA topoisomerase II, RNA polymerases I and II,
oncoproteins such as Myc, Myb, and SV40 large T
antigen, and transcription factors such as serum
response factor. The extraordinary range of substrates
for this enzyme supports the contention that CKII
plays a significant role in cell physiology. We devel-
oped specific antibodies to synthetic peptide antigens
that react with the individual subunits of CKII. These
antibodies allowed us to study the subcellular
localization of the subunits of the enzyme during the
cell division cycle of He La cells (Yu et al. 1991).
Using immunofluorescence microscopy, we exam-
ined asynchronous populations of cells, as well as
cells arrested and released from the G i/S transition
by the chemical hydroxyurea. The results indicated
that the a and f3 subunits are localized to the
cytoplasm during interphase and throughout the cell
during mitosis. Electron micrographs indicate an
abundance of a subunit immunoreactivity associated
with spindle fibers of the mitotic apparatus. During
the G1 phase of the cell cycle, the a' subunit is found
predominantly in the nucleus. Upon transit across the
G1/5 boundary, the a ' subunit appears to disappear
from the nucleus and become cytoplasmic. This is
concomitant with the down-regulation of the activity
in S phase. These dynamics suggest that CKII may
affect cell division cycle control by altering its
localization to different subcellular compartments.
Structural Analysis and
Phosphorylation of Nuclear Proteins
D.R. Marshak, M. Vandenberg, G. Binns, M. Meneilly
[in collaboration with T. Curran, Roche Institute,
J. Kadonaga, University of California at San Diego,
and E. Harlow, Massachusetts General Hospital]
For several years, we have been characterizing the
phosphorylation of nuclear oncoproteins by a variety
of protein kinases. During the past year, we have
focused on three areas of such characterization: (1)
the transcriptional control proteins and proto-onco-
genes, c-fos and c-jun; (2) the recessive oncogene
product, retinoblastoma; and (3) a transcriptional
repressor, histone Hl.
The phosphorylation of c-Fos and c-Jun protein
was done in collaboration with Tom Curran's group
at the Roche Institute. Sites on c-Fos and c-Jun
proteins were analyzed by phosphorylating in vitro
the proteins produced in bacteria as recombinants.
Purified proteins as well as truncated versions with
various domains were deleted. Phosphorylation sites
on c-Fos occur in regions that have been linked
genetically to the regulation of transcriptional con-
trol. Notably, sites for the cell-cycle-regulated protein
kinase, p34cdc2, were identified, suggesting that there
might be significant cell cycle regulation of the tran-
scriptional control by c-Fos. Interestingly, the CKII
site that was predicted from synthetic peptide studies
was not phosphorylated in the intact protein. This is
consistent with very low rates of phosphorylation of
the peptide in solution.
The recessive oncogene, retinoblastoma (RB),
was analyzed in collaboration with Ed Harlow's
group, now at Massachusetts General Hospital (Lees
et al. 1991). RB protein is quite large (105 kD), but it
is found in only minute quantities in cells. It is there-
fore very difficult to identify phosphorylation sites
directly from in vivo, metabolically labeled proteins.
We took a novel approach of using synthetic peptide
model substrates to map phosphorylation sites in
vitro and then compared these to maps of immuno-
precipitated, in-vivo-labeled RB protein. This
approach required that we survey the RB protein se-
quence, inferred from the cDNA structure, for poten-
tial sites of p34cdc2 phosphorylation. We identified
clusters of potential sites and synthesized moderately
long peptides (30-40 residues) covering these sites.
Determination of the stoichiometry and positions of
the phosphates was accomplished by a combination
of mass spectrometry and protein sequencing. The
final compilation of data allowed the assignment of
five sites of phosphorylation of RB by p34cdc2 and
excluded several sites from phosphorylation in vivo.
The protein histone H1 is a nuclear protein asso-
ciated with chromatin but not with the core histones
or the nucleosomes. Jim Kadonaga at the University
of California, San Diego, had isolated a basic protein
from Drosophila embryos that acted as a transcrip-
tional repressor for RNA polymerase II transcription.
We used a combination of peptide mapping by
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HPLC, protein sequencing, and mass
spectrometry to
establish that the purified transcriptional repressor
was histone H1 (Croston et al. 1991).
This observa-
tion has fueled the theory that part
of the activation of
gene transcription arises from
the derepression of
histone Hl.
Glycogen Synthase Kinase 3
and Casein Kinase II during
Differentiation
W. Benjamin, I.J. Yu, D.R. Marshak
During his sabbatical year, Bill Benjamin has been
studying the coordinate regulation of CKII and anoth-
er protein kinase, glycogen synthase kinase
3
(GSK3), in 3T3-L1 fibroblasts. These cells can be in-
duced to differentiate into adipocytes that synthesize
and store lipids and are therefore useful in under-
standing the metabolic regulation and development of
fat cells. Preliminary data available during the past
few months indicated that both enzyme activities
fluctuate during this differentiation. These two
protein kinases may interact at the level of target sub-
strates, as has been established for glycogen metabo-
lism, in which CKII phosphorylation precedes and is
required for GSK3 phosphorylation to proceed. En-
zymes of fatty acid synthesis may well be coordinate-
ly regulated in much the same way. In addition,
recent reports that GSK3 may phosphorylate tran-
scription factors suggest that GSK3, like CKII and
p34cdc2, may be important in the control of gene ex-
pression.
New Methods for Phosphoprotein
Sequence Analysis
D.R. Marshak, G. Binns
Two methods have been developed to determine
complicated phosphorylated protein patterns. These
employ two different technologies: the chemistry of
automated Edman degradations and the physical
analysis of mass spectrometry. Using commercial
membranes made of arylamine-modified polyvinyl-
idene difluoride, it is possible to covalently attach
phosphopeptides via the carboxylate moiety. This
coupling procedure allows the removal of con-
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taminating salts, buffers, and inorganic phosphate, as
well as excess coupling reagent, a water-soluble car.
bodiimide. The innovation comes when these immo-
bilized peptides are loaded into existing protein
se-
quencing instruments. By altering the cycles, we effi-
ciently remove the phosphorylated residues at each
cycle using liquid tri fluoroacetic acid and a modified
solvent consisting of n-butyl chloride, ethyl acetate
and neat phosphoric acid. Bypassing the conversion'
flask permits direct collection of anilinothiazolinone
derivatives of each amino acid
tion counting, the cycle containin
determined. Efficiency of this sequencing method al.
lows the analysis of a few hundred cpm of radioac-
tivity with approximately 20:1 signal:noise ratios.
Figure 3 shows an example of this type of sequence
analysis. In real terms, it means that one can recover
peptides from metabolically labeled, immunoprecip-
itated, and electrophoretically purified samples. Pre-
vious methods were more than 100-fold less sensi-
tiveT.
he second new method arises from our previous
studies of mass spectrometry which showed that
manipulation of the peptide matrix could promote
fragmentation of the molecule, primarily at the pep.
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FIGURE 3 Sequence analysis of a phosphorylated pep-
tide using solid-phase methods. Recovery of radioactivity
is shown for each sequencer cycle using [32P]phosphate
labeled peptide CSH133, based on the sequence of the
p53 recessive oncogene product.
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tide bonds. Extending this method to phosphorylated
peptides, particularly with the RB peptides described
above, has allowed us to determine the sites of
phosphorylation directly from the fragmentation pat-
tern in the spectrometer. The predominant ions that
occur are the A series, arising from the acylium ion at
each peptide bond with loss of carbon monoxide.
Other ions, including the Y' series, arising from
the ammonium ions at each peptide bond, are also
seen at lower frequency. The combination of mass
spectral methods and chemical sequencing methods
in conjunction with synthetic peptide preparation pro-
vides a complete set of techniques for analysis of
phosphorylated proteins in cells.
Protein Chemistry Core
Facility
G. Binns, M. Meneilly, R. Kobayashi, D.R. Marshak
The Protein Chemistry Core facility provides state-
of-the-art methodology to staff members at Cold
Spring Harbor for the chemical analysis of proteins
and the preparation of synthetic peptides. The facility
moved to new quarters in the W.M. Keck Structural
Biology Laboratory in the Beckman Neuroscience
Center in May, 1991. The move involved dismantling
and reassembling the intricate analytical instruments,
including the mass spectrometer, protein sequencers,
peptide synthesizer, and chromatographs. Enormous
credit goes to Georgia Binns and Maria Meneilly
who principally shouldered these burdens. Downtime
was minimized during the move to the new
laboratory, and the instruments were recalibrated,
tested, and fully operational by the end of July. The
new facilities provide space specifically designed for
the instruments, as well as support equipment such as
specialty gases, conditioning power supplies, air
compressors, and chilled water recirculators.
The services provided by the Core facility in-
creased in all areas, on an annual basis, accounting
for the downtime of the move. The progress is shown
graphically in Figure 4. Protein sequencer runs to-
taled 172, representing an annualized rate of 11%
above that for 1990. The sequences ranged from 4 to
50 residues, averaging 19.5 residues. Many of these
runs were at very high sensitivity, from 0.5 to 2.0
picomoles. In one project, Georgia Binns and Adrian
Krainer collaborated to obtain structural information
on two pre-mRNA splicing factors (Krainer et al.
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FIGURE 4 Summary of protein chemical services for
1991. The annualized rate for each service is compared
with that for 1990. (SEQ) protein sequencing; (SYN) pep-
tide synthesis; (AAA) amino acid analysis; (HPLC)
chromatography; (MS) mass spectrometry. The data are
expressed as percentages for normalization.
1991). The repetitive yield curve is shown in Figure
5. Using the reagents and methodologies available,
these results are at the physical limit of detection.
Further innovations in high-sensitivity sequencing are
being pursued by Ryuji Kobayashi (see below).
Peptide synthesis, led by Maria Meneilly, ac-
counted for 77 purified and characterized synthetic
products, representing a total of 1877 synthesis
cycles. This is an annualized rate 30% above that for
1990 and corresponds to two peptides completed per
week, the physical limit of the personnel and automa-
tion resources now available. The length of these
peptides ranged from 3 to 47 residues and averaged
24.4 residues. We look forward to expanding the pep-
tide synthesis functions during 1992. Other areas
showed similar increases: amino acid analysis, 28%;
mass spectrometry, 14%; and chromatography,
723%. The extraordinary increase in chromatography
is due to the introduction of new peptide mapping
and sequencing protocols that place a heavier burden
on chromatographic separation. In addition, Ryuji
Kobayashi has accelerated the rate of protein digest-
ions and chromatographic separations.
The Protein Chemistry Core facility is a member
of the Association of Biomolecular Resource Facil-
ities (ABRF), an organization of similar laboratories
around the world. As a member of the peptide
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synthesis/mass spectrometry subcommittee,
Dan
Marshak was involved in the production
of a
worldwide survey of facilities on their abilities to
synthesize peptides. Maria Meneilly, Georgia
Binns,
and Dan Marshak invented a 16-residue, test
peptide
(VKKRCSMWIIPTDDEA) that was synthesized by
42 facilities. The peptide products, both crude and
supposedly purified, were analyzed by many different
analytical techniques, including mass spectrometry,
and compared with standard pure peptide produced
at
Cold Spring Harbor Laboratory and Yale indepen-
dently. All of the products tested had the correct
amino acids in the proper order, but the majority of
products were either chemically modified, not fully
deprotected, or contaminated by side products. These
results (Smith et al. 1992) indicate that mass spec-
trometry is an essential tool in screening synthetic
peptides and that the Protein Chemistry facility at
Cold Spring Harbor Laboratory is among a very few
Core laboratories that provide highly purified and
verified peptides. This is essential to successful
studies using peptides as substrates for enzymes and
in structure-function studies.
Methodological Study of Protein
Sequence Analysis
R. Kobayashi
I joined the Keck Structural Biology Center at Cold
Spring Harbor Laboratory in April, 1991. One goal is
to develop a new, highly sensitive method for protein
sequence analysis, and a second goal is to collaborate
with other Cold Spring Harbor Laboratory scientists
involved in cancer research to study protein structure
and function.
Since the early days of molecular biology, protein
sequence analysis has played a major role in studies
on the relationship of protein structure and function.
As the technology for identifying and purifying
proteins continues to develop, more sensitive tech-
niques will be required for protein structural analysis.
Often, proteins of significant biological importance
are not easily obtained in sufficient amounts, and this
has caused delays in biological discoveries. Further-
more, attempts to overcome the problem have re-
quired considerable expense; e.g., a tremendous num-
ber of animals may be required to produce sufficient
amounts of biologically active substances for study.
Sampling of blood and tissues from human sources
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FIGURE 5 Amino acid yields for a protein sequencer anal-
ysis of a peptide derived from a pre-mRNA splicing factor
purified by A. Krainer.
has severe limitations as well. For most unknown
proteins, it is necessary to purify the protein to ab-
solute homogeneity prior to cleavage with a specific
protease and isolation of peptides for protein se-
quence analysis. Often, this can only be achieved by
purification using electrophoresis in polyacrylamide
gels containing SDS, followed by elution or blotting
the sample from the gel. As a consequence, there is
often a need to isolate large amounts of protein
(50-200 pmoles) that are detectable by methods such
as Coomassie blue staining in order to finally obtain
peptides at the 10-20 pmole level. With this amount
of peptide, the protein sequence can be usually
determined with high accuracy. It is often difficult,
however, to obtain proteins in these amounts. To im-
prove these matters, further development of protein
sequencing methods is necessary, particularly to im-
prove the sensitivity of the protein sequencing
chemistry so that smaller amounts of protein can be
studied, e.g., the amount detectable only by silver
staining.
The method is based on the manual Edman
degradation established in early 1980s, previously de-
scribed by Kobayashi and Tarr, and has been used for
protein sequencing at the picomole level of detection
for the last 10 years. The major limitation of the cur-
rent technology is the total dependence on ultraviolet
absorption of the sequencing products, although a
fancy computer can help in interpreting the sequenc-
ing data. The new method will introduce a fluores-
cence tag into the Edman chemistry, followed by
analyzing the sequencing product by high-perform-
ance liquid chromatography with a chemilumines-
cence detection (HPLC-CL) system. These two in-
novations will allow two to three orders of magnitude
in increased sensitivity. Several reports have
demonstrated that amino acid analysis can be
achieved at the low- or subfemtomole level with
chemiluminescence detection or by improved fluoro-
genic derivatization with laser-induced fluorescence
detection. Therefore, it is feasible that the sensitivity
of protein sequencing can be increased to the sub-
femtomole level using this technology. No one, how-
ever, has yet succeeded in protein sequence analysis
with chemiluminescence detection. Accomplishing
this project will allow protein sequencing using sub-
picomole amounts of protein. Specifically, it is pro-
posed that an isothiocyanate, 4-(N-t-butoxycarbonyl)
phenylisothiocyanate (Boc-amino-PITC, BAPITC)
will be used for Edman degradation instead of the
conventional phenylisothiocyanate. The 4- amino-
phenyithiocarbamyl amino acids, intermediate pro-
ducts of the modified Edman degradation, will then
be labeled by a fluorescent probe. The final product,
4-(N-1-dimethylaminonaphthalene-5-sulfonyl-amino)
phenylthiohydantoin-amino acid derivatives, will be
analyzed by the HPLC-CL system.
New developments in chemiluminescence chem-
istry (see Fig. 6) and the new Edman reagent can both
be combined to enhance protein sequencing meth-
odology. I have been developing the techniques and
chemistry employed here in related research at the
University of Michigan and at Nagasaki University,
Japan, prior to arriving at Cold Spring Harbor
Laboratory. This research will now be carried out in a
Ar-O-C-C-0-Ar
Aryl oxalate
1,2 - Dioxethanedione Fluorophore
H 20 2
biological research environment where this new
protein sequencing technology, once developed, will
be immediately applied to biologically important
peptides and proteins isolated in small amounts as
part of the Cancer Research Project at Cold Spring
Harbor Laboratory.
Protein Structure of Replication
Factors
R. Kobayashi [in collaboration with B. Stillman,
Cold Spring Harbor Laboratory]
Since I became a part of the Protein Chemistry Core
section in the tumor virus project at Cold Spring Har-
bor Laboratory, 70% of my effort has been to col-
laborate closely with other Cold Spring Harbor
Laboratory scientists to study protein structure and
function. This project will contribute to our under-
standing of the biochemical mechanism of trans-
formation. I am and will be mainly participating in
the study of proteins that have been already purified;
methods include fragmentation of proteins to rela-
tively smaller peptides to determine structures, pep-
tide mapping, and protein sequence analysis. HPLC
is usually employed to separate and purify peptides
fragmented by protease digestion or chemical
cleavage. This year, in collaboration with Bruce
Stillman's laboratory, I have obtained some protein
sequence information on replication factors in human
and yeast using currently available methods and in-
struments in the Protein Chemistry Core facility in
the Keck Center. Collaboration with other scientists
at Cold Spring Harbor Laboratory will be carried out
as well.
Base C -C + 2 ArOH
0-0
1,2 - Dioxethanedione
Fluorophore 2 CO2
Fluorophore Fluorophore
FIGURE 6 Chemiluminescence reaction.
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MOLECULAR GENETICS OF EUKARYOTIC CELLS
Members of the Molecular Genetics of Eukaryotic Cells Section study a variety of topics in cel-
lular and organismal biology, including oncogenes, signal transduction, protein processing, the
cytoskeletion, nuclear processing, and immunological responsiveness.
Jacek Skowronski's laboratory (Transgenic Mice) utilizes gene transfer into the mouse germ
line to model aspects of the acquired immunodeficiency syndrome (AIDS) and to study
brain function. They have observed that the expression of the HIV-1 ref gene leads to the
loss of CD4+ T cells, a loss that occurs also during the progression of AIDS in humans.
Michael Wigler's group (Genetics of Cell Proliferation) studies signal transduction pathways
related to the RAS oncogenes. New elements of these pathways have been defined both in
yeasts and in mammals. The characterization of these new components indicate previously
undiscovered homologies between the signal transduction pathways of yeasts and mam-
mals involving RAS and links to cytoskeletal organization.
The laboratory of Dafna Bar-Sagi (Transmembrane Signaling) focuses on the role of RAS
and phospholipase A (PLA2) in signal transduction. She has demonstrated that cross-linking
of the immunoglobulin receptors causes translocation of RAS to the cytoskeleton and that
PLA2 is involved in biochemical activation of RAS.
Mike Gilman's laboratory (Nuclear Signal Transduction) studies the mechanisms by which
signal transduction pathways lead to activation of gene expression. Recent experiments
suggest a novel role for homeodomain proteins in these pathways.
Nick Tonk's group, Structure, Function, and Regulation of Protein Tyrosine Phosphatases,
studies those important components of signal transduction pathways. Novel forms of
phosphotyrosine phosphatases have been identified. Their characterizations suggest their
role in the control of cytoskeleton and cell adhesion.
David Spector's section (Cell Biology of the Nucleus) develops and applies methods for the
visualization of nuclear events at the ultra-microscopic level. They have visualized the trans-
port of specific RNA products from the nucleus and have visualized the distribution and
time of replication of satellite DNA within the nucleus.
The group of Jim Garrels (Quest Protein Database Center) develops and applies programs
for the analysis of two-dimensional gel electrophoresis separation of cellular proteins. These
methods are being used to create a mouse embryo database, in collaboration with Davor
Solter's group.
Scott Patterson's group (Posttranslational Modifications: Regulatory and Targeting) works in
close collaboration with the QUEST 2D gel group, utilizing those methods to analyze the
posttranslational processing of proteins involved in signal transduction.
The laboratory of Robert Franza (Quantitative Regulatory Biology) studies cellular proteins
involved in the regulation of growth and differentiation of mammalian cells, particularly cells
of lymphoid and hematopoietic lineages. Current studies focus on the components of the
El A complex, the c-rel protein, and proteins that regulate immediate early gene expres-
sion.
David Helfman's laboratory (Molecular Cell Biology) focuses on two fundamental problems:
the mechanisms of regulated RNA splicing and the function of isoforms of cytoskeletal com-
ponents. They have identified an RNA-binding protein involved in the differential splicing of
tropomyosins and have identified a new family of actin-like molecules.
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TRANSGENIC MICE
J. Skowronski R. Mariani L. Usher
N. Peunova G. Enikolopov
Gene transfer into the mouse germ line provides a
model system in which to study complex biological
problems at the organismal level. In particular, trans-
genic mice provide a powerful tool to assess the
disease-inducing potential of viral genes and to gen-
erate animal models where complex processes in-
volved in disease induction are reproduced and acces-
sible to study. In the last 3 years, our main focus has
been to use this transgenic approach to address mech-
anisms involved in induction of acquired immunode-
ficiency syndrome (AIDS) by the human immunode-
ficiency virus type 1 (HIV-1) and to identify HIV-1
genes involved. Recently, our work has demonstrated
that the HIV-1 nef gene effects depletion of the CD4+
T cells when expressed in transgenic animals. This is
reminiscent of CD4+ T-cell depletion invariably asso-
ciated with AIDS immunodeficiency in HIV -1-
infected individuals. Our current experiments address
the mechanism of CD4+ T-cell loss in this transgenic
mouse model and the biochemical mechanisms of
Nef action. In addition, Grigori Enikolopov and
Natalya Peunova are interested in studying signaling
pathways in the brain. They have constructed recom-
binant inhibitors of protein kinases and are applying
them to investigate depolarization-induced gene ac-
tivation in the neuronal cells.
Transgenic Mouse Models for
AIDS Research
R. Mariani, L. Usher, J. Skowronski
HIV infection of CD4+ T cells and antigen-presenting
cells (APCs) is associated with deregulation of the
immune system and the depletion of CD4+ T cells
that is invariably associated with the immunodefi-
cient state in AIDS. However, the mechanisms by
which immunodeficiency viruses subvert the normal
function of infected cells or even the identity of viral
genes that mediate these effects in infected CD4+ T
cells are not well understood.
In search of HIV-1 genes that may play a direct
role in disease induction in HIV-1-infected individu-
als, we became interested in one of the less-
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characterized HIV-1 genes, the nef gene. The nef
gene is found in both human (HIV-1 and HIV-2) and
simian immunodeficiency viruses, and it encodes re-
lated small cytoplasmic proteins of 25-30 kD. Nef
polypeptides are well conserved among independent
HIV-1 isolates; however, nef is not required for virus
replication in established cell lines, suggesting that
nef may have a role in the in vivo infection and per-
haps can perturb the normal function of infected
cells, thus playing a direct role in disease induction.
To test this latter hypothesis, a series of experiments,
in which expression of two independent isolates of
the HIV-1 nef genes was directed to T cells and
APCs in transgenic animals, was initiated approxi-
mately 2 years ago.
CD3 NEF1 TRANSGENIC MICE
Recently, we have constructed strains of transgenic
mice that express the nef gene of the HIV-1 NL43
isolate in T cells. This was accomplished by placing
the HIV-1 nef gene under the control of transcription
regulatory elements derived from the murine gene en-
coding the 8 subunit of the CD3/T-cell receptor com-
plex. Six independent lineages of CD3 Nefl trans-
genic animals have been established.
Nef protein expression in CD3 Nefl animals was
assessed by immunoblot analysis as shown in Figure
1 (top). Rabbit anti-Nef serum detected two proteins
in extracts prepared from the thymus of all six lines
of transgenic animals examined, but not in those
prepared from the control C3H mice. The major
species migrating slightly slower than the recom-
binant Nef standard has a predicted molecular mass
of 25-27 kD and therefore corresponds to the Nef
polypeptide. The nature of a smaller and less
abundant protein migrating at 20-22 kD and faster
than the Nef standard is not known, although it may
represent the amino-terminally truncated form of Nef
or a degradation product. Quantitation of Nef protein
expression, performed by comparison with known
amounts of the recombinant Nef, revealed that Nef
constituted approximately 0.01-0.03% of total
thymic protein in CD3 Neff 1, 2.2, 3.2, and 5.2 mice
and therefore was expressed at a moderate level. In
CD3 Nefl 3.1 and 4 animals, Nef was expressed at
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FIGURE 1 CD4+ T cell depletion in CD3 Nef1 transgenic mice. (Top) Western blot analysis of Nef protein expression in CD3
Neff transgenic mice. Protein extracts prepared from thymus collected from transgenic animals of CD3 Nef1 lines (THYMUS:
#1, #2.2, #3.1, #3.2, #4, #5.2), and control C3H animal (C3H) were analyzed by Western blotting. Aliquots of C3H thymic ex-
tracts supplemented with recombinant Nef protein (rNEF) were used as positive control and standards for quantitation (rNEF).
Blots were probed with affinity-purified rabbit a-nef antibodies and antigen-antibody complexes detected with goat a-rabbit
IgG/alkaline phosphatase conjugates. Arrows indicate the bands corresponding to the rNef (HxB3) and NL43 Nef (NL43)
proteins. Asterisk indicates the 20-22 kD Nef-related protein detected in thymic extracts from transgenic animals. (Bottom) T-
cell subsets in PBLs of CD3 Neff transgenic mice. CD4+ and CD8+ T-cell counts in PBLs of transgenic (-1+) and control (-/-)
littermates are shown. The fraction of CD4+ and CD8+ T cells was determined by flow cytometry analysis of leukocytes isola-
ted from peripheral blood and stained with anti-CD4 and anti-CD8 monoclonal antibodies (GK-1.5 PE and 53-6.7 biotin,
respectively, followed by streptavidin-FITC). The PBL counts were averages of six to eight hemocytometer counts of blood
samples stained with crystal violet. Each mouse analyzed is represented by a pair of circles (closed circles for CD4 and open
circles for CD8, respectively). For each mouse, 30,000 PBLs were analyzed on an EPICS C flow cytometer equipped with an
argon laser, and each circle represents a result of a single determination. Residual dead cells and debris was excluded from
analysis by electronic gating on forward and 90° light scatter.
5-15-fold lower levels (compare lanes 7 and 9 with
6, 8, and 10). Surprisingly, Nef protein was not
detected by Western blotting in lymph node extracts
despite reproducible transgene expression in the
thymus and the demonstrated ability of CD3 tran-
scription regulatory elements to direct expression of
other hybrid genes to both thymic and peripheral T
cells in transgenic mice at comparable levels.
CD4+ T CELLS ARE PREFERENTIALLY
DEPLETED IN CD3 NEF1 ANIMALS
To assess the status of mature T cells, leukocytes iso-
lated from peripheral blood lymphocytes (PBLs) of
transgenic and control littermate animals were
stained with the anti-T-cell receptor antibody and an-
alyzed by flow cytometry. The total T-cell count in
PBLs of the transgenic CD3 Nefl 2.2 and 3.2 animals
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was approximately twofold lower than that in control
littermates. To confirm and extend these observa-
tions, analysis of the CD4+ and CD8+ T-cell subsets
was performed in animals from five transgenic lines.
As seen in Figure 1 (bottom), significant and highly
preferential decrease of the CD4+ T cells was
detected in PBLs of Nefl 2.2, 3.2, and 5.2 animals. In
these mice, the CD4+ T-cell count is two to three
times lower than that in control animals, whereas the
number of CD8+ T cells is almost normal. Sig-
nificantly, this preferential depletion of CD4+ T cells
was not detected in the CD3 Nefl 3.1 and 4 mice,
which display a considerably lower level of transgene
expression, suggesting that a certain threshold of nef
gene expression is required to elicit the perturbation
or that transgenes may be expressed only in a small
population of T cells in these latter lineages, thus
precluding detection of the perturbation.
NEF PERTURBS THYMIC DEVELOPMENT OF
CD4+ T CELLS
To explore the nature of the defect elicited by Nef in
transgenic animals, lymph node and thymic T cells
from 3-5-week-old high-expressor CD3 Nefl 2.2 and
3.2 mice were studied. Lymph nodes of transgenic
animals were smaller and yielded roughly half as
many cells as those of control animals. Flow
cytometry analysis with antibodies reacting with the
CD3, CD4, and CD8 antigens revealed that the CD4+
T cells were preferentially depleted in transgenic
lymph nodes.
Transgenic thymuses had a normal appearance
and contained normal or a slightly higher number of
cells than those of control littermates (1.25- and 1.5-
fold more in Nefl 2.2 and 3.2 lines, respectively, than
in the controls). Flow cytometry analysis of
thymocytes stained for the CD4 and CD8 surface
antigens was used to define the four major develop-
mental thymocyte populations, including the imma-
ture CD4-CD8- double-negative and the CD4+CD8+
double-positive thymocytes and the mature CD4+ or
CD8+ single-positive T cells. Cells were also ana-
lyzed for the CD3 antigen, which is expressed at a
low level on a subpopulation of the double-positive T
cells (CD3I0w) and at a high level on the mature
single-positive thymic T cells (CD3hIgh). This analy-
sis detected several alterations of both the immature
and mature thymocyte populations in transgenic
animals, including a drastic reduction in the level of
CD4 antigen surface expression and a less pro-
nounced reduction of CD8 antigen surface expression
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on double-positive immature T cells. Despite altered
surface phenotypes, the overall numbers of the
CD4+CD8+ double-positive thymocytes were not
decreased, indicating that Nef does not have a direct
toxic effect on these cells. In contrast to the appar-
ently normal frequency of double-positive
CD4+CD8+ thymocytes, the CD4+ single-positive T
cells were two- to threefold underrepresented in CD3
Nefl animals. This depletion of the mature T cells
was also reflected by a twofold lower content of cells
that express high levels of CD3 antigen. These results
indicated that nef perturbs development of the CD4+
T cell subset preferentially.
The late stages of thymic T-cell development,
which are disrupted in CD3 Nefl transgenic mice, are
dependent on interactions of the T-cell receptor
(TCR) with its ligands. Surface CD4 antigen interacts
with the major histocompatibility complex class II
antigens on APCs, and this is required for normal
TCR signaling. Thus, it is possible that a nef-elicited
defect in CD4 antigen function and/or T-cell receptor
function is responsible for compromised development
of CD4+ T cells in CD3 Nefl transgenic mice, and an
analogous mechanism may be used by HIV-1 to
perturb function of infected CD4+ T cells in humans.
We are currently defining alterations in normal func-
tion of CD3 Nefl T cells and the mechanism of
CD4+ T-cell depletion in these transgenic animals.
Downregulation of Surface CD4
Antigen Is a Frequent Property
of HIV-1 nef Genes Isolated from
HIV-1-infected Individuals
R. Mariani, J. Skowronski
Our work has shown that the HIV-1 NL43 nef ex-
pression in transgenic mice is associated with low
levels of CD4 antigen expression on the T-cell sur-
face and depletion of a significant fraction of their
CD4+ T cells. Modulation of the CD4 antigen surface
expression, observed also by other investigators in
experiments in established T cell lines (Garcia et al.,
Nature 350: 508 [1991]), may be critical to the ef-
fects of nef gene expression. It was therefore impor-
tant to determine whether modulation of surface CD4
antigen expression is a common property of different
HIV-1 nef genes isolated directly from infected indi-
viduals. To address these questions, we have cloned
Stains:
CD4 13-gal 13-gal CD4
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Nef CD3 gal
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FIGURE 2 Transient assay for downregulation of CD4 antigen on the surface of human CEM T
cells. CEM cells electroporated with various CD3 Nef expression constructs (CD3 NA) and/or the
CD3 gal reporter gene (right side of the panel) are shown. Cells were stained for the surface CD4
antigen and/or E. coli 13-galactosidase (left). Histograms of the CD4 stain and of the 13-
galactosidase stain are shown on the right and left panels, respectively. Vector, NL43, and HxB3
represent the CD3 expression vector per se, and CD3 vectors that direct expression of the HIV-1
NL43 and HxB3 nef genes, respectively. NA1 and NA13 are selected CD3 nef constructs that
direct expression of new isolates of the HIV-1 nef gene cloned from the peripheral blood of an HIV-
1-infected individual.
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several new isolates of the HIV-1 nef directly
from
infected individuals.
We have developed a novel transient
assay that
permits us to quantitate effect of the
nef on CD4+
antigen expression on the surface of human
CD4
CEM T cells. Nef expression vectors
(CD3 NA vec-
tors) were introduced into CEM T cells by elec-
troporation. To provide an internal control
for elec-
troporation efficiency, the CD3 gal reporter
gene that
directs expression of the Escherichia
coli (3-
galactosidase gene was coelectroporated into CEM
cells; 40-48 hours after electroporation, surface
CD4
antigen was detected with a monoclonal antibody
labeled with phycoerythrin (red fluorescence). The 13-
galactosidase activity was detected in live cells with
the fluorescein-labeled substrate (green fluores-
cence). As shown in Figure 2, both the cell surface
expression of the CD4 antigen and P-galactosidase
activity were detected and quantitated simultaneously
on a cell-by-cell basis by FACS. Several new HIV-1
nef genes isolated from HIV-1-infected individuals
were tested in this assay. It appeared that expression
of most of these new clones (11 of 15 clones that
were tested so far) resulted in downregulation of CD4
on a subpopulation of electroporated cells. Two-color
analysis of electroporated cells demonstrated that
those cells expression of CD4
also show high levels P-galactosidase expression.
Therefore, these cells represent a fraction of CEM
cells that was successfully coelectroporated with both
constructs. Different nef gene isolates had different
abilities to reduce the level of surface CD4 in CEM
cells, and three general classes of HIV-1 nef genes
were defined in these experiments. First, some of the
new isolates (see, e.g., NA10 and NA13 in Fig. 2) ap-
peared to be much more potent in modulating surface
CD4 antigen than the NL43 nef gene, which is asso-
ciated with a low frequency of CD4+ T cells in CD3
Nefl transgenic mice. Genes of the second class had
an effect similar to that of the NL43 nef. Finally, yet
another group of isolates had no measurable effect of
the surface expression of the CD4 antigen. Results of
these studies indicated that the effect of Nef on sur-
face CD4 antigen expression is a frequent property of
HIV-1 nef. The observed modulation of surface CD4
antigen by Nef is, most likely, relevant to AIDS, be-
cause it has been observed with nef genes cloned
directly from HIV-1-infected individuals, rather than
from HIV-1 propagated (and perhaps selected) in
vitro. Results of our studies in transgenic mice sug-
gest that modulation of surface CD4 antigen may be
critical to CD4+ T-cell depletion in AIDS. We there-
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fore will test whether Jul genes in AIDS patients
showing fast or slow rate of disease progression dif-
fer in their ability to modulate expression of the CD4
antigen. In the next year, we will also initiate experi-
ments to address the biochemical mechanism(s) that
mediates effects of nef gene expression in T cells.
Dissection of Signaling Pathways
in Neuronal Cells with Recombinant
Inhibitors of Protein Kinases
N. Peunova, G. Enikolopov
We are interested in how gene activity in the nucleus
is changed when the membrane of the neuronal cell is
excited by an incoming stimulus, such as depolariza-
tion, a neurotransmitter, or a combination of both.
We have developed a new approach to investigate
the components of the signaling machinery in
neuronal cells based on the use of the recombinant
pseudosubstrate inhibitors of protein kinases. Protein
kinases are involved in the modulation of synaptic
plasticity in the brain and are directly implicated in
the transduction of the synaptic signal from the mem-
brane to the nucleus. Several protein kinases are
regulated by an autoinhibitory mechanism involving
a pseudosubstrate domain. We have prepared recom-
binant constructs encoding polypeptides that act as
highly specific pseudosubstrate inhibitors of the cor-
responding protein kinases. We are using them as
tools to dissect signaling events in neuronal cells and
to investigate the points of overlap between different
signal transduction pathways.
This year, our efforts were concentrated on in-
creasing the potency of recombinant inhibitors and on
applying them to study gene activation by membrane
depolarization. We have prepared recombinant ex-
pression constructs encoding pseudosubstrate in-
hibitors of CAMP- dependent protein kinase (PKA),
protein kinase C (PKC), and Ca++/calmodulin-
dependent protein kinase II (CaMK). We were able to
augment the activity of the recombinant inhibitors
(50-100-fold in some cases) while retaining their
specificity toward the cognate kinases by changing
particular residues in the inhibitory regions and by
fusing them to other protein domains. This increase
probably reflects both increased K. and stability of
the polypeptides in the cell. This approach worked
particularly well for inhibitors of PKA, where, by
swapping the autoinhibitory domain of the regulatory
subunit of PKA with a fragment of heat-stable PKA
inhibitor (PKI), we increased the inhibitory activity
of the constructs 300-600-fold. Tagging the in-
hibitory polypeptides with an epitope derived from
the influenza virus hemagglutinin (HA) gene allowed
us to visualize the chimeric products, in addition to
increasing strongly their inhibitory abilities.
We made an additional modification of our ex-
pression vectors with the goal of uncoupling the
cytoplasmic and nuclear effects of protein kinase in-
hibitors and making their action regulatable. We
fused the inhibitory domains to the steroid hormone-
binding domains of the estrogen receptor and gluco-
corticoid receptor, thus making the action of the in-
hibitors hormone-dependent.
We used the chimeric inhibitors of protein kinases
to investigate the signal transduction pathways ac-
tivated by depolarization in the neuronal cell line
PC12. Depolarization of the excitable membrane of a
neuronal cell leads to the activation of voltage-gated
ion channels, an influx of calcium ions into the cell,
and rapid induction of gene transcription. We wanted
to know which protein kinases, transcription factors,
and regulatory DNA sequences mediate depolariz-
ation-induced gene activation. We have addressed
these questions by cotransfecting a series of deriva-
tives of the c-fos promoter linked to the CAT reporter
gene (from M. Gilman and L. Berkowitz) along with
a set of recombinant inhibitors, depolarizing the
membrane of the cells, and monitoring the changes in
transcription of the c-fos plasmids. These experi-
ments confirmed the observation that cAMP-response
element (CRE) can act as a Ca++-responsive element
but showed that other elements contribute to the Ca++
response as well. Next, we cotransfected truncated
variants of c-fos promoter plasmids with the recom-
binant protein kinase inhibitors and monitored
whether inhibition of a particular kinase can block fos
induction going through a particular DNA element.
Our results demonstrate that CaMK, acting through
the CRE element of the promoter, and PKC, acting
through the serum response element (SRE), mediate
the Ca++-dependent induction of fos transcription.
Thus, our data directly implicate CaMK and PKC in
the depolarization-induced gene activation. To under-
stand which transcription factors are involved, we
have tested whether the chimeric proteins containing
the DNA-binding domain of the yeast transcriptional
activator GAL4 fused to the amino terminus of the
CREB protein (constructed by L. Berkowitz and M.
Gilman) can confer Ca++-dependent inducibility on a
reporter gene containing GALA- binding sites in the
promoter region. Depolarization of the cell mem-
brane strongly activated the reporter gene, suggesting
that the CREB is a target of the CaMK-mediated
branch of the pathway. We are currently exploiting
this approach to investigate other Ca++-mediated
events in neuronal cells, including the intracellular
Ca++ release and synergistic interactions of the Ca++-
and cAMP-dependent signaling pathways.
Mobilization of Intracellular
Calcium Potentiates
cAMP-dependent Gene Activation
G. Enikolopov, N. Peunova
The increase of intracellular Ca++ concentration in
neurons either by influx through the voltage-gated
ion channels or by release from intracellular stores is
involved in the regulation of many aspects of
neuronal function. We are interested in how the
Ca++-dependent signaling pathways cross-talk and
overlap with other pathways when a neuronal cell
receives two different stimuli.
We used a c-fos-CAT reporter construct trans-
fected into a neuronal cell line (PC12) to monitor the
rapid induction of transcription by agents that elevate
the calcium levels, in combination with other stimuli.
We have used various procedures to promote the
Ca++ concentration increase-membrane depolariza-
tion, agonist-dependent activation of calcium chan-
nels, neurotransmitter-mediated mobilization of in-
tracellular Ca++, direct release from the intracellular
stores. Different ways of delivering Ca++ ions into
the cells activate c-fos transcription to different ex-
tents. Activation of extracellular Ca++ influx by
membrane depolarization and by mobilization of
Ca++ after acetylcholine receptor stimulation can
directly activate the c-fos promoter. When Ca++ ions
are discharged from different intracellular stores by
thapsigargin or ionomycin, direct induction of c-fos
was not observed, but these treatments greatly
potentiated the response of the fos gene to cAMP.
When accompanied by the mobilization of intra-
cellular calcium, cAMP-dependent induction of the
fos gene is further enhanced up to tenfold.
Using a series of the c-fos-promoter deletion
mutants, we have mapped the CRE site (located at
56 to 71) of the promoter as the site that mediates
the potentiation effect, although other regions of the
gene, located both upstream and downstream, con-
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tribute to the enhanced response. Experiments
with
GAL4-CREB chimeric proteins and
reporter con-
structs containing GAL4-binding sites
have demon-
strated that this effect can be conferred by CREB
transcription factors. We are using combinations
of
recombinant inhibitors of protein kinases
and of
CREB mutants to investigate how the phosphoryla-
tion of CREB and the possible recruitment of other
transcription factors are involved in the calcium-
mediated enhancement of the cAMP response. Con-
vergence of two different signaling pathways in the
neuronal cells, seen as potentiation of cAMP-induced
gene induction by the elevated Ca++ level may ex-
plain the mechanisms of integrating the impulse ac-
tivity and synaptic activity in the nucleus of the
neuron.
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Our laboratory continues to study signal transduction,
with the main focus on RAS-dependent signal trans-
duction. In the yeast Saccharomyces cerevisiae, RAS
proteins regulate adenylyl cyclase. The mechanism
by which they do this is unknown, and this is not
their only function. Since activation of adenylyl cy-
clase is not the function of mammalian RAS, the role
of RAS in Schizosaccharomyces pombe has become a
main effort within the group. The command of both
S. pombe and S. cerevisiae systems gives us some
clearer perspectives on the evolution of signal trans-
duction pathways and provides us with very powerful
tools for the identification and examination of mam-
malian genes encoding components of signaling path-
ways.
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Signal Transduction in S. cerevisiae
R. Ballester, J. Field, T. Michaeli, J. Camonis, J. Gerst,
G. Heisermann, V. Jung, A. Polverino, R. Swanson, L. Van
Aelst, A. Vojtek, H.-P. Xu, M. Barr, M. Riggs, L. Rodgers
We have been studying the cellular components of S.
cerevisiae that regulate RAS. Among these are two
closely related proteins, IRA1 and IRA2 (Tanaka et
al., Mol. Cell. Biol. 9: 757 [1989]; Tanaka et al., Mol.
Cell. Biol. 10: 4303 [1990]). Individually, each has
been shown to down-regulate RAS function. These
proteins are structurally and functionally related to
mammalian GAP, the RAS GTPase-stimulating pro-
tein (Tanaka et al., Mol. Cell. Biol. 9: 757 [1989];
Tanaka et al., Mol. Cell. Biol. 10: 4303 [1990]; Bal-
lester et al., Cell 59: 681 [1989]). Although GAP has
also been shown to be capable of down-regulating
RAS in both mammalian and yeast systems (Ballester
et al., Cell 59: 681 [1989]; Zhang et al., Nature 346:
754 (1990]), there is some experimental evidence
supporting the idea that GAP may also be an effector
of RAS (Yatani et al., Cell 61: 769 [1990]). To test
this hypothesis for IRA, both IRA genes were dis-
rupted in yeast. The resulting phenotype was that ex-
pected for cells with an activated RAS allele: heat
shock and starvation sensitivity. This phenotype was
suppressible by overexpression of the genes encoding
cAMP phosphodiesterases. These results suggest that
the IRA genes do not encode effectors that link RAS
to adenylyl cyclase. We cannot eliminate this hypoth-
esis completely, however, since a third homolog of
these GAP-like genes may yet be discovered in the
genome of yeast, and one can imagine that each of
the three might encode redundant RAS effectors.
Speculations such as this, which invoke the unseen
and undiscovered, will be more readily examined in
the future when the complete genomic sequences of
organisms favored for genetics will be known. More-
over, we have not eliminated the possibility that the
IRA genes are required for the alternate function of
RAS.
Strains lacking IRA2 have the typical phenotype
of cells with activated RAS, and we have isolated
genes that when present on multicopy vectors can
suppress this phenotype. Along with the expected
genes, including IRA2 itself, the PDE genes, encod-
ing the cAMP phosphodiesterases, and JUN1, we
found five other genes. These five fail to suppress the
mutationally activated RAS2va119 allele and hence
probably act through the regulation of wild-type RAS.
One of these genes encodes a carboxy-terminal trun-
cated form of the CDC25 protein that is a RAS-
nucleotide exchange catalyst (Broek et al., Cell 48:
789 [1987]; Powers et al., Mol. Cell. Biol. 9: 390
[1989]). This last result is consistent with the idea
that the truncated form of CDC25 interferes with
proper CDC25 function, since disruption of the
genomic CDC25 locus is known to suppress the
phenotype of an IRA disruption. Thus, either the trun-
cated form of CDC25 titrates a factor required for ac-
tivation of wild-type CDC25 or it forms an ineffec-
tive complex with the wild-type CDC25 protein. The
other four genes fall into two groups. The two genes
of group I also suppress the heat-shock sensitivity of
iral- ira2- cdc25- strains. This result points to the
existence of another mode for the regulation of RAS
that is not dependent on the IRA genes or CDC25.
It is not known how RAS proteins stimulate
adenylyl cyclase. Last year, we described CAP, an
adenylyl-cyclase-associated protein that appears to be
required for RAS to be fully capable of activating
adenylyl cyclase (Field et al., Cell 61: 319 [1990]).
Much of our effort to understand RAS/adenylyl
cyclase interactions has focused on CAP, and this
work is described in a separate section below.
Some time ago, Drs. Kataoka and Powers isolated
a number of suppressor mutations of the RAS2val19
phenotype (heat shock and starvation sensitivity).
Among these were supH, or RAM1, required for the
processing of RAS protein (Powers et al., Cell 47:
413 [1986]), and supC, encoding CAP, as discussed
below (Field et al., Cell 61: 319 [1990]). We have
recently isolated the gene corresponding to supF. It
shows no clear homology with proteins in the data-
bases. Complete disruption of supF does not com-
pletely block the phenotype of RAS2val19 and has no
effect on the phenotype of cells overexpressing the
TPK genes, which encode the cAMP-dependent pro-
tein kinases (Toda et al., Cell 50: 277 [1987]). We
hypothesize that supF encodes either a protein that
facilitates RAS function (e.g., by affecting processing
or localization) or a component of an alternate path-
way for RAS action. These hypotheses are under
study.
Signal Transduction in S. pombe
Y. Wang, D. Young, M. Kawamukai, K. Sen,
E. Chang, V. Jung, S. Marcus, R. Swanson,
H.-P. Xu, G. Asouline, M. Riggs, L. Rodgers
We have continued and expanded an intensive study
of the RAS and adenylyl cyclase signaling pathways
in S. pombe with the hope that the S. pombe systems
may bear greater resemblance to mammalian cells
and with the expectation that knowledge of the two
highly diverged yeasts will lead to a greater under-
standing of each. Figure 1 diagrams some of the
hypothetical wiring of the S. pombe systems inferred
from our work and the work of other investigators.
The figure also embodies some speculative ideas
about homologies in these systems and those of S.
cerevisiae and mammals.
S. pombe contains an adenylyl cyclase, encoded
by the cyrl gene, that has considerable homology
with the S. cerevisiae enzyme (Young et al., Proc.
Natl. Acad. Sci. 86: 7989 [1989]). In S. pombe,
cAMP levels modulate sexual responses (Beach et
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al., Curr. Genet. 10: 297 [1985]; Kawamukai et al.,
Cell Regul. 2: 155 [1991]). Cells that overexpress
cyrl are relatively sterile, and cells that lack cyrl
conjugate prematurely. The S. pombe cyclase is not
regulated by rasl (Fukui et al., Cell 44: 329 [1986];
Nadin-Davis et al., EMBO J. 5: 2963 [1986]), the S.
pombe RAS homolog, but we have inferred that cyrl
is subject to regulatory constraints similar to those of
S. cerevisiae CYR1 (Kawamukai et al., Cell Regul. 2:
155 [1991]). First of all, the S. pombe cyrl contains a
leucine-rich repeat, a region homologous to the
leucine-rich repeat of the S. cerevisiae CYR1 (Young
et al., Proc. Natl. Acad. Sci. 86: 7989 [1989]). Over-
expression of this region in S. pombe interferes with
cyr1, as does overexpression of the comparable
region in S. cerevisiae (Field et al., Science 247: 464
[1990]). Moreover, the S. pombe cyclase binds a
protein, capl, that is homologous to S. cerevisiae
CAP. Disruption of S. pombe capl causes an appar-
ent failure of S. pombe cyrl to be regulated properly.
We do not know what factors activate S. pombe cyrl,
but it is a question of some importance, since data
presented in a subsequent section lead us to speculate
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that mammalian cells have a cyrl homolog.
S. pombe contains a gene, sari, that encodes a
protein that is homologous to the yeast IRA proteins
and the mammalian GAP and NF1 gene products
(Wang et al., Cell Regul. 2: 453 [1991]). sari was
selected as a multicopy suppressor of the activated
rasl vat 17 allele. Like its counterparts in S. cerevisiae,
sari appears to down-regulate rasl, and there is no
evidence whatsoever that it functions as a rasl effec-
tor. Again, we cannot exclude the possibility that S.
pombe contains a functional homolog of sari, but
cells with disruptions of sari are still rasl-sensitive.
sari function differs from that of IRA1, IRA2, and
GAP in that it is capable of inhibiting mutationally
activated rasl. In this respect, sari resembles NF1,
the product of the von Recklinghausen's neuro-
fibromatosis locus, which can inhibit mutationally ac-
tivated Ha-ras (Ballester et al., Cell 63: 851 [1990]).
S. pombe cells that lack rasl are sterile: Haploid
cells fail to conjugate and diploid cells cannot un-
dergo sporulation (Fukui et al., Cell 44: 329 [1986];
Nadin-Davis et al., EMBO J. 5: 2963 [1986]). We
have screened for genes that on high copy are capable
of suppressing these defects. One such gene, pre-
viously identified by other investigators, is byrl
(Nadin-Davis and Nasim, EMBO J. 7: 985 [1988]).
byrl encodes a protein kinase and is capable of in-
ducing sporulation in rasl-lrasl- diploid. We identi-
fied a second gene, byr2, that also encodes a protein
kinase and also can induce sporulation in rash
rasl- diploids (Wang et al., Mol. Cell. Biol. 11: 3554
[1991]). Genetic interactions suggest that the byr2
product lies upstream of the byrl product. We have
found that both byrl and byr2 can weakly suppress
the sterility of rasl- haploids.
byrl is most homologous to the S. cerevisiae gene
STE7, and byr2 is most homologous to the S. cerevis-
iae gene STE11. Both STE7 and STE1 1 are kinases
that function on the mating pheromone pathway in S.
cerevisiae (Teague et al., Proc. Natl. Acad. Sci. 83:
7371 [1986]; Rhodes et al., Genes Dev. 4: 1862
[1990]). Hence, the mating pathways of these two
diverged yeasts are at least partially conserved. We
can speculate further on these relationships. In both
S. pombe and S. cerevisiae, there are other kinases re-
quired for sexual function: in S. pombe, spkl (Toda et
al., Genes Dev. 5: 60 [1991]), and in S. cerevisiae,
FUS3 and KSS1 (Elion et al., Cell 60: 649 [1990];
Courchesne et al., Cell 58: 1107 [1989]). These
kinases are related to the MAP/ERK protein kinases
that have been identified in mammalian cells as
response elements in extracellular signaling mediated
through receptor protein tyrosine kinases (Cantley et
al., Cell 64: 281 [1991]; Cobb et al., Curr. Opin. Cell
Biol. 3: 1025 [1991]). In mammalian cells, the phos-
phorylation and activation of the MAP/ERK kinases
is RAS-dependent (Thomas et al., Cell 68: 1031
[1992]). If we postulate that the KSS1, and FUS3,
and the spkl kinases are regulated by the STE7 and
byrl kinases, respectively, we can imagine drawing a
set of homologies between the yeast and mammalian
signal transduction pathways as shown in Figure 1.
The implication of this speculation, if correct, is that
the RAS effector pathways in mammals and S. pombe
may be homologous.
We have isolated another gene, byr3, that can in-
duce sporulation in rasl-lrasl- diploid yeast. This
gene encodes a protein with seven zinc-finger-
binding domains and is homologous to a mammalian
protein that was isolated based on its DNA-binding
activity (Rajavashisth et al., Science 245: 630
[1989]). In collaboration with Dr. Rajavashisth (Uni-
versity of California, Los Angeles), we are examining
the conservation of function between these two
proteins.
Mammalian Genes That Interact
with Yeast Signaling Pathways
R. Ballester, J. Camonis, E. Chang, J. Gerst, C. Nicolette,
L. Van Aelst, A. Vojtek, G. Asouline, M. Riggs, L. Rodgers
Yeast may be used to select mammalian cDNAs en-
coding products that interact with yeast signaling
pathways (Lee and Nurse, Nature 327: 31 [1987];
Colicelli et al., Proc. Natl. Acad. Sci. 86: 3599
[1989]; Colicelli et al., Proc. Natl. Acad. Sci. 88:
2913 [1991]). We have employed S. cerevisiae
strains containing RAS2va119 to select mammalian
cDNAs that suppress the RAS2vall9 phenotype.
Three cDNA genes were so isolated: JC99, JC265,
and JC310 (Colicelli et al., Proc. Natl. Acad. Sci. 88:
2913 [1991]). All three also suppress the phenotype
of ira- strains but not the phenotype of cells that
overexpress either adenylyl cyclase or the cAMP-
dependent protein kinase catalytic subunits. Sequence
determinations indicate that JC99 and JC265 are in
the same gene family. Otherwise, the three genes
show no significant relationship to other genes in the
databases.
In an attempt to understand how these mam-
malian genes function, we have expressed them in S.
pombe and in mammalian cells. Preliminary studies
indicate that expression of JC310 in NIH-3T3 cells
blocks the mitogenic and morphological responses of
these cells to phorbol esters, but not the activation of
protein kinase C itself. These results are compatible
with the hypothesis that JC310 blocks aspects of
RAS function in mammalian cells, for it is known
that RAS function is required for the morphologic
and mitogenic effects of protein kinase C. This points
to a possible evolutionary conservation in the func-
tion of JC310. However, expression of JC310 appears
to have no evident phenotypic effects in either wild-
type or mutant strains of S. pombe.
Expression of JC99, on the other hand, has
profound effects in S. pombe. Expression has mini-
mal effects on wild-type and rasl- cells, slightly
promoting sporulation in rasl-lrasl- diploids and
haploid sporulation in ras1- or wild-type cells; but
expression strongly suppresses the sexual dysfunction
in cells that have activated the cAMP-signaling path-
ways. Cells that overexpress adenylyl cyclase or that
lack the regulatory subunit of the cAMP-dependent
protein kinase are virtually sterile. Moreover, they are
elongated and heat-shock-sensitive. Expression of
JC99 reverses these phenotypes, yet does not sup-
press the phenotypes of altered glucose metabolism
99
associated with activation of the
cAMP pathway.
Hence, in S. pombe, JC99 acts
downstream from the
cAMP pathway, where it interacts
with gene products
involved in sexual function. We do
not yet under
stand how to reconcile these
results with the effects
of JC99 in S. cerevisiae, where
it does alter
phenotypes due to activation of the cAMP pathway
but is unable to effect strains with
activating muta-
tions in adenylyl cyclase or the cAMP-dependent
protein kinases. If expression of JC99 has
effects in
mammalian cells, these are not yet clear to us.
We have also selected several mammalian
cDNAs on the basis of their ability to complement
loss of rasl function in S. pombe. These genes are
still under study.
CAP, and Adenylyi-cyclase-associated
Protein
J. Field, D. Young, M. Kawamukai, J. Gerst,
A. Vojtek, M. Riggs, L. Rodgers
The year before last we reported the cloning of S.
cerevisiae CAP (Field et al., Cell 61: 319 [1990]).
This gene encodes a product required for full
responsiveness to activated RAS. CAP is bifunctional
(Gerst et al., MoL Cell Biol. 11: 1248 [1991]). The
amino-terminal domain binds adenylyl cyclase and is
required for cellular RAS responsiveness. The
carboxy-terminal domain is required for a variety of
other cellular functions. Cells that lack the carboxyl
terminus of CAP are temperature-sensitive, have dis-
rupted actin cables, are enlarged and round, bud ran-
domly from the cell surface, and show a variety of
nutritional abnormalities, including valine toxicity,
failure to grow in rich medium, and exquisite
sensitivity to starvation (Gerst et al., MoL Cell. Biol.
11: 1248 [1991]; Vojtek et al., Cell 66: 497 [1991]).
The amino and carboxyl termini of CAP appear to act
independently and are connected by a proline-rich
middle portion that to date appears to be phenotypi-
cally silent.
To understand the carboxy-terminal function of
CAP, we have sought genes that when overexpressed
could suppress the phenotypes that result from its
loss. One such gene is profilin, a low-molecular-
weight protein that binds actin monomers and also
binds phosphoinositides (Vojtek et al., Cell 66: 497[1991]). Overexpression of profilin corrects the
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temperature-sensitive growth defects and the cyto
skeletal, morphological, and nutritional abnormalities
of cells lacking the carboxyl terminus of CAP,
but
not the RAS responsive abnormalities of cells lacking
the amino terminus of CAP. Moreover, cells lacking
profilin display growth and morphological
ab-
normalities that closely resemble the phenotype
of
cells lacking the carboxyl terminus of CAP. These
results point to an intimate relationship between
thefunction of CAP and the function of profilin,
a rela-
tionship that is strengthened by the discovery
of
mammalian CAP (see below).
Another multicopy suppressor of the loss
of the
carboxy-terminal function of CAP is a gene
we have
called SNC1. SNC1 encodes a small protein that has
striking homology with the VAMP/synaptobrevin
family of vertebrate synaptic-vesicle-associated
proteins. These are low-molecular-weight proteins
with very hydrophobic carboxy-terminal domains
that are thought to function in neurotransmitter
release. The presence of VAMP homologs in yeast
suggests a more general function, perhaps in
mem-
brane vesicle fusion. We do not understand how
the
function of SNC1 relates to the function of CAP.
Curiously, SNC1 expression suppresses the loss
of the carboxyl terminus of CAP only in cells with
an
activated RAS pathway; activation of the cAMP
pathway is not sufficient. A similar result was ob-
tained in the suppression of loss of carboxy-terminal
CAP by human profilin: Effective suppression was
observed only in RAS-activated strains. These results
suggest that RAS, acting through its alternate path-
way, in some way effects the functions of CAP,
profilin, and SNC1.
The S. cerevisiae CAP gene has an S. pombe
homolog (Kawamukai et al., MoL Biol. Cell 3: 167
[1992]). The existence of this protein was first in-
ferred from the presence of a cross-reacting antigen
in preparations of adenylyl cyclase purified from S.
pombe. The gene was independently cloned in two
ways: by immunological screening of S. pombe
cDNA expression libraries in Escherichia coli and by
complementation screening of a cap- S. cerevisiae
strain with cDNAs from S. pombe. S. pombe and S.
cerevisiae have homologous carboxy-terminal func-
tion. Disruption of the carboxy-terminal domain of S.
pombe capl causes temperature sensitivity and mor-
phological abnormalities. Disruption of the amino-
terminal domain causes loss of proper regulation of
adenylyl cyclase. Thus, it is likely that in both yeasts,
amino-terminal CAP function is required for the
proper regulation of adenylyl cyclase, whereas
carboxy-terminal function is somehow related to cell
morphology and growth.
Recently, Makoto Kawamukai, upon his return to
Japan, cloned a human homolog of CAP. Even more
recently, the isolation and purification of an actin-
binding protein from pig platelets and the sequence
of tryptic peptides were published (Gieselmann and
Mann, FEBS Lett. 298: 149 [1992]). This sequence
showed near identity to the human CAP. Since the
amino-terminal domain of the mammalian CAP has
homology with those of yeast, we infer that we may
find a form of mammalian adenylyl cyclase that is
homologous to the yeast adenylyl cyclases. Since the
mammalian CAP is associated with actin, and can
function in yeast, we infer that the mammalian CAP
also regulates the cellular cytoskeleton and that yeast
CAP, like yeast profilin, may regulate actin function.
Mammalian cAMP-specific
Phosphodiesterases
T. Michaeli, G. Bolger, K. O'Neill,
M. Riggs, L. Rodgers
Selection for mammalian cDNAs that could suppress
the phenotypes of S. cerevisiae strains with the
RAS2va119 mutation led to the cloning of mammalian
cDNAs encoding phosphodiesterases. Several of
these showed homology with the Drosophila melano-
gaster dunce gene. We have now explored the struc-
ture of this gene family in humans and rats. By utiliz-
ing polymerase chain reaction (PCR) primers and
genomic DNA as a template, we have identified a to-
tal of four genes in this family, both from rats and hu-
mans. Functional cDNA sequences of three of these
four genes have been cloned from humans, although
we do not know whether the 5' extremities of the
coding regions have been reached. These genes en-
code high-affinity cAMP-specific phosphodiesterases
which are inhibitable by rolipram. Using yeast lack-
ing endogenous cAMP phosphodiesterases, which
also have a heat-shock-sensitive phenotype, we have
cloned a human cDNA encoding a novel form of
cAMP phosphodiesterase. This gene, given the provi-
sional name TM22, encodes a high-affinity cAMP-
specific phosphodiesterase that is not inhibitable by
either rolipram or milrinone. It therefore encodes a
previously undetected form of cAMP phospho-
diestcrase.
Genomic Difference Cloning
N. Lisitsyn
Sensitive methods for the detection of sequence dif-
ferences between like genomes are potentially of
great utility in understanding the genetic basis of dis-
ease. Such methods have potential application to the
discovery of novel pathogens and the definition of
genetic lesions in tumor cells. We previously pub-
lished a method that allows the enrichment of dif-
ference sequences between two genomes by factors
of several hundred (Wieland et al., Proc. Natl. Acad.
87: 2720 [1990]). We have modified this approach in
two fundamental ways. First, we simplify the
genomes to be compared by taking an "isomorphic
representation" of each. This entails making an equal
sampling of both genomes and examining sequence
differences between these simplified DNA popula-
tions. Second, after rounds of subtractive hybridiza-
tion, we further enrich difference sequences by melt-
ing, annealing, and selecting for double-stranded
DNA. For sequences enriched by a factor of N, this
step can, theoretically, give another N-fold enrich-
ment. Using this approach, and model systems in
which we have added X DNA or E. coli DNA at
single-copy levels to human DNA, subtracted against
the same DNA without the added sequences, we have
enriched the difference sequences by as much as
100,000-fold.
PUBLICATIONS
Colicelli, J., C. Nicoletti, C. Birchmeier, L. Rodgers, M.
Riggs, and M. Wigler. 1991. Expression of three mam-
malian cDNAs that interfere with RAS function in Sac-
charomyces cerevisiae. Proc. Natl. Acad. Sci. 88:
2913-2917.
Daar, I., A.R. Nebreda, N. Yew, P. Sass, R. Paules, E.
Santos, M. Wigler, and G.F. Vande Woude. 1991. The
ras oncoprotein and M-phase activity. Science 253:
74-76.
Gerst, J.E., K. Ferguson, A. Vojtek, M. Wigler, and J. Field.
1991. CAP is a bifunctional component of the Saccharo-
myces cerevisiae adenylyl cyclase complex. Mol. Cell.
Biol. 11: 1248-1257.
Kawamukai, M., K. Ferguson, M. Wigler, and D. Young.
1991. Genetic and biochemical analysis of the adenylyl
cyclase of Schizosaccharomyces pombe. Cell Regul. 2:
155-164.
Vojtek, A., B. Haarer, J. Field, J. Gerst, T.D. Pollard, S.
Brown, and M. Wigler. 1991. Evidence for a functional
link between profilin and CAP in the yeast S. cerevisiae.
Cell 66: 497-505.
101
Wang, Y., M. Boguski, M. Riggs, L. Rodgers, and M. Wig ler.
1991. Sari, a gene from Schizosaccharomyces pombe
encoding a protein that regulates ras1. Cell Regul. 2:
453-465.
Wang, Y., H.-P. Xu, M. Riggs, L. Rodgers, and M. Wig ler.
1991. byr2, a Schizosaccharomyces pombe gene en-
coding a protein kinase capable of partial suppression
of the rasl mutant phenotype. Mol, Cell. Biol. 11:
3554-3563.
Young, D., K. O'Neill, D. Broek, and M. Wig ler. 1991. The
adenylyl cyclase-encoding gene from Saccharomyces
kluyveri. Gene 102: 129-132.
TRANSMEMBRANE SIGNALING
D. Bar-Sagi M. Boyer
N. Gale
P. Geste land
L. Graziadei
K. Degenhardt
S. Kaplan
Y. Yeh
We are interested in signal transduction pathways in-
volved in growth control. Our research focuses on the
role of Ras proteins in signal transduction. Since their
discovery in 1982, cellular ras genes have been the
focus of intense research because their mutated al-
leles are prevalent in various carcinogen-induced
animal tumors as well as in a significant proportion
of human tumors. In addition, ras genes have at-
tracted much interest because they have been highly
conserved during evolution and are therefore
presumed to be involved in a basic cellular function.
The identity of this function is unknown. The
proteins encoded by ras genes bind guanine
nucleotide, possess an intrinsic GTPase activity, and
are localized to the inner face of the plasma mem-
brane. On the basis of these properties, it has been
postulated that Ras proteins are intermediates in a
transmembrane signaling pathway, acquiring a signal
from an upstream element and passing it on to a
downstream target. During the past year, we have
continued to study the mechanism of signal transduc-
tion by Ras. Through the use of signaling events in
the immune system, we have obtained some insights
into the possible identity of the Ras signaling path-
way.
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Interaction of Ras Proteins
with the Cytoskeleton
M.J. Boyer, D. Bar-Sagi
Our laboratory has recently demonstrated that Ras
cocaps with surface immunoglobulin receptors (sIg)
when these receptors are cross-linked by multivalent
ligands. The capping of sIg is an energy-dependent
process that is mediated by the contractile activity of
the peripheral cytoskeleton. Furthermore, it has been
shown that in the course of their ligand-induced
redistribution, sIg molecules form a physical associa-
tion with the underlying cytoskeleton. Since the
redistribution of Ras exactly mimicked the redistribu-
tion of sIg, and since both redistributions were in-
hibited by cytoskeletal disrupting agents, we hypoth-
esized that Ras proteins may become associated with
the cytoskeleton following ligand-receptor interac-
tion. The strategy we used to examine the possible
association of Ras with the cytoskeleton is based on
the use of differential solubilization by nonionic
detergents of cellular proteins. This technique enables
the fractionation of cytoskeletal attached components
(detergent insoluble) from noncytoskeletal attached
components (detergent soluble). Thus, we compared
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FIGURE 1 Detergent extraction of Ras from resting and stimulated B cells. [35S]Methionine-labeled cells were stimulated
with anti-immunoglobulin antibodies and detergent-extracted for various intervals. The amount of Has polypeptides in the
detergent lysate was determined by immunoprecipitation. (A) Densitometric scan of the Has band from respective
samples in the gel shown on panel B. (B) Autoradiogram of immunoprecipitates carried out in detergent extracts from
resting (R) and stimulated (S) cells which were detergent-extracted for the indicated intervals (min ext.). Control im-
munoprecipitations (0 min ext.) to establish the specificity of the reaction were carried out on resting cells using anti-Ras
antibodies that were either unblocked (+) or blocked (-) by preincubation with purified Has protein. Note that the amount
of Has in the detergent-soluble extract is significantly reduced in stimulated cells, indicating that a portion of Has
molecules became associated with the detergent-insoluble fraction.
the detergent solubility of Ras in resting and stimu-
lated B cells. The detergent extraction protocol that
we employed involved the use of nonionic detergent
in high-sucrose buffer. The amount of detergent-
extracted Ras was determined by immunoprecipita-
tion. Our results to date indicate that the amount of
Ras in the detergent soluble extract is significantly
reduced in stimulated cells, indicating that a portion
of Ras molecules became associated with the deter-
gent insoluble fraction (Fig. 1). This is to our knowl-
edge the first demonstration of an interaction between
Ras and the cytoskeletal framework. Ongoing efforts
in the laboratory are directed at identifying the cyto-
skeletal components with which Ras interacts and the
possible functional significance of this interaction.
Participation of Ras Proteins
in T-cell Activation
N. Gale, P. Geste land, D. Bar-Sagi
T lymphocytes can be activated to produce lympho-
kines, to express new cell surface molecules, and,
eventually, to proliferate. This process is triggered by
ligand receptor interactions occurring at the plasma
membrane. As a consequence of these cell-surface in-
teractions, signals are transmitted across the plasma
membrane to the cell interior. The T-cell antigen
receptor (TCR) plays a central role in these trans-
membrane signaling events. Several lines of evidence
from our laboratory and others suggest a role for Ras
in transduction of signals that lead to T-cell activa-
tion. These include: (1) Ras proteins undergo a coin-
cident redistribution with cell-surface receptors in
Jurkat T cells upon mitogenic stimulation with phyto-
hemagglutinin (PHA), a plant lectin that achieves its
mitogenic potential by cross-linking surface recep-
tors, including the T-cell receptor. (2) Overexpres-
sion of oncogenically activated alleles of Ras in
Jurkat cells results in an enhanced ability of these
cells to produce interleukin-2, a specific functional
marker of the activation program. This effect is ob-
served only when the cells are stimulated with a com-
bination of calcium ionophore and phorbol myristate
acetate (PMA), a potent activator of protein kinase C.
(3) Activation of Jurkat cells with a number of
agents, including antibodies to specific components
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of the T-cell receptor complex, PHA, or
PMA, results
in a rapid increase in the amount
of GTP bound to
Ras. It has been shown that the
formation of the ac-
tive Ras-GTP complex is
regulated by the GTPase-
activating protein (GAP). GAP stimulates the
other-
wise weak intrinsic GTPase activity
of Ras proteins
and therefore promotes the return of Ras
to an inac-
tive GDP-bound form. Upon
activation of T cells,
however, GAP is inhibited, thus leading to the ac-
cumulation of active GTP-bound Ras. To understand
how GAP may function as a linker between
Ras and
extracellular signals, we have been investigating the
mechanisms of inactivation of GAP. Two types of
signals for the inactivation of GAP have been postu-
lated: (1) indirect inhibition mediated by protein
kinase C activation and (2) direct inhibition by
biologically active lipids, specifically, arachidonic
acid and some of its metabolites. Arachidonic acid is
produced in cells by the activity of phospholipase A2
(PLA,) and is the rate-limiting precursor in the
synthesis of the eicosanoids, including the prosta-
glandins. Therefore, it has been our aim to test
whether PLA2 activity plays a role in the modulation
of GAP and Ras activities. To test this hypothesis, we
have employed an inhibitor of PLA, para-bromo-
phenacyl bromide (P-BPB). P-BPB is a histidine-
modifying reagent that alters a critical histidine
within the catalytic pocket of PLA,. Our results to
date show that inhibition of PLA2 activity by P-BPB
blocks the biochemical activation of Ras proteins.
This effect is dose-dependent and is believed to be
due to the inhibition of arachidonic acid production
and not its metabolites, because inhibition of the
major pathways of arachidonic acid metabolism has
no effect on the ability to activate Ras. These results
suggest that PLA2 participates in the cascade of sig-
nals leading to the biochemical activation of Ras
proteins. Future experiments in our laboratory will be
aimed at further characterizing the biochemical steps
involved in this process.
Role of Ras Proteins in Signaling via
the Immunoglobulin Receptor
L. Graziadei, D. Bar-Sagi
Immunofluorescence studies performed previously in
the laboratory have demonstrated a spatial and
temporal coincidence between the ligand-induced
migration of surface antigen receptors (sIg) and Ras
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in mitogenically stimulated B lymphocytes, we
wanted to investigate the functional significance of
ithis phenomenon. An increase in the proportion of
Ras molecules in the GTP bound or "active" con
formation has been used by other investigators as an
- Haveindicator of functional activation of Ras. We h
used this approach to determine whether Ras
proteins are involved in signaling through sig. We
utilized an immunoprecipitation protocol in Which
cellular guanine nucleotide pools were metabolically
labeled with 32P. Cells were then stimulated through
their sIg using the appropriate species-specific anti-
immunoglobulin antibody. Cellular Ras proteins were
immunoprecipitated, and bound nucleotides
were
eluted. Thin-layer chromatography was used to dis-
tinguish GDP from GTP.
Initial experiments were performed on the lym-
phoma B-cell line, WEHI-231. The immunoglobulin
receptors expressed on the surface of WEHI-231 cells
are of the IgM isotype (sIgM). Antibody stimulation
of these cells through their sIgM led to a significant
increase in the proportion of GTP-bound Ras
molecules (Fig. 2). In a typical experiment, resting
cells showed 21% of Ras molecules complexed to
GTP, whereas after a 30-minute stimulation on ice,
this value increased to 56%. These results indicate
that sIg receptors are capable of signaling to cellular
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FIGURE 2 Effect of B-cell activation on guanine nu-
cleotides bound to Ras. TLC of the guanine nucleotides
eluted from immunoprecipitates of Has from 32P-ortho-
phosphate-labeled WEHI-231 cells. Immunoprecipitation
was carried out with a monoclonal anti-Ras antibody (+)
or without the addition of specific antibody (-). Cells were
stimulated for 10 min with F(ab ' )2 derivatives of anti-IgM
antibodies. The positions at which GTP and GDP stan-
dards ran are indicated.
Ras molecules. Since B cells undergo a distinct and
progressive rearrangement of slg molecules upon
stimulation, we wanted to see if Ras activation corre-
lated with a particular morphological stage of recep-
tor rearrangement. Immunoglobulin receptors on
cells that are stimulated on ice are capable of un-
dergoing only patching (the earliest, passive cluster-
ing of cross-linked slg). Under these conditions, max-
imal stimulation of Ras molecules was achieved after
10 minutes, with significant increases in the portion
of GTP-bound Ras detected as early as 2 minutes
after stimulation. This indicates that slg- induced ac-
tivation of Ras precedes slg redistribution. To assess
whether the activation of Ras is particular to one
class of immunoglobulin receptor, we have employed
the A20 B-cell line that expresses slg of the IgG
isotype. Experiments such as those described above
have revealed that in these cells, the proportion of
GTP-bound Ras molecules also increased in response
to stimulation through their slg. This indicates that
Ras proteins are involved in signaling from both IgM
and IgG isotypes. We are currently investigating the
biochemical mechanisms linking stimulation of im-
munoglobulin receptors and Ras activation.
Analysis of Tyrosine Phosphorylation
Events Associated with B-cell
Activation
L. Graziadei, Y. Yeh, D. Bar-Sagi
As described above, studies carried out in our
laboratory have indicated a possible link between the
ligand-induced redistribution of the B-cell antigen
receptor (slg) and the activation of Ras proteins. Al-
though slg has no intrinsic tyrosine kinase activity,
receptor activation leads to the inducible phosphory-
lation of a number of cellular proteins on tyrosine
residues. Candidate kinases have been identified and
include the lck- encoded protein, which is a member
of the src family of tyrosine kinases. Since members
of this tyrosine kinase family have been postulated to
act upstream of Ras, we wanted to investigate the re-
lationship between ligand-induced protein tyrosine
kinase (PTK) activity and Ras activation. To this end,
we have employed the tyrosine kinase inhibitor,
genistein. We have found that treatment of small,
dense resting murine primary B lymphocytes with
genistein partially inhibited the activation of Ras
proteins induced by cross-linking of slg. The mech-
anisms underlying this inhibitory effect are being
characterized further. In addition, we have found that
inhibition of tyrosine phosphorylation by genistein
affects ligand-induced slg redistribution. Under
normal conditions, cross-linking of slg is the induc-
tive event for three distinct, sequential stages of
receptor relocalization, which include patching, cap-
ping, and receptor internalization. Stimulation of
cells in the presence of genistein had no effect on the
redistribution patterns of slg at the patching and cap-
ping stages. However, at the stage in which most con-
trol cells had undergone receptor internalization,
genistein-treated cells still displayed prominent caps
of slg on the cell surface (Fig. 3). A comparison be-
tween the kinetics of slg redistribution in control and
genistein-treated cells revealed that genistein does
not effect the rate at which cells enter or complete
patching and capping. This indicates that whereas in-
hibition of receptor-induced tyrosine phosphorylation
has no effect on the kinetics of B-cell slg patching
and capping, PTK activity is required for proper in-
ternalization of capped surface receptors.
B-cell antigen-receptor-induced tyrosine phos-
phorylations have been studied in some detail and
can be divided into early and late events. Western
blotting demonstrated that inducible phosphorylation
is visible as early as 30 seconds after stimulation and
persists for up to 90 minutes after receptor/ligand in-
teraction on ice. As an initial step toward identifying
tyrosine phosphorylation events relevant to slg inter-
nalization, we wanted to investigate the time depen-
dence of the genistein effect. Toward this end, cells
were pretreated for 30 minutes with stimulatory anti-
Ig antibody to allow initial PTK activation and then
treated with genistein. Under these conditions,
genistein was equally effective in inhibiting slg inter-
nalization. Therefore, it appears that persistent
tyrosine phosphorylation is crucial for internalization
of capped slg receptors. Since ligand-induced inter-
nalization of slg is essential for B cells to function as
antigen-presenting cells, we are interested in further
defining the relationships between tyrosine phosphor-
ylation and slg internalization.
Posttranslational Modification
of Ras Proteins
K. Degenhardt, D. Bar-Sagi
We have recently shown that the carboxyl methyl
group on the carboxy-terminal cysteine residue of
Ras proteins turns over with a half-life of approxi-
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AFIGURE 3 Distribution of immunoglobulin receptors in primary murine B lymphocytes following ligand-induced activation.
Control cells (A) or cells pretreated with the tyrosine kinase inhibitor genistein (B) were stimulated for 45 min with 15 nm of
colloidal-gold-conjugated goat anti-mouse IgG. Localization of slg was determined by electron microscopy. In control cells,
essentially all slg molecules (visualized as gold particles) are internalized and present in endocytic vesicles (panel A, ar-
rowheads and inset). In cells treated with genistein, receptor internalization is completely blocked, and all slg molecules
remain capped at the cell surface (panel B, arrowhead and inset). (Nu) Nucleus. Magnifications: (A,B) 26,000x; (insets)
64,000x.
mately 60 minutes (Fig. 4). The biological function
of this dynamic methylation event is currently under
investigation in our laboratory. To study the carboxyl
methylation of Ras, we have established an in vitro
methylation system that specifically assays for
methyl esterification occurring on the a carboxyl
group of the carboxy-terminal cysteine residue of Ras
proteins. This assay utilizes a crude membrane frac-
tion supplying both Ras and the methyl transferase
and an exogenous methyl donor [methyl -3H]S-
adenosyl-L- methionine ([31-1]SAM). Although many
membrane proteins are carboxyl methylated in this
system, the methylation of Ras can be specifically as-
sayed by the immunoprecipitation of Ras polypep-
tides using an anti-Ras monoclonal antibody (Y13-
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259). To study the functional significance of the car-
boxyl methylation of Ras proteins, we will need to
identify the carboxyl methyl transferase that
catalyzes this reaction. To this end, we have initiated
subcellular fractionation experiments. Through frac-
tionation of total cellular membranes over a sucrose
gradient, we have found that the majority (78%) of
protein carboxyl methylation activity is associated
with the plasma membrane fraction. Furthermore, we
have found that the in vitro carboxyl methylation of
Ras is stimulated by guanine nucleotides. This obser-
vation suggests the involvement of a guanine-
nucleotide-binding protein in the regulation of Ras
carboxyl methylation. Along similar lines, initial ex-
periments have been targeted to investigate receptor-
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FIGURE 4 In vitro carboxyl methylation of Ras proteins.
(A) Crude membrane preparations were incubated with
[3H]SAM for the indicated intervals in minutes. Ras
polypeptides were isolated by immunoprecipitation and
fractionated on a SDS-polyacrylamide gel. As can be
seen, carboxyl methylation of Has is time-dependent and
is inhibited by the addition of S-adenosyl homocysteine, a
specific inhibitor of methyltransferases. (8) Turnover of
carboxyl methyl group on Ras. Membranes were methyl-
ated for 30 min and chased for the indicated intervals in
buffer containing an excess of unlabeled SAM. Has
polypeptides were immunoprecipitated and analyzed by
SDS-PAGE. Quantitation of 3H-labeled methyl ester on
Has versus time of chase indicates a t112 of 60 min for the
carboxyl methyl turnover.
mediated alterations in Ras carboxyl methylation. To
this end, we have studied the effects of serum
stimulation on Ras carboxyl methylation in quiescent
NIH-3T3 cells. Serum stimulation is a receptor-
mediated process in which Ras has been implicated.
Results from these experiments show that under the
conditions examined thus far, the carboxyl methyla-
tion of Ras is independent of serum stimulation. We
plan to continue our efforts in investigating the
biological significance of carboxyl methylation of
Ras using this in vitro system.
Role of Ras Proteins in
Exocytotic Secretion
L. Graziadei, S. Kaplan, D. Bar-Sagi
For a number of years, we have been studying the
role of Ras proteins in the regulation of exocytotic
secretion in mast cells. In earlier studies, we used the
microinjection approach to examine the effects of
Ras proteins on exocytosis in rat peritoneal mast
cells. The results of these studies can be summarized
as follows: Microinjection of the ras oncogene
protein into mast cells induces exocytotic degranula-
tion. In contrast, microinjection of similar amounts of
the proto-oncogenic protein had little apparent effect
on mast cells. Degranulation induced by the injection
of the ras oncogene protein occurred in the absence
of an external stimulus and required the presence of
external calcium. The ultrastructural features of the
exocytotic degranulation in mast cells injected with
the ras oncogene protein were similar to those seen
when mast cells are activated by soluble ligand.
To investigate further the mechanisms underlying
the stimulatory effect of Ras proteins on exocytosis,
we have initiated studies on the effects of overexpres-
sion of ras proto-oncogene and oncogene proteins on
the ligand-induced exocytotic secretion in the mast
cell line, RBL-2H3. In these cells, exocytotic secre-
tion is induced by the interaction of an appropriate
ligand with surface IgE receptors. To obtain stable
expression of the normal and activated forms of the
ras gene, RBL-2H3 cells were transfected using the
DEAE-dextran procedure. The plasmids used for
these transfection experiments contain the coding se-
quences of the oncogenic and proto-oncogenic forms
of the human Ha-ras gene. In these plasmids, the ex-
pression of the Ha-ras gene as well as the neoR gene
is under the transcriptional control of murine
leukemia virus long terminal repeat (MLV LTR).
Transfected clones were isolated on the basis of
G418 resistance. RBL-2H3 cells expressing the
normal Ha-ras were morphologically indistinguish-
able from nontransfected cells. In contrast, the mor-
phology of RBL-2H3 cells expressing the Ha-ras on-
cogene was significantly altered; the cells were very
flat and displayed extensive ruffling activity (Fig. 5).
Measurements of IgE-mediated secretion from the
various transfectants revealed a twofold enhancement
of the stimulated secretion in cells expressing the Ha-
ras oncogene. This enhancement did not result from
changes in either number or affinity of the IgE recep-
tor. These results suggest that Ras proteins may be
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FIGURE 5 Morphologies of RBL-2H3 cells transfected with vector (2H3P), ras proto-oncogene (2H3G12) or ras
oncogene (2H3V12). Cells expressing the ras oncogene display altered morphology: They are flat, and, at a
higher magnification (right panel), extensive ruffling activity is detected (arrowheads).
involved in the signaling events that control IgE-
mediated exocytotic secretion. Consistent with this
notion is our recent observation that stimulation of
the IgE receptor induces an increase in the GTP-
bound form of Ras. Studies are currently under way
to characterize the biochemical basis of the effect of
Ras proteins on the exocytotic response.
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NUCLEAR SIGNAL TRANSDUCTION
M. Gilman C. Alexandre
R. Attar
L. Berkowitz
R. Graham
D. Grueneberg
G. Lee
A. Majid
S. Natesan
K. Riabowol
Our major focus continues to be the mechanisms by
which extracellular signals are communicated to the
nucleus to control the proliferation and development
of eukaryotic cells. We view this as a two-part prob-
lem. First, we need to understand the simple mechan-
ics of the process. What are the individual molecular
steps by which signals are relayed from the cell sur-
face to nuclear targets? Second, we need to under-
stand where the biological specificity in these signals
is encoded. How do cells know what signal they have
received and respond appropriately?
Our general approach to these questions has
revolved around studies of the c-fos proto-oncogene.
This gene is rapidly activated at the transcriptional
level by a variety of extracellular stimuli, including
growth and differentiation factors, hormones, and
neurotransmitters. Induction of c-fos transcription oc-
curs within seconds or minutes of exposure to these
signaling molecules and does not require the cell to
synthesize new proteins. Thus, activation of the c-fos
gene is a primary response to the signal transduction
pathways activated by these factors, and our working
hypothesis is that the c-fos gene itself is a physical
target for these signals.
Consequently, our general strategy has been to
identify the sequences that mediate the response of
the c-fos gene to specific signal transduction path-
ways. Then, using these sequences as reagents, we
identify and characterize the cellular proteins that in-
teract with them. Eventually, we use these proteins as
reagents to identify the next proteins up the signaling
chain. As described below, we have made varying
degrees of progress working our way up the different
signal transduction pathways that activate c-fos tran-
scription. For cAMP, for example, we think we un-
derstand at least in a general way the entire route
through which cAMP activates c-fos transcription.
For other pathways, however, we know much less.
These experiments address the first question, the
mechanics of signaling, but in addition, our recent
results have suggested possible answers to the second
question, the specificity of signaling. For example,
we have generated c-fos promoter derivatives that
respond to only subsets of signals. These results show
A. Ryan
H. Sadowski
K.-A. Won
that in some cases, the specificity of signaling is due
to the use of completely distinct cis-acting regulatory
elements. In other cases, different signals target dif-
ferent nuclear proteins that interact with a common
sequence element. A second insight into the
specificity of signaling comes from our recent dis-
covery that homeodomain proteins may participate in
the regulation of c-fos and other genes by ex-
tracellular signals. Since homeodomain proteins play
a role in establishing the specificity of cell identity in
embryonic development, we suspect that the interac-
tion of these proteins with the proteins that control c-
fos expression may be an important aspect of how the
specificity of signaling is achieved. Third, we have
begun to study a family of genes that may be
downstream targets of the c-fos gene product, which
is itself a transcription factor. These are the G1
cyclins, which have key regulatory roles in control-
ling the entry and exit of cells from the proliferative
cycle. By understanding how the transcription of
these genes is controlled, we hope to get a picture of
how cells are able to discriminate mitogenic from
nonmitogenic signals.
Most of the work in the laboratory is focused on
the serum response element (SRE), a relatively
simple sequence that nevertheless integrates a great
deal of signaling information. We describe below
several of our approaches to understanding the func-
tion of this element and the proteins that interact with
it. We begin, however, by describing our work with
two signal transduction pathways that activate c-fos
transcription independently of the SRE.
Regulation of c-fos Transcription
by cAMP
L. Berkowitz
Transcription of the c-fos proto-oncogene is rapidly
induced as a primary response to signals that increase
the intracellular concentration of the second mes-
senger cAMP. We learned early on that induction by
cAMP was not prevented by mutations that destroyed
the SRE. Using deletions and point mutations, we
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identified three sequence elements in the c-fos
promoter that mediate induction by cAMP. All of
these elements contain the consensus sequence iden-
tified in the cAMP response elements (CREs) of
other genes, although their transcriptional strengths
and affinities for cellular CRE-binding proteins vary.
We found that microinjection of double-stranded
oligonucleotides corresponding to the major c-fos
CRE prevented the induction of endogenous c-fos ex-
pression by cAMP in fibroblasts, showing that these
elements are indeed required in vivo for this induc-
tion.
Our search for intracellular mediators of c-fos in-
duction focused first on the cAMP-dependent protein
kinase A (PKA). We found that microinjection of the
purified catalytic subunit of PKA was sufficient to in-
duce c-fos transcription, indicating that protein
phosphorylation was involved in this induction. To
identify the putative target for PKA, we focused on
the previously characterized CRE-binding protein,
CREB. CREB is phosphorylated in vitro by PKA and
can activate transcription of a CRE-containing gene.
We isolated CREB cDNAs by the polymerase chain
reaction (PCR) and discovered that two different
CREB mRNAs are produced in cells, leading to the
synthesis of proteins that differ by the insertion of 14
amino acids. To study the activity of CREB in the
presence of cAMP, we reprogrammed its DNA-
binding specificity by attaching the DNA-binding
domain of the yeast transcriptional activator GAL4.
This allowed us to measure CREB transcriptional ac-
tivity without interference from endogenous CREB
or related proteins. These experiments showed that
the transcriptional activity of CREB is directly modu-
lated in response to cAMP and that some but not all
of this effect requires the characterized PKA
phosphorylation site. That residual cAMP-inducible
activity remains in the absence of this site suggests
that CREB contains other sites for PKA or that other
regulatory mechanisms are able to influence the tran-
scriptional activity of the protein.
We have raised both polyclonal and monoclonal
antibodies to CREB and have made a series of
mutants to identify important regulatory sites in the
protein. In collaboration with G. Enikolopov (see this
Section), we have also examined the role of CREB in
the regulation of gene expression by calcium in PC12
cells. We find that CREB is indeed able to mediate
calcium-responsive transcription and that this activity
is only partially abolished by mutation of the PKA
phosphorylation site, again suggesting that alternative
mechanisms exist for activating CREB.
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FIGURE 1 Our current view of the intracellular signaling
pathways that control c-fos transcription. At least four dis-
tinct signal transduction pathways can activate c-fos tran-
scription. cAMP acts by releasing the catalytic subunit of
cAMP-dependent protein kinase (PKA), which migrates to
the nucleus, where one of its actions is to phosphorylate
the transcription factor CREB. Phosphorylation of CREB
activates its transcriptional stimulatory function. Intra-
cellular calcium acts on the c-fos gene through at least
two or three discrete targets. In PC12 cells, calcium ap-
pears to activate CREB via a pathway similar to that used
by cAMP. In T cells, in contrast, calcium acts to enhance
initiation of c-fos transcription through as yet un-
characterized cis- and trans-acting elements and to pro-
mote the efficient elongation of c-fos transcripts, perhaps
through a regulatory element in the body of the c-fos
gene. Polypeptide growth factors that act through recep-
tors with intrinsic or tightly linked protein-tyrosine kinase
activity transmit at least two distinct signals to the c-fos
gene. One signal, via protein kinase C (PKC), acts
through a protein complex assembled at the c-fos serum
response element (SRE) that consists of SRF and TCF.
Other signals, independent of PKC (PKC-I), act through
distinct SRF-containing complexes. At least one of these
activates a latent DNA-binding protein, termed SIF, that
binds just 5' to the SRE. Several other proteins interact at
the SRE; some, such as p62DBF and ZBP, bind directly to
the SRE, whereas we believe that others, such as
homeodomain proteins and the p65 subunit of NFKB, in-
teract with SRF. For details, see the individual sections.
Regulation of c-fos Transcription
by Intracellular Calcium
G. Lee
Intracellular calcium is an important second mes-
senger in many cells, particularly in neuronal cells
where it is a second messenger for neurotransmitters
and in T cells where it is important in the activation
of T cells by antigen. One of the cardinal properties
of calcium in T cells is its ability to act synergistical-
ly with activators of protein kinase C. This synergy
can be seen at the level of the biological response of
T cells: Calcium and PKC together but neither alone
can fully activate T cells. In addition, it can be seen at
the level of c-fos induction. PKC activators and cal-
cium ionophores, at concentrations that have negli-
gible effects on c-fos transcription singly, elicit large
inductions of c-fos transcription when used together.
We are interested in defining the mechanisms of this
synergy and understanding how calcium signals are
transmitted to the c-fos gene.
To study the regulation of c-fos transcription by
calcium in T cells, we have used nuclear run-on as-
says. We find that whereas treatment with the PKC
activator PMA induces transcription of sequences at
the 5 ' end of the c-fos transcription unit, transcription
does not proceed efficiently into the body of the
gene. In the presence of calcium, however, there is a
dramatic transient enhancement in the transcription
of downstream sequences, with little change in the
transcription of the 5 ' region of the gene. Thus, part
of the synergistic action of calcium is due to the en-
hanced elongation of transcripts initiated in response
to PMA. We are currently considering and testing
two different models for this elongation enhance-
ment. One model is that there is a specific block to
transcript elongation as seen in the c-myc gene.
Alternatively, transcription of the c-fos gene in the
absence of calcium may be poorly processive, and a
calcium-induced modification of the transcription
complex enhances the general elongation properties
of RNA polymerase. To distinguish between these
models, we are performing nuclear run-on assays
with short probes from different segments of the c-fos
gene.
At higher concentrations, calcium is capable of
inducing c-fos transcription alone by a second distinct
mechanism. This mechanism has proven difficult to
study because, in contrast to the synergistic interac-
tion with PMA, direct induction by calcium is not
faithfully recapitulated by transfected c-fos genes,
despite the presence of long 5' - and 3' -flanking se-
quences. Thus, direct induction of c-fos transcription
by calcium must require sequences not present on our
clones or it may require integration of the c-fos gene
into cellular chromatin. One mechanism of c-fos tran-
scription we can clearly rule out is that it is mediated
by CREB, as seen in PC12 cells. In contrast to PC12
cells, a promoter containing a CRE is not inducible
by calcium in T cells, nor is CREB activity changed
in response to calcium. This last observation suggests
that there are significant cell-type-specific differences
in the activity of CREB.
Distinct Protein Complexes at
the SRE Mediate Growth Factor
Induction of c-fos Transcription
R. Graham, M. Gilman
The serum response element (SRE) is required for the
response of the c-fos gene to at least two distinct sig-
nal transduction pathways, one dependent on PKC
and one or more independent of PKC. In addition, the
SRE is the target for the rapid repression of c-fos
transcription that follows induction. Given the com-
plexity of SRE function, it is not surprising that the
SRE binds several different cellular DNA-binding
proteins. One of these proteins, SRF, appears to be
required for all activities of the SRE. As described in
more detail below, our working hypothesis is that
SRF works by recruiting an array of distinct proteins
to the SRE and that it is these accessory proteins that
carry signaling information to the SRE. One such ac-
cessory protein is a 62-kD protein termed ternary
complex factor (TCF), recently identified as a mem-
ber of the ETS family. TCF specifically recognizes
the SRF-SRE complex, probably contacting both
SRF and the SRE. Indeed, we were able to generate a
set of mutant SREs that bound SRF with wild-type
affinity but failed to support formation of the SRF-
TCF ternary complex. When tested for inducibility in
vivo, these mutants lost response to only one of the
two signal transduction pathways the target the SRE.
They failed to respond to the PKC pathway but
responded at wild-type levels to PKC-independent
signals. We concluded from these experiments that
these two signal transduction pathways act through
distinct protein complexes at the SRE: PKC acts
through the SRF-TCF ternary complex, whereas
PKC-independent signals act through SRF alone or in
conjunction with other unidentified accessory factors.
We describe in the next section a candidate for such
an accessory factor for PKC-independent signals.
Regulation of c-fos Transcription
by Receptor Tyrosine Kinases
H. Sadowski
Nuclear signaling by polypeptide growth factors or
hormones such as platelet-derived growth factor
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(PDGF), whose receptor possesses ligand-induced
tyrosine kinase activity, is complex.
In the case of
PDGF, at least three rapid signals can
be sent to the
nucleus, two as a consequence of phospholipase-C
activation (PKC and calcium) and at least one that
does not involve PKC. As
described above,
mutagenesis of the c-fos promoter has revealed that at
least two of these pathways act through proteins
binding to the SRE. PKC-dependent signals
act
through a ternary complex composed of SRF and
TCF, whereas PKC-independent signals act either
through SRF alone or in conjunction with other ac-
cessory proteins. These accessory proteins may either
bind directly to specific sequence elements within the
promoter (close to or distant from the SRE) or be
recruited to the SRE by regulated protein-protein in-
teractions.
We have been investigating whether the previous-
ly described v/c-sis (PDGF)-inducible DNA-binding
factor (SIF; Hayes et al., Proc. Natl. Acad. Sci. 84:
1271 [1987]) is such an accessory protein. The SIF-
binding element (SIE) is approximately 20 by up-
stream of the SRE and coincides with an epidermal
growth factor (EGF)-inducible in vivo footprint of
the c-fos promoter in A431 cells. We have found that
in BALB/c 3T3 cells, mutations in the c-fos promoter
that selectively disrupt ternary complex formation but
still allow SRF binding lose the PKC-dependent com-
ponent of the PDGF signal, whereas constructs lack-
ing an intact SRF-binding site are essentially un-
responsive to PDGF. Our preliminary experiments
also suggest that constructs with mutations that
abolish SIF binding lose a portion of the PDGF
response (presumably, the PKC-independent com-
ponent), whereas a construct with mutations abolish-
ing both SIF binding and ternary complex formation
is largely uninducible by PDGF, despite the presence
of an intact binding site for SRF. Surprisingly, its ac-
tivity is comparable to a construct entirely lacking an
SRF-binding site. Therefore, the PKC-independent
component of the c-fos induction by PDGF appears
to involve interactions between the SIE and the SRE,
most likely through the proteins that bind to these
sites.
We have concentrated on the biochemical charac-
terization of the SIE-binding activity. Of the several
growth factors tested, only PDGF (both AA and BB
homodimers) causes potent and rapid induction of
SIE-binding activity in BALB/c 3T3 cells, as
measured by mobility shift assays. However, small
increases in SIE-binding activity in extracts from
EGF-treated cells are detectable. In addition, SIE-
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binding activity is rapidly induced by insulin in Nai-
3T3 cells expressing the human insulin receptor and
maintained at this high level in the continued
presence of insulin (at least 60 min). Furthermore, in
A431 cells, EGF causes a massive induction of SIE-
binding activity that is maximal within 1 minute. Ex-
pression of the nett oncogene, which encodes a con-
stitutively activated receptor tyrosine kinase, leads to
constitutively high levels of SIE-binding activity. As
expected, neither PMA, a direct activator of PKC, nor
calcium ionophore induces SIE binding in any of the
cell lines tested, whereas the phosphotyrosine phos-
phatase inhibitor sodium orthovanadate enhances
both basal and tyrosine kinase activated levels of SIE
binding. Further studies are in progress to determine
whether other tyrosine kinases (receptor and non-
receptor type) induce this activity, but our results
suggest that the SIE and SIE-binding activity may be
a general pathway through which several receptor
tyrosine kinases activate c-fos transcription in a PKC-
independent manner.
Experiments aimed at addressing the mechanism
of activation of the SIE-binding factor have been per-
formed, although no conclusive results have yet
emerged. Interestingly, SIE-binding activity is
abolished by treatment of extracts with potato acid
phosphatase. We are testing the possibility that the
SIE-binding activity contains phosphotyrosine, as the
rapid kinetics of induction (detectable increases in
binding in both cytosol and nuclear extracts within 20
sec of growth factor addition) suggests that this ac-
tivity is very closely linked to the earliest events in
signal transduction. Using UV cross-linking and mi-
croscale DNA-affinity precipitation, we have identi-
fied the SIE-binding protein(s) as a doublet of 90-94
kD. Whether these represent different posttransla-
tionally modified forms of the same protein or dif-
ferent gene products is not yet clear.
Purification and Characterization of
the SRE-binding Protein p62DBF
S. Natesan
Previous work by Bill Ryan in our laboratory identi-
fied a novel 62-kD SRE-binding protein that we
termed p62D13F. p62DBF binds directly to the 5 ' side
of the SRE in an asymmetric fashion, in contrast to
the symmetrical binding of SRF. We have purified
this protein from HeLa cells, using a combination of
conventional and affinity chromatography. Currently,
we are scaling up the purification procedure to obtain
sufficient amounts of the protein for sequence analy-
sis.
In the course of our studies of p62DBF, we have
discovered some unexpected properties of the
protein. First, despite the highly overlapping binding
sites of p62DBF and SRF, we believe that the two
proteins can occupy the SRE simultaneously. In fact,
in the presence of p62DBF, the rate of association of
SRF with the SRE is greatly enhanced, a phenome-
non we also observe with the homeodomain protein
Phox 1, as detailed below. Second, we have learned
that p62DBF bends the DNA when bound to the SRE.
This activity may contribute to its ability to enhance
the interaction of SRF with the SRE. Indeed, we
suspect that the direction of the bend may be
determined by the sequence of the AT-rich core in
the center of the SRE. We are testing this hypothesis
using circularly permuted probes and phasing analy-
sis, as described by Kerppola and Curran (Cell 66:
317 [1991]).
named that protein SRE-ZBP (serum response
element-zinc finger containing binding protein). This
gene is expressed at very low levels in most human
cell lines, but at high levels in the hepatoma cell line
HepG2. In HeLa cells, expression of SRE-ZBP is in-
duced by serum stimulation with a maximum level at
6 hours of stimulation. Antibodies raised against
SRE-ZBP do not recognize any previously character-
ized SRE-binding proteins. These observations, to-
gether with the methylation interference protection
pattern obtained with the cloned protein, suggest that
this clone identifies a novel protein that interacts with
the 3 ' side of the SRE. Immunofluorescence assays
performed on transfected COS cells show that SRE-
ZBP is localized in the nucleus. Preliminary results
suggest that the cellular SRE-ZBP protein has an ap-
parent molecular weight of 70,000. The presence of
zinc fingers in this clone strongly suggests that it is a
DNA-binding protein and probably is a transcription
factor. Our current efforts are directed at understand-
ing the role of this protein in the regulation of c-fos
transcription.
Cloning of SRE-ZBP, a Novel
SRE-binding Protein
R. Attar
As described above, the SRE is a target for multiple
signals that activate and repress c-fos transcription.
To understand the complex mechanisms by which the
SRE regulates the c-fos transcription, we have at-
tempted to identify and clone previously unidentified
SRE-binding proteins. We screened a HeLa cell
cDNA expression library for phage expressing pro-
teins that specifically bound an SRE oligonucleotide.
We isolated a phage that encoded a lacZ fusion
protein that specifically bound this oligonucleotide
but not a mutant site. The fusion protein binds specif-
ically to the SRE in both a Southwestern blot and a
mobility-shift assay.
Analysis of the partial DNA sequence of this
clone revealed that it was a previously unidentified
gene that belongs to the family of zinc-finger-
containing proteins related to the Drosophila Kriippel
gene. The clone contains seven tandem repeats in the
carboxyl terminus that match the zinc-finger con-
sensus for this gene family. In the zinc-finger region,
the clone shares up to 65% sequence identity with
several human and mouse Kriippel-related genes. We
A Human Homeodomain Protein
That Interacts with SRF
D. Grueneberg
Our studies of the organization of the SRE and the
function of SRF suggest that SRF works primarily by
recruitment of accessory proteins with distinct func-
tions. In this regard, SRF resembles the yeast protein
MCM1, to which it is closely related. MCM1 also
acts in conjunction with accessory proteins, including
the DNA-binding proteins MATal, MATa2, STE12,
and SFF. Because SRF and MCM1 are so closely re-
lated in structure and function, we have attempted to
use a genetic approach in yeast to identify novel ac-
cessory proteins for SRF. We have constructed a
yeast strain in which the expression of a selectable
marker (HIS3) is regulated by the UAS of the STE3
gene. The element binds the complex of MCM1 and
MATa 1 and is active in MATa cells. Thus, in wild-
type cells, this STE3::HIS3 reporter gene confers a
His phenotype. When the MATal gene is deleted
from this strain, expression of the reporter is lost,
leading to a His- phenotype. Using this latter strain
as a recipient, we introduced a human cDNA library
on a yeast expression plasmid and selected for human
cDNAs that restore the His phenotype. Our hope
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was that we would identify cDNAs that
encode
proteins able to cooperate with MCM1 to
activate the
reporter gene and that such proteins would interact
with SRF as well.
In our first screen using this strain, we isolated
clones for the same human gene more than 30 times.
Sequence analysis revealed that the gene
contains a
homeodomain that shares 70% homology with the
homeodomain of the Drosophila paired gene, which
is an embryonic development gene of the pair-rule
class. Genetic and biochemical studies in yeast (in
collaboration with Cyril le Alexandre) indicated that
this protein, which we have called Phox 1, interacts
with MCM1 to activate the STE3::HIS3 reporter
gene. Moreover, studies with purified bacterially ex-
pressed proteins show that Phoxl is also capable of
interacting with SRF. The consequence of the Phoxl-
SRF interaction is the enhancement of binding of
SRF to the SRE. This is a specific interaction that
Phox 1 shares with the closely related Drosophila
homeodomain proteins but not with more distantly
related members of the homeodomain family. By ex-
amining the kinetics of the SRF-SRE interaction in
the presence and absence of Phoxl, Sridaran Natesan
has shown that Phoxl accelerates the rate of both as-
sociation and dissociation of the SRF-SRE complex.
Our interpretation of these data is that the formation
of a stable SRF-SRE complex requires an isomeriza-
tion from an initial complex into the final complex
detected in our DNA-binding assays and that this
isomerization is greatly enhanced by Phoxl. Muta-
genesis of the Phoxl homeodomain suggests that this
enhancement does not require sequence-specific
DNA-binding activity. Thus, the ability to enhance
the binding of SRF appears to be a novel function of
the homeodomain that almost certainly involves
direct protein-protein interactions between the
homeodomain and SRF. We believe that the interac-
tion of homeodomain proteins with members of the
SRF/MCM1 family will prove to be important in de-
velopment.
Interaction of SRF with Members
of the KBIrel Family
C. Alexandre
In a repeat of the genetic selection in yeast described
in the previous section, we have identified additional
human cDNAs that activate the MCM1-dependent
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reporter gene. Six independent isolates encoded the
p65 subunit of the heterodimeric transcription factor
NFKB. NFKB binds to the consensus sequence
GGGRNNYYCC found in the immunoglobulin en-
hancer, the interleukin -2 (IL-2) receptor gene, the
long terminal repeat (LTR) of human immuno-
deficiency virus type 1 (HIV-1), and elsewhere. Both
p65 and the p50 subunit of NFKB belong to the
rel /dorsal family. These proteins are transcriptional
activators that shuttle between the cytoplasm and
nucleus. Indeed, activation and nuclear translocation
of NFKB occurs in response to many of the same sig-
nals that activate c-fos transcription. It is the p65 sub-
unit that regulates the translocation of NFKB together
with the cytoplasmic inhibitor IKB. Moreover, p65
carries a potent trans-activation domain. Thus, it is
intriguing to us that p65 may interact with SRF: This
offers a strong clue as to how the SRF complex may
be activated in response to extracellular signals.
Our current work focuses on a genetic analysis of
p65 function in yeast and biochemical studies of the
protein in vitro. In yeast, genetic evidence suggests
that p65 activates the STE3::HIS3 reporter via inter-
action with MCM1. Mutations in the reporter that
prevent the binding of MCM1 also blocked activation
by p65. In contrast, reporters carrying multiple copies
of a consensus NFKB-binding site were not activated
by p65. We are currently investigating whether p65
interacts with SRF.
SRF Family Proteins in Drosophila
A. Ryan [in collaboration with Martin Kling ler and
J. Peter Gergen, SUNY Stony Brook]
Our discovery that human SRF interacts with human
and Drosophila homeodomain proteins suggests that
interactions between these proteins may be important
in development. We have chosen to test this
hypothesis in the Drosophila embryo, where the roles
of homeodomain proteins have been most extensively
studied. A further advantage of studying the Dros-
ophila embryo is the availability of both classical and
molecular genetic tools to manipulate the embryo.
Thus, we have begun to clone Drosophila genes re-
lated to human SRF. Our goal is to study the
genetics, expression pattern, and function of these
genes in embryogenesis.
Meanwhile, we are taking a more direct approach
to address the role of SRF in the Drosophila embryo.
Earlier work in our laboratory has shown that it is
possible to inactivate SRF in vivo by microinjection
of excess SRE oligonucleotides into cells. These
oligonucleotides presumably titrate SRF and prevent
it from binding to its natural target sites in the
genome. In fibroblasts, microinjection of SRE
oligonucleotides blocks the induction of c-fos tran-
scription by serum. Since we know that Drosophila
embryos contain a protein with the same DNA-
binding specificity as human SRF, we should be able
to neutralize this activity in embryos by injection of
SRE oligonucleotides. The effect would be to
phenocopy an SRF loss-of-function mutation. Our
preliminary data suggest that injection of SRE
oligonucleotides results in specific perturbations of
embryonic development that we have not yet fully
characterized.
Linking Growth Factors to Cell Cycle
Control: G1 Cyclins
K.-A. Won
How the initial intracellular signaling events trig-
gered by growth factors are linked to the regulatory
machinery that controls cell cycle progression in
mammalian cells is still poorly understood. The
transition from the Go to the G1 phase of the cell
cycle involves quantitative and qualitative changes in
the expression of many genes and their products.
Within minutes after growth factor or serum stimula-
tion and independently of protein synthesis, a set of
genes, termed the immediate early genes, becomes
transcriptionally active. Yet, not all signals that ac-
tivate the immediate early genes cause cells to enter
or leave the cell cycle. To understand how cells are
able to discriminate among such signals, we are
studying the regulation of a family of genes whose
expression may be critical to the control of cell cycle
progression-the G1 cyclins.
Yue Xiong and David Beach here at Cold Spring
Harbor Laboratory have cloned a family of human
cyclin genes termed D-type cyclins. One of these
genes, cyclin D l, appears to correspond to the on-
cogene bc11, whose chromosomal locus is amplified
and translocated in many tumors. We have examined
the expression of the cyclin al and D3 genes in pri-
mary human fibroblasts undergoing the Go /G1 transi-
tion. We find that transcription of these genes is in-
duced by mitogenic growth factors, with increased
mRNA levels appearing 2-4 hours after stimulation
and peak levels just prior to the onset of S phase.
Cyclin D expression is induced by all signals that are
mitogenic for these cultures, consistent with the idea
that cyclin D expression is required for the G1 /S
transition. However, the genes are also activated by
signals such as phorbol esters that are not mitogenic
in these cells, suggesting that cyclin D expression is
not sufficient for entering S phase.
We are now studying the promoter/regulatory
regions of the cyclin DI and D3 genes with the goal
of identifying the cis- and trans-acting factors that
regulate the expression of these genes in response to
growth and differentiation factors. Among the trans-
acting regulators, we expect to find products of the
immediate early genes. Our goal is to understand how
signaling information is processed to generate the de-
cision to enter or exit the cell cycle.
PUBLICATIONS
Graham, R. and M. Gilman. 1991. Distinct protein targets for
signals acting at the c-fos serum response element.
Science 251: 189-192.
In Press, Submitted, and In Preparation
Attar, R. and M.Z. Gilman. 1992. Expression cloning of a
novel zinc-finger protein that binds to the c-fos serum
response element. Mol. Cell. Biol. (in press).
Grueneberg, D.A., S. Natesan, C. Alexandre, and M.Z. Gil-
man. 1992. A human homeodomain protein that en-
hances the exchange of SRF with its binding site: A
novel function for the homeodomain. (Submitted.)
Riabowol, K., J. Schiff, and M.Z. Gilman. 1992. Transcription
factor AP-1 activity is required for initiation of DNA
synthesis and is lost during cellular aging. Proc. Natl.
Acad. Sci. 89: 157-161.
Watson, J.D., M. Gilman, J. Witkowski, and M. Zoller. 1992.
Recombinant DNA, second edition. W.H. Freeman and
Co., New York.
STRUCTURE, FUNCTION, AND
REGULATION OF PROTEIN
TYROSINE PHOSPHATASES
N.K. Tonks S. Brady-Kalnay
R. Del Vecchio
A. Flint
P. Guida, Jr.
A. Samatar
H. Sun
Q. Yang
The phosphorylation of tyrosyl residues in
proteins is
a key component of the control of many fundamental
physiological processes. Our laboratory is particular-
ly interested in the role of tyrosine phosphorylation in
transducing an extracellular signal into an intra-
cellular response, such as proliferation or differentia-
tion. Most laboratories have focused their studies on
the protein tyrosine kinases. However, phosphoryla-
tion is a reversible, dynamic process in which the net
level of phosphate observed in a target substrate
reflects not only the activity of the kinases that
phosphorylate it, but also the competing action of
protein phosphatases that catalyze the dephosphoryla-
tion reaction. We direct our attention to the expand-
ing family of protein tyrosine phosphatases (PTP-
ases) that, like the kinases, comprise both trans-
membrane, receptor-linked forms and nontrans-
membrane cytosolic species (Fig. 1). The structures
of the PTPases indicate important roles in the control
of processes such as cell adhesion, cytoskeletal func-
tion, and the cell cycle. Clearly, their characterization
will generate a more sophisticated understanding of
the precise physiological roles of tyrosine phosphor-
ylation.
IDENTIFICATION OF NOVEL PTPASES
We utilized polymerase chain reaction (PCR) from
primers corresponding to conserved segments within
the catalytic domains to amplify PTPase-related
cDNA from a He La cell library. This approach
revealed the presence of four known PTPases termed
LAR, RPTPa, PTP1B, and TCPTP and three novel
isoforms termed PTPH1, H2, and H3. These PCR
products are being used to screen libraries for full-
length cDNAs.
The sequence of the first of these novel isoforms
(PTPH1) was published recently (Yang and Tonks
1991). Its structure can be described in terms of three
segments. (1) The amino-terminal segment displays
homology with the domains in the cytoskeleton-
associated proteins band 4.1, ezrin, and talin that
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direct their interaction with proteins at the interface
between the plasma membrane and the cytoskeleton.
(2) The central segment is not homologous to any
factor in the database but does bear a number of puta-
tive sites of phosphorylation by casein kinase II and
p34cdc2. (3) The catalytic domain is located at the
carboxyl terminus, and we have now demonstrated
intrinsic activity. The structure of this PTPase is in-
dicative of a potential involvement in the control of
cytoskeletal integrity. Since many of the substrates
for the transforming protein tyrosine kinase pp60v-sre
are cytoskeleton-associated proteins, we are currently
investigating whether expression of PTPH1 reverts
the phenotype of a src-transformed cell to that of its
nontransformed counterpart. Perhaps PTPH1 will be
a useful probe with which to determine the precise
role of tyrosine phosphorylation in generating the
morphology of a transformed cell. By analogy with
band 4.1 and talin, which bind to glycophorin and the
integrin [3 subunit, respectively, through their amino-
terminal domains, we are also trying to identify the
proteins that interact with the homologous amino-
terminal domain in PTPH1. Their identification and
characterization should provide important informa-
tion as to the mechanisms of regulation of PTPH1 ac-
tivity and may provide indicators of possible sub-
strates of physiological importance.
PTPH2, also referred to as RPTPt,t, (Gebbink et
al., FEBS Lett. 290: 123 [1991]), is a transmembrane
PTPase the extracellular segment of which displays
similarity to that of the neural cell adhesion
molecules (NCAMs), containing an Ig-like domain
and a fibronectin type-III-like domain (Fig. 1). It is
the intracellular segment that is of particular interest.
The juxtamembrane segment, separating the trans-
membrane domain from the first of the two catalytic
domains is some 70 residues longer than the equi-
valent segment in other receptor PTPases and dis-
plays sequence homology with the intracellular seg-
ment of the cadherins (Fig. 2).
Cadherins are adhesion molecules that participate
in the mechanisms of coordinated association of cells
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FIGURE 1 Structural organization of protein tyrosine phosphatases (for review, see Fischer et al.,
Science 253: 401 [1991]). Conserved catalytic domains are shown in black. The PTPases can be cate-
gorized as transmembrane, receptor-like, or nontransmembrane molecules. The receptor-like species
can be subdivided into four types on the basis of the structure of their extracellular segments. Type I
represents the CD45 family, multiple isoforms of which arise from differential splicing of a primary
mRNA transcript of a single gene; three exons encoding sequences at the extreme amino terminus
(horizontal shading) are differentially expressed. Type II, containing immunoglobulin-like (diagonal
lines) and fibronectin type-III-like (stippled) domains, includes LAR, DLAR, DPTP, and HPTP[t. Type III
bears multiple fibronectin type III repeats such as in HPTP[3, which is also characterized by the
presence of only one PTPase domain in its intracellular segment. Type IV, such as HPTPa and HPTPE,
has very small, glycosylated extracellular segments. Multiple nontransmembrane forms have also
been identified. In TCPTP and PTP1B, a carboxy-terminal noncatalytic segment appears to play a role
in modulating activity and controlling subcellular localization. Several PTPases bearing noncatalytic
amino-terminal segments have now been identified. These segments include two SH2 domains in
PTP1C, a band-4.1 homology domain in PTPH1, and structures apparently unrelated to sequences in
the database in STEP, PYP1, and YOP2b. The vaccinia protein VH1 is smaller than the other PTPase-
related segments and presumably encodes only a catalytic domain. This is not an exhaustive list and
the family continues to expand. A number of partial cDNAs for additional PTPases have also been
identified but are not included.
during tissue development and morphogenesis (for
review, see Takeichi, Science 251: 1451 [1991]). Es-
sentially all cells that associate into tissues express
cadherins, and reduction in the level of expression of
E cadherin has been linked with tumor invasiveness
and metastasis. Cadherins are concentrated in ad-
herens junctions where they are linked to cortical ac-
tin bundles. Four subclasses of cadherin have been
well characterized at a structural level: LCAM (liver
cell adhesion molecule) in chickens and E(epithelial),
N(neural), and P(placental) cadherins in mammals.
However, the repertoire of cadherins is also now ex-
panding rapidly. Their structure can be described in
terms of three segments. The extracellular segment is
glycosylated and comprises at least three repeated
structural motifs containing stretches of acidic
residues involved in binding Ca++. Cadherin binding
is homophilic and Ca++-dependent; binding speci-
ficity is governed by the amino-terminal 113 residues
of the extracellular segment. There is a single trans-
membrane domain and an intracellular segment of
approximately 150 residues. It is the intracellular seg-
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FIGURE 2 (Top) Alignment of amino acid residues in the juxtamembrane domain of PTPH2 with the
conserved cytoplasmic domains of cadherins. Identities are highlighted in shaded boxes and con-
servative substitutions in open boxes. (Bottom) Schematic diagram illustrating the structure of
PTPH2 as well as its relationship to the cadherins and the low-Mr PTPase, PTP1B. Diagonal lines
denote PTPase catalytic domains. The segment of homology between PTPH2 and the cadherins is
represented in black. The transmembrane segments also share eight identities. Using the ALIGN
program, the mutation data matrix for scoring and a gap penalty of 10 to compare residues 742-917
in PTPH2 (Gebbink et al., FEBS Lett. 290: 123 [1991]) with 553-722 in LCAM (Gallin et al., Proc.
Natl. Acad. Sci. 84: 2808 [1987]) and 555-724 in E cadherin (Ringwald et al., EMBO J. 6: 3647
[1987]) scores of 7.3 and 7.5, respectively, were obtained. These alignment scores are expressed in
units of standard deviation from the average background scores of 100 randomly generated se-
quences. Scores greater than 5 indicate homology.
ment that is most highly conserved, displaying about
90% identity among the cadherins. Extensive analysis
by site-directed mutagenesis has shown that in E and
N cadherin, deletions in the intracellular segment,
particularly in the carboxy-terminal 72 amino acids,
abolish adhesion despite the presence of an intact ex-
tracellular segment. The intracellular segment inter-
acts with cortical actin indirectly, a process that is
mediated by the binding of cytoplasmic proteins
termed catenins. Catenin a (102 kD) displays homol-
ogy with vinculin, catenin I (92-94 kD) is
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homologous to plakoglobin, and catenin y (-80 kD)
remains to be characterized. Deletions of the
carboxy-terminal sequences of cadherin also abolish
the binding to catenins. Thus, the association of the
cadherin cytoplasmic domain, the domain that dis-
plays homology with PTPH2, with catenins is essen-
tial for the interaction of cadherins with the cyto-
skeleton and their adhesive function.
A second type of intercellular junction, des-
mosomes, is also characterized by the presence of
cadherin-related proteins termed desmogleins and
desmocollins (for review, see Magee and Buxton,
Curr. Opin. Cell. Biol. 3: 854 [1991]). Like the clas-
sical cadherins, these are transmembrane proteins
with glycosylated extracellular segments comprising
repeated Ca++-binding motifs. Their intracellular
domains are distinct from, but nevertheless structural-
ly related to, those of the cadherins displaying ap-
proximately 20-30% identity, similar to the degree of
identity between the juxtamembrane domain of
PTPH2 and the cadherins. Interestingly, these
domains in the desmogleins/desmocollins also inter-
act with cytoskeletal elements, in this case, interme-
diate filaments, a process mediated by catenin-like
molecules including plakoglobin. However, the
details of these interactions remain to be described in
full.
Homophilic interactions between NCAMs are of
lower affinity than those involving cadherins. In this
case, the role of the cytoplasmic segment is unclear;
in fact, this segment is truncated in the small
cytoplasmic domain (sd) form of NCAM, whereas
the small surface domain (ssd) form is linked to the
outer surface of the membrane by a phosphatidyl in-
ositol-glycan anchor and lacks both transmembrane
and intracellular segments. No association with the
cytoskeleton has been documented, although there
are reports of the triggering of signal transduction
pathways involving G-protein-mediated changes in
the levels of second messengers such as Ca++ by
NCAM and N cadherin (Doherty et al., Cell 67: 21
[1991]). PTPH2 may provide a link between cell ad-
hesion and signal transduction pathways involving
reversible tyrosine phosphorylation. Interestingly, the
adherens junctions have recently been identified as
major sites of tyrosine phosphorylation within the
cell and sites at which members of the src family of
tyrosine kinases are concentrated (Tsukita et al., J.
Cell. Biol. 113: 867 [1991]). Furthermore, treatment
of chick lens cells with inhibitors of PTPase activity
leads to a pronounced accumulation of phosphotyro-
sine at adherens junctions, implying a ready revers-
ibility of the phosphorylation reaction and a rapid
turnover of tyrosine phosphate at these sites (Volberg
et al., Cell. Reg. 2: 105 [1991]). We also suggest that
the cadherin-related juxtamembrane domain of
PTPH2 may regulate the interaction of this im-
munoglobulin superfamily molecule with the cyto-
skeleton as well as controlling its potential adhesive
function in a manner analogous to that of the cad-
herins.
Finally, PTPH3 is similar to, but distinct from, the
gene product of the previously described HPT1313 (see
Fig. 1). At the moment, we have a cDNA clone en-
coding the intracellular segment containing a single
PTPase domain, a transmembrane segment, and a
partial extracellular segment comprising eight
repeated fibronectin type-III-like domains (16 such
domains exist in HPTP(3). Repeated fibronectin type
III domains have been observed in a variety of recep-
tors including those for interleukin-2 (IL-2), IL-4,
and IL-6, GM-CSF, prolactin, erythropoietin, and
growth hormone (Patthy, Cell 61: 13 [1990]). How-
ever, the identity of ligands for this, or any other
receptor-PTPase, remains an important area of study
still to be addressed.
How many PTPases are there? Despite the recent
explosion in the number of members of the family to
be identified, it seems safe to assume that at present
we are only reviewing the tip of the iceberg. We are
currently searching for novel PTPases in a number of
systems. Of particular note, we have identified by
PCR 15 distinct PTPase-related sequences in a Xeno-
pus oocyte cDNA library and have confirmed the
presence of mRNA for each species. Some represent
Xenopus homologs of known PTPases, but several
appear to be novel. In addition, in collaboration with
Bob Horvitz at the Massachusetts Institute of Tech-
nology, we have to the
identification of PTPases in Caenorhabditis elegans.
Thus far, ten distinct PCR fragments have been isola-
ted, and chromosomal mapping is in progress.
Studies with these systems are currently in their in-
fancy, but we hope that they will yield interesting in-
formation in the coming months.
REGULATION OF PTPASE ACTIVITY
A striking characteristic of the members of the
PTPase family is their absolute specificity for
phosphotyrosyl residues in proteins, coupled with a
high affinity for substrate and a specific activity some
one to three orders of magnitude in excess of that of
the protein tyrosine kinases in vitro (Tonks et al., J.
Biol. Chem. 263: 6731 [1988]). Consequently, the
PTPases have the potential to control effectively the
level of phosphotyrosine within the cell and to keep
the activity of the kinases in check. One might
anticipate that the activity of the PTPases would
therefore be tightly controlled so as to permit the
normal function of the PTKs. The identification of
such control mechanisms represents a major focus of
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my laboratory and may illustrate new tiers
of regula-
tion of the level of cellular phosphotyrosine.
A general theme among the PTPases is
becoming
apparent, as typified by the molecules described
above; within the protein, distinct functional motifs
may control activity by restricting intracellular
localization or targeting to interaction with regulatory
factors. The structures of PTPH1, H2, and H3 suggest
that they may be involved in a link between adhesion
phenomena, changes in cytoskeletal integrity, and
tyrosine phosphorylation. We are currently
trying to
clarify potential regulatory proteins with which
they
may interact in vivo.
The first PTPase isolated in homogeneous form
was the cytosolic enzyme termed PTP1B. It was
purified from human placenta as a truncated catalytic
subunit of 37 kD. Isolation of cDNA for PTP1B, and
the closely related TCPTP, has indicated that in vivo,
the protein comprises an amino-terminal catalytic
domain and a carboxy-terminal segment of 11 kD not
present in PTP1B as purified from placenta, which
appears to be important for both regulating activity
and controlling intracellular localization. We noted
that this regulatory segment bears a number of puta-
tive sites of phosphorylation for the serine/threonine
kinases, p34cdc2, and casein kinase II. We have there-
fore directed our attention toward the possibility that
phosphorylation of PTP1B may be of regulatory sig-
nificance. Indeed, PTP1B is a phosphoprotein in
vivo. More interestingly, its phosphorylation state is
- Nocodazole
altered in a cell-cycle-dependent manner (Fig. 3); out
data suggest that there is enhanced phosphorylation
of PTP1B as cells enter mitosis. Currently, we are ex-
amining the effects of phosphorylation on activity
and attempting to characterize the kinase involved.
Our most recent observations suggest that in im-
munoprecipitates of PTP1B from HeLa cells, a
serine/threonine kinase that recognizes histone HI as
a substrate coprecipitates with the phosphatase. Fur-
thermore, there are up to fivefold higher levels of
kinase activity in PTP1B immunoprecipitates from
nocodazole-arrested (mitotic) HeLa cells than in such
immunoprecipitates from asynchronous populations.
Experiments directed toward identifying this kinase
are under way.
PTPASES AND INSULIN ACTION
In collaboration with Dr. J. Sommercorn and his col-
leagues at the National Institutes of Health in Phoe-
nix, Arizona, we have been investigating whether a
defect in the level of expression or activity of a
PTPase may contribute to the mechanism of
noninsulin-dependent diabetes mellitis (NIDDM),
This is a life-threatening disease that affects about
10% of the general population over the age of 40 in
the United States. Due to its association with aging
and the fact that the population as a whole is getting
older, the prevalence of NIDDM is likely to increase.
+ Nocodazole
FIGURE 3 lmmunoprecipitation of PTP1B from 32P-labeled HeLa cells. PTP1B
was immunoprecipitated using a monoclonal antibody, FG6 (generated by Dr.
Dave Hill, Applied Biotechnology, Inc., Cambridge, Massachusetts) and subjected
to two-dimensional gel analysis. The figure highlights the section of the gel con-
taining PTP1B, identified by autoradiography.
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The Phoenix group studies this disease in Pima In-
dians, of which 50% of adults over 35 years of age
are diabetic. Studies of the development of NIDDM
indicate that prior to becoming diabetic, subjects first
develop impaired glucose tolerance, characterized by
a reduced capacity of skeletal muscle to respond to
insulin. Insulin resistance limits the ability of the
hormone to influence the activities of various muscle
enzymes, including S6 kinase, type I protein serine/
threonine phosphatase, and glycogen synthase, which
are thought to mediate insulin action intracellularly.
However, several lines of study suggest that the
defect is not in the insulin receptor itself, but rather
an early post-receptor step in the pathway of signal
transduction stimulated by insulin. Recently, we have
shown a higher basal level of particulate PTPase ac-
tivity in resistant subjects than in insulin-sensitive
subjects. In addition, insulin infusion in vivo pro-
duced a rapid inhibition of soluble PTPase activity
measured in extracts of skeletal muscle from insulin-
sensitive subjects that was impaired in subjects who
were insulin resistant (McGuire et al., Diabetes 40:
939 [1991]). Both of these effects may contribute to
an antagonism of signaling through the insulin recep-
tor. PCR-based strategies have identified five distinct
PTPases in the skeletal muscle samples, and one of
these appears to be novel. We are presently trying to
obtain full-length clones for the novel enzyme and
are looking for alterations in the level of expression
of the PTPases in insulin resistance. In addition,
antibodies are being generated to the various PTPases
with the aim of looking for changes in activity of a
particular isoform.
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CELL BIOLOGY OF THE NUCLEUS
D.L. Spector S. Huang
S. Henderson
R. O'Keefe
L. Jimenez-Garcia
R. Derby
G. Lark
S. Landon
Studies in our laboratory are focused on the structural
and functional organization of the mammalian cell
nucleus. Our research program evolves around two
specific areas of study: (1) understanding the organi-
zation of factors associated with pre-mRNA splicing
and the RNA substrates with which the factors inter-
act and (2) elucidating the organization of specific
DNA sequences (genes and chromosomal regions) in
the interphase nucleus. The use of the electron mi-
croscopy core facility has continued to expand, and
the use of fluorescence and confocal laser scanning
microscopy has significantly increased over the past
year. With the recent addition of the Zeiss Micros-
copy Center, our core services have been expanded to
include the microinjection and examination of living
cells by time-lapse microscopic cinematography. A
large number of collaborations are under way with
the excellent technical expertise of Robert Derby.
Organization of Chromosome-
specific DNA Sequences in the
Interphase Nucleus
S.C. Henderson, R. O'Keefe, D.L. Spector
We have previously identified five distinct patterns of
DNA replication during S phase in asynchronous and
synchronous cultures of mammalian cells by conven-
tional fluorescence microscopy, confocal laser scan-
ning microscopy, and immunoelectron microscopy.
During early S phase, replicating DNA (as identified
by 5-bromodeoxyuridine incorporation) appears to be
distributed at sites throughout the nucleoplasm, ex-
cluding the nucleolus. In Chinese hamster ovary
(CHO) cells, this pattern of replication peaks at 30
minutes into S phase and is consistent with the
localization of euchromatin. As S phase continues,
replication of euchromatin decreases, and the
peripheral regions of heterochromatin begin to repli-
cate. This pattern of replication peaks at 2 hours into
S phase. At 5 hours, perinucleolar chromatin and
peripheral areas of heterochromatin peak in replica-
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tion. Seven hours into S phase, interconnecting
patches of electron-dense chromatin replicate. At the
end of S phase (9 hr), replication occurs at a few
large regions of electron-dense chromatin. Similar or
identical patterns have been identified in a variety of
mammalian cell types.
To determine the position and timing of chromo-
some-specific a-satellite DNA sequences, we have
developed a method to evaluate simultaneously the
position of a specific gene sequence and the pattern
of DNA replicating at the time of fixation in S phase.
a-satellite DNA, which is associated with the
chromosome centromere, consists of chromosome-
specific "monomers" of approximately 171 base pairs
that are tandemly repeated for several kilobases.
Bromodeoxyuridine (BrdU)-labeled He La cells were
hybridized in situ with a probe to a-satellite DNA
from the X chromosome. The localization of the X-
chromosome a-satellite DNA was visualized relative
to each of the BrdU-labeling patterns in both syn-
chronous and asynchronous populations of cells by
superimposition of optical sections (sampled in each
channel of fluorescence) generated by confocal laser
scanning microscopy. Due to the disposition of
centromeres within the three-dimensional space of
the nucleus, usually a-satellite DNA from only one
centromere was detected in any one optical section.
At times of DNA synthesis characterized by the first
(Fig. I a), second (Fig. lb), fourth (Fig. 1 d), and fifth
(Fig. le) patterns of DNA replication, the X-
chromosome a-satellite DNA was visualized as a
bright white spot, which did not overlap with the pat-
tern of BrdU labeling (gray regions) in all cells exam-
ined. Only at the time characterized by the third pat-
tern (Fig. 1c) of DNA replication, which occurs dur-
ing mid S phase, did the hybridization to the X-
chromosome a-satellite DNA colocalize with the
BrdU labeling. Therefore, the replication of the X-
chromosome a-satellite DNA appeared to occur dur-
ing mid S phase, which is characterized by the third
pattern of DNA replication. The replication of a-
satellite DNA during mid S phase appears to be true
for other chromosomes as well. Probes to a-satellite
FIGURE 1 Replication of centromeric (a-satellite) DNA (arrowheads) occurs during mid S phase of human cells. Hu-
man cells were labeled with BrdU and hybridized in situ with biotinylated DNA probes to chromosome-specific a-
satellite DNA. BrdU incorporation and hybridization of probes were visualized by labeling with FITC-conjugated anti-
BrdU and Texas Red-conjugated avidin, respectively. Regions of DNA replication are shown in gray and localization of
a-satellite DNA is shown in white. Optical sections of synchronized He La cells, labeled with BrdU and hybridized with
a probe to the X-chromosome a-satellite DNA, show that the X-chromosome centromere replicates during mid S
phase, which is characterized by the third pattern of BrdU incorporation (c). No colocalization of the X centromere and
DNA replication occurs in either the first (a), second (b), fourth (c/), or fifth (e) patterns of BrdU incorporation. The
replication of centromeric (a-satellite) DNA in He La cells during mid S phase (characterized by the third pattern of
BrdU incorporation) also occurs for a-satellite DNA of chromosomes 1 (f), 3 (g), 10 (h), 17 (i), and 18 (j). Furthermore,
the replication of X-chromosome a-satellite DNA occurs during mid S-phase (third pattern of BrdU incorporation) in a
variety of human cell types including human umbilical vein endothelial (HUVE) cells (k), Detroit 551 (fibroblast) cells (I),
WI-38 (fibroblast) cells (m), SW-620 (adenosarcoma) cells (n), and MG-63 (osteosarcoma) cells (o). Bars, 5 Rm.
DNA from chromosomes 1 (Fig. 10, 3 (Fig. 1g), 10
(Fig. 1h), 17 (Fig. 1i), and 18 (Fig. 1j) as well as
chromosomes 2, 8, and 12 (data not shown) colocal-
ized with the third pattern of DNA replication. a-
satellite DNA from homologous chromosomes does
not necessarily replicate at precisely the same time,
although a-satellite DNA from both centromeres
replicates within the same pattern. Often, the replica-
tion of a-satellite DNA from one member of a
chromosome pair precedes the other, yet both repli-
cate during mid S phase (the third pattern of DNA
replication). The replication of a-satellite DNA dur-
ing mid S phase appears to be independent of cell
type, nuclear size or shape, or ploidy. In a variety of
human cell types, HUVE (normal human umbilical
vein endothelial cells, Fig. 1k), Detroit 551 (normal
diploid fibroblasts, Fig. 11), WI-38 (normal diploid
fibroblasts, Fig. 1m), SW-620 (human adenocar-
cinoma, Fig. 1n), MG-63 (human osteosarcoma, Fig.
lo), X-chromosome a-satellite DNA replicates dur-
ing the third pattern of BrdU labeling (mid S phase).
This pattern differs between cell types in that the ex-
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tent of perinucleolar BrdU incorporation is less in
some cell types (i.e., fibroblasts vs. epithelial cells).
However, in all cases, regardless of chromosomal
location or cell type, the a-satellite DNA is found as-
sociated with either the surface of the nucleolus or
the nuclear periphery. This technique is currently
being applied to analyze the timing of replication of
single copy genes. In addition, studies are under way
to determine if chromosome-specific a-satellite DNA
sequences and single-copy genes occupy a similar
three-dimensional position in an interphase cell popu-
lation at different times during the cell cycle.
Transport of Nascent c-fos
Transcripts and Associations
with Nuclear Regions Enriched
in Pre-mRNA Splicing Factors
S. Huang, D.L. Spector
We have used in situ hybridization and immu-
nocytochemistry to compare the nuclear localization
of a specific nascent pre-mRNA and the essential
non-snRNP splicing factor SC-35. We have chosen to
evaluate c-fos pre-mRNA at the single-cell level be-
cause induction of the c-fos gene is well character-
ized at the level of transcription. The c-fos gene is
highly conserved among vertebrates, and its protein
product serves a role in coupling external stimuli
such as mitogens to long-term transcriptional
responses, leading to cell proliferation. The c-fos
gene encodes a nuclear protein that forms a part of
the AP-1 transcription factor complex and is thought
to regulate the transcription of a diverse complement
of genes associated with cellular growth and differen-
tiation. Using in situ hybridization combined with
confocal laser scanning microscopy, we observed c-
fos transcripts in the nuclei of cells within 5 minutes
of serum stimulation of quiescent NIH-3T3 cells, and
by 15 minutes poststimulation, the c-fos signal
peaked. Our findings, at the single cell level, of the
transient expression of c-fos transcripts are consistent
with previous biochemical studies that evaluated run-
off transcripts from nuclei isolated at various time
points poststimulation. Prior to serum induction, no
c-fos RNA is detected. In our experiments, hybridiza-
tion with a biotinylated genomic c-fos probe showed
that the c-fos transcripts were present as two discrete
dots in the nuclei of NIH-3T3 cells. The dots that we
observe with the c-fos probe appear to represent tran-
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scripts from each of the two c-fos alleles in this cell
line. Using a digoxigenin-labeled intron-specific c-
fos probe, we have shown that pre-mRNA is a com_
ponent of this dot localization pattern. RNase A
pretreatment of cells results in no hybridization sig-
nal. In addition, pretreatment of cells with the RNA
polymerase inhibitor actinomycin D results in no
hybridization signal. We interpret the intensely
stained dots to represent the active sites of transcrip-
tion and the localization of transcripts that are still at-
tached to the DNA backbone. This possibility is like-
ly in light of our findings that DNase I digestion
decreased the size of the dots. We interpret these
results to mean that upon removal of the cellular
DNA, a subset of the c-fos transcripts that were being
transcribed and were therefore still attached to the
DNA were removed as well. Upon further analysis by
confocal laser scanning microscopy, we have
determined that the dots extend through the depth of
the nucleus, forming "paths." By using high-voltage
electron microscopy, we have found that the c-fos
"path" extends out and comes into direct contact with
the nuclear envelope (Fig. 2). This is the first study to
demonstrate the pathway taken by nascent transcripts
of a mammalian cellular gene and to show a direct
association of these nascent RNA transcripts with the
nuclear envelope. We propose that the path-like dis-
tribution represents the movement of nascent tran-
scripts from the site of transcription to the nuclear en-
velope. The vectorial transport of c-fos RNA tran-
scripts toward the nuclear envelope indicates a highly
organized and regulated means of transport of mRNA
through the nucleus to the nuclear pores.
When we compared the localization of c-fos tran-
scripts with the localization of SC-35, an essential
splicing factor, we found the transcripts to be in close
proximity to a portion of the speckled nuclear regions
enriched in SC-35 and small nuclear ribonucleo-
proteins (snRNPs) (Fig. 3). In fact, the regions en-
riched in transcripts and splicing factors were ob-
served to be intermingled and/or surrounding each
other. The possibility that this association is a random
event is unlikely in light of the fact that the nuclear
speckles were determined to occupy approximately
17% of the nuclear volume and that the c-fos tran-
scripts occupied less than 1% of the nuclear volume
of NIH-3T3 cells. These data are in agreement with
our previous study in CHOC400 cells which showed
that the speckled pattern occupied approximately
18% of the nuclear volume. This study is the first to
localize specific nascent transcripts in a mammalian
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FIGURE 2 c-fos transcripts extend in a "path" from their site of transcription to the nuclear en-
velope. Stereo-pair electron micrograph of a cell cut in cross-section showing the localization of c-
fos transcripts visualized by peroxidase-conjugated streptavidin. The 1 -µm -thick section was ex-
amined at 600 kV using a high-voltage electron microscope (HVEM). The transcript path (large ar-
rowhead) comes into direct contact with the nuclear envelope. The path extends into the
cytoplasm (small arrowhead) and transcripts are observed in the cytoplasm (C) on the side of the
nucleus where the path of the transcripts exited. Section was not poststained.
cell and to demonstrate a direct link between nascent
RNA transcripts and nuclear speckles that are en-
riched in pre-mRNA splicing factors. These results
suggest that the sites of interaction between the c-fos
RNA transcripts and the speckles are the sites where
the c-fos pre-mRNA is spliced. We are currently
studying the nuclear organization of other cellular
transcripts to elucidate general mechanisms of RNA
movement through the nucleoplasm.
Differences in snRNP Localization
between Transformed and
Nontransformed Cells
D.L. Spector, G. Lark, S. Huang
We have examined the localization of snRNPs in a
variety of mammalian cells and have observed dif-
ferences in the organization of these pre-mRNA
splicing components in transformed versus immortal
or defined passage cells. Cells of defined passage
number and immortal cell lines exhibit a speckled
staining pattern after immunolabeling with anti-Sm,
anti-B " , or anti-m3G antibodies (Fig. 4a). In addi-
tion, 1-6% of the cells, in a given population, exhibit
one to three round "foci" in addition to the speckled
labeling pattern. Antibody-labeled transformed cells
exhibited one to four large, intensely stained "foci,"
in 20-98% of the cells, in addition to the speckled
labeling pattern (Fig. 4b). In addition to localizing
snRNP antigens, we have examined the localization
of U1 and U2 snRNAs by in situ hybridization using
2' -O -alkyl oligonucleotide probes (provided by A.
Lamond, EMBL, Heidelberg). We have found that
these snRNAs, which are essential for pre-mRNA
splicing, colocalize with the snRNP antigens, sup-
porting the notion that we are localizing intact snRNP
particles. When immortal cells (REF-52) that had
been transformed by adenovirus (REF-52 Ad5.4)
were examined, these cells exhibited an increase in
the percentage of cells containing one to two intense-
ly stained "foci," in addition to the speckled labeling,
from 6% to 95%. To determine the structural identity
of these intensely stained "foci," we examined cell
sections by electron microscopy. We have identified
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FIGURE 3 c-fos transcripts are closely associated with nuclear regions enriched in the essential
splicing factor SC-35. Cells were hybridized with a biotinylated c-fos genomic probe (white
regions) and subsequently immunolabeled with anti-SC-35 antibodies (gray regions). Three-
dimensional reconstructions of optical sections of cell nuclei were obtained by confocal laser
scanning microscopy. Three cells are shown at 0°, 50°, 100°, and 150° of rotation. a-d, e-h, and
i-/ represent three different cells.
these structures as coiled bodies that can be visual-
ized in the nucleoplasm of cells with or without
antibody labeling (Fig. 5). Coiled bodies are nuclear
inclusions first identified at the light microscopic
level in 1903 as "accessory bodies" in neuronal cells
(Cajal, S.R. Trab. Lab. Invest. Biol. 2: 129-221).
However, a functional role for this nuclear inclusion
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is presently unknown. This study is the first to corre-
late directly an increase in the number of cells con-
taining coiled bodies in a given cell population with
the transformed phenotype. However, the fact that
snRNP-enriched coiled bodies are not present in all
cells of a given population, which still must process
pre-mRNA, suggests that this nuclear inclusion prob-
FIGURE 4 In cells of defined passage number, such as Detroit 551 (a), snRNPs are localized in
a speckled pattern which form interconnections and extend from the surface of the nucleolus to
the nuclear envelope-lamina. In 293 cells (b), snRNPs are concentrated in a speckled pattern, in
addition to being present in foci (arrowhead).
ably does not play a central role in pre-mRNA splic-
ing. On the basis of this study, we conclude that the
organization of snRNPs within the mammalian cell
nucleus is a reflection of the physiology of the cell
and that this organization can change upon trans-
formation. The localization of these key components
of the pre-mRNA splicing machinery (snRNPs) to
speckled nuclear regions in all cell types examined
suggests that these regions may be involved in pre-
mRNA splicing.
FIGURE 5 "Foci" are coiled bodies. He La cells were immunolabeled with anti-Sm monoclonal
antibody, photographed, and then prepared for electron microscopy. The "focus" shown in panel a
is identified as a coiled body in the same nucleus (panels b,c arrowheads).
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FIGURE 6 He La cells were infected with Ad5 at a multiplicity of infection
of 30 pfu/cell. Adenovirus transcripts (a-a and the
essential non-snRNP splicing factor SC-35 (g-I) were localized in infected cells at various time points after infection. See text
for details.
Reorganization of the Pre-mRNA
Splicing Apparatus upon
Adenovirus Infection
L. Jimenez-Garcia, D.L. Spector
We have been interested in understanding the func-
tional significance of the organization of the splicing
apparatus in cell nuclei. The adenovirus system pro-
vides a unique opportunity to address this goal, since
upon adenovirus infection of mammalian cells, the
viral transcripts (some of which are extremely
abundant) utilize the cellular splicing machinery to
process their transcripts. Cells that are not infected
with adenovirus 5 (Ad5) do not exhibit a detectable
signal after in situ hybridization with an Ad2 biotiny-
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FIGURE 7 At the electron microscopic level, SC-35 appears to concentrate in the doughnut-
shaped inclusions, late in infection, as well as being distributed in smaller clusters throughout
the nucleoplasm. Colloidal gold particles denote the localization of SC-35.
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lated probe (Fig. 6a). In these cells, the non-snRNP
splicing factor SC-35 exhibits a typical speckled pat-
tern (Fig. 6g). Cells infected with wild-type Ad5 at a
multiplicity of infection of 30 pfu/cell were examined
by in situ hybridization at various times postinfection
using conditions that would only detect RNA. At 7
hours postinfection, hybridization signal was detected
as dots in the nucleoplasm (Fig. 6b). At this early
time point, the localization of SC-35 appears to be
unchanged (Fig. 6h), although a close association is
observed between the viral transcripts and com-
ponents of the speckled region. Ten hours after infec-
tion, viral transcripts appear as larger dots or semi-
circles (Fig. 6c), and these structures colocalize with
regions of SC-35 immunoreactivity (Fig. 6i). The as-
sociation between viral transcripts and nuclear
regions enriched in SC-35 becomes more apparent as
the infection process proceeds (compare d and j in
Fig. 6; 14 hr postinfection). During the later time
points of infection (18-24 hr), the speckled pattern
appears to reorganize and splicing factors accumulate
in doughnut-shaped nuclear inclusions (Fig. 6k,1),
which are characteristic for localization of the virus
and viral transcripts (Figs. 6e,f) at these time points.
At the electron microscopic level, SC-35 appears to
concentrate in the doughnut-shaped inclusions as
well as being distributed in smaller clusters through-
out the nucleoplasm (Fig. 7). We are currently
evaluating the distribution of specific viral mRNAs in
order to elucidate the pathways which they take from
their sites of synthesis to the nuclear envelope.
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POSTTRANSLATIONAL MODIFICATIONS:
REGULATORY AND TARGETING
S.D. Patterson J. Horwitz
Z. Yu
Posttranslational modifications are of critical impor-
tance to many proteins for a variety of reasons. The
function of many proteins is regulated through the
transient addition or removal of specific moieties
(posttranslational modification), whereas some post-
translational modifications are permanent and may be
involved in targeting proteins to specific compart-
ments within the cell. The studies of this laboratory
involve analyses of both of these classes of modifica-
tions.
Our basic assay of cellular proteins employs high-
resolution two-dimensional gel electrophoresis that
allows separation of thousands of proteins at once
and the quantitative analysis of these patterns using
the QUEST system. We are beginning studies aimed
at determining what roles some posttranslational
modifications play in cellular processes, such as the
cell-division cycle. Much of this work contributes to
the human database, being built as part of the mission
of the QUEST Protein Database Center, of which I
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am affiliated (see QUEST Protein Database Center in
this Section). Therefore, as we want to use human
cell lines whose normal counterparts can be obtained
from the body with relative ease, many of the experi-
ments are conducted using the human T-lymphoblast
cell line, Jurkat. Our initial studies are aimed at ex-
amining the events associated with the purported G1
arrest inducible in cells by the antihypercholestero-
lemic drug, lovastatin (or mevinolin). This is
achieved by looking for changes in the two-dimen-
sional gel patterns of antiphosphotyrosine immuno-
precipitates, 0-linked sugar (N-acetylglucosamine,
GlcNAc) modification, and the expression of cellular
proteins including those identified as being isopreny-
lated (members of this group include the oncoprotein
Ras and other related proteins).
Although I joined Cold Spring Harbor Laboratory
at the beginning of 1991, I was fortunate to spend the
first 3 months of this year in the laboratory of Dr.
Ruedi Aebersold at the The Biomedical Research
Centre, University of British Columbia, Vancouver,
where I used the latest microsequencing techniques,
including solid-phase sequence analysis. We also
characterized a new experimental protein blotting
membrane (see below). Upon my return, I assumed
management of the 2D Gel Lab Core Facility (see
QUEST Protein Database Center Section) and in
July, moved into my laboratory in Demerec where I
was joined by my technicians Jill Horwitz and Zailin
Yu in August and September, respectively. We have
now established an operational protein chemistry lab-
oratory that includes a Hewlett-Packard 1090L LC
(funded through a LIBA New Investigator Start-Up
Award) and, with Zailin, cell culture support. The in-
strument has been optimized for reversed-phase high-
performance liquid chromatographic separation of
peptides and lipids both for micropreparative pur-
poses and for quantitative analyses. As the laboratory
has only been functional for a few months, the data
presented here will show our interests and direction
but will be of a preliminary nature.
A New Protein Blotting Membrane
with High Yield Recovery
S.D. Patterson [in collaboration with R.H. Aebersold,
The Biomedical Research Centre, Vancouver]
A novel experimental membrane from the Millipore
Corporation, based on polyvinylidene-fluoride and
derivatized to have a cationic surface, was examined
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FIGURE 1 Elution of proteins from the Immobilon CD
membrane. A monoclonal antibody to phosphotyrosine
residues was used to immunoprecipitate proteins from
WEHI-231 B lymphoblasts. This precipitate was then
phosphorylated in vitro using [y-32P]ATP. Radioactively
labeled proteins were separated by SDS-PAGE and elec-
troblotted onto the Immobilon CD membrane, detected by
autoradiography (A), and eluted from the membrane
using 4 M GuHCl/0.1% Triton X-100 (B) or 4 M urea/4
GuHCl/10% acetonitrile/0.1% TFA/0.05% zwittergent (C).
Panels B and C show the membrane strips after protein
elution exposed under the same conditions and for the
same length of time as the sample shown in panel A.
Numbers to the right indicate the estimated molecular
mass in kilodaltons.
for its ability to bind electroblotted proteins and
recover these proteins under relatively mild condi-
tions using solvents compatible with further analyses.
The membrane was shown to have a high binding ca-
pacity (at least equivalent to standard polyvinylidene-
fluoride membrane) and is compatible with both
chemical and enzymatic fragmentation of blotted
proteins in situ. Both intact electroblotted proteins or
fragments thereof (including large cyanogen-bro-
mide-derived peptides) were eluted at high yields, ex-
ceeding 70% (Fig. 1). Further structural analysis was
demonstrated using reversed-phase high-performance
liquid chromatography or gel electrophoresis to sepa-
rate the cleavage fragments for either pulsed-liquid or
solid-phase automated sequence analysis. One draw-
back of this membrane is that detection of proteins
other than by autoradiography is difficult. Much of
the work of this laboratory involves micropreparative
procedures often employing two-dimensional gel
electrophoresis as the final step in the purification.
Therefore, the ability to recover proteins elec-
troblotted from gels at high yield will be of enormous
benefit to our work.
Lovastatin and Isoprenylation
of He La and CHO Cells
S.D. Patterson [in collaboration with M. Sinensky
and R. Lutz, Eleanor Roosevelt Institute]
The drug lovastatin (or mevinolin) is a potent compe-
titive inhibitor of the rate-limiting enzyme of choles-
terolgenesis, 3-hydroxy-3-methylglutaryl coenzyme
A reductase (HMG-CoA reductase), and is used clini-
cally to lower serum cholesterol levels. Another con-
sequence of this competitive inhibition is that post-
translational lipid modification (isoprenylation) of
cellular proteins is blocked. This block can be over-
come by the addition of the product of HMG-CoA
reductase, mevalonic acid. If the mevalonic acid is
radioactively labeled, then proteins carrying this
modification can be identified. In some cell lines, this
drug has also been shown to block cell division.
Thus, our initial collaboration with Drs. Sinensky and
Lutz was to determine which proteins in He La and
CHO cells were labeled using this method and also to
look at the alteration of the whole-cell pattern as a
result of the lovastatin block. The results of the He La
cell experiments are shown in Figure 2, which reveals
that most of the label is incorporated into protein in
b
the 20-30-kD mass range. A similar pattern was ob-
served for CHO cells. These low-molecular-mass
proteins are likely to be the small GTP-binding
proteins that are members of the ras superfamily.
Many of the protein shifts in the [35S]methionine-
labeled patterns correlate with the block of isopreny-
lation. This is due to carboxymethylation, the next
processing step following isoprenylation of proteins,
not taking place. Therefore, no loss of negative
charge occurs and the protein is not basic-shifted
(shifted to the right), as is normally the case. Identi-
fication of the prenylated proteins and those proteins
that exhibit a charge shift but do not appear to be
isoprenylated is under way.
Lovastatin-induced G1 Arrest
of Jurkat Cells (?) and the
Anticarcinogen, Limonene
S.D. Patterson, Z. Yu, J. Horwitz
Lovastatin is known to block the S-phase burst of
DNA synthesis during the late G1 phase of the cell
cycle in a number of cell lines. Our interest in cell
var
FIGURE 2 Isoprenylated proteins from He La cells and the effects of lovastatin treatment. He La cells were incubated overnight
(-17 hr) with (a) or without (b) 12.5 p.m lovastatin and [35S]methionine or with 12.5 [im lovastatin and [3H]mevalonolactone
([3H]MVA) (c). Whole-cell lysates were then subjected to two-dimensional electrophoresis using pH 3-10 ampholytes in the
first dimension IEF gel and a 10% T SDS-PAGE gel in the second dimension. The gels are oriented with the anode of the first
dimension (acid) to the left and at the bottom for the second dimension. The proteins labeled by [3H]MVA in panel c are either
arrowed or circled in panel b depending on whether or not they are labeled by [35S]methionine, respectively. Arrowed proteins
in panel a represent new protein species that have appeared following lovastatin treatment, and circles show the position of
proteins that have disappeared upon treatment.
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cycle control prompted a detailed study of the effects
of lovastatin on Jurkat T lymphoblasts for three rea-
sons: (1) to provide a means of labeling isoprenylated
proteins in vivo, (2) to arrest cells at a specific stage
of the cell cycle (G1) for subsequent release and syn-
chronization to enable cell-cycle-dependent effects to
be observed in these cells, and (3) to attempt to iden-
tify the nonsterol product of mevalonate that is neces-
sary for cellular proliferation and determine the path-
way responsible for this G1 arrest. The first of these
has been achieved, and preliminary data showing
those proteins that are isoprenylated are shown in
Figure 3. Initial results indicate that a number of
proteins in the 20-30-kD region and others at 40-60
kD are isoprenylated. We are currently determining
the type of isoprenylation (C15-farnesyl or C20-
geranylgeranyl) and the identity of some of these
proteins. This will incorporate the use of an in situ
binding assay for the determination of GTP-binding
proteins, as it would appear that some of those in the
20-30-kD region may be members of the family of
small GTP-binding proteins that includes the prod-
a
0
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ucts of the genes ras, rab, and rho. The second and
third aspects are being examined using both cell
biological and high-resolution electrophoretic techni-
ques. We are examining the effects of this drug on
protein expression by metabolically labeling with
[35S]methionine for either short or long periods and
also looking at alterations in the posttranslational
modifications of 0-linked sugar (0-G1cNAc) and
phosphotyrosine (and associated proteins, as detected
by immunoprecipitation). Cells treated with lova-
statin show differences by all of these criteria, and we
are now attempting to identify the proteins that show
these alterations.
Isoprenylation of some 21-26-kD proteins, in-
cluding ras, has also recently been shown to be inhib-
ited by the monoterpene anticarcinogen, d-limonene
(Crowell et al., J. Biol. Chem. 266: 17679 [1991]).
The reported selectivity of this effect is currently
being examined, and from initial data (see Fig. 3),
there does appear to be a selective decrease in
isoprenylation of some, but not all, proteins in the
20-30-kD region.
b
O
FIGURE 3 lsoprenylated proteins of Jurkat T lympho-blasts and the effect of limonene on this posttransla-
tional modification. Jurkat cells were incubated overnight (-18 hr) with 12.5 1.1m lovastatin and then con-centrated and labeled with [31-1]rnevalonolactone in the presence (a) or absence (b) of 5 tim d-limonenefor 3 hr. The arrowed low-mass proteins in panel a show decreased labeling upon limonene treatment. Noother proteins, including the low-mass protein circled in both panels, show decreased labeling uponlimonene treatment. Putative lamin B isoforms are identified by B in panel a. The gels were run and areoriented as described in Fig. 2.
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QUANTITATIVE REGULATORY BIOLOGY
B.R. Franza G. Mak
J. Ross
M. Neumann
A. Giordano
X. Grana
A. Calzolari
J.A. Scheppler
Y. Li
H.R. Tan
G. Niu
We study cellular proteins involved in the growth
control of mammalian cells. Lymphoblasts and
hematopoietic progenitor cells are the normal human
tissues that we use to study the molecular mechan-
isms regulating cell proliferation and differentiation.
So far, the mammalian studied most
comprehensively are human T- lymphoblast cell lines.
During the past several years, we have focused on
three processes. One is the effect expression of on-
cogenes has on the entire complement of proteins
present in a particular cell type. The second is the in-
duction of protein alterations when quiescent cells are
stimulated to proliferate. These studies are directed at
determining the molecules involved in conveying sig-
nals to the genome and the earliest responses of the
genome to these signals. The third process is the con-
trol of gene expression at the level of regulation of
transcription of mRNA encoding genes. The QUEST
protein database system is the tool on which we rely
heavily for performing such a comprehensive qualita-
tive and quantitative analysis of regulatory proteins.
The goal, implicit in all of our studies, is to construct
a molecular description of the networks involved in
regulating transcription and other genome responses
to a change in the growth state of the cell.
Highlights of the past year include the demonstra-
tion of cell-division-cycle-dependent change in the
kinase activity of growth control protein affinity
complexes, of interactions between c-Rel and a Rel-
related gene product, and the elucidation of specific
proteins that associate with the "E2F" DNA control
element. Some details of each study are presented
below. These studies provide further evidence for the
need to characterize the temporal and spatial (sub-
cellular) fluctuation in amounts of specific gene prod-
ucts and their intermolecular interactions. Much to
the credit of our colleagues Jim Garrels, Jerry Latter,
and Pat Monardo, 1992 appears to be the year in
which we will have a database software system suffi-
ciently powerful to support the extensive comparative
analysis of the quantitative and/or qualitative change
among members of different sets of regulatory cel-
lular proteins isolated from cells at different stages of
growth. To take full advantage of this system, we are
constantly expanding the molecular probes necessary
for the identification and characterization of regula-
tory proteins. The individuals listed above work as a
group, with those contributing most to a particular
project being recognized by first authorship of pub-
lished reports (see Publications list).
RETINOBLASTOMA-ASSOCIATED GENE
PRODUCT IS PHOSPHORYLATED IN VITRO BY
GROWTH-CONTROL PROTEIN COMPLEXES
We previously demonstrated that an immune com-
plex containing cellular proteins associated with El A
phosphorylates histone H1 in a cell-cycle-dependent
manner and that association of pRB with El A appar-
ently was not required for this activity. The pRB
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from asynchronously dividing cells have been
resolved that associate with the normal site. They are
either significantly reduced or absent from the mutant
DNAP assays. We appear to have detected pRB in
the functional E2F site DNAP complex by im-
munoblot analysis. We are beginning to study the ef-
fect(s) of E1A and the association of each protein
with the E2F site, the changes in interaction when
cells enriched at different stages of the cell division
cycle are used as sources of extracts for binding as-
says, and the response of these proteins to stimuli
known to activate immediate-early gene expression
(e.g., c-fos).
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The research in our laboratory continues to focus on
two fundamental problems in molecular and cell biol-
ogy: (1) the mechanisms responsible for tissue-
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specific and developmentally regulated patterns of
gene expression and (2) the functional significance of
cell-type-specific protein isoform expression. We
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have been interested in understanding the regulation
and function of tropomyosin gene expression in mus-
cle and nonmuscle cells. Tropomyosins are among
the major components of the thin filaments of skele-
tal and cardiac muscle and the microfilaments of non-
muscle cells. These filaments are involved in a num-
ber of cellular processes, including muscle contrac-
tion, cell movement, and the generation of cell shape.
Of interest to our laboratory is the observation that
different forms of tropomyosin are expressed in dif-
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ferent cell types and tissues. Distinct isoforms are
present in striated muscle (skeletal and cardiac),
smooth muscle, and nonmuscle cells. We now know
that at least 12 different tropomyosin isoforms are ex-
pressed from three separate genes in rat. The a-
tropomyosin (a-TM) gene encodes nine isoforms
(Fig. 1), the (3-tropomyosin ((3-TM) gene encodes two
isoforms (Fig. 2), and the tropomyosin-4 (TM-4)
gene encodes a single isoform. We have been study-
ing the expression of these genes with particular at-
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FIGURE 2 Schematic diagram of the rat 13-tropomyosin gene and the two different isoforms expressed from this
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tention to understanding the mechanisms of their
regulation at the posttranscriptional level, i.e., tissue-
specific alternative RNA splicing. In addition, we
have continued to study the promoter elements in the
(3-TM gene. We have also begun to study alternative
splicing of the clathrin light chain B gene. The ex-
pression of a diverse group of tropomyosin isoforms
in a highly tissue-specific manner via alternative
RNA processing strongly suggests that each isoform
is required to carry out specific functions in conjunc-
tion with the actin-based filaments of various muscle
and nonmuscle cells. The function of these different
isoforms is not known and is under study. We have
recently identified a gene from the fission yeast
Schizosaccharomyces pombe that encodes a distantly
related member of the actin family and have begun to
study the function of this actin-like protein. Below is
a summary of our present studies.
Alternative Splicing of 13-TM
Pre-mRNA: cis-Acting Elements and
Cellular Factors That Block the Use
of a Skeletal Muscle-specific Exon
in Nonmuscle Cells
W. Guo, G. Mulligan, S. Worms ley, D. He lfman
We are using the rat (3-TM gene as a model system to
investigate the molecular basis for developmental and
tissue-specific alternative RNA splicing. The (3-TM
gene expresses both skeletal muscle 13-TM and fibro-
blast TM-1 by an alternative RNA splicing mecha-
nism (Fig. 2). Previous studies from our laboratory
have shown that the intron sequences upstream of the
3 ' -splice site of exon 7 (skeletal muscle-specific
splice) are important for alternative splice site selec-
tion, because deletion of these sequences resulted in
the use of the skeletal muscle-specific exon in non-
muscle cells (Helfman et al., Genes Dev. 4: 98
[1990]). We have carried out an extensive mutational
analysis to identify cis-acting elements that block the
use of the skeletal muscle-specific exon 7 in non-
muscle cells. These studies have localized the critical
elements for regulated alternative splicing to se-
quences within exon 7 and part of the adjacent up-
stream intron. In addition, mutations that inactivate
the 5 ' - or 3 ' -splice sites of exon 6 do not result in
the use of the skeletal muscle-specific exon 7 in non-
muscle cells, suggesting that splice site selection in
vivo is not regulated by a simple cis-acting competi-
tion mechanism but rather by a mechanism that in-
hibits the use of exon 7 in certain cellular environ-
ments. In support of this hypothesis, we have identi-
fied sequence-specific RNA-binding proteins in
HeLa cell nuclear extracts using native gel elec-
trophoresis and binding competition assays. Muta-
tions in the pre-mRNA that result in the use of the
skeletal muscle exon in vivo also disrupt the binding
of these proteins to the RNA in vitro. We propose
that the binding of these proteins to the pre-mRNA is
involved in regulated alternative splicing and that this
interaction is required for blocking the use of the
skeletal muscle exon in nonmuscle cells.
Purification and Characterization
of an RNA-binding Protein That
Interacts with Sequences Involved in
Alternative Splicing of (3-TM
Pre-mRNA: Identity with the
Polypyrimidine Tract Binding Protein
G. Mulligan, W. Guo, S. Wormsley, D. Helfman
As described above, we have found that the regu-
latory sequences in the intron upstream of exon 7 in-
teract with sequence-specific RNA-binding proteins
in HeLa nuclear extracts (Guo et al. 1991). This has
led us to propose that nonmuscle cells contain factors
that interact with specific regulatory sequences in the
pre-mRNA to block the use of the skeletal muscle
exon. To study further the precise nature of the fac-
tors that interact with sequences in the (3-TM pre-
mRNA, we have purified to apparent homogeneity a
protein that interacts specifically with the intron
regulatory element upstream of the skeletal muscle-
specific exon 7. This protein is identical to the
polypyrimidine tract binding protein (PTB) which
other studies have shown to be involited in the recog-
nition and use of 3' -splice sites (Garcia-Blanco et
al., Genes Dev. 3: 1874 [1989]). Our analysis of the
in trons between exons 5 through 8 in the tropomyo-
sin pre-mRNA demonstrates that PTB binds only to
the intron upstream of the skeletal muscle-specific
exon 7. The nature of the interactions in this intron
reveals several new details about the binding
specificity of PTB and suggests that PTB does not
function exclusively in a positive manner in the
recognition and use of all 3' -splice sites. Although
we cannot rule out the possibility that other factors
will also bind to these sequences, our work
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demonstrates that the regulatory element in the intron
upstream of exon 7 can interact with PTB in a
sequence-specific manner. It is also worth noting that
our previous analyses of cis-acting regulatory ele-
ments in 13-TM pre-mRNA indicate that sequences in
exon 7 also participate in blocking the use of this
exon in nonmuscle cells (Guo et al. 1991). However,
these exon sequences do not appear to be required for
the interaction of PTB binding, and mutations in this
exon do not disrupt the binding of PTB (data not
shown). It remains to be determined whether these
exon sequences interact with other factors.
Although the biological significance of the PTB
binding to sequences upstream of exon 7 remains to
be established, a strong correlation exists between the
ability of PTB to bind to these sequences and our pre-
vious results demonstrating that mutations in this
region lead to activation of the skeletal muscle-
specific exon in vivo (Guo et al. 1991). The same
mutations that result in the use of exon 7 in non-
muscle cells in vivo also disrupt the binding of PTB
in vitro. Thus, the interaction of PTB with the intron
regulatory elements in the P-TM pre-mRNA may ac-
count for the regulation of splice site selection. Addi-
tional interactions with PTB are observed with the
long polypyrimidine tract upstream of the 3 ' -splice
site (-117 to -143 nucleotides), which has been
demonstrated to specify the location of the branch-
points used, 144-153 nucleotides upstream of exon 7
(Helfman et al., Genes Dev. 4: 98 [1990]). This inter-
action is likely to be required for branchpoint forma-
tion (Mullen et al., Genes Dev. 5: 642 [1991]). On
the other hand, interaction of PTB with the regulatory
sequences downstream from this polypyrimidine tract
appears to block the use of this exon in nonmuscle
cells. The results suggest both a positive and negative
role of PTB in the regulation of alternative splicing of
exon 7 in skeletal muscle and nonmuscle cells.
How these dual functions of PTB might be
achieved is not clear, but we can offer a few specula-
tions. Since PTB can exist as multiple isoforms via
alternative RNA splicing, skeletal muscle and non-
muscle cells could express a different set of PTB
isoforms with different binding specificities, which
thereby lead to tissue-specific splice site selection.
However, we have thus far been unable to detect dif-
ferences in isoform expression in different cell types
or in the binding of RNAs containing the intron
regulatory sequences in nuclear extracts obtained
from undifferentiated and differentiated myogenic
cells. It is also possible that the binding of PTB to
both the polypyrimidine tract and regulatory element
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is constant in all cell types. PTB bound to the RNA
could then serve as a platform for the interaction or
recruitment of other factors. For example, the distri-
bution or number of PTB binding sites along a region
of RNA could provide different recognition sites for
the interactions of additional binding factors, Which
might be expressed in a tissue-specific manner. Thus,
PTB bound to the polypyrimidine tract associated
with branchpoint use could provide a binding site for
factors that are distinct from PTB bound to the
downstream regulatory sequences. Alternatively, the
binding of PTB might be involved in packaging of
the pre-mRNA into a heterogeneous nuclear ribonu-
cleoprotein (hnRNP) particle. The proper assembly of
the (3-TM pre-mRNA with hnRNP proteins might be
essential for regulation of tissue-specific splicing.
Alterations in the distribution of specific hnRNP
proteins, e.g., PTB, along the pre-mRNA, could, in
principle, result in loss of normal splice site regula-
tion.
In summary, having identified that PTB can bind
to specific regulatory sequences in the (3-TM pre-
mRNA, it remains to be determined whether these in-
teractions do in fact contribute to splice site selection.
Work is currently in progress to identify precisely the
sequences in the RNA that bind to PTB and to devel-
op in vitro splicing systems to test directly the func-
tional role of PTB in alternative splice site selection.
Regulation of Alternative 3' -splice
Site Selection in ii-TM Pre-mRNA
T. Tsukahara, D. Helfman
We previously reported that the splicing of exon 5 to
exon 6 in the rat (3-TM gene required that exon 6 first
be joined to the downstream common exon (Helfman
et al., Genes Dev. 2: 1627 [1988]). Pre-mRNA con-
taining exon 5, intron 5, and exon 6 was not spliced
at all. We have carried out a mutational analysis to
determine which sequences in the pre-mRNA con-
tribute to the inability of this precursor to be spliced
in vitro. Interestingly, we find that mutations in two
regions of the pre-mRNA lead to activation of the
3' -splice site of exon 6, without first joining exon 6
to exon 8. First, introduction of a nine-nucleotide
poly(U) tract near the 3 ' end of intron 5 was suffi-
cient to permit the splicing of exon 5 to exon 6, with
as little as 35 nucleotides of exon 6. Second, intro-
duction of a consensus 5'
-splice site in exon 6 leads
to splicing of exon 5 to exon 6. The result obtained
with the latter mutation is in agreement with the exon
definition model recently proposed by Sue Berget
and colleagues (Mol. Cell. Biol. 10: 84 [1990]). Col-
lectively, our studies demonstrate that three distinct
elements can act independently to activate the use of
the 3 ' -splice site of exon 6: the sequences in exon 8,
a poly(U) tract in intron 5, and the 5 ' splice of exon
6. Work is currently in progress to determine whether
each of these sequences interacts with distinct factors
for 3 ' -splice site utilization.
In Vitro and In Vivo Characterization
of Four Fibroblast Tropomyosins
Produced in Bacteria: TM-2, TM-3,
TM-5a, and TM-5b Are Colocalized
in Interphase Fibroblasts
M. Pittenger, D. Helfman
Most cell types express several tropomyosin iso-
forms, the individual functions of which are poorly
understood. In rat fibroblasts, there are at least six
isoforms: TM-1, TM-2, TM-3, TM-4, TM-5a, and
TM-5b. TM-1 is the product of the (3 gene, TM-4 is
produced from the TM-4 gene, and TM-2, TM-3,
TM-5a, and TM-5b are the products of the a gene.
To begin to study the localization and function of the
isoforms in fibroblasts, cDNAs for TM isoforms TM-
2, TM-3, TM-5a, and TM-5b were placed into bac-
terial expression vectors and used to produce TM
isoforms. The bacterially produced TMs were deter-
mined to be full-length by sequencing the amino and
carboxyl termini. These TMs were found to bind to F
actin in vitro, with properties similar to that of skele-
tal muscle TM, except that TM-5a had a relatively
weaker affinity. To investigate the intracellular
localization of these fibroblast isoforms, each was
derivatized with a fluorescent chromophore and mi-
croinjected into rat fibroblasts (see Fig. 3). TM-2,
TM-3, TM-5a, and TM-5b were each found to associ-
ate along actin filaments. There was no preferred cel-
lular location or subset of actin filaments for any of
these isoforms, although TM-5a appeared to give
weaker labeling in vivo. Furthermore, coinjection of
two isoforms labeled with different fluorochromes
showed identical localization. At the level of the light
microscope, these TM isoforms do not appear to
achieve different functions by binding to particular
subsets of actin filaments or locations in cells, al-
though this needs to be studied further. The results
show that bacterially produced TMs can be used to
study in vitro and in vivo properties of the isoforms.
In the coming year, we plan to study the dynamic dis-
tribution of each isoform using video microscopy to
follow the fluorescently labeled tropomyosins during
cell spreading, mitosis, and cell movement.
Transcriptional Control of 3 -TM
Gene Expression
J. Kazzaz, D. Helfman
The rat 13-TM gene expresses two distinct isoforms
via an alternative splicing mechanism (see Fig. 2).
Although the gene is expressed in different muscle
(skeletal, cardiac, and smooth) and nonmuscle cells, a
single transcription initiation site is used in the vari-
ous cell types that express the gene. We have identi-
fied three cis-acting elements involved in the regula-
tion of transcription of this gene. The first is a region
located 200-500 base pairs upstream of the transcrip-
tion initiation site. This element is responsive to ex-
ogenous MyoD when rat or mouse fibroblast cell
lines (REF52 and NIH-3T3, respectively) are cotrans-
fected with a tropomyosin promoter-CAT construct
and a construct that contains a copy of MyoD cDNA
clone (courtesy of A. Lassar). To determine whether
this element is responsive to endogenous MyoD, we
transfected C2Ci, cells with the various tropomyosin-
promoter constructs. This cell line, upon induction
with low serum, differentiates from myoblasts to
form myotubes, and express MyoD. Transfection into
differentiated myotubes indicates that this region is
sufficient for activation of transcription in differen-
tiated muscle cell lines. Sequence analysis of this
region indicates that it contains three copies of a
skeletal muscle-specific enhancer element located ap-
proximately 304,352, and 398 base pairs upstream of
the transcriptional start site. The consensus sequence
of this 14-nucleotide-long element has been found in
a number of genes expressed in skeletal muscle, in-
cluding the muscle creatine kinase, 8-subunit of the
acetylcholine receptor, myosin-light-chain 1/3, des-
min, and vimentin (Buskin and Hausch-ka, Mol.
Biol. 9: 2627 [1989]).
The second element involved in regulation is
found within the first intron of the gene. This region
contains a 124-base-pair direct repeat within the first
intron of the 13-TM gene. This repeat has a 45-
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FIGURE 3 Localization of TM-2 in fibroblasts. Bacterially produced fibroblast TM-2 was labeled
with lissamine rhodamine B sulfonyl chloride (LRB) and microinjected into rat fibroblasts (REF52
cells). Three hours after injection, the cells were fixed and visualized by fluorescence microscopy.
(A,C,E) Cells microinjected with LRB-TM-2. In panel A, TM-2 can be seen in the long cellular pro-
cess as well as the cell body. An uninjected neighboring cell is also seen in the phase image in
panel B. TM striations can be seen in well-spread cells (see arrows in panel C), which are not seen
with FITC-phalloidin-stained microfilaments (panel D). (E) Injected TM-2 viewed in the rhodamine
channel; (F) same field when cells are stained with antibodies to TM and a fluorescein-labeled
second antibody.
nucleotide purine/pyrimidine (dA-dC) stretch. A
poly(dA-dC) repeat has been shown to have enhancer
properties in SV40 (Berg et al., Mol. Cell. Biol. 9:
5248 [19891). To determine whether this element has
enhancer-like activity, we have cloned both copies of
this element upstream of the promoter elements in the
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tropomyosin-CAT constructs indicated above. Trans-
fection experiments in muscle and fibroblast cell
lines suggest that this element functions as an enhan-
cer in muscle cell lines. Cotransfection with MyoD
indicates that the effect of the internal enhancer is ad-
ditive to that of the muscle regulatory region. Further
investigation will determine whether the enhancer ac-
tivity resides in the poly(dA-dC) repeat, the flanking
regions, or a combination of both.
The third element is found within the second in-
tron. This element activates transcription in non-
muscle cells without exogenous MyoD. Work is in
progress to determine whether this element has
enhancer-like activity and whether its effect is addi-
tive with respect to the cis-acting elements described
above.
Rat Clathrin Light Chain Gene
Structure, Expression, and
Regulation
S. Stamm, D. Helfman [in collaboration with
Jurgen Brosius and Diana Casper, Mount Sinai
School of Medicine, New York]
We are studying the structure, expression, and regula-
tion of the rat clathrin light chain B. Clathrin heavy
and light chains form a basket-like structure that con-
stitutes the protein backbone of coated pits and
vesicles. Coated pits are found on the surfaces of
cells where they participate in the internalization of
various molecules, whereas coated vesicles are
thought to function in the transport of proteins from
the Golgi to the cell surface. There are no tissue-
specific forms of the heavy chains of clathrin,
whereas the light chains can be expressed in a tissue-
specific manner. The rat clathrin light chain B gene
expresses two distinct isoforms via alternative RNA
splicing. Interestingly, one form is only detected in
brain and appears to be specific to neurons. To under-
stand the molecular basis for the tissue-specific splic-
ing, we have isolated and characterized genomic
clones for the clathrin light chain B gene. The gene
was found to span approximately 11 kb of DNA and
contains six exons. The brain-specific exon, termed
exon EN, is located between exon 4 and exon 6. Ex-
pression of this exon is found in brain, primary
neurons from central or peripheral nervous system,
but not in fibrobasts, He La cells, primary glial cul-
tures, or glial-type cells. Thus, it appears that the
brain-specific splicing is found only in neurons. We
have begun experiments to study the cis-elements and
cellular factors required for alternative splice site se-
lection. We have identified a critical sequence in the
brain-specific exon that is required for the use of this
exon in primary neuronal cell cultures. Further work
is planned to identify cellular factors that might bind
to these sequences and thereby mediate tissue-
specific splicing.
Identification of an Essential Gene
Encoding an Actin-related Protein
from Schizosaccharomyces pombe
J.P. Lees-Miller, D. Helfman
Actins are a family of conserved proteins that have
been characterized from a broad range of phyla in-
cluding vertebrates, invertebrates, fungi, plants, and
protozoa. They have between 70% and 90% amino
acid sequence identity and are 374 to 376 amino
acids in length. We have recently cloned a gene
(act2) from the yeast Schizosaccharomyces pombe
that encodes a distantly related member of the actin
family. Disruption of the act2 gene revealed that it is
essential for spore germination. In contrast to pre-
viously identified actins, the derived amino acid se-
quence of the act2 protein is only 35% to 40% identi-
cal to other actins, including that of S. pombe, and is
427 amino acids in length. The crystallographic
structure of rabbit skeletal muscle actin is known
(Kabsch et al., Nature 347: 37 [1990]). The regions
of the act2 amino acid sequence that are conserved
relative to actin include the predicted ATP and cal-
cium ion contact sites and much of the overall core
structure. However, some of the regions in actin that
are predicted to be important for actin:actin and ac-
tin:actin-binding protein interactions are highly
diverged in act2. Recent analyses of actin-related se-
quences from budding yeast (Schwob and Martin,
Nature 355: 179 [1992]), C. elegans, and human
brain indicate that at least three families of actin-
related proteins exist and that each may have essen-
tial cellular functions distinct from that of actin. Our
present efforts are directed at determining the func-
tion of the actin-related proteins. This involves ex-
pression and purification of proteins, immunofluo-
rescence localization, and the development of
temperature-sensitive mutants in S. pombe.
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QUEST PROTEIN DATABASE CENTER
J.I. Garrels C. Chang J. Kos K. Duhamel J. Horwitz
B.R. Franza P. Myers H. Sacco S. Fang J. Slott
G. Latter P. Monardo N. Sareen Z. Yu B. Rose
S.D. Patterson A. Nikzad
Activity in the QUEST Protein Database Center in
1991 has included software development, database
development, and protein characterization. Scott Pat-
terson joined Cold Spring Harbor Laboratory in Janu-
ary as a Staff Investigator and a member of the
QUEST Center. He has taken responsibility for the
QUEST 2D gel laboratory, and his efforts for the
QUEST Center include protein identification and
characterization. Scott spent the first 3 months of
1991 in the laboratory of Dr. Ruedi Aebersold at the
Biomedical Research Center in Vancouver learning
new techniques relevant to the characterization of
proteins from two-dimensional gels. His work is de-
scribed below and in a separate report (see Posttrans-
lational Modifications: Regulatory and Targeting).
The research of the QUEST Center continues to
focus on protein synthesis and modification in mam-
malian and yeast cells using our quantitative two-
dimensional gel technology. Our collaborative pro-
ject to build a mouse embryo database is highlighted
below. The mission of the QUEST Center, as a Na-
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tional Institutes of Health Biomedical Research Tech-
nology facility, has always included service and col-
laboration with the scientific community at large.
This part of our mission was redefined in 1991 so
that we no longer offer two-dimensional gel analysis
services. Instead, our computing group is focused on
providing software and support for scientists at Cold
Spring Harbor Laboratory and in other institutions
who wish to build and access two-dimensional gel
protein databases. A new QUEST software system is
being readied by the Computing Group of Jerry Lat-
ter, and the first application of this software will be a
human database. This database will be a major focus
of the QUEST group, bringing together many past
and future studies by Robert Franza, Scott Patterson,
and Jim Garrels and depending heavily on the sup-
port of the Computing Group. Reports on the soft-
ware and database progress are given below.
Cecile Chang, who had served the QUEST Center
in many roles both in the laboratory and in the com-
puting group, left in July to accept a management
position in a drug company in Taiwan. Phyllis Myers,
who had been our tireless two-dimensional gel ana-
lyst since 1986, retired in March. Arman Nikzad, a
programmer who was hired in September to replace
Jim Kos, was forced by family needs to return to his
native Turkey in December. Staffing changes in the
two-dimensional gel lab are given below.
QUEST Computing Group
G. Latter, P. Monardo, A. Nikzad, J. Kos, J.I. Garrets
The change of emphasis in the QUEST services, from
2D gel analysis services to software and database
support, is consistent with our commitment to offer a
high-end software package to members of the
scientific community who wish to build and access
2D gel databases. The new software system, de-
scribed below, will allow the construction of larger
databases as well as much better access to data and
program modules over the Internet. The primary ap-
plication for the new software within QUEST will be
the construction of a new human database.
As indicated in last year's Annual Report, the
QUEST software system is being dramatically
restructured using modern software standards to pro-
vide a powerful tool for database construction that
will serve QUEST and the scientific community
throughout the 1990s. The software is adapted to
today's networked computer environments where
database servers, computational servers, and graphics
engines may reside on separate computers linked
through a network, and the network may even link
computers at different institutions.
The QUEST software is organized in three layers.
The lowest layer, the database server layer, contains
three servers. One (QDB) provides 2D gel spot data-
base access, another (IDB) provides image database
access, and the third (MDB) provides access to
laboratory records and accounting information. In the
middle layer are the compute servers. The ISP server
performs computational tasks that involve images,
such as background subtraction, smoothing, spot
detection, and spot fitting. The MSP server carries
out computational tasks on spot data, such as match-
ing, editing, and spot set construction. The DSP serv-
er is a graphics engine containing plotting functions
written using the X Graphics Language (XGL). The
top layer is the user interface. The Matchset Tool is
the main editing interface. A separate tool (ISPTooI)
controls the image processing functions. All interface
layers conform to the Open Windows standard.
The architecture described above was designed
and put in place primarily by Pat Monardo. The
modular structure has allowed others to interface par-
ticular modules to the system. For example, Dr. Car-
rels was able to convert the spot detection and fitting
algorithms, which he has developed and improved
over the years, into a quantitation server that is now a
part of ISP.
All six servers are now built and are in a testing
phase. The completion of the Matchset Tool will
soon allow us to begin construction of the human
database. The design and implementation of special-
ized analysis tools will continue during database con-
struction. After a thorough shakedown by the mem-
bers of the QUEST group, the software will be
released to collaborators for use with their databases
and soon thereafter to the general scientific com-
munity.
New Scanning Technology: We have completed
testing of storage phosphor technology as a replace-
ment for film in the detection of radioactively labeled
proteins in 2D gels. Two different systems (Molec-
ular Dynamics and Fuji) were evaluated while on
loan to Dr. Beach's laboratory. Both systems pro-
duced an image equivalent to a 30-day fluorogram
with an exposure of less than 1 week to an imaging
plate. Initial examinations indicate that the dynamic
range of the phosphorimaging systems is sufficient to
replace our present system of multiple film ex-
posures, although a very short exposure (1 hr) may be
needed to detect the most intense proteins without
saturation. The systems evaluated differ with respect
to technical criteria such as resolution, spatial
uniformity, erasure of plates, sensitivity, and rate of
image capture. The errors of quantitation and spatial
resolution are below the level of errors inherent in the
process of resolving proteins on 2D gels.
We expect to adopt phosphorimager technology
as a replacement to our current fluorographic pro-
cessing of gels. This will avoid the cost of film, de-
veloping chemicals, and fluorographic chemicals. It
will also remove the need for calibration strips that
have been used with every film exposure. The
phosphorimager will be further exploited for sensi-
tive double-label analysis to determine protein amino
acid compositions on 2D gels. Our strategy for identi-
fication of human and yeast proteins by this method
is given in a later section.
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2D Gel Laboratory Core Facility
S.D. Patterson, J.I. Garrels, K. Duhamel,
S. Fang,
H. Sacco, N. Sareen
This Cold Spring Harbor Laboratory Core Facility
runs 2D gels for researchers at CSHL as
well as for a
limited number of outside users. As in past years, a
wide range of samples have been handled by the
laboratory. Just over 1600 gels were run this year,
with 86% of these for Cold Spring Harbor Laboratory
staff and the remainder for external users. Although
relatively few external gels were run this year, the
laboratory continues to provide an important service
to the general scientific community. In addition, a
large number of samples were also run for quality
control and optimization of first-dimension running
conditions for the new QUEST human database. In
April, Dr. Garrels handed over the management of
the facility to Dr. Patterson.
This will be the last full year that the gel lab will
be in its original location, the McClintock building.
We are presently gearing up to move to a more com-
pact laboratory in Demerec. This move to lesser
space requires that we change our method of detec-
tion of radioactive samples. Since its inception in
1979, the gel lab has used DMSO/PPO as a
fluorographic enhancer to give increased signal to
noise (five- to eightfold) over direct autoradiography.
With Jerry Latter, we have been involved in evaluat-
ing a new technology, storage phosphor plates, with
the aim of eliminating the hazardous DMSO/PPO
fluorography reagents and the space required for this
system. On average, our longest of multiple ex-
posures are often at least 1 month. This new technol-
ogy allows reduction of that time to 5-8 days with no
loss in resolution. We are looking forward to employ-
ing this new technology to improve the turnaround
time of our service.
By the end of the year, the gel lab staff had turned
over completely, with Kris Duhamel leaving for New
Jersey in March, Shu-Ling Fang for San Francisco
with her husband, upon completion of his Ph.D. in
June, and Heidi Sacco in December to have her sec-
ond child. Only two of the three staff have been re-
placed in an effort to improve both the efficiency and
therefore the cost effectiveness of this core facility.
Neena Sareen has been with us since June and Nick
Bizios will begin in late January 1992. We look for-
ward to this coming year of change for the gel lab
with optimism.
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Identification of Some Members of
the "PCNA-like" Set from Rat Cells
in Human T Lymphoblasts and
Prefractionation Procedures
S.D. Patterson, Z. Yu, J. Horwitz
The so-called "PCNA- like" set of proteins, with
regulation coordinate wIth that of the DNA polymer-
ase 8 processivity factor, proliferating cell nuclear
antigen (PCNA), was identified in REF52 (rat) cells
by Garrels and Franza (J. Biol. Chem. 264: 5299
[1989]).
We are currently engaged in identifying the hu-
man homologs of some of these proteins in Jurkat T
lymphoblasts by finding proteins that have similar
physical properties. These properties include sub-
cellular location, isoelectric point, relative molecular
mass, hydrophobicity (as determined by detergent
phase separation), and peptide maps. Subcellular
fractionation studies have begun with nuclei and
mitochondria being enriched in Jurkat cells, and fur-
ther studies are planned for plasma membrane,
nuclear matrix, microsomes, Golgi apparatus, and
endoplasmic reticulum.
Phase separation using the detergent Triton X-114
(TX-114) has been performed on both WT2 (a
REF52-related cell line) and Jurkat cells. Prefrac-
tionation such as this allows higher loads of protein
to be loaded onto a 2D gel for preparative purposes.
This procedure also provides information as to
whether the protein is lipophilic or not, i.e., whether
it is possibly membrane-associated. The detergent
phase of whole-cell lysates has already shown enrich-
ment of proteins in the 20-30-kD region that may
prove to be the small GTP-binding proteins (mem-
bers of the ras superfamily).
Another protein shown to be enriched in the
detergent phase of WT2 whole-cell lysates and nuclei
is the protein labeled MG20 from the REF52 data-
base. This protein is one of the "PCNA-like" set of
proteins. A protein with similar physical properties
(as defined above) has been located in Jurkat cells,
and this is currently being enriched for comparative
peptide mapping to confirm the identity of this
protein with the REF52 MG20 protein and to provide
sufficient material for subsequent amino acid se-
quence analysis. These prefractionation studies con-
tribute a "preparative" aspect to the human database
and another means of linking the rat and human data-
bases.
Mouse Embryo Database
J.I. Garrels, C. Chang, P. Myers [in collaboration with
Keith Latham, Wistar Institute, and Davor Solter,
Max Planck Institute for Immunology]
The mouse embryo database has grown considerably
and has been applied to several specific questions of
mouse early development. Dr. Latham and Dr. Solter
have designed the database to reveal detailed changes
of protein synthesis in mouse embryos from fertiliza-
tion to postimplantation stages, and they have used
the database for experimental studies utilizing protein
kinase inhibitors and nuclear transplantation, as de-
scribed below. Our role at QUEST has been to couple
our 2D gel technology to this experimental expertise
of the collaborators, to solve new problems in data-
base construction, and to provide critical evaluation
of the results. The analysis of the mouse database has
required cluster analysis and has required linking dis-
similar matchsets to a degree not faced in construct-
ing the REF52 database.
The cornerstone of the mouse embryo database is
the series of embryos labeled each 3 hours from fer-
tilization through the four-cell stage. This study, pub-
lished in 1991, has revealed five significant patterns
of protein synthesis during the two-cell stage of de-
velopment, which is the critical stage when protein
synthesis switches from using maternal mRNA to
using newly synthesized embryonic mRNA. The pat-
terns for the two-cell stage are summarized in Figure
1. About 37% of the proteins detected are synthesized
for the first time at this stage. Another 36% of the
proteins (clusters 2 and 3) are turned off or are sig-
nificantly repressed at this stage. The final two
clusters of proteins show transient induction or
repression during the two-cell stage. It is significant
that the changes among the transient expression pro-
files begin a few hours before the first appearance of
the long-term changes.
These studies have been extended through the
preimplantation period. Profiles (fertilization through
morula) for some representative proteins are shown
in Figure 2. Protein EL60 is one of the proteins that
disappears during the two-cell stage. Protein DE90 is
one that appears transiently during the two-cell stage
and is not seen later. Proteins KJ20 and LD30 first
appear in the two-cell stage and continue to be
synthesized beyond the morula phase. Note that the
transient expression of protein DE90 begins 3-6
hours earlier than the synchronous wave of induction
represented by proteins KJ20 and LD30.
Among the known cytoskeletal proteins, tubulin
is synthesized in substantial quantity, and actin and
tropomyosin-5 (TM5) are synthesized at low levels in
the zygote. Significant increases of all three proteins
occur at the two-cell stage, probably reflecting a
switch from maternal to embryonic mRNA. Tubulin
synthesis then declines by 5-10-fold after the two-
cell stage, whereas actin shows another increase in
synthesis (10-20-fold) in the eight-cell and morula
stages.
The database is a valuable standard against which
to compare abnormal patterns of protein synthesis.
Drs. Latham and Solter use nuclear transplantation to
construct embryos containing only male pronuclei
(androgenones) or only female pronuclei (gynoge-
nones). Such embryos become blocked in later devel-
opment, and 2D gel experiments were carried out to
determine when the first differences in protein ex-
pression are apparent. In one mouse strain (C57
BL/6), no significant differences were seen between
androgenetic and gynogenetic embryos from among
1200 proteins examined at the eight-cell stage. How-
ever, in another mouse strain (DBA/2), 11 changes
were observed. Expression profiles from the database
reveal that eight of these proteins are normally in-
duced during the eight-cell/morula stage but are not
induced in the DBA/2 androgenones. The other three
proteins are normally synthesized at declining rates
during the eight-cell/morula stage, and the synthesis
of these proteins does not decline in the DBA/2
androgenones.
One further use of the database has been to exam-
ine the effects of protein kinase inhibitors on devel-
opment. It has been known that zygotic gene activa-
tion is at least partially sensitive to protein kinase A
inhibitors but is little affected by inhibitors of protein
kinase C. Cluster analysis was used to detect the pat-
terns of protein expression in cells treated with a-
amanitin (inhibitors of RNA polymerase), H8 (in-
hibitors of PKA), or H7 (inhibitor of PKC). One large
cluster was found representing the proteins that
normally increase in the two-cell stage. The members
of this large cluster (36% of detected proteins) are not
induced in the presence of a-amanitin or H8. Two
other clusters (18% of detected proteins) contain
proteins normally repressed in the two-cell stage, but
which are not repressed in the presence of H8. The
PKC inhibitor H7 did not have a significant effect on
the members of these clusters. Proteins induced
transiently in the two-cell stage are likewise not in-
duced in the presence of H8 but are induced in the
presence of H7.
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Major patterns of synthesis from the 2-cell
stage mouse embryo.
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FIGURE 1 Cluster analysis shows the major protein expression profiles during
the two-cell stage of mouse development. Proteins with similar expression patterns
are automatically grouped into 'clusters" and plotted as a composite profile. This
analysis reveals the major patterns of regulation inherent within a critical 21-hr pe-
riod of mouse development.
Yeast Database
J.I. Garrels [in collaboration with C. McLaughlin,
University of California, Irvine, and Jonathan
Warner, Albert Einstein College of Medicine]
The yeast database includes studies of heat shock,
mRNA splicing, and amino-terminal acetylation.
During 1991, we analyzed an experiment in col-
laboration with John Smith and Ulrich Teichert of
Massachusetts General Hospital to characterize a
methionine aminopeptidase (MAP1) mutant of bud-
ding yeast. A knockout of the MAP1 gene is not
lethal but might be expected to affect many of the
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same cellular functions as a knockout of the
NAT1IARD1 genes. The latter genes code for sub-
units of an N-acetyltransferase that recognizes
proteins only after removal of amino-terminal
methionine.
Some of the results of this study are shown in
Figure 3. On these gels, 64 of the known acetylated
(NA T//ARD/-modified) proteins can be scored.
These proteins are normally present in their fully
acetylated state, and the unacetylated precursors are
never detected on 2D gels. In the MAP1 mutant, 16
of the 64 acetylated proteins are only partially acety-
lated, and the remainder are fully acetylated. This
result indicates that other methionine aminopep-
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FIGURE 2 Some representative expression profiles for in-
dividual proteins during the fertilization to blastocyst
stages of mouse development. Each protein intensity is
expressed as parts per million (ppm) of total incorporation
of the radioactive label. The legends give spot numbers
and names when known. The samples are labeled by
hours relative to each stage of development, except for
EB (early blastocyst), EXB (expanded blastocyst), ICM
(inner cell mass), and TR (trophoblast).
tidases are present in cells but that these other ac-
tivities are insufficient in activity, or perhaps not
properly localized, for the complete methionine
removal of all NAT1/ARD1 target proteins. Other
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FIGURE 3 Yeast gels from wild-type, NAT1 (N-acetyl-
transferase), and MAP1 (methionine aminopeptidase)
mutants. Only a small region of the gels is shown. These
results show many of the spots affected by amino-terminal
acetylation and reveal that a fraction of the acetylated
spots are incompletely acetylated in the MAP1 mutant.
than these effects on acetylation, the MAP1 knockout
mutant has very little effect on the protein synthesis
pattern of the cell.
Further studies of amino-terminal modification
are planned in collaboration with Dr. Smith. Another
known acetyltransferase (NAT2 gene product) is
responsible for acetylation of proteins that retain
amino-terminal methionine (Met-Asp, Met-Glu, or
Met-Gln sequences). Actin is one of the substrates for
this transferase, but the fraction of proteins modified
by this protein is not yet known. The N-myristoyl-
transferase (NMT1 gene product) provides a modifi-
cation essential to the function of certain membrane-
associated proteins such as the Got protein (GPA1
gene product) of the mating pathway. Because myris-
toylation occurs only on amino-terminal glycine, this
modification also requires the action of a methionine
aminopeptidase. It will be of great interest to identify
more of the particular proteins modified by each of
these enzymes.
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A Potential New Method of Protein
Identification
J.I. Garrels, G. Latter
We have been interested in the idea of protein identi-
fication by partial amino acid composition since the
first application of this method by Latter, Leavitt, and
colleagues (Electrophoresis 4: 122 [19831). If the rel-
ative composition of a few amino acids can be
determined accurately enough, proteins from the 2D
gels can be matched to known proteins from the
protein sequence databases. We have done simula-
tions for proteins of budding yeast because these cells
contain a relatively small number (5-6000) of genes
and because a relatively high (and rapidly increasing)
number of the genes have been sequenced. We find
that if amino acid ratios can be determined to an ac-
curacy of 3%, then only four ratios are needed to
identify most yeast proteins uniquely. If the amino
acid ratios can be determined to an accuracy of 1%,
then three amino acid ratios would be sufficient to
identify most yeast proteins.
To obtain highly accurate amino acid ratio data,
our strategy is to run gels of double-labeled samples,
using one 35S-labeled amino acid and one 14C-
labeled amino acid. Because the 35S label decays
with a half-life of 87 days, we can measure the rela-
tive amounts of the two isotopes in each pixel of the
image by plotting the rate of decay. The double-label
method should be much more accurate than compar-
ing integrated spot data from gels labeled with single
amino acids because no spot integration is necessary.
If film detection is used, the method is quite daunting
because of calibration and multiple exposure prob-
lems, but using the phosphorimager, which gives a
linear response over 4-5 logs of intensity, these prob-
lems disappear.
Our simulations show that weekly exposures over
a period of 2 months should give the required 1-3%
accuracy in the amino acid ratios.
This method also relies on the ability to align ac-
urately and compare images from separate ex-
posures, but such algorithms are already a part of the
QUEST system. If the simulations are borne out in
practice, it should be possible to identify many of the
proteins that are both detectable on 2D gels and prod-
ucts of sequenced genes. Although the simulation
was carried out for yeast, we also plan to apply the
method to the identification of proteins for the human
database.
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Human Regulatory Protein Sets
B R Franza
With the advent of the new QUEST system, We
bark on the coalescence of protein data from several
different human cell lines. We have accomplished the
identification of a number of transcriptional and cell
division cycle regulatory proteins in both T.
lymphoblast and B-lymphoblast cell lines. This is an
ongoing effort to identify and characterize nuclear
regulatory proteins as a component of the human
protein database. We have also studied the dif-
ferences in gene expression in matched pairs of
lymphoblast cell lines that contain either a normal
chromosomal complement or translocations specific
for different types of hematologic malignancy. This
work continues to be accomplished in collaboration
with Dr. Bayard Clarkson and his colleagues at
Memorial Sloan-Kettering. We have conducted an
extensive characterization of the gene products from
different class I major histocompatibility alleles in an
extensive family of lymphoblast cell lines derived by
mutagenesis of a parent B- lymphoblast cell. These
studies are performed with Dr. Robert De Mars at the
University of Wisconsin. We are extending our
studies with Dr. De Mars to the characterization of the
proteosome complexes in human lymphoblast cell
lines. We also have a number of studies of normal
human peripheral lymphoblasts that will be entered
into the database.
We therefore now have the means to bring all of
these data into a network-based, computer-accessible
system that will permit the study of quantitatively
and/or qualitatively analyzed sets of cellular proteins.
During the next 12 months, we will begin assembling
the sets of oncogene, transcription control, cell divi-
sion cycle control, MHC I, and other identified
proteins into this distributable system. We will use
the coordinate system published for REF52 cells
(Garrels and Franza, J. Biol. Chem. 264: 5283
[19891) to provide for continuity of assignments of
alphanumeric designators to proteins identified to be
conserved between the two species, and we will be-
gin making similar assignments to the mouse protein
products that we demonstrate to be conserved.
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GENETICS
Since the days of the "phage" group, genetic approaches to biological problems
have provided a conceptual and technical cornerstone to the work at Cold Spring
Harbor Laboratory. The revolution brought about by recombinant DNA methods
has its roots in molecular genetic methodology and now leads us to the dawn of
a true era of genetic engineering. Where this will lead is not totally clear, but cur-
rent developments in DNA fingerprinting of individuals and genetic therapy for
disease states give a faint hint of the future. This section describes the work of
the geneticists at Cold Spring Harbor.
EUKARYOTIC CELL CYCLE CONTROL
D. Beach S. Allan
J. Bischoff
M. Caligiuri
D. Casso
T. Connolly
G. Cottarel
S. Davey
D. Demetrick
H. Feilotter
K. Galaktionov
I. Garkavtsev
C. Gawel
J. Hofmann
C. Jessus
N. Kaplan
D. Lombardi
K. Lundgren
T. Matsumoto
T. Mizukami
L. Molz
During the last year, we have continued our work on
the eukaryotic cell cycle. Use was made of genetic
models such as the budding and fission yeast, in addi-
tion to mammalian tissue-culture cells. Furthermore,
1991 marked the year in which the fission yeast
genome project became firmly established at Cold
Spring Harbor Laboratory.
During the course of the year, Ulrich Deuschle
left to take a position with the Basel Institute for Im-
munology in Switzerland. We were joined by Doug
Demetrick (visiting clinician scientist), Nancy
Kaplan (technician), and several postdoctoral fellows,
Koji Okamoto, Johannes Hofmann, and Hui Zhang.
Activation of cdc2 at Mitosis
N. Walworth, D. Beach
The regulation of the activity of p34cdc2 in fission
yeast is dependent on both complex formation of
p34cdc2 with the product of cdcl3 and phosphoryla-
tion of p34cdc2 on threonine and tyrosine residues.
Tyrosine phosphorylation of p34cdc2 prevents entry
into mitosis and is dependent on the products of the
mikl and wee] genes. Simultaneous loss of function
of mikl and weel results in premature advancement
B. Nefsky
K. Okamoto
A. Tesoro
N. Walworth
Y. Xiong
H. Zhang
into mitosis, leading to cell death. A genetic screen
was set up to identify suppressors of this lethal
mitotic phenotype and cold-sensitive alleles of cdc2
were found. These alleles permit the cell to survive
without functional mikl and weel, but themselves
lead to a cell division cycle defect at low tempera-
ture. Multi-copy expression of cdc13, a B-type cyclin
which is known to associate with p34cdc2, suppresses
the cold-sensitive growth defect of these cdc2 alleles.
Weak suppression results from overexpression of
cdc25, which is thought to encode a tyrosine phos-
phatase. A genomic library prepared from Schizosac-
charomyces pombe DNA has been introduced into
two of these cdc2 strains and high-copy suppressors
have been identified. Molecular analysis of the sup-
pressors is under way and should elucidate additional
mechanisms which regulate p34cdc2 activity.
Human D-type Cyclin
Gene Family
Y. Xiong, T. Connolly, D. Beach [in collaboration
with B. Futcher, Cold Spring Harbor Laboratory]
There have been several major developments in the
study of mammalian cell cycle in the past year. Three
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new classes of mammalian cyclins, C, D, and E, were
isolated using a genetic complementation screening
procedure.
Following the isolation of human cyclin D1 gene
last year, we have cloned two additional human D-
type cyclin genes, cyclin D2 and D3. All three human
D-type cyclins encode small (33-34 kD) proteins that
share an average of 57% identity over the entire
coding region and 78% in the cyclin box. The D-type
cyclins are most closely related to cyclin A (39%
identity) and cyclin E (36%), followed by cyclin B
(29%) and cyclin C (21%). The appearance of cyclin
D1 mRNA and protein after serum stimulation is
very early (e.g., 2-5 hr in human A431 cells), sug-
gesting that it may function in the Go/G1 transition or
early G1 phase of cell cycle. We are currently con-
ducting an experiment to search for the genes whose
products interact with D-type cyclins. In a series of
Northern analyses, we found that, unlike cyclin A
and cyclin B genes, which appear to express at a
similar level in different cell types, levels of different
cyclin D gene mRNAs could be dramatically dif-
ferent in different cell types. This suggests that indi-
vidual members of the cyclin D gene family may
function in specific tissues. In a separate line of ex-
periments, we have isolated and characterized the
genomic structure of three cyclin D genes. All three
cyclin D genes are interrupted by an intron at the
same position. We also found two pseudogenes cor-
responding to cyclin D2 and D3, respectively. Se-
quence analysis of the promoter region suggests
several potential regulators of cyclin D gene tran-
scription, some of which are currently being tested.
In a collaboration with Dr. Ward of Yale University,
we have mapped cyclin D2 to chromosome 12p band
p13 and cyclin D3 to chromosome 6p band p21.
Ongoing experiments test the possible involvement
of cyclin D2 and D3 in those neoplastic transforma-
tions that were previously found to be linked to these
chromosomal locations.
Cell Cycle Checkpoints
T. Matsumoto, H. Feilotter, D. Beach
Mitosis normally follows the completion of DNA
replication. Premature initiation of mitosis without
completion of DNA replication will result in lethality
as daughter cells lack the normal complement of ge-
netic information.
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We have investigated a number of genes involved
in regulation of this interdependency of mitosis and
DNA synthesis. The piml gene encodes a homolog of
the mammalian RCC1 gene. Loss of function of
iRCC1 also causes cells to go into mitosis before the
completion of DNA replication, suggesting func-
tional conservation of the gene. A gene known as
spil, which can rescue a piml mutant when carried
on a multicopy plasmid, encodes a 25-kD GTPase,
whose homolog was also found in mammalian and
plant systems. The spil GTPase and its human
homolog together define a novel class in the ras-like
GTPase family, whose members have a common
molecular structure and may act as molecular
switches in signal transduction pathways. It is ex-
pected that the fission yeast piml and spil gene prod-
ucts act in a manner similar to their homologs in
higher eukaryotes.
At least four other genes whose products appear
to play a role on the piml /spil regulatory pathway
have been identified as conditional mutations that
cause premature entry into mitosis in the absence of
DNA synthesis. One of these has been identified as a
mutation in the spil gene itself. Another encodes one
of the two type-1 phosphatase genes of fission yeast.
A biochemical approach to study the function of
piml and spil has suggested that the piml product
converts the spil GTPase into an active form that is
GTP-binding and that mutation of the piml gene
reduces this activity. This may suggest that the active
form of the spil GTPase causes an inhibition of
mitotic events until DNA replication is completed.
The pathways by which such a signal is received or
by which such inhibition is achieved are unknown,
but the biochemical interaction of some of the other
genes on this pathway (i.e., a type-1 phosphatase)
may shed some light on this question.
A Gene Interacting with the cdc2
Protein Kinase of Fission Yeast
L. Molz, D. Beach
MPF (M-phase promoting factor) is an activity
regulating entry into mitosis in eukaryotic cells.
Homologs of the fission yeast cdc2 protein kinase
comprise the catalytic subunit of MPF. Activity of
the cdc2 protein kinase is regulated by both
phosphorylation and association with regulatory sub-
units termed cyclins. We have characterized mutants
from a genetic screen designed to identify new
regulators or substrates of the cdc2 protein kinase.
We isolated mutations (mcs mutations) that suppress
the lethality of a strain carrying a dominant cdc2
mutation. A genetic analysis revealed that the mcs
mutations define six new genes that are not alleles of
previously identified mitotic control genes. Many of
the mcs mutations interact in novel ways with alleles
of the known mitotic control genes. The details of the
genetic interactions have been previously published.
One of the mcs mutations (mcs2-75) displays striking
allele-specific interactions with various alleles of
cdc2. These allele-specific interactions suggest that
the mcs2 and cdc2 gene products may interact.
The genetic analysis suggests that mcs2 may in-
teract closely with cdc2, and therefore we wished to
characterize this gene further. mcs2 was cloned by
complementation of the mcs2-75 mutation. While
cloning mcs2, we also recovered a gene suppressing
the mcs2-75 defect, but which was unlinked to the
mcs2 locus. Both mcs2 and the suppressor were se-
quenced and examined for homologies with proteins
in databases. mcs2 encoded a 37.5-kD protein that
displayed weak homologies with cyclins, known
regulatory subunits of the cdc2 protein kinase. The
mcs2 suppressor encoded a 34.5-kD putative protein
kinase. We further examined the role of mcs2 and the
suppressor in the S. pombe cell cycle by creating null
mutations using the gene-replacement method.
Strains carrying the mcs2 null mutation formed mi-
crocolonies of inviable cells arrested late in mitosis.
Cells have multiple division septa and nuclei contain-
ing condensed chromosomes. This phenotype is in-
dicative of an arrest point late in mitosis and is very
different from the phenotype of null mutations of
other cloned cyclins in S. pombe. Finally, strains car-
rying a null allele of the mcs2 suppressor were viable,
displaying no dramatic cell cycle defect.
To investigate the role of these genes in the S.
pombe cell cycle further, we have produced poly-
clonal antibodies against mcs2 and the mcs2 suppres-
sor proteins expressed in Escherichia coli. We have
also generated a monoclonal antiserum to these gene
products by using the epitope addition method. West-
ern blotting experiments using these reagents reveal
that neither mcs2 nor the rncs2 suppressor proteins
oscillate in abundance during the S. pombe cell cycle.
We are currently using these reagents to investigate
the possibility that mcs2 may be a subunit or a sub-
strate of either the cdc2 or the mcs2 suppressing
protein kinases.
Activation of cdc25 Tyrosine
Phosphatases by Cyclins
K. Galaktionov, C. Jessus, D. Beach
In eukaryotic cells, mitosis is initiated following the
activation of a protein kinase known as MPF, the M-
phase-specific histone kinase, or more simply as the
M-phase kinase. This kinase consists of at least three
subunits; the catalytic subunit (cdc2), a regulatory
subunit (cyclin B), and a low-molecular-weight sub-
unit (p13-Sucl). The cyclin B/cdc2 enzyme is subject
to multiple levels of control. Among these, the
regulation of the catalytic subunit by tyrosine
phosphorylation is the best understood. Tyrosine
phosphorylation inhibits the cyclin B/cdc2 enzyme,
and tyrosine dephosphorylation, which occurs at the
onset of mitosis, directly activates the pre-MPF com-
plex. The cdc2 tyrosine kinases are encoded by two
genes, initially identified in fission yeast and known
as weel and mikl . The cdc25 gene serves as a rate-
limiting mitotic activator. The cdc25 gene is normal-
ly essential for cell division, except in the absence of
the weel and mik 1 tyrosine kinases. Increasing evi-
dence suggests that cdc25 serves as the cdc2 tyrosine
phosphatase. A human cdc25 gene has previously
been described. We assumed that more than one such
gene is likely to exist and therefore designed a
polymerase chain reaction (PCR)-based strategy to
isolate further potential members of the family. Using
this strategy, we isolated two previously undescribed
human cdc25 genes, namely, cdc25A and cdc25B.
Both human cDNAs could efficiently rescue the
temperature-sensitive mutation of the cdc25 gene in
the fission yeast. Human cdc25 A protein had an
endogenous tyrosine phosphatase activity that was
activated by the mitotic cyclins, but not cyclin A or
Dl. Another observation pointing in the same direc-
tion was made during the course of a visual com-
parison of cdc25 A and B with known tyrosine
PTPases and other proteins involved in cell cycle
control (Fig. 1). First, the region of cdc25 that is im-
mediately carboxy-terminal to the putative catalytic
domain (CA) is not highly related to other known
PTPases, such as cytoplasmic PTPases from higher
eukaryotes and the vaccinia virus serine-tyrosine
phosphatase (VH-1). More interestingly, this region
within the PTPases was found to contain sequence
similarity to cyclins, particularly of the B-type (Fig.
1). The similarity is detected immediately at the junc-
tion of the so-called cyclin box and included some
nearly invariable residues among cyclins. In the
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FIGURE 1 (A) Alignment of the cdc25 proteins, PTPases, and cyclins. (B) Model. (A) Tyrosine
phosphatases were aligned with each other and with cyclins and cdc25 proteins. The cyclin align-
ment was done by visual inspection. Only identity or similarity (V or I) within at least three members
of one gene family and a minimal of two members of another family is boxed. CA indicates the
putative catalytic domain of the cdc25 and cytoplasmic tyrosine phosphatases, and CR indicates
the cyclin related domain, present in tyrosine phosphatases but absent in cdc25 proteins. (B)
Schematic representation of a hypothetical relationship between PTPases, M-phase kinase, and
cdc25 phosphatase. The association between cdc2 and p13, and between cyclin and cdc2, is
well documented. The interaction of cdc25 and cyclin is proposed here. p13 is proposed to have
a low-affinity interaction with cdc25. CA is the catalytic domain of PTPases and CR is a region of
similarity between PTPases and cyclins. (Reprinted, with permission, from Galaktionov and Beach1991, copyright by Cell Press).
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region of similarity between PTPases and cyclins that
we call the cyclin region (CR), there is no equivalent
in the cdc25 proteins.
The newly found motif lies almost immediately
adjacent to the domain (V/IXHCXXXXR) that has
been directly implicated in the catalytic function of
the PTPases and cdc25 protein. The finding allows
the following speculation. The catalytic activity of
the other PTPases is considerably greater than that of
cdc25. cdc25 lacks the motif that is shared by cyclins
and other PTPases. This motif may be an activating
domain, which is functioning in "cis" in most
PTPases, but in the case of cdc25, it is provided in
"trans" by intermolecular interaction with cyclin
(Fig. 1).
Genes That Interact with
Human p53
J. Bischoff, D. Casso, D. Beach
Mutations in the p53 gene are the most frequent ge-
netic alteration in human cancer. In normal cells, p.53
probably acts as a negative regulator of the cell cycle,
since overexpression of the wild-type protein, in
some cell types, results in a block in the G1 phase of
the cell cycle.
We have set up a simple system in the fission
yeast S. pombe to study human p53. The overexpres-
sion of wild-type human p53 blocks growth in S.
pombe. We believe that this is a specific effect, since
the overexpression of mutant p.5.3 polypeptides in S.
pombe does not block growth.
To identify genes that interact with p5.3, an S.
pombe strain was constructed that possesses a single
chromosomal copy of a wild-type human p53 cDNA
under the control of an inducible promoter. cDNAs
could then be introduced into this strain and screened
for their ability to suppress the negative growth effect
of wild-type p53. To determine if this type of screen
was feasible, we introduced nine mutant alleles of hu-
man p53 into this strain with the hope of identifying
dominant negative mutations in the p53 gene. Two of
the nine p.5.3 mutants were found to be dominant to
the wild-type gene. One had previously been clas-
sified as dominant and the other was a newly identi-
fied dominant allele of human p.5.3. More than
500,000 transformants from a human cDNA library
have been screened in this strain. So far, one partial
cDNA has been isolated that can relieve the p53-
induced growth arrest in S. pombe. This cDNA has
no effect on the level of expression of p53 and does
not appear to physically associate with p.53. Sequence
analysis of the cDNA does not reveal any significant
homology with any genes in the usual sequence data-
bases. The putative coding region does, however,
have at least five potential calcium-binding pockets
(EF hands). We are currently isolating a full-length
cDNA of this possible p53 suppressor.
Another approach we have taken to identify genes
that interact with p.53 has been to mutagenize chemi-
cally the strain mentioned above in order to isolate
extragenic suppressors of p.5.3. Several strains have
been isolated that can tolerate the overexpression of
wild-type p53. These strains are now being character-
ized.
Fission Yeast Genome Mapping
T. Mizukami, I. Garkavtsev, N. Kaplan, T. Matsumoto,
D. Lombardi, D. Beach [in collaboration with Tom Marr's
group, Cold Spring Harbor Laboratory]
A fivefold representation cosmid library was pre-
pared for the physical mapping of the fission yeast
with multiple
DNA probes that allow contiguous clones (contigs) to
be assigned. The objective of this work is to create a
high-resolution (-10 kb) map of the 14-megabase fis-
sion yeast genome. At the time of writing (February,
1992), essentially the entire genome has been as-
sembled into approximately 50 contigs. Second-
round strategies are being employed to reduce this
figure to three chromosome-sized contigs. In addition
to the linking of clones in contigs, we are generating
a Pstl and BamHl restriction map of the genome that
will aid in the eventual nucleotide sequencing of the
genome of the fission yeast.
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PRE -MRNA PROCESSING AND SMALL NUCLEAR
RNA SYNTHESIS IN FISSION YEAST
D. Frendewey D. Kim
M. Gillespie
A Gene Encoding an RNase Can
Complement a Mutant
Defective in snRNA Synthesis
M. Gillespie, D. Frendewey
A few years ago, we isolated a temperature-sensitive
(ts-) mutant that maintained a reduced steady-state
content of several small nuclear RNAs (snRNAs), in-
cluding the spliceosomal RNAs Ul, U2, U4, U5, and
U6 and the RNA subunit of the tRNA processing en-
zyme RNase P. We named this mutant snml to indi-
cate a defect in snRNA maintenance. When shifted to
the restrictive temperature (37°C), snml also ac-
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cumulates aberrantly large U2 and U4 RNAs, which
are extended at their 3' ends, and an unspliced U6
RNA precursor. A single recessive mutation is
responsible for the ts- growth and snRNA pheno-
types.
To appreciate the nature of the defect in snml ful-
ly, it is necessary to understand how a wild-type fis-
sion yeast strain responds to a change in growth from
23°C to 37°C. When a normal Schizosaccharomyces
pombe culture growing at 23°C is shifted to 37°C, the
culture quickly assumes a new growth rate that is
about twice that at 23°C. Stated another way, the gen-
eration time decreases from approximately 5 hours at
23°C to 2.5 hours at 37°C. We showed that the
elevated growth rate is accompanied by a two- to
fivefold increase in the steady-state content of the
major snRNAs. The snml mutant exhibits a "leaky"
temperature-sensitive growth phenotype; when shift-
ed to the restrictive temperature, it continues to grow
at approximately the same rate as it was growing un-
der the permissive conditions. Therefore, at 37°C, the
growth rate of the snml mutant is about one half that
of the wild type. The effect of temperature shift on
snRNA content in snml correlates with growth rate;
we observe no difference in snRNA levels in snml
grown at either 23°C or 37°C.
Two possible explanations are suggested by the
snml mutant phenotype: either (1) the inability of
snml to increase its net snRNA synthesis in response
to a shift to 37°C is the cause of the ts- growth im-
pairment or (2) the reduced snRNA content in snml
relative to the wild type is only a symptom of a more
general defect in growth rate control that prevents
faster proliferation at 37°C.
To try to learn more about the connection be-
tween snRNA synthesis and growth rate control, we
attempted to clone the snm1+ gene (the normal ver-
sion of the gene mutated in the snml mutant) by
complementation of the ts- growth defect in snml.
The mutant was transformed with a library of S.
pombe genomic fragments carried on a multicopy
plasmid, and temperature-resistant (ts+) transformants
were selected for their ability to grow well at 37°C.
We obtained six ts+ transformants from two indepen-
dent transformation experiments, and plasmid DNA
was isolated from the ts+ clones and recovered in Es-
cherichia coli. Restriction analysis of the clones
showed that five of the six were related; they shared a
3.2-kbp Hind!!! fragment. The sixth clone had a
unique restriction map, and the ts+ yeast transformant
from which it was derived grew much slower at 37°C
than the other five. We have completed the analysis
of one of the clones with the common 3.2-kb Hind!!!
fragment. A 2.2-kb subclone was sufficient to trans-
form snml to rapid growth at 37°C, and its sequence
was determined. A single long open reading frame
was found. To our surprise, this gene had been cloned
by two other groups, one being Mike Wigler's
laboratory (Xu et al., Nucleic Acids Res. 18: 5304
[1990]; see the 1990 Annual Report) at Cold Spring
Harbor Laboratory. The gene was also cloned by
Yamamoto's group in Tokyo (lino et al., EMBO J.
10: 221-226 [1991]).
The gene we have all cloned encodes a protein of
363 amino acids that over its carboxy-terminal two
thirds shares 25% amino acid identity with E. coli
RNase III, including a stretch of 11 identical amino
acids. RNase III is a ribosomal RNA processing en-
zyme in E. coli that also plays a role in mRNA
stability. It is interesting that a mutation that disrupts
RNase III function in E. coli lies within the region of
11 amino acids shared by the yeast and bacterial en-
zymes (Nashimoto and Uchida, Mol. Gen. Genet.
201: 25-29 [1985]). The Wigler laboratory cloned
the putative S. pombe RNase III homolog by virtue of
its ability to cause sterility when present at high copy
number. They named the gene hcs for high-copy
sterile. Yamamoto and his colleagues cloned the gene
as a high-copy suppressor of the pat1 mutant (also
known as rani), which is an inducer of uncontrolled
meiosis, and gave it the name pacl+. They also
demonstrated that pacl+ has double-strand ribo-
nuclease activity when expressed in E. coli and
referred to the S. pombe protein as Pac 1 RNase.
These results indicate a role for the Pac 1 RNase in
mating and sporulation.
How can we reconcile our cloning of pacl+ as a
gene that can complement the snml mutation? Larger
than normal U2 and U4 RNAs accumulate in snml,
perhaps indicative of a defect in snRNA processing.
The Pac 1 RNase might be an snRNA processing
nuclease or it may be able to compensate for loss of
the normal enzyme. Alternatively, our results could
imply a connection between the control of snRNA
synthesis and the switch between vegetative growth
and the mating/sporulation pathway.
PLANT GENETICS
V. Sundaresan
R. Martienssen
T. Peterson
P. Athma E. Grotewold
A. Baron C.-D. Han
J. Colasanti A. Jahrsdoerfer
Evolution of an Intron by
Transposable Element
Insertion
V. Sundaresan, J. Colasanti [in collaboration with
Z.-Y. Zhao, Pioneer Hi-Bred International]
Last year, we described the isolation and character-
ization of a pseudo-revertant allele of the Bronze]
(Bzl) gene of maize. This allele was derived from a
mutable bronze] allele, bz Mum9, that carried an in-
sertion of the Mul transposable element. The deriva-
tive allele conferred full purple color to kernels, but
molecular analysis showed that it still carried about
two thirds of the Mul element. We also found that
the mRNA transcribed from the Bzl promoter was
spliced using donor and acceptor sites within Mu] to
eliminate most of the Mu] sequences from the
spliced transcript; the splicing of the Mu] sequences
maintained the reading frame of the Bz] protein. We
have now demonstrated, by functional complementa-
tion of a bz] mutant in a transient expression system
using particle bombardment, that the spliced tran-
script that we had previously identified encodes a
functional Bzl protein as predicted. Furthermore, we
have shown that the new Bzl allele is stable, is under
the same regulation as the wild-type Bz] gene, and is
not regulated by the activity or the methylation state
of the Mu transposable element system, i.e., the new
Bz] allele is genetically indistinguishable from a
wild-type Bzl gene, and can only be distinguished
molecularly. Therefore, the Mu] sequence in this Bz]
allele behaves like a new intron. Since the discovery
of introns, the question of whether they are "old" or
"new" has been extensively debated. There is now
considerable evidence suggesting that many nuclear
introns are ancient and pre-date the divergence of
plants and animals. Our observations demonstrate
that although most nuclear introns are likely to be
old, the evolution of new introns by transposable ele-
ment insertion can also occur.
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A. Yonetani
Insertional Mutagenesis of Arabidopsis
thaliana Using Gene Trap and
Enhancer Trap Transposons
V. Sundaresan, R.A, Martienssen, P. Weinberg,
A. Baron [in collaboration with H. Ma, Cold Spring
Harbor Laboratory, and J.D.G. Jones and C. Dean,
John Innes Institute, United Kingdom]
To identify and isolate genes that control the devel-
opment of higher plants, we are developing a tech-
nique for efficient insertional mutagenesis of the
model plant Arabidopsis thaliana, using the maize
transposable element Ac. Our approach has two fea-
tures that constitute improvements over existing ap-
proaches: (1) the utilization of engineered trans-
posons carrying a reporter gene (gus) such that inser-
tions of the transposon into a target gene will result in
expression of the reporter gene under the develop-
mental control of the target gene, either directly by
gene fusions ("gene traps") or indirectly by enhancer
action ("enhancer traps") and (2) the development of
a selection scheme that will select for unlinked
transpositions.
The flowering plant A. thaliana has become a
model organism for the study of plant biology for
several reasons. Arabidopsis is a diploid, with a well-
developed genetic map, a short generation time al-
lowing up to six generations a year (vs. two for
maize), and small plant size (6 in. vs. 6 ft. for maize),
allowing thousands of plants to be grown and
screened within a limited space. It also has a small
genome (7 x 107 by vs. 3 x 109 by for maize) with a
low repeated DNA content, and transgenic plants can
be generated using Agrobacterium. However, one
major obstacle has remained in making Arabidopsis a
versatile model genetic system for plants (e.g., as
Drosophila is a model system for animals), i.e., the
lack of an efficient insertional mutagenesis system to
identify and isolate genes of interest.
To address this problem, we are developing a
transposon mutagenesis scheme for Arabidopsis. Our
scheme utilizes a two-element system, in which
transgenic Arabidopsis plants carrying an immobil-
ized (or "wings clipped") Ac element will be crossed
to plants carrying a Ds element (a nonautonomous Ac
element) containing the gus reporter gene. The im-
mobilized Ac element lacks the Ac termini, and there-
fore cannot transpose, but can supply transposase
constitutively. The particular construct we will use
(provided by Drs. J. Jones and C. Dean) carries a
small deletion of GC-rich sequences in the un-
translated leader of the transposase gene, as well as a
strong 35S promoter to drive transcription of the
transposase gene. These modifications result in in-
creasing the germinal transposition frequency of a Ds
element in Arabidopsis to 10-50%, i.e., transposi-
tions occur in one tenth to one half of the progeny of
a plant carrying both this modified Ac element and a
tester Ds element. Ds elements contain a deletion of
the transposase gene but have intact termini; there-
fore, they can transpose when transposase is provided
by an Ac element. In our case, the Ds elements are
engineered so that they also carry the gusA reporter
gene and a kanamycin resistance (KanR) gene. The
gusA (f3-glucuronidase) gene is an Escherichia coli
gene widely used in plant systems as a histochemical
marker instead of lac; most plants show considerable
background activity with lac, but essentially no back-
ground gus activity. For the enhancer trap vector, the
gus gene will have a promoter with a TATA box, but
without an enhancer. Therefore, expression of the gus
gene will depend on the Ds element landing near a
cellular enhancer. For the gene trap vector, the gus
gene is preceded by a triple splice acceptor sequence
(containing three adjacent plant splice acceptor se-
quences in different reading frames) inserted immedi-
ately upstream of the ATG start codon. Therefore, in-
sertion into an intron will generate an in-frame fusion
50% of the time, leading to a fusion protein express-
ing gus activity. It is known that such gus fusions are
active and localize intracellularly according to the
targeting signals present on the fused gene. In addi-
tion, we will utilize endogenous splice-donor sites
within Ds located at 14, 24, and 28 by from one end
of the Ds element, so that insertion into an exon can
also generate an in-frame fusion after the intervening
190 by of Ds sequence is spliced out (the length of
the Ds terminus is approximately 210 bp). All of the
elements described above, i.e., the immobilized high-
efficiency Ac element, and the gene trap and enhan-
cer trap Ds elements carrying the suitably engineered
gus reporter gene as well as the gene for KanR, have
been constructed. Furthermore, both the enhancer
trap and gene trap Ds elements have been tested
using transient assays with the particle gun to con-
firm that (1) the enhancer-trap element results in gus
expression from a nearby enhancer sequence and (2)
the gene-trap element results in gus expression when
inserted into a transcribed DNA sequence. For the
latter, we also verified using various constructions
that all three splice-acceptor sequences of the
synthetic triple splice-acceptor sequence were util-
ized and that the endogenous Ds splice-donor se-
quences at the element function as expected. The Ds
elements have been inserted into T-DNA vectors.
These vectors are used for delivery of DNA to plants
using Agrobacterium. In all cases, the T-DNA vec-
tors carry the IAAH (indole acetic acid hydrolase)
gene, which will be used as a dominant marker for
negative selection. When seedlings carrying the
IAAH gene are germinated on medium containing the
auxin analog NAM (naphthalene acetamide), they
wilt and do not grow due to the conversion of NAM
to toxic levels of naphthalene acetic acid. Seedlings
not carrying this gene are unaffected. In the case of
the immobilized Ac element, the T-DNA vector car-
ries the KanR gene in addition to the IAAH gene. The
T-DNAs carrying the engineered transposons have
been introduced into Arabidopsis by Agrobacterium-
mediated root transformation. KanR calli were
selected, and transgenic plants have been generated
and propagated (see report by Hong Ma in this Sec-
tion). We are currently characterizing the transgenic
lines prior to initiating large-scale mutagenesis.
Intracellular Localization of p34cdc2
Kinase during the Plant Cell Cycle
J. Colasanti, V. Sundaresan
A significant difference between mitosis in plant cells
and animal cells is the determination of the plane of
cell division. Plant cells, unlike animal cells, are en-
closed in a cell wall structure and cannot migrate.
Therefore, the planes of cell division during cell
proliferation are extremely important in plant mor-
phogenesis, and organ initiation is often accompanied
by a change in the plane of cell division, e.g., from
anticlinal to periclinal. What initially determines the
plane of cell division of a given cell is not known, but
some knowledge of the process of determination is
available from extensive studies of the cytoskeleton
FIGURE 1 A maize root tip cell approaching mitosis,
stained with DAPI, showing some chromosome condensa-
tion (top), and p34cdc2 antibody, showing both nuclear
and preprophase band localization of p34cdc2 (bottom).
(The dark region within the nucleus is the nucleolus.)
in dividing plant cells. Immediately before entry into
M phase (at "preprophase"), there appears a belt of
microtubules, called the preprophase band, that
anticipates the division plane and marks the site
where the new cell plate will fuse with the cell walls.
By metaphase, the preprophase band completely dis-
appears. At telophase, however, residual polar micro-
tubules form a structure at the plane of the pre-
prophase band, called the phragmoplast. Golgi
vesicles filled with cell-wall precursors accumulate at
the center of the phragmoplast to form the beginning
cell plate, which expands until it contacts the side
walls at the position of the original preprophase band.
Thus, the plane of cell division is determined at
preprophase, but somehow imprinted until telophase.
The mechanism of this "imprinting" has not been es-
tablished.
We have used an antibody against the functional
homolog of the cdc2 kinase from maize to localize
the p34cdc2 protein within the plant cell through the
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cell cycle. The cytoskeletal structure of plant cells
was visualized concomitantly with monoclonal
antibody specific for the a-tubulin subunit. At inter-
phase, antibody staining localized the cdc2 protein to
the nucleus of the cell, although it was excluded from
the nucleoli. During metaphase and anaphase, the
cdc2 protein was generally diffused throughout the
cell, although there was a higher concentration of
staining in the region surrounding the chromosomes,
with the chromosomes themselves excluded from
staining. In cells at early prophase, a subpopulation
protein was transiently distributed as aof p34cdc2
band bisecting the nucleus (Fig. 1). Triple staining
with anti-cdc2, anti-tubulin, and DAPI revealed that
this band colocalized with the preprophase band of
microtubules. The cdc2 protein did not, however,
colocalize with other microtubular structures, i.e.,
neither the spindle nor the phragmoplast. Cells in
which the microtubules were disrupted with oryzalin
had no band of cdc2 in early prophase, suggesting
that the preprophase band may be involved in
positioning the cdc2 kinase at this position. Associa-
tion of p34cdc2 protein with the preprophase band at
the G2/M transition of the cell cycle, when cdc2
kinase activity is expected to be maximal, suggests
that the cdc2 kinase of higher plants is involved in
setting the plane of cell division.
Isolation of New Alleles of
anther ear and indeterminate
J. Colasanti, V. Sundaresan
We have taken advantage of the proximity of a Ds2
element at the bz2 locus (bz2-m2) on chromosome 1
to isolate new alleles of the closely linked in-
determinate (id) and anther ear (anl) genes by
transposon tagging. In the first set of crosses, plants
homozygous for the bz2-m2 allele and carrying an ac-
tive Ac element were crossed to anlbz2 homozygous
plants. These plants carry a large deletion that in-
cludes both the and and bz2 loci. Germinal revertant
kernels (i.e., bz2-m2 to Bz2) from the Fl of this cross
were planted and screened for semi-dwarf plants typi-
cal of the anther ear phenotype. One plant, from 650
purple kernels planted, that exhibited this phenotype
was selfed and outcrossed. Genetic experiments
showed that this mutant is allelic to and and that an
active Ac element did not segregate with the original
mutant. The outcross progeny from this plant were
found to carry a 4.3-kb Ds2-hybridizing BamHI band
that cosegregates with the semi-dwarf phenotype.
Plants from the original screen of germinal
revertants were also selfed and subsequently screened
for other potential Ds2-induced recessive mutations.
From 600 families screened, one family segregated
mutant plants with a phenotype typical of the id
mutation. These plants flowered between 3 and 8
weeks later than their normal siblings and exhibited
other characteristics of the id phenotype. However,
preliminary experiments with different light regimes
showed that short-day conditions did not reverse the
indeterminate effect. Alleles of id that do not respond
to day length have also been found by other investi-
gators (Burr and Szabo, Maize Genetics Newsletter
65: 110 [1991]). Thus, id mutants appear to be defec-
tive in the vegetative to inflorescence transition of the
meristem. In this respect, it differs from the mutants
floricaula in snapdragon and leafy in Arabidopsis
which are defective at a later stage, i.e., in the transi-
tion from inflorescence to floral meristem. Genetic
experiments show that our putative new id allele is
closely linked to Bz2. A search for a Ds2 element that
cosegregates with this phenotype, which would
permit us to clone the gene, is in progress.
encoded by our partial cDNA clones (which excludes
the sequences of the PCR primers), none of these
cyclins are clearly identifiable as homologs of animal
A- or B-type cyclins, although they have homologies
with both types. The homologies of these cyclins
with cyclin A and cyclin B range from 42% to 56%.
Cyclin 2 showed the greatest homology with cyclin A
(56% amino acid identity) and least with cyclin B
(48%), and cyclin 4 showed the greatest homology
with cyclin B (55%) and the least with cyclin A
(42%); cyclins 1 and 3 have intermediate values of
homology with both A and B. To summarize, we
have evidence for four distinct types of mitotic
cyclins in higher plants, which are not clearly A or B
cyclins, although related to both. Experiments are in
progress to distinguish between the four distinct types
of plant cyclins that we have identified and to
determine if any one or more can be classified as a
homolog of the known animal cyclins on the basis of
the expression pattern. It is possible that some of the
plant cyclins may resemble cyclin A or cyclin B in
terms of expression during the cell cycle or have a
unique expression pattern different from both, sug-
gesting novel functions distinct from both A- and B-
type cyclins.
Mitotic Cyclins in Higher Plants
J.P. Renaudin, V. Sundaresan
Although the key components of the cell division ma-
chinery in plants and animals are likely to be similar,
because of the different strategies used by plants to
control cell division, higher plants offer the chance to
study these same components in a very different con-
text. Considerable attention has been paid to cyclins
in animals and yeasts, but there is relatively little
known about cyclins in higher plants. In this
proposal, we have described experiments to charac-
terize further the putative mitotic cyclins that we
have identified in higher plants. We have used
polymerase chain reaction (PCR) to conserved
domains of animal and yeast mitotic cyclins to isolate
cDNA sequences encoding putative mitotic cyclins
from maize. We have found cDNAs encoding six dif-
ferent mitotic cyclins, which fall into four different
classes. We have termed them I a, lb, 2a, 2b, 3, and
4. Cyclins 1a and I b are very closely related (98%
identity), as are 2a and 2b. The homologies between
cyclins 1, 2, 3, and 4 range from 44% (for 1 and 2) to
65% (for 1 and 3). In the 48-amino-acid region that is
The Hcf106 Gene Product and Its
Role in Thylakoid Membrane
Biogenesis
A. Yonetani, A. Baron, R. Martienssen
High-chlorophyll fluorescence mutants of higher
plants represent a class of nuclear genes that are re-
quired for the development of photosynthetically ac-
tive chloroplasts. These mutants have near-normal
levels of chlorophyll pigments, so that they can
transiently absorb light energy but cannot utilize it in
photosynthesis. The energy is lost as elevated levels
of chlorophyll fluorescence, and hcf mutants die as
seedlings when seed reserves have been depleted. On
the basis of extensive mutagenesis in barley, maize,
and Chlamydomonas, more than 100 hcf genes are
thought to exist in higher plants and algae. Their
products may include nucleus-encoded components
of the photosynthetic apparatus, enzymes required for
the biosynthesis of various cofactors, and regulatory
genes required for the expression of the plastid
genome. Because of their effects on chloroplast mor-
phology, some hcf loci are thought to encode proteins
required for the correct assembly and organization of
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the thylakoid membrane system itself, which is the
site of the primary photosynthetic reactions. These
gene products might include factors required for
protein uptake and assembly, membrane biogenesis
within the organelle, and protein modifications re-
quired for proper thylakoid function and assembly.
Maize seedlings homozygous for the hcf106
mutation have altered thylakoid membrane composi-
tion and morphology. Specifically, the three major
thylakoid electron transport protein complexes
(photosytems I and II and the cytochrome f/b6 com-
plex) are present at severely reduced levels (5-10%
wild type), whereas other thylakoid complexes, and
several soluble proteins, are unaffected. The
thylakoid membranes have lost their characteristic
lateral heterogeneity, and form large whorled struc-
tures instead. The lipid and pigment composition of
mutant membranes is near normal, and nonallelic
mutants of maize that have similar lipid and pigment
profiles do not have aberrant membrane morphology.
This suggests that the gene product is not directly in-
volved in lipid or pigment biosynthesis.
As we reported last year, cDNA encoding the
hcf106 gene product has been cloned using molecular
probes from the locus obtained by transposon tag-
ging. The cDNA sequence encodes a 243-amino-acid
(27 kD) polypeptide with a single membrane-
spanning domain, a potential nucleotide-binding
motif, and no other significant homology with known
proteins. We have raised antibodies against TrpE fu-
sion proteins, and these detect a 30-kD protein in
leaves of wild-type, but not of mutant, plants.
Coupled in vitro transcription and translation of the
cDNA produces a protein that migrates aberrantly as
a 35-kD band on SDS gels and can be specifically
immunoprecipitated with the anti-Hcf106 sera. We
conclude that the precursor is processed to a faster
migrating form in vivo.
The 30-kD protein is quantitatively recovered
(relative to chlorophyll) from purified wild-type
chloroplasts and is found predominantly in low-speed
thylakoid membrane pellets. However, some of the
protein is in a high-speed membrane fraction charac-
teristic of chloroplast envelopes. Immunofluores-
cence using the same antibody detects a protein in
purified chloroplasts that seems to be localized in
both peripheral (envelope) and internal (thylakoid)
membranes. If the Hcf106 protein is localized in both
envelope and thylakoid membranes, this unusual dis-
tribution may reflect a role in membrane biogenesis.
Biochemically, attempts to demonstrate ATP
binding have so far been unsuccessful, but the aber-
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rant migration on SDS gels might be the result of
protein modification. The predicted protein sequence
contains at least four possible sites for phosphoryla-
tion via the major thylakoid membrane protein
kinase, which is responsible for modifying the light
harvesting complex chlorophyll-a/b-binding proteins.
Preliminary results suggest that this kinase is highly
active in mutant membrane preparations as well as
wild type. However, as expected, the major photo-
system II phosphoproteins are severely reduced in
hcf106.
The Molecular Nature of the iojap
Mutation in Maize
C.-D. Han, R. Martienssen [in collaboration with E.H. Coe,
USDA-ARS, University of Missouri]
The maize mutant iojap (ij) has been a model system
in the study of nucleus-plastid interactions in higher
plants since the work of Jenkins (1924) and of
Rhoades (1943). Plants homozygous for this nuclear
mutation have variegated leaves and transmit defec-
tive chloroplasts through their female gametes.
Maternally inherited defective plastids have suffered
an irreversible change that cannot be rescued by the
nuclear genotype of the zygote, resulting in albino
seedlings whose plastids are incapable of differentia-
tion into chloroplasts. Furthermore, the pattern of leaf
variegation observed in homozygous individuals sug-
gests that the gene product is a key component of the
regulatory machinery that coordinates cellular and
plastid development in higher plants. As we reported
last year, a molecular clone of the iojap locus has
been obtained by transposon tagging using the ij-
muml allele, which is caused by the insertion of the
maize transposon Mul. During the last year, cDNA
clones have been obtained corresponding to the Jojap
gene product, and the nature of the original reference
allele described by Jenkins (ij-ref) has been
elucidated. We have also initiated genetic studies
aimed at determining the developmental parameters
involved in the patterns of leaf variegation and
maternal inheritance observed in mutant plants.
The phenotype of plants homozygous for ij-ref
differs markedly in different genetic backgrounds. In
many backgrounds, a bold striping pattern with white
leaf margins is observed (Fig. 2C). In other back-
grounds, 4/4 plants have a more uniform "grainy" ap-
pearance, often with narrow white margins (Fig. 2B).
A B C
FIGURE 2 Three homozygous iojap plants are shown. (A) A revertant green sector in the tassel of the first plant gave rise to
revertant gametes. (B) A revertant green sector in the second plant passed through six leaves, extending to the left margin of
the leaf shown. (C) The bold striping pattern observed in the third plant is typical of iojap homozygotes from several different
inbred backgrounds. (Figures A and C were provided by E.H. Coe, USDA-ARS, University of Missouri.)
In some of these backgrounds, ij-ref is unstable and
can give rise to revertant sectors and revertant
progeny. In Figure 2C, revertant sectors are difficult
to distinguish against the bold striping pattern. In Fig-
ure 2B, the left margin of the leaf has a revertant sec-
tor in which the nuclear genotype has reverted to
normal, restoring green pigmentation. This sector
was found on six successive leaves and passed from
the margin of one leaf to near the middle of the next,
suggesting that it comprised a clone of cells derived
from a single revertant cell early in shoot develop-
ment. This is in contrast to the albino sectors in Fig-
ure 2C, which occur in nonclonal positions on suc-
cessive leaves, predominantly at the margins. In Fig-
ure 2A, a revertant sector passed into the tassel, and
the green tassel branches gave rise to germinal Ij-Rev
revertant progeny. E.H. Coe, at the University of
Missouri, observed two such plants and maintained
the mutant and revertant alleles from each by cross-
ing individual tassel branches to tester stocks.
cDNA clones corresponding to the Iojap gene and
genomic clones corresponding to the original ij-ref
allele have been obtained using the ij-mum/ clone as
a probe. The cDNA clones were found to encode a
229-amino-acid polypeptide that has no striking
homology with known proteins. Molecular cloning of
the ij-ref allele revealed that it contained a 1.5-kb
transposon inserted into the first exon of the /j gene,
about 350-bp upstream of the Mul insertion site in ij-
muml (see Fig. 3). The ends of the 1.5-kb element
closely resemble the ends of the AciDs family of
transposable elements, sharing 10 of 11 by at the
termini and about 60% homology in the subterminal
regions. Insertion of this element was associated with
an 8-bp target site duplication in the first exon of the
Iojap gene. DNA was isolated from two germinal
revertants (provided by E.H. Coe) and five indepen-
dent somatic sectors from leaves such as the one
shown in Figure 2B. In each case, Southern blotting
and polymerase chain reaction (PCR)-mediated clon-
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FIGURE 3 A restriction map of the ij-ref allele. The 1.5-kb
Ds-like element is shown as an insertion. The insertion site
of the Mu/ element in the ij-mum 1 allele is also shown.
The direction of transcription is shown by an arrow. (E)
EcoRl; (S) Sstl; (H) Hindlll; (BI) Bg/11.
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ing showed that phenotypic reversion was ac-
companied by excision of the 1.5-kb element, leaving
in-frame rearrangements at the site of insertion (Fig.
4). We conclude that the insertion of the Ds-like ele-
ment is responsible for the mutant phenotype caused
by the ij-ref allele. We are currently investigating the
possibility that excision of this element is under the
control of the autonomous Ac transposon. DNA
prepared from green and white stripes of the type
shown in Figure 2C had no detectable changes at the
ij locus. Thus, excision of the 1.5-kb element is not
responsible for the striping pattern itself in ij/ij
homozygotes.
In an attempt to elucidate the developmental pa-
rameters controlling the pattern of leaf variegation
and maternal inheritance in iojap mutants, we are
constructing a series of double mutants with ij and
other mutations that affect leaf and flower morphol-
ogy. In addition, we have begun a clonal analysis of
Ij gene action using y-ray-induced chromosome
breakage. The Bronze gene, which affects antho-
cyanin pigmentation in many plant tissues including
the leaf, will be used as a genetic marker for
irradiation-induced clones, by using a reciprocal
translocation stock in which the Bz gene (on
chromosome 9S) is linked to the Ij gene on
chromosome 7L. In a pilot study, 400 germinating
seedlings from the cross T7-9a (G1 Ij wx Bz) x wx bz;
gl ij were irradiated at Brookhaven National
Laboratories last summer and grown up in order to
look for clonal sectors that had lost the Ij allele,
resulting in an ij phenotype. By examination of the bz
phenotype of these sectors, we hoped to learn in
which cells of the leaf the Ij gene product is required.
Numerous ij sectors were observed, but there was in-
sufficient leaf color to observe the bronze phenotype.
Southern blotting revealed that these sectors had lost
both the Ij and the Bz wild-type alleles inherited from
the translocation parent, relative to adjacent tissue.
Thus, the genes are appropriately positioned on the
translocation chromosome for this analysis. We will
repeat this experiment next summer using more in-
tensely pigmented stocks.
Inheritance of Somatic Changes
in Mu Activity
R. Martienssen, A. Baron
As we have described in previous years, the mutant
phenotype associated with the hcf106 mutation is
suppressed when homozygous plants lose Mu ac-
tivity. Mu activity is lost when Mu transposable ele-
ments lose the ability to excise or transpose and inac-
tive Mu/ elements become hypermethylated relative
to elements from active lines. Loss of Mu activity can
occur via loss of the recently identified autonomous
regulatory element MuR, either by segregation or by
transposition. However, Mu activity can also be lost
in a progressive fashion during development. This
can be conveniently observed in plants homozygous
for the hcf106 mutation as sectors of dark green leaf
tissue on a mutant pale green background. The domi-
nant Lesion-mimic mutation is also phenotypically
suppressed by loss of Mu activity, and coordinate
sectors of phenotypically wild-type tissue arise pro-
gressively during development in plants that carry
both mutations.
It has been suggested that this progressive loss of
Mu activity might account for the nonreciprocal loss
of Mu through male and female gametes. The male
inflorescence (the tassel) develops from the apex of
the plant, whereas the female inflorescence (the ear)
is formed from a lower, axillary bud. Thus, the pro-
gressive loss of Mu activity in successive leaves
might be reflected in the proportion of gametes from
each flower that carries Mu activity. This phenome-
non does not occur with most Mu lines but is very
striking in some individual plants. Last summer, we
ij-mum 1 and cDNA ccgagccacggcctcgcctg cgcgcccccgij-ref ccgagccacggcCTCGCCTG ( Ds-like) CTCGCCTGcgcgcccccgIj-Rev #1 ccgagccacggcCTCGCCTG cgcgcccccgIj-Rev #2 ccgagccacggcCTCGCCT TCGCCTGcgcgcccccgIj-Rev #4 ccgagccacggcCTCGCC GTCGCCTGcgcgcccccgIj-Rev #3,5,6,7 ccgagccacggcCTCGCCTCA GTCGCCTGcgcgcccccg
FIGURE 4 Sequence around the excision site from seven lj-Rev alleles resulting from two germinal andfive somatic excisions of the 1.5-kb Ds-like element from ij -ref. The corresponding sequence from the //-mum/ allele, the //cDNA clone, and the ij-ref allele are also shown.
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selected individual plants heterozygous for both
Lesion-mimic and hcf106, which were losing the
Lesion-mimic phenotype in the upper leaves between
the ear and the tassel. These plants were crossed
reciprocally to homozygous hcf106 plants that had
lost Mu activity, and the progeny were scored for
both the Lesion-mimic and hcf phenotypes. Progeny
from the ears of the sectored plants were planted in
the order they appeared on the ear (an "ear map"), so
that spatially distinct clones of kernels that had lost
Mu activity might be apparent from the seedling
phenotype. These clones would occur if Mu activity
were lost from individual cells during somatic devel-
opment of the ear.
In four out of seven cases, 98-100% of the
progeny from both male and female had lost Mu ac-
tivity, so that no significant difference could be
detected. These plants had lost the Lesion-mimic
phenotype relatively early in development (four or
five leaves below the tassel). In another plant, there
was no difference in the proportion of active and in-
active progeny observed whether used as male or fe-
male. This plant expressed the Lesion-mimic pheno-
type even in the topmost leaves. In the remaining two
plants, however, a pronounced difference was ob-
served between transmission of Mu activity through
the male (0%) and through the female (40-43%).
Furthermore, large "sectors" of phenotypically sup-
pressed progeny were apparent from both ear maps.
DNA made from kernels inside one of these sectors
had hypermethylated Mu elements relative to those
outside the sector. This showed that the sectors were
due not to segregation of MuR, but rather to the
epigenetic loss of Mu activity in apparently clonal
sectors during ear development.
Somatic Transposition of Mu
R Martienssen, A. Baron
In many Robertson's mutator lines, somatic sectors
of pale green, yellow, or white tissue, of varying
sizes and extents, have been observed. These sectors
are typically found in plants that have active Mu ele-
ments and have been postulated to be due to some
type of Mu-induced somatic mutation. DNA was
prepared from 11 pale green sectors observed on
plants heterozygous for hcf106 and from adjacent tis-
sue on either side of these sectors. Southern blotting
showed that 5 out of the 11 sectors had detectable
changes at the Hcf106 locus. Four of these were the
result of the insertion of a 1.4-kb element (the same
size as Mul) into the wild-type allele at a position
within a few hundred base pairs of the Mul insertion
site in the mutant allele. This could be either the
result of Mul insertion or the result of mitotic cross-
over between the wild-type and mutant alleles. In the
fifth sector, the insertion into the wild-type allele was
much larger, and reprobing the Southern blot with
other Mu probes revealed that the insertion was re-
lated to the MuR autonomous transposon, which had
inserted into the wild-type allele. PCR cloning using
specific primers was used to recover the insertion
site, and sequencing revealed that the MuR-like ele-
ment had inserted 2 by upstream of the Mul insertion
site in hcf106. As we reported last year, the sequence
of this insertion site is identical to the last 5 by of
both Mul and MuR. It is possible that it represents a
hot spot for Mu insertion.
Molecular and Genetic Analysis of
the Maize P Locus
P. Athma, E. Grotewold, T. Peterson
We are studying the maize P gene as a model for
regulation of gene expression during development.
The P gene is involved in the production of a red
flavonoid pigment in certain maize floral organs in-
cluding the pericarp, cob glumes, and tassel glumes.
The P gene is well-suited for genetic analysis, be-
cause its pattern of expression is immediately appar-
ent from the localization and intensity of the red pig-
ment.
STRUCTURE AND FUNCTION OF THE P GENE
The P gene produces several RNA transcripts, and
we cloned two of these by conventional and
polymerase chain reaction (PCR)-based cDNA clon-
ing. The two transcripts share the same two 5 'exons
but are alternatively spliced to alternate third exons.
The amino termini of the encoded proteins are
homologous to the DNA-binding domain of the Myb
class of transcriptional activators. We have shown by
Northern blot experiments that the P gene regulates
in the pericarp the accumulation of RNA from three
maize genes involved in flavonoid biosynthesis: C2,
CHI, and A1, which encode chalcone synthase, chal-
cone isomerase, and flavonol reductase, respectively
(Grotewold et al. 1991; E. Grotewold and T. Peter-
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son, unpubl.). In collaboration with Ben Bowen and
colleagues at Pioneer Hi-Bred, we used micro-
projectile bombardment to test the transcriptional ac-
tivation properties of the P-encoded products. The P
cDNAs were fused to the constitutive cauliflower
mosaic virus 35S (CaMV35S) promoter and bom-
barded together with a reporter gene (luciferase)
linked to the promoter of the maize Al gene, which is
positively regulated by P in vivo. The results indicate
that the larger P-encoded protein alone activates tran-
scription of the Al promoter; the smaller P-encoded
protein has no detectable activating or inhibiting ef-
fects (E. Grotewold et al., in prep.).
CLONING OF A P-REGULATED CHALCONE-
FLAVONONE ISOMERASE GENE FROM MAIZE
To extend our analysis of P function, we decided to
clone the maize CHI gene, which encodes chal-
cone/flavonone isomerase. The chalcone-flavonone
isomerase enzyme should act between the C2- and
A /-encoded products, which opened the possibility
that its expression would be regulated by the P gene
in the pericarp, as are C2 and Al (see above). How-
ever, CH/ activity has not been reported in maize, nor
has any mutant in this step been isolated. To clone a
maize CHI gene, we used highly degenerate primers
made from sequences conserved between CHI
proteins from several plants (we appreciate very
much the suggestions provided by Dr. Arjen van
Tunen regarding the sequences of the primers). We
obtained a 210-bp cDNA by PCR, which was used as
a probe for screening a cDNA library from pericarps
carrying a functional P gene (P-rr). Full-length
cDNA clones were obtained by extending cDNA
clones using the RACE technique, and genomic
clones were isolated by using the cDNA clones as
probes on a genomic library. The translated sequence
of the cDNA clones showed about 65% identity with
the sequence of two chalcone-flavonone isomerase
proteins described in petunia. However, the in-
tron/exon structure of the maize CHI gene is identical
to the structure of one of the petunia CHI genes,
giving some clues on the evolution of the CHI gene.
Northern blot hybridizations of pericarp poly(A)
RNA showed a single transcript of about 1 kb
hybridizing with these cDNA clones. No transcript
could be detected in RNA from pericarps lacking a
functional P gene, suggesting that the maize CHI
gene is regulated by P in the tissues in which P is ex-
pressed (E. Grotewold and T. Peterson, unpubl.). We
will test whether P regulates the CHI promoter by
using the particle gun to deliver a CHI promoter/
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luciferase reporter gene construct together with P-rr
cDNA into embryogenic callus cells. If the results are
positive, then the CHI promoter will be useful as an
additional P-regulated promoter for comparisons with
the C2 and AI promoters.
Ac INDUCES RECOMBINATION AT THE P LOCUS
We previously demonstrated that the maize trans-
posable element Ac induces recombination between
the long (5.2-kb) direct repeats that flank the P gene.
Even though the Ac element has been subject to in-
tense molecular and genetic analyses, this documents
a new activity of Ac: the destabilization of flanking
direct repeat sequences (Athma and Peterson 1991).
To determine the mechanism by which Ac induces
recombination, we are extending our analysis to cases
in which Ac is located at different positions within
the P locus; for example, will Ac insertions within the
flanking direct repeats give enhanced or reduced
recombination frequencies? In addition, we are look-
ing at the effect on recombination of three Ds inser-
tions derived by internal deletions from a progenitor
Ac insertion in P. Preliminary results indicate that en-
hancement of recombination requires an active Ac, in
addition to the Ds insertion in the P locus (P. Athma
and T. Peterson, in prep.).
INSERTIONAL MUTAGENESIS OF THE MAIZE P
GENE BY TRANSPOSON Ac
A striking feature of P is the organ-specific expres-
sion specified by the P-wr and P-rw alleles, which
condition colorless pericarp/red cob and red pericarp/
colorless cob, respectively. One of our central objec-
tives was to determine whether P-rr, which pigments
both pericarp and cob glumes, comprises two closely
linked organ-specific genes. We reasoned that inser-
tional mutagenesis with Ac, which is known to have a
preference for localized transposition, could disclose
the presence of multiple functional units at P-rr if
they in fact exist. Therefore, we isolated and mapped
the Ac insertion sites in 20 alleles derived by in-
tragenic transposition of Ac (Fig. 5). In all of these al-
leles, the pericarp and cob glume pigmentation was
affected similarly, and these alleles carried Ac inser-
tions within, or near, the limits of the P-rr transcript
previously mapped by conventional molecular meth-
ods. We conclude that P-rr contains a single gene re-
quired for pigmentation of both pericarp and cob
glumes. Our results also demonstrated that Ac
transpositions can occur in either direction in the P
gene, with no apparent minimum distance: In one
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FIGURE 5 (Top) Restriction map of The 5.2-kb direct repeats (hatched boxes) and the 1.2-kb
direct repeat sequences (stippled boxes) are indicated. Open boxes indicate the positions of restriction fragment probes 8B,
15, 16, and 17. Numbers in parentheses indicate the fragment sizes obtained upon digestion of genomic DNA with Sall.
Restriction sites for Sall (S) and Bg111 (B2) are indicated; not all BO sites are shown. The asterisk above the third Sall site from
the left indicates that this site is not digested by Sall in genomic DNA, possibly because of methylation. (Bottom) Location of Ac
insertions. An enlarged map of the 1.8-kb P-rr mRNA is shown. Open boxes correspond to 5' - and 3' -untranslated regions,
closed boxes correspond to protein-coding sequences, and the lines between them correspond to intron sequences. Open tri-
angles represent Ac elements in the same orientation with respect to P as in P-vv, closed triangles represent insertions in the
opposite orientation (i.e., same as P-ovov-1114). Photographs at bottom show the phenotypes resulting from insertion of Ac at
representative sites. The upper and lower panels of photos are of kernels from plants with Ac insertions in the P-vv and P-ovov-
1114 orientations, respectively. Plants producing these kernels were heterozygous with an allele specifying colorless pericarp
(either P-ww or P-wr). (1) Ac insertion sites mapped by Southern blotting but not sequenced. Horizontal lines indicate approxi-
mate locations.
case, Ac transposed just 6 by from its original inser-
tion site. However, the distribution of transposed Ac
elements was markedly nonrandom: Of 19 transposed
Ac elements derived from a single Ac donor, 15 were
inserted in a 1.1-kb region at the 5' end of P,
whereas none had inserted in an adjacent 3.2-kb in-
tronic region (P. Athma et al., in press). In a related
study, we identified a possible hot spot for Ac inser-
tion within the P gene (Grotewold et al. 1991).
We thank Mary Ellen Okar and Michael Persans for
assistance in various aspects of this work.
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ARABIDOPSIS SIGNAL TRANSDUCTION
AND FLOWER DEVELOPMENT
H. Ma C. Flanagan
H. Huang
R. Lavi
Y. Mizukami
A. Oates
A. Tag le
C. Weiss
The research in our laboratory is focused mainly in
two areas: (1) characterization of G protein function
in plant signal transduction pathways and (2 ) analy-
sis of genes involved in flower development. Plant
cells are known to respond to a large number of ex-
ternal and internal signals; however, little is known
about the molecular mechanisms of the plant signal
transduction pathways mediating these responses. To
understand plant signaling processes, we have taken
the approach of studying plant G proteins. G proteins
are known to play important roles in signal transduc-
tion in animals and simple eukaryotes. We believe
that G proteins also play important roles in the signal
transduction processes of plants. Using the polymer-
ase chain reaction (PCR) technique and degenerate
oligonucleotides, we have previously isolated a gene
(GPA1) from Arabidopsis thaliana that encodes a G
protein a subunit (Ma et al., Proc. Natl. Acad. Sci.
87: 3821 [1990]). We are currently characterizing
GPA1 in several ways, and we are attempting to es-
tablish association of GPA1 with particular plant sig-
naling pathway(s). In addition, we are continuing to
look for other G protein genes in Arabidopsis.
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Flower morphogenesis is a complex developmen-
tal process. In recent years, A. thaliana has been in-
creasingly used for plant molecular and genetic
studies, and a number of Arabidopsis floral homeotic
mutants have been characterized, including one
called agamous (Bowman et al., Plant Cell 1: 37
[1989]). Wild-type Arabidopsis flowers have four
whorls (sets) of organs. From the periphery to the
center, there are four sepals, four petals, six stamens,
and an ovary of two fused carpels. The ag-1 mutant
plants have flowers in which the sepals and petals are
normal, but the stamens are replaced by petals and
the ovary is replaced by another ag flower with
sepals, petals, petals and another ag flower. There-
fore, the ag-1 flowers have only sepals and petals and
no stamens or carpels. The AGAMOUS (AG) gene
has been recently cloned (Yanofsky et al., Nature
346: 35 [1990]), and DNA sequence analysis indi-
cates that it encodes a protein that shares striking
similarity in its amino-terminal region with the DNA-
binding domains of transcription factors from hu-
mans (SRF) and yeast (MCMI), suggesting that the
AG protein is a transcription factor. This domain is
also found in another floral homeotic gene, DEFA
from Antirrhinum majus (Sommer et al., EMBO J. 9:
605 [1990]), and has been referred to as the MADS-
box, for MCM1-AG-DEFA-SRF (Schwarz-Sommer
et al., Science 250: 931 [1990]). We reasoned that the
process of flower development is likely to require
more regulatory genes, some of which may also con-
tain a MADS box. Using low-stringency hybridiza-
tion strategies, we isolated six new genes, designated
AGLI through AGL6 for AG-Like, which share sub-
stantial sequence similarity with AG in the DNA-
binding motif as well as in additional amino acid se-
quences (the K box; see Ma et al., Genes Dev. 5: 484
[1991]). Five of the new genes are preferentially ex-
pressed in flowers, and one of them is also expressed
in stems and leaves.
In the past year, we have begun the characteriza-
tion of GPA1 as well as AG and AGLs. In the follow-
ing sections, we summarize the projects in these two
areas and report some preliminary results. In addi-
tion, we describe a collaborative effort to establish an
enhancer/gene trap transposon system in A. thaliana.
Analysis of GPA1 Function
Using Transgenic Plants
H. Huang, H. Ma
We have taken two approaches to probe the function
of GPAI. Many G protein genes are known to be ex-
pressed in specific cell types. Thus, the first approach
is to analyze the effect of altered GPA1 expression.
The second approach is to characterize the pheno-
types of transgenic plants with potential dominant
missense gpal mutations (see below). Although
GPAI is expressed in several organs (flowers, stems,
and leaves), it is still possible the GPA1 is expressed
only in a subset of cell types in these organs. We are
testing this directly by performing more detailed
analyses of the GPA1 expression pattern (see below),
but we would also like to alter the expression of
GPA1 by putting it under the control of heterologous
promoters, for example, the cauliflower mosaic virus
(CaMV) 35S and heat-shock promoters, to obtain
clues about its function. The constitutive CaMV 35S
promoter will direct an increased GPA1 mRNA level
in many types of cells. This misexpression of the
GPA1 gene product may produce detectable pheno-
types. To achieve inducible expression, we would
like to use a heat-shock promoter (HSP). A number
of constructs fusing the 35S and HSP promoters to a
GPA1 cDNA have been made.
Mutations are valuable for the analysis of in vivo
functions of a gene. It is technically impractical in
Arabidopsis to obtain chromosomal recessive muta-
tions starting with a cloned gene. However, in the G
protein a subunit, conserved residues exist that can
be altered in vitro and may lead to dominant muta-
tions in vivo. Using PCR procedures with mutant
oligonucleotides and the GPA1 cDNA, we have gen-
erated four missense mutations. These mutant gpal
alleles have now been fused to the 35S and HSP
promoters, as well as to the native GPAI promoter.
The constructs for altered GPA1 expression and
for expressing gpal mutant alleles have been intro-
duced into the Arabidopsis genome by using an im-
proved procedure (H. Huang and H. Ma, unpubl.) for
Agrobacterium-mediated transformation. Multiple in-
dependent transformants were obtained for each con-
struct. We are currently characterizing the transgenic
lines. Although no gross visible phenotypes have
been observed so far, we are following a few lines of
investigation. We will compare the response of wild-
type and transgenic plants to environmental signals.
For example, the blue light response has been shown
to require a G protein in pea. We will test the blue
light response in the transgenic plants. Other
responses are also being considered. We are also in
the process of studying transgene expression using
Northern and Western procedures. We are hopeful
that some of these constructs will cause phenotypic
changes in transgenic plants and will provide us with
clues about GPA1 functions.
In Search of New G Protein Genes
H. Huang, H. Ma
We believe that Arabidopsis, like most other charac-
terized eukaryotes, has more than one gene coding
for G protein a subunits. We have considered a few
different approaches to isolate additional G protein
genes. PCR was chosen as the major approach to iso-
late as diverse a group of sequences as possible. We
have performed several PCR experiments starting
from sterilely grown plants and have found a number
of new G-protein-like sequences. However, most of
these do not hybridize to Arabidopsis genomic se-
quences, suggesting that they are from non-
Arabidopsis origin(s). We are also using low-
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stringency hybridization to isolate sequences similar
to GPAI.
Isolation and Analysis of the Tomato
GPA1 Homo log, TGA1
H. Ma, H. Huang [in collaboration with M. Yanofsky,
University of California, San Diego]
The Arabidopsis GPAI gene was the first published
plant gene encoding a G protein a subunit. In addi-
tion to amino acid sequence similarity to known G
proteins, it also has some differences from other G
proteins in the conserved consensus regions. We are
interested in determining whether these amino acid
changes are shared by other plant G proteins and thus
may reflect functional properties of plant G proteins.
Toward this end, we have isolated cDNAs for a gene
encoding a G protein a subunit from tomato (Lyco-
persicon esculentum, cv VF36). This gene, named
TGA1, was isolated using a cDNA of the A. thaliana
G protein a-subunit-encoding gene, GPAI, as a DNA
probe. The sequences of four cDNA clones indicate
that the deduced amino acid sequence of the gene
product (TGa.1) has 384 amino acids (44,906
daltons). The predicted TGa 1 protein exhibits
similarity to all known G protein a subunits. The
amino acid sequences are 84.6% identical and 93%
similar (identical residues and conservative changes)
to that of A. thaliana GPa1 and 34% identical and
59% similar to that of the mammalian transducins.
Furthermore, it shares with GPa1 several noticeable
changes in the consensus regions for a GTP-binding
protein. Analysis of silent codon changes between
GPA1 and TGAI supports the conclusion that GPAI
and TGAI are homologs. Finally, hybridizations of
tomato genomic DNA indicate that TGA1 is a single-
copy gene.
Analysis of GPA1 Expression Pattern
H. Huang, C. Weiss, H. Ma
As discussed above, it is of interest to characterize
the time and spatial expression pattern of the GPAI
gene. The expression of many G proteins is known to
be regulated; for example, rod and cone transducins
are expressed specifically in rod and cone photo-
receptors, respectively, and the olfactory G protein is
expressed only in the olfactory epithelium. The
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timing and location of GPAI expression may provide
clues about its functions. We are taking a number of
approaches to analyze the GPAI expression pattern.
First, RNA dot-blot and Northern blot experiments
have been and will be performed to determine GPAI
expression in different organs at different develop-
mental stages. Second, in situ RNA hybridization ex-
periments will be done to analyze in more detail the
spatial pattern of GPA1 expression. Third, transgenic
plants containing the GPA1 promoter fused to a
reporter gene, GUS, have been generated, and these
will be analyzed at different stages both enzymatical-
ly and histochemically. Finally, when we obtain
antisera against the GPa1 protein, we will examine
the GPa1 protein distribution (see below).
Regulation of GPA1 Expression
C. Weiss, R. Lavi, H. Ma
It is likely that GPAI is not expressed in all cell types
at all times. In addition, GPAI expression may
change in response to environmental signals. Further-
more, mutations affecting Arabidopsis signal re-
sponses may also alter GPA1 expression. These pos-
sibilities will be investigated using techniques similar
to those described above. RNA blots will also be
made with RNA from plants grown under different
environmental conditions, such as dark and light
grown plants. When a particular response is found to
affect GPA1 expression, mutants in such a response
will be analyzed for GPAI expression. Plants with
GPA1-GUS fusions will be crossed to the mutants,
and further analysis will be done using the progeny
that have both the mutant and the GUS fusion.
To facilitate future use of the GPAI promoter, a
limited number of GUS fusions will be constructed
and analyzed in transgenic plants to identify a rela-
tively small fragment that is sufficient to drive a
wild-type level and pattern of expression. In addition,
there is a potential regulatory function of two short
open reading frames (ORFs) in the 5 ' leader region
of the GPAI cDNA. Short ORFs in the 5 ' region are
known to affect translation in yeast and, more recent-
ly, in maize cell culture. This possibility will be in-
vestigated by comparing protein levels to mRNA
levels in different organs and at different times. Addi-
tional studies will be carried out using GUS transla-
tional fusions. Mutant constructs with one or both
ATGs removed will be tested and compared to the
wild-type construct.
Isolation and Analysis of Complete
AGL3 Genomic and cDNA Sequences
H. Ma, H. Huang, C. Weiss
AGL3 is unique among the seven reported Arabi-
dopsis MADS-box genes (AG and AGL1-AGL6) in
that it is expressed in both floral and vegetative tis-
sues. To understand its function as a more general
transcriptional regulator, we would like to further
characterize AGL3 at a molecular level. Using pre-
viously identified partial cDNA and genomic se-
quences, we have isolated complete AGL3 cDNA
clones, as well as the entire AGL3 genomic sequence.
These clones were subcloned and analyzed by DNA
sequencing. Comparison of the genomic and cDNA
sequences indicates that AGL3 has eight exons and
seven introns. The intron positions are conserved
when compared to those of other Arabidopsis
MADS-box genes. The predicted AGL3 amino acid
sequence shows that AGL3 has 258 amino acid
residues, with a calculated molecular weight of
29,684. In addition to the conserved MADS-box and
K-box, AGL3 has a glutamine-rich region (10 out of
11 residues) in the carboxy-terminal domain. Because
glutamine-rich regions have been shown to be in-
volved in transcriptional activation, the presence of a
glutamine-rich region in AGL3 suggests that AGL3
may be directly involved in gene activation. Amino
acid sequence comparison with other deduced
MADS-box proteins indicates that AGL3 is more
similar to AGL2 and AGL4 than to any other MADS-
box proteins; this conclusion is also supported by the
exon-intron structures of these genes. The 5 ' leader
region of the AGL3 cDNA has three additional
ATGs, followed by 1, 1, and 13 sense codons, respec-
tively, and then a stop codon. Northern blots with an
AGL3- specific probe show that the AGL3 mRNA is
expressed in several tissues, including rosette leaf,
cauline leaf, floral stem, pedicel, and pistil, but not
detected in root or seedling cotyledon.
Expression of the AGL Genes in
Wild-type and Mutant Flowers
H. Ma, C. Flanagan, A. Tag le [in collaboration with
M. Yanofsky, University of California, San Diego]
Five of the AGL genes are expressed specifically in
flowers. Our previous results indicate that AGL1 is
expressed in carpels. Furthermore, during stages 11
and 12 of flower development, AGL1 expression is
concentrated in the ovules. AGL2 is also expressed in
carpels, as well as in stamens. We have performed
experiments to determine the AGL expression pattern
in more detail. Using in situ hybridization analysis,
we have found that AGL1 is expressed in specific
cells within the carpels. AGL1 expression is con-
centrated in developing ovules and in the regions of
the carpel walls where two carpels fuse to form the
ovary. Additional in situ RNA hybridization experi-
ments with AGL4- and AGL5- specific probes were
carried out. Preliminary results indicate that AGL5 is
expressed in carpels, similar to AGL1. Further analy-
sis will be done with AGL1, AGL2, AGL4, and AGL5
probes. AGL6 expression will also be analyzed.
We believe that the Arabidopsis MADS-box
genes encode transcription factors that function in a
regulatory hierarchy controlling flower development.
To test this hypothesis, we have started a collabora-
tive effort with Martin Yanofsky to analyze the effect
of the ag-1 mutation on the expression of AG and
AGL genes. Northern analysis of wild-type and ag-1
mutant floral RNA with AG and AGL probes indi-
cates that AG, AGL2, AGL4, and AGL6 are expressed
in the ag-1 mutant flowers, and AGL1 and AGL5 are
not. We have begun a more detailed analysis of AG
and AGL2 expression in ag-1 mutant flowers using in
situ RNA hybridizations.
Functional Analysis of the AG
Domains in Transgenic Arabidopsis
Y. Mizukami, H. Ma
The deduced AG protein has a region amino-terminal
to the MADS-box; this amino-terminal region is
much reduced in AGL1 and AGL5 and completely
missing in the other AGL proteins and DEFA. To test
the function of this region, AG cDNAs lacking part or
all of it were constructed in vitro using PCR and
fused to the CaMV 35S promoter. These constructs
are now being introduced into the Arabidopsis
genome using Agrobacterium-mediated transforma-
tion. Wild-type plants were used as the recipient of
the recombinant constructs because of the difficulty
of obtaining enough material for direct transforma-
tion into the sterile ag mutant plants. Our preliminary
results show that the transgenic plants with the full-
length AG cDNA have flowers similar to those in an
apt mutant. Previous genetic results have led to the
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model that AG and AP2 mutually antagonize each
other (Bowman et al., Development 112: 1 [1991]).
Because AG is likely a transcriptional regulator, it is
plausible to propose that AG represses AP2 expres-
sion. The apt -like phenotype of the transgenic plants
can then be explained by repression of AP2 due to the
constitutively expressed AG. This hypothesis can be
tested in the future by examining AP2 expression in
the AG transgenic plants.
Transgenic plants containing constructs with part
or all of the amino-terminal region deleted also have
ap2-like flowers, indicating that the amino-terminal
region is not required for repression of AP2. How-
ever, we do not know whether the amino-terminal
region is required for other AG functions, such as
carpel and stamen morphogenesis. Transgenic plants
with either full-length or amino-terminal-deleted AG
constructs will be crossed to the ag background to
test whether these constructs can complement the ag
defects.
Effects of Altered Expression of
AGL1 and AGL2
Y. Mizukami, H. Ma
AGL1 and AGL2 are specifically expressed in flow-
ers. As a part of the effort to determine the roles of
AGL1 and AGL2, we are studying the effects of sense
and antisense AGL1 and AGL2 cDNAs, under the
control of the CaMV 35S promoter, in transgenic
plants. The AGL1 and AGL2 constructs have been
made, and transformations to introduce them into the
wild-type Arabidopsis genome are well under way.
Our preliminary results show that an initial trans-
formant with the AGL1 sense construct has flowers
with an elongated pistil, which extrude outside the
floral bud prematurely. These same flowers also have
stigmatic tissues at the tips of the sepals and shorter
petals. The fact that the AGLI transgenic flowers
have elongated carpels suggests that AGLI is indeed
involved in carpel development. We have also ob-
tained some preliminary results from analyzing trans-
genic plants carrying the AGLI antisense construct
which show that the carpels have failed to fuse. This
result is in agreement with the observation that AGL1
is expressed in those regions of carpels where fusion
occurs. Further analysis of these and other trans-
formants will be performed to characterize in more
detail the effects of these constructs. Northern and alimited number of in situ hybridization experiments
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will allow us to determine the expression patterns of
the transgenes, related AGL genes, and known floral
regulatory genes.
Establishing a Yeast In Vivo System
for Functional Analysis of AG
C Flanagan, A. Oates, H. Ma
The yeast Saccharomyces cerevisiae has a well-
characterized MADS-box gene, MCMI. MCMI is re-
quired for cell-type-specific gene expression in yeast.
We are setting up a system to test the ability of AG to
replace MCMI functionally. Two assays will be used
initially: the ability of AG to complement an mcml
mutant functionally and the ability of the AG protein
to activate an MCM1 target gene. If AG cannot func-
tionally replace MCMI, then chimeras of AG and
MCMI will be constructed and tested in the above-
mentioned tests. When a functional AG construct is
obtained, it will be further analyzed using molecular
genetics and biochemistry. This assay system will al-
low us to analyze the structure and function of AG,
and its functional relationship to MCMI, a well-
characterized protein. In particular, we can use this
assay system to screen and characterize mutations in
AG (deletions, directed point mutations, or random
point mutations). Mutations of interest can then be in-
troduced into and analyzed in plants.
Generation of Antisera against
AGL1, AGL2, and AGL3
C. Flanagan, H. Ma
Although we have some preliminary results on the
mRNA distribution of the AGL genes, we are more
interested in the distribution of the AGL proteins. In
addition, AGL2 and AGL3 both have short ORFs in
the 5 ' leader region of the cDNAs, suggesting that
they might be translationally regulated. By compar-
ing the mRNA levels to the protein levels, we may
obtain evidence for such a regulation. Finally, a num-
ber of in vitro studies of proteins can be done using
antibodies. Therefore, to characterize the tissue distri-
bution of the AGL proteins and to analyze these
proteins in vitro, we would like to generate antibodies
against these proteins. Fusion constructs for expres-
sion in Escherichia coli have been made for AGL1,
AGL2, and AGL3, using the respective cDNAs.
AGL1 and AGL3 fusion proteins have been purified
from E. coli extracts and used to immunize rabbits.
We are in the process of increasing the titers by boost
injections and analyzing the antisera.
Toward Establishing an
Enhancer/Gene Trap Transposon
System in A. thaliana
H. Ma [in collaboration with V. Sundaresan and
R. Martienssen, Cold Spring Harbor Laboratory]
In an effort to augment the available tools for
molecular analysis of the plant A. thaliana, we have
initiated experiments to establish an enhancer/gene
trap transposon system, based on the maize Ac /Ds
transposon system. Enhancer/gene trap systems have
been used successfully to identify genes with interest-
ing expression patterns and/or phenotypes in Dro-
sophila and mice. We have started experiments to es-
tablish an enhancer/gene trap system in Arabidopsis,
using the maize Ac /Ds transposon system. The con-
structs carrying either a stabilized active Ac, an en-
hancer trap Ds, or a gene trap Ds have been made by
Rob Martienssen and V. Sundaresan here at Cold
Spring Harbor Laboratory (see their reports), using
plasmids kindly provided by Jonathan Jones (Sains-
bury Laboratory) and Caroline Dean (Cambridge
Laboratory) at Norwich, England. I have now intro-
duced these constructs into wild-type Arabidopsis
plants and have obtained seeds from several indepen-
dent transformants for each of these constructs. We
are in the process of testing the marker genes on the
constructs, and we are preparing to test the transposi-
tion properties of the transgenic lines by crossing
them to test lines with known active Ac and Ds ele-
ments.
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CELL CYCLE CONTROL IN SACCHAROMYCES CEREVISIAE
B. Futcher B. Elliott R. Nash
I. Fitch G. Tokiwa
M. Linskens M. Tyers
L. Meng C. Dahmann
Our main interest continues to be the regulation of
START in Saccharomyces cerevisiae. We are most
interested in the tethering of division to cell growth
and in the generation of the basic cell cycle oscilla-
tion. The G1 cyclin genes CLN1, CLN2, and CLN3
encode unstable proteins that form a central part of
the machines that sense growth and generate oscilla-
tions. In the past year, we have compared the
properties of the Clnl, Cln2, and Cln3 proteins and
have found large differences among them. We
propose that there is a cascade of Cln-associated
kinases such that Cln3 regulates Clnl and Cln2, and
173
Clnl and Cln2 regulate START, perhaps with help
from other cyclins.
Our interest in G1 cyclins has led us to examine
the role of various other cyclins. We have partially
characterized the roles of four B-type mitotic cyclins
of S. cerevisiae and have found that they have spe-
cialized roles in both mitosis and meiosis.
Comparison of Ciri, Cin2, and Cln3
M. Tyers, G. Tokiwa
We tagged each Cln protein at its carboxyl terminus
with a triple copy of a nine-amino-acid epitope
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derived from influenza virus. Stringent genetic tests
showed that each tagged protein had essentially wild-
type function. Each protein and its associated protein
kinase activity (which was due to the Cdc28 protein
kinase catalytic subunit) could then be immuno-
precipitated with the 12CA5 monoclonal antibody,
and the Cln proteins could be compared.
This type of experiment led to several interesting
findings. First, the Cln 1 and Cln2 proteins, although
rare, were about 15-fold more abundant than Cln3
(Fig. 1), even though cln3 mutations have stronger
phenotypes than clnl or cln2 mutations. Second,
Clnl and Cln2 had roughly 200-fold more histone H1
kinase activity associated with them than did Cln3
FIGURE 1 Comparison of Cln1, Cln2, and Cln3. (A) Cln3
abundance is much lower than that of Cln1 and Cln2.
Each Cln was immunoprecipitated with the anti-envelope
12CA5 antibody in either the absence (-) or presence
(+) of competing epitope peptide and then detected by
Western blot with the In lane 7, a trace of
Cln3 is visible just above the heavy-chain IgG band. In
lane 9, Cln3 is overexpressed from the GAL1 promoter.
(B) The Cln3-associated kinase activity is very weak. One
quarter of the immunoprecipitated material used in A was
used in histone H1 kinase assays. Various coprecipitated
substrates were visualized in addition to exogenously
added histone H1. (Lane 7) Very weak activity associa-
ted with wild-type levels of Cln3; (lane 9) 200-fold
elevated levels associated with overexpressed Cln3 in a
mutant deficient in a ubiquitin-conjugating enzyme. (C)
Cdc28 is associated with Cln1 and Cln2. Cdc28 was
detected by Western analysis in Cln1 and Cln2 immuno-
precipitates. (D) Comparison of different Cdc28 kinase
complexes. Kinase complexes were precipitated with
12CA5 antibody directed against tagged Cln1, Cln2, or
Cln3 (first three lanes), or with a peptide antibody against
p13 Cdc28 (fourth lane), or with p13-Sepharose beads (fifth
lane). Kinase reactions were exposed to X-ray film for dif-
ferent times to provide equal intensities for each reaction
(i.e., in contrast to part B, the results shown are NOT a
quantitative comparison). Each complex has a character-
istic array of coprecipitated endogenous substrates. The
relative amount of kinase activity in each immuno-
precipitate is shown beneath each lane. The Cdc28
H1 antibody was directed against the amino terminus of
Cdc28 and probably only recognizes a subpopulation of
all Cdc28 complexes. H1 is exogenously added histone
20,000 H1; other bands are endogenous coprecipitated sub-
strates.
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(Fig. 1). Third, although Clnl and Cln2 mRNA and
protein levels oscillated through the cell cycle, we
could find no evidence that any aspect of C1n3 func-
tion oscillated. Fourth, a-factor treatment, which ar-
rests cells in G1, knocked out Cln 1- and Cln2-
associated histone H1 kinase activities but had no
detectable effect on Cln3 abundance or its associated
histone H1 kinase activity; i.e., in an a-factor-treated
cell, Cln3-associated histone H1 kinase activity was
present at unaltered levels but was insufficient for
START. This is a paradoxical result, because a clnl
cln2 deletion strain is quite healthy, suggesting that
cells can live on CLN3 alone.
Because of these and other results, we have for-
mulated a new model for control of START by the
Cln proteins (Fig., 2). The main idea behind this
model is that Cln3 does not and cannot activate
START directly, simply because its associated kinase
activity is too weak. Rather, Cln3 functions near the
top of a cascade to activate the other Cln proteins,
which in turn activate START. In this model, a-
factor (or lack of the Swi4 and Swi6 transcription
factors; Nasmyth and Dirick, Cell 66: 995 [1991])
causes G arrest because it knocks out the activity of
Clnl and Cln2 (and Cln4); normal levels of Cln3 ac-
tivity remain but are insufficient for START. The
model also segregates different functions of cell cycle
control to different Cln proteins. Cln3 (which does
Pheromone
Clnl Cln2
Cln4
Swi4, Swi6
START
FIGURE 2 A model for activation of START. The weak
Cln3-associated kinase activates Clnl and Cln2 (and
Cln4), which activate START. Cin3 may work directly by
phosphorylating the Clnl and 2 kinase complexes, or it
may work indirectly. Clnl and Cln2 are sensitive to a-
factor and are part of a positive feedback loop involving
the Swi4 and Swi6 transcription factors. Since CLN3 is not
an essential gene, there must be some additional mech-
anism for activating CLN1 and CLN2; this unknown mech-
anism is not shown.
not oscillate) is most important for tethering division
to growth, and Cln 1 and Cln2 (and Cln4) are most
important for generating oscillations.
There are two difficulties with the model. First, it
requires the existence of an additional gene, here
named CLN4, to explain the fact that a clnl cln2 dou-
ble deletion is viable. Second, since cln3 deletions
are viable, there must be some CLN3-independent
method of activating Clnl and Cln2.
CLN4: Fishing for Complements
L. Meng (URP Program), B. Futcher
As described above, we predict a fourth CLN gene.
To find this hypothetical gene, we used a conditional
CLN strain (clnl cln2 GAL-CLN3) that is alive on
galactose medium and dead on glucose medium be-
cause of a Cln deficiency. Into this strain, we trans-
formed a high-copy-number yeast genomic library
and selected for colonies on glucose plates. As ex-
pected, we re-cloned CLN1, CLN2, and CLN3. In ad-
dition, there were four independent clones of one new
gene. This gene may be CLN4. Sequence analysis is
under way.
The Signal for Cln3 Degradation
M. Linskens
The Cln3 protein is very unstable, with a half-life of
about 10 minutes. However, a truncated version of
the protein, Cln3-1, which makes cells small and a-
factor-resistant, has a half-life of about 150 minutes.
The stabilized, truncated version lacks the carboxy-
terminal third of Cln3. This third contains regions ex-
tremely rich in proline, serine, and threonine. These
have been called PEST regions and are thought on
the basis of their presence in a variety of unstable
proteins to be signals for proteolysis. Furthermore,
the Cln 1 and Cln2 proteins, which are also unstable,
also have PEST regions.
To determine whether the PEST regions are im-
portant for the instability of Cln3 and whether protein
stability causes the Cln3-1 mutant phenotype, we
made a set of nested deletions from the 3 ' end of the
gene. Almost all of the PEST regions could be
removed without any phenotypic effect. We are in the
process of examining protein stability. The change
from the Cln3 phenotype to the Cln3-1 mutant
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phenotype occurs quite suddenly when an extra 14
amino acids are removed from a shortened but
phenotypically wild-type protein. This region con-
tains PEST residues. However, it also contains a per-
fect consensus site for cAMP-dependent protein
kinase phosphorylation. We are making site-directed
mutations in the critical region to determine whether
it is the PEST region or the phosphorylation site that
is important for the Cln3-1 phenotype.
Characterization of Four Mitotic
Cyclins of S. cerevisiae
I. Fitch, C. Dahmann [in collaboration with U. Surana
and K. Nasmyth, IMP, Vienna]
Last year, we identified four B-type cyclins in S.
cerevisiae; in other organisms, B-type cyclins have
been involved in mitosis. This year, the genes were
partially characterized. None of the single clb dele-
tions is lethal. All possible combinations of clb dele-
tions have been constructed (Table 1). Genetically,
CLB2 is the most important gene. Clb 1 and C1b2
form a pair of closely related homologs, whereas
TABLE 1 Viability of clb Mutants
Spore clones
Are Viable
Eventually form
Microcolonies
Are Inviable
clbl
clb2
clb3
clbl clb3
clbl clb2
clb3
clb1 clb3
clb4
clb4
clb4
c/b4
clb4
clb1 clb2
clb2 clb3
clb1 clb2 clb4
clb1 clb2 clb3
clb2 clb3 clb4
clbl clb2 clb3 clb4
Each CLB gene was deleted and replaced with a selectable
marker. Double mutants were made by crossing single mutants, and
so on. Mutant combinations scored as 'Viable' grew at least moder-
ately well, although in some cases with morphological defects. Com-
bination scored as forming "Microcolonies' varied from combinations
that caused death after a few cell divisions to combinations that pro-
duced visible microcolonies after prolonged incubation. Combina-
tions scored as 'Inviable' produced spores that germinated but did
not go through even one cell division.
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Clb3 and C1b4 form a second such pair; however, the
functional significance of this is not clear, since the
clb3 clb4 double deletion has little if any phenotype.
We do not know whether there are additional B-type
cyclins.
All four transcripts oscillate in abundance (Fig.
3). CLBI and CLB2 are expressed during a fairly nar-
row window around the time of nuclear division,
whereas CLB3 and CLB4 start being expressed in S
phase and continue until the end of nuclear division.
A clbl clb2 clb3 clb4 GAL-CLB2 strain has been
constructed. This strain is alive on galactose but dead
on glucose because of a clb deficiency. Preliminary
analysis suggests that cells arrest with buds, and with
a 2N DNA content (i.e., after S phase), but without
any mitotic spindle. At face value, this suggests that
the CLBs are needed for spindle formation but not for
any earlier event. In S. cerevisiae, the mitotic spindle
starts to form at about the beginning of S phase, per-
haps explaining why CLB3 and CLB4 are expressed
so early. As expected, then, these B-type cyclins
seem to be mitotic cyclins.
Meiotic Defects of clb Mutants
C. Dahmann
Meiotic divisions, like mitotic divisions, are likely to
require cyclins. Perhaps one or more of the four
known B-type cyclins are specialized for meiotic
functions. We have therefore tested all clb single
mutants and all viable combinations of multiple
homozygous clb mutants for their ability to undergo
meiosis.
Quantitative and qualitative effects were seen.
Most of the clb mutations did not significantly affect
the efficiency of sporulation, but for the clbl clb3
clb4 homozygous triple mutant, the frequency of
ascus formation dropped to about 20% of the wild-
type level. Many lysed cells appeared in this culture,
which may have been cells that lysed while attempt-
ing sporulation. Most strikingly, however, several
combinations of mutants caused meiosis to yield two
viable diploid spores, instead of the normal four
haploid spores (Fig. 4). A clbl clb4 strain with three
centromere-linked markers was constructed, and the
genotypes of the resulting dyads showed that meiosis
I had been completed and that meiosis II had not. We
think the most likely interpretation is that the mutants
exit the program of meiotic cell division after just one
CLN1
CLB3
CLB4
CLB2
ACT1
0 30 60 90 120 150 180 210 240
4W
0 * W W 110 IP IN IP It 110 *
FIGURE 3 CLB expression is cell-cycle-regulated. Cells were arrested in late
anaphase using a temperature-sensitive cdc15 mutation. Cells were synchronous-
ly released from the block at 0 time, and samples were taken for 255 minutes. A
Northern blot of the extracted RNA was probed sequentially with CLN1, the CLBs,
and the actin gene (as a loading control). The arrows show the appearance of new
buds, which in these cells occurs at S phase. CLN1 is expressed in G1 phase,
CLB3 and CLB4 appear to be expressed from early S phase until the end of
nuclear division, and CLB1 (not shown) and CLB2 are expressed only around the
time of nuclear division.
00
wild type clb1 clb2 clb3 clb4 clb1,3 clb1,4 cIb2,4
cIb3,4 clb1,3,4
FIGURE 4 A Meiotic defect in clb mutants. Diploids homozygous for viable com-
binations of clb mutations (see Table 1) were sporulated. The ratio of dyads (two
spored asci) to total asci (mainly four spored asci) is shown. The dyads are diploid
and viable and apparently arise because meiosis II does not occur. Even in the
clb1 clb4 double mutant that gives over 95% dyads, the rare tetrads seem to be
entirely normal.
177
division, instead of after two. Thus, CLB1, CLB3, and
CLB4 help to regulate meiosis.
WHI3, a New Regulator of START
R. Nash
Like CLN3-1, whi3 causes cells to divide at abnor-
mally small sizes. Unlike CLN3-1, whi3 is recessive,
suggesting that the wild-type WHI3 gene inhibits or
delays commitment to division. Genetic analysis sug-
gests that WHI3 acts independently of the CLN path-
way. Sequencing showed that WHI3 includes a
domain found in a family of RNA-binding proteins.
Whereas the null mutation causes a small cell
size, multiple copies of WHI3 cause a large cell size,
and the size is correlated with the number of copies.
Thus, WHI3 is a dose-dependent inhibitor of START.
When induced, a GAL-WHI3 construct causes a
lethal, first-cycle, G1 START arrest. This is the same
phenotype as caused by cdc28 temperature-sensitive
mutations or by cln deficiency.
Although WHI3 seems to act independently of the
CLNs, it shows at least one striking interaction. A
CLN3-1 whi3 double mutant is nearly sterile and is
largely defective for a-factor-induced transcription,
whereas the two parental single mutants are nearly
normal for both responses.
In summary, WHI3 seems to work at START as a
dose-dependent inhibitor, but it may not work via the
CLN /CDC28 pathway. It may define an independent
requirement for START.
Stress Resistance in S. cerevisiae
B. Elliott
The RAS/cAMP pathway can regulate cell physiol-
ogy in response to nutritional cues. However, when
this signaling pathway is destroyed, cells still respond
appropriately to nutritional cues and acquire stress
resistance in stationary phase (Cameron et al., Cell
53: 555 [1988]). Thus, there is at least one signaling
pathway in addition to the RAS/cAMP pathway. We
have found two mutations that prevent the cAMp.
independent response. The genes have been cloned,
and sequence analysis is under way.
It has been thought that the stress resistance of
stationary-phase cells requires that the cells be in a
special G1 noncycling state that has been co mpared
to mammalian Go. However, we found that slowly
growing cells also acquired stress resistance, al_
though not quite as much resistance as stationary-
phase cells. Furthermore, cells in S, G2, or M phase
were about as resistant as cells in G1 phase, suggest-
ing that resistance did not depend on cell cycle phase.
We think that although stress resistance and station-
ary phase are correlated in yeast, neither depends on
the other.
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TRANSCRIPTION AND CELL CYCLE REGULATION
IN YEAST
K.T. Arndt C. Devlin
C. Di Como
A. Doseff
M.J. Fernandez-Sarabia
F. Lin
M. Luke
We are using the yeast Saccharomyces cerevisiae to
investigate two basic cellular processes: regulation of
transcription by RNA polymerise II and regulation of
commitment for entry into the cell cycle.
Genetic Selection Schemes for
General Transcription Factors
C. Devlin
In the yeast Saccharomyces cerevisiae, three trans-
acting proteins, BAS1, BAS2, and GCN4, bind to the
HIS4 promoter to activate transcription of the HIS4
gene. A strain containing deletions of BAS1, BAS2,
and GCN4 has a His- phenotype due to insufficient
transcription of HIS4. An additional protein, RAP1,
also binds to the HIS4 promoter but is not by itself
able to activate transcription of HIS4. At HIS4, RAP1
functions to phase nucleosomes away from the
GCN4-, BAS1-, and BAS2-binding sites so that these
sites are accessible when present within chromatin.
Our research objectives with HIS4 can be divided
into two main areas: One area studies the details of
how BAS1, BAS2, GCN4, and RAP1 function for ac-
tivation of HIS4 transcription, and the second area of
research uses the HIS4 promoter for genetic selection
schemes to isolate mutations in genes whose products
function in transcription. To isolate mutations in
genes encoding general transcription factors, we pre-
viously isolated His+ revertants of a strain containing
deletions of BAS1, BAS2, and GCN4. These studies
generated the sill through sit5 mutations. So far, the
sit mutations have altered either general transcription
factors (sit/ or sit2), nucleosomes (sit5 and possibly
sit3), or a factor (sit4) that may regulate a general
transcription factor. Since the selection scheme is
performing as expected, we isolated further sit muta-
tions to identify other factors involved in transcrip-
tion. Most of these new sit mutations were in the pre-
viously identified sit/ through sit5 complementation
groups. From a large-scale selection, we have identi-
fied seven new sit complementation groups: sit6
A. Sutton
T. Zhong
through sit12. Like sill through sit5, the new sit
mutations cause a strong growth defect and therefore
occur in genes required for normal cellular growth.
We are further analyzing these additional sit muta-
tions for their global transcriptional defects and are in
the process of cloning the corresponding wild-type
genes.
Role of the SIT4 Protein
Phosphatase in the Cell Cycle
M.J. Fernandez-Sarabia, A. Sutton
The SIT4 gene predicts a protein that is 55% identical
to the mammalian type-2A and 43% identical to the
mammalian type-1 protein phosphatase catalytic sub-
units. However, the SIT4 protein phosphatase is a
unique phosphatase that is distinct from the S.
cerevisiae type-1 and type-2A phosphatases. The
SIT4 protein phosphatase (PPase) is required in late
G1 (at or very close to the time CDC28 is required)
for passage through START. SIT4 coimmunopre-
cipitates with two high-molecular-weight proteins,
termed p155 and p190. The association of SIT4 with
p155 and p190 is cell-cycle-dependent. In G1
daughter cells, SIT4 is not associated with p155 and
p190. Very close to the G1 /S phase transition, SIT4
associates (in separate complexes) with p155 and
p190. SIT4 remains associated with p155 and p190
until about the middle or end of mitosis. Therefore,
SIT4 associates with p155 and p190 very close to the
time that SIT4 executes its function. For this reason,
we postulate that the p155 and p190 proteins are
probably regulatory subunits of SIT4 that physically
target SIT4 to the proper substrates or regulate the ac-
tivity and/or the substrate specifity of SIT4.
Both p155 and p190 are phosphorylated in vivo.
In contrast, SIT4 is not detectably phosphorylated in
vivo. Interestingly, SIT4 coimmunoprecipitates with
a kinase activity that phosphorylates p155 and p190
in vitro. Therefore, the phosphorylation state of p155
and p190 may regulate their association with SIT4.
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Since SIT4 is required for transcription of CLN1 and
CLN2 (which encode G1 cyclins; see below) and may
in fact regulate this process, the regulation of SIT4 by
p155 and p190 would be of central importance for the
control of START. To investigate p155 and p190
directly, we need to isolate their corresponding genes.
We hope to isolate these genes within the next year.
During the last year, we have been focusing on
the G1 role of SIT4. This research indicates that SIT4
is required for at least two processes: (1) transcription
of the G cyclins CLN1, CLN2, and HCS26 and (2)
some other essential function(s).
TRANSCRIPTION OF CLN1, CLN2, AND HCS26
When a sit4-102 ssdl -d strain (sit4-102 is a temper-
ature-sensitive allele of SIT4; see below for an expla-
nation of SSD1) is arrested in 01 after 4 hours at the
nonpermissive temperature, the levels of CLN1,
CLN2, and HCS26 RNAs are much lower than in
wild-type G1 cells. In contrast, the levels of CLN3
and other control RNAs are similar in G1 cells and
sit4-102-arrested cells. To examine the requirement
of SIT4 for transcription of CLN1, CLN2, and HCS26
more closely, we looked at the levels of the CLN
transcripts after a-factor release. When MATa cells
are treated with a-factor, the levels of CLN1 and
CLN2 RNAs are repressed, whereas the levels of
CLN3 RNA are slightly induced. After release from
the a-factor arrest, the levels of CLN1, CLN2, and
HCS26 RNAs increase dramatically. We investigated
the requirement of SIT4 for this increase using two
different sit4 mutant strains: a sit4-102 ssdl -dl strain
arrested with a-factor at 24°C and then shifted to
37.5°C after a-factor release or a Asit4 SSD1-v1
strain arrested with a-factor at 30°C and maintained
at 30°C after a-factor release. Each of these strains
was compared to an isogenic wild-type SIT4 strain.
Both sets of experiments show that SIT4 is required
for the normal increase in the levels of CLN1, CLN2,
and HCS26 RNAs when the cells are released from
a-factor arrest. In contrast, the levels of CLN3 and
other control RNAs do not require SIT4. These ex-
periments also show that SIT4 function is required
not only for the normal accumulation of CLN1,
CLN2, and HSP26 RNAs, but also for the normal dis-
appearance of CLNI and CLN2 RNAs (but not
HCS26 RNA).
In support of the Northern data, Asit4 SSD1-v1
cells are sensitive to partial loss of CLN activity,
such as the absence of one of the CLN genes.
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Normally, wild-type SIT4 cells that contain a single
deletion of either CLN1, CLN2, or CLN3 have a dou-
bling time that is the same as, or very close to, that of
wild-type cells. In contrast, Asit4 SSD1-v1 Acln2::
TRP1 strains grow much slower than Asit4 SSD1-v1
strains. In addition, Asit4 SSD1-v1 Acln3::UR43
strains are almost inviable. The gene interactions be-
tween SIT4 and CLN3 provide further support for the
model (Fig. 1) that SIT4 is required for normal tran-
scription of CLN1 and CLN2. Normally, wild-type
SIT4 cells can survive with only one of the three CLN
genes. However, at least one of the three CLN genes
is required for viability. In the absence of SIT4 (a
Asit4 SSD1-v1 strain), the levels of CLN1 and CLN2
RNAs are much lower than normal. Therefore, the
model predicts that Asit4 SSD1-v1 cells would be
more dependent on the function of CLN3, whose
transcription does not depend on SIT4. That Asit4
SSD1-v1 Acln3::URA3 cells are almost inviable sup-
ports the model (Fig. 1). A further prediction of the
model is that if the CLN2 open reading frame is tran-
scribed from a promoter that does not depend on
SIT4, then CLN3 should be dispensable in a Asit4
SSD1-v1 strain. The experiments show that the re-
quirement of a Asit4 SSD1-v1 strain for CLN3 is
completely eliminated if CLN2 is provided from a
promoter that is not SIT4- dependent. Additional ex-
periments show that SIT4 and CLN3 provide parallel
pathways for transcription of CLN1, CLN2, and
HCS26. The requirement of SIT4 for transcription of
CLN1, CLN2, and HCS26 may be via SWI4. The
SWI4 and SWI6 genes encode proteins that probably
function as direct DNA-binding factors for CLN1,
CLN2, and HCS26 (but not CLN3) transcription. The
Signals?
+ An Additional
Function
+1- (Essential)
No CLN1
No CLN2
CLN3/CDC28
Transcription of
CLN1 CLN2 and HCS26
CLN1 and CLN2 (HCS26?)
CDC28
Early G1 Late G1
FIGURE 1 Model for the role of SIT4 in late G1.
levels of SWI4 RNA (but not SWI6 RNA) are cell-
cycle-dependent and reach their maximal levels just
prior to that of CLN1, CLN2, and HCS26 RNAs.
Northern analysis shows that the increases in the
levels of SWI4 RNA are SIT4- dependent, whereas the
levels of SWI6 RNA are not SIT4- dependent. There-
fore, the requirement of SIT4 for normal tran-
scription of CLN1, CLN2 and HCS26 could be due to
the requirement of SIT4 for transcription of SWI4.
OTHER ESSENTIAL FUNCTIONS
In addition to the role of SIT4 for transcription of
CLN1, CLN2, and HCS26, the SIT4 and SSD1-v
genes together provide an essential function in late
G1. Much evidence indicates that an additional role
of SIT4 is for turning off the CLN2-associated kinase
(and probably the CLN1-associated kinase). Strains
containing sit4 mutations (both sit4-102 ssdl -d
strains at the nonpermissive temperature and Asit4
SSD1-v1 strains at any temperature) have slower
mobility forms of CLN2 on SDS-PAGE gels. These
slower mobility forms of CLN2 are probably hyper-
phosphorylated CLN2, because these forms are
eliminated if the CLN2 immunoprecipitates are
treated with potato acid or alkaline phosphatase. In-
terestingly, the CLN2 isolated from sit4 mutants has
a very high associated kinase activity. Presumably,
the very high kinase activity is due to the hyper-
phosphorylation of CLN2. In vitro, the SIT4 PPase
not only can dephosphorylate CLN2, but SIT4 actual-
ly causes the disappearance of CLN2 from the CLN2
immunoprecipitates (as assayed by Western analy-
sis). Presently, we do not know if the CLN2 protease
activity comes from the added SIT4 or if SIT4 ac-
tivates a protease that coimmunoprecipitates with
CLN2. Our results raise the possibility that SIT4 con-
trols two aspects of CLN2 function. First, SIT4 could
regulate the rate of increase of CLN2 RNA and con-
trol the timing of START. Second, SIT4 could regu-
late the inactivation of the CLN2 kinase. The cells
may require inactivation of the CLN2 kinase for
normal cell cycle progression, and this process could
correspond to a late G1 checkpoint. Since SIT4/p155
and SIT4/p190 most likely regulate different pro-
cesses, future experiments with SIT4 will require
reagents so that the specific functions of SIT4/p155
and SIT4/p190 can be separated and identified. One
form of SIT4 could regulate transcription of CLN2
and the other form of SIT4 could regulate inactiva-
tion of the CLN2 kinase.
SSD1: A Polymorphic Locus Where
Some Alleles Can Allow Strains to
Grow in the Absence of SIT4
A. Sutton
In certain strain backgrounds, deletion of SIT4 is
lethal, and temperature-sensitive sit4 strains (such as
sit4-102) arrest in late G1. However, in other strain
backgrounds, deletion of SIT4 results in viability, but
with very slow growth. In addition, in the strain back-
grounds where deletion of SIT4 is viable, the sit4-102
mutation does not result in a temperature-sensitive
phenotype. The viability or inviability of a strain con-
taining a deletion of SIT4 is due to a single unlinked
locus, termed SSD1. SSDI alleles that result in slow
growth but viability in combination with a deletion of
SIT4 are called SSD1-v alleles (v for viable). SSD1 al-
leles that result in lethality in combination with a
deletion of SIT4 are called ssdl -d alleles (d for dead).
In a survey of laboratory strains, we found that about
half of the laboratory strains have an ssdl -d allele,
and the other half of the laboratory strains have an
SSD1-v allele. Deletion of SSD1 by itself results in
only subtle phenotypic effects, such as a slight effect
on cell size and increased sensitivity to caffeine.
The effect of SSD1 on sit4 mutations suggests
two possibilities: (1) Either the SSD1-v pathway can
partially substitute for the essential functions of the
SIT4 phosphatase or (2) SSD1-v functions down-
stream from SIT4. In the second case, SSD1-v pro-
vides some function so that the cells can survive
without the proper regulation of some substrate's
phosphorylation state by SIT4. Presently, we cannot
distinguish between these two possibilities. Many
lines of evidence implicate SSD1 in G1 regulation.
First, as described above, SSD1 is a modifier of sit4
mutations that are known to function in late G1. Sec-
ond, deletion of SSD1 alters the arrest morphology of
temperature-sensitive cdc28 strains that arrest in late
G1. Third, disruption of the BCY1 gene (which en-
codes the regulatory subunit of the cAMP-dependent
protein kinases) in an ssdl -d background results in
heat-shock sensitivity, sensitivity to nutrient limita-
tion, and temperature-sensitive growth. Both our
laboratory and Kelly Tachell's laboratory (who inde-
pendently isolated SSD1-v as a suppressor of a pde2
cAMP phosphodiesterase mutation) found that the
SSD1-v gene will partially suppress these three
phenotypic defects due to disruption of BCY1 in a
ssdl background. Fourth, Kim Nasmyth's laboratory
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found that SSD1-v is required in cells that have only
one of the three CLN genes, which encode G1
cyclins. Since SIT4 is required for SWI4ISWI6-
dependent transcription of CLN1, CLN2, and HCS26,
these results suggest that SSD1-v may provide a
SIT4-independent route for transcription of the
CLNS. Alternatively, SSD1 -v may function down-
stream and allow the cells to enter the cell cycle at
lower than normal levels of CLN function.
The DNA sequence of the SSD1-v1 gene predicts
a protein of 1250 amino acids and a molecular mass
of 140 kD. On an SDS-polyacrylamide gel, the SSD1
protein has a mobility of about 180 kD. The SSD1
protein has significant similarity to the S. pombe dis3
gene isolated in M. Yanagida's laboratory. The con-
ditional dis3 strain arrests very similarly to the condi-
tional dis2 strain. Interestingly, the dis2 protein en-
codes the catalytic subunit of a type-1 phosphatase.
In addition, mutations in dis2 and dis3 interact (a dis2
dis3 strain is inviable). Therefore, the homologous
dis3 and SSD1 proteins may function in a similar
fashion relative to the catalytic subunits of type
1/type 2-related protein phosphatases (dis2 and SIT4,
respectively). Unfortunately, the activities provided
by dis3 and SSD1 are not known.
To date, we have not been able to detect
phosphatase activity in SSD1-v immunoprecipitates.
However, such an activity may be very weak. The
levels of SSDI transcript and SSD1 protein are very
low. In fact, expression of the SSD1-vl-coding se-
quences from the GAL10 promoter in cells grown on
glucose medium (which represses the GAL10
promoter) provides complete SSDI -v function and
gives transcript levels equivalent to those from the
normal SSD1-v1 gene. Further analysis will be re-
quired to understand the function of the SSD1-v gene.
A Genetic Search for the SIT4
Regulatory Subunits
A. Doseff
In an otherwise wild-type cell, the SSD1 gene is dis-
pensable. Cells containing a deletion of SSD1 have a
growth rate that is very similar to that of wild-type
cells. However, in cells containing a deletion of
SSDI, the SIT4 gene is essential. Put another way,
Asit4 strains require SSD1 -v. Therefore, to obtain
mutations in genes functioning in the SIT4 pathway,
we isolated mutants that require the SSD1-v1 gene for
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viability. We are most interested in obtaining the
genes encoding p190 and p155, two proteins that
coimmunoprecipitate with SIT4.
From a screen of 160,000 colonies resulting from
EMS-mutagenized cells, we obtained about 80
mutants that are inviable or extremely slow growing
in the absence of SSD1-v1. As expected, some of
these mutants contain a mutation in the SIT4 gene it-
self. The other non-SIT4 mutants were placed into
complementation groups. This analysis shows two
main complementation groups and possibly six addi-
tional complementation groups. We are using further
genetic analysis to demonstrate that these mutations
are in the SIT4 pathway. Meanwhile, we are cloning
the genes for the two main complementation groups.
Hopefully, this analysis will provide us with every
gene whose product is required for the SIT4 pathway.
The identification of the genes for p155 and p190
will greatly aid in the biochemical analysis of SIT4.
The SIS2 Protein: A Component
of the SSD1 Pathway?
C. Di Como
A Asit4 SSD1-v strain is surviving via the SSD1-v
pathway and has a slow-growth defect. The wild-type
SIS2 gene in high copy number dramatically stimu-
lates the growth rate of this strain. This result raises
two possibilities: (1) overexpression of the SIS2
protein stimulates the SSD1-v pathway or (2) SIS2
functions downstream from SIT4 but that overexpres-
sion of SIS2 compensates for the lack of the normal
SIT4-dependent regulation of some substrate's
phosphorylation state. We favor the first possibility
for a number of reasons. First, like SSD1, the SIS2
gene is not essential. Deletion of SIS2 causes only
subtle phenotypic alterations. Second, deletion of
both SSD1 and SIS2 causes no additional phenotypic
effects. Such a result would be expected from genes
functioning in the same pathway. If deletion of SSD1
causes a nonfunctional pathway, then the additional
deletion of SIS2 should cause no additional effect.
Third, deletion of SIS2 (like ssdl-d alleles or deletion
of SSD1) is lethal in combination with deletion of
SIT4. Put another way, a Asit4 strain is surviving via
the SSD1-v pathway and the function of this SSD1-v
pathway requires SIS2. To further support the conten-
tion that SIS2 and SSD1-v function in the same path-
way, we are determining if deletion of SIS2 causes an
effect similar to that of ssdl-d alleles or deletion of
SSD1 for every gene and phenotype for which SSD1
is known to affect.
Like SSD1, the SIS2 gene is expressed at very low
levels. The SIS2 gene predicts a protein with a
molecular mass of 64 kD. The predicted SIS2 protein
has a very unusual carboxyl terminus. Within a se-
quence of 58 amino acid residues, 53 of these
residues are glutamate or aspartate. Therefore, the
carboxyl terminus of SIS2 is extremely acidic. The
remainder of the SIS2 protein does not have sig-
nificant homology with any sequences in the current
databases. In our ongoing biochemical and genetic
analyses of SIS2, we will determine (1) if SIS2 and
SSD1-v coimmunoprecipitate, (2) if SIS2 im-
munoprecipitates have phosphatase activity, and (3)
the biochemical defects of strains containing dele-
tions of SIS2.
The SIS1 Protein: An Essential dnaJ
Homo log
M. Luke, T. Zhong
The wild-type SISI gene in high copy number also
dramatically stimulates the growth rate of a Asit4
SSD1-v strain. The predicted SISI protein is similar
to bacterial dnaJ homologs in the amino-terminal
third and carboxy-terminal third of the proteins. Bac-
terial dnaJ proteins are required for bacteriophage
P1 phage, and host DNA replication. Although it is
believed that dnaJ mediates protein/protein dissocia-
tion and is also involved in proteolysis, the precise
cellular function provided by dnaJ is not known. The
middle third of SISI is not similar to dnaJ proteins.
This middle third region of SIS1 contains a
glycine/methionine-rich region that is required for
SISI to associate with a protein with an apparent
molecular mass of 40 kD. The SISI /p40 complex
elutes as a very large-sized complex (in the exclusion
volume of a Sepharose CL-6B column). This com-
plex appears to contain many p40 molecules for each
SIS1 molecule. We have developed a rapid method to
purify p40. Initial peptide sequence analysis indicates
that p40 does not correspond to any proteins in the
current databases.
The SISI gene is essential. Strains limited for the
SISI protein accumulate cells that are blocked for
migration of the nucleus from the mother cell into the
daughter cell. Certain mutations in SIS1 increase, and
other mutations in SISI decrease, the stability of a
centromere plasmid. The nuclear migration block and
the plasmid stability effects may be a result of the
same defective process in the sis/ mutants. The SISI
protein is localized throughout the cell but is more
concentrated at the nucleus. The daughter cells do not
stain for SISI protein until the nucleus is transferred
into the bud. Treatment of a yeast nuclear fraction
(which contains most of the SISI protein) with
RNase releases about one fourth of the SIS1 protein.
Treatment with DNase does not release SISI.
We currently do not know in what cellular pro-
cess(es) SISI functions. In addition, we do not know
if the essential function of SIS1 is the function that
stimulates the growth rate of a Asit4 SSD1-v1 strain.
However, our primary objective is to determine what
function SIS1 provides to stimulate the growth rate of
Asit4 SSD1-v1 strains. In vivo and in vitro experi-
ments are in progress to determine this function.
The Role of Type-2A Protein
Phosphatases in the
S. cerevisiae Cell Cycle
F. Lin
S. cerevisiae has two genes, termed PPH2a and
PPH2j3, that encode good homologs (about 80%
identity) of the catalytic subunit of mammalian type-
2A protein phosphatases. The predicted proteins,
PPH2a and PPH213, have amino-terminal extensions
not seen for other type-2A PPases. Although these
amino-terminal extensions are different for PPH2a
and PPH2(3, the remainder of the proteins are very
similar (98% identity over 310 amino acids). Strains
containing a deletion of PPH2a or PPH213 have only
subtle growth defects. However, deletion of both
PPH2a and PPH213 results in viability but with a
slow-growth phenotype. A third gene, termed PPH3,
was isolated by Hans Ronne and encodes a predicted
protein that is about 60% identical to the mammalian
type-2A catalytic subunit. Deletion of PPH3 by itself
causes no readily detectable phenotypic alterations.
However, deletion of PPH2a, PPH213, and PPH3
results in lethality. Therefore, PPH3 can partially do
some of the functions that PPH2a and PPH213
primarily perform.
One of our goals is to determine the role(s) of the
S. cerevisiae type-2A phosphatases in the cell cycle.
This analysis is greatly simplified with strains con-
taining temperature-sensitive mutations in PPH2a or
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PPH2(3. Since we had a very good temperature-
sensitive mutation in SIT4 (i.e., sit4-102) and since
the residue altered in sit4-102 is conserved between
SIT4 and all known type-2A PPases, we prepared
mutant PPH2a and PPH2I3 genes that alter this
residue. We term these alleles pph2a -102 and pph2(3-
102. A Apph2a Apph2(3 Apph3 strain containing ei-
ther pph2a -102 or pph213-102 is temperature-
sensitive for growth. When an asynchronous culture
of either strain is shifted to the nonpermissive
temperature, greater than 90% of the cells arrest with
a 2n DNA content. The majority of the cells contain a
single nucleus with a single microtubule-organizing
center. These results suggest that type-2A phospha-
tases are required for spindle pole body duplication
or separation, but not for DNA synthesis. We are fur-
ther characterizing the requirements of type-2A
PPases for the S. cerevisiae cell cycle.
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INITIATION AND TERMINATION OF TRANSCRIPTION IN
HUMAN sNRNA GENES AND HIV-1
N. Hernandez S. Lobo
J. Moreno
F. Pessler
R. Ratnasabapathy
SMALL NUCLEAR RNA GENES
C. Sadowski
M. Sheldon
M.L. Sullivan
Small nuclear RNA (snRNA) genes are members of a
family of genes that we refer to as the processor RNA
(or pRNA) gene family. pRNA genes encode RNAs
involved in the processing of other RNA molecules.
In addition, these genes share common promoter ele-
ments, even though some, such as the UI and U2
genes, are transcribed by RNA polymerase II,
whereas others, such as the U6 gene, are transcribed
by RNA polymerase III. Thus, both the RNA
polymerase II and III snRNA promoters contain an
enhancer characterized by the presence of an octamer
motif and a proximal sequence element (PSE), lo-
cated around position -50. We have shown previous-
ly that the element that defines the U6 promoter as an
RNA polymerase III promoter is a TATA box located
around position -25, which is absent from the RNA
polymerase II snRNA promoters. We are now in the
process of characterizing the factors involved in tran-
scription of both the RNA polymerase II and III
snRNA genes.
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HUMAN IMMUNODEFICIENCY VIRUS TYPE 1
Regulation of expression from the human im-
munodeficiency virus type-1 (HIV-1) promoter is a
complex process that involves cellular and viral
proteins. The viral protein Tat is a potent trans-
activator of HIV-1 gene expression, which functions
by activating transcription at the levels of both initia-
tion and elongation. Tat acts through an RNA target,
referred to as TAR, which constitutes the upper half
of a stable stem-and-loop structure encoded just
downstream from the HIV-1 transcriptional start site,
between positions +1 and +59.
Intriguingly, in the absence of Tat, transcription
from the HIV-1 promoter results mainly in the forma-
tion of short, stable transcripts that extend to posi-
tions +59 to +65 and therefore encompass the entire
stem-and-loop structure including the TAR element.
In the presence of Tat, the number of short transcripts
is strongly diminished, whereas the number of tran-
scripts that extend through the entire transcription
unit is increased. The short transcripts are believed to
result from transcription complexes that are not cap-
able of efficient elongation and therefore terminate at
random sites along the template. The resulting pre-
maturely terminated RNAs would then be trimmed
back by exonucleases to the base of the stable stem-
and-loop structure. In the presence of Tat, the number
of elongation-competent transcription complexes in-
itiated at the HIV-1 promoter would be increased at
the expense of the transcription complexes incapable
of efficient elongation, thus a resulting increase in
full-length RNAs and decrease in short transcripts.
We are interested in the mechanisms that govern
the formation of short transcripts. Indeed, the short
transcripts contain TAR, the target for Tat trans-
activation, and are therefore likely to play an impor-
tant role in the regulation of Tat trans-activation. In
addition, formation of short transcripts in HIV-1
depends only on cellular factors, suggesting the exis-
tence of equivalent processes in some cellular genes.
In past years, we found that the HIV-1 sequences be-
tween positions -5 and +82 relative to the start site of
transcription contained an element(s), which we refer
to as inducer of short transcripts (IST), that could in-
duce the formation of short transcript from the HIV-1
promoter or any other promoter we tested. IST ac-
tivates transcription, but the resulting RNAs are all
short. Thus, IST may be activating the formation of
transcription complexes not capable of efficient
elongation. We are now characterizing IST in more
detail and searching for factors involved in IST func-
tion.
Factors Involved in Transcription
of the Human U6 Gene
S. Lobo, J. Moreno, M. Sullivan, N. Hernandez
The factors required for transcription of RNA
polymerase III genes with internal promoter ele-
ments, such as the 5S genes, the tRNA genes, and the
VA genes from adenovirus 2 (Ad2), can be separated
into three fractions by chromatography of a crude
cellular extract on a phosphocellulose column. The
flowthrough fraction (A fraction) contains TFIIIA, a
factor required only for transcription of the 5S genes,
the 100-350 mm KCl fraction (B fraction) contains
TFIIIB, and the 350-600 mM KC1 fraction contains
TFIIIC. Both TFIIIB and TFIIIC are required for
transcription of all RNA polymerase III genes tested
to date. In yeast, TFIIIA and TFIIIC have been
shown to correspond to assembly factors, whose role
is to recruit TFIIIB into the initiation complex.
TFIIIB then contacts RNA polymerase III. Although
TFIIIA has been cloned and consists of a single
polypeptide, little is known about the polypeptide
composition of TFIIIB and TFIIIC. TFIIIB may con-
tain a polypeptide of about 60 kD, whereas TFIIIC
can be separated into two activities, TFIIIC1 and
TFIIIC2. TFIIIC2 activity has been purified to five
polypeptides, but TFIIIC1 has not been characterized
at all.
Transcription from the human U6 gene can be
reproduced in vitro in a combination of three frac-
tions from a phosphocellulose column: the B fraction,
the C fraction, and an additional high-salt (600-1000
mM KC1) fraction or D fraction. The D fraction is not
required for transcription of other RNA polymerase
III genes, but it is known to contain the TFIID com-
plex, which is involved in transcription of mRNA-
encoding genes by RNA polymerase II. One of the
components of the TFIID complex is the TATA-box-
binding protein TBP. We have shown that both the C
and D fractions can be replaced by TBP. Indeed,
cloned human TBP expressed in Escherichia coli
binds to the U6 TATA box and selects RNA poly-
merase III to transcribe the U6 gene. Thus, TBP is
not exclusively an RNA polymerase II transcription
factor as was widely believed; it can also direct the
formation of RNA polymerase III initiation com-
plexes. How, then, does TBP recruit RNA poly-
merase III to the U6 promoter rather than RNA
polymerase II, as it does on TATA boxes of mRNA
promoters? A possibility is that TBP interacts with
the PSE-binding factor and that the resulting protein
surface recruits TFIIIB into the initiation complex.
TFIIIB would then in turn recruit RNA polymerase
III. An interaction between TBP and the PSE-binding
factor is suggested by our observation that the spac-
ing between the TATA box and the PSE is critical for
RNA polymerase III transcription of the human U6
gene.
To characterize in more detail the involvement of
TBP in transcription of the U6 gene and other RNA
polymerase III genes, we have generated a battery of
monoclonal antibodies directed against TBP. We
have obtained 33 different monoclonal antibodies,
which all recognize human TBP in Western blots and
in immunoprecipitations. These antibodies will allow
us to determine whether TBP involved in RNA
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polymerase III transcription is in a complex and
whether this complex differs from the TFIID com-
plex involved in RNA polymerase II transcription.
We are also fractionating the B and the C
phosphocellulose fractions further to identify addi-
tional factors involved in U6 transcription. The B
fraction has been fractionated over two additional
columns, and the activity required for U6 transcrip-
tion copurifies with an activity required for transcrip-
tion of the Ad2 VA gene. This activity therefore most
probably corresponds to TFIIIB. The C fraction has
been further purified over several columns. Fractions
required for U6 transcription contain a factor that
binds to the U6 PSE. The activity may therefore cor-
respond to the PSE-binding factor.
Factors Involved in Transcription
of the Human U1 and U2
snRNA Genes
C. Sadowski, S. Lobo, N. Hernandez
Transcription of RNA polymerase II snRNA genes
has been very difficult to reproduce in vitro. Yet, an
efficient in vitro transcription system is a prerequisite
for the identification and characterization of tran-
scription factors involved in transcription of these
genes. Recently, Gunderson et al. (Genes Dev. 4:
2048 [1990]), using a G-less cassette construct, were
able to obtain transcription of the human Ul snRNA
gene in vitro. We have reproduced these results and
can now obtain efficient in vitro transcription of
RNA polymerase II snRNA genes. We are in the pro-
cess of determining whether TBP is required for
RNA polymerase II transcription of snRNA genes.
Precise Mapping of the 1ST
Element in the HIV -1 LTR
M. Sheldon, R. Ratnasabapathy, N. Hernandez
From our previous work, the IST element was known
to be located between positions -5 and +82 relative
to the HIV-1 start site of transcription. Its precise
location, however, was not clear, and we did not
know whether IST consisted of a DNA or an RNA
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element, or both. To characterize IST further, we in-
troduced a series of mutations in the HIV-1 region
extending from +1 to +65. Because the secondary
structure that folds the short RNAs may be required
for their stability, all of the mutations we generated
maintain the secondary structure. In addition, the ef-
fects of the different mutations were tested both by
analysis of steady-state RNA and by analysis of nas-
cent RNA in run-on assays.
These analyses showed that the IST element is
located at the base of the stable stem-and-loop struc-
ture, consistent with the strong conservation of this
region in different HIV-1 isolates. As shown in Fig-
ure 1A, IST is distinct from TAR, which en-
compasses the upper half of the secondary structure.
Indeed, IST can be inactivated by the six double
point mutations shown in Figure 1A, which have
little effect on Tat trans-activation. In fact, IST ac-
tivity can be completely separated from TAR activity
by deletion of the upper part of the stem-and-loop
structure, as shown in Figure 1B. This construct,
referred to as pISTBu, produces large amounts of
short transcripts (which are shorter than the short
transcripts produced by the wild-type construct), but
cannot be trans-activated by Tat.
Interestingly, the construct pIST shown in Figure
1C, which is identical to that shown in Figure 1B ex-
cept for the insertion of two nucleotides that provide
pairing partners for the two bulged nucleotides, does
not produce any short transcripts as determined by
analysis of steady-state RNA. However, this con-
struct is active as determined by analysis of nascent
RNA in run-on experiments. This observation sug-
gests that this construct generates short RNAs effi-
ciently but that these are too unstable to be detected
by analysis of steady-state RNA. Thus, one element
required for IST function is an RNA element, whose
role is probably to stabilize the short transcripts. The
analysis of additional constructs shows that IST also
consists of a second element located between posi-
tions +1 and +19, which activates transcription of the
short RNAs.
Factors Involved in 1ST Function
R. Ratnasabapathy, F. Pessler, N. Hernandez
To understand further the mechanisms that govern
1ST function, we need to identify the trans-acting
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FIGURE 1 (A) Secondary structure that folds the first 59 nucleotides of HIV-1
RNAs. The six double point mutations that inactivate the 1ST element are shown,
as well as the locations of the TAR and 1ST elements. (B) Putative secondary
structure assumed by the short transcripts encoded by pISTBu. (C) Putative
secondary structure assumed by the short transcripts encoded by pIST. The two
inserted nucleotides are indicated.
factors involved in the process. We are screening
crude extracts as well as more purified fractions for
factors that will bind to the RNA and DNA com-
ponents of 1ST but not to mutated versions of the ele-
ment that do not direct the formation of short tran-
scripts in transfection experiments.
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TELOMERASE BIOCHEMISTRY AND
REGULATION
C.W. Greider C. Autexier
A.A. Avilion
L.A. Harrington
L.L. Mantel)
K.R. Prowse
S.K. Smith
Telomerase is a highly specialized DNA polymerase
that synthesizes the telomeric sequence repeats
found
at the ends of eukaryotic chromosomes. The enzyme
contains an essential RNA component that is used as
a template for the de novo synthesis of telomeric se-
quences. This de novo synthesis allows maintenance
of telomere length during replication and may allow
healing of broken chromosomes. Telomerase activity
has been found in ciliates and transformed human
cell lines. Our long-term goals are to understand both
the detailed biochemistry and mechanism of telo-
merase and its regulation and effects on telomere
length in senescent and immortalized mammalian
cells. In the past year, our efforts have been con-
centrated in the following areas: The role of telo-
merase RNA in primer recognition, the regulation of
Tetrahymena telomerase RNA in vivo, the structure
and dynamics of human telomere shortening, and the
role of telomere length and telomerase in cellular
senescence and immortalization.
Telomerase Primer Recognition
and Chromosome Healing
L.A. Harrington, C.W. Greider
Last year, we described the analysis of Tetrahymena
telomerase processivity. The essential RNA of
telomerase contains within it the sequence 5 ' -CAA-
CCCCAA-3 ' , which provides the template for the
synthesis of d(TTGGGG) repeats (Greider and
Blackburn, Nature 337: 331 [1989]; Yu et al., Nature
344: 126 [1990]). Characterization of the telomerase
mechanism using primer challenge experiments indi-
cated that the enzyme processively synthesized about
500 nucleotides before half of the enzyme dissociated
from a given primer. Analysis of the banding pattern
suggested that translocation on the RNA template is a
slow step in the elongation of the TTGGGG repeat
chain.
To define the role of the RNA in primer binding
and elongation further, we examined the elongation
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of chimeric oligonucleotides. Telomeric oligonucleo-
tides are elongated by telomerase, whereas nontelo-
meric oligonucleotides are not telomerase substrates.
To test whether hybridization between the 3 ' end of
primer oligonucleotides and the telomerase RNA
template was an absolute requirement for elongation,
a series of chimeric oligonucleotides containing non-
telomeric sequence and telomeric d(TTGGGG)
repeats at either the 5 ' or 3 ' end were tested for
elongation in vitro. One to three d(TTGGGG)
repeats, or d(GGGG), when placed at the 3' end of
the nontelomeric pBR sequence, were sufficient for
elongation. Strikingly, two or three repeats of
d(TTGGGG) placed at the 5 ' end of oligonucleotides
with nontelomeric 3 ' ends were also telomerase sub-
strates. We tested chimeric oligonucleotides contain-
ing two d(TTGGGG) repeats at the 5 ' end and from
6 to 36 bases of pBR sequence at the 3 ' end; all of
these chimeric oligonucleotides were elongated by
The elongation of all primers was in-
hibited by preincubation of telomerase with RNase
A, indicating that elongation of these chimeric
oligonucleotides, like that of telomeric sequences, re-
quires telomerase RNA. To determine the specificity
of telomerase for the chimeric oligonucleotides, titra-
tion experiments were performed. Chimeric oligonu-
cleotides with two d(TTGGGG) repeats at the 5 ' end
were elongated at concentrations as low as 24 nM, as
was the telomeric substrate d(TTGGGG)4. The non-
telomeric oligonucleotide was only a very weak sub-
strate at oligonucleotide concentrations above 3 mm.
Three pieces of evidence showed that the elonga-
tion of chimeric oligonucleotides with 5' d(TTG-
GGG) repeats was not due to removal of nontelo-
meric sequences. First, telomerase elongation prod-
ucts began above the position of the input marker
oligonucleotide. Second, oligonucleotides incubated
with telomerase in the presence of [32P]dTTP
migrated with full-length marker oligonucleotides on
denaturing acrylamide gels. Finally, these end-
labeled chimeric oligonucleotides were subjected to
Maxam-Gilbert cleavage at dC residues. Digestion
products of the predicted sizes were obtained, provid-
ing further evidence that nontelomeric pBR se-
quences were retained during telomerase labeling.
Thus, hybridization of the 3 ' end of primer
oligonucleotides to the 5 ' -CAACCCCAA-3 ' tem-
plate region is not required for primer elongation.
We envision at least three models for the specific
elongation of oligonucleotides with nontelomeric se-
quence at the 3' end (Fig. 1). In the first model,
telomerase binds to the 5 ' end of a chimeric
oligonucleotide by RNA hybridization, and "slides"
to the 3 ' terminus to initiate d(TTGGGG) synthesis.
Alternatively, the 3 'nontelomeric sequences are
"looped out" to juxtapose directly the 3' end of the
oligonucleotide with the RNA template. A third pos-
sibility is that telomerase recognizes telomeric DNA
independent of telomerase RNA, for example, by
DNA-protein recognition of G-rich sequences. This
complex could then translocate to the 3 ' terminus of
the oligonucleotide, to initiate d(TTGGGG)n syn-
thesis. In addition to dissecting the telomerase mech-
anism, these experiments also provided the first
biochemical evidence that telomerase can "heal"
broken chromosomes by adding telomere repeats
onto nontelomeric sequences.
To distinguish between the RNA-dependent and
RNA-independent mechanisms for primer recogni-
tion, we needed to develop a new assay. Previously,
primer binding was measured by assaying telomerase
d(TTGGGG) addition. However, since the RNA
component is required for elongation, this assay can-
not distinguish between RNA-dependent and RNA-
independent primer recognition. To distinguish be-
tween these models, we have begun using methods
that look directly at primer binding, without the re-
quirement for elongation.
Telomerase Proteins and Antibodies
L.A. Harrington
We are continuing our efforts to identify the protein
components of telomerase. Our most highly purified
preparations are approximately 3000-fold purified
and contain about eight polypeptide species. Al-
though purification has been difficult due to the in-
stability of the enzyme, we are pursuing several ap-
proaches to identify telomerase subunits. First, we are
purifying the enzyme further to identify the polypep-
tides that copurify with enzyme activity. Second, we
are using UV cross-linking and South- and North-
western blots to identify the polypeptides that bind
(TTGGGG) primer and RNA. Finally, we are making
monoclonal antibodies against the most highly
purified fractions. These approaches should allow the
identification of the functional polypeptide(s) in our
most pure preparations.
Telomerase RNA Expression
A.A. Avilion, L.A. Harrington
We have carried out a developmental study of
telomerase expression to study enzyme regulation
and to determine the optimal conditions for enzyme
preparation. Preliminary experiments suggested that
more telomerase activity was present during macro-
nuclear development in Tetrahymena than during
vegetative growth (Greider and Blackburn, Cell 43:
405 [1985]). During macronuclear development,
germ-line chromosomes are fragmented and new
telomeres are added onto the ends of each fragmented
piece. Since telomerase adds these new telomeres, it
was reasonable to believe that more enzyme might be
present during this developmental stage.
To test this directly, we estimated the amount of
telomerase by determining level
RNA present in mating, starved, or vegetative cul-
tures. Using quantitative Northern blots and the
Phosphor Imager, we determined that there are ap-
proximately 25,000 telomerase RNA molecules per
cell. We next compared the amount of telomerase
RNA at 0, 3, 6, 9, 12, 15, and 24 hours after mixing
of cells for mating. To normalize the Northern signal
to the number of cells loaded, equal counts of a
radioactive marker were added to equal numbers of
cells before RNA extraction. Telomerase RNA levels
increased at 9 hours after mixing cells of opposite
mating type (Fig. 2). There was only a small increase
in the level of telomerase RNA in the mated cultures
compared to nonmated (starved vegetative) control
cultures. To determine whether the RNA levels
reflect the level of telomerase activity, extracts were
made from mated or nonmated cultures. Again, only
a small increase in the activity of the mated extracts
was found. These results indicate that the level of
telomerase activity parallels the amount of telomer-
ase RNA. The finding that extracts from both starved
and mated cultures had significantly more activity
than extracts from cells growing in rich media has al-
lowed us to optimize our enzyme preparation.
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FIGURE 1 Three models for telomerase elongation of nontelomeric oligonucleotide termini. The
telomerase RNA template region and complementary telomeric sequence are shown in bold. Newly
synthesized d(TTGGGG) is shown in bold and underlined. (A) Telomerase binds to the 5 ' telomeric
or G-rich sequence via hybridization of telomerase RNA. After recognition, the complex tracks to the
3' end of the oligonucleotide and initiate d(TTGGGG) synthesis. (B). Telomerase RNA recognizes 5'
G-rich sequences as in A. Nontelomeric sequences are looped out, retaining hybridization of the 5'
end of the oligonucleotide, while bringing the 3' end close to the RNA template to allow
d(TTGGGG) synthesis. (C) Telomerase possesses an RNA-independent ability to recognize and
bind G-rich structures that positions telomerase RNA at the 3' terminus of the oligonucleotide to in-
itiate telomere addition.
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FIGURE 2 Northern blot analysis of Tetrahymena telomerase RNA levels in mated and nonmated cells. RNA
was extracted from a total cell lysate (4.5 x 105 cells per time point) and analyzed by a Northern blot. The
radioactively labeled 346 and 396 DNA fragments were used as an internal control. (A) Mated cells. (Lane 1)
Telomerase T7 RNA transcript (1 ng) mixed with total cellular RNA from vegetative cells; (lanes 2-8) cellular
telomerase RNA from mated cells at the time points indicated above each lane; (lane 9); cellular telomerase
RNA from mated cells that were transferred to complete media 13 hr after mixing and harvested at 24 hr;
(lane 10) cellular telomerase RNA from vegetative cells grown in complete media (control). (B) Same as in A
but with nonmated (starved vegetative) cell culture.
Structure and Dynamics of
Human Telomeres
K.R. Prowse [in collaboration with B. Abella
and B. Futcher, Cold Spring Harbor Laboratory,
and C. Harley, McMaster University, Canada]
In addition to telomerase biochemistry, we are inter-
ested in how telomere length is maintained in vivo.
We have found that as primary human fibroblasts di-
vide and undergo senescence in culture, telomeric se-
quences are lost from chromosome ends (Harley et
al., Nature 345: 458 [1990]). The limited replicative
capacity of primary fibroblasts was well documented
by Hayflick and others in the 1960s; however, the
mechanism that limits cellular life span is not yet
known. We have recently shown that telomere
shortening occurs in vivo as well as in vitro. Primary
fibroblasts from older individuals have shorter
telomeres than those from younger individuals.
To determine whether telomere shortening in
vitro was due to the cell's chronological age or to the
number of divisions, primary fibroblasts were pas-
saged for 48 mean population doublings (MPD). The
culture was then divided into two, and half of the
cells were cultured continuously at 1:8 split ratios.
The other half were allowed to reach quiescence (day
5) and held quiescent for a further 3, 10, or 17 days.
The genomic DNA was prepared from each culture,
digested with restriction enzymes, and hybridized
with the (TTAGGG)3 probe. Similar experiments
were carried out using cells that were passaged con-
tinuously for either 57, 66, or 69 MPD: At each of
these MPD, several plates were set aside and the cells
were held quiescent for up to 30 days. The mean
length of the terminal restriction fragment was
determined from quantitation of the (TTAGGG)3
hybridization signal in the agarose gels (Fig. 3). No
shortening of the terminal restriction fragment was
seen while the cells were quiescent in culture. How-
ever, those cells that were passaged continuously did
show the characteristic telomere shortening. The con-
stant length of the telomere restriction fragments
when cells are not allowed to divide suggests that
telomere shortening is linked to DNA replication.
Primary cells from different donors show distinct
modes of telomere length distributions (Fig. 4A).
These multimodal distributions could arise in several
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FIGURE 3 Cell division is required for telomere shortening.
The mean length of the terminal restriction fragment was
determined by quantitating the (TTAGGG) hybridization sig-
nal in the gel at 30 contiguous regions ranging from 4 kbp to
30 kbp. Several plates were set aside from a continuously
growing culture of HSC172 at four different mean population
doublings (MPD) (48, 57, 66, and 69). The cells were al-
lowed to reach confluence and held quiescent for the num-
ber of days indicated. The TRF length is plotted versus the
total number of days in culture for both the passaged and
the quiescent cells. The solid line connects cells that were
continuously passaged. Dashed lines represent cells that
were held quiescent in culture. The numbers at each point
refer to the number of MPD the cells attained before the cul-
ture was either passaged or held quiescent.
ways. They may reflect the different position of the
most terminal restriction site on different chromo-
somes or sets of chromosomes. Alternatively, if the
terminal restriction site is a fixed distance from the
beginning of the d(TTAGGG) repeats, the multi-
modal distribution could be due to different numbers
of d(TTAGGG) repeats on different chromosomes. If
the amount of d(TTAGGG) on the end of human
chromosomes determines the number of replications
the cells can undergo, it is important to know whether
there is one or several distinct tract lengths of
d(TTAGGG) on all of the chromosome ends. Quanti-
tative analysis of several different multimodal
samples suggests that most of the length differences
in the different modes are attributable to different
amounts of subtelomeric DNA. There is only a small
amount of variation in the length of d(TTAGGG) be-
tween the different modes (Fig. 4B). This is con-
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FIGURE 4 Fibroblast DNA samples from different individ-
uals show multimodal telomere distributions. (A) Fibroblast
DNA from F001, S4A, S2C, or HSC172 cells at the indi-
cated MPD were digested with Mspl and Rsal and sepa-
rated in a 0.5% agarose gel, and the gel was hybridized to
end-labeled (TTAGGG)3 oligonucleotide. (Lane 1) End-
labeled 1-kbp ladder marker DNA; (lanes 2,3) F001 DNA;
(lanes 4,5) S4A DNA; (lanes 6,7) S2C DNA; (lanes 8,9)
HSC172 DNA; (lane 10) end-labeled HMW(BRL) markers.
(B) Multiple modes are due primarily to difference in the
non-TTAGGG "barren" DNA on the terminal restriction frag-
ment.
sistent with what has been found for telomeres in
single-cell eukaryotes, where the number of telomeric
repeats is similar on different chromosomes.
Human Telomeres and Telomerase
in Cellular Senescence
and Immortalization
A.A. Avilion [in collaboration with C. Counter, C. Harley,
and S. Bacchetti, McMaster University, Canada]
Human sperm telomeres are several kilobases longer
than somatic cell telomeres. This, together with the
telomere reduction observed during replication of pri-
mary fibroblasts, suggests a simple model for telo-
mere shortening: Human telomerase is active in the
germ line where telomeres are lengthened, and then
telomerase is inactive in somatic cells. The net loss of
telomeric sequences may then occur in somatic tissue
through incomplete replication at each round of divi-
sion. We have begun experiments to look for the
presence of telomerase activity in the primary
fibroblasts where telomere shortening has been docu-
mented. In three separate experiments, we found that
activity was detected in transformed human 293 cells
but was not detectable in extracts from primary cells.
As a control, primary fibroblasts were mixed with
293 cells; telomerase activity was detected, indicating
that a diffusible inhibitor is not present in the
fibroblasts. These experiments support the model that
telomerase may not normally be active in somatic
cells.
Telomerase activity is found in some immortal
human cell lines such as He La and 293, where telo-
mere length is maintained at a constant, but shorter,
size than that of the tissue of origin. In collaboration
with Calvin Harley and Silvia Bacchetti at McMaster
University, we have looked at the effect of SV40
transformation on telomere length and telomerase ac-
tivity in primary human embryonic kidney (HEK)
cells. HEK cells undergo only 10-12 doublings in
vitro. Clones of HEK cells transformed with SV40
have an extended life span; after about 100 dou-
blings, the clones undergo "crisis." Most clones die at
crisis; however, the few that survive are immortal-
ized. Telomere length decreased as the primary HEK
cells were passaged and continued to decrease in the
extended life span clones. However, in the one im-
mortal clone obtained to date, telomere length was
short but stable after many rounds of division.
Telomerase activity was absent in the three extended
life span clones tested but was present in the im-
mortalized clone. These results suggest that one of
the events which occurs during immortalization is the
reactivation of telomerase activity.
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MOLECULAR CHROMOSOME STUDIES OF
ARABIDOPSIS THALIANA
E.J. Richards A. Vongs
S. Chao
J. Yang
We are currently pursuing three related projects in-
vestigating different aspects of molecular chromo-
some structure and genome organization using the
flowering plant Arabidopsis thaliana as a model sys-
tem. Two projects concern the characterization of
genomic DNA organization of centromeric and telo-
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meric regions. We are also continuing our character-
ization of A. thaliana mutants that contain markedly
reduced levels of cytosine methylation in an effort to
understand the function of DNA modification.
CHARACTERIZATION OF TELOMERIC DNA
FROM A. THALIANA
The ends of linear eukaryotic chromosomes are spe-
cialized structures, called telomeres, which allow
complete replication of the end of the chromosomal
DNA molecule and stabilize otherwise reactive DNA
ends. Telomeres in most organisms have an unusual
DNA structure, being composed of tandem arrays of
short, G-rich repeats. The genomic regions that flank
the telomeric repeats, termed telomere-associated se-
quences, are generally rich in more complicated
repetitive elements that exhibit variability in terms of
DNA structure and chromosome distribution.
In an effort to complete the molecular description
of A. thaliana chromosomal termini, we are analyz-
ing A. thaliana telomere clones recently isolated by
selection for plant DNA fragments that function as
telomeres on yeast artificial chromosome (YAC) vec-
tors. The eight telomere clones represent six different
genomic locations. We have characterized three of
these clones in some detail. All three clones contain a
block of telomeric repeats and flanking telomere-
associated sequences. Surprisingly, the flanking se-
quences in two of the clones are composed of single-
copy sequences. The region flanking the telomeric
repeat block in the third clone contains a repetitive
element present at several other A. thaliana telo-
meres. DNA sequence analysis revealed a substruc-
ture to the telomeric repeat block in two of the
clones: Long arrays of TTTAGGG repeats are found
in the distal portions of the clones, whereas the
centromere-proximal regions contain variant and
degenerate repeat motifs.
In addition to providing a description of the
genomic organization of the chromosome ends, we
hope that the new telomere clones will allow the ends
of the genetic and physical maps of A. thaliana
chromosomes to be established. Toward this end, we
have been collaborating with a number of A. thaliana
mapping groups. Recently, the DuPont group (Wil-
mington, Delaware) and the Meyerowitz laboratory
(California Institute of Technology) have positioned
two of the telomere clones on the restriction-frag-
ment-length polymorphism (RFLP) map, at the end
of chromosomes 1 and 5.
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CHARACTERIZATION OF CENTROMERIC DNA
FROM A. THALIANA
We are interested in identifying and characterizing
the DNA sequences required for centromere function
as a first step toward understanding how centromeres
work. At present, functional centromeric DNA se-
quences have been identified in only two systems,
Saccharomyces cerevisiae and Schizosaccharomyces
pombe. The picture that emerges from centromere
studies in the yeasts is rather confusing; the budding
yeast centromeres are quite small (120 bp) and do not
resemble the large (50-100 kb) arrays of repetitive
DNAs that make up S. pombe centromere regions
(Clarke, Trends Genet. 6: 150 [1990]). Although it is
thought that the S. pombe centromeres may provide a
simple model for the larger, more structurally com-
plex centromeres of higher eukaryotes, we have de-
cided to begin characterizing a higher eukaryotic
centromere directly.
Our approach to isolating A. thaliana centromeric
DNA is based on the strategy initially used to clone
yeast centromeres. The first stage involves determin-
ing a genetic map position for the target centromere
and identifying molecular markers that flank the
centromere. Analysis of the genomic regions en-
compassing the centromere can then be initiated
using these flanking markers. In addition, cloning of
the centromere can be achieved by isolating the
genomic DNA between the flanking markers.
We have focused on mapping and characterizing
A. thaliana centromere 1. The initial mapping stage
of the project has been completed this year, as sum-
marized in Figure 1. To map A. thaliana centro-
mere 1, we relied on a set of aneuploid mutants that
contain a single telocentric chromosome 1 derivative
in addition to the diploid set of ten metacentric
A. thaliana chromosomes. Two such telotrisomic
lines exist (Tr1A and Tr1B), each carrying one of the
two arms of chromosome 1 as an additional telocen-
tric. Genomic DNA was prepared from TrlA plants
carrying two copies of the A chromosome arm from
one ecotype parent and one dose from another
ecotype parent. Similar Tr1B material was also gen-
erated, and genomic DNA was prepared. RFLP
markers located in the center of chromosome 1 were
positioned on the A or B arm by determining the
dosage of the RFLP alleles after Southern hybridiza-
tion. The markers were then ordered by reference to
recombination breakpoints. The centromere was posi-
tioned between the most proximal markers as il-
lustrated in Figure 1.
Our focus now shifts to assembling a long-range
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FIGURE 1 The genetic map of A. thaliana chromosome 1 is shown at the top of the figure (Koornneef, Genetic maps, Cold
Spring Harbor Laboratory [1987]). The approximate position of cent relative to classical genetic markers was determined by
Koornneef (Genetica 62: 33 [1983]) by analyzing crosses between marked strains and telotrisomic plants carrying the
telocentric chromosome derivatives. Correlations between the classical genetic and RFLP maps (Nam et al., The Plant Cell
1: 699 [1989]) are indicated by the dashed lines. The stippled boxes shown below the RFLP map indicates the coverage of
the overlying RFLP markers by the telocentric chromosome derivatives Tr1A and Tr1B. The position of cent is shown at the
bottom of the figure, bracketed by the RFLP markers bAt299 and pAtT12 (shown in boxes; window size = roughly 4 cm).
restriction map of the region to determine the size
and DNA organization of the centromere. Such in-
formation will supply a foundation for the next
phase: isolation of centromeric sequences in YAC
vectors and functional analysis of these sequences.
DNA HYPOMETHYLATION MUTANTS
Although DNA methylation has been implicated in a
number of cellular processes in eukaryotes, very little
is known about the nature and regulation of the en-
zymatic machinery that carries out cytosine methyla-
tion or the function of this DNA modification. In col-
laboration with Rob Martienssen's laboratory (see
this Section), we are taking a genetic approach to ad-
dress these questions, using A. thaliana as a experi-
mental organism. Plants, such as A. thaliana, provide
an opportunity to dissect a fundamental process that
cannot be easily addressed in well-developed genetic
models such as nematodes, Drosophila, and the
yeasts, which lack detectable levels of cytosine
methylation.
At present, three independent, allelic hypo-
methylation mutations have been recovered from M2
populations of EMS-mutagenized seeds by screening
for plants that have centromeric satellite repeats sus-
ceptible to digestion by methylation-sensitive
endonucleases. Both satellite arrays and rDNA are
hypomethylated in the mutants, although methylation
at some single-copy sequences is unaffected.
Measurement of global methylation levels indicate
that the cytosine methylation is reduced up to 80% in
the mutants. Strikingly, the mutants do not display a
morphological phenotype that can be associated with
hypomethylation.
Study of the hypomethylation mutants is now
focused on isolation of more severe alleles or second-
site mutations that reduce or abolish the residual
levels of cytosine methylation. In addition, the extant
hypomethylation mutants are being investigated to
assess the role that cytosine methylation plays in a
variety of processes, including epigenetic regulation
of transgenes, recombination, rDNA expression,
DNA replication timing, and chromosome behavior.
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It is anticipated that study of these mutants, as well as
isolation of mutations that cause hypermethylation or
alterations in the sequence distribution of methyla-
tion, will provide an understanding of the biology of
DNA methylation in eukaryotes.
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STRUCTURE AND COMPUTATION
This section includes five laboratories interested in the detailed structural
properties of proteins and computational biology. Dr. John Anderson is a macro-
molecular crystallographer currently attempting to solve the structure of the Pvull
restriction endonuclease. His laboratory is also pursuing studies of transcription
factors. Dr. Jim Pflugrath is also a crystallographer whose laboratory has recently
solved the structure of T7 lysozyme. Dr. Rich Roberts' laboratory has had a long-
standing interest in restriction enzymes and methylases. Recently, in collabora-
tion with Drs. Jim Pflugrath and Xiaodong Cheng, crystals of the first cytosine
methylase have been obtained. Dr. Jeff Kuret studies protein kinases and is
working on the structure of the cAMP-dependent protein kinase from yeast in col-
laboration with Dr. Pflugrath. Dr. Kuret is also studying casein kinase I. Finally, Dr.
Tom Marr is a computational biologist who joined this section in 1989 and whose
laboratory has expanded considerably during the last year. Dr. Marr is interested
in database problems particularly those arising from the Human Genome Project.
MACROMOLECULAR CRYSTALLOGRAPHY
J.E. Anderson
J.W. Pflugrath
G.K. Balendran J. Keller D. Milano
X. Cheng C.-L. Lin F. Papanikolaou
C.K. Cheung T. Malone J.C. Wu
Structural Studies of Pvull
Endonuclease and Its
Interaction with DNA
G.K. Balendran, J. Keller, M. Slawecki, J.C. Wu,
J.E. Anderson [in collaboration with I. Schildkraut,
New England BioLabs]
The restriction endonuclease from Proteus vulgaris,
RPvull, recognizes the DNA sequence CAGCTG. In
the presence of magnesium, RPvull cleaves between
the central guanine and cytosine bases. We have
cocrystallized RPvull with an oligodeoxynucleotide
carrying its recognition sequence. To prevent
cleavage of the oligo, EDTA is included in the crys-
tallization buffer. The crystals are space °group
P212121 with unit cell dimensions a = 95.1 A, b =
85.6 A, c = 47.7 A, and they diffract to at least 2.6 A
resolution. We have collected native data to 3 A
resolution. To obtain phases for these data, we are
preparing isomorphous heavy atom derivative crys-
tals in two ways. The first is the conventional method
of soaking native cocrystals in solutions of various
heavy atom reagents. Two reagents, platinum ter-
pyridinium chloride and parachloromercuribenzoic
sulfate, yielded isomorphous crystals, and data sets
are being collected for each of these. The second ap-
proach takes advantage of the presence of DNA in
the crystal. The heavy atom is introduced by covalent
modification of the oligo, substituting an iodine atom
for the methyl group of thymine at two symmetrically
related positions in the sequence. This simplifies the
task of locating the iodine atoms and hence of cal-
culating the phases, because we expect the conforma-
tion of the DNA in the crystal to be similar to the
well-known structure of B-DNA. Isomorphous
cocrystals were grown with two such iodinated
oligos. Analysis of data collected from them indi-
cated that the percentage of oligos actually containing
iodine was too low to provide phases. Iodinated
oligos have been resynthesized, taking care in pro-
cessing and handling to ensure a useful iodine oc-
cupancy, and data collection is under way. Once
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phases are determined using the various derivatives,
we will calculate a multiple isomorphous replace-
ment (MIR) electron density map and begin building
a model of the complex.
To truly understand the enzymology of RPvt/II,
we need the structure of the apoprotein. We have two
crystal forms of RPvull grown in the absence of
DNA that diffract to better than 2.5 A. One crystal
form is space group P422 with a = b = 176.2 A, c =
50.6 A, and the other is space group P21212 with a =
106.6 A, b= 84.6 A, c= 46.9 A. We have collected a
partial native data set from the P21212 crystal form,
which is more stable but less abundant than the P422,
and have initiated a search for heavy atom derivatives
using the conventional soaking technique.
Structural Studies of AP-1 Proteins
C.K. Cheung, J. Keller, J.E. Anderson [in collaboration
with T. Curran, Roche Institute]
The protein products of the proto-oncogenes c-fos,
c-jun, and a number of related genes form a major
component of eukaryotic transcription factor AP-1
activity. Heterodimers of Fos-related and Jun-related
proteins, and homodimers of Jun-related proteins,
bind to DNA at AP-1 sites (TGACTCA) in the
promoters of many genes. Once bound, they can ac-
tivate or repress transcription, depending on the com-
position of the dimer and the context within which it
binds DNA. During the last year, we have con-
centrated our efforts on purifying and crystallizing
complexes of bacterially expressed rat Fos- and Jun-
related proteins with cognate DNA. We have purified
and prepared complexes of intact Jun with oligo-
deoxynucleotides containing AP-1 sites. We have
also prepared protein-DNA complexes using trun-
cated Fos and Jun proteins that contain the DNA-
binding basic region/leucine zipper (bZIP) domains
of each protein, along with some additional flanking
residues. Although the concentration and purity of
these preparations are suitable for crystallization,
none have yet produced crystals. The reason for this
may lie in the stability of the folded structure of the
proteins. Intact Jun, a 334-residue transiently ex-
pressed protein that is normally part of a multi-
protein transcription complex, may not fold properly
in the absence of the other transcription factors, even
in the presence of cognate DNA. The truncated
proteins contain sequences outside of the bZIP
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domain that may not fold properly in the absence of
the rest of the protein. We therefore decided to focus
on proteins containing only Fos or Jun residues cor-
responding to the respective bZIP domains. We ob-
tained Escherichia coli strains expressing Fos and
Jun bZIP proteins from Dr. Curran. We have purified
the bZIP proteins, and crystallization trials are now
under way.
Structural Studies of S1000
T. Malone, F. Papanikolaou, J.W. Pflugrath [in collaboration
with D. Marshak, Cold Spring Harbor Laboratory]
Predominant among water-soluble brain proteins is
S100(3, an acidic 10.5-kD protein that contains the se-
quence requirements necessary to form two EF hand
calcium-binding loops. Besides the postulated cal-
cium signal mediation function, S10013 binds zinc
very tightly and has been implicated in its dimer form
as a neurite extension factor. In both Alzheimer's dis-
ease and Down's syndrome, elevated levels of S10013
have been detected. To understand better the function
of S10013 and the role that calcium plays in its dimer-
ization, we will determine its structure to atomic
resolution.
Although we had previously crystallized bovine
S10013, the analysis of these crystals was not pursued
because we could not purify the protein to homo-
geneity from brain extracts, making reproducible
crystals difficult to obtain. We were much more suc-
cessful with the recombinant rat S10013 produced in
the bacterium Escherichia coli. We now obtain
15-20 mg of pure S10013 from a liter of bacterial cell
culture in 3 days. The recombinant protein was as ac-
tive as our earlier bovine brain preparations in an as-
say for neurite extension factor activity. This indi-
cates that the lack of amino-terminal acetylation and
loss of some of the initiator methionine in the recom-
binant protein do not alter its function and activity.
Early crystallization trials of the recombinant
S10013 yielded crystals that did not diffract well in an
X-ray beam. By adjusting the pH of the trials, we
were able to obtain crystals with a different morphol-
ogy that diffract to beyond 2.2-A resolution. These
crystals are thick diamond-shaped plates and have
space group C2221 with cell dimensions 36 x 88 by
61 A. A diffraction data set of 14,890 measurements
collected on our FAST area detector was merged into
2910 unique structure factors with a Rmerge of 4.9%
that was 94% complete to 2.7 A resolution. We plan
to use the molecular replacement method with search
model phases calculated from the atomic coordinates
of the homologous intestinal calcium-binding protein
to determine the structure of s oop.
Yeast cAMP-dependent
Protein Kinase
J.W. Pflugrath, T. Malone, X. Cheng, J. Kuret
An initial electron density map that we obtained for
the yeast cAMP-dependent protein kinase proved to
be only partially interpretable. In an effort to over-
come this, we will recollect all of our diffraction data
at the nearby National Synchrotron Light Source. In
addition, we have changed the crystal harvesting
buffer to one that stabilizes the crystals for months
instead of a few weeks. This increased stability al-
lowed us to soak crystals for a longer time than was
previously possible in heavy atom compounds. Un-
fortunately, such soaks did not reveal any new sub-
stitutions.
Area Detector Software
J.W. Pflugrath [in collaboration E.M. Westbrook,
Argonne National Laboratory]
In the past year, the device-independent area detector
software system MADNES was adapted for use on
the larger CCD-based detector of M. Strauss and E.
M. Westbrook of Argonne National Laboratory for
use at synchrotrons. This detector, which has 1024 by
1024 pixels, is being tested at beamline X8C of the
National Synchrotron Light Source.
Three-dimensional Structure of
Bacteriophage T7 Lysozyme
X. Cheng, J.W. Pflugrath [in collaboration with X. Zhang
and F.W. Studier, Brookhaven National Laboratory]
T7 lysozyme is a unique enzyme in several ways. (1)
Most of the well-studied lysozymes, such as hen egg
white and phage T4 lysozymes, are endoacetyl-
muramidases that cut the glycosidic bond between
sugar residues of NAM and NAG on the pep-
tidoglycan layer of bacterial cell walls. T7 lysozyme,
however, is an N-acetylmuramyl-L-alanine amidase
that cuts the amide bond between peptide and sugar.
It has recently been identified to be a Zn++ metal-
loenzyme. (2) T7 lysozyme can specifically bind to
T7 RNA polymerase and inhibit its transcription.
Therefore, this protein has been used in an inducible
T7 expression system to reduce the basal level of
target gene expression and allow the cloning of rela-
tively toxic genes. (3) Unlike other phage lysozymes
that are synthesized late in phage infection and sim-
ply perform cell lysis, T7 lysozyme is expressed early
and is involved in the transcription shutoff and DNA
replication, as well as in lysis and progeny phage
release. These unique properties of T7 lysozyme
make it an interesting protein for structural analysis.
CRYSTALLIZATION
T7 lysozyme is a 17-kD protein encoded by T7 gene
3.5. It has been cloned, overexpressed, and purified
to homogeneity. However, extensive trials to obtain
the crystal of wild-type T7 lysozyme have been un-
successful. X. Zhang and F.W. Studier constructed a
lysozyme mutant (named AK6) that deletes amino
acids 2 through 5 (Arg-Val-Gln-Phe) from the amino
terminus. The AK6 mutant has normal cell wall cut-
ting activity but is completely unable to bind or in-
hibit T7 RNA polymerase.
Optimum conditions to crystallize AK6 mutant
were found: 5 ill of 10 mg/ml protein solutions were
mixed with the same volume of 20% (w/v) polyethy-
lene glycol 4000, 50 mM ammonium sulfate, and 50
mM sodium citrate at pH 6.6 and equilibrated versus
1 ml of the latter solution. At 16°C, small crystals be-
gan to appear within 10 minutes and reached a size of
0.5 x 0.6 x 1.5 mm overnight (Fig. 1). After crystals
of AK6 mutant were obtained, we crystallized wild-
type lysozyme by microseeding with crushed AK6
crystals. The size of the wild-type crystal reached
about 0.3 x 0.4 x 0.6 mm after 3-4 weeks, whereas
the same size crystal was obtained after 1 week when
the wild-type crystals were subsequently used for mi-
croseeding. No crystals of the wild-type lysozyme
were ever observed without microseeding.
The crystals displayed space group C2221 with
cell dimensions a = 46.5 A, A, = 62.5 A, and c = 110.0
A. There is one molecule in each of the eight asym-
metric units. The crystals diffracted beyond 2.2 A
and were stable in the X-ray beam for 6 days.
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FIGURE 1 Crystal shown is from AK6 mutant lysozyme
from bacteriophage T7.
HEAVY ATOM DERIVATIVE, ELECTRON DENSITY
MAP, AND REFINEMENT
We obtained two mercury derivatives by cocrystalliz-
ing protein with mercury chloride and soaking native
crystals in p-chloromercuriphenyl sulfonate. Both
showed the same single mercury site in isomorphous
difference Patterson and anomalous Patterson maps
(Fig. 2). Initial 2.5 A phases were obtained by multi-
ple isomorphous replacement from these two deriva-
tives, along with mercury anomalous scattering sig-
nals. The overall figure of merit was 0.80 at 2.5 A
resolution. The initial 2.5 A phases produced electron
density maps that enabled us to trace the polypeptide
backbone and fit the complete sequence of 146 amino
acids. The crystal structure was subsequently refined
to the current crystallographic R factor of 21.5%
without water molecules for reflections between 10
and 2.2 A resolution with the use of restrained refine-
ment and molecular dynamics by the program X-
PLOR.
PROTEIN STRUCTURE
The most striking feature of the T7 lysozyme is a
Zn++-containing cleft built by three a-helices, five (3-
strands, and four loops (Fig. 3). The five (3 strands
031: residues 14-18; P2: residues 48-51; (33: residues
FIGURE 2 Harker section at w = 1/2. Peaks show mercury sites in isomorphous difference Patterson
map (left) and anomalous Patterson map (right).
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FIGURE 3 Topological diagram for the structure of T7 lysozyme. The central
region contains five adjacent p strands, numbers 5, 1, 4, 2, and 3. The active-site
zinc atom is bound to side chains of His-122 and Cys-130, which are part of the
loop region outside strand 05. In addition, His-17, which is the last second residue
of strand (31, is also bound to zinc. (Figure made by Mol Script [Kraulis, J. Appl.
Cryst. 24: 946 (1991)]. )
55-59; (34: residues 77-81; (3S: residues 117-121)
form a sheet: 131, (32, p4, and ps are parallel, and (32
and (33 are arranged in an antiparallel hairpin struc-
ture. This sheet constitutes the lining of the bottom of
the catalytic cleft. The long, 18-residue helix (a2:
residues 98-115) is underneath this sheet. The four
loops (11: residues 29-47; /2: residues 60-76; 13:
residues 82-96; /4: residues 122-134) form the two
edges of the catalytic cleft. Loops /1 and /2 are on
one side facing loops /3 and /4 on the other side. The
overall dimension of the cleft is 22-26 A long, 10-11
A deep, with two open ends of different widths.
Loops 11 and l3 form the wider end (20 A), and loops
l2 and l4 form the narrower end (10 A). The helix al
(residues 29-39) is part of loop 11, and a3 (residues
135-139) is near the carboxyl terminus.
A zinc cofactor was identified in the cleft that is
likely to be the substrate-binding site. Recent bio-
chemical study showed that the T7 lysozyme requires
Zn++ for its cell-wall cutting activity but not the tran-
scription inhibition activity, suggesting a catalytic
role, rather than structural role, for the Zn++. The zinc
atom is coordinated by three protein ligands His-17,
His-122, and Cys-130, and Tyr-46 is connected to
Zn++ through a fourth ligand (possibly an ordered
solvent molecule). Potential possible catalytic
residues within the cleft are His-36, Gln-39 on one
side and Lys-128 on the other. The side chains of
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His-36, Gln-39 and Lys-128, have the right orienta-
tion to interact with the bound substrate molecule. As
expected, no homology is found by comparing this
metalloenzyme with hen egg white and T4 lysozymes
in amino acid sequences, the respective backbones, or
the presumed modes of catalysis. We think that the
catalytic mechanism of T7 lysozyme is similar to that
of zinc proteases such as carboxypeptidase A and
thermolysin.
Mutants of T7 lysozyme that have decreased ac-
tivity to inhibit T7 RNA polymerase but retain
catalytic activity have been located in the amino
terminus and residues Arg-33, Gly-40, and Leu-42.
Arg-33 is within the helix al, and together with Gly-
40 and Leu-42, it is part of the loop 11 that resides on
the surface of the molecule. All of these three
residues face away from the catalytic crevice, and the
possible catalytic residues in loop 11 all face inward.
The distance between the amino terminus and this
region in loop 11 is about 10 A in the AK6 mutant
that lacks the interaction with T7 RNA polymerase. It
is conceivable that the additional four amino acids in
the wild-type protein will bring the two regions
closer and form a surface that specifically interacts
with T7 RNA polymerase.
Crystallization and Preliminary
X-ray Diffraction Studies
of the M. Hhal Methylase
X. Cheng, J.W. Pflugrath [in collaboration with S. Kumar
and R.J. Roberts, Cold Spring Harbor Laboratory]
The MHhal methylase from the bacterium Haemo-
philus haemolyticus catalyzes the transfer of a methyl
group from S-adenosylmethionine to C-5 of the inter-
nal cytosine in the tetranucleotide DNA sequence
GCGC. We searched for suitable MHhal crystalliza-
tion conditions using the hanging-drop vapor diffu-
sion technique combined with a sparse matrix screen-
ing method. We discovered crystals growing after 1
day from polyethylene glycol at 16°C. After careful
refinement of precipitant, salt concentrations, and pH,
we were able to grow crystals of the same morphol-
ogy at room temperature as well. The crystals grown
at higher temperature are larger in size and reached a
maximum size of approximately 0.9 x 0.3 x 0.1 mm
after 1 week. These conditions have consistently
yielded crystals from separate preparations of the
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protein. Since the MHhal protein was purified and
crystallized in the presence of S-adenosylmethionine,
we believe that the crystal obtained is possibly a
more informative cocrystal between MHhal and S-
adenosylmethionine, although this has not yet been
confirmed.
X-ray diffraction data were collected from single
crystals on our FAST area detector attached to a GX-
21 X-ray generator producing monochromated Ka
radiation (1.54 A). Crystals remain stable in the X-
ray beam for at least 3 days. At a crystal-to-detector
distance of 90 mm and swing angle of 20°, we were
able to complete our native data set to 3.0 A (>90%
completeness) and partially complete to 2.5 A
(>60%) from two crystals.
Crystals were of monoclinic space group P21 and
have unit-cell dimensions of a = 55.2 A, b = 75.0 A,
c = 90.2 A, and 1 103°. Assuming that the crystals
have an average packing density of approximately
2.4 A3 per dalton, the molecular weight of the asym-
metric unit is approximately 76,000 (= 2 x 38,000).
This is close to twice the predicted molecular weight
(37,000) of one polypeptide of MHhal methylase
and suggests that there are two molecules in the
asymmetric unit. Experiments are under way to
search for useful heavy atom derivatives and to
cocrystallize the protein with oligonucleotides con-
taining the recognition sequence GCGC.
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One major research effort in this laboratory is
directed at m5C-methylases, enzymes that are com-
mon to organisms ranging from bacteria to mammals.
The function of the methylases is to transfer a methyl
group from S-adenosylmethionine (SAM) to the C5
position of a cytosine residue in a specific double-
stranded DNA sequence. Methylated DNA sequences
have many different in vivo biological functions.
Prokaryotic m5C-methylases methylate the target se-
quences to prevent digestion by their cognate restric-
tion endonuclease. In eukaryotes, m5C is mainly
localized in CpG islands and may be involved in gene
regulation and cell differentiation. From a biochemi-
cal and structural standpoint, relatively little is known
about how m5C-methylases work. Comparison of the
primary structure of prokaryotic m5C-methylases
reveals an overall architecture and also in-
teresting differences: There are five highly conserved
sequence motifs about 10-20 amino acids long and
five moderately conserved motifs. We have recently
shown that DNA sequence recognition specificity
resides in the so-called variable region that lies be-
tween conserved motifs VIII and IX.
Sequence Specificity Domain
of m5C-Methylases
S. Klimasauskas
Prokaryotic DNA methylases recognize the same
short sequences on DNA as do the better-known
restriction enzymes, which they usually accompany.
To identify the region responsible for DNA sequence
recognition in the mono-specific DNA methylases,
we have constructed a series of hybrids between the
mono-specific methylases, MHpall (recognition se-
quence: Cm5CGG) and MHhal (recognition se-
quence: Gm5CGC), and tested the specificity of these
hybrid enzymes. These constructions take advantage
S. Klein
S. Kumar
C. Marcincuk
J. Posfai
of the conserved sequence motifs that are present
within the m5C-methylases so that the boundaries in
the hybrids are defined by the sequence motifs. The
first and the second junctions mark the boundaries of
the so-called variable region located between con-
served motifs VIII and IX, whereas the third junction
separates motifs IX and X. Two approaches were
used to make hybrid methylases. In the first ap-
proach, a plasmid was constructed with the two
methylase genes in tandem and arranged in the same
orientation. The polymerase chain reaction (PCR)
was used to construct exact deletions from the plas-
mid containing both methylase genes such that the
amino terminus of one methylase becomes joined to
the corresponding carboxyl terminus of the second
methylase. An alternative method (Splicing by Over-
lap Extension) used two PCR-generated intermediate
fragments, one of which contained a 20-nucleotide
extension overlap, so that fusion during PCR led to
the production of the required hybrid.
Each methylase gene was transferred into the vec-
tor, pUHE25-2, that contains a lad-repressible ex-
pression system driven by an early bacteriophage T7
promoter. Upon induction, it leads to hybrid
methylase synthesis in amounts above 10% of total
soluble proteins in the cell. The corresponding clones
carrying the genes for the wild-type MHpall and
MHhal have been used in separate experiments for
large-scale production, purification, and protein crys-
tallization experiments (X. Cheng and S. Kumar, un-
publ.).
All plasmid DNAs overexpressing the hybrid
methylases were tested for their susceptibility to
cleavage, in vitro, with the Hpall and Hhal restric-
tion enzymes. This allowed a determination of the ex-
tent of methylation in vivo. In the case of hybrids
with detectable activity, the specificity as well as a
qualitative estimation of the efficiency of methylation
could be determined. For hybrids providing detec-
table protection against RHpall, an additional direct
measure of activity was performed. This analysis
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took advantage of RMspl, an isoscliizomer of
RHpaII, which cleaves both methylated and un-
methylated HpaII sites. The RMspl fragments were
32P-labeled at their 5 ' ends and digested to mono-
nucleotides, and the labeled mononucleotides were
analyzed by thin-layer chromatography. The ratio of
methylated and unmethylated cytosines at Hpall
sites, as estimated by this method, correlates well
with the extent of protection of each hybrid against
the action of RHpa II.
We have constructed 11 plasmids coding for
hybrids between the two methylases containing vari-
ous combinations of domain swaps. All of the
hybrids proved to be considerably weaker methylases
than their wild-type parents. Six were inactive by our
assay, and five of them retained partial methylation
activity. Despite the poorer enzymatic properties, the
hybrids retained sequence specificity. Two of the
constructs contained exact swaps of the variable
regions, but in neither case were we able to detect
methylation activity in vivo. Thus, we were not able
to determine the specificity potential of this region
directly. However, other hybrids allow us to define
the boundaries of the specificity domain by excluding
regions nonessential for this function. In all five
cases, the specificity matched that of the parent
methylase which contributed the variable region, lo-
cated between conserved motifs VIII and IX. This
was the only sequence held in common between the
active hybrids and for the first time provides un-
equivocal evidence that the specificity determinants
of the mono-specific m5C-methylases are located
within the variable region. Correlation of the hybrid
methylase structure with the efficiency of methyla-
tion suggests that conserved motif IX may interact
with the variable region, whereas motif X most prob-
ably interacts with the amino-terminal half of the
molecule.
Hybrids between the Mspl and
HpaII Methylases
M. Sha
The Mspl and HpaII methylases both recognize the
same DNA sequence, CCGG, but have different vari-
able regions and methylate a different base in the
recognition sequence. MMspl methylates the first
cytosine and MHpall methylates the second
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cytosine. To discover how the methylase determines
which base to methylate within its recognition se-
quence, we have constructed a series of hybrids be-
tween MMspl and MHpall and have tested their
recognition specificity.
Many hybrids have been constructed, but two
have proved highly informative. HM1 and HM2 are
two hybrid methylases designed to share the same se-
quence except for the variable regions. HMI contains
the amino-terminal region of the HpaII methylase up
to the variable region and continues with the variable
region and carboxyl terminus of MMspl. HM2 also
contains the amino-terminal region of the Hpall
methylase, but the MMspl sequences are fused
beyond the variable region so that only motif IX and
the extreme carboxyl terminus are from MMspl.
Thus, the two hybrids differ only in the source of
their variable regions. An extensive series of experi-
ments shows that HM1 has Mspl methylation speci-
ficity and HM2 has HpaII methylation specificity.
Nearest-neighbor experiments indicate that HM1
methylates the first C in the CCGG sequence and
HM2 methylates the second C in the CCGG se-
quence. We also compared the relative transforma-
tion efficiency of the hybrid methylases into Es-
cherichia coli strains having either mcrA or mcrBC
backgrounds. HM1 was restricted in the mcrBC
strain about 1000-fold (Mspl is restricted about
10,000-fold) but not in the mcrA strain. HM2 was
restricted in the mcrA strain about 5-fold (HpaII is
restricted about 3000-fold) but was not restricted in
the mcrBC strain. Hybrid methylases HM1 and HM2
are weakly active in comparison with their wild-type
progenitors as demonstrated by an in vitro methyl
group transfer assay. It is likely that this low activity
is caused by imperfections in the final folding and
raises the possibility that mutations could be found
that will lead to increased activity by restoring the
proper folding. Such mutants may reveal intermotif
interactions. Random mutagenesis and selection to
find such mutants is in progress.
DNA Binding by the Mspl
Methylase
A. Dubey
The Mspl methylase (M.MspI) recognizes the se-
quence CCGG and catalyzes the formation of 5-
methylcytosine at the first cytosine residue. We have
investigated the sequence-specific DNA-binding
properties of MMspI using gel-mobility shift assays
and DNase I footprinting. MMspI binds to DNA in a
sequence-specific manner either alone or in the
presence of the normal methyl donor S-adenosyl-L-
methionine as well as the analogs, sinefungin and S-
adenosyl-L-homocysteine. MMspI shows the highest
binding affinity to DNA containing a hemimethylated
recognition sequence (Kd = 3.6 x 10-7 M) but binds
less well to unmethylated DNA (Kd = 8.3 x 10-7 M).
Surprisingly, it shows specific, although poor, bind-
ing to fully methylated DNA (Kd = 4.2 x 10-6 M).
MMspI binds approximately 100-fold more tightly
to DNA containing its recognition sequence, CCGG,
than to nonspecific sequences in the absence of co-
factors. In the presence of S-adenosyl-L-methionine,
S-adenosyl-L-homocysteine, or sinefungin, the dis-
crimination between specific and nonspecific se-
quences increases greatly. During binding, equi-
librium is reached so rapidly that the normal kinetic
properties cannot be studied using a gel-shift assay.
DNase I footprinting studies indicate that 16 base
pairs of DNA are covered by MMspI, with the
recognition sequence CCGG located asymmetrically
within the footprint.
Purification and Crystallization
of M.Hhal
S. Kumar
No previously characterized DNA-binding motifs
have been identified within the group of m5C-
methylases, suggesting that a novel method is used
for DNA binding and sequence recognition. For
several years, we have been attempting, unsuccess-
fully, to obtain crystals of an m5C-methylase that
might be suitable for structure determination by X-
ray crystallography. Our most recent effort with one
of the smallest methylases known, MHhaI (recogni-
tion sequence: GCGC), has been spectacularly suc-
cessful.
MHhaI (Mr = 37,000) was purified from an
IPTG-inducible overexpression strain constructed by
S. Klimasauskas. An unusual property of the enzyme
was exploited to greatly simplify the purification and
to enhance the yield of MHhaI. After induction and
cell lysis, the majority of the enzyme (>70%)
remained associated with the disrupted cellular
debris. Back-extraction of this pelleted material with
high-salt (0.4 tvi NaCI) buffers selectively solubilized
MHhaI. The resulting soluble fraction (termed S2)
was greatly enriched for MHhaI, which made up ap-
proximately 80% of the fraction. Nucleic acids were
removed by protamine sulfate precipitation, and the
cleared S2 supernatant was fractionated by ion-
exchange chromatography on a Mono-S (cation ex-
change) FPLC column. This single column procedure
yielded 0.75-1.0 mg of MHhaI per gram of bacterial
cell paste, with 95% purity or better. Remaining con-
taminants could be removed by an additional ion-
exchange chromatography step using a Mono-Q
(anion exchange) FPLC column.
A significant finding made during the develop-
ment of the purification scheme was that MHhaI ex-
ists as a heterogeneous mixture of two forms. On
Mono-S columns, MHhaI was observed to elute as
two peaks: one containing the enzyme bound with its
cofactor, S-adenosylmethionine (Ado Met), the other
without Ado Met. This was based on the observation
that MHhaI from the "Ado Met-bound" peak was
capable of methylating DNA in vitro in the absence
of exogenous Ado Met. Addition of exogenous
Ado Met to the cleared S2 fraction at micromolar con-
centration prior to FPLC chromatography yielded a
single peak, presumably consisting of a homogeneous
preparation of Ado Met-bound MHhal The binding
of Ado Met to the methylase was sufficiently stable to
survive chromatography on the optional Mono-Q
FPLC column.
Crystallization of purified MHhaI bound to Ado-
Met and preliminary X-ray diffraction studies were
carried out in collaboration with Xiaodong Cheng in
Jim Pflugrath's laboratory (see this Section). Crystals
were obtained in a remarkably short time using the
hanging drop vapor-diffusion method and reached a
size of approximately 0.9 x 0.3 mm. Ado Met-bound
MHhaI crystallizes in space group P21 with unit cell
dimensions: a = 55.2 A, b = 75.0 A, c = 90.2 A. The
asymmetric unit appears to consist of two molecules
of MHhaI. Crystals diffracting to 2.5 A have been
obtained.
Currently, work is continuing toward the deter-
mination of the crystal structure of the AdoMet-
MHhaI complex. We are also attempting to
cocrystallize the enzyme with DNA substrates and
competitive inhibitors (S-adenosyl homocysteine and
sinefungin). In parallel, biochemical analysis of
cofactor binding by site-specific mutagenesis is also
planned. The latter studies will use comparative se-
quence analysis to predict Ado Met-binding sites
within the protein to targeted for mutagenesis.
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Selection of Mutant Restriction
Endonuclease and Methylase Genes
S. Kulakauskas
Prokaryotic m5C-methylases show ten conserved se-
quence motifs. To understand the function of these
motifs and to study interactions between them, it
would be useful to have a system that would allow
the in vivo selection of mutations in methylase genes
and that would also allow the subsequent isolation of
suppressor mutations. To this end, a plasmid carrying
the HpaII restriction-modification system has been
used to obtain temperature-sensitive mutants in the
HpaII methylase gene. We expected that at elevated
temperature, the function of the methylase would be
partially or fully inactivated, causing the cellular
DNA to become sensitive to the action of the restric-
tion endonuclease in vivo. Such mutants would die
by self-restriction at 42°C but would survive at 30°C
where the methylase would be fully active. An
alternative, and equally interesting, thermosensitive
phenotype could result from a change in the
specificity of the methylase or the restriction
endonuclease.
After mutagenesis with hydroxylamine, the plas-
mid carrying the HpaII restriction endonuclease and
methylase genes was transformed into E. coli cells,
and transformants were tested for the thermosensitive
phenotype by replica-plating. Candidates were ana-
lyzed by introducing a deletion mutation into the
restriction endonuclease gene in vitro and testing the
thermosensitivity of these new constructs. All of the
initial mutants lost their thermosensitive phenotype,
confirming that the restriction endonuclease was
responsible for cell death. Plasmid DNA was
prepared from the deletion mutants grown at 30°C
and 42°C and then challenged with the HpaII restric-
tion enzyme in vitro to test for methylation. Only 1 of
11 mutants analyzed contained DNA that was differ-
entially methylated at the two growth temperatures.
Sequence analysis has shown that this mutant con-
tained a C.-T transition in conserved motif 2 causing
an amino acid change from cysteine to tyrosine. No
function has previously been assigned to this motif.
We are now selecting second-site suppressor muta-
tions that may give insight into the internal interac-
tions among motifs. The remaining 10 thermosensi-
tive mutants are also being analyzed. Future experi-
ments will concentrate on the isolation of similar
mutations in the Hhal restriction-modification sys-
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tern, now that crystals of the Hhal methylase are
available.
An interesting finding has emerged from our
studies of hybrids between the HpaII and Hhal
methylase genes (Klimasauskas et al. 1991). Two
hybrids, H3 and H4, can effectively repress (3_
galactosidase activity in a strain carrying a
metF::lacZ fusion after the hybrid methylase genes
are overexpressed in vivo. However, other hybrids
and the wild-type methylase show no such effects.
This phenotype was not abolished by the introduction
of a complementing metF+ plasmid, indicating that it
was not merely the result of methionine starvation.
The sequence of the metF gene contains nine sites
with the sequence CCGG, the recognition sequence
for both the 1-13 and H4 hybrids. The effect is metF-
specific since replacement of the metF::lacZ fusion
and mutation of the lacZ gene to wild type did not
lead to repression of 13-galactosidase activity. Our
current hypothesis is that the hybrids, H3 and H4,
bind tightly to the CCGG sites but are defective in
the catalytic step of methylation. Their continued
presence bound to the DNA of the metF gene could
interfere with transcription, causing a decrease in (3-
galactosidase expression. We are presently testing
this idea and using it as a means of selecting mutant
methylases.
We are constructing a system for the selection of
mutant HpaII methylase genes (or other hybrids)
using the toxic effect of the Bacillus subtilis sacB
(levansucrase) gene. A 79-bp oligonucleotide, con-
taining four CCGG sites, the HpaII recognition se-
quence, was inserted between the promoter and the
coding sequence of the sacB gene. Expression of the
levansucrase gene makes E. coli sensitive to sucrose;
sacB-containing cells cannot grow in the presence of
5% sucrose. Cells containing both the HpaII
methylase gene and this sacB gene construct will al-
low us to select methylase mutants in vivo. Mutant
methylases that can bind tightly should block expres-
sion of sacB and allow cell growth on sucrose-
containing media.
Representation and Detection
of Sequence Motifs by
Artificial Neural Nets
J. Posfai
A question of great interest to molecular biologists
concerns the meaning of similar sequence segments
or motifs in different proteins. These are often de-
scribed as consensus patterns, sequence signatures, or
weight matrices, and heuristic rules are used to find
them. No matter which of the current methods is
chosen, many arbitrary assumptions are usually made
when defining them. One new technique, that of
artificial neural nets, requires fewer assumptions and
imposes few restrictions on possible answers. We are
exploring the use of this technique for the identifica-
tion of common sequence features.
Artificial neural nets were originally intended to
simulate the structure and activity of a simplified
brain. Units called "neurons" receive stimuli on their
inputs, change their internal states and give state- and
input-dependent responses as their outputs. Such
neurons are organized into a "network," where out-
puts from neurons in one layer are connected to the
inputs of neurons in the next layer. The system first
undergoes a "teaching process" as known examples
of some objects are presented to the input-layer
neurons. The neurons in this layer respond to the
stimulus and propagate a transform of their excitation
pattern to the layer that lies below, the so-called "hid-
den" layer. The signals then propagate to the third
(output) layer, and the outputs of this layer constitute
the network's response to the stimulus. This output
pattern is compared to the known answer, and to
make them match, the connections between the
neurons are modified by a learning algorithm. After
repeated rounds of teaching, the connections in the
system usually stabilize, and the system is expected
to then give mostly correct answers not only to the
examples of the teaching set, but also to previously
unseen examples.
Using this technique, we have studied protein se-
quence segments that contain disulfide-bond-forming
cysteines. Because disulfide bonds occur in hundreds
of sequences, neither a simple consensus pattern nor
a simple rule can describe why some cysteines form
disulfide bridges and others do not. For the training
set, we chose SWISSPROT entries that had full and
definite annotations on disulfide bridges. Segments of
11 amino acids, centered on the disulfide-bond-
forming cysteines, were selected for the teaching set
of true examples. Eleven banks of 20 neurons formed
the input layer of the network, one bank being as-
signed to each amino acid position and every bank al-
lowing a unipolar representation of the 20 possible
amino acids. Forty neurons, each connected to every
input neuron and to both output neurons, constituted
the middle layer. Two output neurons represented the
YES and NO answers to the question: Can the
cysteine in the center of the input segment form a di-
sulfide bond? The outputs on these neurons had con-
tinuous outputs in the range of [0,1], high output
values meaning good chances either for YES or NO.
A standard back-propagation technique was selected
as the learning algorithm.
At the start of the teaching session, the internal
states of the neurons and the strengths of the connec-
tions between the neurons are initialized by random
values. One by one, the 640 examples of the training
set are presented to the network. After each example,
the connections in the network are adjusted, accord-
ing to back-propagation rules, to match the actual
response to the expected one. After 26 rounds over
the 640 examples, the network learned the patterns of
the teaching set and was able to recognize all the pat-
terns, at a tolerance level of 0.1. Previously unseen
patterns of the test set were characterized correctly in
75% of the cases, at a tolerance level of 0.4. Despite
its simple structure, the network has acquired the
ability to recognize a fuzzy sequence feature and is
able to make predictions about this feature.
An expansion of the input layer, using longer se-
quence segments, combined with an expansion of the
hidden layer should improve the performance of the
network. A more substantial modification would take
into account the sequence neighborhood of the
recipient cysteine as well. Another extension might
replace the 20-neuron banks by banks of three times
four neurons, to match the genetic coding scheme ex-
actly. The major problem with this approach comes
during the teaching phase. One cannot be completely
confident about the false examples, since the absence
of a suitable recipient cysteine may leave an other-
wise satisfactory disulfide-bridge-forming cysteine
unpaired and would lead to the incorrect recording of
a false example. The replacement of the "supervised"
teaching method by an "unsupervised" one may solve
the problem.
Error Detection in DNA
Sequences
R.J. Roberts, J. Posfai, C. Lin
We have developed a program that can detect
frameshift errors within coding regions of DNA se-
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quences. The program is based on the idea that an in-
sertion or deletion error present within a coding se-
quence leads to the interruption of a reading frame,
meaning that the correct translation of that DNA se-
quence would require one or more frameshifts. If the
coding sequence is similar to that of a known protein
sequence, then such frameshift errors can be detected
by comparing the conceptual translations of the new
DNA sequence in all six reading frames with every
sequence in the protein sequence database. The pro-
gram that implements these ideas is called DETECT
and can serve as an aid to an experimentalist who is
determining a new DNA sequence. This program al-
lows obvious errors to be located and suggests
regions of a sequence where new data should be col-
lected before the sequence is considered "finished."
The output from the program is both a graphic
display showing the relative locations of matching
segments that serve as the basis for detecting a poten-
tial error and a more detailed listing of the precise
location of these segments within the DNA sequence.
The graphic output is extremely informative when a
sequence contains more than one frameshift error,
since the errors and their location are immediately
obvious. In many cases, the combination of matching
sequence segments in different reading frames and
the position of termination codons within those read-
ing frames can lead to very precise pinpointing of the
location of the error.
We have tested the program using both raw ex-
perimental data and sequences from the EMBL data-
base that are known to contain frameshifts. We have
also tested it extensively using unidentified open
reading frames that flank known annotated genes in
the GENBANK database. In the latter series of tests,
many potential errors have been found, and in some
cases, functions can be suggested for the "corrected"
versions of the reading frames on the basis of their
similarity to known gene products. Clearly, as more
DNA sequences are determined and new genes are
identified, the power of this approach will increase
substantially. It should be noted that the use of this
program can also identify features of sequences that
are of more than usual biological interest. For in-
stance, ribosomal frameshifting is known to account
for bona fide products in many instances. Such
frameshifts will also register as potential errors dur-
ing our analysis as will some sites of posttranscrip-
tional editing. Similarly, some pseudogenes or intron-
containing genes will also register as hits by our pro-
gram.
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Comparative Methods of
Sequence Analysis
G. Otto
We are continuing our work on probabilistic methods
of comparative sequence analysis.
The major focus is
on the comparison of protein sequences sharing a
common function. The goal of these comparisons is
to define significant sequence patterns that correlate
with and are predictive of function. In this context,
functions are taken to be specific ligand-binding ac-
tivities. The elements of the derived patterns are often
structurally relevant, tending to be those amino acids
in close contact with the bound ligand. There is a
large element of phylogenetic analysis in these meth-
ods. It has become clear that the best representation
of sequence similarities predictive of function is ac-
tually a phylogenetic tree of related sequence pat-
terns. A single, maximally inclusive pattern is just the
root of this larger tree. Beyond the pragmatic goal of
predicting protein function it will be interesting to ex-
amine the set of these pattern trees for similarities
that might reflect the evolution of protein diversity.
Our work on comparative methods involves a
number of mathematical issues. We departed from
standard comparative techniques by defining the
measure of similarity as the probability that an op-
timal alignment of sequences is due just to the ran-
dom matching between unrelated sequences. We pro-
posed a basic, empirical test that any probabilistic
measure must satisfy. An estimator of these probabil-
ities for pairwise comparisons was developed that
satisfied the test quite well. This measure has been
incorporated into a program for the comparison of
one sequence with a database and has been general-
ized to the case of multiple sequence comparisons,
providing an estimate of the probability of a given
multiple alignment occurring among a random set of
proteins. We have also developed a probabilistic
measure for the matching of consensus patterns with
protein sequences and have written a program that
searches a database for pattern matches of varying
qualities. However, many new developments are re-
quired for this approach to achieve its full power.
The sheer volume of sequence data and the addi-
tional structure imposed on these data by biological
theory and experiments have generated considerable
interest among mathematicians and computer scien-
tists. It is also recognized that the measure of se-
quence similarity arises in many fields and is of gen-
eral scientific interest. We are beginning collabora-
tions with a number of these mathematical scientists
with the aim of developing a coherent interdisciplin-
ary effort in the New York area.
Identification of Functional
Domains of Integration
Host Factor
D. Roberts
Integration host factor (IHF) is a site-specific DNA-
binding protein of E. coli. Binding to DNA generates
a sharp bend of 140° (Kosturko et al., Nucleic Acids
Res. 17: 317 [1989]; Thompson and Landy, Nucleic
Acids Res. 16: 9687 [1988]). IHF is a heterodimer
composed of two homologous subunits, IHFa and
IHF13, that are encoded by two separate genes, himA
and hip /himD. IHF is required for a variety of cellular
processes (for review, see Friedman, Cell 55: 545
[1988]), including integration, excision, and packag-
ing of bacteriophage A., replication of plasmid
pSC101, partitioning of phage P1, and transposition
of Tn /O. We have been interested in understanding
the structural elements of IHF that are responsible for
the specific binding and bending of DNA.
We have mapped functional domains of IHF by
analysis of point mutations and hybrid proteins. Point
mutations were isolated either by random mutagen-
esis and selection for loss of IHF function or by site-
directed mutagenesis. Hybrid proteins were con-
structed by exchanging segments between IHFa and
IHF[3. The construction of hybrids was guided by the
crystal structure of the homologous protein HbS
(Tanaka et al., Nature 310: 376 [1984]; White et al.,
Proteins 5: 281 [1989]). In each subunit of this struc-
ture, there are two amino-terminal a helices and one
carboxy-terminal a helix that form a globular base
that supports a flexible arm. For IHF, it has been pro-
posed that the arms fit into the minor groove of DNA,
and additional protein/DNA contacts support the
bending of the DNA around the protein (Yang and
Nash, Cell 57: 869 [1989]).
Our results are consistent with (and add to) the
structural model. (1) Amino acid substitutions in the
IHF arms reduce IHF activity, consistent with a role
for the arm in DNA binding. However, the arms of
IHFa and IHF(3 are not identical. IHF requires at
least one a-like arm for activity, and amino acid sub-
stitutions in IHF13 are better tolerated than changes in
IHFa. We are currently testing the idea that the se-
quence specificity resides in the IHFa arm and the 0
arm provides nonspecific binding. (2) The carboxy-
terminal a helix is also important for IHF function.
Mutations of basic amino acids in this region reduce
IHF activity. In contrast to the flexible arm, this helix
is interchangeable between IHFa and IHFP. We are
testing the idea that the basic amino acids in this
region provide nonspecific contacts for DNA bend-
ing.
Restriction Endonucleases
J. Earl-Hughes, S. Klein, D. Macelis, R.J. Roberts
The collection of type II restriction endonucleases
continues to grow and more than 2000 have now
been characterized; 179 different specificities are
known. During the last year, we have characterized a
number of new restriction endonucleases, although
none of these have provided new specificities. In
light of the increasing difficulty of finding new en-
zymes with interesting recognition sequences, we
have recently discontinued this program of research,
which first began in 1973. Future efforts will focus
on the use of recombinant DNA methods to alter the
specificity of existing enzymes.
The restriction enzyme database, REBASE, con-
tinues to grow and provide primary information about
restriction enzymes to researchers worldwide. During
the last year, we have essentially completed the trans-
fer of the data management system from ORACLE to
SYBASE. In the new implementation, many addi-
tional fields, describing useful properties of enzymes,
are present and much future work will be required to
consolidate the known properties of restriction en-
zymes into the new database and to provide cross-
references to other databases relevant to REBASE.
We are just beginning to develop an interface into the
SYBASE version that will allow online entry of in-
formation and extensive capabilities for browsing.
We anticipate that during 1992, the ORACLE version
of the database will disappear and be replaced com-
pletely by the SYBASE version.
In addition to electronic mailings of useful reports
from the database, we have also implemented an
anonymous FTP site at Cold Spring Harbor Labora-
tory that enables users to log on anonymously and ac-
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cess information from REBASE. This has proved
very popular, and many of our previous users have
chosen the FTP route as the most appropriate to ob-
tain data files. We also have plans to include
REBASE on various CD ROMS that will be distrib-
uted widely through the National Library of Medicine
and through EMBL.
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PROTEIN KINASE STRUCTURE AND FUNCTION
J. Kuret G. Carmel
A. Desai
F. Giorgini
P. Kearney
T. Mitcheson
A. Vancura
P.C. Wang
Protein kinases are important components of many
regulatory pathways because they can integrate
several input signals and coordinate a response
through the phosphorylation of substrate proteins. In
an effort to determine the common three-dimensional
structure kinases adopt, and the implications of that
structure for selective recognition of protein sub-
strates and catalysis of the phosphotransferase reac-
tion, we study TPK1, the Saccharomyces cerevisiae
homolog of the cAMP-dependent protein kinase
catalytic subunit. This kinase, along with its
isozymes, regulates the ability of that organism to
grow. In a separate project, we seek to elucidate the
biological function of casein kinase-1, an enzyme
found in all eukaryotic cells in which it has been
sought. It is unrelated to casein kinase-2, which is de-
scribed elsewhere in this volume. Our progress in ap-
plying the techniques of X-ray crystallography and
molecular genetics to the study of protein kinases is
described below.
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Yeast Casein Kinase-1
A. Desai, J. Kuret, T. Mitcheson, A. Vancura,
P.C. Wang
Casein kinases are enzymes that phosphorylate casein
(an acidic, heavily phosphorylated family of proteins
found normally in milk) efficiently. Although casein
is an unlikely target for casein kinases in living cells,
it is a useful and surprisingly specific tool in the iso-
lation, assay, and characterization of these enzymes
because few of the many protein kinases cloned or
purified are capable of phosphorylating it. Two
classes of casein kinases are recognized in eukaryotic
cells, termed casein kinase-1 (CK1) and casein
kinase-2. Our goal is to discover the biological role
of CK1 using lower eukaryotes as a model system.
This year, we deduced the primary structures of
two S. cerevisiae and two Schizosaccharolnyces
pombe CK1 cDNAs. Comparison of their structures
catalytic core
hydrophilic tether
lipid anchor
membrane
FIGURE 1 Proposed model of yeast CK1 structure.
reveals a conserved structural organization (Fig. 1).
All four sequences begin Met-Ser- or Met-Asp and
are probable substrates for Na-acetylation. This is
followed by a typical, 280-residue eukaryotic protein
kinase domain that is highly conserved. Sequence
similarity ends abruptly with a long stretch of
hydrophilic residues that are predicted to be highly
flexible in the folded protein. The final segment of
these proteins contains a 12-residue sequence that in-
cludes a pair of carboxy-terminal cysteine residues.
This region is similar to the carboxy-terminal se-
quences shared by members of the GTP-binding
protein family, including YPT1, SEC4, YPT3, and
SAS1ISAS2. In those proteins, carboxy-terminal
cysteine residues are thought to be linked to prenyl
groups through thioether bonds and contribute to
membrane localization. In addition to cysteine
residues, the carboxy-terminal regions of most of
these proteins contain lysine residues that vary in
number and distance from the cysteines. As in the
case of cellular Ki-ras, these positively charged
amino acids may assist in targeting proteins to mem-
branes.
The catalytic core of yeast CK1 shares more than
50% sequence similarity with three mammalian CK1
isozymes and with HRR25, a protein kinase associat-
ed with repair of damaged DNA in S. cerevisiae. All
of these enzymes share an unusual sequence motif in
subdomain VIII, where the common peptide triplet
Ala-Pro-Glu is replaced by Ser-Ile-Asn (Fig. 2). In
the cAMP-dependent protein kinase, the third residue
(Glu) of this triplet forms a salt bridge with a con-
served arginine residue located in subdomain XI. Al-
though the Asn substitution can no longer bond in
this manner, it may still make contact with domain
XI through hydrogen bonds. Not surprisingly, the in-
variant arginine residue normally found 11 residues
carboxy-terminal to a conserved hydrophobic amino
acid in domain XI is not apparent in this protein
kinase family.
Subcellular fractionation in conjunction with
Western blotting was used to determine whether CK1
is membrane-associated or soluble. To facilitate
detection of the enzyme, CKI1 was tagged with the
influenza hemagglutinin epitope recognized by
monoclonal antibody 12CA5. The tag was placed at
the amino terminus of CKI1 to avoid interference
with the putative site of prenylation found at its car-
boxyl terminus. When cells expressing tagged CKI1
were lysed, boiled immediately in 2% SDS, and sub-
jected to Western analysis, epitope-tagged CKI1 was
detected as a 66-kD protein (Fig. 3, lane 3). As ex-
pected, this protein was not detected in strains that
did not express the epitope-tagged CKI1 (Fig. 3, lane
4). When cells were lysed in the absence of SDS,
epitope-tagged CKI1 underwent rapid proteolysis to
smaller immunoreactive forms. The inclusion of
protease inhibitors during cell lysis reduced but could
not prevent proteolysis. Nevertheless, membranes
prepared in the presence of protease inhibitors clearly
contained intact epitope-tagged CKI1 along with a
major proteolysis product of 52 kD (Fig. 3, lane 2). In
cytosolic fractions, however, only the 52-kD frag-
ment was detected and no intact epitope-tagged CKI1
(Fig. 3, lane 1). We conclude that epitope-tagged
CKI1 associates exclusively with yeast cell mem-
branes and that proteolysis occurring at the carboxyl
terminus releases truncated forms of it into the cyto-
sol.
As mentioned above, S. cerevisiae contains two
CK1 genes, and we have named them CKI1 and
CKI2. To determine if CK1 supplied an essential
function in yeast cells, we disrupted the CKI genes
alone and in tandem. Although haploid spores that
are deficient in CKI1 or CKI2 germinate and grow
normally, spores that are cki- either fail to germinate
or germinate and arrest as small cells prior to bud
formation. Thus, although neither of the two CKI
genes is essential by itself, at least one CKI gene is
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CKI1
CKI2
1 MSQvQSpLTATNSGLAVNNNTMNSQMPNRSNVRLVNGTLPPSLHVSSNLNHNTGNSSA-SYSGSQSRDDSTIVG
.....
: :
1 MSmPIAST--TLAWNLT-NINGNANENV-QANKQLHHQAVDSPARSSMTATTAANSNSNS-SRDDSTIVG
I
II
CKI1 74 LHYKIGKKIGEGSFGVLFEGINMIN-GLPVAIKFEPRKT
CKI2 67 LHYKIGKKIGEGSFGVLFEGTNMIN-GVPVAIKFEPRKT
cAPK 41 DQFERIKTLGIGSFGRVMLVKHMET-GNHYAMKILDKQKVVKLK-QIEHTLNEKRILQAV--NFPFLVKLEFSFKDN
III
IV
EAPQLKDEYRTYKILA-GTPGIPQEYYFGQEG
EAPQLRDEYKTYKILN-GTPNIPYAYYFGQEG
V
VI
CKI1 143 LHNILvIDLLGPS-LEDLEDWCGRR-FSVKTVVQVAVQMITLIEDLHAHDLIYRDIKPDNFLIGRPGQPDAN
CKI2 136 LHNILVIDLLGPS-LEDLFDWCGRK-FSVKIVVQVAVQMITLIEDLHAHDLIYRDIKPDNFLIGRPGQPDAN**
-*
......
cAPK 114 SNLYMVMEYVPGGEMESHLRRIGP--ESEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQG
CKI1 213
CKI2 206
cAPK 179
VII
VIII IX
KVHLIDFGMAKQYRDPKTKQHIPYREK-KSLSGTARYMSINTH-LGREQSRRDDMEAMGHVFFYFLRGQLPWQGLKA
:::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::
NINLIDEGMAKQYRDPKTKQHIPYREK-KSLSGTARYMSINTH-LGREQSRRDDMEALGHVFFYFLRGHLPWQGLKA
YIQVTDFGFAKRVKGRT WTLCGTPEYLAPEII-LSKGYNKAVDWWALGVLIYEMAAGYPPFFA---
X
XI
CKI1 288 PNNKQKYEKIGEKKRLINVYDLAQGLPIQFG-RYLEIVRNLSFEETPDYEGYRMLLLSVLDDLGETADGQYDWMKLN
::::::::::::::::::::::::::
::::::::::::::::::::::::::::::::::::::::::
CKI2 281 PNNKQKYEKIGEKKRSINVYDLAQGLPVQFG-RYLEIVRSLSFEECPDYEGYRKLLLSVLDDLGETADGQYDWMKLN
cAPK 241 DQPIQIYEKIVSGKVR FPSHESSDLKDLLRNLLQVDLIKREGNLKDGVNDIKNHKWFA--TTDWIAIY/44
CKI1 364 GGRGWDLSINKKPNLHGYGHPNPPNEKSKRHRSKNHQYSSPDHHHHYNQQQQQQQAQAQAQAQAQAKVQQQQLQQ
CKI2 357 DGRGWDLNINEKPNLHGYGHPNPPNEKSRKHRNK
QLQMQQLQMQQ
CKI1 439 AQAQQQANRYQLQPDDSHYDEEREASKLDPTSYEAYQQQTQQKYAQQQQKQMQQKSKQFANT
CKI2 402 LQQQQQQQQY-AQKTEADMRNSQYKPKLDPTSYEAYQHQTQQKYLQEQQKRQQQQKLQEQQLQEQQLQQQQQQQQQ
CKI1 501 GANGQTNKYPYNAQPTANDEQNAKNAAQDRNS-NKSSKGFFSKLGCC*
CKI2 477 LRATGQPPSQPQAQTQSQQFGARYQP--YQPQQQPSAALRTPEQHPNDDNSSLAASHKGFFQKLGCC*
FIGURE 2 Sequence alignment of CKI I , CKI2, and the cAMP-dependent protein kinase (bovine Ca). Se-
quences were first aligned using the FASTDB program, then
adjusted by eye, and divided into 11 sub-
domains.
required for yeast cell viability. In the coming year,
we will continue our genetic approach to CK1 func-
tion in both S. cerevisiae and S. pombe.
Yeast CAMP- dependent
Protein Kinase
G. Carmel, F. Giorgini, P. Kearney, J. Kuret, J. Pflugrath
[in collaboration with R. Sweet, Brookhaven National
Laboratory]
Despite clear amino acid sequence homology among
members of the eukaryotic family of protein kinases,
and the probable existence of a common enzymatic
mechanism of phosphoryl transfer, each protein
kinase possesses a unique (although potentially over-
lapping) recognition selectivity for protein substrates.
For the handful of kinases studied in detail, the
ability of a protein to serve as a substrate is
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determined by the amino acid sequence surrounding
its phosphorylatable hydroxyamino acid (i.e., serine,
threonine, or tyrosine), with the location and spacing
of charged amino acids being especially important.
Because we wish to understand the overall folding
pattern of eukaryotic protein kinases and to identify
the structural features of kinases that are involved in
catalysis, regulation, and substrate selectivity, we in-
itiated a crystallographic study of the well-charac-
terized cAMP-dependent protein kinase catalytic sub-
unit from yeast, TPKI.
In previous years, we described the overexpres-
sion, purification, crystallization, and derivatization
of a truncated version of TPKI, termed TPK1A. The
crystals grow to over a millimeter in length, are
hexagonal dipyramids in shape, and diffract beyond
2.8 A resolution. Because these crystals possess a
very long unit cell, collection of X-ray diffraction
data at Cold Spring Harbor Laboratory (CSHL) is
1 2 3 4
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39 -
FIGURE 3 CKI1 is a particulate enzyme. Cytosol, mem-
branes, and whole-cell lysates were subjected to Western
analysis using monoclonal antibody 12CA5. (Lane 1)
Cytosol; (lane 2) membranes; (lane 3) whole-cell lysate
prepared in 2% SDS with immediate boiling; (lane 4) control
lysate prepared in 2% SDS with immediate boiling from cells
not expressing epitope tagged CKI1. Prestained markers
(lane M) included phosphorylase b (130 kD), bovine serum
albumin (75 kD), ovalbumin (50 kD), and carbonic an-
hydrase (39 kD).
difficult. To overcome this problem, we collaborate
with Dr. Robert Sweet, who operates a beamline at
the National Synchrotron Light Source at Brook-
haven National Laboratory. The synchrotron delivers
X-rays that are two orders of magnitude greater and
of shorter wavelength than those available at CSHL,
and it overcomes many of the physical problems as-
sociated with the analysis of crystals such as ours.
We will return to the synchrotron in the coming
year and will collect complete and accurate native
and derivative data sets. The resulting electron
density map, combined with the coordinates of the
recently solved mammalian homolog of TPK1,
should allow us to bring this project to a successful
conclusion.
A Solid-phase Screen for TPK1
Substrate Selectivity
G. Carmel, J. Kuret
Synthetic peptides of known amino acid sequence are
useful in defining the substrate specificity of protein
kinases. This is because their structures can be varied
systematically to identify critical residues involved in
recognition and because the contribution of these
residues can be quantified through steady-state
kinetics. Nevertheless, the synthetic peptide approach
has limitations. First, the design of useful synthetic
substrates requires a priori knowledge of a kinase's
phosphorylation selectivity, which, of course, is fre-
quently unknown. Second, peptide synthesis can be
expensive and time consuming. A new approach that
combines inexpensive synthesis of recognition se-
quences with an ability to screen them in complex
mixtures is clearly desirable.
We have developed a strategy for producing and
screening substrate recognition sequences in bacteria
and have applied the method to TPK1A. The strategy
uses cassette mutagenesis to create a phosphory-
latable serine residue that is flanked on both sides by
degenerate amino acids known to be important in
substrate recognition, including arginine (e.g., cyclic
nucleotide and calcium-dependent protein kinases),
glutamic acid (e.g., casein kinase-2), and proline
(e.g., p34cdc2); also included are alanine, glutamine,
and glysine residues, which contribute small hydro-
phobic, hydrophilic, and nonexistent side chains,
respectively.
The carrier protein used to house the cassette is
BCY1, the regulatory subunit of the cAMP-depen-
dent protein kinase from S. cerevisiae. BCY1 is use-
ful because it (1) contains a single phosphorylation
site for TPK1 that is located in a well-characterized
"hinge" region, (2) is expressed in E. coli at high
levels in a soluble and dephosphorylated form, and
(3) is easily purified (by cAMP-agarose affinity
chromatography) to facilitate kinetic studies in solu-
tion.
The resultant library of recognition sites, housed
within BCY1, is processed like other bacterial ex-
pression libraries and is "probed" with a purified pro-
tein kinase in a radiometric, solid-phase phosphoryla-
tion assay. Individual bacterial colonies that express a
phosphorylatable sequence are thereby identified.
The plasmid DNA from these colonies is isolated and
sequenced through the cassette region to reveal the
preferred location of amino acid residues involved in
substrate recognition.
The results of a screen with TPK1A are sum-
marized in Table 1. The pattern of deduced amino
acid sequences is dominated by the requirement for
arginine residues in positions p-3 (10/11) and p-2
(11/11). In addition, the p-1 position most frequently
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TABLE 1 Deduced Substrate Selectivity of TPK10
Clone Deduced amino acid
sequence
Position: -4 -3 -2 -1 p +1 +2 +3
1
...0 E R S E Q Q..
2 ...E R R
S A Q G...
3 ...C) R R A S R A G...
4 ...G R R
S G R G...
5 ...0 R R S G Q A...
6 ...A R R
S 0 Q G...
7 ...Q R R G S A A E...
8 ...Q R R P S Q A G...
9 ...P R R A S Q P E...
10 ...P R R
S E A E...
Amino acid Frequencya
A 1 0 0 2-2 4 1
R 0 9 10 1
1 0
5 0 0 1 3 4 1
1 1 0 0 2 0 3
G 1 0 0 5
2 0 5
P 2 0 0 1
0 1 0
aFrequency refers to the number of times an amino acid is
found in a given position. The data are derived from clones
1
through 10.
(8/11) contains the small residues alanine or glysine,
whereas the p-4 position frequently (6/11) contains
glutamine. Clear trends in other positions are not ap-
parent. Nevertheless, some unfavorable substitutions
are discernible. Pro line residues are underrepresented
at all positions except p-4. Glutamic acid residues are
acceptable carboxy-terminal to
the phosphorylatable
serine but rarely are they found on the amino-
terminal side of this residue.
The consensus recognition sequence deduced for
TPK1A by our method is similar to that established
with synthetic peptides for the mammalian cAMp_
dependent protein kinase. Consistent with this behav-
ior in vitro, the mammalian kinase can substitute for
TPK1 and its isozymes in vivo. That the selectivities
of the two enzymes are so similar is surprising, con-
sidering they share only 50% sequence identity in
their catalytic domains. The substrate selectivity
screen described herein will complement our crystal-
lographic efforts to characterize the structural fea-
tures of TPK1A responsible for substrate recognition.
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COMPUTATIONAL MOLECULAR BIOLOGY
T. Marr W. Chang
S. Cozza
A. Reiner
J. Salit
M. Zhang
This marks the second year of the new Computa-
tional Molecular Biology group at Cold Spring Har-
bor Laboratory. Five people were recruited in 1991:
Steve Cozza, a software engineer, joined the group in
February; Bill Chang, a postdoctoral fellow, came to
my laboratory in August-Dr. Chang received his
Ph.D. in theoretical computer science from Univer-
sity of California, Berkeley; Andy Reiner, a visiting
computer scientist, joined us in May; Jacqueline
Salit, a software engineer, joined the group in Sep-
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tember; and Michael Zhang, a postdoctoral fellow
and theoretical physicist came to us in October from
the Courant Institute of Mathematical Sciences at
New York University. Our group is working on com-
puterized methods for studying genome organization
and function.
We are working on new database technologies,
new analytic methods, and new software approaches
that allow us to study the genomes of organisms at
scales of resolution spanning several orders of mag-
nitude. The system will allow us to examine classes
of sequences, such as repetitive elements, multi-copy
genes, and motifs, from a global perspective so that
we can get a handle on the gross patterns of distribu-
tions of distinct types of genetic elements. The sys-
tem will also allow us to view high-resolution local
genome organization, such as detailed contiguous
maps (contigs) of regions containing genes or even
sequence motifs embedded within sequenced genes
or sequenced genomic segments.
When viewed as templates for information pro-
cessing, genomes serve two primary functions: (1)
templates for self-duplication and (2) templates from
which collections of polynucleotides become pro-
cessed in combinatorial ways. Nucleotide sequences
accrue biological function and meaning at many
levels of organization. Genes usually exist in one
copy per genome (most genes) or they can exist in
multiple copies per genome (e.g., histone genes).
Genes sometimes form large co-evolved clusters
within a genome, e.g., the mouse T complex. Many
of these complexes are conserved between genomes;
there are numerous examples of orthologous gene
collections between humans and mice. In addition,
there are many genes and gene families that are es-
sentially identically conserved from yeasts to hu-
mans.
In addition to the more traditional view of genes,
and how they are distributed within and between
genomes, there exists a wide variety of evolutionarily
conserved short sequences. These are sequences that,
when studied in detail, perform one particular func-
tion and are reused in different combinations with
other such sequences. We call these sequences short
functional elements (SFEs). SFEs can be thought of
as being the shortest sequences about which it makes
sense to study, or atomic elements in database
terminology. In general terms, SFEs include, but are
not limited to, the following types of sequences: (1)
sequences that are sites for the binding of proteins to
DNA or RNA, such as sites that bind transcription
regulatory proteins, sites that bind replication initia-
tion proteins, and sites that bind translation inhibiting
proteins; (2) sequences that affect the secondary and
tertiary structures of DNA and RNA such as coiling
in DNA or looping in RNA; (3) repetitive elements;
(4) sequences that have intrinsic kinetic or thermo-
dynamic lability, such as long runs of homo-puri nes
or homo-pyrimidines; (5) sequences that in general
are involved in the regulation of replication, tran-
scription, and translation that are not mentioned
above; (6) signal peptides such as those polypeptides
that allow migration of a protein into the nucleus; (7)
ligand-binding sites in proteins; (8) amino acid
"motifs"; and (9) restriction sites.
Because nucleotide sequences accrue biological
function and meaning at many levels of organization,
it is useful to view- genomes as a sequence of se-
quences (Fig. 1). Gene and/or genome mapping typi-
cally begins by knowing only partial information
about the sequence of sequences associated with a
particular gene or other target sequence(s). Finding
the location(s) of a target sequence(s) in a genome in-
volves stepwise refinement of characterization of the
landmark sequences within or around the sequence of
sequences.
We make a distinction between two basic types of
maps: reference maps and working maps. Reference
maps are maps that are, by scientific consensus, con-
sidered to reflect the best understanding of the rela-
tive order of, and/or distance between, various map
elements. Reference maps fall into two basic classes,
landmark maps and marker maps. Landmark maps
are maps constructed from physically mapped ele-
ments, where the distance between elements is
measured in units of base pairs. Examples of land-
mark maps are the standard cytogenetic banding
maps used in mammalian genetics and the polytene
salivary gland chromosome maps of the fruit fly.
Marker maps are maps constructed from polymorphic
markers ordered by genetic linkage analysis, where
the distance between elements is measured in units of
centiMorgans. We use reference maps primarily for
navigational purposes, but also to provide us with
reference intervals into which we place a variety of
working maps and map elements.
Working maps and map elements are by far the
largest number of objects that we need to deal with in
the database. Fortunately, the variety of working
maps and map elements is limited in number. We
have also found that the organism-specific represen-
tations of all working maps and map elements vanish
once one gets beyond the familiar reference landmark
maps. Thus, working maps and map elements can be
handled in a general way. The following is a list of
objects, or named-fragments, that will be supported
by our database and software: (1) genes, DNA seg-
ments, and polymorphics markers (loci); (2) DNA
and protein sequences, including SFEs; (3) genomic
restriction fragments and maps; (4) rearrangements,
deletion segments, and breakpoints; (5) restriction
maps of clones; (6) probed clones and contigs; (7)
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FIGURE 1 A hierarchical view of a typical eukaryotic genome. In this diagram, we show
broad classes of types of DNA sequences. Note that we have not attempted to indicate
the order of these sequences, but rather to show simple distinctions between them.
Gene and genome mapping involves finding particular sequences embedded within or
around landmark sequences. We are working on computer methods and software that
allows users to examine locations and orderings of sequences across several orders of
magnitude of SFE stands for short function element (see text for description
of SFE).
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probed somatic cell lines; and (8) composite collec-
tions and maps of these objects.
In addition to having the capability of storing the
above information, provision is made so that users of
the database can enhance the basic information in the
database by being able to assign connections between
(1) working maps, map elements, and reference land-
mark intervals and/or marker intervals; (2) objects
placed in and between reference intervals (so that
reference intervals can be bridged) and store these
connections by name in the database; and (3) map ob-
jects and interval maps between different species.
Connections to reference maps are made by
recording when a probe known to be within a
reference interval is connected to a map element. So,
by making successive connections between probed
map elements and by observing which interval the
anchoring probe resides in, the system can form con-
tigs using a variety of map elements. This is simply
another type of "fingerprinting" scheme, but we are
using a variety of signals to detect underlying
genome continuity by "walking" in random directions
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until reference probes are encountered and bridged.
Some of these connections may be able to be done
automatically, but our intention is to make the system
highly interactive, so that experts in different biologi-
cal domains can incorporate their knowledge into the
system.
Progress on this system has been substantial. We
have implemented prototype software for a sig-
nificant portion of framework maps of the human
genome using our new technology. In collaboration
with David Beach (see Genetics Section), we have
used our software to assemble a molecular map of
most of the fission yeast genome. About 98% of a
2000 cosmid-clone library of the fission yeast has
been assembled into contiguous regions, or contigs,
since June of 1991. The collection of anchoring
probes includes more than 70 genes and over 500
probes made from ends of inserts in the library. Fig-
ure 2 shows an example of the results obtained by
using our software.
An example of how we utilize reference maps
using the fission yeast data follows. Note in Figure 2
144717 144713 psf6 119817 1198t3 psf9 9717 mik1 9713 atb2 99413 pNot106 99417
d(3)
i(2) 0
9
a(6) c(3)
h(2) b(1)
g(2) c(2)
f(2)
FIGURE 2 The top row shows the order of probes used to construct complex contigs for the fission
yeast genome. The lines represent simple contigs that were constructed by hybridization. The letters
on the lines are codes used to denote simple contigs, and the number in the parentheses shows the
number of cosmid clones anchored by probes.
that we have two anchoring probes: the genes named
"mikl" and "atb2." These genes also have been
mapped and ordered on the classic (genetic) map, and
they have been probed onto both Notl and SfiI
genomic restriction fragments. We now have com-
plete long-range genomic restriction maps of the fis-
sion yeast genome using both Notl and SfiI (by Dr.
Igor Garkavtsev, see Genetics Section). Therefore,
we have independent evidence, using the consensus
genetic map and macro-restriction maps, that allows
us to localize and orient the contig shown in Figure 2
to the distal region of the "short arm" of chromosome
2 of the fission yeast. Many other contigs have been
mapped in this way.
Initially, we are focusing our attention on study-
ing the genomes of human, mouse, and fission yeast
through collaborations with the Genome Database
group at Johns Hopkins University (human), Dr. Lee
Silver at Princeton University (mouse), Drs. Eric
Lander and Nathan Goodman at the Massachusetts
Institute of Technology (mouse), and Dr. David
Beach at Cold Spring Harbor Laboratory (fission
yeast). Later on, we will most likely include the
genomes of the budding yeast, nematode, and fruit
fly. These all are organisms whose genomes are
being studied in detail by researchers all over the
world, and individual speciality databases are emerg-
ing to support those particular organisms. Our ap-
proach is to derive information from these other data-
bases, abstract the details we need, and provide
mechanisms that allow our collaborators to enhance
our database.
In Press, Submitted, and In Preparation
Marr, T. 1992. Mapping and sequencing the genomes of the
human and model organisms: A computational
biologist's view of the computing problems. (In prepara-
tion.)
Marr, T., W. Chang, and J. Salit. 1992. Computer methods
for contig assembly and minimal path determination for
contigs generated by unique probe hybridization, fol-
lowed by restriction fingerprinting. (In preparation.)
Marr, T., S. Cozza, E. Cuddihy, and A. Reiner. 1992. An
object-oriented implementation of the Genome Data-
base. (In preparation.)
Zhang, M. and T. Marr. 1992. Correlation analysis of 5' -
splice signals in pre-mRNA sequences of the fission
yeast. (In preparation.)

NEUROSCIENCE
There are few problems in science as significant as understanding the brain.
Neuroscience at Cold Spring Harbor Laboratory took a major step forward this
year with the dedication and opening of the Beckman Neuroscience Center and
the recruitment of three neuroscientists. The Laboratory's effort in neuroscience
utilizes molecular, cellular, and genetic techniques to understand learning and
memory processes, development of neurons, and neurodegenerative diseases.
One major focus is the study of learning and memory in Drosophila melano-
gaster. This animal is being used because of the ease of identifying mutants that
disrupt learning and of subsequently cloning the important genes. A second
focus is the study of cellular factors which affect the growth and differentiation of
neurons. We look forward to continued expansion in the neurosciences and to
establishing Cold Spring Harbor Laboratory as a preeminent center for brain re-
search.
NEURONAL GROWTH AND DIFFERENTIATION
D.R. Marshak E. Azmitia
Y.-S. Bae
N. Chester
M. Meneilly
L. Pena
I.J. Yu
This laboratory conducts research on the biochemical
basis of neuronal growth and differentiation. Overall,
the questions that we approach in our research in-
volve the decisions of neuroblasts to cease prolifera-
tion and to subsequently elaborate neuritic processes
prior to terminal differentiation. These questions thus
involve understanding how signal transduction sys-
tems that control cell proliferation in the neuroblast
are altered upon becoming postmitotic and learning
which growth factor molecules control these switches
within cells. Specifically, we are interested in the ac-
tion of a growth-stimulating protein, S10013, pro-
duced by astrocytes in the brain. The mechanism of
action of S10013 is compared with that of other
growth factors, such as those in the family of
neurotrophins or the family of heparin-binding
(fibroblast) growth factors. The involvement of such
neurotrophic factors in degenerative diseases, such as
Alzheimer's disease, has prompted our interest in the
role of such factors in neuropathological processes.
There appears to be interesting interplay among fac-
tors important to development and the degeneration
of the brain in the aged.
Mechanism of Action of S10013
L. Pena, E. Azmitia, D.R. Marshak
S100(3 is a 91-residue protein that causes neurite out-
growth from cortical neurons of the brain and is
mitogenic for glial cells in culture. During develop-
ment, S100(3 is synthesized and released by astroglia
during their proliferation concomitant with the initia-
tion of neurite outgrowth from postmitotic neurons.
Critical to understanding the role of S10013 in
neuronal differentiation is unraveling the mechanism
of action of this factor. We have taken two ap-
proaches to this problem: (1) in vitro experiments to
identify a receptor molecule for S100(3 and (2) in
vivo experiments in rats to analyze the release of
S10013 in the hippocampus.
We have initiated studies of radioactively labeled
S100(1 binding to neuronal membranes. Iodination of
S100(3 results in high specific activity without loss of
biological activity in the neurite outgrowth assay.
High-affinity saturable binding has not been satisfac-
torily demonstrated. This raises the possibility that
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S10013 binds with low affinity to neuronal mem-
branes (and possibly glial membranes) in a relatively
nonspecific manner. Activity might then arise from
internalization and binding to a cytoplasmic target or
from interaction with integral membrane proteins
through lateral diffusion. To address these pos-
sibilities, cross-linking studies have been initiated
using water-soluble, homobifunctional reagents. Ad-
ditionally, immunohistochemical studies by electron
microscopy will aid the identification of the target
cellular compartment of S10013 action in neurons.
For in vivo studies, radioactively labeled S100(3
was injected into the dorsal aspect of the ventral mid-
brain of adult rats. This area contains the Raphe
nuclei, centers of serotonergic neuronal cell bodies
that have been shown to respond to S 100(3 by E. Az-
mitia and his colleagues at New York University.
Autoradiographs of these tissues at various time
points suggest uptake by glia and perhaps selected
neurons of the Raphe. However, no retrograde trans-
port of the injected S100(3 was seen, It appears that
S10013 is unlike the neurotrophins, which are target-
tissue-derived factors that are taken up presynaptical-
ly and transported in a retrograde fashion to the
neuronal cell body. As a glial-derived factor, S10013
appears to act locally on adjacent neurons and glia.
Lesion studies of the serotonergic projections to the
hippocampus were performed by E. Azmitia, using a
serotonin analog, 5,7-dihydroxytryptamine. This
compound causes selective degeneration of seroto-
nergic fibers and a corresponding decrease in S100(3
production in the hippocampus. Treatment of le-
sioned animals with a serotonin receptor type-la
agonist, ipsapirone, causes a large increase in the hip-
pocampal S10013. These studies suggest that sero-
tonin regulates S10013 production in vivo through a
type-la receptor-mediated mechanism.
Protein Kinase Modulation
during Neuronal Differentiation
L. Pena, Y.-S. Bae, I.J. Yu, D.R. Marshak
Studies of protein kinase modulation are designed to
compare the mechanisms of neurotrophin action with
those of 5100(3 and heparin-binding growth factors.
Studies of S100(3 action have centered on the role of
the factor as a mitogen as well as a differentiative
factor. In an autocrine fashion, S100(3 causes prolif-
eration of astroglial cells, the source of the protein in
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vivo. In recent studies, L. Pena has begun to study the
effects of S10013 on neuroblasts, prior to the commit-
ment to stop cell division. Chicken embryo forebrain
neurons from embryonic day 6 appear to respond to
increased thymidine incorporation in response to
S100f3 in primary culture. Neuroblastoma cell lines
have varied responses: Some differentiate and others
proliferate. Distinguishing the differences in signal
transduction pathways, including protein kinases, will
help us to understand how neurons decide to differen-
tiate.
A more complete study of p34cdc2 kinase in cells
that respond to nerve growth factor (NGF) has been
conducted. The rat pheochromocytoma cell line,
PC12, undergoes morphological and biochemical dif-
ferentiation into sympathetic neurons in culture under
the influence of NGF. The enzyme p34cdc2 kinase,
which is critical to the induction of mitosis, appears
to be down-regulated during NGF-stimulated differ-
entiation. This process may involve a related protein,
p46, that cross-reacts with p34cdc2 antibodies. We are
currently trying to obtain a cDNA clone and se-
quence of this related molecule.
Characterization of the Heparin-
binding Growth-associated Molecule
D.R. Marshak [in collaboration with W.H. Burgess,
American Red Cross]
Heparin-binding growth-associated molecule (HB-
GAM), isolated from bovine brain, was characterized
biologically, physically, and chemically (Hampton et
al. 1991). The complete amino acid sequence of HB-
GAM was established by analysis of overlapping
peptides derived from the protein. The protein is
highly basic and is cysteine-rich. The mass of bovine
HB-GAM was confirmed by plasma desorption,
time-of-flight mass spectrometry. The measured mass
was 15,291, compared with the predicted mass of
15,289, and this accuracy (0.01%) is well within the
experimental limits of the method. There do not ap-
pear to be any posttranslational modifications other
than proteolytic cleavage of the precursor to the
released form. HB-GAM was not mitogenic for a va-
riety of fibroblast, endothelial, and keratinocyte cell
lines. However, the protein is highly active in
promoting neurite outgrowth from embryonic chick-
en embryo forebrain neurons. Interestingly, the factor
acts maximally when used to coat the surface of the
culture dish, and it has little activity when presented
as a soluble factor. This finding, together with evi-
dence that extraction of HB-GAM from brain re-
quires high salt and that HB-GAM binds heparin,
suggests that the protein may exist within large com-
plexes of the basal lamina or other substructure. This
material may be important to neuronal development
in association with cell-surface interactions.
Investigation of Serotonin
Systems in Neuronal
Differentiation
E. Azmitia, I.J. Yu, M. Meneilly, D.R. Marshak
As described above, in vivo data from lesion studies
in rats indicated a role for the neurotransmitter,
serotonin, in the release of S100(3. In addition, studies
of cultured neurons of the Raphe nuclei show that
S10013 is a potent neurotrophic factor for these
serotonergic neurons. Unfortunately, reagents for
studying the serotonergic systems are not as available
as they are for catecholaminergic and cholinergic sys-
tems. Therefore, we set out to produce antibodies to
two proteins that are critical to these studies: (1) tryp-
tophan hydroxylase, the mixed function oxidase that
is the rate-limiting step in serotonin biosynthesis, and
(2) serotonin receptor type la, which has been linked
pharmacologically to S10013 induction and cAMP-
mediated responses in glia. We chose to produce
these antibodies in rabbits using antigens based on
synthetic peptides that correspond to particular
regions of the molecules. Regions chosen for
antigenic sites are unique to these proteins and are
thought to be located on the proteins' surfaces. High-
titer antisera were thus prepared and are excellent
tools for immunohistochemical studies as well as
biochemical analysis of proteins.
Involvement of S10013 in
Alzheimer's Disease
and Down's Syndrome
D.R. Marshak [in collaboration with W.S.T. Griffin,
University of Arkansas, P. Whitaker, SUNY
Stony Brook, and J. Korenberg, Cedars-Sinai
Medical Center, Los Angeles]
The gene for S100(3 is localized to human chromo-
some 21, near the telomere of the long arm (21q).
This localization suggests a potential involvement in
Down's syndrome (DS), since this region of the
chromosome is duplicated in the disease. Many of the
genes related to Alzheimer's disease (AD) have been
localized to chromosome 21. In addition, besides the
developmental, neurological symptoms of DS, mid-
dle-aged DS patients acquire a degeneration of the
brain very similar to that of elderly AD patients. Be-
cause of the neurotrophic activity discovered for
S100(3, it is possible that abnormal levels or regula-
tion of S100(3 might participate in the degeneration
related to these diseases. We studied the levels of
S100(3 in AD temporal cortex and hippocampus and
found that the protein was 20-fold elevated in AD
over age-matched controls. In addition, the mRNA
and biological activities of S100(3 were found to be
approximately 10-fold elevated. The excess S10013
was localized to reactive astrocytes adjacent to dense-
core amyloid plaques. These data indicate that
elevated levels of S100(3 might play a role in the
neuropathology of AD and DS. In DS, elevated levels
of S10013 were seen in samples of young brain tissue
(3-6 months) returning to normal by 9-12 months.
Although preliminary, these data suggest that there
may be developmental patterns of S10013 expression
that are altered in DS. In one set of DS patients carry-
ing a ring chromosome 21, an extra copy of the gene
for S10013 was not found (Falik-Borenstein et al.
1992). Thus, abnormal gene expression, rather than a
gene-dosage effect, could explain the high levels of
S100(3 thought to occur in DS and shown to occur in
AD.
Analysis of CREB Phosphorylation
in Astroglia
N. Chester, D.R. Marshak
Astroglial cells are thought to serve an important role
in producing growth factors and other molecules in
support of neuronal function. One of these factors,
S100(3, is the subject of much of the interest in our
laboratory. Astrocytes also possess receptor mole-
cules for a variety of neurotransmitter and hormonal
signals thought to modulate the expression of genes
for the protein growth factors through complicated
signal transduction systems. Hippocampal astrocytes
contain serotonin type-la receptors, which are linked
to the production of cAMP as a second messenger.
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One of the targets of the cAMP-dependent protein
kinase is a molecule called CREB (cAMP response-
element-binding protein). This protein binds to spe-
cial DNA sequences that mediate the cAMP-respon-
sive genes, including c-fos. Another gene that is
cAMP-responsive is that for S100(3. Thus, the regula-
tion of phosphorylation of CREB in astrocytes may
be a key element in S100(3 expression. Our studies
have focused on another phosphorylation site that
modifies the CREB protein at points distal to that for
cAMP-dependent protein kinase or calcium-depen-
dent kinases. This site is phosphorylated by casein
kinase II, an enzyme that is cell-cycle-regulated and
depressed in Alzheimer's disease. We expect that our
studies will lead to a more complete understanding of
S10013 expression in astrocytes under normal and ab-
normal physiological conditions.
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MOLECULAR AND CELLULAR BIOLOGY OF LEARNING
R. Davis J. Alexander
J. Cherry
B. Dauwalder
C. Funk
P.-L. Han
A. Nighorn
Y. Qiu
C. Skoulakis
E. Skoulakis
K. Wu
Our laboratory continues with its long-term goals of
probing the molecular and cellular biology of learn-
ing. We approach these goals using the techniques of
genetics, molecular biology, biochemistry, behavior,
and anatomy. In general, techniques of genetics and
behavior are used to identify genes required for
normal learning/memory, the techniques of molecular
biology and biochemistry are used to clone the re-
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quired genes and to characterize the gene products,
and anatomical methods are used to trace the flow of
information in the brain and to understand where the
genes are required to be expressed for normal learn-
ing/memory. One focus continues to be on the Dros-
ophila dunce locus, the best-characterized "learning
gene" of the fly. In the last year, we have completed
our studies of the gene's structure, probed the spatial
expression pattern of the gene, and continued with
transformation studies designed to alter the spatial
and/or temporal expression pattern of the gene. We
have expanded our studies of other genes important
for learning/memory in the fly, including the
rutabaga locus and nine other partially characterized
loci.
The laboratory moved from the Baylor College of
Medicine to Cold Spring Harbor Laboratory in Sep-
tember of 1991. We are excited about the prospects
of future growth in the neurosciences at Cold Spring
Harbor. The move forced a split in the laboratory.
Cindee Funk and Pyung-Lim Han remained in Hous-
ton and continue to pursue their goals, keeping in
constant communication with the majority of the
group at Cold Spring Harbor Laboratory. We said
goodbye this year to our friend and colleague,
Yuhong Qiu. Yuhong finished a very nice thesis on
the dunce locus and has begun postdoctoral work at
M.D. Anderson Cancer Center in Houston. And we
have welcomed Joan Alexander, Carrie Skoulakis,
and Jim Cherry into the laboratory this year.
Spatial Expression Pattern of dunce
A. Nighorn
The dunce locus is the prototype of Drosophila learn-
ing/memory genes. The gene was defined in a search
for mutants that disrupt fly learning and from our
subsequent cloning and biochemical experiments,
shown to code for the enzyme cAMP phosphodi-
esterase (PDE).
Using antisera prepared against the dunce PDE,
we performed a detailed survey of the spatial expres-
sion pattern by immunohistochemistry. We observed
a striking concentration of the PDE within the
neuropil of mushroom bodies, structures that have
previously been implicated on other grounds to be in-
volved in insect learning and memory. The enhanced
immunoreactivity is also found in larval mushroom
bodies, and in situ hybridization to adult brain sec-
tions shows that the enhanced level of protein within
the mushroom bodies is due in part to elevated levels
of dunce RNA within mushroom body perikarya.
These were important observations for several
reasons. Since the mushroom body neuropil contains
dendritic elements, axonal processes, and synaptic
contacts, the enzyme must be synthesized in cell
bodies and transported to become concentrated in
processes, perhaps at synapses. The PDE potentially
plays a direct role in regulating synaptic transmis-
sion. In addition, mushroom bodies have been impli-
cated in other studies as neuroanatomical centers
responsible for integrating sensory information and
regulating complex behaviors in other insects. The
enrichment of the dunce PDE in mushroom bodies
suggests that these structures mediate learning/
memory through the action of the products of identi-
fied learning/memory genes. Finally, these observa-
tions along with other information have allowed for
the formulation of a circuit model describing the
pathways and integration of information within the
Drosophila brain.
Structure and Function of dunce
Y. Qiu [in collaboration with S. Beckendorf and T. Malone,
University of California, Berkeley]
The dunce locus presented a special challenge in
elucidating the sequences of its RNAs. This is due to
the large number of RNAs detected by RNA blotting
experiments (at least ten), their large sizes (4.2-9.6
kb), and their scarcity. From the sequence analysis of
more than 40 different cDNA clones collected from
oligo(dT)-primed and primer-extension cDNA librar-
ies, the sequence analysis of the corresponding
genomic coding regions, RNA blotting experiments
with exon-specific probes, and primer-extension and
S1- nuclease protection experiments, we have de-
duced the structure of this complex locus described
below and depicted in Figure 1.
Exons that comprise dunce are distributed over
more than 148 kb. This makes dunce the largest
Drosophila locus characterized to date. Comple-
mentary DNA clones have identified at least six dif-
ferent RNA structures. The alternatively spliced
forms predict the presence of multiple isoforms of the
PDE product. Transcription of dunce begins at a min-
imum of five sites (one is not shown in Fig. 1): One
transcription start site (tss) is at an undefined exon
upstream of exon 0.9, a second is within exon 0.9
(class IA), a third at exon 2.1 (class II), a fourth at
exon 2.7 (classes III and IV), and a fifth somewhere
to the right of coordinate 0. The fifth transcription
start site has been deduced from genetic evidence.
Flies carrying chromosomal deficiencies removing
the sequences upstream of coordinate 0 retain ap-
proximately 50% of the normal PDE activity. The
223
III
IVA
IVB
>40kb - 50
// 1
0.9
11 1
1 2
- 20
II 1 111
2.1 2.2
-.10
23 2.8
+, 20
I
3 4
+ 30
I II
5 6 7
++140 145
1 1 1 1 1
8 9 101112 13
STOP
STOP
ATG
ATG
rti
';TC2ANitqOP.
tss
T
ts,
ATG
/1\STOP
\21STOP
(4)
(7)
FIGURE 1 Schematic representation of the dunce locus. The coordinate system extends from -50 to +45 and is measured in
kilobase pairs. dunce exons are represented as numbered boxes. Various RNAs as deduced from cDNA clones are shown
with several structural classes denoted as IA through IVB. (Closed boxes) Protein coding regions; (open boxes) untranslated
regions. Transcription start sites are designated tss. The number of clones isolated from each class is indicated in parentheses
on the right.
transcription start site located to the right of coor-
dinate 0 has not been identified molecularly. The
most unusual feature of the locus is the existence of
numerous unrelated genes (not shown) nested within
the intron defined by exons 0.9 and 1.0 and within
another intron defined by exons 2 and 3. The overall
picture of the dunce locus is one of remarkable com-
plexity.
Transformation and Rescue of dunce
B. Dauwalder
An important question is whether the phenotypes as-
sociated with mutation at the dunce locus are caused
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by a developmental requirement for the cAMP PDE
or a physiological requirement during adulthood. To
answer the question of "developmental versus
physiological" role, we generated transgenic flies car-
rying dunce-coding sequences driven by the hsp70
promoter in the genetic background of several dunce
mutations so that the gene could be turned on by the
external cue of heat shock at various times during de-
velopment or during adulthood.
A dunce cDNA clone and a rat cDNA homolo-
gous to dunce were used to construct transformation
vectors, and these were inserted into flies carrying
two different dunce alleles (dncl and dncm1). Induc-
tion of the transgene after heat shock was monitored
by enzymatic assay of whole-fly homogenates. For
behavioral rescue experiments, flies were heat-
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FIGURE 2 Rescue of the dunce learning deficiency after
heat-shock-induced expression of the Drosophila dunce
cDNA as well as a homologous rat cDNA (RD1). dncml-
mutant flies homozygous for the Drosophila transposon
(hspdnc-dncM1-) or a transposon constructed with the rat
gene (hspRD1-dncm1-) were heat-shocked, rested for 2 hr,
and trained. Performance of the flies is expressed as a
learning index in which 1.0 represents perfect learning and
0.0 represents no learning. Flies were tested without heat
shock (open bars) or after heat shock (stippled bars).
shocked and subsequently trained using a negatively
reinforced classical conditioning paradigm. The
learning scores of transformed flies were significant-
ly higher after heat shock than those of their nonheat-
shocked siblings or those of nontransformed dunce
mutants (Fig. 2). This effect was observed for both
the fly and rat cDNA clones, showing that the rat
cDNA meets the biochemical needs for learning in
the fly. These data suggest that a functional cAMP
PDE is an active component of learning/memory
physiology. In addition, induction of the transgene
during adulthood partially rescued the female sterility
of the dunce mutants. Thus, the transgenes rescue
both phenotypes when induced during adulthood.
Mushroom Body Genes
J. Alexander, B. Dauwalder, P.-L. Han, A. Nighorn,
C. Skoulakis, M. Skoulakis, K. Wu
Our laboratory has screened for new learning/
memory mutants using P-element-mediated enhancer
trap mutagenesis. Using histochemical methods,
about 100 stocks (MB stocks) have been isolated
with I' elements near genes preferentially expressed
in miihroom bodies. Each of these genes potentially
represents one required for normal olfactory learning.
From preliminary behavioral tests of approxi-
mately 30 of these lines, 9 of these with the P ele-
ment near or in unknown genes have been shown to
have defective olfactory learning/memory in prelim-
inary tests. One stock, named MB21, showed normal
learning but a faster memory decay than normal flies.
Line MB1116 showed a very labile memory several
minutes after training, but the memory decay rate
slowed such that by 3 hours after training, the scores
were similar to those of control flies. MB2225 dis-
played a memory curve which parallels that of con-
trol flies, being reduced at all time points tested. The
90-minute retention of the other six lines was reduced
relative to control flies. These stocks and the genes
identified by the enhancer detector are currently the
subject of additional behavioral and molecular
studies.
rutabaga Structure and Expression
P.-L. Han [in collaboration with L. Levin and
R. Reed, Johns Hopkins School of Medicine]
Several of the lines identified by enhancer detection
with preferred expression of 13-galactosidase in
mushroom bodies were shown to have a P element
insertion at the cytogenetic position corresponding to
the rutabaga locus, the second best-characterized
learning gene of Drosophila. To determine whether
these insertion elements had indeed landed in the
rutabaga locus, the genomic DNA flanking the inser-
tions was isolated and compared to that isolated from
an adenylyl cyclase (AC) gene thought to be the
rutabaga function. Seven insertions were identified
within 2 kb upstream of the transcription start of the
AC gene. In addition, we were able to show that
several of these insertions were new alleles at the
rutabaga locus. By RNA in situ hybridization with
AC probes and immunohistochemistry with anti-AC
antibodies, we demonstrated that the AC RNA is
preferentially expressed in mushroom bodies, that the
AC immunoreactivity was concentrated in mushroom
body neuropil, and that the insertion elements of the
new rutabaga alleles compromised the expression of
the AC gene. These observations add great strength
to the idea that mushroom bodies are neural centers
for insect learning and that the products of known
learning mutants have their effects by altering
mushroom body cell physiology.
225
4- 5 - galactosidase
plArB
172 by
C
I
906 by
0
_c
X
0 as
_0
w x
EE0
w
EE EE0 0
w0 0w
1050 byirleirVririnnelointaa-
0)
co
p581H
..-
N
CL
I I
=
03
w
1.6 Kb
FIGURE 3 Insertion element plArB in the protein kinase A (dco) catalytic subunit gene. (Stippled boxes) Exons of the dco
gene; (open boxes) introns and flanking DNA; (checkered box) protein-coding region. The precise location of the insertion was
determined by sequence analysis.
co E
co
co
dcO
1:=3
581 genomic DNA isolated by "plasmid rescue"
Protein Kinase A
E. Skoulakis
Stock MB581 was shown to have an insertion ele-
ment at the cytogenetic position of the gene for the
catalytic subunit of protein kinase A (dco). The
MB581 insertion is associated with recessive leth-
ality. Since MB581 could be an insertion in the PKA
gene, the genomic DNA flanking the insertion was
cloned and characterized.
Sequence analysis of the DNA adjacent to the
MB581 insertion demonstrated that the transposon
was inserted in exon 1, 71 by downstream from the
transcriptional start site of the dco gene (Fig. 3). This
disruption reduces PKA RNA as determined by in
situ hybridization to homozygous MB581 embryos.
The resulting reduction in PKA is reflected in a 40%
decrease in PKA activity in MB581 heterozygous
adults using in vitro enzymatic assays. In situ
hybridization with PKA probes to adult brain sections
demonstrated that the p-galactosidase expression in
MB581 flies accurately reflects the PKA message
distribution. Thus, the preferential expression of PKA
in mushroom bodies along with the rutabaga-
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encoded AC and the dunce-encoded cAMP PDE
lends strong support for a role of the cAMP cascade
in these neurons to serve learning/memory processes.
Mushroom Body Enhancers
P.-L. Han, A. Nighorn, Y. Qiu
An important goal is to be able to direct the expres-
sion of foreign genes specifically in the mushroom
bodies of transgenic flies. To achieve this, we have
begun to search for a mushroom body enhancer in the
vicinity of (1) the rutabaga promoter, (2) one of the
dunce transcription start sites, (3) the PKA gene, and
(4) an unknown gene identified in the enhancer
detector screen as showing very specific mushroom
body expression. We have provisionally identified
one fragment in the vicinity of a dunce transcription
start site that can specifically direct the expression of
a P-galactosidase reporter gene to mushroom bodies.
Follow-up studies are currently in progress.
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GENETICS OF LEARNING AND MEMORY IN DROSOPHILA
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We are pursuing a genetic dissection of learning and
memory in fruit flies. To date, this problem has been
tackled at both the genetic and behavioral levels. We
have identified two new genes-latheo (lat) and
linotte (lio)-involved with learning and memory,
and molecular cloning of these genes has begun. We
also have isolated a temperature-sensitive allele of
the pale gene, which is known to encode a tyrosine
hydroxylase and which we suspect may be involved
with associative learning. Similar suspicions have
prompted us to study the effects on learning of two
other genes: period (per) and Amyloid precursor pro-
tein-like (App/). In wild-type flies, we have produced
long-lasting memory after classical conditioning of
an olfactory avoidance response: Adults show some
memory 7 days after extended training, and larvae
can retain odor-shock associations through metamor-
phosis.
We will continue to study the behavioral proper-
ties of learning and memory and to isolate new genes.
With this approach, we will be able to organize func-
tional sets of learning/memory genes. Once these
genes are cloned, such information will enable us to
piece together the molecular relationships among
their gene products.
Identification of New Genes
Involved with Learning
and Memory
T. Tully, S. Boynton, R. Mihalek, T. Preat, M. Regulski,
C. Jones, M. DelVecchio, D. Wood
In the past year, we have completed a behavior-
genetic characterization of two new genes involved
with learning and memory in fruit flies: latheo and
linotte. These genes were identified from a P-element
mutagenesis, in which 3-hour memory retention after
classical conditioning of an olfactory avoidance
response was assayed in 1600 mutant strains each
homozygous for a single, autosomal P-element inser-
tion. Figure 1 shows the memory retention curves of
latheoP1and linotte1 1 mutant flies, relative to wild-
type controls. The primary effect of each of these
mutations is on initial learning levels. Thereafter,
mutant memory decay curves run parallel to those of
wild-type flies.
Associative learning (and memory) is a hypotheti-
cal construct that cannot be measured directly. In our
experimental context, it is defined as a change in ol-
factory avoidance behavior that cannot be attributed
to effects on olfactory acuity (naive fly's ability to
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smell the odors) or shock reactivity (naive fly's
ability to sense electric shock and to escape from it).
Before concluding that associative learning per se
was aberrant, we had to show that these two impor-
tant "peripheral" behaviors were normal in mutant
latheo and linotte flies. We developed task-relevant
assays of olfactory acuity and shock reactivity by as-
saying avoidance of each odor (octanol or methyl-
cyclohexanol) versus air, or of electric shock versus
no shock, in the T maze of the teaching machine. The
behavior of latheoP1 and linotteP1 homozygous
mutants appeared to be normal in both of these as-
says.
Our initial genetic concern was to show that the
learning deficits observed in the latheoP1 and
linottem mutant strains actually resulted from the P-
element insertions, rather than spurious changes in
the genetic backgrounds of the strains. We addressed
this issue with two corroborative approaches: (1) gen-
eration of P-element excisions and (2) complementa-
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FIGURE 1 Learning and memory in two new P-element in-
sertional mutants. Flies were classically conditioned by ex-
posing them for 60 sec to one odor (either octanol or
methylcyclohexanol) paired with 12 1.25-sec 60-volt pulses
of electric shock delivered at 5-sec intervals. After a 45-sec
rest, the flies then were exposed for 60 sec to a second
odor (either methylcyclohexanol or octanol) without shock.
After training, flies were transported to the choice point of a
T maze between converging air currents of octanol or
methylcyclohexanol. They were allowed to choose between
these two odors for 120 sec, at which time, the flies were
trapped in their respective T-maze arm, anesthetized, and
counted. A normalized percent correct was calculated as
the {[(fraction of flies that correctly avoided the shock-paired
odor) x 2] -1) x 100. A second group of flies was then
trained and tested to the reciprocal odor combination, and
the normalized percents correct from the two groups were
averaged to produce one Performance Index (PI). Pls could
range from 0 (flies were distributed 50:50 in the T maze) to
100 (all flies avoided the shock-paired odor). Learning is
defined as t = 0 time point of the retention curve. (Top)
Mutant latheoP1 flies (open squares) and their white (C-S4)
controls (closed diamonds). (Bottom) Mutant linotteP1 flies
(open squares) and their Canton-S wild-type controls
(closed diamonds).
tion mapping with chromosomal deficiencies. Behav-
ioral analysis of excision lines from linotte flies
showed that seven out of ten were wild-type
revertants, indicating clearly that the original P-
element insertion was responsible for the behavioral
deficits in mutant flies. In contrast, no wild-type
revertants were obtained among 14 latheo excision
lines. Instead, a continuous distribution of learning
scores-ranging from latheoP1 -like to near wild-
type-was observed, and about 5% of excision events
produced lethal mutations. These results indicated
that latheoP1 and the excision alleles were hypomor-
phic alleles of an essential gene.
Since P-element DNA had been cloned, we easily
identified the cytological locations of the latheo and
linotte P insertions via in situ hybridization of a P-
element DNA probe on polytene chromosomes. The
latheo insert was localized to 49F7-8, and the linotte
insert was localized to 37D, on the second chromo-
some. This cytological mapping placed the latheo
gene near vestigal in a region that has been saturated
for ethylmethanesulfonate (EMS)- and y-ray-induced
lethal mutations. Lethal complementation analysis
between these alleles and the lethal excisions of
latheo mapped the latheo gene unambiguously to one
lethal complementation group. Subsequent behavioral
analysis of flies heterozygous for latheoP1 and an
EMS-induced lethal allele showed clearly that the be-
havioral deficit mapped to the same lethal com-
plementation group.
On the basis of the cytological positions of
latheoP1 and linottePI, we also obtained stocks carry-
ing chromosomes with deletions of the same regions
of the second chromosome-Df(2R)vgb and Df(2R)-
vg56 for latheo and Df(2L)VA12 and Df(2L)TW5° for
linotte. In each case, mut /Df flies yielded learning
scores lower than those of + /Df controls. These
results corroborated the results from behavioral ex-
periments with excision alleles, indicating again that
the P-element insertions were responsible for the be-
havioral deficits.
Since all existing learning/memory genes are X-
linked, the autosomally linked latheo and linotte
genes are new. Moreover, we still are chasing several
additional putative mutants. Importantly, all of the
genes we identify have been disrupted by P-element
insertions, thereby "sequence tagging" the new genes,
which, in turn, will expedite their cloning. Such
molecular experiments are under way for latheo and
linotte.
We also have isolated an EMS-induced tempera-
ture-sensitive allele of the pale gene, which recently
has been shown to be the structural gene for a
tyrosine hydroxylase in fruit flies. Since this enzyme
is involved in the synthesis of dopamine and since
dopamine metabolites are required for normal cuticle
schlerotization, the two extant mutations of pale were
embryonic lethals. In contrast, flies homozygous for
our new pale's allele survive at permissive tempera-
ture, thereby enabling us to study the effects of this
mutation on learning and memory in adults. These
experiments are relevant because past work on flies
homozygous for temperature-sensitive alleles of the
Dopa decarboxylase (Ddc) gene reported a sig-
nificant learning deficit at restrictive temperature. In
Drosophila, this enzyme is involved in the synthesis
of both dopamine and serotonin. Consequently, we
do not know from the Ddc experiments whether
dopamine or serotonin is the relevant (putative) trans-
mitter involved with associative learning. Mutant
pale's flies, in contrast, have normal levels of
serotonin but no detectable levels of catecholamines
in brains 24 hours after shifting them to the restrictive
temperature. Analysis of palets may yield a dissection
of the transmitter systems implicated in associative
learning. The next phase of this project is to assay
learning in these mutants, and to verify the learning
deficits in mutant Ddc flies.
Biological Rhythm Mutants Show
Normal Associative Learning
T. Tully [in collaboration with D.A. Gailey,
Brandeis University]
We investigated a long-standing claim in the litera-
ture that mutant flies with long-period rhythms also
show learning deficits. We assayed learning in three
different contexts-courtship suppression toward im-
mature males, conditioned inhibition of courtship
toward females, and classical conditioning of olfac-
tory avoidance responses-using mutant flies hemi-
zygous for per', peru, perL2, and per° and trans-
genic flies carrying a copy of per+ on either a per° or
perU background. We replicated the original claim
that peru males performed poorly in conditioned in-
hibition of courtship toward females, but we went on
to show that perL1 males learned normally when they
were exposed longer to females during training. We
also showed that pert- males suppressed their court-
ship of immature males normally and that the original
claim for aberrant behavior was an artifact of the way
a "learning index" was calculated. Furthermore, per"
flies showed normal classical conditioning. We se-
quenced the perL2 mutation and discovered that it had
the same nucleotide substitution as the perU muta-
tion. Mutant perL2 flies performed normally in each
learning assay, however, as did flies from each of the
transgenic strains. Taken together, these data indicate
that long-period biological rhythm mutants do not
have learning deficits.
Human Amyloid Precursor
Protein Functions in Fruit Flies
T. Tully, M. DelVecchio [in collaboration
with K. White, Brandeis University]
A major component of extracellular amyloid plaques
in brains of Alzheimer's disease patients is amyloid
0-protein, which is a secreted cleavage product of p-
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amyloid precursor protein (APP). A single gene gen-
erates-by alternative splicing-several APP iso-
forms, most of which contain a protease inhibitor
domain and are found ubiquitously. The APP695
isoform, however, does not contain a protease in-
hibitor domain and is more abundant in the nervous
system. Although abnormal cleavage has been impli-
cated in the formation of amyloid plaques, the normal
function of APP695 is not known.
K. White and co-workers have reported previous-
ly that the fruit fly Appl gene encodes a protein
(APPL) that shows significant homology with APP,
especially APP695. We were interested creating Appl-
mutant flies in an effort to disrupt, and thereby identi-
fy, the normal function of APPL. We identified an X-
chromosome deficiency and a Y-linked X-chromo-
some duplication, which in combination produced a
fly containing no APPL protein. Surprisingly, these
Appl- flies were viable and fertile, with no apparent
morphological abnormalities externally or in paraffin
sections of adult head (at the light microscope level).
To determine whether the absence of APPL leads
to any behavioral defects, we first compared condi-
tioned odor avoidance responses between Appl- and
Appl+ flies in our standard classical conditioning ex-
periments. We discovered that the mean learning
score for Appl- flies was only 52% of that for Appl+
controls. Further control experiments revealed that
untrained Appl- and Appl+ flies avoided to the same
extent the odors used during the classical condition-
ing experiments, but Appl- flies were not able to es-
cape from electric shock as well as Appl+ flies. This
failure of App/- mutants to show normal shock reac-
tivity-a necessary "peripheral behavior" for con-
ditioning experiments-prevents us from concluding
that associative learning per se is defective in these
mutants.
The shock reactivity procedure induces an escape
response, one behavioral component of which is
locomotor reactivity. Fast phototaxis is another be-
havioral assay in which an escape response is in-
duced, and thus we quantified this behavior in several
genetic variants of Appl. We found a strong correla-
tion between APPL and phototaxis: When APPL was
present, phototactic scores were high, and when
APPL was absent, phototactic scores were low. The
mean phototactic score for Appl- flies was only 62%
of that for Appl+ flies. Consequently, we decided to
use the fast phototaxis assay to study transgenic flies
expressing various mutant or normal forms of
APP(L) on an Appl- genetic background.
Since the Appl gene spans at least 40 kb of
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genomic DNA and the Appl promoter is not well
delineated, we made a transgene from Appl+ cDNA
and the heat-shock promoter (hsp). Transgenic App! -
flies carrying one copy of this hsp-App/+ construct
yielded mean phototactic scores significantly higher
than that of Appl- mutants, indicating some "rescue"
of the aberrant behavior associated with Appl-. Com-
pared to the mean phototactic score of Appl+ controls,
this rescue is only about 50%. Such partial rescue is
not too surprising considering the facts that hsp-
driven gene expression is ectopic and only one copy
of our transgene was present in Appl- mutants. Thus,
brain-specific levels of expression of Appl+ may not
have been completely normal in our transgenic flies.
That 50% rescue is relevant and specific to the
Appl+ transgene was demonstrated by the effects on
phototactic behavior of an hsp App!- mutant con-
struct carried by App!- transgenic flies. The Appl
gene sequence in this mutant construct contained a
small deletion, which prevented the normal cleavage
and secretion of APPL. These transgenic flies
showed the same aberrant phototactic scores as Appl-
mutants, i.e., no rescue was observed.
Finally, we tested whether the human APP695
protein could rescue the defective phototactic behav-
ior of App/- flies. We assembled an hsp-APP695 con-
struct using cDNA. Transgenic Appl- flies
carrying this fly/human construct showed the same
amount of rescue (50%) as those transgenic Appl-
flies carrying the hsp Appl+ construct.
These results strongly suggest a functional
homology between human APP and fly APPL. Thus,
we may be able to ascertain the normal function of
amyloid precursor protein by studying fly behavior.
To date, we have shown that flies with no functional
APPL show a deficit in locomotor reactivity and may
show a deficit in associative learning. These latter ob-
servations are not conclusive, however, because the
locomotor deficit interfered with our ability to
measure learning in classical conditioning experi-
ments. Other learning tasks exist for flies, however,
that do not require the same kind or degree of
locomotor activity. Our next task is to quantify learn-
ing in normal and mutant Appl flies with such assays.
Flies Have Long-lasting Memory
T. Tully, T. Preat, V. Cambiazo
An important behavioral issue concerning the fruit fly
as a model system of memory formation is whether
they are able to form stable, long-lasting memory as
do vertebrates. Our usual classical conditioning pro-
cedure produces strong learning, but memory decays
quickly, yielding retention levels 24 hours after train-
ing only 20% of initial learning levels. Moreover,
memory decay is complete within 2-4 days.
We recently have lengthened memory retention in
adult flies significantly by changing several proce-
dural aspects of classical conditioning, the most im-
portant of which appears to be the amount of training.
A tenfold increase in the amount of training produces
memory lasting at least 7 days, which, when normal-
ized for the life expectancy of a fly, is equivalent to
human memory lasting 10 years. This long-lasting
level of retention is about 20% of initial learning
levels.
More interestingly, we have shown that third in-
star larvae can be trained to avoid a shock-paired
odor and then remember this odor-shock association
through metamorphosis. Three-day-old adults,
trained as larvae 8 days earlier, show memory reten-
tion levels similar to those of 10-day-old adults
trained as adults 8 days earlier. Thus, this 20% level
seems to represent a stable form of long-lasting
memory.
The Jump Reflex Can Be Habituated
by Olfactory Cues
T. Tully, S. Koss, S. Boynton
We also are interested in knowing whether the
molecular mechanisms of memory formation after
nonassociative and associative learning are similar.
Since learning through different sensory modalities,
in fact, may involve different molecular mechanisms
and since our associative learning assay is based on
odor-shock pairings, we first had to develop an assay
for nonassociative learning based on olfactory cues.
To do this, we semi-automated the olfactory jump
procedure of J. Carlson and co-workers to deliver 4-
second presentations of an airborne odor stimulus
repeatedly to individual flies. We found, as J. Carlson
described, that flies would jump up as if to fly away
when presented with a concentrated, noxious odor
stimulus. If we presented the same stimulus repeated-
ly, however, the flies eventually would stop jumping
(Fig. 2).
This response decrement in wild-type flies shows
many definitive behavioral properties of vertebrate
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FIGURE 2 Habituation of the jump reflex to olfactory cues in
lat P 1 /lat P1 mutants (open squares) and lat P11+ control flies
(closed circles). Individual flies of each genotype were ex-
posed repeatedly to 4-sec pulses of 10% benzaldehyde
delivered in a constant current of air. Habituation is shown
as a decrement in the percentage of flies jumping during
the 4-sec odor stimulus over 30 trials. Mutant latheo flies
habituated normally, suggesting that their sensory input and
motor output systems are normal and that the latheo gene
may be involved specifically with associative, rather than
nonassociative, learning.
habituation: More stimulus trials are required for a
fly to stop jumping if the interval of time between
trials (ITI) is longer. Fewer trials are required for a
fly to stop jumping if the odor concentration is lower.
After habituating, flies will jump in response to the
odor stimulus if they have been disturbed or "dis-
habituated" by a novel, strong stimulus (90 sec of
vortexing, in our case).
Preliminary data indicate that the learning/
memory mutants rutabaga and amnesiac show
slower than normal habituation and normal dis-
habituation, whereas mutants with defective locomo-
tion or olfaction show faster than normal habituation
and abnormally low levels of dishabituation. Further-
more, one of our new learning mutants, latheo, shows
normal habituation and dishabituation, suggesting
that this gene may be involved specifically with asso-
ciative learning (see Fig. 2).
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CSH LABORATORY JUNIOR FELLOWS
In 1986, Cold Spring Harbor Laboratory began a Junior Fellow program to en-
courage independent research by outstanding young scientists who, during their
graduate studies, displayed exceptional promise of becoming leading scientists
of the future. The purpose of this program is to provide an opportunity for each
Fellow to work independently at the Laboratory for a period of up to 3 years on
projects of their choice. The Fellow is provided with a salary, research support,
and technical assistance so that they can accomplish their goals free from other
distractions. The interaction among research groups at the Laboratory and the
program of courses and meetings on diverse topics in molecular biology contrib-
ute to a research environment that is ideal for innovative science by these fel-
lows.
Three previous Cold Spring Harbor Fellows, Dr. Adrian Krainer (1987), Dr.
Carol Greider (1988), and Dr. Eric Richards (1989), are currently members of the
scientific staff at the Laboratory. Dr. David Barford is our most recent Fellow, hav-
ing joined us in 1991 from Professor Louise Johnson's laboratory at Oxford. Dr.
Barford is an X-ray crystallographer who has previously worked on glycogen
phosphorylase, but whose present interests lie in the area of protein-mediated
signal transduction. Dr. Barford's current focus is on the serine/threonine-specific
protein phosphatases. Immediately before coming to Cold Spring Harbor, Dr.
Barford spent some time in Dr. P. Cohen's laboratory in Dundee working on
protein phosphatase 2A (PP2A) from rabbit muscle. Dr. Barford hopes to crystall-
ize and solve the structure of this phosphatase.
D. Barford
X-ray Crystallographic Studies on
Serine/Threonine-specific Protein
Phosphatases and Protein Tyrosine
Phosphatase
D. Barford
The purpose of my research is to determine the three-
dimensional structures of serine/threonine-specific
protein phosphatases PP1, PP2A (and the structure of
selective enzyme substrate complexes), and protein
tyrosine phosphatases by X-ray crystallography. This
information will be useful in determining the mech-
anism of enzyme catalysis and the stereochemical
basis for substrate recognition and selectivity.
Knowledge of the phosphatase structures will enable
a comparative study of the conformation, catalytic
mechanism, and basis for substrate specificity to be
made between the two classes of phosphatases and
with protein kinases and other phosphatase enzymes
(e.g., alkaline phosphatase and purple acid phospha-
tase).
Information about the structures will be used to
design protein engineering experiments to alter the
substrate specificity of the enzymes in a defined and
predicted manner. The structures of the protein
phosphatase catalytic subunits complexed to their
regulatory subunits and to various tumor viral gene
products (e.g., the small T antigens of polyomavirus
and SV40) will allow insight into the structural
mechanism for phosphatase regulation.
SERINE/THREONINE-SPECIFIC PROTEIN
PHOSPHATASE
Complementary DNA (cDNA) clones encoding ser-
ine/threonine-specific protein phosphatases have
been isolated and sequenced (for review, see Cohen
and Cohen, J. Biol. Chem. 264: 21435 [1989]). The
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cDNAs encoding rabbit skeletal muscle protein
phosphatase 1 (PP1), PP2A, and a Drosophila
phosphatase, PPV, have been incorporated in the
baculovirus DNA under the control of the strong
polyhedron promoter, allowing expression in the
baculovirus/insect cell system. In addition, the cDNA
encoding the catalytic subunit of PP2A has been
cloned into the T7 bacterial expression vector and ex-
pressed under the control of the T7 promoter. Al-
though all phosphatase catalytic subunits are ex-
pressed as insoluble protein aggregates, 10-20 mg of
protein may be obtained from 1 liter of insect cell or
bacterial cell culture. The insoluble material when
washed in Triton X-100 and 0.5 M NaC1 is 50%
homogeneous and may be solubilized in guanidinium
chloride and DTT. The solubilized protein can be
renatured in renaturation buffer at an enzyme con-
centration of 2-3 [1g/ml. The protein is concentrated
by absorption onto phenyl Sepharose followed by
elution in low-salt buffers. This procedure yields 3-4
mg of soluble active protein per liter of cell culture
relatively easily. Crystallization trials are currently in
progress.
BACTERIOPHAGE kgt10 ORF221
The bacteriophage kgt10 genome encodes a sequence
(ORF221) that is similar to that of eukaryotic protein
phosphatase 1 (35% sequence identity over the
amino-terminal 115 residues, with 22% sequence
identity overall). This gene has been cloned into an
expression vector under the control of the T7
promoter. The gene is expressed at high levels in Es-
cherichia coli, corresponding to 30-50% of the
soluble cell protein at levels of 20-40 mg per liter of
cells. The protein shows phosphatase activity toward
glycogen phosphorylase, casein, and para-nitrophos-
phophenyl substrates, hence confirming its identity as
a protein phosphatase. This material will be purified
and subject to crystallization trials.
PROTEIN TYROSINE PHOSPHATASE
The cDNA encoding the T-cell protein tyrosine
phosphatase is expressed in the baculovirus/insect
cell system (Zander et al., Biochemistry 30: 6964
[1991]). Purified protein will be subject to crystal-
lization trials.
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56th COLD SPRING HARBOR SYMPOSIUM
ON QUANTITATIVE BIOLOGY
The Cell Cycle
May 29-June 5, 1991
ARRANGED BY
David Beach, Cold Spring Harbor Laboratory
Bruce Stillman, Cold Spring Harbor Laboratory
James D. Watson, Cold Spring Harbor Laboratory
461 participants
It is an infrequent occurrence in biology when two seemingly disparate areas of
research are fused by a few key experiments. Such was the case in 1988 when it
was reported that the function of the maturation-promoting factor (MPF) that regu-
lates meiosis in amphibian oocytes depended on a key cell-cycle-regulated
protein kinase that previously had been identified using the genetics of yeast. In-
deed, it was soon recognized that the protein kinase was a component of MPF
and that another essential component was a cyclin protein, again through the
combined efforts of investigators studying early development in amphibian and
marine invertebrate embryos and yeast geneticists studying cell growth regula-
tion. Cell cycle research was revitalized, and during the last 3 years, there has
been an explosion of information. As a result, the general principles of cell cycle
regulation in eukaryotic cells have been established. New and exciting develop-
ments have been emerging daily, including the involvement of tumor suppressor
proteins in cell cycle regulation and the bridging of cell cycle control to cellular
events such as transcription and DNA replication. It was because of this exciting
background that it seemed obvious to hold the 56th Cold Spring Harbor
Symposium on The Cell Cycle, bringing together almost all of the key investi-
gators in the field.
After opening remarks by Dr. James Watson, the themes of the Symposium
were outlined by excellent presentations from Arthur Kornberg, Marc Kirschner,
Lee Hartwell, and Richard McIntosh. At the end of a long and truly exciting week,
the enthusiastic Tim Hunt concluded with a thoughtful summary.
The final program included more than 450 scientists from research centers in
Europe, Asia, and the United States. The program included 90 speakers who dis-
cussed such fundamental problems as control of mitosis; entry into the cell cycle;
the role of anti-oncogenes and tumor suppressor genes in regulating cell growth;
DNA replication; cell differentiation and cessation of proliferation; role of on-
cogenes and growth factors in control of cell proliferation; and chromosome be-
havior and division. The participating leading researchers in these areas use a
variety of approaches from genetics to biochemistry to study control of the cell
cycle. A variety of model systems from yeast to humans were discussed, and the
meeting provided the opportunity to demonstrate how these different approaches
complement each other. The meeting was one of great intensity and scientific in-
terchange.
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A. Stenlund, B. Stillman, P. Howley
This year's Symposium received support from the the National Cancer In-
stitute/National Institutes of Health, the National Science Foundation, and the U.S.
Department of Energy. Essential funds also came from our Corporate Sponsors:
Alafi Capital Company; American Cyanamid Company; AMGen Inc.; Applied
Biosystems, Inc.; Becton Dickinson and Company; Boehringer Mannheim Corpo-
ration: Bristol-Myers Squibb Company; Ciba-Geigy Corporation/Ciba-Geigy Ltd.;
Diagnostic Products Corporation; The DuPont Merck Pharmaceutical Co.; East-
man Kodak Company; Genentech, Inc.; Hoffmann-LaRoche, Inc.; Johnson &
Johnson; Kyowa Hakko Kogyo Co., Ltd.; Life Technologies, Inc.; Eli Lilly and
Company; Millipore Corporation; Monsanto Company; Oncogene Science, Inc.;
Pall Corporation; Perkin-Elmer Cetus Instruments; Pfizer Inc.; Pharmacia, Inc.;
Sandoz Research Institute; Schering-Plough Corporation; SmithKline Beecham
Pharmaceuticals; Sumitomo Pharmaceutical Co., Ltd.; Toyobo Co., Ltd.; The Up-
john Company; Wellcome Research Laboratories, Burroughs Wellcome Co.; and
Wyeth-Ayerst Research.
D Beach
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R. Morris E. Karsenti
T. Hunt, J.M. Bishop, M. Kirschner
PROGRAM
Welcome: J.D. Watson
Introduction
Chairman.. M Mitchison, University of Edinburg
START
Chairman: H Weintraub, Fred Hutchinson Cancer Research Center
Cycling
Chairman: D. Botstein, Stanford University School of Medicine
Mitotic Regulation
Chairman.. E Karsenti, European Molecular Biology Laboratory
Checkpoints
Chairman.. R. Morris, University of Medicine and Dentistry of New Jersey, Robert Wood
Johnson Medical School
Transcriptional Regulation
Chairman.. S. McKnight, Carnegie Institution of Washington
Centrosomes and Kinetochores
Chairman.. M Yanagida, Kyoto University
K t lasrn M Yanagida, D Botstein
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J. Ruderman
J M. Mitchison, T. Mitchison
Exit
Chairman: A. Levine, Princeton University
Surprising Events
Chairman: K. Nasmyth, Research Institute of Molecular Pathology, Vienna
Dorcas Cummings Lecture
Speaker: J. Michael Bishop, University of California, San Francisco
DNA Replication
Chairman: B. Alberts, University of California, San Francisco
Oncogene Interactions
Chairman: I. Herskowitz, University of California, San Francisco
G2M Regulation
Chairman: T. Hunter, Salk Institute
Mitosis
Chairman: J. Ruderman, Harvard Medical School
Mitogenesis
Chairman: D. Nathans, Johns Hopkins University School of Medicine
Summary: T. Hunt, Imperial Cancer Research Fund
G. Vande Woude, H. Weintraub, S. McKnight
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MEETINGS
The Role of Isoform Diversity in Cytoskeletal Functions
April 24-April 28, 1991
ARRANGED BY
Henry Epstein, Baylor College of Medicine
Donald Fischman, Cornell University Medical College
David Helfman, Cold Spring Harbor Laboratory
119 participants
This meeting focused on the functional significance of the isoform diversity found
among cytoskeletal proteins. The cytoskeleton is involved in a variety of cellular
processes including cell division, exocytosis, endocytosis, adherence to the sub-
stratum, motility, and cell shape. The cytoskeleton of eukaryotic cells is com-
posed of three filamentous systems: actin filaments, intermediate filaments, and
microtubules. Each of these systems possesses a major core protein, namely,
actin, intermediate filament protein, and tubulin. In a given organism or cell type,
considerable isoform diversity of both core proteins and associated proteins is
often present. In many cases, the different isoforms exhibit distinct cell- and
tissue-specific patterns of expression. A remaining question in biology is to un-
derstand the function and significance of the extensive polymorphism found
among these proteins. The scientific program encompassed both invertebrate
and vertebrate systems. The emphasis of the meeting was also placed on cel-
lular functions as opposed to a particular filament type or protein species in order
to focus attention on the role different isoforms play in a cell. Investigators from a
wide number of disciplines attended, including cell biologists, biochemists,
molecular biologists, and developmental biologists. Topics included cell motility
and contractility, molecular motors and intracellular trafficking, cell division,
chromosome movement, nuclear structure, isoform switching in development,
and neuronal function.
A Ben-7e'ev, D Helfman, H Epstein
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E Korn R. Stewart, S. Hawley
This meeting was funded in part by the Muscular Dystrophy Association of
America, The Council for Tobacco Research-USA, Inc., Merck Sharp and
Dohme, and Carl Zeiss, Inc.
PROGRAM
Cell Motility and Contractility I
Chairman: E. Korn, National Institutes of Health
Cell Motility and Contractility II
Chairman: G. Gerisch, Max Planck Institute, Martinsried
lsoform Switching during Development and Differentiation
Chairman: A. Ben Ze'ev, Weizmann Institute of Science, Israel
Membrane-Cytoskeletal Attachment, Extracellular Matrix
Chairman: M. Becker le, University of Utah
Special Platform Session
Isoform Diversity in Neuronal Function
Chairman: M. Shelanski, Columbia University
Intracellular Trafficking and Organelle Movement
Chairman: R. Vallee, Worcester Foundation for Experimental Biology
Cell Division, Chromosome Movement, and Nuclear Structure
Chairman: S. Hawley, Albert Einstein College of Medicine
Cell Shape and Morphogenesis
Chairman: M. Mooseker, Yale University
Closing Remarks
H. Holtzer, University of Pennsylvania
242
M. Becker le
D. Fischman
Stress Proteins and the Heat Shock Response
April 29-May 2, 1991
ARRANGED BY
Costa Georgopoulos, University of Utah
Richard Morimoto, Northwestern University
296 participants
Cold Spring Harbor was the setting for the largest (to date) and most comprehen-
sive meeting on Stress Proteins and the Heat Shock Response. There were 296
participants in this three and a half day meeting. The program consisted of eight
sessions and a total of 61 speakers, the majority of which were selected from the
abstracts. A substantial amount of exciting data was also presented in three
poster sessions for a total of 152 posters. The scientific highlights of the meeting
were the sessions that focused on the biochemical role of stress proteins in
chaperoning, transport and protein folding reactions, and the social highlight un-
doubtedly was the square dance that, like stress proteins, allows for multiple in-
teractions.
This meeting was funded in part by the Stress Gen Biotechnologies Corp.,
Biogen, Inc., Berlex Biosciences, Inc., Takara Shuzo Co., Ltd., and Kureha
Chemical Industry Co. Ltd.
Back A Tissieres, W Neupert, G. Hahn, T Ura, C. Wu
Front C Georgopoulos, S Lindquist, M -L Pardue, R Morimoto
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PROGRAM
Introductory Remarks:
R. Morimoto, Northwestern University
C. Georgopoulos, University of Utah
Organismal Responses to Physiological Stress:
Activation of Heat Shock Genes in Prokaryotes and Yeast
Chairman: T. Yura, Institute for Virus Research, Japan
Activation of Heat Shock Gene Transcription in Larger Eukaryotes
Chairman: C. Wu, National Institutes of Health
Other Stress Responses and Developmental and
Tissue-specific Stress Responses
Chairman: M.-L. Pardue, Massachusetts Institute of Technology
Mechanisms of Protein Folding and the Biochemical Properties of Stress Proteins
Chairman: A. Tissieres, University of Geneva
Functions of HSP70-related Stress Proteins
Chairman: W. Neupert, Universitat Munchen
Biochemical and Cell Biological Properties of Other Heat Shock and Stress-induced Proteins
Chairman: S. Lindquist, Howard Hughes Medical Institute, Chicago
Biochemical Properties of Stress Proteins
Chairman: M. Schlesinger, Washington University School of Medicine
A Role for the Stress Response in Infectious Disease, Immunorecognition, Neuronal Expres-
sion and Injury, Aging, Thermotolerance, and Cancer
Chairman: G.N. Hahn, Stanford University
Wine and cheese party at Grace Auditorium
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D Porteous M. Koob, W. Szybalski S. Brenner, J. Weissenback
developing convincing criteria for proving that a particular candidate gene in the
region is actually the one whose mutant alleles cause disease.
This meeting was funded in part by the National Center for Human Genome
Research/National Institutes of Health.
PROGRAM
Genome Organization
Chairman: M.L. Pardue, Massachusetts Institute of Technology
Large DNA Cloning
Chairman: D.J. Porteous, Medical Research Council, Edinburgh
Alu -PCR and Other Methods
Chairman: W. Szybalski, University of Wisconsin
Informatics
Chairman: S Brenner, Medical Research Council, Cambridge
Polymorphisms and Linkage Methods
Chairman: H. Donis-Keller, Washington University, Missouri
Sequencing/Automation
Chairman: L. Smith, University of Wisconsin
Large-scale Mapping Projects
Chairman: G. Evans, Salk Institute for Biological Studies
Interesting Loci
Chairman: R. Myers, University of California, San Francisco
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K. Davies
R. Gemmill, R. Roberts
RNA Processing
May 15-May 19, 1991
ARRANGED BY
Chris Greer, University of California, Irvine
Jim Manley, Columbia University
Alan Weiner, Yale University School of Medicine
437 participants
This year marked the 10th anniversary of the first RNA Processing Meeting. Con-
tinuing the trend of the last 2 years, the meeting was oversubscribed and at-
tendance had to be limited. Exciting developments were reported in several
areas. The idea that RNA plays an important role in the catalysis of pre-mRNA
splicing was strengthened by the demonstration of new interactions involving
snRNAs and the pre-mRNA. However, it is also clear that multiple, perhaps
dozens, of proteins are required for splicing. In yeast, 1991 was dubbed the
year of the DEAD" in honor of the several putative RNA helicases that are essen-
tial for splicing and which contain the characteristic DEAD box motif. In contrast,
proteins identified in mammalian systems all appear to be RNA-binding proteins,
sharing sequence similarities with genetically defined regulators of alternative
splicing in Drosophila. Several studies addressed the question of where in the
nucleus splicing might take place. Although the details were provocative, and the
functional implications uncertain, it is now clear that at least some splicing factors
are concentrated in specific subdomains within the nucleus. Progress in identify-
ing factors involved in pre-mRNA polyadenylation continued, with an important
conclusion being that this seemingly simple reaction requires a complex array of
protein factors.
Novel and refined techniques for tRNA and rRNA structural analysis were
used to identify transient, precursor-specific conformations and to probe features
that define RNA folding pathways. The conformation of these molecules is sur-
prisingly dynamic, and this conformational fluidity appears to be essential for
N. Proudfoot, J Manley, J. Alwine
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both their function and biosynthesis. Refined structural analyses of the active
sites of RNA catalysts were also described. The results establish certain general
features common to RNA and protein catalysts and also define many other fea-
tures, including the functional role of the phosphate backbone and the implica-
tions of template interactions, as unique to RNA enzymes. Surprising results were
reported in studies of the mechanism of RNA editing. Indirect evidence for
covalent guide/target RNA intermediates was presented, a result that led to the
discussion of an analogy between guide RNAs and the viroid class of catalytic
RNAs. The identification of a novel 3' processed structure for U6 RNA suggests
an intriguing analogy to guide RNAs with interesting implications for U6 interac-
tions in pre-mRNA splicing.
This meeting was funded by the National Science Foundation and the Nation-
al Institute of General Medical Sciences/National Institutes of Health.
PROGRAM
mRNA splicing I: Ribonucleoprotein Particles and Mechanism
Chairman: I. Mattaj, EMBL, Heidelberg
mRNA Splicing II: Protein Factors and Mechanism
Chairman.. T. Blumenthal, Indiana University
mRNA 3' Ends
Chairman: N. Proudfoot, University of Oxford, England
Stable mRNAs
Chairman: B. Sollner-Webb, Johns Hopkins University School of Medicine
RNA Transport/Localization
Chairman: M. Green, University of Massachusetts
mRNA Splicing III: Alternative Splicing
Chairman: T. Maniatis, Harvard University
Catalytic RNA
Chairman: M. Belfort, Wadsworth Center, Albany
Guide RNAs/Modification/Turnover
Chairman: E. Blackburn, University of California, San Francisco
T. Blumenthal
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T. Maniatis M. Green
RNA Tumor Viruses
May 21-May 26, 1991
ARRANGED BY
John Coffin, Tufts University School of Medicine
Irvin Chen, University of California, Los Angeles
436 participants
Papers presented at the 1991 RNA Tumor Virus meeting covered all aspects of
retrovirus biology, including replication mechanisms and virus-host interactions,
and important pathogenic mechanisms, including oncogenesis and im-
munodeficiency. All important retrovirus groups were represented, and some-
what more than half the presentations involved the human pathogenic
retroviruses HIV and HTLV.
Topics of particular note included the nature and normal function of retroviral
receptors; a lively discussion of the mechanisms of viral DNA integration; reveal-
ing studies on the mechanisms and role of trans-activators and "minor" gene pro-
ducts in the expression and replication of complex retroviruses like HIV and
HTLV and the roles in infection of model animals; the surprising relationship of
some retroviruses and superantigens; and new insights into the mechanism of
virion assembly. The traditional retrotrivia contest provided an opportunity for
participants to sharpen their sense of retrohistory. Unlike most recent meetings,
the unbroken spell of fine weather permitted participants to enjoy the surround-
ings as well as the science.
Contributions from CSHL Corporate Sponsors provided core support for this
meeting.
Back: H. Fan, R. Desrosiers, B. Cullen, A. Rein, L. Ratner, D. Blair, M. Linial
Front: P. Jolicoeur, D. Ito, J. Coffin, K. Chen, K. Beemon, N. Hopkins
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PROGRAM
Viral Entry
Chairmen: D. Ho, Aron Diamond Research Center
J. Cunningham, Howard Hughes Medical Institute, Boston
Reverse Transcription and Integration
Chairmen: H. Temin, University of Wisconsin, Madison
S. Goff, Columbia University
Genetics, Mutation, and Evolution
Chairmen: M. Linial, Fred Hutchinson Cancer Research Center
S. Hughes, Frederick Cancer Research and Development Center, NCI
Expression 1: Enhancers and Promoters
Chairmen: N. Hopkins, Massachusetts Institute of Technology
F. Clavel, Institut Pasteur
Expression 2: Trans-activation
Chairmen: M. Yoshida, University of Tokyo
C. Rosen, Roche Institute of Molecular Biology
Pathogenesis 1: Oncogenesis
Chairmen. N Rosenberg, Tufts University School of Medicine
D. Blair, National Cancer Institute
Expression 3: Posttranscriptional Events
Chairmen.. K. Beemon, Johns Hopkins University
B. Cullen, Duke University Medical Center
Pathogenesis 2: Immunological and Neurological Diseases
Chairmen: P. Jolicoeur, Clinical Research Institute of Montreal
R. Desrosiers, Harvard Medical School
Retrovirus Potpourri
Chairmen: L. Ratner, Washington University
A. Rein, Frederick Cancer Research and Development Center, NCI
Virion Assembly and Structure
Chairmen: J. Leis, Case Western Reserve University
A. Skalka, Fox Chase Cancer Center
C. Rosen
N. Rosenberg
0 Heldman, 0. Danos, P. Charneau, F. Arenzana-Seisdedos, P. Jolicoeur, F. Clavel
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Yeast Cell Biology
August 13-August 18, 1991
ARRANGED BY
Scott Emr, California Institute of Technology
John Pringle, University of North Carolina
Steven Reed, Scripps Clinic and Research Foundation
363 participants
The 1991 meeting on Yeast Cell Biology was the third in a series of very success-
ful biannual meetings on this subject. At the 1991 meeting, 363 participants pre-
sented a total of 110 talks and 140 posters covering a very wide range of topics,
including the structure and function of the cytoskeleton and the mechanisms of
intracellular movements; plasma membrane structure and function; mor-.
phogenesis and cell wall biogenesis; protein processing, secretion, and in-
tracellular targeting; the biogenesis and function of membrane-bounded
organelles (nucleus, endoplasmic reticulum, .Golgi complex, vacuole,
mitochondria, and peroxisomes); cell signaling and the role of calcium;
chromosome structure and function; and growth control and the cell division
cycle
The major attraction of yeasts as experimental objects remains the ex-
traordinary ease of classical and molecular genetic manipulations, and nearly all
of the presenters had exploited this property. The power of the genetic methods
was well illustrated by the striking results obtained by both "forward genetics"
(discovery of unanticipated types of proteins involved in familiar processes) and
"reverse genetics" (often surprising revelations about the in vivo roles of proteins
that had originally been identified biochemically). However, a major theme of this
meeting was the increasing sophistication of yeast cell biologists in complement-
ing their genetic methods with powerful biochemical and morphological methods,
J. Pringle
M. Kretschmer, G. Straussberger, G Achatz, K. KOhrer, M. Aebi
251
such as those used with animal cells; advances in the
applications of im-
munoelectron microscopic techniques provided a particularly striking example.
The power of the combined methodologies seems to guarantee that yeast cell
biology will continue to move ahead quickly. That this progress
will have a major
impact on cell biology generally is suggested by two other major themes of this
meeting. The first is the continuing stream of revelations about the remarkable
degree to which fundamental cellular mechanisms have been conserved
throughout the eukaryotic world, from yeasts to humans to flowering plants. The
second is the remarkable complexity of intracellular processes in terms both of
the sheer numbers of proteins involved and of the degree to which these proteins
have fully or partially overlapping functions. This complexity seems unlikely to be
sorted out without the kinds of genetic methods that can be applied to yeast.
Yeast cell biologists have good reasons to expect another very exiciting meeting
in 1993.
This meeting was funded in part by John Labatt Limited, Miller Brewing Com-
pany, and Anheuser-Busch Companies, Inc.
PROGRAM
Calcium and Cytoskeleton
Chairman: J. Cooper, Washington University
Mitochondria and Peroxisomes
Chairman: M. Douglas, University of North Carolina
Secretion and Endocytosis
Chairman: R. Schekman, University of California, Berkeley
Cell Cycle
Chairman: H. lida, National Institute for Basic Biology, Japan
Methodology
Chairman: J. Pringle, University of North Carolina
Morphogenesis and Cell Wall
Chairman: M. Breitenbach, University of Vienna
Protein Sorting
Chairman: E. Jones, Carnegie Mellon University
Nuclear Traffic and Vacuole Function
Chairman: J. Woolford, Carnegie Mellon University
Signaling and Growth Control
Chairman: J. Thorner, University of California, Berkeley
Protein Processing
Chairman: R. Fuller, .Stanford University
Nucleus and Chromosomes
Chairman.. K. Bloom, University of North Carolina
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S. Reed, B. Futcher
J McKoy, C. Moore, K. Bloom
Molecular Genetics of Bacteria and Phages
August 20-August 25, 1991
ARRANGED BY
Susan Gottesman, National Cancer Institute
Lucia Rothman-Denes, University of Chicago
Miriam Susskind, University of Southern California
252 participants
More than 250 participants were at the 1991 Bacteriophage meeting. About half
of the 203 abstracts were presented as talks, and half were presented as posters
during the 2-day poster sessions. At least 53 of the abstracts had, as a primary
author, a scientist from outside the United States, continuing the strong interna-
tional flavor of these meetings.
Among the highlights of work presented was the continuing investigation of
the basis of positive activation of transcription, with a paper by Richard Ebright
(UMDNJ) pinpointing the location of a large number of mutations in the catabolite
activator protein (CAP) which do not interfere with DNA binding but block activa-
tion. His results suggest that protein-protein interactions are important for CAP
activation at promoters such as lac. Sarah French (UVA) provided striking elec-
tron microscopy evidence that replication forks can displace active transcription
complexes, although when the two collide, replication is slowed.
This meeting continued to provide an important forum for interactions be-
tween scientists studying the molecular basis of basic processes and those ex-
amining the consequences of the control of these processes for the physiology of
the organism and its interaction with the environment.
Contributions from CSHL Corporate Sponsors provided core support for this
meeting.
S. Gottesman
M. Susskind
W. McAlister
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PROGRAM
DNA Rearrangements
Chairman: H. Nash, National Institutes of Health
DNA Replication and Cell Division
Chairman: N. Kleckner, Harvard University
RNA Polymerase
Chairman: G. Gussin, University of Iowa
Regulation of Transcription I
Chairman: N Craig, University of California, San Francisco
Regulation of Transcription II
Chairman.. W.T. McAllister, State University of New York, Brooklyn
Changing Lifestyles
Chairman: C. Miller, University of Illinois, Urbana
Phage Regulation and Posttranslational Regulation
Chairman: D. Wulff, State University of New York, Albany
Protein Structure and Function
Chairman: A. Poteete, University of Massachusetts
Surfaces and Structures
Chairman: M. Russel, Rockefeller University
Plasmids and Tricks
Chairman: M. Yarmolinsky, National Institutes of Health
M. Russell, P. Model
Wine and cheese party at Airs lie
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Regulation of Eukaryotic mRNA Transcription
August 28-September 1, 1991
ARRANGED BY
Winship Herr, Cold Spring Harbor Laboratory
Robert Tjian, University of California, Berkeley
Keith Yamamoto, University of California, San Francisco
458 participants
The 1991 Cancer Cells meeting, Regulation of Eukaryotic mRNA Transcription,
followed upon the success of the 1989 meeting on the same topic. Again, more
than 400 scientists sharing overlapping interests in regulation of transcription in
eukaryotic cells from yeast to humans attended the meeting. The reports present-
ed by participants spanned a broad spectrum of topics, including the
biochemistry general transcription factors, analysis of sequence-specifi.c ac-
tivators and repressors, structural studies, yeast genetics, and transcriptional
regulation in development. Major advances were reported in the cloning of
cDNAs encoding general transcription factors, including TFI IA, TFIIB, TFIIE, and
TFIIF. It was described how the prototypical general RNA polymerase II factor
TFIID, which recognizes the so-called TATA box found in many promoters, can
also activate transcription by RNA polymerase III. There was continued debate
on the regulatory targets within the transcriptional initiation complex for
sequence-specific activators. The candidates range from TFIID or TFIIB as
targets of an acidic activator and TFIID-associated proteins as a target for a
glutamine-rich activator. Yeast genetics was again shown to be an excellent tool
to uncover interactions between elements involved in transcriptional regulation.
For example, altered DNA sequence specificity mutants were described for both
TFIID and the sequence-specific activator GCN4. Yeast genetics was also used
to reveal how the higher-order structure of DNA, as occurs in chromatin, may
regulate transcription. Structural studies revealed new DNA-binding motifs. In-
I. Herskowitz, W. Dyan, R. Tjian
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W. Herr
deed, the crystal structure of the GAL4 DNA-binding domain revealed a unique
zinc-containing structure. The interplay between members of different classes of
transcription factors such as steroid receptors and Fos/Jun proteins displayed
the complexity of regulatory interactions generating both positive and negative
effects on transcription. Posttranslational protein processing was also shown to
be key in the regulation of transcription factor activity. Examples of such regula-
tion were revealed by reports on regulation of sporulation in bacteria and the p50
subunit of NF -KB in mammalian cells. The meeting closed with an excellent meet-
ing review by Dr. Ira Herskowitz from the University of California, San Francisco.
He emphasized how the mechanisms by which transcription is regulated are so
similar in different eukaryotic species.
This meeting was funded in part by the National Science Foundation and the
National Institute of General Medical Sciences, division of the National Institutes
of Health.
K. Yamamoto, F. Schaufele, J. Miner
PROGRAM
Basal Transcription Factors and RNA Polymerase II
Chairman: R. Roeder, Rockefeller University
Initiation and Postinitiation Events
Chairman: N. Hernandez, Cold Spring Harbor Laboratory
Activators, Basal Factors, and Multisubunit Complexes
Chairman: J. Greenblatt, Banting and Best, University of Toronto
Structure and Function of Transcription Factors
Chairman: P.S. Kim, Howard Hughes Medical Institute, Whitehead Institute, Massachusetts
Institute of Technology
Factor/Factor Interplay
Chairman: H. Weintraub, Fred Hutchinson Cancer Research Center
Regulation of Transcription Factor Activity
Chairman: S. Kustu, University of California, Berkeley
Chromatin Function and Regulation
Chairman: R. Kornberg, Stanford University Medical School
Transcription in Development
Chairman: R. Losick, The Biological Laboratories, Harvard University
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Eukaryotic DNA Replication
September 4- September 8, 1991
ARRANGED BY
Thomas Kelly, Johns Hopkins University
Bruce Stillman, Cold Spring Harbor Laboratory
315 Participants
The third biannual meeting on Eukaryotic DNA Replication attracted over 300
scientists to an exciting 4 days of high-quality discussion. The topics covered at
the meeting included the mechanics of both virus and cellular chromosome
replication, the identification and characterization of cellular origins of DNA
replication, the function of and interactions between DNA replication, proteins,
regulation of DNA replication, and chromosome structure, including telomere
function. It was clear that studies on eukaryotic DNA replication have progressed
rapidly since the last meeting 2 years ago, but it was equally obvious that many
key and important biological problems remain to be solved.
At this year's meeting, we were again fortunate to be entertained by the multi-
talented Ron Laskey. A highlight this year was the recording of a dozen of his
most famous songs for scientific posterity (tape available from Cold Spring Har-
bor Laboratory Press).
The organizers wish to acknowledge generous financial support from the Na-
tional Science Foundation.
S. Linn, T. Kelly, B. Stillman
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Wine and cheese party at Grace Auditorium
PROGRAM
Mechanisms of DNA Replication
Chairman: D. Clayton, Stanford University
Chromosomal Replication
Chairman: R. Hay, University of St. Andrews, Scotland
Regulation
Chairman: C. Newton, University of Medicine and Dentistry of New Jersey Medical School
Viral DNA Replication
Chairman: J. Borowiec, New York University Medical Center
Replicons
Chairman: B. Brewer, University of Washington, Seattle
Interactions of Replication Proteins
Chairman: S. Linn, University of California, Berkeley
Chromosome Structure and Function
Chairman: P. Traktman, Cornell University Medical College, New York
H. Klein, C. Newton
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B. Brewer
Synthesis of Ribosomes
September 11-September 15, 1991
ARRANGED BY
Lasse Lindahl, University of Rochester
Edward Morgan, Roswell Park Memorial Institute
Robert Perry, Fox Chase Cancer Center
Barbara Sollner-Webb, Johns Hopkins University
Jonathan Warner, Albert Einstein College of Medicine
214 participants
The second Cold Spring Harbor meeting on Synthesis of Ribosomes was held
September 11-15, 1991. Because of the complexity of the ribosome and be-
cause of its importance in the overall economy of the cell, the study of ribosome
synthesis leads down many paths, from the regulation of transcription, of splic-
ing, and of translation to the transport of components across the nuclear en-
velope, to the structure of that enigmatic organelle, the nucleolus. This meeting
brought together more than 200 researchers in the field of ribosome biosynthesis,
studying prokaryotic as well as eukaryotic systems. Indeed, one of the major
motivations behind the meeting is to bring together the "euk's" and the "prok's",
who rarely attend the same meetings. Key issues covered included the regulation
and the mechanism of transcription of ribosomal RNA in E. coli and in higher
cells, as well as the initiation of translation of ribosomal protein mRNAs, which ap-
pears to be a major mechanism of regulation both in prokaryotes and in
eukaryotes, although probably by different mechanisms. Other sessions con-
cerned the proteins and small RNAs involved in the processing of ribosomal RNA
precursors, the nature of the nucleolus, and the regulation of ribosome synthesis
through development. A successful innovation of this year's meeting was the
Lecture on patio at Grace Auditorium
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holding of concurrent workshops on Sunday morning, which livened up a session
often characterized by the "morning-after" blahs. Another meeting on Synthesis of
Ribosomes is scheduled for 1994.
This meeting was funded in part by Abbott Laboratories, Bio 101, Inc., Bristol-
Myers Squibb Company, Connaught Laboratories, Inc., Du Pont Medical Produc-
ts, Supelco, Inc., United States Biochemical Corporation, and Worthington
Biochemical Corp. Grants were also received from the National Science Founda-
tion and the National Institute of General Medical Sciences, division of the Nation-
al Institutes of Health.
0. Meyuhas, J. Warner, L. Steel
PROGRAM
Transcription of rRNA Genes I
Chairman: C. Squires, Columbia University
Transcription of rRNA Genes II
Chairman: B. Sollner-Webb, Johns Hopkins University
Ribosomal Protein Synthesis I
Chairman: R. Perry, Fox Chase Cancer Center
Ribosomal Protein Synthesis II
Chairman: L. Lindahl, University of Rochester
Ribosomal RNA Processing
Chairman.. J. A. Steitz, Howard Hughes Medical Institute, Yale University
Regulation and Development
Chairman: M. Pellegrini, University of Southern California
Ribosome Assembly and the Nucleolus
Chairman: J.R. Warner, Albert Einstein College of Medicine
Workshops
Transcription by RNA Polymerase I
Chairman: M.R. Paule, Colorado State University
The Nucleolus and RNA Processing
Chairman: J.R. Warner, Albert Einstein College of Medicine
RNA Structure in Regulation
Chairman: M. Springer, Institute de Biologie Physico-Chemie, Paris
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I. Gonzalez, B. Sollner-Webb
P. Labhart, E. Sanchez-De Jimenez
Modern Approaches to New Vaccines Including
Prevention of AIDS
September 19-September 23, 1991
ARRANGED BY
Fred Brown, USDA, Plum Island Animal Disease Center
Robert M. Chanock, NIAID, National Institutes of Health
Harold S. Ginsberg, Columbia University College of Physicians & Surgeons
Richard A. Lerner, Research Institute of Scripps Clinic
208 participants
The ninth annual meeting on Modern Approaches to New Vaccines brought to-
gether scientists who had a wide variety of research interests ranging from basic
molecular biology, immunology, or pathogenesis to clinical infectious diseases
and vaccine trials. The meeting provided an opportunity for basic scientists and
clinical investigators to exchange their latest observations and broaden their per-
spective of the diverse interactive components of vaccine development.
Advances relevant to vaccine development were reported for a number of im-
portant human viral pathogens such as HIV (the etiologic agent of AIDS) and
HBV (the cause of hepatitis B). For example, compelling evidence that serum
antibodies provide effective protection against infection by cell-free simian im-
munodeficiency virus (SIV) or human immunodeficiency virus type 2 (HIV-2) was
presented for the first time. Conference participants also learned that an in-
activated whole-virus vaccine derived from a proviral DNA clone of SIV induced
complete protection against infection by the homologous cell-free virus as well as
a disparate strain of SIV that varied significantly in its envelope glycoprotein
amino acid sequence from the vaccine virus.
Conference participants described the first successful efforts to generate hu-
man monoclonal antibody Fab sequences against hepatitis B virus surface
R Lerner F Brown, R. Chanock,
H. Ginsberg
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antigen (HBsAg) or the envelope glycoprotein of HIV-1 by antigen selection from
a combinatorial library expressed on the surface of
filamentous phage. These
high-affinity Fabs should prove useful in defining the repertoire of human
antibody response to immunization, and full-length antibodies prepared from the
Fabs may prove useful in passive immunoprophylaxis as well as immunotherapy.
This meeting was supported in part by the Rockefeller Foundation.
PROGRAM
Immunology
Chairman: R.N. Germain, NIAID, National Institutes of Health
Immunology and AIDS
Chairman: J.A. Berzofsky, NCI, National Institutes of Health
Bacteriology and Parasitology
Chairman: F. Brown, USDA, Plum Island Animal Disease Center
Virology I
Chairman: C J Lai, NIAID, National Institutes of Health
AIDS II
Chairman: E. Norrby, Karolinska Institute
AIDS III
Chairman: P.R. Johnson, Georgetown University
Virology II
Chairman: R.M. Chanock, NIAID, National Institutes of Health
Virology II (continued) and AIDS IV
Chairman: H.S. Ginsberg, Columbia University College of Physicians & Surgeons
AIDS and Virology
Chairman: R.A. Lerner, Scripps Research Institute
Summary
Fred Brown, USDA, Plum Island Animal Disease Center
R. Houghten, J. Berzofsky, R. Germain
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S. Zebedee
1
M. Bray
C.-J. Lai
A. Prince
Molecular Neurobiology of Drosophila
September 25-September 29, 1991
ARRANGED BY
Ralph Greenspan, Roche Institute of Molecular Biology
John Pa Ike, University of Washington
226 participants
The molecular neurobiology of Drosophila is a new field of study, rooted in the
spectacular advances made in fly molecular biology and in the feasibility of rath-
er detailed studies on the nervous system despite the small size of the organism.
The record attendance at the 1991 meeting testifies to the vigor of the field.
Molecular and genetic techniques are being applied to the study of many
aspects of nervous system development and function. Genes essential to the ini-
tial segregation, proper spatial distribution, and correct number of nerve cell
precursors are being identified in increasing numbers, and their interactions are
being analyzed. Mechanisms of cell-cell communication are being dissected in
ever finer detail. Our understanding of the great diversity of ion currents found in
excitable cells is expanding, with several new channel-related genes being iden-
tified, cloned, and sequenced. Some of the more subtle aspects of neural func-
tion, such as rhythmicity and plasticity, are also being examined at the genetic
and molecular levels, as is the evolution of at least one behavior (courtship).
S. Kunes, S. Datta, J. Heilig
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The meeting hosted the first Elkins Memorial Lecture; William Zagotta (Stan-
ford University) was selected to present his thesis work on the biophysics of
genetically modified potassium channels.
This meeting was funded in part by the National Science Foundation and the
National Institute of Neurological Disorders and Stroke, division of the National In-
stitutes of Health.
PROGRAM
Behavior
Chairman: M. Young, Rockefeller University
Transduction and Second Messengers
Chairman: R. Davis, Cold Spring Harbor Laboratory
Channels and Excitability
Chairman: L. Hall, State University of New York, Buffalo
Elkins Memorial Lecture
William Zagotta, Stanford University
Guidance and Synaptogenesis
Chairman H. Keshishian, Yale University
Gene Regulation
Chairman.. K. White, Brandeis University
Cell Fate-Intercellular Signaling
Chairman: L Zipursky, University of California, Los Angeles
Cell Fate:lntracellular Regulation
Chairman: E. Knust, lnstitut fur Entwicklungsphysiologie, Ko In H. Keshishian
R. Davis
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R Horsch, K. Ikeda, Y. Shimura, J.D. Watson
Molecular Biology of Signal Transduction in Plants
October 2-October 6, 1991
ARRANGED BY
Frederick Ausubel, Harvard Medical School
Nam-Hai Chua, Rockefeller University
Gerald Fink, Whitehead Institute
Venkatesan Sundaresan, Cold Spring Harbor Laboratory
148 participants
The meeting on Molecular Biology of Signal Transduction in Plants represents the
first Cold Spring Harbor meeting devoted entirely to plant biology. The develop-
ment of a plant is regulated by numerous external and internal signals such as
light, gravity, and plant hormones. These signals lead to both general and
specific biological responses by the plant, and an understanding of the mechan-
ism of signal transduction is essential to understanding plant development. There
have been rapid advances in this field over the last 2 years, many of which were
presented at this meeting. The subjects covered ranged from light receptors to
transcription factors regulating flowering and leaf development. Some other
topics that generated much discussion included the role played by calcium in
signal transduction; the cloning and characterization of kinases, phosphatases,
and G-proteins from plants; and the isolation of several types of mutants in dif-
ferent signaling pathways. A final session was devoted to the presentation of
technical advances in the field, including the development of for cloning
genes using previously generated deletions and the introduction of cloned genes
into plants, especially cereals and crop plants.
This meeting was funded in part by the National Science Foundation, the U.S.
Department of Energy, and Pioneer Hi-Bred International.
F. Ausubel, V. Sundaresan, N.-H. Chua, Y. Shimura
265
M Grant, R Ranjeva, C Weiss, K. Hammond-Kosack, T Ashfield
PROGRAM
Reception of Environmental Signals
Chairman: J. Chory, The Salk Institute
Reception of Hormbnal Signals
Chairman: J. Ecker, University of Pennsylvania
Cell-Cell Recognition
Chairman: J.B. Nasrallah, Cornell University
G Proteins and Protein Kinases
Chairman: H. Ma, Cold Spring Harbor Laboratory
Targets of Signals I
Chairman: E. Coen, John lnnes Institute
Targets of Signals II
Chairman: S. Hake, University of California, Berkeley
Mutants in Signaling Pathways
Chairman: Y. Shimura, Kyoto University
Transgenic Approaches and Technologies
Chairman: R. Horsch, Monsanto Company
R. Martienssen, P. Scolnik
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DIRECTOR'S REPORT
The Banbury Center continues to play its role as one of the world's most effective
small conference centers. 1991 was one of our busiest years ever, with 15
scientific meetings attended by almost 600 scientists. The gaps between these
scientific meetings were filled with five other meetings, so that together with the
courses held here during the summer, there seemed to be hardly a moment
when the Center was not being used.
Molecular Biology
Two meetings early in the year set very high standards both for their scientific
content and for the interest that they aroused. The first of these meetings was on
Adhesion Molecule Receptors and Disease. Large families of adhesion
molecules and their receptors have been identified in recent years, and it has be-
come clear that a variety of responses to pathological conditions are mediated
by these molecules. For example, they are involved in the cell movements in in-
flammation and in the mobilization of the immune system. The field has blos-
somed with the realization that adhesion molecule receptors are a target for
therapies directed at modifying the body's response to inflammation, metastasis,
and immune cell function.
Banbury Conference Center
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The second meeting was also concerned with the cell surface, but with a very
large number of membrane proteins that share a common structural motif-the
amino acid chain of the protein loops across the membrane from cytoplasm to
the exterior of the cell seven times. The Seven-transmembrane Segment
Proteins meeting examined the various functions of this family of proteins that
include the receptors for pharmacologically active drugs like acetylcholine and
dopamine, G proteins that help transmit messages across the membrane, and
hormone receptors. The novel element of the meeting was that it compared these
proteins, employing a common molecular design, across a wide evolutionary
range. Participants thus included scientists working on diverse organisms includ-
ing bacteria, yeast, the fruit fly, and vertebrates.
The Molecular Immunobiology of Lyme Disease meeting was particu-
larly appropriate for the Long Island area. Lyme disease was recognized as a
distinct clinical entity in 1977, and the causative agent, a spirochete Borrelia
burgdorferi, was identified in 1982. It is the subject of increasingly intensive re-
search as the disease spreads, and this meeting reviewed the latest findings. Re-
search discussed ranged from the basic (trying to understand how the
spirochete infects cells and how our immune system responds to infection), to
the practical (trying to devise new diagnostic tests), to the future (examining how
vaccines might be developed).
The bacterium Escherichia coli is one of the most intensively studied
organisms. There is a detailed genetic map of its chromosome that is only 3 mil-
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lion base pairs long. It is reasonable to regard E. coli as a model organism for
genome studies and the Banbury meeting, The Genome of E. coli was in-
tended to survey the current state of E. coli genome analysis. The topics covered
included the amount of sequence available, the design and coordination of DNA
sequence and genetic databases, interpretation of sequence data, and the ways
in which the data can be quickly made available to all E. coli researchers. The
meeting was outstanding in that it brought together all the leading participants
from the United States, Europe, and Japan and that it received financial support
from all the agencies that are interested in genome sequencing.
The Receptor-mediated Virus Entry into Cells meeting dealt with the
earliest steps in virus infection. The mechanisms by which viruses enter cells are
poorly understood, but progress has been made recently in identifying the cel-
lular proteins that serve as receptors for viruses. In addition, the proteins in viral
coats that are involved in the binding of virus to cell receptors have been ana-
lyzed by X-ray crystallography. We brought together scientists studying virus
structure, cellular virus receptors, the kinetics of virus-receptor interactions, and
what happens when a virus binds to a receptor. One hoped-for outcome of this
research is the development of new antiviral drugs that will work by interfering
with the process by which cells take up viral particles.
Human Molecular Genetics
In 1991, there were four meetings that continued Banbury Center's interest in hu-
man molecular genetics. The most timely of these meetings was The Molecular
Genetics and Cell Biology of Marfan Syndrome meeting. Marfan
Syndrome is a disorder of connective tissue, and the patients are also remark-
ably tall and thin (Abraham Lincoln is thought by some to have had Marfan
Syndrome). Scientists have been mapping the chromosomal location of the gene
involved and cloning DNA from that location, in addition to studying proteins
known to be important for connective tissue function. Two lines of research came
together at this spring meeting when it was found that both the gene mappers
and the candidate protein researchers had cloned the same gene: the gene for a
connective tissue protein called fibrillin. This was the first occasion on which the
two groups had come together to discuss these findings, and their discussions
hastened the publication of several papers in Nature reporting this work.
Although research on breast cancer is not so advanced, our Molecular
Genetics of Breast Cancer meeting showed that progress is being made in
determining the genetic factors that are involved in breast cancer. The meeting
brought together scientists who are following two different lines of research in the
pursuit of the genetic causes of breast cancer. Epidemiologists and population
geneticists are using linkage studies to map genes in families with a high in-
cidence of breast cancer, and at this meeting, they were able to compare their
data from different families. On the other hand, scientists are studying the ex-
pression of known oncogenes in breast tumors, trying to dissect out the
genetic
changes going on in these tumors. These two research strategies are
beginning
to complement each other; chromosomal location provides clues about
which
genes might be involved, and genes known to be altered
provide resources for
gene mapping.
The Genetics of Psychiatric Disorders meeting tackled two even
more
difficult fields: schizophrenia and bipolar disorder (manic depression). The dif-
ficulties of doing genetic studies of disorders common in the
general population
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are compounded by the difficulties of accurate diagnosis. Thus, much of the
meeting was taken up with discussions of what diagnostic criteria to use and how
these might be standardized so that comparable studies can be done in different
families in different countries.
Although these meetings contributed to the work on trying to unravel the
molecular genetic basis of human inherited disorders, the DNA-based Diag-
nosis: From Laboratory to Application meeting was concerned with the
practical applications of that new knowledge. Many tests have now been devised
to detect mutations in human genes, and increasing numbers of PCR-based tests
are being developed for use in parasitology, microbiology, forensic science, and
so on. However, relatively few of these tests have moved from the research
laboratory to routine diagnostic laboratories. This meeting brought together those
individuals who are developing DNA-based tests with those who have experi-
ence in the routine deployment of tests to consider how DNA-based tests can be
transferred to routine use cheaply and efficiently.
Sloan Foundation Workshops
This year for the first time we invited both Congressional staff and science jour-
nalists to attend the same workshops, rather than segregating the two groups. It
was a successful change, leading to further interesting interactions. Our Sloan
Foundation Workshops typically cover research in biology that has important so-
cial implications, and this year was no exception. The first workshop was on
Aging. Topics ranged from basic research on the molecular biology andgenetics of senescence in cells in tissue culture and in the nematode Caenor-
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habditis elegans, through Alzheimer's disease, to economic and social con-
sequences of a society made up increasingly of the elderly. The second work-
shop discussed topics in which political and social considerations play a large
part in determining what research can be done and how it can be used Ap-
propriately called Biology and Society: Controversial Issues, the workshop
dealt with topics such as using human fetal tissue for transplantation, in vitro fer-
tilization and preimplantation diagnosis, genetic screening, and risk assessment.
Human Genetics and Genome Analysis Workshops
This was the first of what we hope will be a series of workshops intended to intro-
duce the basics of human molecular genetics to nonscientists who are con-
cerned about the human genome projects. Funded by the Department of Ener-
gy's Office of Health and Environmental Research (responsible for the DOE's Hu-
man Genome Project), the workshops are a joint effort by Banbury Center and
the DNA Learning Center. Participants were selected from teachers, journalists,
bioethicists, congressional staff, parent groups, and concerned citizens. The pro-
gram had three components: lectures on the basic science of genetics, experi-
ments at the DNA Learning Center, and talks by invited speakers. Appropriately,
the first meeting began with a talk by David Galas, Associate Director of the Of-
fice of Health and Environmental Research, on the genome projects. The work-
shop was very successful, judging by the questionnaires returned by participants
after the meeting.
Social Aspects of Science Policy
In October 1981, the Banbury Center hosted an influential meeting entitled
Patenting of Life Forms. At that time, the first patent (for a bacterium that
could metabolize oil) was a little over 1 year old, and both scientists and patent
attorneys were trying to understand the implications of that decision for their own
fields. In October 1991, the Intellectual Property and Biotechnology meet-
ing was held to assess how events have measured up to the expectations and
predictions of 10 years ago. There has been an extraordinary proliferation of
biotechnology companies, academic institutions are much more sensitive to re-
search of commercial potential, and many scientists have links directly or as con-
sultants to companies. In addition to legal questions that are still unresolved,
there was discussion of various socio-scientific questions. For example, there
have been fears that the drive for commercial exploitation of research has led to
more secretiveness and a reluctance to share data and materials. Fortuitously,
the meeting was held just a few weeks after the announcement by the National
Institutes of Health that patents had been filed for brain cDNAs.
Baring Brothers/Cold Spring Harbor Laboratory Meeting
Signal transduction-the means by which messages outside the cell are trans-
mitted to the interior of the cell-was especially big news in biotechnology circles
in 1991. We thus made the Signal Transduction meeting the sixth in the
series of meetings sponsored by Baring Brothers for executives of biotechnology
companies and investors. As usual, an outstanding group of scientists spoke at
the meeting and the participants also spent time with Cold Spring Harbor
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Laboratory scientists. A highlight of the meeting was the laboratory class, held
this year in the teaching laboratories of the Beckman Neuroscience Center. The
experiment was simple-isolating DNA from bacteria-but the participants had
the privilege of being taught by Nobel laureate Sydney Altman. The scientists
who attend Banbury Center meetings in 1992 and thereafter owe Baring Brothers
a special vote of thanks. The chairs in the conference room have been renovated
so that for the first time in many years participants will be at the correct height for
the tables and not be in fear of falling off the chairs!
The William Stamps Farish Fund Meeting
The Farish Fund has given the Center funding for three meetings over a 3-year
period. The general subject for the meetings is the genetics of complex human
diseases. The first of the meetings was Molecular Basis of HLA Predisposi-
tion. It has been known for a long time that certain diseases, especially autoim-
mune diseases like diabetes, are associated with particular forms of genes found
in the major histocompatibility locus. The molecular mechanisms underlying
these associations are just beginning to be understood, i.e., we are beginning to
see how changes in proteins that play an essential role in immune system func-
tion can have an effect on many apparently unrelated systems. Participants in the
meeting reviewed the latest advances in this field.
Other Meetings
The Banbury Center continued to host a small number of meetings outside the
main program. The Joint Informatics Task Force of the Department of Energy's
genome project came here in January to review what needs to be done in an
area that will prove crucial for the full exploitation of genome data. The Carnegie
Council on Ethics and International Affairs held the Sixth Annual U.S.-Japan Agri-
cultural Conference at Banbury Center. Appropriately, the topic for the meeting
was a discussion of U.S.-Japan advances in biotechnology. Three other groups
held meetings at Banbury Center: the Trustees of Huntington Hospital, the
Psychiatry Department at Mt. Sinai, and the Trustees of the Planting Fields Foun-
dation. The first in a new series of Lloyd Harbor seminars was given by Ann Gill
of the Cold Spring Harbor Whaling Museum.
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Two meetings held at Banbury Center spawned meetings in Grace
Auditorium! George Cutting (chairman of LIBA) and I decided to exploit the
presence of experts on Lyme disease and breast cancer at Banbury by having
meetings for LIBA associates on these topics. So one day in April, four speakers
from the meeting on Lyme disease were whisked away to Grace Auditorium for
talks and a question and answer session, and 6 months later, we did the same
with Mary-Claire King and Marc Lippman for a session on breast cancer.
Meetings Publications
Banbury Center meetings have continued to be a source of books published by
Cold Spring Harbor Laboratory Press. Four titles in the new Current Communica-
tions in Cell and Molecular Biology series appeared, and most notably in the
Banbury Report series, the book from the meeting, The Biological Basis for Risk
Assessment of Dioxins and Related Compounds, was published. This was eager-
ly awaited as the definitive account of a meeting where misinformation following
the meeting had been the source of much confusion.
Funding
I have already acknowledged the Alfred P. Sloan Foundation for their support of
the Congressional staff and science journalists' workshops. The Foundation has
been a staunch supporter of the Banbury Center for many years. The Human
Genetics and Genome Analysis meetings funded by the Office of Health and
Environmental Research, Department of Energy, allow us to expand this program
of providing information for nonscientists. We are very grateful to the William
Stamps Farish Fund for its 3-year grant. Such support gives us flexibility in
planning ahead, instead of having to scramble for funds each year. It was partic-
ularly pleasing that the Genome of E. coli meeting received funding from all the
federal agencies interested in genome research: the National Center for Human
Genome Research, the National Science Foundation, the National Library of
Medicine, the Office of Health and Environmental Research, and the Department
of Energy. The exciting meeting on the Molecular Genetics and Cell Biol-
ogy of Marfan Syndrome was funded by the National Marfan Foundation and
by the National Institute of Arthritis and Musculoskeletal and Skin Diseases. Once
again, the corporate world was the Banbury Center's principal benefactor,
through contributions to individual meetings and by company support of the Cold
Spring Harbor Laboratory Corporate Sponsor Program. The legal divisions of five
companies contributed to the costs of the meeting on Intellectual Property
and Biotechnology, and the meeting on the Molecular Biology of Lyme
Disease was funded by contributions from Met Path, Allen & Hanburys (Glaxo
Inc.), Home Infusion, and the National Multiple Sclerosis Society. As usual, our
greatest debt is to the members of the Cold Spring Harbor Laboratory Corporate
Sponsor Program as funding for no fewer than five of our meetings came from
this source.
Acknowledgments
The Banbury Center could not possibly operate with its present intensity
without
the hard work and enthusiasm of all involved. In particular, our tight
schedule
puts a tremendous strain on Bea To liver and Ellie Sidorenko
in the Center's office
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and on Katya Davey at Robertson House. The importance of their contributions
can be seen in the many letters of appreciation that we receive from participants.
The groundskeepers, Danny Miller and Andy Sauer, battle leaves in the fall and
grass in the summer to make the Banbury estate a very special place for meet-
ings. The Laboratory's housekeeping and catering staff also did a wonderful job
coping with the rapid turnover of meetings and the increased numbers of
participants at our meetings.
Jan A. Witkowski
Publications
Watson, J.D. , M. Gilman, J.A. Witkowski, and M. Zoller. 1992. Recombinant DNA. W.H.
Freeman, New York.
Sammis Hat, guest house
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MEETINGS
Sloan Foundation Congressional Workshop on Aging
January 24-January 26
ARRANGED BY
J.A. Witkowski, Banbury Center, Cold Spring Harbor Laboratory, New York
SESSION 1
O.M. Pereira-Smith, Baylor College of Medicine, Houston,
Texas: The molecular biology of aging of cells in vitro.
T.E. Johnson, University of Colorado, Boulder: Cell death in
vivo and its role in normal development.
P. Davies, Albert Einstein College of Medicine, Bronx, New
York: Alzheimer's Disease: Molecular pathology.
R. Tanzi, Massachusetts General Hospital, Boston: The
genetics of Alzheimer's Disease.
SESSION 2
R. Suzman, National Institute on Aging, Bethesda, Maryland:
The demography of aging populations.
R. Berg, Strong Memorial Hospital, Rochester, New York:
Special features of health care for the elderly.
D. Callahan, The Hastings Center, Briarcliff Manor, New
York: Provision of health care for the aged.
J. Witkowski, R. Herdman, R. Levinson
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Adhesion Molecule Receptors and Disease
March 10-March 13
ARRANGED BY
J. M. Harlan, University of Washington, Seattle
T.A. Springer, Center for Blood Research, Boston, Massachusetts
SESSION 1: The Matrix, Cell Interactions, and Disease
Chairperson: R. Hynes, Massachusetts Institute of Technology, Cambridge
R. Hynes, Massachusetts Institute of Technology, Cam-
bridge: Genetic analyses of cell-matrix adhesion.
M.E. Hemler, Dana-Farber Cancer Institute, Boston, Massa-
chusetts: VLA-2 and VLA-4 in the integrin family: Adhe-
sion receptors of critical importance to inflammation and
metastasis.
C.F. Ockenhouse, Walter Reed Army Institute of Research,
Washington, D.C.: Molecular basis for adhesion to CD36
and ICAM-1 by Plasmodium falciparum malaria-infected
erythrocytes.
J. Leong, New England Medical Center, Boston, Massachu-
setts: Cellular penetration by yersina pseudo-
tuberculosis.
S.-I. Hakomori, The Biomembrane Institute and University of
Washington, Seattle: Multiple functional roles of car-
bohydrates in cell adhesion.
SESSION 2: Adhesion and Inflammation
Chairperson: T.A. Springer, Center for Blood Research, Boston, Massachusetts
T.A. Springer, Center for Blood Research, Boston, Massa-
chusetts: How many ICAMs?
M.S. Diamond, Center for Blood Research, Boston, Massa-
chusetts: Mac-1 (CD11b/CD18) and its interaction with
ICAM-1 (CD54).
S.D. Wright, The Rockefeller University, New York, New
York: Regulation of CD18 function: Activation of ELAM-1,
and role of a novel small molecule as an allosteric effec-
tor of CD18.
F. Sanchez-Madrid, Hospital de la Princesa, Madrid, Spain:
Functional mapping and regulation of VLA-4 adhesion
activities.
S. Shaw, National Cancer Institute, Bethesda, Maryland: Ad-
hesion molecules in T-cell differentiation and function.
D. Anderson, M. Diamond
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SESSION 3: Adhesion and Inflammation: Inflammation and Selections
Chairperson: B. Furie, Tufts University School of Medicine, Boston, Massachusetts
C. MacKay, Basel Institute for Immunology, Switzerland:
Correlations between the physiological recirculation of
lymphocytes and expression of adhesion/homing
molecules.
B. Furie, Tufts University School of Medicine, Boston, Mass-
achusetts: PADGEM: A receptor that mediates platelet-
leukocyte interaction by recognition of a lineage-specific
carbohydrate role in thrombosis and inflammation.
R.P. Mc Ever, University of Oklahoma Health Science Center,
Oklahoma City: Leukocyte interactions with GMP-140.
G.A. Zimmerman, University of Utah School of Medicine,
Salt Lake City: Proadhesive molecules expressed by ac-
tivated endothelium-binding and -signaling functions.
J.C. Paulson, Cyetel Corporation, La Jolla, California: Com-
parison of the carbohydrate specificities of ELAM-1 and
GMP-140.
SESSION 4: Adhesion and Inflammation: The Immune System
Chairperson: T.F. Tedder, Dana-Farber Cancer Institute, Boston, Massachusetts
R. Lobb, Biogen, Cambridge, Massachusetts: BCAM1 and
ELAM1: Recent studies.
T.F. Tedder, Dana-Farber Cancer Institute, Boston, Massa-
chusetts: LAM-1 mediates lymphocyte and neutrophil
binding to endothelium in cooperation with other adhe-
sion receptors.
T. Kishimoto, Boehringer Ingelheim Pharmaceuticals, Inc.,
Ridgefield, Connecticut: ELAM-1 is a receptor for skin-
homing lymphocytes.
U. von Andrian, Pharmacia Experimental Medicine, La Jolla,
SESSION 5: Adhesion Molecules and Therapy
Chairperson: J.M. Harlan, University of Washington, Seattle
J.M. Harlan, University of Washington, Seattle: CD18
monoclonal antibody reduces vascular and tissue injury
in acute inflammation.
R.F. Todd III, University of Michigan Medical School, Ann
Arbor: 131 integrin expression on human small cell lung
cancer cells.
California: A two-step model of leukocyte-endothelial cell
interaction: Different roles for LECAM-1 and the B2 in-
tegrins in vivo.
L.A. Lasky, Genentech, Inc., South San Francisco, Califor-
nia: The homing receptor: A lectin cell adhesion
molecule of the immune system.
P W. Kincade, Oklahoma Medical Research Foundation, Ok-
lahoma City: Adhesion molecules utilized in bone mar-
row.
D.C. Anderson, Baylor College of Medicine, Houston, Texas:
Role of ICAM-1 in canine myocardial reperfusion injury:
Mechanisms of regulation and therapeutic applications.
R. Rothlein, Boehringer Ingelheim Pharmaceuticals, Inc.,
Ridgefield, Connecticut: The anti-inflammatory effects of
anti-ICAM-1 MAb.
Seven-transmembrane Segment Proteins
March 17-March 20
ARRANGED BY
M.R. Brann, National Institute of Neurological Disorders and Stroke,
Bethesda, Maryland
M.G. Caron, Howard Hughes Medical Institute, Duke University
Medical Center. Durham, North Carolina
M.R. Hanley, University of California, Davis
SESSION 1
Chairperson: M.R. Hanley, University of California, Davis
R. Henderson, MRC Laboratory of Molecular Biology, Cam-
bridge, United Kingdom: Structure of bacteriorhodopsin.
E.L. Berson, Harvard Medical School, Boston, Massachu-
setts: Rhodopsin gene mutations in patients with
autosomal dominant retinitis pigmentosa.
D.D. Jenness. University of Massachusetts Medical School,
Worcester Factors controlling stability and internalization
of the yeast a-factor pheromone receptor.
J.A. Kurjan, University of Vermont College of Medicine, Bur-
lington: Role of a G protein in yeast pheromone
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response: Effect of mutations in guanine nucleotide bind-
ing and carboxy-terminal domains.
L. Marsh, Albert Einstein College of Medicine, Bronx, New
York: Determinants of ligand specificity and activation for
the yeast a-factor receptor.
J.W. Thorner, University of California, Berkeley: New insights
in desensitization: Role of the SST2 gene product in
adaptation of the yeast pheromone response pathway.
G. Vassart, R. Sprengle
SESSION 2
J. Shine, 0. Civelli
Chairperson: M.G. Caron, Howard Hughes Medical Institute, Duke University Medical
Center, Durham, North Carolina
P.N. Adler, University of Virginia, Charlottesville: The frizzled
tissue polarity gene of Drosophila.
P.N. Devreotes, Johns Hopkins Medical School, Baltimore,
Maryland: The cAMP receptor of slime mold.
N.M. Nathanson, University of Washington, Seattle: Function
and regulation of muscarinic acetylcholine receptors and
G proteins.
E.C. Hulme, MRC National Institute for Medical Research,
SESSION 3
London, United Kingdom: Muscarinic acetylcholine
receptors: Structure-function relationships.
M.R. Brann, National Institute of Neurological Disorders and
Stroke, Bethesda, Maryland: Localization of muscarinic
receptor subtype gene expression: mRNAs and proteins.
J. Wess, National Institutes of Health, Bethesda, Maryland:
Mutational analysis of muscarinic receptors: Identification
of ligand binding and effector coupling domains.
Chairperson: M. R. Brann, National Institute of Neurological Disorders and Stroke,
Bethesda, Maryland
R.J. Lefkowitz, Howard Hughes Medical Institute, Duke Uni-
versity Medical Center, Durham, North Carolina:
Adrenergic receptors: Structure and regulation.
0. Civelli, Oregon Health Sciences University, Portland:
Molecular biology and complexity of dopamine recep-
tors.
J.-C. Schwartz, INSERM, Paris, France: The dopamine D3
receptor gene and its products: Localization and func-
tion.
M.G. Caron, Howard Hughes Medical Institute, Duke Univer-
sity Medical Center, Durham, North Carolina:
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Catecholamine receptors/structure-function.
G. Vassart, Institut de Recherche Interdisciplinaire en
Biologie Humaine, Brussels, Belgium: Identification of
adenosine Al and A2 receptors amongst a series of or-
phan receptors.
S. Nakanishi, Kyoto University Faculty of Medicine, Japan:
Molecular characterization of metabotropic glutamate
receptors.
E. Mulvihill, ZymoGenetics, Inc., Seattle, Washington: Clon-
ing and expression of the metabotropic glutamate recep-
tor.
SESSION 4
Chairperson: R. J. Lefkowitz, Howard Hughes Medical Institute, Duke University
Medical Center, Durham, North Carolina
J. Shine, St. Vincent's Hospital, Sydney, Australia: Molecular
cloning and expression of G protein coupled receptors.
M. Brownstein, National Institute of Mental Health, Bethesda,
Maryland: Novel G protein coupled receptors.
M.C. Gershengorn, Cornell University Medical College, New
York, New York: The TRH receptor.
J.B.C. Findlay, University of Leeds, United Kingdom: Protein
chemistry and computer-based approaches to the struc-
ture of G-protein-linked receptors.
SESSION 5
J. Battey, National Institute of Neurological Disorders and
Stroke, Bethesda, Maryland: Bombesin receptors.
D. Richter, University of Hamburg, Germany: Neuropeptide
receptors.
T.J. Murphy, Emory University School of Medicine, Atlanta,
Georgia: The angiotensin II receptor.
C. Dykes, Glaxo Group Research Limited, Middlesex,
United Kingdom: Expression of MAS oncogene in
Xenopus oocytes.
Chairperson: R. Henderson, MRC Laboratory of Molecular Biology, Cambridge, United
Kingdom
R. Cone, Oregon Health Sciences University, Portland: New
sites for expression for the glycoprotein hormone recep-
tors: TSH receptor in adipocytes and LH/CG receptor in
the thyroid.
R. Sprengel, ZMBH, University of Heidelberg, Germany: Sig-
nal transduction at gonadotropin receptors.
E.M. Ross, University of Texas, Dallas: Role of extreme
carboxy-terminal regions in determining receptor
localization.
A.D. Strosberg, CNRS, Institut Cochin de Genetique
Moleculaire, Paris, France: Ligand and G protein binding
to B-adrenergic and serotoninergic receptors expressed
in E. coli.
DNA-based Diagnosis: From Laboratory to
Application
March 31-April 3
ARRANGED BY
R.A. Gibbs, Baylor College of Medicine, Houston, Texas
D.W. Yandell, Massachusetts Eye and Ear Infirmary, Boston
Coffee break in Conference Center Library
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SESSION 1: DNA Screening Programs
P. Reilly, Shriver Center for Mental Retardation, Waltham,
Massachusetts: The CF debate: Do medico-legal forces
drive the implementation of new tests?
R.A. Gravel, Montreal Children's Hospital Research Institute,
Quebec, Canada: Mutation screening in Tay-Sachs dis-
ease.
SESSION 2: New Developments in Instrumentation
L.M. Smith, University of Wisconsin-Madison: High-speed
DNA sequencing by horizontal ultra-thin gel elec-
trophoresis with fluorescence detection.
L.J. McBride, Applied Biosystems, Foster City, California:
SESSION 3: Techniques for DNA Screening
D. Nickerson, California Institute of Technology, Pasadena:
DNA diagnostics using an oligonucleotide ligation assay.
S.S. Sommer, Mayo Clinic/Foundation, Rochester, Min-
nesota: An efficient two-tiered diagnostic approach ap-
plied to DNA-based testing in hemophilia and familial
amyloidotic polyneuropathy.
D.J. Kemp, The Walter and Elizabeth Hall Institute of Medi-
cal Research, Victoria, Australia: Capture of PCR produc-
SESSION 4: Applications in Genetic Diseases
D.J. Prockop, Jefferson Medical College, Philadelphia,
Pennsylvania: Repetitive sequencing of collagen genes
for mutations that can cause common diseases such as
osteoarthritis, arterial aneurysms, and osteoporosis.
L.-C. Tsui, The Hospital for Sick Children, Toronto, Ontario,
Canada: Identification of mutations in the cystic fibrosis
transmembrane conductance regulator gene.
F.F. Chehab, University of California, San Francisco:
Molecular diagnostics of cystic fibrosis in a clinical
laboratory: A new perspective.
F. Smith, Shriver Center for Mental Retardation, Waltham,
Massachusetts: Use of single-strand conformation
H.H. Kazazian, Jr., Johns Hopkins Hospital, Baltimore,
Maryland: Impact of DNA testing on family diagnosis.
F.K. Fujimura, Nichols Institute, San Juan Capistrano, Cali-
fornia: Clinical applications of DNA-based diagnosis.
Automated genetic analysis: PCR and analytical
fluorescence-based detection.
A. Costa, Beckman Instruments, Palo Alto, California:
Robotics in the laboratory.
is with DNA binding proteins.
S.R. Bouma, Abbott Laboratories, Abbott Park, Illinois: The
ligase chain reaction (LCR) in DNA-based diagnostics.
E.R.B. McCabe, Baylor College of Medicine, Houston,
Texas: DNA analysis using newborn screening
specimens: Evolving applications for dried blood spot
technology.
polymorphism (SSCP) analysis and denaturing gradient
gel electrophoresis for screening patient samples for
defects in the acid 13-glucosidase and proteolipid protein
genes.
J.S. Chamberlain, University of Michigan Medical School,
Ann Arbor: Diagnosis and carrier detection of DMD via
PCR.
L. Ugozzoli, Beckman Research Institute, Duarte, California:
Allele-specific PCR: A new application.
D.F. Wirth, Harvard School of Public Health, Boston, Massa-
chusetts: DNA probe diagnosis of parasitic diseases:
Use of PCR.
B. Trask, R. Gibbs
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SESSION 5: DNA-Based Diagnosis Of Cancer
S.H. Friend, Massachusetts General Hospital Cancer Cen-
ter, Charlestown: Screening for germ line p53 mutations:
Within and outside of L.-Fraumeni families.
D.W. Yandell, Massachusetts Eye and Ear Infirmary, Boston:
DNA-based diagnosis of cancer predisposition: Analysis
of RB and p53 genes.
K. Hayashi, National Cancer Center Research Institute,
SESSION 6: Detection of Viruses and Other Pathogens
T.J. White, Roche Diagnostic Research, Alameda, Califor-
nia: Development of PCR-based diagnostic kits and ser-
vices for HIV-1.
R.A. Gibbs, Baylor College of Medicine, Houston, Texas:
Analysis of mixed DNA sequences in genetic and in-
fectious diseases.
B. Weiser, State University of New York at Stony Brook:
Measurement of HIV-1 nucleotide sequence diversity
among close contacts for epidemiologic investigation.
Tokyo, Japan: PCR-SSCP analysis: Detection of DNA
polymorphisms and mutations in oncogenes, anti-
oncogenes, or genes for hereditary diseases.
B.J. Trask, Lawrence Livermore National Laboratory, Califor-
nia: Chromosome analysis using flow cytometry and fluo-
rescence in situ hybridization.
S.M. Wolinsky, Northwestern University Medical School, Chi-
cago, Illinois: Characterization of HIV-1 sequence varia-
tion between mother-infant transmission pairs using PCR-
temperature gradient gel electrophoresis (TGGE) and
direct PCR cycle sequencing.
D. Shibata, University of Southern California, Los Angeles:
Applications of the PCR to routinely obtained fixed tissue.
H.H. Kazazian, Jr., Johns Hopkins Hospital, Baltimore,
Maryland: Concluding remarks.
The Molecular Immunobiology of Lyme Disease
April 7-April 10
ARRANGED BY
J.J. Dunn, Brookhaven National Laboratory, Upton, New York
S.E. Schutzer, UMDNJ-New Jersey Medical School, Newark
SESSION 1: Pathogenesis
Chairperson: J.L. Benach, State University of New York at Stony Brook
J.L. Benach, State University of New York at Stony Brook:
Diversity in the adhesion process of Borrelia to
eukaryotic cells.
P.H. Duray, Fox Chase Cancer Center, Philadelphia,
Pennsylvania: Mammalian tissue-spirochete interactions.
G. Peltz, Syntex, Palo Alto, California: T cells in the
pathogenesis of human Lyme arthritis.
S.W. Barthold, Yale University School of Medicine, New
Haven, Connecticut: Lyme borreliosis in the laboratory
mouse.
N. Bhardwaj, The Rockefeller University, New York, New
York: Dendritic cells in human blood and synovial ex-
udates.
SESSION 2: Neurology
Chairperson: P.K. Coyle, State University of New York at Stony
Brook
P.K. Coyle, State University of New York at Stony Brook: Im-
mune complex analysis in Borrelia burgdorferi infection.
D.E. Griffin, Johns Hopkins University School of Medicine,
Baltimore, Maryland: Immune responses to CNS infec-
tions.
S.A. Lukehart, University of Washington School of Medicine,
Seattle: Early involvement of the central nervous system
by Treponema pallidum.
G. Habicht, State University of New York at Stony Brook:
Molecular mechanisms of Borrelia burgdorferi
pathogenicity.
J.C. Garcia-Monco, Hospital de Galdacano, Vizcaya, Spain:
Early central nervous system invasion by Borrelia burg-
dorferi.
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SESSION 3: Molecular Biology I: Surface Antigens
Chairperson: J.J. Dunn, Brookhaven National Laboratory, Upton, New York
J.J. Dunn, Brookhaven National Laboratory, Upton, New
York: High-level expression of Borrelia burgdorferi sur-
face proteins.
P.A. Rosa, Rocky Mountain Laboratories, Hamilton,
Montana: The molecular basis of (some) outer surface
protein variation in Borrelia burgdorferi.
J. Radolf, University of Texas, Dallas: Immunobiology of
spirochete lipoproteins.
D.H. Persing, Mayo Clinic, Rochester, Minnesota: Ticks,
mice, and men: Molecular detection of the Lyme disease
spirochete.
I. Saint-Girons, Institut Pasteur, Paris, France: Genome orga-
nization of Borrelia.
SESSION 4: Immunobiology I: Immune Response
Chairperson: S.E. Schutzer, UMDNJ-New Jersey Medical School, Newark
R.C. Johnson, University of Minnesota, Minneapolis: Im-
munogenicity of Borrelia burgdorferi.
S.E. Schutzer, University of Medicine & Dentistry of New Jer-
sey/New Jersey Medical School, Newark: Autoimmune
reactions triggered by Borrelia burgdorferi infection,
versus persistent infection.
J. Zabriskie, Rockefeller University, New York, New York:
Cross-reactive antibody against bacteria.
S.-M. Cheng, Wyeth-Ayerst Research, Radnor, Pennsyl-
vania: Antigen capture PCR.
B. Johnson, Centers for Disease Control, Fort Collins,
Colorado: Evaluation of recombinant Ospa as a protec-
tive immunogen in tick-challenged hamsters.
E. Fikrig, Yale University School of Medicine, New Haven,
Connecticut: Protective immunity in Lyme borreliosis.
D.J. Volkman, State University of New York at Stony Brook:
Borrelia antigens eliciting early T- and B-cell responses.
U.E. Schaible, Max-Planck-Institut fur Immunbiologie,
Freiburg, Germany: A mouse model for Borrelia burgdor-
feri infection: Pathogenesis immune response and pro-
tection.
SESSION 5: Special Topics
Chairperson: F.S. Kantor, Yale University School of Medicine, New Haven, Connecticut
Molecular Biology II
J. Hinnebusch, University of Texas, San Antonio: Structural
characterization of Borrelia linear plasmids.
lmmunobiology II-Round Table: Detection of Bb
M. Sand, MetPath Inc., Teterboro, New Jersey: Serological
detection of Lyme disease.
M. Golightly, State University of New York at Stony Brook:
Comparative studies of antibody detection of Borrelia
burgdorferi.
NIH Report and Questions to be Researched
B.J. Luft, State University of New York at Stony Brook: De-
velopment and use of recombinant proteins for serodiag-
nosis of Lyme disease.
S.P. Heyse, National Institutes of Health, Bethesda,
Maryland: Brief report on the NIAMS Lyme disease re-
search and education programs.
B. Johnson, S. Lukehart, R. Montgomery
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The Molecular Genetics and Cell Biology of Marfan
Syndrome
April 19-April 21
ARRANGED BY
F.S. Collins, Howard Hughes Medical Institute, University of Michigan, Ann Arbor
U. Francke, Howard Hughes Medical Institute, Stanford University Medical Center, Cali-
fornia
J.A. Witkowski, Banbury Center, Cold Spring Harbor Laboratory, New York
OPENING SESSION
F.S. Collins, Howard Hughes Medical Institute, University of Michigan, Ann Arbor: Deduc-
ing the genetic pathogenesis of MFS: Examples from other disorders.
Meeting participants during coffee break in Conference Room
SESSION 1: Phenotype and Heterogeneity
Chairperson: F.S. Collins, Howard Hughes Medical Institute, University
of Michigan,
Ann Arbor
R.E. Pyeritz, John Hopkins University School of Medicine,
Baltimore, Maryland: The MFS and related disorders:
History and nosology.
R.B. Devereux, New York Hospital-Cornell Medical Center,
New York, New York: Phenotype and clinical complica-
tions of the MFS: The need for definitive (genetic) and in-
termediate (nongenetic) therapies.
SESSION 2: Linkage Studies
Chairperson: C.A. Francomano, Johns Hopkins Hospital, Baltimore,
Maryland
M. Sarfarazi, University of Connecticut Health Center,
Farmington: The linkage map of 15q markers.
H.C. Dietz, The Johns Hopkins Hospital, Baltimore,
L. Peltonen, National Public Health Institute, Helsinki, Fin-
land: Location of the MFS locus and heterogeneity analy-
sis with markers of 15q.
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Maryland: Linkage relationships between the MFS locus
and chromosome 15 markers.
P. Tsipouras, University of Connecticut Health Center,
Farmington: Fine mapping of the region surrounding the
MFS locus on chromosome 15.
SESSION 3: Elastic Tissue Microfibrils and Fibril lin
Chairperson: P. Byers, University of Washington, Seattle
R.W. Glanville, Shriners Hospital for Crippled Children, Port-
land, Oregon: Structural studies on fibrillin and microfibril
assembly.
L.Y. Sakai, Shriners Hospital for Crippled Children, Portland,
Oregon: Biochemical characterization of fibrillin.
C. Maslen, Shriners Hospital for Crippled Children, Portland,
Oregon: Cloning and sequence analysis of fibrillin cDNA.
E. Magenis, Oregon Health Sciences University, Portland:
Chromosome localization of the fibrillin gene.
SESSION 4: Other Elastic Fiber Genes
Chairperson: B. Sykes, University of Oxford, United Kingdom
R.P. Mecham, The Jewish Hospital of St. Louis, Missouri:
The elastic fiber microfibril: Catalyst of elastic fiber.
J. Rosenbloom, University of Pennsylvania, Philadelphia:
Molecular cloning of elastic fiber genes.
M.W. Kilpatrick, University of Birmingham, United Kingdom:
Localization of a gene for MFS by linkage analysis with
chromosome 15 markers.
Discussion: Linkage and heterogeneity.
M Godfrey, University of Nebraska Medical Center, Omaha:
Immunohistochemical analyses of microfibrils in MFD
and other pathological conditions.
D. McGookey, University of Washington, Seattle: MFS:
Defective synthesis, secretion, and extracellular matrix
formation of fibrillin by cultured dermal fibroblasts.
K. Potter, Washington State University, Pullman: Bovine
model for MFS.
Discussion: Fibril lin gene defects in MFS.
B. Lee, Mt. Sinai School of Medicine, New York, New York: A
candidate gene approach toward characterizing the
molecular lesions in MFS.
SESSION 5: Summary and Strategies for Future Research
Chairperson: U. Francke, Howard Hughes Medical Institute, Stanford University Medi-
cal Center, California
P Ciccariello, National Marfan Foundation, Port Washington,
New York: The role of NMF.
Sloan Foundation Science Journalists/Congressional
Workshop on Biology and Society: Controversial Issues
May 5-May 7
ARRANGED BY
J.A. Witkowski, Banbury Center, Cold Spring Harbor Laboratory, New York
SESSION 1
A. Charo, University of Wisconsin Law School, Madison:
RU486 and contraceptive research.
R.M.L. Winston, Royal Postgraduate Medical School, In-
stitute of Obstetrics and Gynaecology, London, United
SESSION 2
D. Vawter, Center for Biomedical Ethics, University of Min-
nesota, Minneapolis: Ethical and legal aspects of re-
search using human fetal tissue.
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Kingdom: Preimplantation genetic diagnosis.
K.J. Lafferty, Childhood Diabetes Center, University of
Colorado Health Sciences Center, Denver: Human fetal
tissue transplantation.
R. Winston, A. Charo
SESSION 3
P.T. Rowley, Division of Genetics, University of Rochester
Medical Center, New York: Screening populations for ge-
netic mutations: Cystic fibrosis.
W.C. Thompson, Program in Social Ecology, University of
California, Irvine: DNA fingerprinting in forensic science:
Scientists on the witness stand.
J.D. Graham, Department of Health Policy and Manage-
ment, Harvard School of Public Health, Boston, Massa-
chusetts: Setting limits for environmental exposure: The
use of expert scientific judgment.
Intellectual Property and Biotechnology
October 10-October 13
ARRANGED BY
A.P. Halluin, Flies ler, Dubb, Meyer & Lovejoy, San Francisco, California
J. Maroney, Cold Spring Harbor Laboratory, New York
J.A. Witkowski, Banbury Center, Cold Spring Harbor Laboratory, New York
OPENING SESSION: Introduction
Chairperson: A.P. Halluin, Flies ler, Dubb, Meyer & Lovejoy, San Francisco, California
A.P. Halluin, Flies ler, Dubb, Meyer & Lovejoy, San Francis-
co, California: Unanswered questions following the pros-
ecution of Cohen and Boyer patent: The dust has not
settled.
N.J. Reimers, Stanford University, California: Managing the
Cohen and Boyer licensing program and patent prosecu-
tion.
B.I. Rowland, Cooley, Godard, Castro et al., Palo Alto, Cali-
fornia: Prosecuting the Cohen and Boyer patent applica-
tion under the public eye: Pros and cons.
SESSION 1: Prosecuting Patents in the Patent and Trademark Office
Chairperson: J.A. Goldstein, Stern, Kessler, Goldstein and Fox, Washington, D.C.
K. Murashige, Irell & Manella, Menlo Park, California: Deal-
ing with scope of claim issues and related problems in
interference proceedings.
P. Granahan, Hamilton, Brook, Smith and Reynolds, Lex-
ington, Massachusetts: Establishing patentability over
the Prior Art.
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SESSION 2: European Issues
Chairperson: J.F. Haley, Jr., Fish & Neave, New York, New York
Higher Life Forms
R.E. Biz ley, Hepworth, Lawrence, Bryer, & Biz ley, Harlow,
United Kingdom: Developments in life patenting in
Europe.
European Prosecution
V. Vossius, Vossius & Partner, Munich, Germany: Strategies
for prosecuting European patent applications and oppo-
sitions.
SESSION 3: Emerging Issues for Scientists
Chairperson: N. Zinder, The Rockefeller University, New York, New York
Patenting from Scientist's Viewpoint
T.J. White, Roche Diagnostics Research, Alameda, Califor-
nia: Unstated assumptions about scientific publication
from industrial laboratories.
N. Zinder, Rockefeller University, New York, New York:
Using data from the Human Genome Project.
How Do Academic and Corporate Entities Manage the Licensing Process?
G.M. Gould, Hoffmann-La Roche Inc., Nutley, New Jersey:
Licensing biotechnology inventions from the corporate
perspective.
L.L. Nelsen, Massachusetts Institute of Technology, Cam-
bridge: Licensing biotechnology inventions from the aca-
demic perspective. G. Frank, K. Mullis, E. Kubasiewicz
SESSION 4: Appealing Patent Decisions
Chairperson: G. Rich, U.S. Court of Appeals for the Federal Circuit, Washington, D.C.
H.C. Wegner, Wegner, Cantor, Mueller & Player, Washing- A. Lourie, U.S. Court of Appeals for the Federal Circuit,
ton, D.C.: Decisions of the PTO Board of Appeals and In- Washington, D.C.: The Federal Circuit's perspective of
terferences, and the Court of Appeals for the Federal Cir- biotechnology cases.
cuit. E.E. Kubasiewicz, Patent and Trademark Office, Arlington,
L. Misrock, Pennie & Edmonds, New York: Appeals to the Virginia: PTO's handling and dissemination of Board of
Federal Circuit from the Federal District Courts and the Appeals and Interferences and Federal Circuit decisions.
ITC.
SESSION 5: Managing Patent Litigation
Chairperson: S. Raines, Genentech, Inc., South San
Francisco, California
B. Eisen, Genetics Institute, Inc., Cambridge, Massachu-
setts: Overview in managing patent litigation.
K. Mullis, La Jolla, California: Perspective of the in-
ventor/scientist in patent litigation before a jury.
M. Hall Patel, U.S. District Court Judge for the Northern Dis-
trict of California, San Francisco: Managing complex
biotechnology patent litigation from the courts' point of
view.
SESSION 6: Overviews
Chairperson: A.P. Halluin, Flies ler, Dubb, Meyer & Lovejoy, San Francisco, California
Patent Office
Legal
Science
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The Genome of E. Co li
October 16-October 19
ARRANGED BY
F.R. Blattner, University of Wisconsin, Madison
G.M. Church, Harvard Medical School, Boston, Massachusetts
J.H. Miller, University of California, Los Angeles
K.E. Rudd, National Institutes of Health, Bethesda, Maryland
C.L. Smith, University of California, Berkeley
Opening Remarks
J.H. Miller, University of California, Los Angeles
SESSION 1: E. coli Sequence
Chairperson: J.A. Witkowski, Banbury Center, Cold Spring Harbor Laboratory, New York
F.R. Blattner, University of Wisconsin, Madison: Status of the
E. coli sequence.
D.L. Daniels, University of Wisconsin, Madison: E. coli se-
quencing.
K.I. Isom, Kobe University, Rokkodai, Japan: Genome anal-
ysis of E. coli K-12: Summary of joint work conducted in
Japan.
G.M. Church, Harvard Medical School, Boston, Massachu-
setts: Automation, multiplex DNA sequencing, and E. coli
proteins.
K.E. Rudd, National Institutes of Health, Bethesda,
Maryland: E. coli genome data bases: EcoMap, EcoSeq,
and EcoGene.
SESSION 2: Data Bases (A)
Chairperson: K.E. Rudd, National Institutes of Health, Bethesda, Maryland
M. Kroger, Justus-Liebig-Universitat Giessen, Germany:
Collection of E. coli DNA sequence data; structure and
use of the ECD data bank; detection of sequencing or
other errors; comparison of different strains.
S. Henikoff, Howard Hughes Medical Institute, Hutchinson
Cancer Research Center, Seattle, Washington: Protein
blocks as aids to sequence interpretation.
R. VanBogelen, University of Michigan Medical School, Ann
Arbor: Genome-linked protein data base of E. coll.
M.R. Riley, Marine Biological Laboratory, Woods Hole, Mas-
sachusetts: A data base of E. coli metabolism connected
to the underlying genes.
M. Berlyn, Yale University, New Haven, Connecticut: Genes,
products, functions, maps: A subset of the E. coli Genet-
ic Stock Center data base.
SESSION 3: Data Bases (B)
Chairperson: C.L. Smith, University of California, Berkeley
K.E. Sanderson, University of Calgary, Alberta, Canada:
Data management at the Salmonella Genetic Stock Cen-
ter.
J.C. Wootton, National Institutes of Health, Bethesda,
Maryland: NCBI data bases and sequence interpretation.
D.W. Mount, University of Arizona, Tucson: Some short and
long-range planning considerations for an E. coli data
base.
C.L. Smith, University of California, Berkeley: The applica-
tion of logic programming to genomic analysis.
K. Rudd, G. Church, M. Kroger, D. Daniels, R. Gesteland
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SESSION 4: Organization of the Genome
Chairperson: F.R. Blattner, University of Wisconsin, Madison
J.R. Roth, University of Utah, Salt Lake City: Genetic stability
and plasticity of the bacterial genetic map.
G. Ferro-Luzzi Ames, University of California, Berkeley:
Tandem chromosomal duplications: A role for REP se-
quences.
P.M. Sharp, Trinity College, Dublin, Ireland: DNA sequence
variability in E. coll.
G.D. Stormo, University of Colorado, Boulder: Using the E.
SESSION 5: The Future
Chairperson: J.H. Miller, University of California, Los Angles
This session was devoted to additional unannounced talks
about the issues raised at the meeting and the planning
for the next meeting, a larger meeting of 150-200 to be
held 1 year hence.
coif sequence to learn about biology.
S. Gottesman, National Cancer Institute, Bethesda,
Maryland: A new cryptic prophage in E. coli.
D.E. Berg, Washington University Medical School, St. Louis,
Missouri: Transposon and PCR-based methods for effi-
cient DNA sequencing. Large-scale reverse genetic
analysis of the E. coli genome.
Molecular Genetics of Breast Cancer
November 10-November 13
ARRANGED BY
M.-C. King, University of California, Berkeley
D. Slamon, University of California, Los Angeles
SESSION 1: Expression of Oncogenes and Growth Factor Receptors in Breast Cancers
Chairperson: D. Slamon, University of California, Los Angeles
D. Slamon, University of California, Los Angeles: HER2/neu
amplification and breast cancer metastasis.
M.F. Press, University of Southern California, Los Angeles:
HER2/neu expression and risk of recurrence in node-
negative breast cancers.
A. Chan, National Cancer Institute, Bethesda, Maryland: Ex-
pression cDNA cloning of genes important in mitogenic
signaling pathways.
SESSION 2: p53, Protein Kinases, nm23, and Stromelysin
Chairperson: D. Slamon, University of California, Los Angeles
G. Casey, University of California, Irvine: p53 mutations and
breast cancer.
E.Y.-H. Lee, University of Texas Health Science Center, San
Antonio: Suppressing neoplasia by replacing RB and
p53 genes in breast cancer cells.
E. Liu, University of North Carolina at Chapel Hill: Protein
kinases in human breast cancer.
P. Basset, Institute of Biological Chemistry, Strasbourg,
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W.J. Gullick, Hammersmith Hospital, London, United King-
dom: Expression of the ERBB3 protein in normal and
malignant tissues.
A.L. Harris, Churchill Hospital, Oxford, United Kingdom: Ex-
pression of epidemal growth factor receptors in breast
cancer.
S.A.W. Fuqua, University of Texas, San Antonio: Variants of
estrogen receptor RNA in breast tumors.
France: Stromelysin and breast cancer metastasis.
M.E. Lippman, Georgetown University Medical Center,
Washington, D.C.: Growth factor control of malignant
progression in human breast cancer.
H.M. Shepard, Genentech, Inc., San Francisco, California:
Monoclonal antibody therapy of human cancer. Taking
the HER2 proto-oncogene to the clinic.
SESSION 3: Gene Mapping of Breast Cancer in Families
Chairperson: M.-C. King, University of California, Berkeley
M.-C. King, University of California, Berkeley: Closing in on a
breast cancer gene on chromosome 17q.
G.M. Lenoir, International Agency for Research on Cancer,
Lyon, France: Closing in on a breast cancer gene on
chromosome 17q.
N.K. Spurr, Imperial Cancer Research Fund, Herts, United
Kingdom: ICRF studies on the genetic analysis of familial
SESSION 4: Mapping Breast Cancer Genes in Tumors
Chairperson: M.-C. King, University of California,
Berkeley
P. Devi lee, Sylvius Laboratories, Leiden, The Netherlands:
Deletion mapping in primary tumors as a tool to identify
tumor suppressor.
R. Callahan, National Cancer Institute, Bethesda, Maryland:
Mutations in breast cancer.
G. Peters, Imperial Cancer Research Fund, London, United
Kingdom: Amplification of chromosome 11q13 and cyclin
SESSION 5: Tools for Genetic Analysis
Chairperson: N.J. Risch, Yale University School of Medicine,
Physical and Genetic Mapping of Chromosome 17q
E. Solomon, Imperial Cancer Research Fund, London,
United Kingdom: Physical and genetic mapping of early
onset breast cancer region on 17q.
R.L. White, Howard Hughes Medical Institute, University of
Utah Medical Center, Salt Lake City: Genetic mapping of
chromosome 17.
F.S. Collins, Howard Hughes Medical Institute, University of
Michigan, Ann Arbor: Genetic and physical mapping of
17q21-q23.
breast cancer.
B.J. Ponder, University of Cambridge, United Kingdom:
Closing in on a breast cancer gene on chromosome 17q.
D.T. Bishop, Imperial Cancer Research Fund, Leeds, United
Kingdom: Genetic heterogeneity and breast cancer.
Discussion: Critical recombinants from informative
pedigrees.
D1 in breast cancer.
H.S. Smith, Geraldine Brush Cancer Research Institute, San
Francisco, California: Tumor suppressor genes and
breast cancer progression.
Discussion: Consensus regions of interest on chromosome
17 and elsewhere.
New Haven, Connecticut
Application of Molecular Genetics to Early Detection
D.L. Page, Vanderbilt University Medical Center North,
Nashville, Tennessee: Precursor lesions of human breast
cancer.
P. Steeg, National Cancer Institute, Bethesda, Maryland:
Genetic alterations associated with breast cancer ag-
gressiveness.
General Discussion: How can results from molecular
genetics be applied to early diagnosis of breast tumors
generally (not only in families)?
G. Casey, J. Witkowski, B. Ponder, R. Callahan
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Genetics of Psychiatric Disorders
November 17-November 20
ARRANGED BY
K. Berg, National Institute of Mental Health, Bethesda, Maryland
S.M. Paul, National Institute of Mental Health, Bethesda, Maryland
D.G. Kirch, National Institute of Mental Health, Rockville, Maryland
SESSION 1: Bipolar Disorder
Chairperson: J.A. Egeland, University of Miami North Psychiatric Research Office, Hershey, Pennsylvania
E.S. Gershon, National Institute of Mental Health, Bethesda,
Maryland: A systematic genomic scan for linkage to
manic-depressive illness: Current results.
W.F. Byer ley, University of Utah School of Medicine, Salt
Lake City: Genomic mapping of Utah bipolar pedigrees.
M. Baron, New York State Psychiatric Institute, New York:
Uncertainties in linkage studies of bipolar affective dis-
order.
N. Barden, Laval University Hospital, Quebec, Canada:
Linkage studies of bipolar disorders in a very large
pedigree derived from a Quebec isolate.
E.I. Ginns, National Institute of Mental Health, Bethesda,
Maryland: Update on the search for DNA markers linked
to manic depressive illness in the Old Order Amish.
Discussants
T. Reich, Jewish Hospital of St. Louis, Missouri
E. Thompson, University of Washington, Seattle
D. L. Pauls, Yale University School of Medicine, New
Haven, Connecticut
SESSION 2: Schizophrenia
Chairperson: I.I. Gottesman, University of Virginia, Charlottesville
K.S. Kendler, Medical College of Virginia, Richmond: A
case-control family study and linkage study of
schizophrenia in Ireland.
C.A. Kaufmann, New York State Psychiatric Institute, New
York: Diagnostic interview for genetic studies: A
polydiagnostic, multidimensional instrument.
J. Mallet, CNRS, Gif-sur-Yvette, France: Schizophrenia and
the pseudoautosomal region.
H.M.D. Gurling, University College and Middlesex School of
Medicine, London, United Kingdom: Increasing the ef-
ficiency of detection of heterogeneity of linkage or false
positive results in psychiatric genetics.
M.J. Owen, University of Wales College of Medicine, Cardiff,
United Kingdom: Chromosome 11q and schizophrenia.
L.E. DeLisi, State University of New York, Stony Brook: X
and Y chromosome linkage in schizophrenia: The evi-
dence for and against.
Discussants
S.S. Kety, National Institute of Mental Health, Bethesda, Maryland
J. Ott, New York State Psychiatric Institute, New York
D. R. Cox, University of California, San Francisco
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T. Reich, J. Ott
SESSION 3: Markers and Mapping
Chairperson: J.R. Kelsoe, University of California, San Diego
A. Chakravarti, University of Pittsburgh, Pennsylvania: Can-
didate gene association studies in schizophrenia.
C. Gilliam, New York State Psychiatric Institute, New York:
Genome-wide search for linkage to bipolar disorder
using mini- and micro-satellite markers.
J.L. Kennedy, Clarke Institute, Toronto, Canada: Antibody
selection of candidate genes in psychiatric disorders.
D.R. Cox, University of California, San Francisco: Sorting the
haystack: A sequential approach to identify bipolar dis-
order genes by using genetic linkage analysis.
Discussants
R. Freedman, University of Colorado, Denver
T. Keith, Collaborative Research Inc., Bedford, Massachusetts
SESSION 4: Quantitative Analysis
Chairperson: N.J. Risch, Yale University School of Medicine, New Haven, Connecticut
J. Ott, New York State Psychiatric Institute, New York:
Linkage analyses with psychiatric traits under one-locus
and two-locus models.
B. K. Suarez, Washington University School of Medicine, St.
Louis, Missouri: Detecting loci for oligogenic traits via
linkage analysis.
E. Thompson, University of Washington, Seattle: Linkage
and segregation analysis for the quantitative indicators of
complex traits.
Discussants
R.C. Elston, Louisiana State University Medical Center, New Orleans.
H.M.D. Gurling, University College and Middlesex School of Medicine, London,
United Kingdom
R. Plomin, Pennsylvania State University, University Park
SESSION 5: Overview and Strategies for Future Research
Discussants
T. Keith, Collaborative Research Inc., Bedford, Massachusetts
R. C. Elston, Louisiana State University Medical Center, New Orleans
C. Van Broeckhoven, University of Antwerp, Belgium
N.S. Wexler, Columbia University College of Physicians & Surgeons, New York
D.A. Regier, National Institute of Mental Health, Rockville, Maryland
S.S. Kety, National Institute of Mental Health, Bethesda, Maryland
A.I. Leshner, National Institute of Mental Health, Rockville, Maryland
L. DeLisi, I. Gottesman
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Receptor-mediated Virus Entry into Cells
November 24-November 27
ARRANGED BY
R.A. Weiss, Institute of Cancer Research, London, United Kingdom
E. Wimmer, State University of New York at Stony Brook
Opening Remarks
E. Wimmer, State University at New York at Stony Brook: Viruses and viral receptors.
SESSION 1: Glycoprotein-mediated Endocytosis, Polarized Cells
Chairperson: B. Fields, Harvard Medical School, Boston, Massachusetts
J.J. Skehel, National Institute for Medical Research, London,
United Kingdom: Receptor binding and membrane fu-
sion by influenza hemagglutinin.
D.C. Wiley, Howard Hughes Medical Institute, Harvard Uni-
versity, Cambridge, Massachusetts: Binding of influenza
virus to cells: A second binding site, synthetic inhibitors.
SESSION 2: Retroviruses
A. Helenius, Yale University School of Medicine, New
Haven, Connecticut: Uncoating and intracellular target-
ing during virus entry.
S. Tucker, University of Alabama at Birmingham: Interaction
of viruses with polarized epithelial cells.
Chairperson: P.G. Spear, Northwestern University, Chicago, Illinois
R.A. Weiss, Institute of Cancer Research, London, United
Kingdom: Entry of HIV into cells.
S.C. Harrison, Howard Hughes Medical Institute, Harvard
University, Cambridge, Massachusetts: Structure of CD4
domains.
J. Gavalchin, State University of New York at Syracuse: A
monoclonal antibody, 34-23, blocks HTLV-I binding and
infection.
J. Cunningham, Harvard Medical School, Boston, Massa-
chusetts: Mouse ecotropic retrovirus receptor: Cellular
function and role in infection.
K Holmes
294
D. Kabat, Oregon Health Sciences University, Portland:
Basic amino acid transport by the receptor for ecotropic
murine retroviruses.
B. O'Hara, Leder le Laboratories, Pearl River, New York:
Regions of GLVR1 required for infection by gibbon ape
leukemia virus.
J.A.T. Young, University of California, San Francisco, School
of Medicine: Isolation and characterization of avian DNA
sequences that confer susceptibility to subgroup A-ALV
infection upon mammalian cells.
SESSION 3: Corona- and Sindbisvirus
Chairperson: E. Wimmer, State University of New York at Stony Brook
K.V. Holmes, Uniformed Services University of the Health
Sciences, Bethesda, Maryland: Coronavirus receptors.
J.H. Strauss, California Institute of Technology, Pasadena:
Identification of a cellular receptor for sindbis virus.
SESSION 4: Picornaviruses
Chairperson: J.J. Skehel, National Institute for Medical Rese
dom
R.L Crowell, Hahnemann University School of Medicine,
Philadelphia, Pennsylvania: Characteristics of the group
B cox-sackie virus receptors.
J.M. Hog le, Harvard Medical School, Boston, Massachu-
setts: Conformational changes in poliovirus associated
with cell entry.
V. Racaniello, Columbia University, New York, New York:
Poliovirus-receptor interaction: Role in entry and
pathogenesis.
S. Koike, The Tokyo Metropolitan Institute of Medical
arch, London, United King-
Science, Japan: Poliovirus receptor: Structure and func-
tion.
J.M. Greve, Miles Research Center, West Haven, Con-
necticut: The interaction and consequences of ICAM-1
interaction with rhinovirus in vitro and in vivo.
T.A. Springer, Center for Blood Research, Boston, Massa-
chusetts: ICAM-1 as a rhinovirus receptor: Structural fea-
tures important in virus entry.
D. Blaas, University of Vienna, Austria: The rhinovirus minor
group receptor.
SESSION 5: Herpesviruses
Chairperson: J.M. White, University of California, San Francisco
B. Roizman, University of Chicago, Illinois: Herpes simplex
virus glycoproteins interact with more than one cellular
receptor and restrict the entry of superinfecting virus into
infected cells.
P.G. Spear, Northwestern University, Chicago, Illinois:
SESSION 6: HBV
A.R. Neurath, The New York Blood Center, New York: HBV:
HBV-cell receptor interactions mediated by the pre-Si
region of the virus envelope protein.
Virion-cell interactions required for the binding of herpes
simplex virus to cells and for infection of the cells.
N.R. Cooper, Scripps Research Institute, La Jolla, California:
Human herpes virus ligands and receptors.
H. Schaller, University of Heidelberg, Germany: Early steps
in hepadnavirus infection: Mechanism of virus uptake
and participation of env proteins.
SESSION 7: Reovirus
Chairperson: R.L. Crowell, Hahnemann University School of Medicine, Philadelphia,
Pennsylvania
B. Fields, Harvard Medical School, Boston, Massachusetts:
Entry of reovirus into cells: Role of ISVPs.
P.W.K. Lee, University of Calgary Health Sciences Centre,
Alberta, Canada: Structure-function relationships of the
reovirus cell-attachment protein sigma 1.
SESSION 8: Polyomavirus
R.A. Consigli, Kansas State University, Manhattan: Early
events of polyomavirus infection: Adsorption, penetra-
tion, uncoating, and nuclear entry.
SESSION 9: Inhibitors
J M. White, University of California, San Francisco: Fusion
mechanism of the influenza hemagglutinin: Toward ra-
tional drug design
F J. Dutko, Sterling Research Group, Rensselaer, New York:
Antiviral drugs that inhibit rhinovirus-receptor interactions
and virus uncoating.
J. Gavalchin, V. Zakis, A. Neurath
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The William Stamps Farish Fund Conference on the
Molecular Basis of HLA Predisposition
December 1-December 4
ARRANGED BY
J. Bell, John Radcliffe Hospital, Oxford, United Kingdom
J.L. Strominger, Harvard University, Cambridge, Massachusetts
Introduction
J. Bell, John Radcliffe Hospital, United Kingdom.
SESSION 1: MHC Structure/Function and Peptide Binding
Chairperson: J. Trowsdale, Imperial Cancer Research Fund, London, United Kingdom
molecules in normal H-2d mice.
D.C. Wraith, Cambridge University, United Kingdom:
Molecular characterization of MHC and T-cell interac-
tions with a dominant autoantigenic epitope: Biological
significance and implications for disease.
D. Madden, Harvard University, Cambridge, Massachusetts:
Structural views of peptide binding to HLA B27.
T. Elliott, Institute for Molecular Medicine, Oxford, United
Kingdom: Role of peptides in MHC class I assembly.
G. Ruberti, Stanford University School of Medicine, Califor-
nia: Presentation of antigen by mixed isotope class II
SESSION 2: MHC Disease Genetics
Chairperson: J. Bell, John Radcliffe Hospital, Oxford, United Kingdom
A.V.S. Hill, John Radcliffe Hospital, Oxford, United Kingdom:
HLA associations with malaria: A route to an effective
vaccine?
G.T. Nepom, Virginia Mason Research Center, Seattle,
Washington and Ann Begovich, Cetus Corporation,
Emeryville, California: Probing beneath the surface: Ge-
netic control of class II allelic variation.
H.A. Erlich, Cetus Corporation, Emeryville, California: Role of
individual residues and of haplotypes in HLA disease
SESSION 3: Transporters and Proteases
Chairperson: P. Parham, Stanford University, California
J.J. Monaco, Medical College of VirginiaNirginia Com-
monwealth University, Richmond: H-2 linked transporter
(HAM1 and HAM2) and proteasome (LMP) genes.
J. Trowsdale, Imperial Cancer Research Fund, London,
United Kingdom: A cluster of transporter and protease
predisposition.
P. Parham, Stanford University, California: Unusual class I
HLA molecules of American Indians: Role in disease.
A.B. Rickinson, University of Birmingham, United Kingdom:
HLA polymorphism and target antigen choice in the
Epstein-Barr virus system.
A.J. McMichael, John Radcliffe Hospital, Oxford, United
Kingdom: HIV escape mutants in vivo.
genes in the HLA class II region that may have a role in
antigen processing.
A.J. McMichael, Institute of Molecular Medicine, Oxford,
United Kingdom: MHC-linked factor(s) affecting epitopes
presented by class I.
SESSION 4: Diabetes and Target Antigens
Chairperson: A.J. McMichael, John Radcliffe Hospital, Oxford, United Kingdom
L. Wicker, Merck Sharp & Dohme Research Laboratories,
Rahway, New Jersey: Influence of non-MHC-linked
diabetogenic genes in the NOD mouse.
J. -F. Bach, Hospital Necker, Paris, France: Cellular level of
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MHC and non-MHC gene expression in type-1 diabetes.
J. Bell, John Radcliffe Hospital, Oxford, United Kingdom: An
HLA DR4-dependent diabetes susceptibility gene on
chromosome 11.
S. Baekkeskov, University of California, San Francisco: Role
of MHC-class I antigen expression in presentation and
targeting of autoantigen.
N. Willcox, John Radcliffe Hospital, Oxford, United King-
dom: Autoimmune T cells and HLA restriction in
myasthenia gravis: First footsteps.
S. Reeders, Yale University School of Medicine, New Haven,
Connecticut: Preliminary studies on the molecular char-
acterization of the Goodpasture antigen.
SESSION 5: TCR Repertoire
Chairperson: D.C. Wraith, Cambridge University, United Kingdom
J. Silver, North Shore University Hospital, Manhasset, New
York: Influence of HLA genes on the human T-cell recep-
tor repertoire.
X. Paliard, Howard Hughes Medical Institute Research
Laboratories, Denver, Colorado: Interaction of EBV with
human T cells.
J. Oksenberg, Stanford University Medical Center, Califor-
nia: TCR usage in MS brain plaques.
J. Bell, John Radcliffe Hospital, Oxford, United Kingdom: T-
cell receptor repertoire in man.
U.S. Department of Energy Workshop on Human Genetics
and Genome Analysis
December 8-December 11
ARRANGED BY
M. Bloom, DNA Learning Center, Cold Spring Harbor Laboratory, New York
D. Mick los, DNA Learning Center, Cold Spring Harbor Laboratory, New York
J. A. Witkowski, Banbury Center, Cold Spring Harbor Laboratory, New York
SESSION 1
D. Galas, U.S. Department of Energy, Washington, D.C.:
Origins and impacts of the Human Genome Project.
SESSION 2
D. Mick los, DNA Learning Center, Cold Spring Harbor
Laboratory, New York: Mendelian genetics and linkage.
J.A. Witkowski, Banbury Center, Cold Spring Harbor
Laboratory, New York: DNA, restriction enzymes, and
molecular cloning.
SESSION 3
D. Mick los, DNA Learning Center, Cold Spring Harbor
Laboratory, New York: Laboratory: Measurements, mi-
cropipetting, and sterile techniques: DNA restriction
analysis and restriction mapping.
SESSION 4
P. Reilly, Shriver Center for Mental Retardation, Waltham,
Massachusetts: The Eugenics movement.
SESSION 5
M Bloom, DNA Learning Center, Cold Spring Harbor
J. Edwards, M. Peck
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Laboratory, New York: Construction and screening of hu-
man gene libraries.
J.A. Witkowski, Banbury Center, Cold Spring Harbor
Laboratory, New York: DNA polymorphisms and linkage
analysis.
SESSION 6
D. Mick los, DNA Learning Center, Cold Spring Harbor
Laboratory, New York: Laboratory: Transformation of E.
coli with plasmid DNA.
M. Bloom, DNA Learning Center, Cold Spring Harbor
Laboratory, New York: Laboratory: Human DNA finger-
printing by polymerase chain reaction.
SESSION 7
M. Wallace, University of Florida Hillis Miller Health Center,
Gainesville: Cloning human disease genes:
Neurofibromatosis 1.
SESSION 8
D. Micklos, DNA Learning Center, Cold Spring Harbor
Laboratory, New York: Laboratory results: Transformation
of E. coli with plasmid DNA.
M. Bloom, DNA Learning Center, Cold Spring Harbor
Laboratory, New York: Laboratory: DNA fingerprinting by
polymerase chain reaction.
SESSION 9
C. Gilliam, New York State Psychiatric Institute, New York:
Searching for genes for mental disorders.
SESSION 10
K. Culver, National Institutes of Health, Bethesda, Maryland:
The first human gene therapy trials.
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COLD SPRING HARBOR LABORATORY PRESS
After the fine financial performance of the previous year, the Press began 1991
with high hopes of similar success. However, like other science publishers, we
found we had entered a difficult period in which sales slowed in all of our major
markets. Faced with diminished grant support, many scientists told us frankly that
they were opting to pay for experiments, not books, and some authors had to
delay work on projects that we had hoped would be 1991 publications.
Nevertheless, 15 new book titles were published. The most spectacular of
these, indeed the most striking book ever published at the Laboratory, was
Houses for Science by Elizabeth Watson. A gorgeously illustrated pictorial history
of the Laboratory from its foundation to the present, the book grew out of the au-
thor's expertise in restoration and close involvement with the refurbishment and
expansion of the Laboratory in the past two decades. The book is a beautiful and
intriguing introduction to the institution and was an instant success among staff,
friends, and neighbors when published in November, just in time for the gift-
giving season. Assisted by Liz Watson's unstinted round of signings and inter-
views, our promotion to libraries and bookstores in the local and metropolitan
area, and good reviews, sales of the book approached 1000 copies by the end
of the year.
Turning the author's manuscript into a 351-page book with over 300 photo-
graphs and other illustrations was an extraordinarily complex task. Many people
made vital contributions to this process, but the key figures were Andrew Garn,
the principal photographer, Emily Harste, the designer, and Nancy Ford, the
Press's Managing Editor, for whom the book was a personal publishing chal-
lenge. Its beauty is an eloquent tribute to their success.
Three New Book Series Are Launched
All of the new book titles in 1991 confirmed once again the commitment to
the
highest publishing standards shown by the staff of the Editorial Production De-
partment, coordinated by Dorothy Brown and Annette Kirk. These books included
the first volumes in three new series. Genome Analysis is a timely information
source for the growing community of scientists who map genes in
humans and
other species. The editors, Kay Davies of Oxford University and
Shirley Tilghman
at Princeton, began the series in January with an excellent
volume on genetic
and physical mapping methods that won praise for its content
and design. A
book on gene expression followed in mid-year, and in December, a
third volume
highlighted successes in the isolation of human disease genes.
Much time was spent preparing the re-launch of the series
Cancer Surveys,
to which we acquired publishing rights in 1990. Careful
coordination was needed
between our editorial, production, and marketing activities
and the work of the
editor L.M. Franks and his staff at ICRF in London. This
resulted, in November, in
a handsomely designed volume on cancer related to AIDS, followed
in Decem-
ber by a volume of prostate cancer. This series has a more
clinical orientation
than any of the many previous Cold Spring Harbor
publications in the cancer
field.
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Another new book series, Current Communications in Cell and Molecular Biol-
ogy, began with the publication of four volumes. Each had a different theme
linked by a common thread: the dramatic impact of recombinant DNA technol-
ogy. Volumes were published on DNA electrophoresis, fiber carcinogenesis, and
mammalian developmental biology, but the most striking success was Apoptosis,
a book on cell death and its role in development, neurodegeneration, and
aspects of immune function. With its origins in a formative meeting at the Banbury
Center, it is an invaluable summary of a fast-moving field and is already being
revised.
The foundation of our book-publishing program remains our best-selling
laboratory manuals and the annual Symposium series. Molecular Cloning,
Antibodies, and Manipulating the Mouse Embryo continued their remarkable
dominance of the technical literature in their fields, and an updated version of the
course manual in yeast genetics had strong sales. This year's Symposium
volume, number 55, The Brain, was the first neuroscience book to be published
at Cold Spring Harbor Laboratory for several years. It was warmly welcomed as
an up-to-date review with an unusually broad editorial sweep, its attraction en-
hanced by the initial low price of the paperback edition.
The Symposium apart, the value of meetings proceedings volumes in the
eyes of scientists has sunk dramatically in recent years. However, as part of the
Laboratory's centennial celebrations in 1990, Ed Harlow, Tom Curran, Frank
McCormick, and Joan Brugge organized a remarkable meeting that provided, in
a week, a panoramic view of human cancer research. At the organizers' urging,
nearly all of the celebrated contributors to the meeting subsequently wrote review
articles on the topics they discussed. These were published in December as
Origins of Human Cancer: A Comprehensive Review, a notable 900-page book
that has to both research scientists and clinicians.
One Journal Closes and Another Begins
The convergence of laboratory and clinic in oncology is rooted in the growing
conviction that insights into the molecular origins of cancer do assist diagnosis
and may improve treatment of many kinds of tumors. The wish to spread aware-
ness of these advances was the ambitious goal of the journal we began in 1989,
Cancer Cells: A Monthly Review. In 1991, the journal continued to publish a wide
range of good-quality articles skillfully edited to appeal to a broad spectrum of
professional interests in cancer research. However, its distinctive voice had to
struggle to be heard among half a dozen new journals clamoring for the attention
of the same research community. Neither the dedicated efforts of the editors nor
our marketing activities produced the hoped for increase in the journal's circula-
tion in its second full year of publication, resulting in another significant financial
loss. The risk of continuing losses in future years was clearly high. After careful
review, the painful decision was made to discontinue publication of the journal
with the December 1991 issue. We remain committed to publishing for the can-
cer research community and discussions began immediately about ways of
building upon the foundation provided by Cancer Cells. Paula Kiberstis, who
founded the journal, moved to Washington, D.C., to become a senior editor of the
Journal of the National Cancer Institute, and Catriona Simpson, the assistant
editor, transferred to work on our books.
Elsewhere in our journal publishing program, there was excellent news. The
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first issue of our new journal PCR Methods and Applications was published in Au-
gust, after a well-planned publicity campaign that attracted papers as well as
subscriptions. A second issue of the quarterly followed in November. The journal
offers a mixture of commissioned reviews, technical tips, and peer-reviewed
original research papers. Our designer, Jim Suddaby, created an innovative
cover for the journal and an attractive interior layout. The editor, Judy Cuddihy,
assembled a fine collection of commissioned articles for these issues, which sig-
naled the journal's intention of covering all kinds of amplification-based tech-
nologies. The invaluable assistance of the associate editors Rick Myers, Eric
Green, David Bentley, and Richard Gibbs, the editorial board members, and
many ad hoc reviewers ensured that the quality of the original research pub-
lished in the journal was high from the start. The journal's sponsors, Perkin-Elmer
Cetus Instruments, provided a large database of PCR users to whom the journal
could be promoted and purchased multiple subscriptions that gave the journal's
circulation a solid foundation. The first issues were well received by scientists
worldwide and subscriptions rose rapidly through the end of the year.
The journal was also greeted warmly by companies marketing DNA detection
products, and Nancy Kuhle was able to place a substantial amount of advertising
in each issue, allowing us to keep the initial subscription price attractively low.
The success of this launch did not overshadow the continuing progress of
Genes & Development. In its fifth year of publication, the journal grew in size,
submission rate, and subscriptions. The number of papers submitted to the
editorial offices rose to over 600 and the acceptance rate remained at the pre-
vious year's level of 36%. The number of editorial pages in the average issue in-
creased by 9%. The critical judgment of editors Terri Grodzicker and Nick Hastie
and their advisors ensured that the quality of the journal's editorial content
remained high. There was a satisfactory 13% increase in overall subscription
growth. The journal now has subscribers in 40 countries, predominantly in the
United States, Japan, Canada, the United Kingdom, and Germany, and expan-
sion was seen in all these major markets.
Our satisfaction in the journal's performance was underlined by the results of
the 1990 citation analysis from The Institute for Scientific Information,
which
showed that the journal had the highest impact factor of any monthly journal in
biology. By this measure, Genes & Development was once again
the top journal
in genetics and in developmental biology. A pleasing corollary
to this growing
reputation was the substantial increase in demand for
advertising space in its
pages.
New Books Are Initiated and Books for Children Are a Great
Success
The year's acquisition activities initiated a number of diverse
publishing projects,
most of which will come to fruition next year or
beyond. Because the reputation of
the Press is founded so securely on high-quality technical
books, we were
delighted to be able to form talented editorial teams to
work on several important
new manuals. In addition, the organizers of
well-established Cold Spring Harbor
Laboratory courses in Schizosaccharomyces
pombe biology, neural gene clon-
ing, and plant molecular biology were persuaded to
construct manuals of the
methods they have taught. The series of
monographs revived in 1989 will con-
tinue with volumes now being assembled on
RNA, Arabidopsis, and reverse tran-
scriptase. The complex history of molecular biology
and genetics, neglected in
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publishing terms, will be illuminated by three books commissioned in 1991 on
yeast genetics, transposable elements, and protein synthesis. A new edition of
the long out-of-print classic Phage and the Origins of Molecular Biology with new-
ly added material will be published in 1992. Another book with a historical slant
was commissioned from Tom Silhavy and Jonathan Beckwith. Based on the
prokaryote genetics courses they teach at Princeton and Harvard, it is a course
text on genetics that relies on the discussion and analysis of landmark research
papers.
The 1991 projects included two novelties for the Press. The eminent biologist
Ron Laskey occasionally performs witty songs at conferences about life in the
laboratory, and in September, he was persuaded to give an hour-long concert in
Grace Auditorium during the DNA Replication meeting. Our audiocassette of his
concert, Songs for Cynical Scientists, proved to be an immediate hit. Another
striking success was a series of award-winning books for children imported from
Harper Collins, U.K., for exclusive distribution in the United States. Cell Wars,
Cells Are Us, and DNA Is Here To Stay by Fran Balkwill and Mic Rolph explain
the workings of cells and genes simply and clearly, assisted by colorful graphics.
Our professional audience, delighted by this novel way of explaining their work,
bought the books by the thousands. We were delighted to be able to extend the
Laboratory's educational mission in a new direction.
Staff Changes
We entered 1991 with a new organizational structure and an additional facility at
Plainview that houses the Business Operations Department. The staff of this de-
partment had to cope not only with separation into new and very different sur-
roundings, but also with the advent in January of a more complex computer sys-
tem for order processing and fulfillment. Conversion to the new system put the
staff under great strain, but they responded willingly to the challenge and the de-
partment was soon fully functional. By December, the benefits in customer ser-
vice and marketing analysis were already clear. The smooth orchestration of the
move and conversion was an enormous credit to the department's head, Char-
laine Apsel, and the staff. Toward the end of the year, Charlie announced her in-
tention to leave the Laboratory after 11 years of service in customer service,
financial, and marketing capacities. Her knowledge and expertise were invalu-
able, but we were fortunate to have in Guy Keyes, promoted from Warehouse
Manager to Fulfillment and Distribution Manager, someone who knew the Press
well and brought to it a commitment to improved sales and excellent customer
service. Responsibility for monitoring and reporting the financial affairs of the
Press was devolved to the new post of Finance Coordinator.
The position of Marketing Manager created by the reorganization was filled in
March by Ingrid Benirschke, who had gained much relevant experience with
Springer Verlag in Manhattan. She quickly impressed us with her efficiency and
enthusiasm. The seven conference exhibits she attended between April and De-
cember immersed her rapidly in our publications list, and by the end of the year,
she had created the first of the new series of attractive subject-specific catalogs
with which we intend to exploit the targeted marketing and analytic capacities of
our new customer database.
The Marketing Department also encompasses the campus bookstore in thebasement of Grace Auditorium, managed by Connie Halloran. During the winter
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months, the store was refurbished to make maximum use of its small space. It
reopened during the first laboratory course season, restocked with a greater
range of books of general interest to scientists, an expanded range of CSHL-
branded clothing, and sundry items useful for conference attendees. Both visitors
and the Laboratory's staff applauded the new approach, and this enthusiasm
was reflected in the bookstore's increased revenues.
A Year of Consolidation Follows
The past few years have been a time of extraordinary change in publishing at
Cold Spring Harbor Laboratory, and no aspect of it remains untouched. New
technology is an enormous influence. Our decision to undertake in-house
typesetting has led to certain efficiencies in editorial production, and we are ex-
ploring the possible complementary benefits of electronic page design. Most of
the manuscripts we receive from authors are now on disk. The new computer
system for order processing offers many opportunities for better marketing and
sales management. As we move ahead with these innovations, we are fortunate
to have a dedicated staff willing to accept the new and capable of making it
work.
The greatest single change has been the advent of journal publishing.
Doing this well requires a dedicated, forward-looking editorial staff, innovation in
marketing, advertising sales, production, and customer service, and significant
investment. But most importantly, to justify a new journal, there has to be a clearly
defined, unmet need. We remain alert for such opportunities. We are also aware
of the possibilities offered by electronic media. In the meantime, however, for the
first time in several years, we look forward to the next 12 months with no new jour-
nal launch in progress. 1992 is planned as a year of consolidation, for improving
the success of existing publications, expanding our successful book list still fur-
ther, improving overall cost-effectiveness, and maintaining our hard-won reputa-
tion for high-quality publishing at Cold Spring Harbor.
John R. Inglis
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David A. Mick los, Director
Mark V. Bloom, Assistant Director
Susan M. Lauter, Designer
Margaret E. Henderson, Education Manager
Sandra H. Ordway, Administrative Assistant
Jane P. Conigliaro, Middle School Specialist
It has now been seven years since we began introducing precollege students
and teachers to the intellectual challenge of molecular genetics. Our goal has al-
ways been to give students and teachers a view of the cutting edge" of biologi-
cal research and a base of knowledge that allows them to follow new develop-
ments on their own. With its assemblage of young enthusiastic researchers and
visiting scientists from all corners of the globe, Cold Spring Harbor Laboratory is
an ideal place from which to look into the future of biology. We at the DNA Learn-
ing Center (DNALC), endeavor to exploit this unique vantage point to help direct
the future of biology education. We have clung stubbornly to the notion that stu-
dents should always be given the chance to experience the fun of biology-which
is doing experiments. So, much of our effort has been devoted to finding safe
ways for students to successfully perform experiments that closely parallel those
done by research biologists.
When we initiated our teacher-training activities in 1985, we were one of only
a very few research institutions in the nation that had made a substantive commit-
ment to help precollege educators bring biology teaching into the gene age. At
that time, even reasonable people could dismiss our emphasis on genetics as
too narrow or appropriate only for the upper echelon of advanced students. How-
ever, there is now growing awareness that genetic literacy is an essential element
of basic health education and cultural literacy for all young people.
There can be no doubt that the Human Genome Project has accelerated the
pace of research that is propelling our culture into a brave new world, where
DNA diagnosis can detect serious disease well in advance of symptoms, where
defective genes can be replaced by healthy ones, where scantron machines
identify individuals by reading the bar code of their DNA profiles, and where
criminals cannot afford to leave even a few of their own cells at a crime scene. It
promises to be a world of triumph over genetic disease and crime, but also one
fraught with new questions of personal and social responsibility:
How will individuals deal with the knowledge that they harbor genes that
predispose them to crippling or painful diseases?
Should screening for certain genetic diseases or conditions be mandatory?
Who should have access to personal genetic profiles?
Will employers and insurance companies be permitted to use genetic
data
to exclude individuals from jobs or insurance?
Will prospective parents be permitted to pick and choose among
in vitro
fertilized embryos for those with the "best" genes?
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DNALC staff David Micklos, Jane Conigliaro, Sandra Ordway, Margaret Henderson, Mark Bloom, and Susan
Lauter in front of new exhibit, Eye on the Prizes. Jane and Mark display plans for the DNA Learning Center
addition.
The Growth and Problems of Genetics Education
When we began our efforts in genetic literacy, the Education Directorate of the
National Science Foundation (NSF) was just arising, phoenix-like, after its dis-
bandment under the Reagan administration in 1982-1984. (The NSF Education
Directorate traditionally is the largest single funder of'science education in the
U.S.) There was little money to go around, and we were thankful in 1986 to
receive the first of several NSF grants for our teacher-training programs. By the
end of the decade, funding for the Education Directorate had risen to its highest
level in history ($278 million). Funding for NSF, as well as other federal funding
agencies, is likely to remain at high levels throughout the 1990s, given the charge
of the President's America 2000 Program, "By the Year 2000, U.S. students will
be first in the world in science and mathematics achievement." Private founda-
tions have also initiated major science education initiatives, including the Howard
Hughes Medical Institute, the Pew Memorial Trust, and the Johnson Foundation.
Genetics education has been among the beneficiaries of the dramatic increase in
funding, both federal and private.
By 1991, the world of biotechnology and genetics education had become suf-
ficiently large that the NSF convened a conference for leaders in the field, which
filled a conference facility at the University of Wisconsin at Madison. It was
gratifying to see the large number of creative educators now involved in biotech-
nology/genetics education-quite a few of these educators had been trained
through the DNALC's DNA Science Workshops, had used our DNA Science text,
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and had in some way modeled their programs after ours. The sense of shared
accomplishment and consensus on key issues was amazing. There was unani-
mous agreement that biotechnology is not just a "flash in the pan" topic, but an
opportunity to integrate concepts from biology, chemistry, and physics, as well
as the personal and social implications of new technologies. This is consistent
with a "whole learning" approach that relates learning to the life and culture of the
individual.
A number of project leaders had been surprised to find that efforts targeted at
one level of the educational system had unforeseen effects at a higher level. This
"trickle-up" effect is caused by the elevated expectations of students who have
been exposed to novel instruction and who then challenge higher-level teachers
to update their instructional methods. Thus, the familiarity of graduating high
school seniors with gene manipulation methods challenges college faculty to of-
fer more entailed experiments with DNA in their introductory courses. Likewise, a
growing number of middle school teachers who now allow their students to trans-
form bacteria with a new gene challenge high school teachers to do even better
experiments. This trickle-up effect is contrary to the traditional notion that educa-
tional innovation trickles down from higher levels. It suggests that focusing in-
structional change at the elementary level can have a multiplier effect, which,
ultimately, ramifies throughout middle school, high school, and college. Further-
more, student and teacher enthusiasm, flexible scheduling, and lack of standard-
ized curricula greatly simplify instructional change at the elementary level. Thus,
with encouragement from the NSF, educators are now placing increased empha-
sis on upgrading elementary science instruction.
An undercurrent of tension, however, pervaded the meeting. Participants
agreed that funding agencies' emphasis on model programs had created a
patchwork of competing and often redundant programs, whose survival hangs on
a nearly constant battle for grants. No foundation or agency, including NSF, has
addressed the problem of how to provide continuing funding to mature programs
whose usefulness as models has been established. Lacking long-term support,
the very best investigators must devote inordinate effort to developing specific
grant proposals and administering an intricate web of interlocking programs.
Their rare communicative talents could be better employed writing new curricula,
rather than writing still another grant.
The Need for Human Genome Education Centers
Many voices now argue that American biology education is in urgent need of
major reform. The task of rebuilding the biological education system might be
well served by strategies that have made America's biological research system
vv. ithout peer in the world. Mechanisms and infrastructures that
support innovation
In the biology laboratory might also support innovation in the
biology classroom.
NSF and other funders of biology education have,
indeed, followed the lead of
their research counterparts by providing most support to individual
investigators
for well-defined projects of approximately 3 years duration. However,
well -
supported, multidisciplinary research centers are another important
element of
biological research in the United States and include the Human
Genome Re-
search Centers funded by the National Institutes of Health (NIH)
and the Depart-
ment of Energy, NIH Comprehensive Cancer Centers and
Program Project
Grants, and the Howard Hughes Medical Institutes. This approach acknowledges
that innovation arises from a critical mass of highly motivated individuals. Such
large-scale core support for exemplary centers is essentially absent from biology
education today. (NSF and other federal agencies have provided major block
grants to state education authorities, but these cannot be viewed as parallels to
independent research centers.)
The educational challenges of the Human Genome Project present an ideal
test for a centers approach in biology education. Imagine the potential impact of
creating eight regional Human Genome Educational Centers-stable, well-
equipped environments in which multidisciplinary teams of biologists, educators,
designers, and computer programmers can devote their creative energies entire-
ly to the problems of public genetics education. Genome Education Centers
would be sited at innovative institutions with established educational outreach
programs, expertise in genetics education, and strong linkages to research biol-
ogy. If each center was funded for a renewable term of 5 years at a level of
$500,000-750,000 per year, the total annual cost of the centers program would
be less than 3% of the combined annual NIH-DOE budget for the Human
Genome Project. The meeting at the University of Wisconsin made clear that the
nucleus institutions for regional centers and an infrastructure for collaboration be-
tween them, in fact, already exists.
Plans for a Major Capital Development Program
A 1991 planning grant from the E.S. Webster Foundation allowed us to complete
the concept design phase of a major capital development program, which would
firmly establish the DNALC as a comprehensive prototype of such a Genome Ed-
ucation Center. An architectural study was conducted by Centerbrook Associa-
tes, who have been responsible for all of the major design work at the Laboratory
for more than a decade. Floor plans and elevations of a 3500-square-foot
BioMedia addition to the south of the building, redevelopment of the existing
building, and a site plan for improved parking and visitor access were completed
in time for the November meeting of the Board of Trustees.
The term Bio Media engenders our goal to explore ways to link together ex-
perimental, computer, and audiovisual resources to encourage understanding of
biological concepts. The addition will include a genetics laboratory, multimedia
computer laboratory, student research library, and a much needed
atrium/lunchroom. The laboratory facilities will be adjacent to the existing Bio2000
Laboratory and will include a redeveloped research/prep lab for instructional
support and student research. The new and redeveloped facilities will allow stu-
dents to move between biochemical experiments, microscope observations, and
parallel computer experiences that illustrate molecular events. Library and
laboratory resources will allow students to search the literature and work inde-
pendently on specialized projects. Redevelopment of the original auditorium will
create a 96-seat Cellarium for specialized video presentations and seminars. The
new facility will also provide a much needed meeting space for the many small
museums and educational organizations in the Cold Spring Harbor-Huntington
area.
The capital campaign was quietly launched by year's end with lead grants of
$250,000 from the Stone Foundation and $100,000 from the Weezie Foundation.
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The Stone grant will outfit the BioMedia addition with specialized laboratory and
computer equipment, including some items that we have for years only dreamed
of affording. The laboratory equipment will be used for new student experiments
in cell culture and microscopy and to support advanced research projects by
student interns from neighboring school districts. The computer equipment will
allow us to initiate a program of computer multimedia field trips to complement
experiment field trips that are currently available. The Weezie grant will allow us
to complete construction of a new permanent exhibit, Exploring the Human
Genome, which will be located in a remodeled gallery in the existing building.
BioMedia Laboratory Development
With support from the New York State Legislature and the William Randolph
Hearst Foundation, designer Susan Lauter has organized an efficient multimedia
computing laboratory occupying the former offices on the main level. The
BioMedia Laboratory is currently equipped with three Macintosh II computers, a
top-of-the-line Quadra 900, and supporting audiovisual equipment. The Quadra
will be the central file server of an integrated multimedia network of 12-15 com-
puter stations, which will be installed in the student computer laboratory of the
proposed BioMedia addition.
With strong support from our computer-savvy interns, Sue completed our first
interactive computer program, DNA Detective, which features real-life cases in-
volving DNA fingerprints. The program was presented to the museum world in
October at the annual meeting of the Association of Science-Technology Centers
in Louisville, Kentucky. DNA Detective is the first of eight multimedia computer
programs scheduled for development as part of the forthcoming exhibit, Explor-
ing the Human Genome.
Our ultimate objective is to configure the enlarged BioMedia Laboratory as a
prototype node of a BioMedia Network to demonstrate the use of a central server
to distribute multimedia programs to schools around the country. We intend to
seek additional funding to purchase and maintain a multiprocessor and to install
a fiber optic backbone and connections to public optical trunk lines. In this sys-
tem, one central processor would respond to routine keyboard commands from
clients' personal computers to retrieve files from the central storage disk; another
processor is available to perform computationally intensive activities, such as
manipulations of video files and three-dimensional rotations.
Although a central
multiprocessor is expensive, it would provide the computing power to allow
simple receiving computers at client schools around the country to access and
manipulate multimedia files maintained at the DNALC.
The BioMedia Laboratory also provides an unprecedented opportunity
for
students and biology educators to work coordinately with Cold Spring
Harbor
scientists as they develop a prototype computational
system for genetic re-
search. Cold Spring Harbor Laboratory is part of a newly formed
consortium,
funded by the External Research Program of Digital Equipment Corporation
(DEC), which includes the California Institute of Technology,
San Diego Super-
computer Center, University of Michigan, Massachusetts Institute
of Technology,
and Johns Hopkins University. The objective of the consortium
is to develop "A
Unified Interactive Environment for Scientific Collaboration" that
will allow
biologists to manage and interface effectively with
the vast amounts of DNA and
protein sequence data generated by human genome
research. Laboratory staff
scientist Thomas Marr, who helped conceive the DEC
consortium, serves as ad
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Plans developed by Centerbrook Associates for the BioMedia addition to the DNA Learning Center.
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hoc adviser to the BioMedia Laboratory. He can facilitate a direct flow of ex-
pertise, allowing us to apply solutions to problems of biological computing to ed-
ucational computing:
How to construct a "user friendly" computing network that allows information
to be accessed at low cost by individuals in all parts of the country.
How to allow transparent interfacing with different types of com-
puters/operating systems (e.g., IBM vs. Mac).
How to distribute computationally intensive activities among a number of
regional "nodes."
How to provide for real-time flow of computationally intensive activities be-
tween a central multiprocessor and personal computers.
Routinizing Human DNA Fingerprinting for Educational Purposes
In 1989, Mark Bloom began developing an experiment that would allow students
to make their own DNA fingerprints using the automated procedure of
polymerase chain reaction (PCR). We thought that this would be an ideal way to
"personalize" gene technology and to illustrate the uses of individual DNA varia-
tions (polymorphisms) in forensic biology, identity testing, and disease diagnosis.
In principle, the experiment is brilliantly safe and simple. Cheek cells are ob-
tained by rinsing the mouth with a mild salt solution. The cells are collected by
centrifugation, mixed with an agent to bind impurities, and boiled for several
minutes to liberate DNA. A sample of this crude DNA extract is added to a "cock-
tail" of reagents that identifies and amplifies a specific region of DNA on
chromosome 1. The amplified DNA is then separated by electrophoresis and
stained with a dye that reveals a simple "bar code" consisting of one or two
bands. However, routinizing the experiment so that it could be reproduced by
novices proved daunting. The amplification procedure relies on pure
biochemistry involving ten key components, each of which must be present in
strictly prescribed amounts. Mark's experimental system worked brilliantly at first,
but then crashed unexplainedly. In the course of more than 1 year of experi-
ments, Mark tested and retested every component of the system, finally uncover-
ing the culprit that had spoiled the results. In the process, he had become an
authority on DNA amplification of this type.
Thanks to Mark's tenacity, the human DNA fingerprinting experiment has
been successfully performed by members of diverse groups, including middle
school through college faculty, business leaders, museum personnel, ethicians,
and administrators from government agencies. At the end of the year, the experi-
ment became part of the regular laboratory "menu" available for high school
laboratory field trips. Comprehension of the experiment is much improved
through an animated computer program, developed in our Bio Media Laboratory,
that illustrates the complex biochemistry of the polymerase chain reaction. The
program is available in a computer kiosk in the Bio2000 Laboratory, which is
linked to a new closed-circuit TV system. Thus, students can visualize the chemi-
cal reactions that are taking place in their test tubes. The DNALC is, to our knowl-
edge, the only place in the world where DNA fingerprints are produced by non-
scientists on a routine basis; we estimate that 1000-1500 students will perform
this experiment annually.
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Corporate Advisory Board Formed
Competition in the global market increasingly demands access to a number of
emerging technologies. Gone are the days when a region could exist under a
single government-supported industry. Most agree that the long-term economic
health of Long Island depends on finding growth industry to replace an aged in-
dustrial infrastructure based on military aircraft. Many now look to biotechnology
as a "great hope" for the Island's future. The preexisting infrastructure to support
such an industry is often cited-a concentration of major research facilities with
biotechnical expertise (Cold Spring Harbor Laboratory, Brookhaven National
Laboratory, Cornell/North Shore Medical Center, and the new Picower Institute), a
state-supported biotechnology center and industrial incubator at SUNY Stony
Brook, and a number of existing start-up companies.
Less often considered is the educational infrastructure that primes tech-
nological development and community support. Since 1985, the DNALC of Cold
Spring Harbor Laboratory has precipitated a quiet revolution within Long Island
school systems. More than 300 faculty have been trained to bring cutting-edge
biotechnology experiments into primary, secondary, and college classrooms.
More than 4000 area students visit the DNALC each year to perform state-of-the-
art experiments-many of which are not available to students elsewhere in the na-
tion. Thanks to the partnership between DNALC staff and local educators, Long
Island school systems rank alongside those of San Francisco as the nation's
leaders in biotechnological education at the precollege level. The DNALC con-
tinues to build, at the grass-roots level, an educated constituency that supports
the growth of high technology on Long Island. Moreover, it contributes to the aca-
demic excellence that can attract and retain the intellectual work force needed to
drive Long Island's effort to retool itself for the gene age.
The biotechnology industry has acknowledged the DNALC as an innovative
force in promoting biotechnological development. Biotechnology companies
have supported its activities since 1986. A training program conducted by the
DNALC was the kickoff event and continuing model for the education programs
of the North Carolina Biotechnology Center, which is widely regarded for its ef-
fective promotion of the Research Triangle area. The Biotechnology Center at
Stony Brook has supported the DNALC as its major contribution to public educa-
tion and is now developing a "sister" learning center to serve teachers and stu-
dents from eastern Suffolk County. Unfortunately, too few Long Islanders are
aware of the DNALC and its role in the long-term economic health of the
region.
Thus, the Laboratory's Development Department was charged to work with us to
establish a Corporate Advisory Board with the following objectives:
To educate business leaders and the Long Island community about
the
importance of quality science education in maintaining Long
Island's
technological base, developing future talent, and attracting
high-caliber
employees.
To identify opportunities for industry/DNALC
partnerships to improve the
quality of Long Island science and technology education.
To provide expertise in strategic planning,
marketing, and other business
practices that will help ensure the DNALC's long-term
success.
To provide a sustainable level of annual core
funding for DNALC programs
from the Long Island business community-primarily
to expand access to
local students and teachers. 317
Corporate Advisory Board members brought high-level expertise and
represented a range of businesses: Michael Aboff, President, Aboff's, Inc.; Mark
Abrahams, President, Cybex; Thomas J. Calabrese, Vice President and General
Manager-Long Island, New York Telephone; Vincent Carosella,President, Jetson
Direct Mail Services; Marybeth Chritie, Community Affairs Manager, Cablevision;
Robert E. Diller, Vice President-Marketing, Brinkmann Instruments; Douglas Fox,
President, Newsday; D. Kent Gale, Chief Executive Officer, Daniel Gale Agency;
Arthur D. Herman, Chairman, A.D. Herman Construction; Richard K. Koehn,
Director, Center for Bio technology, SUNY, Stony Brook; Lilo Leeds, Chair, CMP
Publications; Joseph McDonnell, Vice President, LILCO; Robert R. McMillan,
McMillan, Rather, Bennett & Rigano, P.C.; Francis Roberts, Superintendent, Cold
Spring Harbor Central School District; Paul A. Vermylen, Jr., Vice President-
Finance, Meenan Oil Company, Inc.; Michael Vittorio, Vice President, Chase
Manhattan Bank; and Lawrence Waldman, Partner, KMPG Peat Marwick.
Local Programs Expand Despite the Recession
It is a tribute to the foresightedness of school teachers and administrators that
programs for local schools continued to flourish despite severe budget cutbacks.
Membership in the Cold Spring Harbor Curriculum Study, for which there is an
Great Moments in DNA Science lecturers Lynda Sherlock, Scott Henderson, and Raymond O'Keefe.
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annual fee, actually increased to 28 districts in 1991. Curriculum Study schools
receive free or reduced admission to all DNALC programs, spaces in stu-
dent/teacher workshops, and equipment purchase options. The Bio2000
Laboratory operated at peak capacity, with 3900 students representing 75 high
schools participating in hands-on experiments on DNA restriction analysis, bac-
terial transformation, and human DNA fingerprinting. The Great Moments in DNA
Science series, which has been held annually since 1985, attracted 600 students
and teachers to seminars on a range of topics:
DNA Typing in Forensic Case Work, Lynda Sherlock, Suffolk County Crime
Laboratory
Clinical Applications of Human Gene Therapy, Elizabeth Fenjves, SUNY at
Stony Brook
3-D Organization of the Cell Nucleus, Scott Henderson and Raymond
O'Keefe, CSHL
Telomerase and Aging, Carol Grieder, CSHL
A new grant from the William Randolph Hearst Foundation and continued
support from the Center for Biotechnology at SUNY Stony Brook provided the im-
petus for us to greatly enlarge our enrichment activities for middle school stu-
dents. Supported by these grants, Jane Conigliaro joined the staff in the spring
and immediately organized a mailing to advertise a series of 5-day summer
camps for gifted fourth to seventh graders. Calling on our network of teachers at
collaborating schools on Long Island, we had hoped to fill four Fun With DNA
Camps. Despite the late date and limited number of schools contacted, response
was nearly overwhelming. Six Fun With DNA Camps were filled within several
weeks of the announcement, drawing the participation of 150 students from 45
Long Island schools.
Fun With DNA focuses on science as a way of making sense of the world and
solving problems. Students learn a system to expand creative and critical think-
ing skills while mastering basic principles of genetics and gene manipulation.
Categorizing mutations in the fruit fly Drosophila, analyzing kernel characteristics
in Indian corn, and compiling a ministudy of classmates' traits illustrate principles
of variation and Mendelian genetics. Constructing models of biological
structures
("baggie" cells and popsicle stick DNA) is paralleled by observing cells under the
microscope and extracting DNA from bacterial cells. The relationship
between
genes and visible characteristics is discovered by adding a gene
for antibiotic
resistance to an antibiotic-sensitive strain of bacteria. In the culminating
experi-
ment, students construct a "DNA fingerprint" by cutting virus
DNA with restriction
enzymes and sorting the resulting fragments by size in an
electric field. Current
newspaper and magazine articles are used extensively to evaluate
the use of
DNA fingerprints in law and medicine, and as a basis for debate on
societal is-
sues of biotechnology. The highlight of each week was the
final "parent participa-
tion day," when the student teams demonstrated
experiments and explained to
their parents what they had learned.
Following the great success of the the summer program,
Jane organized a
new program of laboratory field trips for middle school
students. Modeled after
the existing high school field trip program, Genetic
FUNdamentals offers a
"menu" of five genetics laboratories, each of which has
been rigorously tested
over a 2-year period during student and teacher workshops.
Laboratories are of-
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Fun With DNA participant, Stacey Mon, demonstrates a DNA extraction on Parent Participa-
tion Day.
fered Mondays and Fridays at the DNALC; special arrangements can be made
for in-school instruction by DNALC staff. Teachers may select one laboratory as
stand-alone enrichment or build a unit composed of several experiences. Partici-
pating teachers receive a planning packet to prepare students for the laboratory
experience, including current articles, vocabulary list, pre- and post-activities,
and topics for follow-up discussion. Fifty laboratories were booked for the
1991-92 school year, with an estimated 1000 students from 32 different schools
participating. The new program increased student laboratory participation at the
DNALC by 25%.
Minority and Special Programs
We always stand ready to assist graduates of our training courses in implement-
ing DNA manipulation laboratories. However, we take special interest in col-
laborations to help upgrade biology teaching at minority institutions. This commit-
ment dates to our earlier collaboration with the Josiah Macy, Jr., Foundation to
set up molecular genetics laboratory programs at four minority high schools in
the urban northeast-A. Phillip Randolph (Harlem), Clara Barton (Brooklyn),
Dewitt Clinton (The Bronx), and Hill House School (New Haven)-and a Navajo In-
dian high school in Arizona. We also organized a mobile laboratory program to
reach rural schools in Alabama. In 1991, we collaborated with Ventures in Educa-
tion (the foundation spinoff of the Macy minority programs) to help set up a
molecular genetics laboratory at the John McDonogh High School in New Or-
leans. We also collaborated with the Abell Foundation to set up model teaching
laboratories at Baltimore City College High School and Baltimore Polytechnic In-
stitute. In August 1991, Margaret Henderson traveled to Claverack State Prison to
help instruct a laboratory illustrating principles of DNA fingerprinting to juvenile
offenders. The program was arranged by Lynn Lee, a middle school teacher who
participated in our NSF training program.
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During the last several years, we have devoted a substantial portion of our
NSF funds for teacher training in rural and historically minority regions of the
south and southwest. For example, high school workshops have been held in
Columbia and Charleston, South Carolina; Columbus, Mississippi; Murray, Ken-
tucky; San Antonio, Texas; Pensacola, Florida; and Harvey, Louisiana. Additional
workshops will serve rural populations in Kentucky, Arkansas, and the inter-
mountain west in 1992. Morehouse College, in Atlanta, was the site of a college
workshop in 1991 and Howard University will be a host school in 1992. NSF-
sponsored workshops, at both the high school and college levels, will be held in
Puerto Rico in 1992.
The DNALC's curriculum development and nationwide teacher training pro-
grams are funded through major federal and foundation grants; however, enrich-
ment activities for local students are largely supported through fees charged to
participating schools and/or parents. Although fees are waived in hardship
cases, this funding dichotomy has limited participation by minority and dis-
advantaged populations in our own "back yard." Thus, late in 1991, we estab-
lished a Special Programs Fund as a means to redress this situation.
Our experience thus far has highlighted the difficulties of introducing innova-
tion in disadvantaged school settings-especially the need to overcome teachers'
"science phobias" and to provide intensive support and follow-up. We will have to
commit considerable staff resources if we are serious about providing enrich-
ment opportunities to deserving schools in our local area. Therefore, the Special
Programs Fund will initially be used to provide start-up support for minority Fun
With DNA summer camps and an Intensive Enrichment Program. Through this
program, we will essentially "adopt" several deserving school systems in the
metro-New York area to demonstrate the vertical integration of the DNALC's
existing laboratory curricula at several levels of instruction.
A Hectic Summer Schedule
Summer is traditionally reserved for teacher training workshops, and 1991 was
our most rigorous to date. A hectic schedule of two college faculty workshops,
eight high school faculty workshops, and 11 middle school faculty workshops
was compounded by the addition of six Fun With DNA Camps for students. The
organization of four different types of workshops in eight states is an extremely
complicated task -- mailing several thousand announcements;
screening several
hundred applications; shipping, setting up, and repacking approximately 500
pounds of reagents and equipment; motel reservations, paying participant
stipends, etc. It still amazes us that (in a pinch) we can arrive at a location on
Monday at 7:30 am, meet with our local organizer (often for the first
time face-to-
fade!), unload a van-load of equipment, have a molecular biology
laboratory
functioning by 10:00 a.m. and still have time for a cup of coffee!
Developed in 1985 and supported by the NSF since 1987,
the DNA Science
Workshop is our best known workshop. The 5-day program,
designed for ad-
vanced high school teachers, introduces modern methods for
producing and
analyzing recombinant DNA molecules, including
microbial culture, gel elec-
trophoresis, DNA restriction analysis, DNA ligation,
and plasmid transformation
and Purification. In keeping with our recent
geographical focus in the south and
southwest, workshops were taught in Miami, Tampa, and
Pensacola, Florida;
Columbus, Mississippi; and Houston and San Antonio, Texas.
These work-
shops-plus additional ones at the DNALC and in Montgomery
County,
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Maryland-drew 170 participants. Collaborators in California, Florida, and Wis-
consin taught the DNA Science curriculum to 235 participants at ten additional
workshops. Our records show that since 1985, the DNA Science curriculum has
been the basis of at least 110 teacher-training workshops, organized by the
DNALC and other education agencies, which have been taken by 2300 biology
educators in 30 states.
The 4-day Exploring Human Genetics Workshop, developed under an NSF
grant in 1990, prepares middle school instructors to introduce an experience-
based unit on Mendelian and human genetics. The activities in this program are
the basis of the Fun With DNA Camp and Genetic FUNdamentals field trips for
middle school students. With strong support from Margaret Henderson, a cohort
of New York State teachers trained in summer 1990 introduced new genetics ac-
tivities during the 1990-1991 school year. Then, the lead teachers coordinated
with Margaret to organize eight "second-round" workshops in summer 1991,
which reached an additional 80 teachers in regions around the state. The lead
teachers incorporated into the second-round workshop insights and resources
drawn from their own classroom experiences during the prior school year.
Several went on to share their experiences at professional conferences through-
Jane Conigliaro prepares middle school students to observe fruit flies with dissecting
microscopes during a Genetic Fundamentals class.
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out the state. A similar level of enthusiasm was evidenced by a second cohort of
lead teachers trained in Maryland in summer 1991. Hopefully, the success of the
New York and Maryland programs will demonstrate that this type of training can
be replicated elsewhere in the nation.
Developed in 1989, the 10-day Advanced DNA Science Workshop introduces
college faculty to many of the modern methods for analyzing complex genomes,
including restriction mapping, gene library construction and screening, Southern
hybridization, and polymerase chain reaction. The Advanced DNA Science cur-
riculum articulates with and extends the concepts introduced in DNA Science.
Structured to follow directly from an introduction to principles of biology, the
entire laboratory series can form the basis of a first course in a molecular biology
sequence, or appropriate sets of laboratories can be integrated as modules in
many types of courses, including introductory biology, genetics, microbiology,
and biochemistry. In summer 1991, 46 faculty from 24 states participated in NSF-
sponsored Advanced DNA Science Workshops held at Morehouse College, At-
lanta, and the University of California, San Francisco. As the San Francisco work-
shop was concluding, we were pleased to learn that the Fund for Improvement of
Post-secondary Education, of the U.S. Department of Education, had approved a
2-year grant that will allow us to expand the college workshop program to four
sites in summer 1992. After incorporating feedback from the summer 1992 work-
shops, the laboratories will be formally published later in the year as Advanced
DNA Science: An Introduction to Methods of Genome Analysis.
New DOE Workshop for Opinion Leaders and Public Policy Makers
Communications and sociological research suggest that information campaigns
have an indirect effect on public opinions and behavior. Information often flows to
the public in two steps: "Opinion leaders" assess information from a variety of
sources and form attitudes about issues. These well-informed individuals, in turn,
influence the opinion and behaviors of people around them. Thus, information
campaigns aimed at a relatively small number of opinion leaders may provide a
cost-effective means to reach large segments of the general public.
With this model in mind, we collaborated with Jan Witkowski of the
Laboratory's Banbury Center to design a new workshop for influential non-
scientists who interface with human genetics research and society. We were very
pleased when our program, Human Genetic and Genome Analysis: A Practical
Workshop for Opinion Leaders and Public Policy Makers, received 2-year fund-
ing from the Department of Energy under its new program, Ethical, Legal, and
Social Implications of the Human Genome Initiative. The first workshop was held
in December, 1991 and drew together a heterogeneous mixture of congressional
staff and government administrators, officers and staff in health-related founda-
tions, genetic rights activists, science journalists, and staff at science museums.
The workshop is composed of three components that juxtapose the theory,
practice, applications, and implications of human gene manipulation. Concept
seminars, presented by Banbury and DNALC staff, introduce key
principles that
underpin human genome analysis, including Mendelian genetics,
the molecular
basis of inheritance, gene mapping and cloning, and DNA diagnosis.
These
topics were made tangible through laboratory sessions where
participants con-
struct a restriction map, transform Escherichia coli with an
ampicillin resistance
gene, and make their own DNA fingerprint using PCR. Feature
seminars, present-
ed by working scientists, provide first-person insight into the
research process
and the ethical dilemmas of human genetics research:
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College intern, Amy Phillips,
prepares a colony hybridization;
this lab is included in the new
Advanced DNA Science
curriculum.
David Mick los (left foreground) monitors a bacterial transformation during "Human Genetics and Genome
Analysis," a DOE-sponsored workshop for opinion leaders and public policy makers.
Origins and Impacts of the Human Genome Project, David Galas, U.S.
Department of Energy
The Eugenics Movement, Philip Reilly, Shriver Center for Mental Retardation
Cloning Human Disease Genes: Neurofibromatosis 1, Margaret Wallace,
University of Florida Health Sciences Center
The First Human Gene Therapy Trials, Ken Culver, National Institutes of
Health
Searching for Genes for Mental Disorders, Conrad Gilliam, Columbia
University
International Collaborations: Ending the Cold War and
"Warm Spring Harbor"
Following up on a collaboration initiated in 1990 with the Shemyakin Institute of
Bioorganic Chemistry, Mark Bloom returned to Moscow in February to co-instruct
a DNA Science Workshop with three Shemyakin staff members. The week-long
workshop was attended by 12 students and 6 teachers selected for their science
and English ability from four Moscow area high schools. Professor Konstantine
Skryabin, Vice-Director of the Engelhardt Institute of Molecular Biology, opened
the workshop with a seminar on the origins and implications of DNA manipulation
technology. Participants used the DNA Science lab/text supplemented with Rus-
sian translations of the laboratory protocols, with Dr. Bloom and Dr. Nikolai
Zvonok presenting laboratory briefings that alternated English with Russian trans-
lation. This team-teaching approach, coupled with meticulous preparation,
yielded experimental results on par with those routinely achieved in the United
States.
Efforts to continue the collaboration were delayed by the dramatic events that
dissolved the former Soviet Union. As the year ended, we received word from
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Professor V.T. lvanov, Director of the Shemyakin Institute, that funds to continue
our exchange were available through the newly formed Russian Academy of
Sciences. With this letter of support in hand, we submitted a request to NSF for a
3-year Russian/American program in Undergraduate Biomolecular Manipulation.
The year also brought opportunity for a new collaboration with Marcel lo Sinis-
calco. A human geneticist of the first order, Marcel lo has based his life's research
on the island of Sardinia, where his early studies provided evidence that the gene
for the blood disorder thalassemia provides protection from malignant malaria. In
the 1950s, he showed that thalassemia was restricted primarily to populations
living in lowland areas of Sardinia, where malaria had been prevalent. Our friend-
ship with Marcel lo dates to 1985, when, on sabbatical at Cold Spring Harbor
Laboratory, he and his family lived next door to Dave Mick los. Over the years,
Marcel lo had watched with keen interest the development of the DNA Learning
Center.
Several years ago, Marcel lo left his research position at Memorial Sloan Ket-
tering Cancer Center to assume responsibility for the development of a new
genetics research institute on the Sardinian coast-the Porto Conte Research and
Training Laboratories, which will open in 1992. Marcello's intent is to model his
new institution after Cold Spring Harbor Laboratory, and, due to its location on
the warm waters of the Mediterranean Sea, he refers to the Porto Conte facility as
"Warm Spring Harbor." He envisioned public genetics education as an integral
part of the new institute and set about to gather support for a museum of science
modeled after the DNA Learning Center.
Marcel lo invited Dave to Sardinia to participate in a week of "Disseminating
Scientific Culture," March 18-22, sponsored by the Italian Ministry of Scientific
and Technological Research. Although events were held at universities and
science museums throughout the country, the Sardinian event was the largest
and most publicized in Italy. Participants included Nobel laureate Rita Levi
Montalcini and Piero Angela, a television science reporter whose phenomenal
celebrity is comparable to Walter Cronkite in his heyday. The need for DNA liter-
acy took on national scope during a 50-minute program on Italian network televi-
sion, moderated by Piero Angela and Marcel lo Siniscalco, which included a 15-
minute documentary on the DNA Learning Center.
The proposed collaboration gained substance in December, when Marcel
lo
received a major grant from the Italian Ministry of University, Scientific and Tech-
nological Research, to develop plans for a science museum at Porto
Conte. Mar-
cello, in turn, subcontracted the DNALC to produce a mini-exhibit
to be dis-
played in Sassari, Sardinia as a focal point of celebrations conducted
there dur-
ing the Italian national "Week of Science," in April. The "genetic
video arcade" will
include four interactive computer modules, which will play several
multimedia
programs developed with Hearst support-DNA Detective,
DNA Diagnosis, and
Gene Therapy. Following presentation during the Italian Week
of Science, the
video arcade will be installed at the Porto Conte Research and Training
Laboratories in anticipation of its own museum. Marcello's efforts,
together with
the Italian translation of DNA Science by the Piccin New
Library, will likely estab-
lish Italy as a European model for public genetics education.
Staff and Interns
In early spring, we recruited a new part-time staff member,
Jane Conigliaro, to
take responsibility for expanding our programs for
middle school students. With
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degrees in elementary and special education, Jane has consulted for six Long Is-
land school districts to design multidisciplinary programs for intellectually gifted
elementary and middle school students. In addition to her position here, Jane
juggles a consultancy for Roslyn Public Schools, an adjunct faculty position at
Long Island University's C.W. Post campus, and a private practice in the
remediation of learning disabilities. Jane was among the first local educators to
use the DNALC as an enrichment opportunity for young students. She also
served on the advisory committee for the original Fun With DNA student work-
shop in 1988 and the NSF training program for middle school teachers. Her inter-
est in educating the "whole child" and unique ability to facilitate associative learn-
ing is an inspiration to the staff, as well as to the many teachers for which she is a
model educator.
A number of middle and high school faculty assisted with summer programs,
getting a "micro-teaching" experience and a behind the scenes look at how our
workshops run. DNA Science Workshop alumnus Ellen Mayo, of Douglas
Freeman High School in Richmond, traveled with us to instruct workshops in
Miami and Tampa. A number of faculty assisted with instruction of the Fun With
DNA Camps: Barbara Cullen, Huntington SEARCH Gifted Program; Gerri Faivre,
East Woods School; Peggy Frisina; Karen Gough, Half Hollow Hills High School;
Diane Jedlicka, Roslyn OMNI Gifted Program; James Lauter, Huntington
Elementary School; Adele Nicefero, Hicksville Academic Enrichment Program;
and Nancy Van Vranken, St. Bernard's School.
A small group of high school interns supply "behind the scenes" support that
allow us to provide high-quality laboratory experiences to more than 4000 precol-
lege students per year. Before departing for her first year at SUNY, Geneseo,
senior intern Amy Phillips pretested experiments for the Advanced DNA Science
curriculum. She became so proficient with these advanced techniques that she
functioned as sole laboratory aide for two 10-day summer workshops for college
faculty-a task previously performed by undergraduate and graduate interns.
Mark Staudinger, a junior at Cold Spring Harbor High School, functioned without
flaw as laboratory aide at DNA Science Workshops held in Houston, San Antonio,
and the DNALC. Nicole Nicefero, a senior at Cold Spring Harbor High School,
functioned as a mentor to younger students participating in five Fun With DNA
Workshops. New interns Maggie Choi, a sophomore at Syosset High School and
Charles Rexer, a senior at Manhasset High School, assumed responsibility for the
Bio2000 Laboratory, but also found time for independent research projects.
With the opening of the BioMedia Laboratory, interns also have the op-
portunity to apply their computer abilities to the problems of biology education.
Intern involvement in multimedia development began during a summer stay by
Claudio Siniscalco, the son of our Italian collaborator, Marcel lo. A freshman at
Westminster School in London, Claudio completed casework for the initial pro-
gram, DNA Detective. David Hollman, a junior at Cold Spring Harbor High
School, completed a program that accesses a laser disk containing video
demonstrations of student laboratory techniques. The program is now used in the
Bio2000 Laboratory, allowing our instructors to call up, at the touch of a button,
appropriate video clips that serve as visual references to assist students as they
perform experiments.
Publication
Bloom, M., G. Freyer, and D. Mick los. Advanced DNA Science An Introduction to Meth-
ods of Genome Analysis. (In preparation.)
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Sites of Major 4-8 Day Workshops 1985-1991
ALABAMA University of Alabama, Tuscaloosa
ARIZONA Tuba City High School
1987,1988,1989,1990
CALIFORNIA 1988University of California, Davis 1986
San Francisco State, San Francisco 1991
CONNECTICUT Choate Rosemary Hall, Wallingford 1987
FLORIDA N. Miami Beach Senior High School, Miami 1991
University of W. Florida, Pensacola 1991
Armwood Senior High School, Tampa 1991
GEORGIA Fernbank, Inc., Atlanta 1989
Morehouse College, Atlanta 1991
HAWAII Kamehameha Secondary School, Honolulu 1990
ILLINOIS Argonne National Laboratory, Chicago 1986, 1987
INDIANA Butler University, Indianapolis 1987
IOWA Drake University, Des Moines 1987
KENTUCKY Murray State University 1988
LOUISIANA Jefferson Parish Public Schools, Harvey 1990
MANITOBA Red River Community College, Winnipeg 1989
MARYLAND Annapolis Senior High School 1989
McDonogh School, Baltimore 1988
Montgomery County Public Schools 1990,1991
St. John's College, Annapolis 1991
MASSACHUSETTS Beverly High School 1986
Dover-Sherborn High School, Dover 1989
Randolph High School 1988
Winsor School, Boston 1987
MICHIGAN Athens High School, Troy 1989
MISSISSIPPI Mississippi School for Math & Science, Columbus 1990,1991
MISSOURI Washington University, St. Louis 1989
NEW HAMPSHIRE St. Paul's School, Concord 1986,1987
NEW YORK Albany High School 1987
Bronx High School of Science 1987
Cold Spring Harbor High School 1985,1987
DeWitt Middle School, Ithaca 1991
DNA Learning Center, High School Workshop 1988(3),1989(2),
1990(2), 1991
DNA Learning Center, College Workshop 1990
DNA Learning Center, Middle School Workshop 1990,1991
Fostertown School, Newburgh 1991
Huntington High School 1986
Irvington High School 1986
Junior High School 263, Brooklyn 1991
Lindenhurst Junior High School
1991
Orchard Park School, Orchard Park 1991
Plainview-Old Bethpage Middle School, Plainview
1991
1989
State University at Purchase 1987,1988,1989,1990
State University at Stony Brook 1991
Titusville Middle School, Poughkeepsie 1985
Wheatley School, Old Westbury 1987
NORTH CAROLINA North Carolina School of Science,
Durham
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OHIO Case Western Reserve University, Cleveland 1990
Cleveland Clinic 1987
North Westerville High School, Westerville 1990
PENNSYLVANIA Duquesne University, Pittsburgh 1988
Germantown Academy, Fort Washington 1988
SOUTH CAROLINA Medical University of South Carolina, Charleston 1988
University of South Carolina, Columbia 1988
TEXAS J.J. Pearce High School, Richardson 1990
Langham Creek High School, Houston 1991
Taft High School, San Antonio 1991
VERMONT University of Vermont, Burlington 1989
VIRGINIA Jefferson School of Science, Alexandria 1987
Mathematics and Science Center, Richmond 1990
WEST VIRGINIA Bethany College 1989
WISCONSIN Marquette University, Milwaukee 1986,1987
University of Wisconsin, Madison 1988,1989
WYOMING University of Wyoming, Laramie 1991
1991 Workshops, Meetings, and Collaborations
January 10
January 25
January 25-26
January 29-Feb. 11
February 2-3
February 26
March 2
March 8-10
March 14
March 18-22
March 26-31
April 4
April 11
April 11-13
April 15-17
April 17
April 22
June 3-4
June 10-14
June 12-14
June 17-21
June 24-26
June 24-28
June 25-27
June 27-July 1
July 8-10
July 8-12
July 8-19
July 10-12
July 15-19
July 22-26
July 29-August 1
July 29-August 2
Meeting, Association of American Colleges, Washington, D.C.
Congressional Workshop, DNA Learning Center, Cold Spring Harbor, New York
Follow-up High School Workshop, National Science Foundation,
Kamehameha Secondary School, Honolulu, Hawaii
High School Workshop, Shemyakin Institute, Moscow, Russia
Follow-up High School Workshop, National Science Foundation, Jefferson Parish
Public Schools, Harvey, Louisiana
Seminar, University of Massachusetts, Amherst, Massachusetts
Middle School Follow-up Workshop, National Science Foundation, Albany,
New York
Meeting, Math and Science Schools, Columbus, Mississippi
Great Moments in DNA Science, Curriculum Study, Cold Spring Harbor, New York
Italian Week at Science, Sassari, Sardinia
NSTA Meeting, Houston, Texas
Great Moments in DNA Science, Curriculum Study, Cold Spring Harbor, New York
Great Moments in DNA Science, Curriculum Study, Cold Spring Harbor, New York
College Workshop, Bates College, Lewiston, Maine
Collaboration with Terri Woodin of University of Nevada, Reno
Great Moments in DNA Science, Curriculum Study, Cold Spring Harbor, New York
Abell Foundation Meeting, Baltimore, Maryland
Collaboration with Raynard Sanders and Michelle Brierre of New Orleans,
Louisiana
High School Workshop, National Science Foundation, University of
West Pensacola, Florida
ABLE Workshop, Laramie, Wyoming
High School Workshop, National Science Foundation, Armwood Senior
High School, Tampa, Florida
Second-round Middle School Workshop, National Science Foundation,
Lindenhurst, New York
High School Workshop, National Science Foundation, N. Miami Beach Senior
High Schools, Miami, Florida
High School Workshop, National Science Foundation, Mississippi School for Math
and Sciences, Columbus, Mississippi
Second-round Middle School Workshop, National Science Foundation,
Poughkeepsie, New York
Second-round Middle School Workshop, National Science Foundation,
DNA Learning Center, Cold Spring Harbor, New York
Second-round Middle School Workshop, National Science Foundation, Ithaca,
New York
Fun With DNA, DNA Learning Center, Cold
Spring Harbor, New York
College Workshop, National Science Foundation,
Morehouse College,
Atlanta, Georgia
Second-round Middle School Workshop, National
Science Foundation, Orchard
Park, New York
Fun With DNA, DNA Learning Center,
Cold Spring Harbor, New York
High School Workshop, Montgomery
County, Burtonsville, Maryland
Fun With DNA, DNA Learning Center,
Cold Spring Harbor, New York
Middle School Workshop, National
Science Foundation, Annapolis, Maryland
Fun With DNA, DNA Learning Center,
Cold Spring Harbor, New York
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August 5-9
August 5-16
August 12-14
August 12-16
August 14-16
August 26-28
August 26-30
August 27-29
August 28-30
September 19
September 23-24
October 1
October 8-9
October 18-21
October 23
October 26-27
October 28-30
November 1
November 2-3
November 3-23
November 5-6
November 9-10
November 14
November 15
November 15
November 15-16
December 7-8
December 8-11
December 9-11
December 14-15
Workshop, National Science Foundation, Taft High School, San Antonio, Texas
Fun With DNA, DNA Learning Center, Cold Spring Harbor, New York
College Workshop, National Science Foundation, University of California,
San Francisco, California
Second-round Middle School Workshop, National Science Foundation, Delmar,
New York
High School Workshop, National Science Foundation, Langham Creek
High School, Houston, Texas
Fun With DNA, DNA Learning Center, Cold Spring Harbor, New York
Second-round Middle School Workshop, National Science Foundation, Newburgh,
New York
Second-round Middle School Workshop, National Science Foundation,
Germantown, New York
High School Workshop, Curriculum Study, DNA Learning Center, Cold Spring
Harbor, New York
Second-round Middle School Workshop, Brooklyn, New York
Second-round Middle School Workshop, Plainview, New York
Physicians' Continuing Education Program, Huntington Hospital, Huntington,
New York
Carolina Biological Supply Co., Burlington, North Carolina
New Jersey Science Workshop
Project Share, Middle School Workshop, Killingworth, Connecticut
ASTC, Louisville, Kentucky
Rutgers University Lecture, New Jersey
Follow-up High School Workshop, National Science Foundation, University of
West Florida, Pensacola, Florida
Meeting, Madison, Wisconsin
NRC Meeting, Washington, D.C.
DOE Grant Meeting, Washington, D.C.
WHO Grantee, Antonio Jacalne, Manila, Phillippines
Middle School Workshop, Centerbrook, Connecticut
Follow-up High School Workshop, National Science Foundation, Langham Creek
High School, Houston, Texas
Genome Presentation, Baltimore, Maryland
Lecture, United States Military Academy, West Point, New York
Site Visit, Raynard Sanders of New Orleans, Louisiana
Follow-up High School Workshop, Montgomery County, Maryland
Follow-up High School Workshop, National Science Foundation, Mississippi School
for Math and Science, Columbus, Mississippi
DOE Workshop, Cold Spring Harbor, New York
Proposal Development Workshop, Washington, D.C.
Follow-up High School Workshop, National Science Foundation, Taft High School,
San Antonio, Texas
EDUCATIONAL
ACTIVITIES
The academic program at Cold Spring Harbor Laboratory comprises a wide-ranging series of
postgraduate laboratory and lecture courses, workshops, large meetings, and a summer research
program for undergraduates. The program now extends from a spring session of courses early in
April through a fall session of courses ending early in November. Hundreds of visiting scientists
participate in the courses as students, instructors, assistants, and lecturers.
Several new courses and meetings were begun this year and new facilities were used for the
first time. The Howard Hughes Medical Institute (HHMI) teaching laboratories in the Beckman
Neuroscience Center were inaugurated this summer when three courses moved up the hill from
James Laboratory: Molecular Embryology of the Mouse, Advanced Molecular Cloning, and Clon-
ing of Neural Genes. The greatly expanded space and state-of-the-art facilities were immediately
hugely popular with all of the instructors and students. Next year, the Neurobiology Laboratory
courses that are now held in Jones Laboratory will move to a second HHMI teaching laboratory. A
new neurobiology laboratory course, Imaging Structure and Function in the Nervous System, was
offered this year, taught by Larry Katz and Richard Lewis. In addition, two new courses were of-
fered in the fall session: Analysis and Genetic Manipulation of YACs, taught by Georges Carle,
Eric Green, and Rodney Rothstein, and Computational Genomics, taught by Elbert Branscomb,
Nate Goodman, Eric Lander, and Tom Marr. In total, the Laboratory was host to 15 laboratory
courses in molecular genetics and neurobiology during the spring, summer, and fall sessions (in-
structors and students are listed in the following pages) and four 1-2-week summer neurobiology
lecture courses held at the Banbury Center.
The courses are supported by, and would not be possible without, a series of grants from fed-
eral and private sources. The summer molecular genetics courses have been supported for many
years by grants from the National Institutes of Health and the National Science Foundation, and a
grant from the National Institute of Mental Health has supported several of the neurobiology
courses. However, it has been a large education grant (renewed again this year) from HHMI that
has provided stable support for the neurobiology program and has allowed the Laboratory to be-
gin its series of spring and fall courses. The Laboratory also received an award from the Klingen-
stein Fund for the support of neurobiology courses. As has been the case for several years, the
Grass Foundation provided funds for scholarships for students in neurobiology courses.
Although conferences at the Laboratory started with a single Symposium in 1933 and have
since grown to 14 meetings per year covering a wide variety of topics, the Symposium continues
to be a highlight. This year's Symposium, The Cell Cycle, organized by David Beach, Bruce
Stillman, and James Watson, was, in fact, oversubscribed; more than 450 scientists gathered to
discuss their work in this rapidly moving area of research. Several of the meetings, in addition to
the Symposium, were filled to capacity as every seat (and sometimes parts of the floor) in Grace
Auditorium was occupied. These meetings included RNA Processing, RNA Tumor Viruses, and
the Cancer Cells meeting on Regulation of Eukaryotic Transcription. The success of the meetings
really depends on all of the scientists who serve as organizers (listed in the following pages) and
on the enthusiastic participation of all of the visiting scientists. A highlight of the meeting season in
1991 was the opening of Dolan Hall for the accommodation of visiting scientists. These facilities
were very much needed and elicited enthusiastic comment.
The fact that so many scientists can participate in the courses and meetings is due, in great
measure, to the skill and hard work of the staff in the Meetings Office; Barbara Ward, Diane Tighe,
Micki McBride, Laurie Myers, Eileen Paetz, Marge Stellabotte, and Nancy Weeks. The audiovisual
staff, headed by Herb Parsons, has become well known to visiting scientists who are continually
amazed at their ability to juggle thousands of slides and overhead projections with such efficiency.
The course instructors have come to depend on the skills of Cliff Sutkevich in setting up and
maintaining all of the necessary equipment and supplies. The success of the academic programdepends, to a great extent, on the work and assistance of Laboratory staff from all areas-from
scientists who give lectures (and sometimes teach) in the courses, to those in the Purchasing andGrants Offices, to staff in the Buildings and Grounds Department and Blackford Hall.While graduate students, postdoctoral fellows, and faculty participate in the courses and meet-ings, the Undergraduate Research Program (URP) provides an opportunity for college under-graduates to spend 10 weeks during the summer at the Laboratory. The program, headed byWinship Herr, allows students to do research in the laboratories of staff scientists.
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Postgraduate Courses
The summer program of Postgraduate Courses at Cold Spring Harbor Laboratory
is aimed at meeting the special need for training in interdisciplinary subjects that
are either so new or so specialized that they are not adequately treated by uni-
versities. Our aim is to provide intensive study in the most recent developments
and techniques in these subjects and to prepare students to enter directly into
research in a particular area. To ensure up-to-date coverage of current research
work, we bring together a workshop staff from many laboratories around the
world and supplement this staff with a series of seminar speakers.
Protein Purification and Characterization
April 8-April 22
INSTRUCTORS
Erickson, Bruce, Ph.D., University of North Carolina, Chapel Hill
Kadonaga, James, Ph.D., University of California, San Diego
Marshak, Daniel, Ph.D., Cold Spring Harbor Laboratory, New York
Smith, John, M D., Ph.D., Merck Sharpe & Dohme Research Labs, Rahway, New Jersey
ASSISTANTS
Kerrigan, Leslie, University of California, San Diego
Vazquez, Greg, University of North Carolina, Chapel Hill
Williams, Kevin, Massachusetts General Hospital, Boston
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This course was intended for scientists who are not familiar with techniques of
protein isolation and characterization. It was a rigorous program that included
laboratory work all day and a lecture with discussion session every evening.
Each student became familiar with each of the major techniques in protein
purification by actually performing four separate isolations including (1) a
regulatory protein from muscle tissue; (2) a sequence-specific, DNA-binding
protein; (3) a recombinant protein overexpressed in E. coif; and (4) a membrane-
bound receptor. A variety of bulk fractionation, electrophoretic, and
chromatographic techniques were employed including precipitation by salts, pH,
and ionic polymers; ion exchange, gel filtration, hydrophobic interaction, and
reverse-phase chromatography; lectin affinity, oligonucleotide affinity, and im-
munoaffinity chromatography; polyacrylamide gel electrophoresis, two-
dimensional gel electrophoresis, and electroblotting; and high-performance liq-
uid chromatography. Methods of protein characterization were utilized including
immunological and biochemical assays, peptide mapping, amino acid analysis,
protein sequencing, and mass spectrometry. Emphasis was placed on
strategies of protein purification and characterization rather than on automated
instrumental analysis. Guest lecturers discussed protein structure, modifications
of proteins, methodologies for protein purification and characterization, chemical
synthesis of peptides, and applications of protein biochemistry to cell and
molecular biology.
PARTICIPANTS
Asselin, C., Ph.D., University of Sherbrooke, Canada
Attie, A., Ph.D., University of Wisconsin, Madison
Catala, F., Ph.D., Institut Pasteur, Paris, France
El Ridi, R., Ph.D., Cairo University, Egypt
Grant, S., M.D., Columbia University, New York, New York
Howe, M., Ph.D., University of Tennessee, Memphis
Jenison, S., M.D., Fred Hutchinson Cancer Center, Seattle,
Washington
Kiebler, M., B.S., Institute of Physiological Chemistry,
Munich, Germany
SEMINARS
Aebersold, R., University of British Columbia. Protein se-
quence analysis.
Chamow, S., Genentech, Inc. CD4 immunoadhesins as anti-
HIV therapeutics.
Erickson, B., University of North Carolina. Peptide synthesis.
Garrels, J., Cold Spring Harbor Laboratory. Two-
dimensional electrophoresis: Methods and analysis.
Hart, G., Johns Hopkins University. Glycosylation of
proteins.
Kadonaga, J., University of California, San Diego. DNA-
binding proteins.
Kelly, J., Texas A & M University. Spectroscopic techniques
for studying protein structure.
Koh, G., M.D., Cornell Medical College, New York, New York
Marshall, C., Ph.D., University of Pennsylvania, Philadelphia
Neckelmann, S., Ph.D., Emory University, Atlanta, Georgia
Riva, M., Ph.D., CEN Sac lay, Gif-sur-Yvette, France
Rubin, B., B.A., Cornell University, New York, New York
St-Arnaud, R., Ph.D., Shriners Hospital, Montreal, Canada
Stebbins-Boaz, B., Ph.D., Worcester Foundation,
Shrewsbury, Massachusetts
Upton, C., Ph.D., University of Alberta, Edmonton, Canada
Marshak, D., Cold Spring Harbor Laboratory. 1. Purification
of proteins, Part II. 2. Mass spectroscopic methods.
Pace, N., Texas A & M University. Protein denaturation.
Paterson, Y., University of Pennsylvania. Anti-peptide
antibodies.
Rose, G., Pennsylvania State University. Protein structure.
Smith, J., Merck Sharp & Dohme Research Laboratories.
Purification of proteins, Part I.
Smith, J. and Marshak, D., Cold Spring Harbor Laboratory.
Translational modification of proteins.
Wiktorowicz, J., Applied Biosystems. Protein and DNA isola-
tion and characterization.
Cloning and Analysis of Large DNA Molecules
April 8-April 22
INSTRUCTORS
Birren, Bruce, Ph.D., California Institute of Technology, Pasadena
Klapholz, Sue, Ph.D., Cell Genesys Inc., Foster City, California
Shepherd, Nancy, Ph.D., DuPont Merck Pharmaceutical Co., Wilmington, Delaware
ASSISTANTS
Campbell, Michael, Stanford University, California
Henderson, Nancy, DuPont Merck Pharmaceutical Co., Wilmington, Delaware
Pfrogner, Beverly, DuPont Merck Pharmaceutical Co., Wilmington, Delaware
Wang, Yu Kang, California Institute of Technology, Pasadena
This course covered the theory and practice of manipulating and cloning high-
molecular-weight DNA. Lectures and laboratory work dealt with the use of bac-
teriophage P1 and yeast artificial chromosome (YAC) cloning systems, the isola-
tion and manipulation of high-molecular-weight DNA from mammalian cells for
cloning (including the size selection of >200-kb DNA fragments), and the analy-
sis of high-molecular-weight DNA by pulse field gel (PFG) separation techniques.
P1 and YAC recombinant DNA molecules were produced, introduced into cells
(E. coli and yeast, respectively), and reisolated after appropriate clone selection
and colony screening procedures. A variety of size standards for pulsed-field gel
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electrophoresis were prepared, and gels were run to compare the DNA separa-
tion capabilities of the common PFG techniques. Students gained experience
with physical mapping of YAC inserts and high-molecular-weight genomic DNA.
Lectures by outside speakers on topics of current interest supplemented the
laboratory work.
PARTICIPANTS
Am ler, L., B.A., Deutsches Krebsforschungszentrum,
Heidelberg, Germany
Beard, H., B.S., USDA Plant Molecular Biology Laboratory,
Beltsville, Maryland
Cairns, P., Ph.D., Marie Curie Institute, Oxted, England
Chiu, S., Ph.D., Hong Kong Baptist College, Kowloon
Cohn, M., M.S., Wallenberg Laboratory, Lund, Sweden
Fioretos, T., M.D., University Hospital, Lund, Sweden
Gardiner, J., M.A., University of Missouri, Columbia
Levesque, R., Ph.D., University Laval, Quebec, Canada
SEMINARS
Burke, D., Princeton University. YAC cloning.
Cox, D., University of California, San Francisco. Use of
radiation hybrid mapping in the analysis of large
genomes.
Gemmill, R., Eleanor Roosevelt Institute. Pulsed-field gel
mapping of human chromosomes.
Hieter, P., Johns Hopkins Medical School. Yeast artificial
chromosomes: Promises kept and pending.
Lai, E. , University of North Carolina, Chapel Hill. New meth-
ods in electrophoresis and restriction fragment analysis.
Advanced Bacterial Genetics
Melville, S., Ph.D., University of Cambridge, England
Morzaria, S., Ph.D., ILRAD, Nairobi, Kenya
Ng, S., Ph.D., University of California, Santa Barbara
Ozelius, L., B.S., Massachusetts General Hospital East,
Charlestown
Stahl, J., M.D., Walter & Eliza Hall Institute, Victoria, Austra-
lia
Tawheed, A., M.S., Institut Pasteur, Paris, France
Wagner, K., Ph.D., Institute for Medical Biology & Human
Genetics, Graz, Austria
Pierce, J., DuPont Merck Pharmaceutical Co. Cloning in the
P1-positive selection system.
Skorupski, K., DuPont Merck Pharmaceutical Co. The P1 in
vitro packaging reaction: Proteins involved in cleavage of
the pac site.
Smith, D., Collaborative Research Inc. PFGE and YAC clon-
ing.
Smoller, University School of Medicine.
Large DNA cloning of the Drosophila genome.
June 7-June 27
INSTRUCTORS
Maloy, Stanley, Ph.D., University of Illinois, Urbana-Champaign
Stewart, Valley, Ph.D., Cornell University, Ithaca, New York
Taylor, Ronald, Ph.D., University of Tennessee, Memphis
ASSISTANTS
Chen, Li-Mei, University of Illinois, Urbana-Champaign
Peek, Joel, University of Tennessee, Memphis
Rabin, Ross, Cornell University, Ithaca, New York
This laboratory course demonstrated genetic approaches that can be used to an-
alyze biological processes and their regulation, as well as detailed struc-
ture/function relationships of genes. Techniques covered include isolation, corn-
plementation, and mapping of mutations; use of transposable genetic elements;
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construction of operon and gene fusions; cloning of DNA; restriction
endonuclease mapping; Southern blotting; polymerase chain reaction; site-
directed mutagenesis; and DNA sequencing. The course consisted of a set of
experiments incorporating most of these techniques in the genetic analysis of
diverse bacterial and bacteriophage species. These experiments were supple-
mented with lectures and discussions. The aim was to develop in students the
ability to design a successful genetic approach to any biological problem.
PARTICIPANTS
Alpuche, C., M.D., Massachusetts General Hospital, Boston
Behlau, I., M.D., Massachusetts General Hospital, Boston
Brown, A., B.S Albert Einstein College of Medicine, Bronx,
New York
Budrene, E. Ph.D., Harvard University, Cambridge, Massa-
chusetts
Eliasson, A., B.A., Uppsala University, Sweden
Forsberg, D., Ph.D., University of Guelph, Canada
Granger, D., M.D., Duke University, Durham, North Carolina
Hedderich, R., Ph.D., Phillips Universitat, Marburg, Germany
Kiessling, L., Ph.D., California Institute of Technology,
Pasadena
SEMINARS
Manoil, C., University of Washington. 1. Membrane protein
localization: Using gene fusions to make a complicated
process a little simpler. 2. Genetics of F factor conjugation
in Escherichia coll.
Roth, J., University of Utah. 1. Genetic analysis of
chromosome rearrangements. 2. Regulation of vitamin
Maldonado, R., B.A., University of Seville, Spain
Moreillon, P., M.D., Rockefeller University, New York, New
York
Poole, R., Ph.D., King's College, London, England
Regnier, P., Ph.D., Institut de Biologie Physico-Chimique,
Paris, France
Smith, D., Ph.D., Case Western Reserve University,
Cleveland, Ohio
Stein, J., M.S., Scripps Institution of Oceanography, La
Jolla, California
Thune, R., Ph.D., Louisiana State University, Baton Rouge
B12 synthesis in Salmonella typhimurium.
Silhavy, T., Princeton University. 1. SDI and protein secre-
tion. 2. Osmoregulation of porin synthesis in Escherichia
coll.
Weinstock, G., University of Texas. Molecular genetics of
shipping fever.
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Molecular Embryology of the Mouse
June 7-June 27
INSTRUCTORS
Lovell-Badge, Robin, Ph.D., National Institute for Medical Research, London, England
Parada, Luis F., Ph.D., Basic Research Program, NCI-FCRDC, Frederick, Maryland
CO-INSTRUCTORS
Mann, Jeff, Beckman Research Institute, Duarte, California
Rastan, Sohaila, Clinical Research Centre, Middlesex, England
ASSISTANTS
Conlon, Frank, Columbia University, New York, New York
Nichols, Jenny, University of Edinburgh, Scotland
Reid, Susan, Basic Research Program, NCI-FCRDC, Frederick, Maryland
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This course was designed for molecular biologists, biochemists, and cell
biologists interested in applying their expertise to the study of mouse embryonic
development. Lecture and laboratory components of the course emphasized
both the practical aspects of working with mouse embryos and the conceptual
basis of current embryonic research. The following procedures and their poten-
tial applications were described: isolation and culture of germ cells and
preimplantation and postimplantation embryos, embryo transfer, establishment
and genetic manipulation of embryo-derived stem cell lines, germ layer separa-
tion, chimera formation, nuclear transplantation, microinjection of DNA into eggs,
microinjection of cell lineage tracers, in situ hybridization and im-
munohistochemistry. Guest lecturers discussed current research in the field.
PARTICIPANTS
Collo, G., M.D. Scripps Clinic & Research Foundation, La
Jolla, California
Cordes, S., Ph.D. Stanford University, California
Covarrubias, L., Ph.D. UNAM, Cuernavaca, Mexico
Crossley, P., Ph.D., Imperial College of Science, Technology
& Medicine, London, England
Ikuta, K., Ph.D., Stanford University, California
Labosky, P., B.A. Wesleyan University, Middletown,
Connecticut
Noakes, P., Ph.D., Washington University, St. Louis, Missouri
Pearson-White, S., Ph.D., University of Virginia,
SEMINARS
Bradley, A., Baylor College of Medicine. Homologous
recombination.
Bronner-Fraser, M., University of California, Irvine. Neural
crest cell migration and differentiation.
Copeland, N., NCI-FCRDC, Frederick, Maryland. Insertional
mutagenesis and oncogene activation by retroviruses.
Curran, T., Roche Institute. fos and jun: Inducible proto-
oncogene transcription factors.
Hastie, N., Western General Hospital. Wilm's tumour-
Anaeridia and mouse model systems.
Herr, W., Cold Spring Harbor Laboratory. Pou genes: Tran-
scriptional regulation.
Hogan, B., Vanderbilt University Medical School. 1. Ex-
traembryonic membranes. 2. TGF-13-like proteins.
Jessell, T., Columbia University. Vertebrate nervous system
development.
Joyner, A., Mt. Sinai Hospital, Toronto. Role of engrailed
genes in murine development.
Krumlauf, R., National Institute of Medical Research. HOX
genes.
Lovell-Badge, R., National Institute for Medical Research. 1.
Germ cells and sex determination I. 2. Germ cells and sex
determination II.
McMahon, A., Roche Institute of Molecular Biology. Wnt
genes.
Charlottesville
Siracusa, L., Ph.D., Thomas Jefferson University,
Philadelphia, Pennsylvania
Swain, A., Ph.D., Tufts University, Boston, Massachusetts
Talarico, D., Ph.D., New York University, New York, New
York
Tecott, L., Ph.D., University of California, San Francisco
Wilson-Gunn, S., Ph.D., University of Michigan, Ann Arbor
Zack, D., Ph.D., Johns Hopkins Medical School, Baltimore,
Maryland
Noden, D., Cornell University. Craniofacial development.
Papaioannou, G., Tufts University. Chimeras in develop-
ment.
Parada, L., NCI-FCRDC, Frederick, Maryland. Cellular proto-
oncogenes in development.
Rastan, S., Clinical Research Centre. The X-inactivation
region.
Rinchik, E., Oak Ridge National Laboratory. Genetic
resources.
Robertson, E., Columbia University. ES cells; biology and
uses.
Rossant, J., Mt. Sinai Hospital, Toronto. Preimplantation de-
velopment.
Soifer, D., Max Planck Institute. Genomic imprinting.
Strickland, S., SUNY at Stony Brook. Maternal RNA and the
mouse oocyte.
Tam, P., University of Sydney. 1. Postimplantation develop-
ment: Analysis of cell lineage and tissue fate. 2. The al-
location of cells to the paraxial mosoderm during
somitogenesis
Wassarman, P., Roche Institute of Molecular Biology. Fertil-
ization.
Wilkinson, D., National Institute for Medical Research. Seg-
mentation in the hindbrain.
Williams, D., Children's Hospital, Boston. Hematopoiesis.
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Molecular Approaches to Ion Channel Expression
and Function
June 7-June 27
INSTRUCTORS
Goldin, Al, M.D., Ph.D., University of California, Irvine
Hausdorff, Sharon, Ph.D., Brandeis University, Waltham, Massachusetts
Snutch, Terry, Ph.D., University of British Columbia, Vancouver, Canada
Yang, Xian-Cheng, Ph.D., California Institute of Technology, Pasadena
ASSISTANTS
Dubel, Stefan, University of British Columbia, Vancouver, Canada
Gilbert, Mary, University of British Columbia, Vancouver, Canada
Application of the techniques of molecular biology to neurobiology has provided
novel approaches and a new level of sophistication to the examination of many
neurobiological problems. This intensive laboratory/lecture course was designed
to introduce students to the application of model systems in which to express
cloned neurotransmitter receptors and voltage-gated ion channels. The course
covered the following topics: preparation of RNA transcripts in vitro and micro-
injection in Xenopus oocytes; characterization of exogenous receptors and ion
channels in oocytes using two-microelectrode voltage clamping and patch
clamping; transient expression of voltage-gated ion channels in mammalian cells
using vaccinia virus vectors; transient expression of voltage-gated ion channels
in insect cells using baculovirus vectors; characterization of exogenous ion chan-
nels in mammalian and insect cells using patch clamping; theory, and analysis of
ionic currents.
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PARTICIPANTS
Deitcher, D., B.S., Harvard Medical School, Boston, Massa-
chusetts
Furman, I., M.A., Hebrew University, Jerusalem, Israel
Gel li, A., B.S., University of Toronto, Canada
Ketchum, K., Ph.D., Yale University, New Haven, Con-
necticut
Lin, D., M.D., Yale University, New Haven, Connecticut
SEMINARS
Enyeart, J., Ohio State University. Calcium channels in
secretory cells: Excitation transcription coupling.
Hsu, H., California Institute of Technology. Channels and
receptors expressed in mammalian cells infected with
recombinant vaccinia virus.
Joho, R., Baylor College of Medicine. Voltage-gated K chan-
nels: Expression cloning and structure-function analysis.
Leonard, J., University of Illinois, Chicago. Expression and
modulation of excitatory amino acid receptors.
MacKinnon, R., Harvard Medical School. A look into the
Moll, C., M.D., Salk Institute, La Jolla, California
Moss, G., Ph.D Yale Medical School, New Haven, Con-
necticut
Rogart, R., Ph.D., University of Chicago, Illinois
Valera, S., M.S., University of Geneva, Switzerland
Zhao, B., M.S., Columbia University, New York, New York
pore of K channels.
Mandel, G., SUNY at Stony Brook. Sodium channel expres-
sion in the nervous system.
Margiotta, J., Mt. Sinai School of Medicine. Regulation of
AChR expression.
Ribera, A., University of Colorado. Developmental regulation
of neuronal excitability.
White, M., University of Pennsylvania Medical School. Feel-
ing your way around the AChR.
Molecular Neurobiology: Brain Development and Function
June 15-June 30
INSTRUCTORS
McKay, Ronald, Ph.D., Massachusetts Institute of Technology, Cambridge
Patrick, James, Ph.D., Baylor College of Medicine, Houston, Texas
Reichardt, Louis, Ph.D., University of California, San Francisco
Schwarz, Thomas, Ph.D., Stanford University, California
This lecture course presented both basic concepts and currently exciting re-
search problems in molecular neurobiology. It focused on approaches and
methods now used to study the development and function of the nervous system.
Topics covered included gene expression, receptor structure and function, ion
channel cloning, second messenger systems, learning, sensory transduction, be-
havioral genetics, neural induction, cell lineage, immortal cell lines, cell adhesion,
oncogenes, and neurite outgrowth. The course provided the opportunity to dis-
cuss this rapidly expanding research area with invited lecturers. Individuals from
a wide variety of backgrounds (graduate students to faculty) were encouraged to
apply.
PARTICIPANTS
Bohner, A., B.S., Stanford University, California
Cagan, R., Ph.D., University of California, Los Angeles
Conneely, 0., Ph.D., Baylor College of Medicine, Houston,
Texas
Dahlstrand, J B.S., Karolinska Institute, Stockholm, Sweden
Garner, A., B A., Case Western Reserve University,
Cleveland, Ohio
Gordon, P., Ph.D., Tufts University, Boston, Massachusetts
Harkness, P., B.A., Medical Research Centre, Cambridge,
England
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Hata, Y., M.D., University of Tokyo, Japan
Hernandez, M., M.S., University of Geneva, Switzerland
Huntsman, M., B.S., University of California, Irvine
II ling, N., Ph.D., University of Cape Town, South Africa
Kirchhof, B., B.A., Freie University, Berlin, Germany
Nye, S., Ph.D., Regeneron Pharmaceuticals, Tarrytown, New
York
Okano, H., M.D., Rockefeller University, New York, New
York
SEMINARS
Bastiani, M University of Utah. Development of the nervous
system.
Beach, D., Cold Spring Harbor Laboratory. Control of cell
growth.
Chalfie, M., Columbia University. C. elegans neurobiology.
Curran, T., Roche Institute. Immediate early gene expres-
sion.
Greenberg, M., Harvard Medical School. c-fos regulation in
neurons.
Hall, J., Brandeis University. Drosophila behavior.
Hayes, T., Massachusetts Institute of Technology. Regula-
tion of cell growth.
Hiromi, Y., Princeton University. Neuronal determination in
Drosophila.
Howard, J., University of Washington. Biophysics of hair
cells.
Jessell, T., Columbia University. Neuronal commitment in
chick.
Katz, L., Duke University. Cortical development.
Kobilka, B., Stanford University. Serpentine receptors.
Kuwada, J., University of Michigan. Axon guidance in ze-
brafish.
Lillien, L., Harvard Medical School. Cell differentiation and
lineage.
Logothetis, N., Baylor College of Medicine. Primate visual
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Rappaport, D., Ph.D., University of Sydney, Australia
Rejas, M., Ph.D., Instituto Cajal, Madrid, Spain
Ronnett, G., Ph.D., Johns Hopkins University, Baltimore,
Mar land
Seitanidou, A., B.A., Pasteur Institute, Paris, France
Skoglund, P., B.A., University of California, San Diego
Suri, C., B.S., Tufts University, Boston, Massachusetts
Tang, C., Ph.D., University of Pennsylvania, Philadelphia
Ultsch, A., M.S., University of Heidelberg, Germany
system.
Madison, D., Stanford University. Long-term potentiation.
McKay, R., Massachusetts Institute of Technoloay. Mam-
malian neuronal differentiation.
Myers, R., University of California, San Francisco. Genetics
of Huntington's disease.
Patrick, J., Baylor College of Medicine. Ligand gated ion
channels.
Reichardt, L., University of California, San Francisco.
Chemistry of axon growth.
Schwarz, T., Stanford University. Voltage gated ion chan-
nels.
Siegelbaum, S., Columbia University. Ion channel modifica-
tion.
Stryker, M., University of California, San Francisco. Visual
cortex development and plasticity.
Sweat, J., Baylor College of Medicine. Second messager
systems and LTP.
Tank, D., Bell Laboratories. Neurotransmitter
release/imaging.
Ts'o, D., Rockefeller University. Mammalian visual cortex.
Weinmaster, G., Salk Institute. Schwann cell differentiation.
Yancopoulous, G., Regeneron Pharmaceuticals. Nerve
growth factors.
Neurobiology of Drosophila
July 1-July 21
INSTRUCTORS
Hartenstein, Volker, Ph.D., University of California, Los Angeles
Ready, Don, Ph.D., Purdue University, West Lafayette, Indiana
ASSISTANTS
Green, Patricia, University of California, Los Angeles
Wolff, Tanya, Purdue University, West Lafayette, Indiana
This laboratory/lecture course was a series of in-depth discussions with research-
ers active in genetic, physiological, cellular, molecular, and behavioral studies of
Drosophila neurobiology. It was organized around a core of seminars, extensive
informal discussion, and lab work. Lecturers often brought original preparations
for viewing and discussion and directed lab exercises and experiments in their
areas of special interest. The course was intended for researchers at all levels
who want to use Drosophila as an experimental system for studying neurobiol-
ogy. The course covered basic electrophysiological techniques, as applied to
mutants with altered ion channels or sensory physiology. In addition, the course
familiarized students with various preparations, including the embryonic nervous
system, imaginal discs, and adult nervous system.
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Topics included Shaker and the biophysics and diversity of potassium chan-
nels, the genetics and molecular biology of excitability, the control of
neurogenesis and neuronal diversity, embryonic and postembryonic develop-
ment of the CNS and PNS, axonal pathfinding, development of the nervous sys-
tem, mesoderm and muscle development, eye and optic lobe development, ol-
faction, learning, and the neural control of flight.
PARTICIPANTS
Chang, H., M.D., University of California, Los Angeles
Cobb, M., Ph.D., CNRS, Gif-sur-Yvette, France
Di Antonio, A., M.S., Stanford University, California
Fernandes, J., M.S., Tata Institute, Bombay, India
Glaesener-Cipollone, G., Ph.D., University of Wurzburg,
Germany
McNabb, S., Ph.D., University of Cambridge, England
Miller, C., M.D., University of Southern California, Los
SEMINARS
Bate, M., University of Cambridge. Muscle patterning in the
fly.
Bieber, A., Purdue University. Axonal guidance in
Drosophila.
Campos-Ortega, J., University of Koln. Neurogenesis.
Doe, C., University of Illinois. CNS II: Neuronal fate.
Ganetzky, B., University of Wisconsin. Genetics of mem-
brane excitability.
Hardie, R., University of Cambridge. Channels and signal
transduction in the fly visual system.
Hartenstein, V., University of California. Introduction to de-
velopment.
Martinez-Arias, A., University of Cambridge. Pattern forma-
tion in the Drosophila embryo.
Ready, D., Purdue University. Compound eye mor-
Angeles
Prokop, A., M.S., University of Mainz, Germany
Schmucker, D., M.S., Institute of Genetics, Munich,
Germany
Vosshall, L., B.A., Rockefeller University, New York, New
York
Wang, E., B.S., Purdue University, West Lafayette, Indiana
Yang, X., Ph.D., National University of Singapore
Molecular Cloning of Neural Genes
phogenesis.
Schwarz, T., Stanford University. Ion channels and Shaker
Strausfeld, N., University of Arizona. Neuroanatomy of the
adult brain.
Taghert, P., Washington University. Stomatogastric nervous
system and peptide transmitters.
Truman, J., University of Washington. Development of adult
CNS.
Tully, T., Brandeis University. Learning/Behavior.
Wu, C.-F., University of Iowa. Neuronal plasticity and ex-
citability in Drosophila.
Young, M., Rockefeller University. per and circadian
rhythms.
Zuker, C., University of California, San Diego. Molecular
biology of signal transduction.
July 1-July 21
INSTRUCTORS
Boulter, James, Ph.D., Salk Institute, San Diego, California
Eberwine, James, Ph.D., University of Pennsylvania, Philadelphia
Evinger, Marian, Ph.D., SUNY at Stony Brook, New York
CO-INSTRUCTOR
Inman, Irene, Stanford University, California
ASSISTANTS
Cao, Yan, University of Pennsylvania, Philadelphia
Lai, Cary, Salk Institute, San Diego, California
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This intensive laboratory/lecture course was intended to provide scientists with abasic knowledge of the use of the techniques of molecular biology in examining
questions of neurobiological significance. Particular emphasis was placed on
using and discussing methods for circumventing the special problems posed in
the study of the nervous system; for example, examination of low abundance
mRNAs in extremely heterogeneous cell populations. The laboratory work in-
cluded mRNA quantitation methods (nuclease protection, etc.), preparation of
hybridization probes, library construction (X ZAP and 1ST procedure), plaque
screening techniques (probe hybridization, antibody interaction), DNA sequenc-
ing, PCR amplification, RNA amplification, and DNA-mediated gene transfer. A
major portion of the course was devoted to in situ hybridization and in situ tran-
scription technologies. The lecture series, presented by invited speakers,
focused on emerging techniques and how they may be applied to the study of
the nervous system.
PARTICIPANTS
Brown, J., B.A., University of California, San Francisco
Buxbaum, J., Ph.D., Rockefeller University, New York, New
York
Dawson, T., Ph.D., Johns Hopkins University, Baltimore,
Maryland
Fishman, R., Ph.D., Columbia University College of
Physicians & Surgeons, New York, New York
Gershon, M., M.D., Columbia University College of
Physicians & Surgeons, New York, New York
Gray, G., B.A., Washington University Medical School, St.
Louis, Missouri
Herman, J.-P., Ph.D., Washington University Medical
School, St. Louis, Missouri
Jacobson, L., Ph.D., Stanford University, California
McKeon, R., Ph.D., Case Western Reserve University,
Cleveland, Ohio
Navaratnam, D., Ph.D., University Department of Pharma-
cology, Oxford, England
Nitabach, M., B.A., Columbia University, New York, New
York
Sahin, M., B.S., Yale University, New Haven, Connecticut
Snyder, D., Ph.D., Duke University Medical Center, Durham,
North Carolina
Soha, J., Ph.D., E.K. Shriver Center, Waltham, Massachu-
setts
Sullivan, J., Ph.D., Salk Institute, San Diego, California
Yucel, Y., Ph.D., University of British Columbia, Vancouver
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SEMINARS
Brugge, J., University of Pennsylvania. Signal transduction
through src-related tyrosine protein kinases in neural
cells.
Cepko, C., Harvard Medical School. Lineage analysis of the
vertebrate CNS.
Chao, M., Cornell University Medical Center. Mechanism of
action of neurotrophic factors.
Curran, T., Roche Institute of Molecular Biology. fos and jun:
Inducible proto-oncogene transcription factors.
Lemke, G., Salk Institute. Transcriptional control in glial dif-
ferentiation and myelination.
Merlie, J., Washington University Medical School. Regula-
tion of synapse formation and acetylcholine receptor gene
expression in muscle.
Nef, P., Salk Institute. A molecular biological approach to
understanding olfactory functions.
Quinn, C., Massachusetts Institute of Technology. Genes re-
lated to learning and memory in Drosophila.
Reichardt, L., University of California, San Francisco. Growth
factor regulation of CNS gene expression.
Stevens, C., Salk Institute. Site-directed mutagenesis and
the molecular basis of gating in nicotinic acetylcholine
receptors.
Molecular and Developmental Biology of Plants
July 1-July 21
INSTRUCTORS
Klessig, Daniel, Ph.D., Rutgers University, Piscataway, New Jersey
Maliga, Pal, Ph.D., Rutgers University, Piscataway, New Jersey
Varner, Joseph, Ph.D., Washington University, St. Louis, Missouri
ASSISTANTS
Cutt, John, Rutgers University, Piscataway, New Jersey
Dixon, Dave, Rutgers University, Piscataway, New Jersey
Gibson, Susan, Michigan State University, East Lansing
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Hajdukiewicz, Peter, Rutgers University, Piscataway, New Jersey
Kanevski, Ivan, Rutgers University, Piscataway, New Jersey
Staub, Jeffrey, Rutgers University, Piscataway, New Jersey
Svab, Zora, Rutgers University, Piscataway, New Jersey
Ye, Z.-H., Washington University, St. Louis, Missouri
This course provided an intensive overview of current topics and techniques in
plant biology, with an emphasis on molecular and developmental biology and
genetics. It was designed for scientists with experience in molecular techniques
who are working, or wish to work, with plant systems. The course consisted of a
rigorous lecture series, a hands-on laboratory, and informal discussions. Guest
speakers provided both an in-depth discussion of their work and an overview of
their specialty. The laboratory sessions covered established and novel techni-
ques in plant biology including transformation via Agrobacterium, electropora-
tion, and the particle gun, assays for transient gene expression, microinjection,
tissue printing, and in situ detection of RNA and protein, reconstitution of protein
transport, in vivo and in vitro analysis of transcription factors, genome mapping
using yeast artificial chromosomes, and cytogenetics.
PARTICIPANTS
Allison, L., Ph.D., CNRS, Gif-sur-Yvette, France
Atkinson, R., M.S. University of Auckland, New Zealand
Desiderio, A., B.S., Universita Deg li Studi di Roma, Italy
Douma, A., Ph.D., State University of Leiden, The Nether-
lands
Haub, 0., B.S., Columbia University College of Physicians &
Surgeons, New York, New York
Hayes, R., Ph.D., Imperial College of Science, Technology &
Medicine, London, England
Hershkovitz, M., Ph.D., University of California, Davis
Jacobs, J., M.S., University of Nijmegen, The Netherlands
SEMINARS
Beachy, R., Scripps Research Institute. Molecular biology of
plant RNA viruses.
Cashmore, A., University of Pennsylvania. Control of tissue-
specific gene expression in plants.
Clarke, A., University of Melbourne. Self- incompatibility in
flowering plants.
Federoff, N., Carnegie Institution of Washington. Maize
transposable elements.
Goodman, H., Massachusetts General Hospital. The
Arabidopsis genome.
Gruissem, W., University of California, Berkeley. Function of
RNA-binding proteins in regulation of mRNA stability.
Hanson, M., Cornell University, Ithaca. Molecular biology of
plant mitochondria: Cytoplasmic male sterility.
Jones, A., University of North Carolina. Signal transduction
in plants.
Keegstra, K., University of Wisconsin. Protein targeting in
plants.
Klessig, D., Rutgers University. Pathogenesis-related
proteins in plants.
Kondorosi, A., CNRS, Gif-sur-Yvette. Rhizobium-plant sym-
biotic interactions.
Ohm, H., Ph.D., Purdue University, West Lafayette, Indiana
Orosz, L., Ph.D., Institute of Molecular Genetics, Godollo,
Hungary
Perez Flores, L., Ph.D., Universidad Autonoma, Mexico City,
Mexico
Reddy, A., Ph.D., Washington State University, Pullman
Reuveni, M., Ph.D., Purdue University, West Lafayette, Indi-
ana
Savka, M., M.S., University of Illinois, Urbana
Taschner, P., Ph.D., Leiden University, The Netherlands
Tavladoraki, P., Ph.D., E.N.E.A., Rome, Italy
Lucas, W., University of California, Davis. Application of mi-
croinjection to the study of plasmodesmatal transport.
Ma liga, P., Rutgers University. Transgenic plants.
Meyerowitz, E., California Institute of Technology. Genes
regulating flower development in Arabidopsis.
Mullet, J., Texas A & M University. Chloroplast development
and gene expression.
Nester, E., University of Washington, Seattle. Agrobac-
terium-mediated transformation of higher plants.
Ow, D., Plant Gene Expression Center. Application of a
prokaryotic site-specific recombination system in plants.
Phillips, R., University of Minnesota. Genomic rearrange-
ments induced by tissue culture.
Poethig, S., University of Pennsylvania. Developmental pat-
terns in plants.
Rochaix, J.-D., University of Geneva. Molecular biology of
chloroplasts.
Somerville, C., Michigan State University. Biochemical
genetics in Arabidopsis.
Varner, J., Washington University. The plant cell wall.
Vierstra, R., University of Wisconsin. Control of phytochrome
turnover.
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Molecular Genetic Analysis of Human Neurological Disease
July 2-July 9
INSTRUCTORS
Breakefield, Xandra, Ph.D., Massachusetts General Hospital, Charlestown and Harvard
Medical School, Boston
Evans, Glen, Ph.D., Salk Institute, San Diego, California
Gusella, James, Ph.D., Massachusetts General Hospital, Charlestown and Harvard Medi-
cal School, Boston
This intensive lecture/discussion course was designed to provide a comprehen-
sive overview of strategic approaches and state-of-the-art technology for the
analysis of diseases of the nervous system. The course focused on the analysis
and understanding of human disease at the molecular level emphasizing ap-
proaches to gene localization and cloning, as well as gene expression, molecular
physiology, and the creation and use of animal models. Topics included genetic
linkage and transmission genetics; the identification and isolation of disease
genes; the molecular biology and physiology of genes expressed in the brain;
multigene families encoding receptors and ion channel and their role in diseases;
animal models for neurological diseases using transgenics and stem cell
chimeras manipulated using homologous recombination paradigms for
neurological disorders such as Huntington's disease, Duchenne's muscular
dystrophy and Fragile X syndrome; gene transfer and expression in the nervous
system; neural expression of proto-oncogenes and neurotropic viruses;
348
mitochondrial genetics and inherited epilepsies; genes active in neural regenera-
tion and programmed cell death. This course was intended for students with
backgrounds in neurology, molecular biology, or medical genetics and those in-
vestigators interested in the molecular dissection of neurological disorders.
PARTICIPANTS
Andersen, J., Ph.D., Massachusetts General Hospital, Char-
lestown
Andreason, G., Ph.D., Salk Institute, San Diego, California
Astarloa, R., Ph.D., Fundacion Jimenez Diaz, Madrid, Spain
Brown, A., M.D., Vanderbilt University, Nashville, Tennessee
Chernak, J., Ph.D., National Institute on Aging, Baltimore,
Maryland
Duyao, M., B.A., Boston University School of Medicine, Mas-
sachusetts
Gravel, C., Ph.D., Clinical Research Institute, Montreal, Can-
ada
Hashimoto, L. B.S., University of Western Ontario, London,
Canada
Henske, E., M.D., Massachusetts General Hospital, Boston
Konig, G., M.S., University of Heidelberg, Germany
Kristensen, P., M.D., Novo Nordisk, Bagsvard, Denmark
SEMINARS
Breakefield, X., Massachusetts General Hospital. Gene
transfer using viral vectors.
Cannon, S., Massachusetts General Hospital. Na channel in
hyperkalemic periodic paralysis.
Cepko, C., Harvard Medical School. Cell lineage in the de-
veloping nervous system.
Civelli, 0., Vollum Institute. Dopaminergic receptors.
Curran, T., Roche Institute of Molecular Biology. Role of on-
cogenic transcription factors, fos and jun, in stimulus-
transcription coupling in the brain.
Evans, G., Salk Institute. 1. Strategies for scanning the hu-
man genome. 2. DNA repair syndromes.
Gravel, R., Montreal Children's Hospital. Mutational analysis
of Tay-Sachs.
Green, E., Washington University School of Medicine. YACs
as cloning vehicles.
Gusella, J., Massachusetts General Hospital. Linkage analy-
sis in Huntington's disease.
Heinemann, S., Salk Institute. Receptors: The glutamate
receptor family and structure and function.
Hoffman, E., University of Pittsburgh. Dystrophin in muscular
dystrophy.
Korsmeyer, S., Washington University School of Medicine.
Sequences involved in translocations.
Lathe, R., M.S., University of Edinburgh, Scotland
Lee, S., Ph.D., New York Blood Center, New York, New York
Lin, C., Ph. D., Massachusetts General Hospital, Char-
lestown
Maurer, S., Ph.D., Salk Institute, La Jolla, California
Mirow, A., M.D., University of California, San Diego
Reyes Lezama, M., M.S., Instituto Mexicano de Psiquiatria,
Xochimilco
Riba-Ramirez, L., M.S., Massachusetts Institute of Technol-
ogy, Cambridge
St. Clair, D., Ph.D., Western General Hospital, Edinburgh,
Scotland
Taylor, S., Ph.D Massachusetts General Hospital, Char-
lestown
Yao, K., Ph D , Brandeis University, Waltham, Massachu-
setts
Lemke, G., Salk Institute. Myelination mutations and myelin
mutants.
Mansour, S., University of Utah. Creating mouse mutants:
Homologous recombination.
McKay, R., Massachusetts Institute of Technology. Gene
delivery to the nervous system: Grafting genetically
modified cells.
Moyzis, R., Los Alamos National Laboratory. Repeat ele-
ments.
O'Connell, P., University of Utah. Neurofibromatosis type 1.
Popko, B., University of North Carolina. Creating mouse
mutants: Transgenics.
Prusiner, S., University of California, San Francisco.
Neurodegenerative diseases: Prions.
Rosenfeld, M., University of California, San Diego.
Homeobox genes in development.
Sapienza, C., Ludwig Institute for Cancer Research. Imprint-
ing.
Sutcliffe, G., Research Institute of Scripps Clinic. Identifying
mouse disease genes.
Wallace, D., Emory University. Mitochondrial defects.
Willard, H., Stanford University School of Medicine. X-
inactivation.
The Cell and Molecular Biology of Learning and Memory
July 14-July 28
INSTRUCTORS
Byrne, Jack, Ph.D., University of Texas Medical School, Houston
Kandel, Eric, Ph.D., Columbia University College of Physicians & Surgeons, New York,
New York
Pearson, Keir, Ph.D., University of Alberta, Canada
Squire, Larry, Ph.D., University of California, San Diego
This lecture course provided an introduction to cell and molecular biological ap-
proaches to learning and memory. It was suited for graduate students in
molecular biology, neurobiology, and psychology as well as research workers
who are interested in an introduction to this new field. The course covered topics
ranging from behavioral considerations of learning and memory to gene regula-
tion in the nervous system. The lectures provided an intensive coverage of six
selected areas: (1) an introduction to modern behavioral studies of learning and
memory; (2) an overview of the cell biology of neuronal plasticity and second
messenger systems; (3) the regulation of gene expression; (4) cellular and
molecular mechanisms of simple forms of learning and memory in invertebrates
and vertebrates; (5) cellular and molecular mechanisms of long-term potentiation
in various regions of the mammalian brain; and (6) neural approaches to human
learning and its abnormalities.
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PARTICIPANTS
Alvarez-Royo, P., M.S., University of California, San Diego
Bringuier, V., M.S., Universite Paris-Sud, France
Brulet, P., Ph.D., Unite de Genetique Cellulaire, Paris,
France
Buonomano, D., B.S., University of Texas, Houston
Cai, H., M.S., University of California, Los Angeles
Castro-Alamancos, M., M.S., Institute Cajal, Madrid, Spain
Davidson, J., B.S., Queen's University, Belfast, Ireland
Durand, G., M.S., Albert Einstein College of Medicine, New
York, New York
Gal liot, B., Ph.D., Center for Molecular Biology, Heidelberg,
Germany
Greenspan, R., Ph.D., Roche Institute of Molecular Biology,
Nutley, New Jersey
SEMINARS
Byrne, J., University of Texas, Houston. 1. Overview of mem-
branes and synaptic transmission. 2. Learning in Aplysia
///. Classical conditioning.
Clark, G., Princeton University. Cellular mechanisms of as-
sociative learning in Hermissenda.
Dash, P., University of Texas, Houston. Cloning of genes im-
portant to learning II.
Davis, R., Baylor College of Medicine. Genetic approaches
to study associative learning in Drosophila.
Eichenbaum, H., University of North Carolina. Role of the
hippocampus and hippocampal long-term potentiation in
learning.
Ganetzky, B., University of Wisconsin. Introduction to the
study of genes and behavior.
Gould, J., Princeton University. Ethological approaches to
learning.
Greenough, W., University of Illinois. Morphological corre-
lates of learning and experience.
Holland, P., Duke University. Introduction to learning theory.
Kandel, E., Columbia University. 1. Introduction to the cel-
lular study of learning. 2. Learning in Aplysia I. Habitua-
tion. 3. Learning in Aplysia II. Sensitization.
Kenyon, C., University of California, San Francisco. Genes
Li, X.-C. Ph.D., Columbia University, New York, New York
Nick, T., B.S., Yale University, New Haven, Connecticut
Paulsen, 0., M.D., University of Oslo, Norway
Pieroni, J., Ph.D., University of Texas, Houston
Roder, J., Ph.D., Mt. Sinai Hospital, Toronto, Canada
Saron, C., B.A., Albert Einstein College of Medicine, New
York, New York
Smith, B., Ph.D., Ohio State University, Columbus
Torroja, L., B.S., Institute Cajal, Madrid, Spain
Valenzuelo, D., Ph.D., Massachusetts General Hospital,
Charlestown
Wang, X., B.S., University of Illinois, Urbana
Wiel, D., B.A., University of Oregon, Eugene
Zimmerly, S., B.A., Yale University, New Haven, Connecticut
and the behavior of C. elegans.
Lisberger, S., University of California, San Francisco.
Plasticity in the vestibulo-occular reflex.
Malinow, R., University of Iowa. Long-term potentiation II.
Merzenich, M., University of California, San Francisco. Corti-
cal plasticity and learning.
Nicoll, R., University of California, San Francisco. Long-term
potentiation I.
Nottebohm, F., Rockefeller University. Bird-song learning.
Pfaffinger, P., Baylor College of Medicine. Cloning of genes
important to learning I.
Posner, M., University of Oregon. Neuropsychology of cog-
nition.
Schulman, H., Stanford University. Overview of second mes-
senger systems and their role in learning and memory.
Squire, L., University of California, San Diego. 1. Memory in
nonhuman primates. 2. Human memory and disorders of
memory.
Stock, A., Center for Advanced Biotechnology and Medi-
cine. Genes and the behavior of bacteria.
Thompson, R., University of Southern California. Classical
conditioning of the nictitating membrane response.
Advanced Molecular Cloning and Expression
of Eukaryotic Genes
July 23-August 12
INSTRUCTORS
Kingston, Robert, Ph.D., Harvard Medical School, Boston,
Massachusetts
Learned, Marc, Ph.D., University of California, Davis
Myers, Richard, Ph.D., University of California, San Francisco
Robbins, Alan, Ph. D., DuPont Merck Pharmaceutical Co.,
Wilmington, Delaware
ASSISTANTS
Mak, ArkadY, University of California, San Francisco
Stuve, Laura, University of California, San Francisco 351
This course focused on how to manipulate cloned eukaryotic genes to probe
questions on their structure, expression, and function. As a model system, they
examined cis- and trans-acting components involved in the regulation of
eukaryotic gene expression. Students learned the theoretical and practical
aspects of constructing genomic and cDNA libraries. Expression libraries from
various organisms were screened with recognition site probes for specific DNA-
binding proteins. A variety of transfection techniques were used to introduce
cloned DNA molecules that had been manipulated in vitro into eukaryotic cells in
culture. Mutants were generated by oligo-directed and random mutagenesis
procedures and characterized by DNA sequencing. The expression pattern of
wild-type and mutant DNAs were analyzed by S1 nuclease, RNase protection,
and enzymatic assays. Techniques and theory for detecting and characterizing
the interaction between regulatory DNA sequences and trans-acting protein fac-
tors were presented. Guest lecturers discussed present problems in eukaryotic
molecular biology as well as technical approaches to their solutions. Experience
with basic recombinant DNA techniques was a prerequisite for admission to the
course.
PARTICIPANTS
Adams, J., Ph.D., Brigham & Women's Hospital, Boston,
Massachusetts
Aird, W., M.D., Brigham & Women's Hospital, Boston, Mass-
achusetts
Boyd, J., Ph.D
, University of California, Davis
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Briegel, K., B.S., Institute of Molecular Pathology, Vienna,
Austria
Chung, C., Ph.D., Seoul National University, Korea
Datson, N., M.S., Leiden University, The Netherlands
Fernandez, A., B.S., M.D. Anderson Cancer Center, Hous-
ton, Texas
Harley, V., Ph.D., Imperial Cancer Research Fund, London,
England
Ho, M., B.S., University of Oxford, England
Houglum, K., M.D., University of California, San Diego
Johnson, R., Ph.D., Hospital for Sick Children, Toronto, Can-
ada
SEMINARS
Chandler, V., University of Oregon, Eugene. The B locus of
maize: A regulator of specific gene expression and its
regulation by paramutation.
Hernandez, N., Cold Spring Harbor Laboratory. Initiation
and termination of transcription in RNA polymerase II and
III snRNA genes.
Johnson, A., University of California, San Francisco. Yeast
homeodomain proteins.
Kingston, R., Harvard Medical School. HSF, Gal-4, TFIID,
and nucleosomes.
McKnight, S., Carnegie Institution of Washington. On the
importance of heteromeric interactions in eukaryotic tran-
scription factors.
Yeast Genetics
Miller-Davis, S., B.S., Vanderbilt University, Nashville, Ten-
nessee
Perilleux, C., B.S., University of Liege, Belgium
Redhead, C., Ph.D., Columbia University College of
Physicians & Surgeons, New York, New York
Rooke, K., B.S., St. Mary's Hospital, London, England
Trejo, J., B.S., University of California, San Diego
Myers, R., University of California, San Francisco, Molecular
studies of Huntington's disease.
Rio, D., Whitehead Institute. Mechanism of regulation of P-
element transposition in Drosophila.
Sharp, P., Massachusetts Institute of Technology. Regula-
tion of transcription and splicing.
Treisman, R., Imperial Cancer Research Fund, London.
SRF: Relatives and friends.
Winston, F., Harvard Medical School. Analysis of TFIID,
histones, and other transcription factors of yeast.
Yamamoto, K., University of California, San Francisco. Fac-
tor interactions at a composite GRE.
July 23-August 12
INSTRUCTORS
Michaelis, Susan, Ph.D., Johns Hopkins University, Baltimore, Maryland
Mitchell, Aaron, Ph.D., Columbia University, New York, New York
Rose, Mark, Ph.D., Princeton University, New Jersey
ASSISTANTS
Berkower, Carol, Johns Hopkins University, Baltimore, Maryland
Bowdish, Kathy, Columbia University, New York, New York
Stasenko, Laurie Jo, Princeton University, New Jersey
The major laboratory techniques used in the genetic analysis of yeast were
studied, including the isolation and characterization of mutants, tetrad analysis,
complementation, and mitotic recombination. Micromanipulation used in tetrad
analysis was carried out by all students. Molecular genetic
techniques, includ-
ing yeast transformation, gene replacement, analysis of gene fusions,
and elec-
trophoretic separation of chromosomes, were applied to the analysis
of yeast
DNA. Indirect immunofluorescence experiments were done to
identify the
nucleus, microtubules, and other cellular components. Lectures on
fundamental
aspects of yeast genetics were presented along with seminars
given by outside
speakers on topics of current interest.
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PARTICIPANTS
Akiyama, M., Ph.D., Stanford University, California
Breiding, D., Ph.D., New England Medical Center, Boston,
Massachusetts
Casadevall, A., Ph.D., Albert Einstein College of Medicine,
New York
De Repentigny, L., M.D., University of Montreal, Canada
Guan, K., Ph.D., Purdue University, West Lafayette, Indiana
Kang, H., M.S., University of California, Davis
Kohno, K., Ph.D., Osaka University, Japan
Lesage, P., Ph.D., Institut de Biologie, Paris, France
Lim, A., M.S., Northeastern University, Boston, Massachu-
SEMINARS
Adams, A., University of Arizona. Morphogenesis and the
actin cytoskeleton.
Boeke, J., Johns Hopkins University. Transposition in yeast.
Broach, J., Princeton University. Growth control by the yeast
adenylate cyclase cascade.
Carlson, M., Columbia University. Transcriptional control of
glucose repressible genes.
Fink, G., Whitehead Institute. Diverse topics of broad inter-
est.
Futcher, B., Cold Spring Harbor Laboratory. Coordination of
yeast cell growth and division.
Guthrie, C., University of California, San Francisco. How
snRNPs snip.
Hieter, P., Johns Hopkins University. Genetics of
chromosome segregation in yeast.
Hinnebusch, A., National Institutes of Health. Regulation of
initiation factors in GCN4 transcriptional control.
354
setts
M., B.S., McGill Cancer Centre, Montreal, Canada
Pande, S., Ph.D., University of Maryland, Baltimore County
Romisch, K., Ph.D., EMBL, Heidelberg, Germany
Schiebel, E., Ph.D., University of California, Los Angeles
Silos, S., B.S., Thomas Jefferson University, Philadelphia,
Pennsylvania
Silverman, L., Ph.D., Memorial Sloan-Kettering Center, New
York, New York
Zheng, P., M.D., Yale University School of Medicine, New
Haven, Connecticut
Hoyt, A., Johns Hopkins University. Mechanisms and
regulation of mitosis in S. cerevisiae.
Johnson, A., University of California, San Francisco. Regula-
tion of cell-type-specific gene expression in yeast.
Michaelis, S., Johns Hopkins University. Modification and
export of the yeast mating pheromone, a factor.
Mitchell, A., Columbia University. Control of entry into
meiosis in yeast.
Petes, T., University of North Carolina. Homologous and
nonhomologous recombination in yeast.
Rose, M., Princeton University. Microtubule motors and the
spindle pole body in yeast mating and mitosis.
Schekman, R., University of California, Berkeley. Protein
secretion in yeast.
Winston, F., Harvard Medical School. Analysis of TFIID,
histones, and other transcription factors in yeast.
Imaging Structure and Function in the Nervous System
July 23-August 12
INSTRUCTORS
Katz, Larry, Ph.D., Duke University, Durham, North Carolina
Lewis, Richard, Ph.D., Stanford University, California
ASSISTANTS
Callaway, Edward, Duke University, Durham, North Carolina
Dolmetsch, Ricardo, Stanford University, California
Peinado, Alex, Duke University, Durham, North Carolina
Yuste, Rafael, Duke University, Durham, North Carolina
Recent advances in optical and video microscopy, coupled with the develop-
ment of powerful new fluorescent probes, present unique opportunities for
visualizing the structure and function of individual neurons and neuronal assem-
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blies. This intesive laboratory/lecture course provided participants with the
theoretical and practical tools to utilize these emerging technologies. Course
topics included principles of fluorescence and video microscopy; image pro-
cessing techniques; theory and practice of confocal microscopy; and the use of
fluorescent tracers to visualize neuronal subpopulations in slices and in dis-
sociated cell culture. Particular emphasis was placed on the use of calcium-
sensitive probes (e.g., fura-2, fluo-3) to monitor cell function in slices and in
single cells. Using state-of-the-art equipment, students explored a variety of
preparations, including mammalian brain slices, acutely dissociated neurons,
and cultured cells.
PARTICIPANTS
Carrive, P., Ph.D., University of Sydney, Australia
Clark, B., B.S., University College London, England
Finch, E., B.A., Cambridge Neuroscience Research Inc.,
Massachusetts
Henzi, V., B.S., Columbia University, New York, New York
Kania, D., B.S., SUNY at Buffalo
Lim, S., Ph.D., Indiana University Medical Center, In-
dianapolis
McPherson, D., Ph.D., Marquette University, Milwaukee,
SEMINARS
Augustine, G., Duke University Medical Center. Simulta-
neous optical recording and voltage clamp measure-
ments.
Bonhoeffer, T., Max Planck Institute, Frankfurt. Roller cul-
tures and optical imaging.
Bookman, R., University of Miami. Excitation-secretion coup-
ling.
Connor, J., Roche Institute of Molecular Biology. Fast cal-
cium imaging and the use of CCD cameras for imaging
fura-2.
Fraser, S., California Institute of Technology. Frontiers in im-
aging: MRI microscopy.
Grinvald, A., Weizmann Institute of Science. Designing opti-
cal probes and visualizing intrinsic signals.
Wisconsin
Mooney, R., Ph.D., Stanford University, California
O'Brien, E., M.A., Cornell University Medical College, New
York, New York
Reid, C., Ph.D., Rockefeller University, New York, New York
Solomon, J., B.A., Washington University Medical School,
St. Louis, Missouri
Wong, R., Ph.D., Stanford University, California
Llinas, R., New York University Medical Center. Dendritic
dynamics of calcium in mammalian central neurons.
O'Rourke, N., Stanford University. In vivo confocal micros-
copy.
Purves, D., Duke University Medical Center. Repetitive im-
aging of neurons in living animals.
Smith, S., Stanford University. Principles of scanning laser
confocal microscopy.
Steinbach, P., ETM Systems. Principles of image proces-
sors.
Tank, D., Bell Laboratories. Combining imaging with physiol-
ogy: Modeling Ca dynamics.
Tsien, R., University of California, San Diego. New fluores-
cent indicators for cell function.
Genetic Approaches to Human Disease Using DNA Markers
August 5-August 12
INSTRUCTORS
Lander, Eric, Ph.D., Whitehead Institute & Massachusetts Institute of
Technology, Cambridge
Page, David, M.D
, Whitehead Institute & Massachusetts Institute of
Technology, Cambridge
This intensive lecture course explored the ways to map the genes underlying hu-
man diseases and traits of unknown molecular basis by studying individuals from
families and populations with DNA polymorphisms. The goal was to teach the full
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range of strategies for mapping genetic diseases and traits by discussing the
methods and illustrating their practical application. Specifically, the course dis-
cussed important methods in linkage analysis, segregation analysis,
cytogenetics, population genetics, epidemiology, and molecular biological tech-
niques for exploring large genomes. Their application was illustrated by a range
of examples, spanning the range from simple to complex genetic problems.
Among the topics discussed were Alzheimer's disease, Fragile-X syndrome, hu-
man cancer, diabetes, hypertension, genetic imprinting, Down's syndrome, rare
recessive diseases, and quantitative traits. The course was intended for students
with backgrounds in either molecular biology, molecular genetics, or medical
genetics, who are interested in undertaking research on the genetic basis of par-
ticular diseases, traits, or physiological systems.
PARTICIPANTS
Ebers, G., M.D., University Hospital, London, Canada
Glenn, C., B.S., University of Alabama, Birmingham
Guillem, J., M.D., Lahey Clinic Medical Center, Burlington,
Massachusetts
Heinrich, G., Ph.D Massachusetts Institute of Technology,
Cambridge
Kwok, P., Ph.D., Washington University Medical Center, St.
Louis, Missouri
O'Flaherty, E., B.S., Alfred Hospital, Victoria, Australia
Peltomaki, P., M.D., University of Helsinki, Finland
Riba-Ramirez, L., M.S. Massachusetts Institute of Technol-
SEMINARS
Chakravarti, A., University of Pittsburgh. Down's syndrome
and Charcot-Marie-tooth disease.
Fearon, E., Johns Hopkins University School of Medicine. 1.
Tumor suppressor genes. 2. Genetic alterations underly-
ing colorectal tumorigenesis.
Gilliam, C., New York State Psychiatric Institute. Spinal
muscular atrophy.
Green, E., Washington University Medical School. YAC clon-
ing.
ogy, Cambridge
Rosenberg, M., Ph.D., USSR Academy of Science, Moscow,
Russia
Seiberg, M., Ph.D., Bristol-Myers Squibb Institute, Princeton,
New Jersey
Van Dyke, D., M.D., University of Iowa, Iowa City
Vulpe, C., B.S., University of California, San Francisco
Wang, C., Ph.D., Columbia Presbyterian Hospital, New York,
New York
Yager, T., Ph.D., California Institute of Technology,
Pasadena
Hobbs, H., University of Texas Southwest Medical School.
Dissecting heart disease.
Nicholls, R., University of Florida. Genomic imprinting.
Puck, J., University of Pennsylvania School of Medicine. X-
linked immunodeficiency.
Tanzi, R., Massachusetts General Hospital. Mapping
Alzheimer's disease.
Warren, S., Emory University. Molecular genetics of Fragile-
X syndrome.
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Analysis and Genetic Manipulation of Yeast
Artificial Chromosomes
October 8-October 21
INSTRUCTORS
Carle, Georges, Ph.D., Universite de Nice, France
Green, Eric, M.D., Ph.D., Washington University, St. Louis, Missouri
Rothstein, Rodney, Ph.D., Columbia University, New York, New York
ASSISTANTS
Schmidt, Laurence, Universite de Nice, France
Sunjevaric, Ivana, Columbia University, New York, New York
Tidwell, Rose, Washington University, St. Louis, Missouri
Cloning in yeast artificial chromosomes (YACs) is rapidly being applied to a wide
variety of molecular genetic problems. This course provided basic scientific ex-
pertise in current techniques for the analysis and manipulation of YACs. In gen-
eral, a blend of theoretical and practical information was provided, with the goal
to establish a strong foundation for applying YAC cloning to a diversity of
scientific problems. Topics included standard yeast genetic techniques (such as
the propagation and storage of cells, tetrad dissection, colony hybridization, and
DNA transformation), YAC library screening using both PCR- and genetic-based
strategies, characterizing YAC inserts by pulsed-field gel electrophoresis and
PCR, manipulating YAC clones by recombination-mediated disruption, targeted
integration, and YAC-YAC recombination, and techniques for introducing YACs
into mammalian cells. Participants learned through hands-on experience, in-
formal discussions, and lectures given by prominent experts designed to com-
plement the experimental activities.
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PARTICIPANTS
Best, S., B.S., National Institute for Medical Research,
London, England
Boldog, F., Ph.D., University of Nebraska, Omaha
Byrd, P., Ph.D., University of Birmingham, England
Clerc, P., Ph.D., Harvard Medical School, Boston, Massa-
chusetts
Darras, B., M.D., Tufts-New England Medical Center, Bos-
ton, Massachusetts
Deloukas, P., B.S., F. Hoffmann La Roche, Basel, Switzer-
land
Engler, P., Ph.D., University of Chicago, Illinois
SEMINARS
Bentley, D., Guy's Hospital, London. Isolation and analysis
of YACs: Application to mapping the human X
chromosome.
Burke, D., University of Michigan Medical School. Develop-
ment and uses of a mouse genomic YAC library.
Garza, D., Stanford University School of Medicine. Applica-
tion of YACs to the study of model genetic organisms.
Hieter, P., Johns Hopkins University School of Medicine.
Modification of YACs using homologous recombination-
Macromolecular Crystallography
Forstner, M., B.S., University of Graz, Austria
Henriksson, J., B.S., Uppsala University, Sweden
Jones, E., Ph.D., Howard Hughes Institute in Dallas, Texas
Lee, Y., Ph.D., Children's Hospital, Boston, Massachusetts
Libert, F., Ph.D., Genmark, Salt Lake City, Utah
Liu, A., Ph.D., VA Medical Center, Los Angeles, California
Palmer, L., B.S., McLaughlin Research Institute, Great Falls,
Montana
Polzin, K., Ph.D., Iowa State University, Ames
Tanguay-Stowers, L., B.A., Bio 101, La Jolla, California
based techniques.
Huxley, C., Washington University School of Medicine.
Transfer of YAC DNA from yeast to mammalian cells.
Olson, M., Washington University School of Medicine. In
vitro manipulation of large DNA molecules.
Ward, D., Yale University School of Medicine. Physical map-
ping of DNA with fluorescent in situ hybridization tech-
niques.
October 10-October 23
INSTRUCTORS
Furey, W., Ph. D., VA Medical Center, Pittsburgh, Pennsylvania
Gilliland, G., Ph.D., Center for Advanced Research in Biotechnology, Rockville,
Maryland
McPherson, A. Ph.D., University of California, Riverside
Pflugrath, J., Ph.D. Cold Spring Harbor Laboratory, New York
Crystallography and X-ray diffraction yield a wealth of structural information
un-
obtainable through other methods. This intensive laboratory/computational
course focused on the major techniques used to determine the three-dimensional
structures of macromolecules. It was designed for scientists
with a working
knowledge of protein structure and function, but who are new
to macromolecular
crystallography. Topics covered included protein purification,
crystallization,
crystal characterization, data collection, data reduction,
anomalous dispersion,
phase determination, molecular replacement and averaging,
electron density in-
terpretation, structure refinement, molecular graphics, and
molecular dynamics.
Participants learned through extensive hands-on experiments,
informal discus-
sions, and lectures on current applications of these and
related procedures given
by outside speakers.
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PARTICIPANTS
Bhandary, K., Ph.D., SUNY at Buffalo, New York
Cueto, M., B.A., Rutgers University, Piscataway, New Jersey
Curry, S., Ph.D., Institute for Animal Health, Surrey, England
Faust, C., Ph.D., Texas Tech University, Lubbock
Gastinel, L., Ph.D., California Institute of Technology,
Pasadena
Johansson, A., M.S., University of Copenhagen, Denmark
Lee, P., Ph.D., Brookhaven National Laboratory, Upton, New
York
Melhorn, I., Ph.D., University of California, San Francisco
Miller, H., B.S., Wake Forest University, Winston-Salem,
North Carolina
Nolte, R., B.S., Boston University, Massachusetts
Phipps, B., Ph.D., NRC Institute for Biological Sciences, Ot-
tawa, Canada
Quirk, S., Ph.D., Johns Hopkins University, Baltimore,
Maryland
Rao, J., Ph.D., Texas College of Osteopathic Medicine, Fort
Worth
Rech, J., B.A., Vanderbilt University, Nashville, Tennessee
Stoll, V., Ph.D., Max Planck Institute, Heidelberg, Germany
Zhou, G., Ph.D., Oregon State University, Corvallis
SEMINARS
Anderson, J., Cold Spring Harbor Laboratory. Crystallization
of proteins with DNA.
'Barford, D., Cold Spring Harbor Laboratory. Molecular re-
placement I and II.
Brunger, A., Yale University. New approaches to crystal-
lographic refinement and moleCular replacement.
Burley, S., Rockefeller University. Structure determination of
leucine aminopeptidase.
Furey, W., Veterans Administration Medical Center. 1.
Isomorphous replacement I and II. 2. Solvent flatten-
ing/phase combination.
Gilliland, G., Center for Advanced Research in Biotechnol-
ogy. 1. Biological macromolecule crystallization database:
A tool for the development of crystallization strategies. 2.
The three-dimensional structure determination of isozyme
3-3 of a glutathione S-transferase from the Mu gene class.
Gronenborn, A., National Institutes of Health. Determination
of protein structure by 2D, 3D, and 4D NMR.
Hendrickson, W., Columbia University. Application of multi-
wavelength anomalous diffraction to direct macro-
molecular structure determination.
Herzberg, O., University of Maryland. Two crystal structures
from the phosphoenopyruvate:sugar phosphotransferase
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system: A paradigm for protein-protein phosphoryl trans-
fer.
Jones, T.A., University of Uppsala. Map interpretation.
Kuriyan, J., Rockefeller University. Structural studies on di-
sulfide reductases.
McPherson, A., University of California, Riverside. 1. Crystal-
lization of macromolecules I, II, and III. 2. Preliminary crys-
tal characterization. 3. More on Bragg's Law. 4. Precision
photography. 5. Difference patterns.
Minor, W., Purdue University. Data collection in protein crys-
tallography: Tricks and traps I and II.
Rose, J., University of Pittsburgh. Crystallographic study of
the neurophysin-hormone system.
Sigler, P., Yale University. Crystal structures showing how
steroid receptors recognize their DNA targets.
Sweet, R., Brookhaven National Laboratory. 1. Introduction
to crystallography. 2. Crystallographic symmetry and unit
cells. 3. X-ray sources and optics.
Tronrud, D., Institute of Molecular Biology. Refinement with
TNT.
Westbrook, E., Argonne National Laboratory. Structure
determination of cholera toxin.
Essential Computational Genomics for Molecular Biologists
October 27-November 5
INSTRUCTORS
Branscomb, Elbert, Ph.D., Lawrence Livermore Laboratory, California
Goodman, Nat, Ph.D., Massachusetts Institute of Technology
Lander, Eric, Ph.D., Massachusetts Institute of Technology
Marr, Tom, Ph.D., Cold Spring Harbor Laboratory, New York
Myers, Gene, Ph.D., University of Arizona
This course was intended primarily for molecular biologists and geneticists who
are mounting large-scale projects that require informatics components. No prior
experience with the use of computers or mathematics was assumed. Lectures
and computer work delved deeply into both the theoretical issues and practical
approaches to a number of important computational problems in genomic analy-
sis. The course included an overview of informatics systems analysis and design
principles. Topics included such basics as database design and data modeling
to more complex analytical methods. Technical issues relating to the analysis of
raw data such as image analysis, sequence assembly, physical mapping,
genetic-linkage analysis, and data integration were covered. Students were intro-
duced to, and gained hands-on experience with, a variety of software tools used
in computer systems design and data acquisition and analysis running on
Macintosh computers. It was intended that students gain sufficient knowledge
and experience from this course to enable them to initiate active collaborations
with computational scientists at their home institutions.
PARTICIPANTS
Bergh, S., M.S., Royal Institute, Stockholm, Sweden
Fernandez-Larsson, R., Ph.D., University of Massachusetts,
Worcester
Francke, U., M.D., Stanford University, California
Mahtani, M., B.S., Stanford University, California
Mao, J., Ph.D., Collaborative Research, Inc., Waltham, Mas-
sachusetts
Marin, A., M.D., University of Seville, Spain
Rine, J., Ph.D., University of California, Berkeley
Wang, F M.S., University of Texas, Austin
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Molecular Genetics of Fission Yeast
October 24-November 7
INSTRUCTORS
Fantes, Peter, Ph.D., University of Edinburgh, Scotland
Hyams, Jeremy, Ph.D., University College London, England
McLeod, Maureen, Ph.D., State University of New York, Brooklyn
ASSISTANTS
Alfa, Caroline, University College London, England
Devoti, Jamie, State University of New York, Brooklyn
Warbrick, Emma, University of Edinburgh, Scotland
The fission yeast (Schizosaccharomyces pombe) is increasingly being used as a
model organism for the study of basic aspects of cell biology. This course intro-
duced the student to all aspects of fission yeast biology, but with particular em-
phasis on genetic manipulation (both classical and with recombinant DNA) and
the use of the organism for the study of cell biology. Topics covered included
chemical mutagenesis and mutant analysis, transformation and gene replace-
ment techniques, isolation of nuclei, preparation of nuclear DNA, plasmid
recovery from yeast into bacteria, cell cycle methods, cytology, and im-
munocytochemical techniques. In addition to hands-on experience, participants
had the opportunity to learn through informal group discussions and a lecture
series designed to complement the experimental section.
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PARTICIPANTS
Benko, Z., M.S., L. K. University, Debrecen, Hungary
Brazill, D., B.S., University of California, Berkeley
Finkelstein, C., M.S.. lnstituto Investigaciones, Buenos Aires,
Argentina
Germain, D., Ph.D., National Research Council, Montreal,
Canada
Guan, K., Ph.D., Purdue University, West Lafayette, Indiana
He, X., B.S., Baylor College of Medicine, Houston, Texas
SEMINARS
Beach, D., Cold Spring Harbor Laboratory. Role of
phosphatases in cell cycle regulation.
Chappell, T., Duke University. The Golgi apparatus of S.
pombe.
Fantes, P., University of Edinburgh. New mitotic control ele-
ments.
Hoffman, C., Boston College. Glucose repression of trans-
cription of the S. pombe fbpl gene.
Hyams, J., University College London. Cell cycle control in
fission yeast.
Klar, A., NCI-Frederick Facility. Fission yeast mating type.
Moser, M., B.S., University of Washington, Seattle
O'Connell, M., Ph.D., University of Medicine & Dentistry of
New Jersey, Piscataway
Sander, P., B.S., Max Planck Institute, Frankfurt, Germany
Shpakovski, G., Ph.D., National Institute of Mental Health,
Bethesda, Maryland
Zou, J., M.S., Johns Hopkins University, Baltimore, Maryland
Koh li, J., University of Bern. Recombination in fission yeast.
McLeod, M., SUNY, Brooklyn. Regulation of meiotic initia-
tion.
Niwa, 0., Kyoto University. Chromosome stability in fission
yeast.
Simanis, V., ISREC, Switzerland. Identification and analysis
of a bypass supressor of the cdc10 gene.
Wig ler, M., Cold Spring Harbor Laboratory. ras oncogene in
fission yeast.
Young, P., Queen's University. Isolation of mutants defective
in sodium metabolism.

Seminars
Cold Spring Harbor Seminars were initiated to provide a semiformal avenue for
communication between the various research groups at the Laboratory. They are
particularly useful for research personnel who have joined the Laboratory during
the summer. The seminars also afford a necessary opportunity for the graduate
students and postgraduate staff to develop their skills in defending, organizing,
and presenting their research. In addition to those listed below, seminars were
given by many others involved in research at this laboratory.
1991
January
R. Scott Hawley, Albert Einstein College of Medicine, Bronx,
New York. Molecular genetics and cell biology of
chromosome segregation in Drosophila.
Stan Fields, State University of New York at Stony Brook.
Applications of a genetic system to detect protein-protein
interactions.
Greg Hannon, Case Western Reserve, Cleveland, Ohio.
Trans-splicing of nematode pre-messenger RNA.
Huseyin Mehmet, University College, London, England. Sig-
nal transduction in glial cell development.
February
Richard Marais, Imperial Cancer Research Fund, London,
England. Posttranslational modification and the control of
serum response factor activity.
Carl Pabo, Johns Hopkins University, Baltimore, Maryland.
Co-crystal structures of zinc finger/DNA and
homeodomain/DNA complexes: New perspectives in
protein-DNA recognition.
Joan Massague, Sloan Kettering Cancer Center, New York,
New York. Cell regulation by transforming growth factors.
Brian Holaway, Boehringer Mannheim Corp., Indianapolis,
Indiana. Advances in nonradioactive nucleic acid labeling
and detection.
Larry Simpson, University of California at Los Angeles. RNA
editing in trypanosome mitochondria.
March
Masayori Inouye, Robert Wood Johnson Medical School at
Rutgers University, New Brunswick, New Jersey. Retroele-
ments in bacteria.
Ruth Lehmann, Whitehead Institute, Cambridge, Massachu-
setts. Maternal control of germ line determination and pat-
tern formation in the Drosophila embryo.
Chris Hardy, Columbia University, New York, New York.
Identification by the two hybrid approach of a gene pro-
duct that interacts in the RAP1 at yeast silencers and
telomeres.
Alan Hinnebusch, National Institutes of Health, Bethesda,
Maryland. Regulation of initiation factors in translational
control of yeast transcriptional activator GCN4.
April
Erin O'Shea, Whitehead Institute, Cambridge, Massachu-
setts. Structure/function studies of leucine zipper pep-
tides.
Olivia Peirera-Smith, Baylor College of Medicine, Houston,
Texas. Molecular genetic analysis of immortalization of hu-
man cells.
Jef Boeke, Johns Hopkins University, Baltimore, Maryland.
Retrotransposition: Mechanism and host functions.
Peter Drain, Stanford University, California. Molecular genet-
ic approaches to learning in Drosophila.
May
Philippe Soriano, Baylor College of Medicine, Houston,
Texas. Genetic manipulation of the early mouse embryo.
June
Nam-Hai Chua, Rockefeller University, New York, New York.
Molecular switches for gene expression during plant de-
velopment.
Jonathan Jones, John Innes Institute, United Kingdom.
Transposition of Ac in tobacco and Arabidopsis.
July
Michel Saure, University Paris-Sud, France. CDC25 and
SDC25: Two genes of S. cerevisiae that encode exchange
factors for small GTP binding of proteins.
Christoph Muller, Albert-Ludwigs-Universitat, Freiburg,
Germany. Wild-type and mutant structures of adenylate
kinase from Escherichia coli.
September
Yi Zhong, University of Iowa, Iowa City. Activity-dependent
synaptic plasticity in Drosophila memory mutants.
Tom Broker, University of Rochester, New
York. Complete
productive program of a papillomavirus in culture.
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October
Howard Schulman, Stanford University Medical Center, Cali-
fornia. Multifunctional Ca++/calmodulin kinase: An en-
zyme with a memory.
Ming Lei, Cornell University, Ithaca, New York. Cloning and
characterization of a rice cell wall protein gene; Evolution-
ary studies using plant cytochrome c genes.
Alex von Gagain, Karolinska Institute, Sweden. Environmen-
tally regulated stability of mRNA in E. coli: A model to
study the mechanism of mRNA degradation.
Robin Wharton, Columbia University, New York, New York.
RNA regulatory elements and the control of posterior seg-
mentation in Drosophila.
November
Kerry Bloom, University of North Carolina at Chapel Hill.
Molecular structure of a yeast centromere.
Max Gottesman, Columbia University, New York, New York.
v-ras-induced dedifferentiation in rat thyroid cells.
Gerald Hart, Johns Hopkins University, Baltimore, Maryland.
Glycosylation of nuclear proteins: A putative regulatory
modification.
Martin Hammer, Berlin. Behavioral and physiological analy-
sis of olfactory learning in bees.
December
Jerry Yin, Massachusetts Institute of Technology. Ap-
proaches to cAMP and the establishment of long-term
memory in Drosophila.
Ken Marcu, State University of New York at Stony Brook.
Mechanisms and regulation of lymphoid antigen receptor
rearrangement.
Sarah Hake, USDA/Plant Gene Expression Center, Albany,
California. Ectopic expression of the maize homeobox
gene Knotted causes altered leaf development.
Hazel Sive, Whitehead Institute, Cambridge, Massachusetts.
Determination of the anteroposterior axis in Xenopus
laevis.
Undergraduate Research
An important aspect of the summer program at the Laboratory is the participation
of college undergraduate students in active research projects under the supervi-
sion of full-time laboratory staff members. The program was initiated in 1959.
Since that year, 355 students have completed the course, and many have gone
on to creative careers in biological science.
The objectives of the program are to provide (1) a greater understanding of
the fundamental principles of biology; (2) an increased awareness of major prob-
lem areas under investigation; (3) a better understanding of the physical and in-
tellectual tools for modern research and the pertinence of this information to fu-
ture training; and (4) a personal acquaintance with research workers and centers
for study.
The following students, selected from over 173 applicants, took part in the
program, which was supported by the Burroughs Wellcome Fund, Baring
Brothers, Miles Inc./Bayer AG, Cold Spring Harbor Laboratory Robert H.P. Olney
Fund, BioRad/Laboratories, National Science Foundation, Phillips Petroleum
Foundation, Inc., Edwin Whitehead Association, and anonymous gifts.
Joseph Beauchamp, SUNY, Cortland
Advisor: Thomas Peterson
Sponsor: National Science Foundation
Investigation of mosaic pericarp color in maize.
David Birschbach, University of Wisconsin, Madison
Advisor: Kim Arndt
Sponsor: National Science Foundation
Identification of suppressor of transcription (SIT) mutants
in Saccharomyces cerevisiae.
Lisa Catapano, Dartmouth College
Advisor: Thomas Marr
Sponsor: National Science Foundation
Short functional elements in DNA.
Clark Chen, Stanford University
Advisor: Bruce Stillman/Anindya Dutta
Sponsor: Burroughs Wellcome Fund
Cloning the human homolog of Saccharomyces
cerevisiae CDC7 gene using cross-species
complementation.
367
Marie-Dominique Galibert, Rene-Descartes,
University, Paris
Advisor: Michael Mathews/Claude Labrie
Sponsors: Miles, Inc.; Bio-Rad Laboratories;
Whitehead Associates
Characterization of DNA sequences mediating the
trans-activation of PCNA by E1A.
Leena Gandhi, University of Utah
Advisor: Arne Stenlund
Sponsor: Burroughs Wellcome Fund
BrdU density-labeling analysis of BPV replication in
rodent cell lines.
Per Geste land, Allegheny College, Pennsylvania
Advisor: Dafna Bar-Sagi
Sponsor: Burroughs Wellcome Fund
The elucidation of possible upstream regulators of the ras
protein in the process of T-cell activation.
Flaviano Giorgini, Purdue University
Advisor: Jeff Kuret
Sponsor: Whitehead Associates
Solution of the three-dimensional structure of the
catalytic subunit of the cAMP-dependent protein kinase
from Saccharomyces cerevisiae following a mutagenic
approach.
Gilbert L. Henry, University of California, Santa Barbara
Advisor: Winship Herr
Sponsor: National Science Foundation
An analysis of the binding specificity of two POU
domain proteins: Oct-1 and Pit-1.
Christina M. Hull, University of Utah
Advisor: Carol Greider
Sponsor: Anonymous Contributor
Direct assay for telomerase primer binding.
Lei Meng, Barnard College
Advisor: Bruce Futcher
Sponsors: Olney Memorial Cancer Fund; Philips
Petroleum Foundation, Inc.
Searching of a new CLN-like gene by screening a
Saccharomyces cerevisiae genomic library.
Juan Moreno, University of California, Irvine
Advisor: Nouria Hernandez
Sponsor: National Science Foundation
A PCR approach for the identification of the cDNA encoding
the largest subunit of human RNA polymerase III.
Adam John Oates, Newcastle-Upon-Tyne University,
United Kingdom
Advisor: Hong Ma
Sponsor: Baring Brothers
Analysis of the agamous gene product in yeast.
Johanna O'Dell, Beloit College
Advisor: Robert Martienssen
Sponsor: National Science Foundation
A new PCR technique for cloning suppressible genes
in maize.
Frank Papanikolaou, University of Toronto
Advisor: James Pflugrath/Daniel Marshak
Sponsor: Anonymous Contributor
Study of the neurite extension factor S100b.
Jennifer L. Saeger, Cedar Crest College
Advisor: David Helfman
Sponsor: National Science Foundation
Isolation and identification of a cDNA encoding the
polypyrimidine tract binding protein.
Melissa Slawecki, Dickinson College
Advisor: John Anderson
Sponsor: Burroughs Wellcome Fund
Crystallization and X-ray diffraction analysis of R.Pvull.
David Stark, Cambridge University, United Kingdom
Advisor: Nicholas Tonks
Sponsor: Baring Brothers
Identification of protein tyrosine-phosphatases (PTPases) in
PC12 cells.
Kathy Tsapos, Harvard University
Advisor: B. Robert Franza
Sponsor: National Science Foundation
Characterization of NFKB/p105 and cRel.
Jin Yang, SUNY, Oneonta
Advisor: Eric Richards
Sponsor: Anonymous Contributor
Structure and function of telomere-associated sequences.
Nature Study Program
The Nature Study Program gives elementary and secondary school students the
opportunity to acquire a greater knowledge and understanding of their environ-
ment. Through a series of specialized field courses, students can engage in such
introductory programs as Nature Detectives, Seashore Life, and Pebble Pups, as
well as more advanced programs such as Marine Biology and Nature Photog-
raphy.
During the summer of 1991 a total of 420 students participated in the Nature
Study Program. Most classes were held outdoors, when weather permitted, or at
the Uplands Farm Preserve, the headquarters of the Long Island Chapter of the
Nature Conservancy. The Laboratory has equipped and maintains class-
rooms/laboratories as well as a darkroom at Uplands Farm. This facility is used
as a base for the student's exploration of the local environment. Field classes are
held on Laboratory grounds, St. John's Preserve, Fire Island National Seashore,
Caumsett State Park, the Cold Spring Harbor Fish Hatchery and Aquarium, as
well as other local preserves and sanctuaries.
In addition to the 2-week courses, the 2-day Adventure Education class took
students on a 10-mile bike hike to Sagamore Hill and a 12-mile canoe trip on the
Nissequogue River.
PROGRAM DIRECTOR
William M. Payoski, M.A., Adjunct Professor,
Nassau Community College
INSTRUCTORS
Tricia Decarmine, B.S., science teacher, St. Anthony's High School
Michael Manfredonia, teaching candidate, Marist College
Kim Hamilton, B.S., Colgate University
Linda Payoski, B.A., science teacher, Uniondale High School
Marjorie Pizza, B.A., science teacher, Glen Cove School District
Donna Stokes, teaching candidate
Edward Tronolone, B.A., M.S., Principal, Locust Valley School District
COURSES
Nature Bugs
Nature Detectives
Advanced Nature Study
Ecology Explorers
Frogs, Flippers, and Fins
Pebble Pups
Bird Study
Fresh Water Life
Seashore Life
Marine Biology
Nature Photography
Adventure Education

FINANCIAL
STATEMENT
FINANCIAL STATEMENT
BALANCE SHEET
Year ended December 31, 1991
with comparative amounts for 1990
ASSETS
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-,1N.)
Operating Funds
Endowment &
Similar Funds
Land,
Building, &
Equipment Funds
Total All FundsUnrestricted
RestrictedUndesignated Designated 1991 1990
Cash and cash equivalents $3,117,239 750,000 856,904 3,333,907 8,058,050 17,913,193
Marketable securities 780,813
- 19,517,935 154,969 20,453,717 11,442,776
Accounts receivable:
Publications (less allowance for doubtful accounts
of $50,000 in both 1991 and 1990) 525,989
- - - - 525,989 729,472
Other 174,269 19,296 - - 193,565 128,830
Grants receivable 3,047,419 - - 3,047,419 1,301,854
Accrued interest receivable 506,674 - 506,674 273,426
Publications inventory 1,167,301 1,167,301 900,727
Other assets, principally prepaid expenses 95,735 537,910 633,645 836,965
Investment in employee residences
- - 1,457,746 1,457,746 1,084,424
Land, buildings, and equipment:
Land and improvements 4,248,012 4,248,012 4,181,050
Buildings
- 46,886,748 46,886,748 24,047,478
Furniture, fixtures, and equipment - - - 2,482,465 2,482,465 2,278,950
Laboratory equipment
- - 7,063,973 7,063,973 5,044,457
Library books and periodicals
- 365,630 365,630 365,630
61,046,828 61,046,828 35,917,565
Less accumulated depreciation and amortization
- 14,509,155 14,509,155 12,610,734
Land, buildings, and equipment, net
- - - 46,537,673 46,537,673 23,306,831
Construction in progress
- - - 3,188,616 3,188,616 20,166,508
Total assets $5,861,346 750,000 3,066,715 20,881,513 55,210,821 85,770,395 78,085,006
LIABILITIES AND FUND BALANCES
Operating Funds
Endowment &
Similar Funds
Land,
Building, &
Equipment Funds
Total All FundsUnrestricted
RestrictedUndesignated Designated 1991 1990
Liabilities:
Accounts payable and accrued expenses $2,633,248 - 511,692 410,288 3,555,228 3,192,036
Notes payable - - 910,127 910,127 964,869
Bonds payable - 20,000,000 20,000,000 20,000,000
Deferred revenue 1,290,707 - 2,555,023 - 3,845,730 2,818,458
Total liabilities 3,923,955 3,066,715 21,320,415 28,311,085 26,975,363
Fund balances:
Unrestricted-undesignated 1,937,391 - - - - 1,937,391 1,652,547
Unrestricted-designated 750,000 750,000 650,000
Endowment and similar funds 20,881,513 20,881,513 18,039,437
Land, buildings, and equipment:
Expended - - - 31,352,674 31,352,674 28,222,713
Unexpended-Donor restricted 1,079,986 1,079,986 1,460,522
Unexpended-Board authorized 1,457,746 1,457,746 1,084,424
Total fund balances 1,937,391 750,000 20,881,513 33,890,406 57,459,310 51,109,643
Total liabilities and fund balances $5,861,346 750,000 3,066,715 20,881,513 55,210,821 85,770,395 78,085,006
STATEMENT OF SUPPORT, REVENUE AND EXPENSES,
AND CHANGES IN FUND BALANCES
Year ended December 31, 1991
with comparative amounts for 1990
Operating Funds
Endowment &
Similar Funds
Land,
Building, &
Equipment Funds
Total All FundsUnrestricted
Undesignated Designated Restricted 1991 1990
Support and revenue:
c...) Public support $1,898,003 6,540,534 3,584,438 1,093,533 13,116,508 7,557,930V
41 Government grant awards - - 7,982,835 - - 7,982,835 10,250,777
Indirect cost allowances 7,280,352 - - - - 7,280,352 6,633,895
9,178,355 14,523,369 3,584,438 1,093,533 28,379,695 24,442,602
Other revenue:
Program fees 1,329,875 - - - 1,329,875 1,123,793
Rental income 278,840 - - - 278,840 248,333
Publications 3,078,938 - - - 3,078,938 4,222,694
Dining services 1,439,224 - 1,439,224 1,154,033
Rooms and apartments 1,239,585 - - - 1,239,585 795,995
Distribution from Robertson Funds 375,000 975,000 - - 1,350,000 1,150,000
Investment income 164,371 - - 1,333,374 475,836 1,973,581 2,853,915
Royalty & licensing 318,029 - - - 318,029 84,677
Miscellaneous 92,042 - 92,042 84,887
Total other revenue 8,315,904 975,000 1,333,374 475,836 11,100,114 11,718,327
Total support and revenue 17,494,259 15,498,369 4,917,812 1,569,369 39,479,809 36,160,929
Expenses:
Program services:
Research 13,026,253 - - 13,026,253 11,348,636
Summer programs 849,168 2,145,416 - - 2,994,584 3,052,125
Publications 3,488,100 - - 3,488, 100 3,708,062
Banbury Center conferences 204,801 242,243 - - 447,044 499,942
DNA Education Center programs 6,643 373,161 379,804 323,219
Total program services 4,548,712 15,787,073 20,335,785 18,931,984
Supporting services:
Direct research support 903,032 - - - 903,032 609,502
Library 433,496 - - - 433,496 388,221
Operation and maintenance of plant 4,221,594 - - 4,221,594 4,070,385
General and administrative 3,005,496 - - 75,791 - 3,081,287 2,877,460
Dining services 1,322,422 - - - - 1,322,422 1,296,009
Interest
- - 934,105 934,105 1,413,344
Total supporting services 9,886,040 75,791 934,105 10,895,936 10,654,921
Depreciation 1,898,421 1,898,421 1,485,084
Total expenses 14,434,752 15,787,073 75,791 2,832,526 33,130,142 31,071,989
Excess (deficiency) of support and
revenue over expenses before designation $3,059,507 (288,704) 4,842,021 (1,263,157) 6,349,667 5,088,940
Designation:
Funds designated for research
program (100,000) 100,000 - -
Excess (deficiency) of support and
revenue over expenses and designation 2,959,507 100,000 (288,704) 4,842,021 (1,263,157) 6,349,667 5,088,940
Other changes in fund balances:
Capital expenditures (2,564,962) (1,925,942) - 4,490,904 -
Transfer to restricted funds - - 2,214,646 (2,214,646) - -
Transfer to endowment funds (109,701) - - 214,701 (105,000) -
Net increase in fund balances 284,844 100,000 - 2,842,076 3,122,747 6,349,667 5,088,940
Fund balances at beginning of year 1,652,547 650,000 - 18,039,437 30,767,659 51,109,643 46,020,703
Fund balances at end of year $1,937,391 750,000 - 20,881,513 33,890,406 57,459,310 51,109,643
Copies of our complete, audited financial statements, certified by the independent auditing firm
of KPMG, Peat, Marwick & Co., are available upon request from the Comptroller, Cold Spring
Harbor Laboratory.
SOURCES OF REVENUE
YEAR ENDED DECEMBER 31, 1991
Federal Grants 37.1 %
Endowments and Similar Funds 7.4 (X,
Foundation and Private
Contributions and Grants 28.1 %
4411111i81tp,,/
Interest and Miscellaneous 2.7
Auxiliary Activities 18.6 %
Corporate Contributions and Grants 6.1 %
COMPARATIVE OPERATING HISTORY
1987-1991
(Dollars in Thousands)
1987 1988 1989 1990 1991
Income:
Main Lab:
Grants & contracts 10,409 10,799 13,062 13,535 15,172
Indirect cost reimbursement 4,779 5,707 6,412 6,558 7,170
Other 2,727 3,205 4,034 3,976 5,056
C41
c) CSH PressBanbury Center
1,556
982
1,641
976
4,450
1,012
4,223
1,120
3,079
1,090
DNA Learning Center 349 660 622 585 744
Total income 20,802 22,988 29,592 29,997 32,311
Expenses:
Main Lab:
Grants & contracts 10,409 10,799 13,062 13,535 15,172
Operation & maintenance of plant 2,791 3,010 3,412 3,759 3,904
General & administrative 1,975 2,102 2,377 2,414 2,468
Other 2,633 3,049 3,165 2,973 3,375
CSH Press 1,311 1,719 3,934 3,708 3,488
Banbury Center 947 910 1,038 1,125 1,063
DNA Learning Center 260 590 635 615 752
Total expenses 20,326 22,179 27,623 28,129 30,222
Excess before depreciation and designation of funds 476 809 1,969 1,868 2,089
Depreciation (1,127) (1,286) (1,399) (1,485) (1,898)
Designation of funds (1)
- (400) (250) (100)
Net operating excess (deficit) $ (651) (477) 170 133 91
The above amounts are presented on a combined basis for all funds for which Cold Spring Harbor Laboratory prepares operating budgets.
(1) Funds designated to underwrite future direct and indirect expenses of the neuroscience and other research programs.
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FINANCIAL SUPPORT
OF THE LABORATORY

SOURCES OF SUPPORT
Cold Spring Harbor Laboratory is a nonprofit research and educational institution
chartered by the University of the State of New York. Less than half of its annual
support is derived from Federal grants and contracts. Contributions from the pri-
vate sector are tax exempt under the provisions of Section 501(c)(3) of the Inter-
nal Revenue Code. In addition, the Laboratory has been designated a "public
charity" and, therefore, may receive funds resulting from the termination of "pri-
vate foundations."
Over the years, the Laboratory has earned a reputation for innovative re-
search and high-level science education. By training young scientists in the latest
experimental techniques, it has helped spur the development of many research
fields, including tumor virology, cancer genes, gene regulation, movable genetic
elements, yeast genetics, and molecular neurobiology. This continual develop-
ment of new research programs and training courses requires substantial sup-
port from private sources.
Because its endowment is small and because government support is highly
competitive and the uses of research grants are restricted, the Laboratory
depends on annual contributions from the private sector (foundations, corpora-
tions, and individuals) for its central institutional needs.
As of December 31, 1991, the Second Century Campaign had raised
$45,965,194, exceeding its goal of $44,000,000. These are capital funds and
will be used for construction of new facilities and for staff and student endow-
ment.
METHODS OF CONTRIBUTING TO COLD SPRING HARBOR LABORATORY
Gifts of money can be made directly to Cold Spring Harbor Laboratory.
Securities You can generally deduct the full amount of the gift on your income tax return,
and, of course, you need pay no capital gains tax on the stock's appreciation.
We recommend any of the following methods:
(1) Have your broker sell the stock and remit the proceeds to Cold Spring Harbor
Laboratory.
(2) Deliver the stock certificates to your broker with instructions to him to open an ac-
count for Cold Spring Harbor Laboratory and hold the securities in that account
pending instructions from Cold Spring Harbor Laboratory.
(3) Send the unendorsed stock certificates directly to the Laboratory: Comptroller, Cold
Spring Harbor Laboratory, Box 100, Cold Spring Harbor, New York 11724. In a sepa-
rate envelope send an executed stock power.
Pooled Income Funds Combine gifts from a number of donors in a pool for attractive in-
vestment and tax purposes.
Appreciated real estate or personal property Sizable tax benefits can result from
such donations; the Laboratory can use some in its program and can sell others.
Life insurance and charitable remainder trusts can be structured to suit the
donor's specific desires as to extent, timing, and tax needs.
Bequests Most wills probably need to be updated. Designating Cold Spring Harbor Labo-
ratory as beneficiary ensures that a bequest will be utilized as specified for continuing
good.
Conversion of private foundation to "public" status on termination This may be
done by creating a separate fund within Cold Spring Harbor Laboratory whereby the as-
sets of the private foundation are accounted for as a separate fund and used for the pur-
poses specified by the donor. Alternatively, the private foundation can
be established as
a "supporting organization of Cold Spring Harbor Laboratory."
For additional information, please contact the Director of Development, Cold Spring
Harbor
Laboratory, Box 100, Cold Spring Harbor, NY 11724, or call 516-367-8840.
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GRANTS
January 1, 1991-December 31, 1991
COLD SPRING HARBOR LABORATORY
Grantor Program/Principal Investigator Duration of Grant Total Award
FEDERAL GRANTS
NATIONAL INSTITUTES OF HEALTH
Program Projects Cancer Research Center, Dr. Mathews
Cancer Center Support, Dr. Roberts
PEBRA-HIV Grant, Dr. Herr
Oncogene Program Project, Dr. Wigler
Research Support Dr. Anderson
Dr. Arndt
Dr. Arndt
Dr. Bar-Sagi
Dr. Beach
Dr. Beach
Dr. Beach
Dr. Beach
Dr. Davis
Dr. Franza
Dr. Franza
Dr. Frendewey
Dr. Futcher
Dr. Futcher
Dr. Garrels
Dr. Gilman
Dr. Greider
Dr. Greider
Dr. Helfman
Dr. Hernandez
Dr. Hernandez
Dr. Krainer
Dr. Kuret
Dr. Kuret
Dr. Marr
Dr. Marr
Dr. Moran
Dr. Moran
Dr. Moran
Dr. Peterson
Dr. Pflugrath
Dr. Richards
Dr. Roberts
Dr. Roberts
Dr. Roberts
Dr. Spector
Dr. Stillman
Dr. Stillman
Dr. Tonks
Dr. Tully
Dr. Wigler
Dr. Wigler
1/87 -12/91
8/87 -7/95
9/88 -8/91
3/88 -2/93
4/90 -3/93
4/88 -3/93
1/91 -12/94
7/91 -6/96
12/84 -1/93
9/86 -8/94
7/88 -6/93
8/90 -7/93
9/91 -8/95
9/85 -11/94
10/91 -8/94
4/87 -3/92
4/88 -3/93
1/91 -12/94
1/85 -12/92
9/87 -8/92
12/89 -11/94
8/91 -7/96
9/85 -3/94
7/87 -6/92
9/91 -8/96
7/89 -6/94
7/89 -6/94
5/91 -4/95
9/89 -7/91
8/91 -7/94
3/88 -6/91
8/91 -6/96
8/91 -5/95
4/88 -3/93
4/88 -3/91
7/90 -6/93
7/88 -6/93
9/88 -8/94
4/91 -3/95
4/90 -3/95
7/83 -5/96
7/91 -6/95
8/91 -5/96
9/91 -1/93
7/85 -6/92
8/90 -7/93
$16,787,416
8,823,360
3,672,816
4,869,923
176,000
1,288,964
773,411 *
1,280,538 *
1,481,482
3,032,957
1,488,740
1,287,507
847,368 *
1,497,483
487,949 *
775,814
1,115,434
604,467 *
5,016,584
608,291
1,130,019
1,465,240 *
2,109,264
1,293,754
1,141,822*
1,298,402
1,312,808
760,241 *
156,455
1,122,933 *
473,959
1,299,986
1,122,557
704,475
573,503
424,932
1,598,876
1,180,152
891,380*
1,441,475
2,672,015
763,393 *
1,631,345*
126,301 *
8,426,929
640,923
New Grants Awarded in 1991
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Program/Principal Investigator Duration of Grant Total AwardGrantor
Equipment Support Dr. Roberts
Dr Roberts
8/90 -7/91
6/91 -5/92
37,583
37,327 *
Dr Roberts 4/91 -3/92 54,922 *
Dr Spector 4/90 -3/91 180,000
Fellowships Dr Ballester
Dr Brill
2/89 -1/92
8/89 -7/92
63,996
46,667
Dr Connolly 1/90 -1/93 69,000
Dr Del Vecchio 12/91 -11/93 22,700 *
Dr Grueneberg 10/90 -9/93 69,000
Dr Jones 10/91 -9/94 85,800"
Dr Kessler 8/88 -7/91 63,996
Dr Otto 9/90 -8/93 100,500
Dr Regulski 8/91 -6/92 49,658 *
Dr Stern 11/88 -11/91 63,996
Dr Szymanski 11/90 -11/92 49,000
Training Support Institutional, Dr. Grodzicker 7/78 -4/94 2,364,146
Course Support Advanced Bacterial Genetics,
Dr. Grodzicker 5/80 -4/93 559,540
Cancer Research Center
Workshops, Dr. Grodzicker 1/83 -3/92 1,010,057
Neurobiology Short Term Training,
Dr. Hockfield 5/82 -4/96 1,300,588
CSH Analysis Large DNA Molecules 1991 -1996 475,538 *
Essential Computational Genomics for
Molecular Biologists 1991 -1996 132,619 *
Meeting Support Genome Mapping and Sequencing Conference 1990 -1993 78,040
56th Symposium: The Cell Cycle 1991 10,000 *
Ribosome Synthesis Conference 1991 *
Regulation of Eukaryotic mRNA Transcription 1991 2,000
Molecular Neurobiology of Drosophila 1991 12,000 *
RNA Processing 1988 -1991 9.500
NATIONAL SCIENCE FOUNDATION
Research Support Dr. Anderson 9/90 -8/93 315,000
Dr. Herr 6/88 -5/91 240,000
Dr. Ma 5/91 -4/93 399,000 *
Dr. Ma 8/91 -7/94 360,000 *
Dr. Marr 7/90 -6/91 49,290
Dr. Martienssen 7/89 -6/92 305,000
Dr. Peterson 11/91 -4/93 106,753"
Dr. Roberts 8/87 -7/92 63,106
Dr. Roberts 2/90 -2/93 210,000
Dr. Sundaresan 5/87 -4/91 360,000
Training Support Undergraduate Research Program, Dr. Herr 6/91 -5/94 150,000 *
Course Support Plant Molecular Biology, Dr. Grodzicker 8/86 -8/93 160,929
Meeting Support RNA Processing Conference 4/88 -3/91 30,000
RNA Processing Meeting 4/91 -3/94 30,000*
Eukaryotic DNA Replication Conference 5/91 -4/92 12,000 *
56th Symposium: The Cell Cycle 5/91 -4/92 13,000 *
Regulation of Eukaryotic mRNA
Transcription 7/91 -6/92 10,000*
Ribosome Synthesis Conference 7/91 -6/92 10,000 *
Molecular Biology of Signal
Transduction in Plants 8/91 -1/92 4,000*
Molecular Neurobiology of Drosophila 7/91 -6/92 10,700*
" New Grants Awarded in 1991
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Grantor Program/Principal Investigator Duration of Grant Total Award
DEPARTMENT OF ENERGY
Research Support Dr. Marr
Dr. Martienssen
Meeting Suport 56th Symposium: The Cell Cycle
Molecular Biology of Signal
Transduction
OFFICE OF NAVAL RESEARCH
Course Support Computational Eye Movement Workshop
U.S. DEPARTMENT OF AGRICULTURE
Dr. Sundaresan
Dr. Martienssen
NONFEDERAL GRANTS
Research Support
Aaron Diamond Foundation Dr. Anderson
American Cancer Society Dr. Bar-Sagi
Dr. Spector
Dr. Spector
Dr. Wig ler
Dr. Wig ler, Professorship
Dr. Gilman
Dr. Gilman, Institutional Award
American Heart Association Dr. Helfman
Amersham International plc Dr. Krainer
American Foundation for Dr. Laspia
AIDS Research Dr. Mathews
Argonne National
Laboratories Dr. Pflugrath
Sara Chait Foundation Dr. Marshak
Council for Tobacco
Research Dr. Helfman
Donaldson Charitable
Trust Dr. Enikolopov
Hechler Private
Investments Dr. Enikolopov
Howard Hughes Medical
Institute Neurobiology Support
Istituto Farmaco-terapico
Italiano (IFI) Dr. Marshak
Lucille P. Markey Neurobiology Support
Charitable Trust Neuroscience(Building Fund)
Mathers Charitable
Foundation Dr. Davis
Mellam Family Foundation Dr. FranzaDr. Franza
* New Grants Awarded in 1991
7/91 -2/94
8/91 -8/93
1991
1991
7/88 -6/91
8/91 -8/94
9/91 -8/93
12/88 -11/91
7/89 -6/91
7/87 -6/91
7/91 -6/92
4/91 -3/92
1986 -2012
7/91 -5/94
7/90 -6/92
7/91 -6/96
11/86 -10/92
12/91 -11/92
10/91 -9/92
2/91 -8/93
12/91 -11/96
7/91 -6/92
12/91 -5/92
12/91 -5/92
1987 -1993
5/91 -4/92
7/90 -6/96
8/91 -7/94
12/88 -11/91
12/91 -11/95
762,000*
144,000*
15,000*
5,000*
87,125
221,000*
128,000*
200,000
194,000
363,000
50,000 *
10,000 *
1,333,333
300,000 *
100,000
175,000 *
827,925
60,000*
60,000 *
89,473 *
125,000 *
80,000 *
100,000 *
26,328 *
1,000,000
22,221 *
2,000,000
2,000,000
1,028,000 *
150,000
200,000 *
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Grantor Program/Principal Investigator Duration of Grant Total Award
Richard Meltzer Fund Dr. Stillman 3/90 -2/92 50,000
Fund for Cancer Research
(World Business Council)
Massachusetts Institute of
of Technology (Subcontract) Dr. Marr 11/91 -7/92 49,006 *
Muscular Dystrophy
Association Dr. He If man 1/91 -12/93 126,100*
National Down's
Syndrome Society Dr. Marshak 7/90 -6/92 50,000
Oxnard Foundation Dr. Gilman 2/91 -1/94 150,000 *
Pall Corporation Swiss Project 8/91 -12/91 50,000 *
Pew Memorial Trust Dr. Greider 7/90 -6/94 200,000
Dr. Tonks 7/91 -6/95 200,000 *
Pioneer Hi-Bred Cooperative Research 8/85 -9/91 2,500,000
International Inc. Dr. Peterson 8/91 -7/94 150,000 *
Rita Allen Foundation Dr. Hernandez 10/89 -9/94 150,000
Samuel Freeman Charitable Freeman Laboratory
Trust of Cancer Cell Biology 7/89 -6/94 1,000,000
Equipment Support
Fannie E. Rippel Neurobiology Equipment 10/89 -7/91 250,000
Florence Gould
Foundation Neuroscience Equipment 7/91 -6/94 300,000 *
Fellowships
American Cancer Society Dr. Nefsky 7/90 -6/93 69,000
Dr. Caligiuri 1/91 -12/93 69,000 *
Dr. Dutta 1/91 -12/92 47,000 *
American Foundation for Dr. Laspia 7/89 -6/92 112,200
AIDS Research Dr. Phares 10/91 -9/92 5,000*
Dr. Scheppler 7/91 -6/94 112,000*
Bristol-Myers Company Fellowship Support 6/86 -12/91 500,000
Damon Runyon-Walter Dr. Melendy 1/89 -12/91 69,000
Winchell Cancer Fund Dr. Walworth 9/90 -8/93 84,000
Dr. Wilson 1/91 -12/93 69,000 *
Dr. Ruppert 8/91 -7/94 84,000 *
Ford Foundation Dr. Pena 9/91 -5/92 30,000 *
Garfield Foundation Dr. Skowronski 12/91 -5/92 100,000*
Government of Canada Dr. Tyers 9/90 -8/91 1,099
Dr. Labrie 10/90 -9/91 1,300
Dr. Demetrick 11/91 -10/92 2,923*
Joyce Green Family
Foundation Dr. Sun 12/91 -2/92 5,000 *
Helen Hay Whitney
Foundation Dr. Bell 7/91 -6/94 75,000 *
Human Frontier Dr. Clarke 7/91 -6/93 76,000 *
Science Program Dr. Mayeda 7/91 -6/93 77,000 *
Irvington Institute
for Medical Research
Dr. Giordano 7/90 -6/93 78,000
Ladies Auxiliary to the VFW Dr. Yaciuk 7/90 -6/91 20,000
The Leukemia Society Dr. Das 7/89 -6/92 76,140
of America Dr. Riabowol 7/90 -6/91 29,160
Dr. Bischoff 7/91 -6/94 76,140*
LIBA Four Fellowships a Year 1987 -1992 750,000
Life Science Research Dr. D. Roberts 9/89 -8/93 105,000Foundation
McKnight Endowment Dr. Davis 11/91 -12/91 5,167*John Merck Fund Dr. Tully 9/91 -5/94 180,000*
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Grantor Program/Principal Investigator
Muscular Dystrophy Association
Andrew Seligson
Memorial Fellowships
Weizmann Institute of Science
Training Support
Anonymous
Baring Brothers & Co., Ltd.
Bio-Rad Laboratories
Burroughs Wellcome
Foundation
Grass Foundation
Phillips Petro Co.
Merck Sharp & Dohme
Research Laboratories
Miles Inc.
Robert H.P Olney
Memorial Fund
Whitehead Associates
Course Support
Howard Hughes Medical
Institute
Esther A. and Joseph
Klingenstein Fund, Inc.
Meeting Support
Abbott Laboratories
Accurate Chemical
& Scientific Corp.
Affinity Bioreagents, Inc.
Anheuser-Busch
Companies
Berlex Biosciences, Inc.
Biogen, Inc.
Bio-101 Inc.
Bristol-Myers
Squibb Company
Connaught Laboratories,
Inc.
Connaught Laboratories,
Inc.
Council for Tobacco
Research-USA, Inc.
E.I. du Pont de
Nemours & Co.
Fidia Research
Foundation
Fondazione Sigma-Tau,
Foundation
GIBCO BRL Research
Products Division
Kureha Chemical
Industry Co., Ltd.
John Labatt Limited
New Grants Awarded in 1991
Dr. Tsukahara
Two Postdoctoral Fellows
(Cancer Research Support)
Dr. Gerst
Summer Undergraduate Program
Summer Undergraduate Program
Summer Undergraduate Program
Summer Undergraduate Program
Neurobiology Scholarship Foundation
Summer Undergraduate Program
Summer Undergraduate Program
Summer Undergraduate Program
Undergraduate Research Program
Summer Undergraduate Program
Neurobiology Courses
Postgraduate Courses
Advanced Neurobiology Courses
Synthesis of Ribosomes
Synthesis of Ribosomes
Stress Proteins and Heat Shock
Yeast Cell Biology
Stress Proteins and Heat Shock
Stress Proteins and Heat Shock
Synthesis of Ribosomes
Synthesis of Ribosomes
Synthesis of Ribosomes
Modern Approaches to New Vaccines
Including Prevention of AIDS
Role of Isoform Diversity in
Cytoskeletal Functions
(Meeting Support)
Synthesis of Ribosomes
Molecular Neurobiology
of Aplysia
Molecular Neurobiology
of Aplysia
Stress Proteins and Heat Shock
Stress Proteins and Heat Shock
Yeast Cell Biology
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Duration of Grant Total/Award
7/91 -6/93 76,000 *
9/90 -12/91 70,000
9/89 -8/91 57,000
1991 18,750*
1990 -1992 75,233
1991 1,000*
1991 21,000*
1980 -1991 181,670
1991 2,500*
12/88 -11/90 30,000
1991 5,250*
1991 4,000*
1991 10,000*
1987 -1990 1,000,000
1991-1995 1,000,000"
3/91 -2/94 180,000*
1991 250*
1991 250*
1991 500*
1991 500*
1991 1,500*
1991 1,000*
1991 250*
1991 250*
1991 250*
1991 2,000*
7/90 -6/91 1,000
1991
1991
1991
1991
1991
1991
250*
5,000 *
5,000*
500 *
3,600 *
100 *
Grantor
Program/Principal Investigator Duration of Grant
Merck Sharp & Dohme
Research Laboratories
Merck Sharp & Dohme
Research Laboratories
Miller Brewing Company
Miscellaneous Support
Muscular Dystrophy
Association
Pioneer Hi-Breed
International, Inc.
Rockefeller Foundation
Alfred P. Sloan
Foundation
Stress Gen Biotech-
nologies Corp.
Supelco, Inc.
Takara Shuzo Co., Ltd.
U.S. Biochemical
Corporation
Worthington Bio-chemical
Corp.
Carl Zeiss, Inc.
New Grants Awarded in 1991
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Isoform Diversity in Cytoskeletal 1991
Functions
Synthesis of Ribosomes 1991
Yeast Cell Biology 1991
Isoform Diversity in Cytoskeletal Functions 1991
Isoform Diversity in Cytoskeletal Functions 1991
Signal Transduction in Plants
Modern Approach to New
Vaccines (Publication Support)
Evolution: From Molecules
to Culture
Stress Proteins and Heat Shock
Synthesis of Ribosomes
Stress Proteins and Heat Shock
Sythesis of Ribosomes
Synthesis of Ribosomes
Isoform Diversity in Cytoskeletal
Functions
1991
9/90 -8/91
3/90 -2/28/91
1991
1991
1991
1991
1991
7/90 -6/91
Total Award
250 *
500 *
1,000*
422*
7,500*
500 *
20,000
30,000
2,000 *
250*
3,700 *
500 *
250*
1,000
BANBURY CENTER
Grantor Program/Principal Investigator Duration of Grant Total Award
FEDERAL GRANTS
NATIONAL INSTITUTES OF HEALTH
NATIONAL SCIENCE FOUNDATION
DEPARTMENT OF ENERGY
NONFEDERAL SUPPORT
Meeting Support
Alfred P. Sloan
Foundation
Allen & Hanburys
Amgen, Inc.
Baring Brothers & Co.
E.I. du Pont de
Nemours & Co.
Eli Lilly and Company
Genentech, Inc.
Glaxo Group Research
Limited
Hoffmann-La Roche Inc
Home Infusion
Pharmaceutical Services
Merck Sharp & Dohme
Research Laboratories
Met Path Inc.
National Multiple Sclerosis
Society
NovoNordisk
Repligen Corporation
The William Stamps
Farish Fund
ZymoGenetics
" New Grants Awarded in 1991
Workshop on the Genome of E. coli (NLM)
Workshop on the Genome of E. coli (NCHGR)
Molecular Genetics and Cell
Biology of Marfan Syndrome
Meeting (NIAMSD)
Issues in Training Computational and
Mathematical Biologists: A Workshop
Workshop on the Genome of E. Co li
Human Genetics and Genome Analysis:
Practical Workshop for Public Policy
Makers and Opinion Leaders
Workshop on DNA Sequence Acquisition
and Interpretation
Journalists and Congressional
Workshops
Molecular Immunobiology of Lyme Disease
Intellectual Property and
Biotechnology
Baring Brothers Conference
Intellectual Property and
Biotechnology
Intellectual Property and
Biotechnology
Intellectual Property and
Biotechnology
Seven-transmembrane Segment
Proteins
Intellectual Property and
Technology
Molecular Immunobiology
of Lyme Disease
Seven-transmembrane Segment Proteins
Molecular Immunobiology
of Lyme Disease
Molecular Immunobiology
of Lyme Disease
Seven-transmembrane Segment Proteins
Control of HIV Gene Expression
Meetings on Complex
Genetic Diseases
Seven-transmembrane Segment
Proteins
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1991
1991
1991
1991
1991
3/91 -3/93
9/91 -9/92
1990 -1992
1991
1991
1991
1991
1991
1991
1991
1991
1991
1991
1991
1991
1991
1991
1991 -1993
1991
6,000 *
23,000 "
10,000 *
19,650 *
6,000*
128,059 *
6,000 *
150,000
10,000 *
5,000*
88,324 *
5,000 *
5,000 *
5,000 *
4,000 *
5,000*
5,000 *
3,000*
10,000 *
2,000 *
1,000*
5,000*
150,000
1,000*
DNA LEARNING CENTER
Grantor Program/Principal Investigator Duration of Grant Total Award
High School Faculty Enhancement
Middle School Faculty Enhancement
College Faculty Enhancement
1990 -1993
1990 -1993
1991-1993
474,036
252,614
264,467 *
FEDERAL GRANTS
NATIONAL SCIENCE FOUNDATION
DEPARTMENT OF EDUCATION
College Faculty Enhancement 1991 -1993 177,925 *
DEPARTMENT OF ENERGY
Opinion Leader Workshops 1991 -1993 128,059 *
(joint grant with Banbury Center)
NONFEDERAL GRANTS
Brinkmann Instruments, Inc. Special Programs 1991 2,000 *
CMP Foundation Special Programs 1991 1,000*
Corporate Advisory Board Special Programs 1991 14,500 *
CSHL Centennial Fund "Partners in the Future" 10/91 -6/92 27,000 *
Harweb Foundation Special Programs 1991 2,000 *
William Randolph Hearst Middle School Program 1991-1992 35,000 *
Foundation
Howard Hughes Medical Institute High School Faculty Enhancement 1990 -1993 46,500
Montgomery County, Maryland
The Esther A. and Joseph Core Support 1989 -1991 75,000
Klingenstein Fund, Inc.
Josiah Macy, Jr. Foundation Core Support 1990 -1991 98,905
Richard Lounsberry Foundation Core Support 1991 35,000 *
Natural Heritage Trust, Exhibit Support 1991 66,300 *
New York State
Stone Foundation Capital Support 1991 -1994 250,000 *
Nancy Van Vranken Core Support 1991 500
Edwin S. Webster Foundation Capital Support 1991 15,000 *
The Weezie Foundation Exhibit Support 1991-1992 100,000 *
John R. Young Special Programs 1991 5,000 *
Hillsborough County, Tampa, Vector Workshop 1991 2,410 *
Florida
Independent School Districts, Vector Workshop 1991 2,400 *
Houston
Mississippi School for Vector Workshop 1991 7,300 *
Math and Science
Northside Independent School Vector Workshop 1991 2,410*
District, San Antonio
Project Share, Killingworth, Vector Workshop 1991 1,900*
Connecticut
SUNY at Stony Brook Middle School Program 1991 10,000 *
Commack Union Free Curriculum Study 1991 500School District
East Williston Union Free
School District
Curriculum Study 1991 500
Garden City Union Free
School District
Curriculum Study 1991 1,500
Great Neck Public Schools
Half Hollow Hills Central
Curriculum Study
Curriculum Study
1991
1991
500
500
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School District
Grantor Program/Principal Investigator Duration of Grant Total Award
Harborfields Central School District Curriculum Study 1991 500
Herricks Union Free School District Curriculum Study 1991 500
Huntington Union Free School District Curriculum Study 1991 500
Island Trees Union Free School District Curriculum Study 1991 500
Jericho Union Free School District Curriculum Study 1991 500
Kings Park Central School District Curriculum Study 1991 1,500
Lawrence Union Free School District Curriculum Study 1991 500
Lindenhurst Union Free School District Curriculum Study 1991 500
Locust Valley Central School District Curriculum Study 1991 500
Manhasset Union Free School District Curriculum Study 1991 500
Massapequa Union Free School District Curriculum Study 1991 2,000 *
Northport-East Northport Curriculum Study 1991 500
Union Free School District
North Shore Central School District Curriculum Study 1991 500
Oyster Bay-East Norwich Central Curriculum Study 1991 500
School District
Plainview-Old Bethpage Central Curriculum Study 1991 500
School District
Plainedge Union Free Curriculum Study 1991 500
School District
Port ledge School Curriculum Study 1991 500
Port Washington Union Free Curriculum Study 1991 500
School District
Roslyn Public Schools Curriculum Study 1991 500
Sachem Central School District
at Holbrook
Curriculum Study 1991 500
South Huntington Union Free Curriculum Study 1991 500
School District
Syosset Central School District Curriculum Study 1991
500
* New Grants Awarded in 1991
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ANNUAL CONTRIBUTIONS
Long Island Biological Association (LIBA)
The Long Island Biological Association is the oldest supporting organization for
Cold Spring Harbor Laboratory. Over the years a most unique and productive
partnership has developed wherein LIBA has become our "Friends of the
Laboratory" and accounts for the largest amount of unrestricted annual giving for
the Laboratory. (The detailed report of their activities appears later in this Annual
Report.)
Summary of Annual Contributions
Unrestricted Annual Contributions
CSHL Associates (1/1/91-12/31/91)
LIBA Members (1/1/91-12/31/91)
General
Memorials
Restricted Annual Contributions
Miscellaneous
Total Annual Contributions
$265,245
75,728
5,722
8,055
2,500
$354,750
$ 2,500
$357,250
CORPORATE SPONSOR PROGRAM
Restricted
The response of the corporate world to invitations to renew or become new members of the
Cold Spring Harbor Laboratory Corporate Sponsor Program in 1991 can only be described as
extraordinary. In a period that experienced increasing economic recession and correspond-
ingly increasing financial constraints on companies, membership in the Program increased
from 28 to 32 in 1991! The companies that we are proud to acknowledge as friends of Cold
Spring Harbor Laboratory are listed below. It was particularly pleasing that we now have three
Japanese companies with us. In 1991, Sumitomo Pharmaceuticals Co., Ltd. and Toyobo Co.,
Ltd. joined Kyowa Hakko Kogyo Co., Ltd. in becoming members of the Program.
This level of funding enabled us to go ahead with confidence in putting together a truly
outstanding meetings program at the Laboratory and at the Banbury Center. Details of these
meetings are described elsewhere in this Annual Report. Corporate Sponsor attendance was
strong at all meetings, but especially at the 56th Cold Spring Harbor Laboratory Symposium
on Quantitative Biology on The Cell Cycle, the meeting on Genome Mapping and Sequenc-
ing, and the Cancer Cells meeting on Regulation of Eukaryotic mRNA Transcription. At the
Banbury Center, no fewer than 15 Corporate Sponsors came to the meeting on Adhesion
Molecules and Their Receptors, a record number!
It is, of course, the remarkable quality of the Laboratory's meetings programs that per-
suades so many of the world's leading biotechnology companies to join with us in promoting
biological research. In acknowledgment of our members' contributions, we waive all on-site
fees for eight representatives at our meetings. Three of these meetings may be at the Banbury
Center, where attendance is otherwise only by invitation of the organizers. Furthermore, Cor-
porate Sponsors receive gratis copies of all publications of the Cold Spring Harbor Laboratory
Press, including the internationally acclaimed Genes & Development journal and the new,
rapidly rising journal PCR. These benefits add up to a package that accounts for a substantial
part of the membership fee.
Quite apart from the direct benefits that our sponsors receive, they are also acknowledged
in all relevant publications, abstract books, and other materials published by Cold Spring Har-
bor Laboratory Press. In this way, the several thousand scientists coming here each year
learn which are the companies that look beyond their own immediate interests to promote re-
search throughout the world by their support of meetings at Cold Spring Harbor Laboratory.
Alafi Capital Company
American Cyanamid Company
AMGen Inc.
Applied Biosystems, Inc.
Becton Dickinson and Company
Boehringer Mannheim Corporation
Bristol-Myers Squibb Company
Ciba-Geigy Corporation/Ciba-
Geigy Limited
Diagnostic Products Corporation
The Du Pont Merck
Pharmaceutical Company
Eastman Kodak Company
Genentech, Inc.
Hoffmann-La Roche, Inc.
Johnson & Johnson
Kyowa Hakko Kogyo Co., Ltd.
Life Technologies, Inc
Eli Lilly and Company
Millipore Corporation
Monsanto Company
New England BioLabs, Inc.
Oncogene Science, Inc.
Pall Corporation
Jan A. Witkowski
Perkin-Elmer Cetus Instruments
Pfizer Inc.
Pharmacia Inc.
Sandoz Research Institute
Schering-Plough Corporation
SmithKline Beecham Pharmaceuticals
Sumitomo Pharmaceuticals Co., Ltd.
Toyobo Co., Ltd.
The Upjohn Company
The Wellcome Research Laboratories,
Burroughs Wellcome Co.
Wyeth-Ayerst Research
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SECOND CENTURY CAMPAIGN
January 1, 1986-December 31, 1991
Unrestricted Contributions
Anonymous
Anonymous
Anonymous
Mr. Amyas Ames
Mr. S. Reed Anthony
Mr. and Mrs. Benjamin H. Balkind
Mr. Edmund Bartlett
Mrs. Patricia Bell-Thomson
Mr. Rodney B. Berens
Mr. and Mrs. Nicholas Biddle, Jr.
Mrs. Dorothy Bird
The Cornelius N. Bliss Memorial Fund
Mr. and Mrs. Allen L. Boorstein
Dr. Jonathan Borkum
Mr. and Mrs. William Braden
Mrs. Leonie T. Brigham
Mr. G. Morgan Browne
Mr. and Mrs. Samuel Callaway
Mr. and Mrs. John Campbell
Mr. and Mrs. Ward Campbell
Mr. and Mrs. Peter Canna II
Mrs. Jean Cattier
Chemical Bank
Dr. Eleanor Chernick
Dr. Bayard Clarkson
Mr. and Mrs. John Cleary
Mrs. C. Payson Coleman
Mr. and Mrs. Miner D. Crary, Jr.
Mr. and Mrs. Arthur Crocker
Mr. Robert L. Cummings
Mr. and Mrs. Roderick H. Cushman
Mr. A. Neville Cutting
Mr. and Mrs. George W. Cutting, Jr.
Mr. Theodore N. Danforth
Mr. and Mrs. Norris Darrell, Jr.
Ms. Katya Davey
Mrs. Rosamond Arthur Dean
Mr. and Mrs. Raymond deClairville
Mr. Charles Delafield
Mrs. Jamie Tilghman Deming
Mr. and Mrs. Donald Deming
Mrs. Carolyn C. Dilworth
Mr. and Mrs. Joseph P. Downer
Dr. and Mrs. Lester Dubnick
Mr. and Mrs. James Eisenman
Mr. Martin Elias
Mr. William Everdell
Mr. and Mrs. Harold L. Fates
Mr. and Mrs. Jack B. Friedman
Mr. and Mrs. Jack N. Friedman
Dr. Barry Michael Gaines
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$4,976,620
Mr. and Mrs. Clarence Galston
Mr. and Mrs. Robert B. Gardner, Jr.
Dr. and Mrs. H. Bentley Glass
BF Goodrich Company
Mr. Maurice Green
Mr. and Mrs. Edward Greenberg
Mr. C. Groel, Jr.
Mr. and Mrs. Gordon S. Hargraves
Mr. and Mrs. Henry U. Harris, Jr.
Mr. and Mrs. Sinclair Hatch
Dr. and Mrs. Alfred D. Hershey
Mrs. Julie Hunnewell
Mr. and Mrs. Robert Dean Jay
Mr. and Mrs. Morris I. Karpen
Mr. and Mrs. Albert Key
Dr. and Mrs. Alan M. Kisner
Mr. and Mrs. Townsend J. Knight
Dr. Barbara B. Knowles
Mr. and Mrs. Abraham Krasnoff
Mr. and Mrs. Mort Kunst ler
Mr. and Mrs. Edward M. Lamont
Mrs. John H. Leib
Mr. and Mrs. George N. Lindsay, Jr.
Mr. Angus C. Littlejohn
Mr. and Mrs. John Livingston
Mr. and Mrs. David L. Luke III
Ms. Martha Makanna
Lucille P. Markey Charitable Trust
Marks Family Foundation
Mr. and Mrs. Robert R. Maxfield
Mr. and Mrs. Edward McCann II
Mr. and Mrs. Warren J. McEntee
Miss Diana Mcllvaine
Mr. and Mrs. Robert M. McLane
Mr. and Mrs. Robert G. Merrill
Mr. and Mrs. Clarence Michalis
Mr. William H. Miller
Mr. and Mrs. William R. Miller
Mr. O.B. Miller
Milliken Foundation
Leo Model Foundation
Mr. and Mrs. Grinnell Morris
Dr. and Mrs. Larry Nathanson
Mr. and Mrs. Adams H. Nickerson
Mr. and Mrs. Charles Noyes
Mr. and Mrs. George O'Neill
Mr. and Mrs. William H. Osborn, Jr.
Dr. and Mrs. David B. Pall
Mr. Edward L. Palmer
Mr. William Parsons, Sr.
Mr. Sterling Pile, Jr.
Mrs. Francis T.P. Plimpton
Mr. and Mrs. Martin Pollak
Mr. and Mrs. F. Thomas Powers
Mrs. H. Irving Pratt
Mr. and Mrs. Richardson Pratt, Jr.
William and Maude Pritchard Charitable
Trust
Mr. Edward Pulling
Mr. and Mrs. Thomas Pulling
Mr. James T. Pyle
Mrs. Eleanor Raynolds
Mrs. Curtis S. Read
Mr. and Mrs. John R. Reese
Mr. Jon Rehnberg
Dr. Frederic Richards
Mr. Arthur M. Rogers, Jr.
Mrs. Quentin Roosevelt
Mr. and Mrs. J. Wright Rumbough
Mr. and Mrs. David Salten
Mr. and Mrs. Harvey E. Sampson
Mrs. Josephine Schiff
The Schiff Foundation
Dr. Carl J. Schmidlapp II
Mrs. Franz Schneider
Mr. and Mrs. Frederick E. Seymour
Mrs. Edward M. Shepard
Mr. Richard Slade
Mr. and Mrs. H. Turner Slocum
Mr. and Mrs. Peter Solbert
Dr. George F. Sprague, Jr.
Seth Sprague Educational and Charitable
Trust
The Stebbins Fund
Mr. Byam K. Stevens, Jr.
Drs. Carol and Sidney Strickland
Mr. and Mrs. David S. Taylor
Mr. and Mrs. Seth A. Thayer
Mrs. Robert Tilney, Jr.
Mr. and Mrs. George Toumanoff
Dr. and Mrs. Robert N. Van Son
Mr. and Mrs. Philip R. von Stade
Mr. and Mrs. Colton Wagner
Mrs. Bayard Walker
Dr. Jonathan Warner
Dr. and Mrs. James D. Watson
Mr. and Mrs. Bradford G. Weekes III
John L. Weinberg Foundation
Mr. and Mrs. Taggart Whipple
Mr. and Mrs. A. Morris Williams
Mrs. Henry A. Wilmerding
Mrs. John C. Wilmerding
Mr. and Mrs. Robert Winthrop
Mr. and Mrs. Sigi Ziering
Restricted Contributions $39,450,474
Endowment
Anonymous Professorship in Molecular Neuroscience
Anonymous Senior Staff Fellowship for Cancer Research
Doubleday Professorship for Advance Cancer Research
Russell and Janet Doubleday Fund
Garfield Undergraduate Internship
George Garfield
Oliver and Lorraine Grace Director's Chair
Libby Undergraduate Internship
Holly Brooks
Margaret S. Pomeroy Cancer Research Chair
Charles Robertson Neuroscience Chair
Frederica von Stade Undergraduate Internship
Posy White Fund
Elinor White Montgomery
Mrs. Edward H. Auchincloss
Mrs. Jean Cattier
Mr. and Mrs. David C. Clark
Mr. and Mrs. Paul Sheeline
Mrs. Alexandra White Smith
Mrs. George G. Walker
Program
Howard Hughes Medical Institute
Facilities Development
Cancer Biology
Michel David-Weill Foundation
Lita Annenberg Hazen
$5,764,470
$2,000,000
$31,686,004
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Structural Biology
Oliver and Lorraine Grace
Lucille P. Markey Charitable Trust
Page Laboratory of Plant Genetics
Anonymous
Charles E Culpeper Foundation
Ira W. DeCamp Foundation
Long Island Biological Association
Morgan Guaranty Trust Company of New York
National Institute of Health
National Science Foundation
North Country Garden Club
Dr. and Mrs. David B. Pall
Pioneer Hi-Bred International
William and Maude Pritchard Charitable Trust
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Guest Facilities
Cabins
Alumni Cabin Contributors
Dr. Herbert Boyer
The Hyde-Watson Foundation
Dr. Thomas Maniatis
New England Biological Laboratories
Dr. Mark Ptashne
Visiting Scientist Guest House
Russell and Janet Doubleday Fund
DNA Learning Center
Banbury Fund #1
Banbury Fund #2
The Brinkmann Foundation
Mr. and Mrs. Henry U. Harris, Jr.
New York State
Stone Foundation, Inc.
Weezie Foundation
Total Second Century Campaign
Contributions $44,415,094
Net Interest Earned 12/31/91
Final Total
$1,538,100
$45,953,194
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SECOND CENTURY CAMPAIGN COMMITTEES
David L. Luke Ill, Chairman
Steering Committee
Oliver R. Grace, Co-chairman*
George W. Cutting, Jr., Co-chairman
Mrs. Sinclair Hatch, Co-chairman
Townsend J. Knight, Co-chairman
Taggart Whipple, Co-chairman
Leadership Gifts Committee
Oliver R. Grace, Chairman*
G. Morgan Browne
Bayard D. Clarkson, M.D.
David L. Luke Ill
James D. Watson, Ph.D.
Taggart Whipple
Major Gifts Committee
Mrs. Sinclair Hatch, Chairman
Amyas Ames
Mrs. Harry A. Brooks
Robert L. Cummings
William Everdell
Mrs. Henry U. Harris, Jr.
Abraham Krasnoff
Laurie Landeau, V.M.D.
Dr. Cynthia MacKay
Mrs. George G. Montgomery, Jr.*
H. Turner Slocum
Colton Wagner
Special Gifts Committee
George W. Cutting, Jr., Co-chairman
William H. Miller, Co-chairman
Mrs. Philip R. von Stade, Co-chairman
Mrs. Edward Greenberg, Co-chairman
Edmund Bartlett
David C. Clark
*deceased 1992
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H. Gray Co 'grove*
Arthur M. Crocker
Lawrence L. Davis
Mrs. Donald L. Deming
Joseph P. Downer
Charles J. Hubbard
Gordon Lamb
Edward Pulling*
John R. Reese
J. Wright Rumbough, Jr.
Mrs. James F. Stebbins
Corporate Committee
David L. Luke III, Chairman
G. Morgan Browne
Peter B. Cannell
Robert E. Cawthorn
William R. Miller
David B. Pall, Ph.D.
Douglas E. Rogers
James D. Watson, Ph.D.
Henry Wendt
Sigi Ziering, Ph.D.
Foundation Gifts Committee
Taggart Whipple, Chairman
Mrs. C. Payson Coleman
Robert Ebert,
James W. Fordyce
John Klingenstein
Clarence F. Michalis
William E. Murray
Planned Gifts Committee
Townsend J. Knight, Chairman
Maureen Augusciak
John Cleary
William J. Kramer
William Parsons, Sr
Colton Wagner
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Officers
George W. Cutting, President
Mrs. Henry U. Harris, Jr., Vice-President
Mrs. E. Maxwell Geddes, Secretary
Byam K. Stevens, Jr., Treasurer
G. Morgan Browne, Asst. Secretary/Treasurer
Directors
Mrs. Allen L. Boorstein
Mrs. Harry A. Brooks
John P. Cleary
George W. Cutting
Mrs. Donald L. Deming
Joseph P. Downer
John R. Drexel IV
Mrs. Duncan Elder
Mrs. E. Maxwell Geddes, Jr.
Mrs. Edward Greenberg
Mrs. Henry U. Harris, Jr.
Mrs. Sinclair Hatch
Alan M. Kisner, M.D.
Gordon E. Lamb
Mrs. James L. Large
Edward F. McCann II
Mrs. Waltei C. Meier
Mrs. Vincent Nesi
Douglas E. Rogers
Phillip M. Satow
Mrs. Peter G. Schiff
James L. Spingarn
Byam K. Stevens, Jr.
Mrs. Philip R. von Stade
James D. Watson, Ph.D.
CHAIRMAN'S REPORT
With the "number crunching" in Washington in recent years, it seemed a particu-
larly appropriate time to redefine the mission of the Long Island Biological
Association (LIBA) today and make whatever changes would best serve the inter-
est of the Cold Spring Harbor Laboratory in the future. In February 1991, the
Board of Directors determined that it should gather for an extensive study of LIBA
and its relationship to the Laboratory. Jane Pierson of Cavanaugh, Hagan, and
Pierson in Washington, D.C. was engaged as "Facilitator," and the Arden
Homestead was reserved for the second weekend in November. The process of
preparing ourselves was in itself an interesting effort, and this effort produced a
"mission statement" for LIBA today:
raising unrestricted annual support for research and education at the
Laboratory
informing the public about the science and education programs of the
Laboratory and their importance to us all
assisting the scientific staff with personal and family needs.
The "retreat" itself was attended by 19 of the 27 Directors. Most importantly, the
mission was affirmed, and the Directors resolved to implement this mission
through a more organized effort using the expertise and interests of its members
and their contacts in ever broadening areas.
As this report goes to press, the membership of LIBA will be asked to ap-
prove some changes in the By-Laws of the corporation and a change of its name
to Cold Spring Harbor Laboratory Association. Although we have become very
accustomed to "LIBA" over the years, it seemed to the Directors that in today's
world, particularly with our attempts to draw support from more distant areas, the
confusion of LIBA's identity and its relationship to the Laboratory had become
more and more apparent.
The role that the Cold Spring Harbor Laboratory plays in the search for an-
swers to many afflictions through basic research will require an ever-increasing
level of unrestricted support from individuals. Therefore, all effort has been taken
to make the association of supporters as effective as possible.
As for 1991 operations, I am pleased to report that in LIBA's fiscal year, which
ended September 30, 1991, significant progress was made in all three areas.
Contributions and membership have reached new all time highs. These results
come from a number of fund-raising activities involving many members of the
Laboratory staff and volunteers.
ANNUAL GIVING
Year ended September 30,
Contribution
Associates (Donors of $1,000 or more)
Total number of contributors
LIBA endowment funds
1991
$384,571
156
829
$115,686
1990
$284,214
139
671
$87,216
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Included within the Annual Giving totals are Memorial Contributions which
were given in memory of:
Agnes Alesi Nick Giammalvo Helen Morris
Carmela Barbagallo Arthur Greenberg Eva Nagy
Caroline Bomeisler Herbert Hallaran James L. O'Conner
Mamie Botwick Maxine Harrison Daniel Olian
Leonie Brigham Philip K. Hills Jimmy Parsons
Rudy Caputo, Sr. Frank Hohner Edward Pulling
Margaret Carroll Thomas Holland Madeline Ridder
Merrill Christiansen Robert Humphrey Salvatore Santoro
Garner Cline James M. Kay Anthony Snow
Beverly Davis Robert Kalka Joseph Squillaro
William M. Duryea Lilly Kurfess Elizabeth Schneider
Harry Dwoskin Louis Maniscalco Clara Wisnewski
Mimi Matthaei
Group and individual tours of the facilities increased as well as the total at-
tendance at LIBA lectures, and new efforts have been taken to assist the families
of our scientists with some particular success in finding affordable housing in the
area. All this has been made possible through the efforts of the Laboratory's
small, but most effective, development staff, LIBA Directors, and the special ef-
forts of many members.
Winter '91
The Annual LIBA Meeting was held on Sunday, January 13th in the Grace
Auditorium with more than 250 LIBA members, guests, and members of North
Country Garden Club in attendance. After a call to order, retiring Directors
Eleanor Campbell, Jack Evans, John Reese, and Susie Trotman were thanked for
Members of the Long Island Biological Association (LIBA)
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their loyal service. In addition, Taggart Whipple was named Ambassador of the
Year for his continuing efforts to bring the Laboratory's importance and its needs
to the attention of the surrounding community and to his friends and associates
nationwide. Larry Davis, Chairman of the Nominating Committee, which included
Eleanor Campbell, John Cleary, and Phyllis Weekes, presented a slate of new
Directors. Holly Brooks, Nick Drexel, Laurie Nesi, and Jim Spingarn were ap-
proved by acclamation.
Judith Chapman, Chairperson of the North Country Garden Club, and her
committee arranged for Richard W. Underwood to address us. Mr. Underwood is
a pioneer in space photography, worked for NASA for 30 years, and authored
numerous technical papers in photogrammetry and aerospace technology. He
presented an interesting talk on "The World's Environment: The View from Space."
Startling were the pictures of pollution in our harbors and rivers and the un-
controlled advance of the Sahara Desert.
Spring '91
Through the invitation of Dr. Alan Kisner, a LIBA Director, a "Saturday Afternoon
at the Lab" was arranged for doctors at Huntington Hospital and their families.
More than 50 accepted and were given tours through the facilities including dis-
cussions with several scientists. The afternoon ended with the guests attending
an Associate lecture by Drs. Nouria Hernandez and Winship Herr on their AIDS
research. Nouria and Winship and many other scientists provide LIBA with a
most valuable link in supporting our effort to explain scientific research to the
community in terms the public understands. This is an important part of LIBA's
mission, and we sincerely thank them all for giving us their most valuable time.
As the Laboratory's Banbury Center had arranged a special conference on
Lyme disease, the LIBA Board of Directors felt that it would be a service to the
community to present a panel discussion on the disease for the public. Some of
the world's leading authorities on Lyme disease presented the latest information
on research, diagnosis, and treatment. The announcement was sent to LIBA
membership, as well as to Long Island newspapers and veterinary clinics. The
attendees included many residents who are suffering from Lyme disease and
who had never visited the Laboratory. As a number of new contributors joined the
LIBA rolls, this event served as another Laboratory outreach.
On April 28, James L. Spingarn and his wife Jane gave a cocktail reception
for 35 of their friends at the Laboratory following a tour of the campus. This intro-
duction has resulted in numerous new members and Associates.
In the past several years, the Dorcas Cummings Memorial Lecture has been
given during the Cold Spring Harbor Laboratory Symposium on Quantitative
Biol-
ogy. The topic in 1991 was "The Cell Cycle," and LIBA invited Dr. Michael Bishop,
a 1989 Nobel laureate, to address its membership. Following in the footsteps of
Dr. Francis Crick the year before, Dr. Bishop's talk titled "Misguided
cells: The
Genesis of Human Cancer," which was augmented by excellent slides and
films,
was delivered with great humor. The more than 500 LIBA members,
guests, and
visiting scientists received a "primer" on how cells divide and how cancers
are
formed when control of cell division is lost. Dr. Bishop was one
of the earliest
scientists to recognize the impact of oncogenes.
Following the talk, the traditional
"Symposium dinner parties" were given for the visiting
scientists and many mem-
bers of the Laboratory's staff. This year's hosts and
hostesses were
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Mr. and Mrs. Harry A. Brooks
Mr. and Mrs. Morgan Browne
Mr. and Mrs. John P. Cleary
Mr. and Mrs. W. Tucker Dean
Mr. and Mrs. James J. Eisenman
Mr. and Mrs. Henry U. Harris
Mrs. Sinclair Hatch
Mr. and Mrs. David L. Luke III
Mr. and Mrs. Vincent R. Nesi
Mr. and Mrs. David B. Pall
Mrs. Francis T.P. Plimpton
Mr. and Mrs. Thomas A. Saunders Ill
Mr. and Mrs. James F. Stebbins
Mr. and Mrs. Byam K. Stevens, Jr.
Mr. and Mrs. John C. Stevenson
Mr. and Mrs. Martin B. Travis, Jr.
Mr. and Mrs. Robert P. Walton
Mr. and Mrs. Taggart Whipple
Summer '91
On June 16, Dr. and Mrs. Watson gave a dinner party for Dr. John Cairns and his
wife Elfie, who were returning to their native England after many years in this
country. Dr. Cairns was Director of the Laboratory from 1960 to 1968 and a dis-
tinguished researcher in Cambridge, Massachusetts since that time. Attending
this wonderful event were the present LIBA Directors as well as many former
Directors who had close personal ties with the Cairns family over the years.
Fa II '91
Through the great generosity of Mrs. Eric Ridder, who loaned 32 of her miniature
rooms for display in the Plimpton Seminar Room on September 21, a benefit
reception for the Laboratory was held giving the attendees an opportunity to view
the exquisite creations which varied from colonial to the most elaborate rococo.
Many of the rooms included whimsical animals which added to their charm. The
success of this event was ensured by the tireless effort of Mrs. Sinclair Hatch and
her committee.
The following day, the 5th annual Associates cocktail reception was held to
give the Cold Spring Harbor Laboratory Associates (contributors of $1000 or
more) a chance to see Mrs. Ridder's wonderful works of art. The Associates,
whose number now stands at 156, provide the Laboratory with the cornerstone in
its Annual Giving campaign. It is with great sadness that we note the sudden
death of Mrs. Ridder on November 2, 1991, so soon after her wonderful show.
Probably the most important contribution that LIBA has made to date in its
mission to inform the community about elements of biology was a lecture on
"Genetics of Breast Cancer" given by Dr. Mary-Claire King and Dr. Marc Lippman
on November 11th. They were attending a conference at the Banbury Center and
agreed to talk to our membership about some of the recent discoveries. As Dr.
King is an epidemiologist and Dr. Lippman a surgeon, the exchanges between
them and the audience were most informative. We hope to be able to present a
similar program again in early fall 1992.
These specific LIBA events were augmented throughout the year by the spe-
cial efforts of LIBA Directors and other members who introduced some of our
scientists to new funding sources, and new members of the community to the
Laboratory.
It is only through the combined energetic response from so many LIBA mem-
bers that the results shown in this report were achieved. Clearly, this partnership
has made the Cold Spring Harbor Laboratory a unique, independent, researchinstitution.
George W. Cutting, Jr., Chairman
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COLD SPRING HARBOR LABORATORY ASSOCIATES*
Anonymous
Mr. Warren S. Adams II, Esq.
Mr. Amyas Ames
Mr. & Mrs. David L. Banker
Mr. & Mrs. Vincent C. Banker
Mrs. William N. Bannard
Mr. & Mrs. Sherburn M. Becker
Mr. & Mrs. Rodney B. Berens
Ms. Jane S. Block
Mr. & Mrs. Allen L. Boorstein
Dr. David Botstein & Dr. Renee Fitts
Mrs. William T. Brigham
Mr. & Mrs. Lester E. Brion, Jr.
Mrs. Harry Brooks
Drs. John & Elaine Broome
Mr. & Mrs. G. Morgan Browne
Ms. Mary Griggs Burke
Mr. & Mrs. John P. Campbell
Mr. & Mrs. Peter B. Cannell
Mr. & Mrs. Vincent Carosella
Centerbrook Architects
Mr. John T. Chandler
Mr. & Mrs. Thomas H. Choate
Mr. & Mrs. David C. Clark
Dr. & Mrs. Bayard D. Clarkson
Mrs. Robert L. Clarkson, Jr.
Mr. James W. Cleary
Mr. & Mrs. John P. Cleary
Mrs. C. Payson Coleman
Mrs. John K. Colgate, Sr.
Mrs. Nathalie P. Comfort
Craigmyle Foundation
Mr. & Mrs. Arthur M. Crocker
Mr. & Mrs. Robert L. Cummings
Mr. & Mrs. Richard T. Cunniff
Mr. & Mrs. Roderick H. Cushman
Dr. & Mrs. Paul Cushman, Jr.
Ms. Lucy Cutting
Mr. & Mrs. George W. Cutting, Jr.
Mr. & Mrs. Theodore N. Danforth
Mr. & Mrs. Norris Darrell, Jr.
Mrs. John L. Davenport
Ms. Deborah Davidson
Mr. & Mrs. Donald L. Deming
Mr. & Mrs. Daniel C. De Roulet
Mr. & Mrs. Charles F. Dolan
Mr. & Mrs. Joseph P. Downer
Mr. & Mrs. John R. Drexel IV
Dr. & Mrs. Lester Dubnick
Mr. & Mrs. William T. Dunn, Jr.
Mr. & Mrs. James A. Eisenman
Mr. & Mrs. Duncan Elder
*Contributors of $1,000 or more
Mr. & Mrs. William Everdell
Ewing Foundation
Mr. & Mrs. Stephen C. Eyre
Dr. Orrie Friedman
Dr. Barry Michael Gaines
Mr. & Mrs. Clarence E. Galston
Mr. Robert B. Gardner, Jr.
Mr. & Mrs. Charles S. Gay
Mr. & Mrs. E. Maxwell Geddes, Jr.
Mr. & Mrs. Joseph Gerrity
Mr. & Mrs
Mr. & Mrs
Mr. & Mrs
Mr. & Mrs
Mr. & Mrs
Mr. & Mrs
Dr. & Mrs
Morris W. Get ler
Thomas S.T. Gimbel
Lionel M. Goldberg
Oliver R. Grace
Oliver R. Grace, Jr.
Edward Greenberg
Peter M. Guida
Mr. & Mrs. John W.B. Hadley
Rev. Linda Peyton Hancock
Mr. & Mrs. Gordon S. Hargraves
Miss Maxine Harrison
Mr. & Mrs. Henry U. Harris, Jr.
Mrs. Sinclair Hatch
Mrs. Horace Havemeyer, Jr.
Mrs. Lita Annenberg Hazen
Mrs. Thomas L. Higginson
Mr. & Mrs. Waldo Hutchins III
Mr. & Mrs. John C. Jansing
Mrs. Gilbert W. Kahn
Mr. & Mrs. Francis S. Kinney
Dr. & Mrs. Alan M. Kisner
Mr. & Mrs. John Klingenstein
Mr. & Mrs. Townsend J. Knight
Mr. Winthrop Knowlton
Mr. & Mrs. Gordon E. Lamb
Dr. Laurie J. Landeau
Mr. & Mrs. James Large
Mr. & Mrs. Henry C. Lee
Dr. Robert V. Lewis
Mr. & Mrs. George N. Lindsay
Mr. & Mrs. Robert V. Lindsay
Mrs. V. S. Littauer
Mr. & Mrs. John H. Livingston
Mr. & Mrs. David L. Luke III
Ms. Martha Makanna
Mr. Thomas Maniatis
Marks Family Foundation
Mr. & Mrs. William L. Matheson
Mr. & Mrs. Robert R. Maxfield
Mr. & Mrs. Gerald M. Mayer, Jr.
Miss Diana Mcllvaine
Dr. & Mrs. Walter C. Meier
Mr. Arthur C. Merrill
Mr. & Mrs. Robert G. Merrill
Mr. & Mrs. Clarence F. Michalis
Mr. & Mrs. William R. Miller
Dr. Peter Model
Mr. & Mrs. George G. Montgomery, Jr.
Mr. & Mrs. F. Warren Moore
Mr. & Mrs. Grinnell Morris
Mr. & Mrs. Charles E. Murcott
Mr. & Mrs. Stephen V. Murphy
Mr. & Mrs. William J. Nammack
Dr. & Mrs. Larry Nathanson
Mr. Albert C. Nolte
Nordemann Foundation
Norwood Foundation
Mr. & Mrs. Charles P. Noyes
Mr. & Mrs. Bernard Nussdorf
Mr. & Mrs. George D. O'Neill
Mr. & Mrs. Walter H. Page
Mr. & Mrs. Arthur W. Page, Jr.
Dr. & Mrs. David B. Pall
Mrs. Marcel A. Palmaro
Mr. William Parsons, Jr.
Mr. Nicholas B. Paumgarten
Mr. & Mrs. Howard Phipps, Jr.
Mrs. Francis T.P. Plimpton
Mr. & Mrs. Martin Pollak
Mr. & Mrs. A. Jay Powers
Mr. & Mrs. F. Thomas Powers, Jr.
Mrs. H. Irving Pratt
Mrs. Sherman Pratt
Mr. & Mrs. Richardson Pratt, Jr.
Mr. Edward Pulling
Mrs. Seena H. Purdy
Mrs. Curtis S. Read
Miss Augusta Reese
Mr. & Mrs. John R. Reese
Miss Victoria Reese
Mrs. Willis L.M. Reese
Mr. & Mrs. Seymour Reich
Mr. & Mrs. Eric Ridder
Mr. & Mrs. William S. Robertson
Mr. & Mrs. Douglas E. Rogers
Mr. & Mrs. Walter N. Rothschild, Jr.
Mr. Robert Sabin
Mr. & Mrs. Thomas A. Saunders III
Mrs. John M. Schiff
Mr. & Mrs. Peter G. Schiff
Mr. & Mrs. Alan Seligson
Mr. & Mrs. Enrique F. Senior
Mr. & Mrs. Tony Shogren
Mr. & Mrs. Owen T. Smith
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Mr. & Mrs. Peter Solbert
Mrs. H. G. Spencer
Mr. & Mrs. James L. Spingarn
Mr. & Mrs. James F. Stebbins
Mr. & Mrs. Henry R. Stern, Jr.
Mr. & Mrs. Byam K. Stevens, Jr.
Contributors of $1,000 or more
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Mr. & Mrs. Robert L. Strong
Mr. & Mrs. Richard M. Sykes
Mr. & Mrs. Seth A. Thayer
Mr. & Mrs. Stanley S. Trotman
Mrs. Ernest T. Turner
Mrs. Martin Victor
Mr. & Mrs. Philip R. von Stade
Mrs. Margo G. Walker
Dr. & Mrs. James D. Watson
Mr. Theodore Weiler
Mr. & Mrs. Taggart Whipple
Mr. Robert Winthrop
MEMBERS**
Mr. & Mrs. Bertram D. Aaron
Dr. & Mrs. Bruce M. Alberts
Mr. & Mrs. Lee C. Alexander
Dr. & Mrs. Ralph F. Alfenito
Mr. & Mrs. Spencer Alpert
Dr. & Mrs. Reese F. Alsop
Mr. & Mrs. Prescott Ammarell
Mrs. Hoyt Ammidon
Dr. & Mrs. Carl W. Anderson
Dr. Harold Anderson
Mr. Ronald C. Anderson
Dr. & Mrs. Vincent Ansanelli, Jr.
Mr. & Mrs. Silas Reed Anthony
Mr. & Mrs. Robert W. Anthony
Mr. & Mrs. J.S. Armentrout, Jr.
Aron Charitable Foundation
Mrs. Jules Aubry
Dr. & Mrs. Alfred A. Azzoni
Mr. & Mrs. Henry D. Babcock, Jr.
Mrs. Harriet W. Bailey
Ms. Antoinette L. Baker
Ms. Susan A. Baker-Carr
Mr. & Mrs. Jens Bakke
Ms. Eileen M. Baldwin
Mr. & Mrs. Benjamin H. Balkind
Mr. & Mrs. Daniel P. Barbiero
Mr. & Mrs. George Barclay
Dr. & Mrs. Henry H. Bard
Mrs. Dudley R. Barr
Mr. & Mrs. Stephen A. Barre
Mr. & Mrs. Edmund Bartlett
Dr. William R. Basta
Dr. & Mrs. Neil J. Battinelli
Mr. & Mrs. Frederick Baum
Ms. Joan Baxter
Mr. & Mrs. Pierre Beauchamp
Mr. & Mrs. Sherburn M. Becker
Mr. & Mrs. Spencer B. Beebe
Mr. & Mrs. James Bell
Mrs. Patricia Bell-Thomson
Mr. Edward R. Benkert
Mr. & Mrs. Robert E. Benson
Mr. & Mrs. Adelrick Benziger, Jr.
Mr. & Mrs. Anthony Berejka
Mrs. Conrad Berens
Dr. Barbara Bergman
Dr. & Mrs. Arthur Bernhang
Mrs. Rynn Berry
Mrs. Joyce A. Bertoldo
Mrs. Maureen G. Beuerlein
Mr. & Mrs. Nicholas Biddle, Jr.
Mrs. William Binnian
Mrs. Dorothy E. Bird
Ms. Mary Lenore Blair
Mr. & Mrs. J. Richard Bliss
**Contributors of $25.00-999.00
Mr. Peter H. Blohm
Mr. & Mrs. Bruce R. Blovsky
Mr. & Mrs. Andrew M. Blum
Ms. Margery Blumenthal
Mr. & Mrs. John Bogut
Mr. Geoffrey T. Boisi
Mr. & Mrs. Elito J. Bongarzone
Dr. Jonathan M. Borkum
Mr. & Mrs. Murray Borson
Dr. Patricia Bossert
Mr. & Mrs. James C. Bostwick
Mr. & Mrs. William Braden
Mr. Thomas A. Bradley, Jr.
Ms. Joan B. Brady
Dr. & Mrs. Arik Brissenden
Mrs. Audrey S. Brokaw
Mr. Harry A. Brooks
Ms. Melissa Brooks
Ms. Miranda Brooks
Mr. & Mrs. F. Sedgwick Browne
Ms. Caroline C. Brune
Mr. & Mrs. Julian G. Buckley
Mr. & Mrs. Horst E. Buelte
Mr. & Mrs. Robert M. Bunnell
Mr. C. P. Burke
Ms. Mary Griggs Burke
Mr. Earl P.
Mr. & Mrs.
Mr. & Mrs.
Mr. & Mrs.
Mr. & Mrs.
Mr. & Mrs.
Mr. & Mrs.
Burke, Jr.
John W. Busby
Thomas J. Calabrese
Samuel R. Callaway
Michael Cammarota
David A. Campbell
Ward C. Campbell
Ms. Lisa Casentini
Ms. Sophia Casey
Ms. Mary Caslin
Mrs. Napoleon Cerminara
Mr. & Mrs. Lionel Chaikin
Mr. & Mrs. Larry L. Chamberlin
Mr. & Mrs. Alvah H. Chapman, Jr.
Mr. & Mrs. Gilbert W. Chapman, Jr.
Mr. & Mrs. Harry G. Charlston
Dr. Eleanor Chernick
Mr. & Mrs. Anwar Chitayat
Mrs. Thomas H. Choate
Mrs. Ann G. Christ
Mr. & Mrs. Donald C. Christ
Mr. Lawrence M. Clum
Mr. & Mrs. Gary H. Coelho
Mr. & Mrs. Francis X. Coleman
Mr. & Mrs. John H. Coleman
Mr. & Mrs. Emilio G. Collado
Mr. Bradley Collins
Mr. & Mrs. Patrick Collins
Mr. & Mrs. Kingsley Colton
Mrs. Ralph C. Colyer
Mr. Glenn A. Connolly
Dr. & Mrs. Joseph B. Conolly, Jr.
Mr. & Mrs. Robert Cooper
Ms. Patricia Grace Corey
Mrs. Howard Corning, Jr.
Ms. Elizabeth Correa
Rev. Mario Costa
Mr. & Mrs. Charles Craig
Mr. & Mrs. Miner D. Crary, Jr.
Mr. & Mrs. Peter 0. Crisp
Mr. & Mrs. Robert Cuddeback
Mr. & Mrs. Robert L. Cummings Ill
Mr. & Mrs. Curtis Cushman
Mr. & Mrs. A. Neville Cutting
Ms. Eileen M. Dana
Mrs. Howard H. Dana
Mrs. Katya Davey
Mr. & Mrs. Murat H. Davidson, Jr.
Mr. Lawrence L. Davis
Mr. & Mrs. W. Tucker Dean
Mr. & Mrs. Robert B. Deans, Jr.
Mr. Donald Death
Mr. & Mrs. Donald C. Death, Jr.
Mr. & Mrs. Raymond deClairville
Mr. & Mrs. Louis D. DeLalio
Dr. David T. Denhardt
Mr. & Mrs. William R. Dens low, Jr.
Dr. & Mrs. R. J. Desnick
Mrs. Douglas C. Despard, Jr.
Ms. Suzanne V. Dillenbeck
Ms. Carolyn C. Dilworth
Mrs. Cynthia W. Doersam
Mr. & Mrs. Richard Donsky
Ms. Audrey Dorn
Mr. & Mrs. Nelson Doubleday
Mrs. Eugene DuBois
Mr. & Mrs. Charles Dubroff
Mr. & Mrs. Leonard K. DuBrul
Dr. & Mrs. John L. Duffy
Mr. & Mrs. Edgar P. Dunlaevy
Mr. Don Durgin
Mr. John H. Dyett
Ms. Jean P. Eakins
Dr. & Mrs. Gerard L Eastman
Dr. & Mrs. James D Ebert
Mrs. Fred J. Eissler
Mr. Martin Elias
Mr. & Mrs. Stephen Ely
Ms. Monica Enke
Dr. Henry F. Epstein
Mr. & Mrs. N. Dennis Eryou
Mrs. James M. Estabrook
Mrs. Raymond Z. Fahs
Mr. & Mrs. Joel M. Fairman
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Mr. & Mrs. Harold L. Fates
Mr. & Mrs. Robert J. Feeney
Mr. John R. Fell
Mr. & Mrs. James C. Ferrer
Mr. & Mrs. Peter L. Fetterolf
Mr. & Mrs. Noah Finkel
Mrs. Joanne Fitzgerald
Mr. Michael L. Fitzgerald
Mr. & Mrs. Dugald A. Fletcher
Mrs. Joan E. Flint
Ms. Rosemary Ann Foehl
Mr. & Mrs. Henry L. Fox
Mrs. Felice H. Francis
Mrs. Ann Kerr Franklin
Mr. & Mrs. Seth B. French, Jr.
Mr. & Mrs. J. Jordan Frey, Jr.
Dr. Susan Friedlander
Mr. & Mrs. Jack N. Friedman
Mr. & Mrs. Jack B. Friedman
Mr. & Mrs. Guy Fritts
Dr. C. R. Fuerst
Mr. Stephen D. Fuller
Mr. Charles R. Gabalis
Mr. & Mrs. D. Kent Gale
Mr. & Mrs. John W. Galston
Mrs. John F. Garde
Mr. & Mrs. Murray B. Gardner
Mrs. James E. Gardner, Jr.
Mr. Robert L. Garland
Mr. & Mrs. John A. Garver
Mr. & Mrs. John W. Gates
Mr. & Mrs. Robert A. Gay
Mr. & Mrs. William C. Gay, Jr.
Mr. & Mrs. Eugene M. Geddes
Mr. & Mrs. Martin Gellert
Ms. Lucille G. Gemson
Mrs. Edward H. Gerry
Mr. & Mrs. Roger G. Gerry
Dr. & Mrs. Stephen A. Gettinger
Mrs. Vera C. Gibbons
Mr. Harry Giffords
Mr. & Mrs. Stephen E. Gilhuley
Mr. Robert Gilmor
Dr. Gail Girovard
Dr. & Mrs. H. Bentley Glass
Mrs. J. Wooderson Glenn
Mr. & Mrs. Bernard J. Gloisten
Mr. & Mrs. Edward R. Godfrey, Jr.
Goelz Chemists
Dr. & Mrs. Lewis Goldfinger
Mrs. Barbara L. Goldstein
Mr. & Mrs. Thomas Golon
Mr. & Mrs. Elliot Goodwin
Mr. & Mrs. Kilbourn Gordon, Jr.
Ms. Patricia L. Gould
Mr. & Mrs. Henry W. Grabowski
Mr. & Mrs. William R. Grant
Mr. & Mrs. Austen T. Gray
Mr. & Mrs. Craig P. Greason
Mr. Edward R. Greeff
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Mr. & Mrs. Alfred T. Gregory
Dr. & Mrs. Raymond B. Griffiths
Mrs. Sylvie Griffiths
Dr. & Mrs. Donald S. Gromisch
Mr. & Dr. William Guidi
Dr. Susan Gunduz
Mr. & Mrs. I. Cyrus Gutman
Mr. & Mrs. Irving Haber
Mr. & Mrs. Hamilton Hadden, Jr.
Mr. & Mrs. Lawrence J. Hahn
Mr. & Mrs. Richard N. Hall
Dr. & Mrs. Seymour Halpern
Dr. Thomas M. Halton
Mr. & Mrs. John F. Harper
Dr. & Mrs. Alan Harris
Ms. Eleanor P. Harris
Dr. Matthew N. Harris
Mr. & Mrs. Gerald W. Hart
Dr. & Mrs. Chester Hartenstein
Mr. & Mrs. Rolf D. Hartmann
Mr. & Mrs. Harold W. Hawkey
Mr. & Mrs. Thomas M. Hearn
Mr. & Mrs. Kenneth J. Heim
Mr. Huy ler C. Held
Mr. Anthony S. Hendrick
Mr. & Mrs. Robert V. Henning
Dr. & Mrs. Alfred D. Hershey
Mr. & Mrs. Herman William Hertweck
Mr. Philip R. Herzig
Mrs. Charles L. Hewitt
Mrs. Fred L. Heyes
Mr. & Mrs. Charles A. Hickmann
Mr. Albert P. Hildebrandt
Mrs. Lucien Hill
Ms. Dorothy H. Hirshon
Mrs. William Hoest
Mr. & Mrs. John M. Hoey
Mrs. Albert L. Hoffman
Mr. & Mrs. William H. Hoffman
Hoffman & Borron
Mrs. Ernst Hofmann
Mrs. Frank Hohner
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